data_2klg_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2klg _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.1 mp0 . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.634 0.254 . . . . 0.0 111.05 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 17.4 tt -139.01 153.17 24.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.985 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -118.79 97.06 5.53 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.968 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.5 t -98.97 152.72 4.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.981 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.28 130.92 56.11 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.698 0.285 . . . . 0.0 111.014 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.6 p -100.03 175.53 5.73 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.45 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.415 ' CD2' ' CG2' ' A' ' 9' ' ' THR . 0.0 OUTLIER -66.86 -21.91 66.0 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 179.417 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.415 ' CG2' ' CD2' ' A' ' 8' ' ' LEU . 67.8 p -105.54 28.87 7.01 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.19 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 47.59 32.85 8.21 Favored Glycine 0 C--N 1.336 0.541 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.991 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.49 146.37 27.63 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.969 0.385 . . . . 0.0 111.023 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.0 t -103.22 110.32 22.25 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.804 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.0 pt -125.08 166.67 20.36 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.297 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.1 p -104.49 152.52 22.27 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.711 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 tp -137.99 140.29 40.11 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.668 0.271 . . . . 0.0 111.044 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -101.0 139.05 37.24 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.701 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.6 t -138.53 138.3 42.71 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 CA-C-O 120.78 0.324 . . . . 0.0 111.354 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.418 ' HB2' ' HD2' ' A' ' 19' ' ' PRO . 11.6 pt-20 -100.08 167.87 10.33 Favored Pre-proline 0 C--N 1.332 -0.156 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.55 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.418 ' HD2' ' HB2' ' A' ' 18' ' ' GLU . 52.7 Cg_exo -54.86 -58.88 0.99 Allowed 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.39 2.06 . . . . 0.0 112.164 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.5 t -90.58 38.51 0.95 Allowed 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -75.42 114.13 13.61 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-O 120.576 0.227 . . . . 0.0 111.067 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 31.1 p -85.18 158.43 20.37 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.639 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.5 tp -57.97 -32.83 44.56 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-N 116.718 -0.219 . . . . 0.0 111.277 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -77.89 -40.76 38.86 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.642 0.258 . . . . 0.0 110.858 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -62.94 -34.77 78.18 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.15 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 12.1 p -69.32 -15.68 19.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.47 -33.0 63.26 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.582 0.229 . . . . 0.0 111.104 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.19 -36.39 79.51 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.57 0.224 . . . . 0.0 111.045 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.3 mttp -64.04 -43.49 95.39 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.706 -0.225 . . . . 0.0 111.114 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.2 tt -64.82 -30.36 50.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 116.727 -0.215 . . . . 0.0 111.252 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -65.22 -20.81 66.61 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 120.44 0.162 . . . . 0.0 111.238 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -51.99 -24.76 7.05 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 112.181 0.438 . . . . 0.0 112.181 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.88 -73.49 0.22 Allowed 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.967 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -167.1 41.36 0.05 OUTLIER 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.419 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . 53.02 87.81 0.01 OUTLIER Glycine 0 C--N 1.335 0.504 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.443 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.423 ' CG2' ' HD2' ' A' ' 38' ' ' PRO . 4.2 mp -78.55 110.76 15.09 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-O 120.571 0.225 . . . . 0.0 111.02 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.436 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 36.3 Cg_exo -59.86 -47.05 16.86 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.614 2.21 . . . . 0.0 113.085 -179.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.436 ' HD2' ' N ' ' A' ' 37' ' ' PRO . 77.3 Cg_exo -41.12 96.24 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.669 2.246 . . . . 0.0 112.924 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -68.22 -20.29 64.82 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.449 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -99.98 34.39 2.32 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 111.552 0.205 . . . . 0.0 111.552 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 3.7 tp60 -93.2 115.32 27.94 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-O 120.526 0.203 . . . . 0.0 110.485 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 11.1 ptt-85 -143.98 178.92 7.52 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.653 0.263 . . . . 0.0 111.199 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -97.85 152.67 18.95 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.918 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.2 tt -104.59 77.06 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 CA-C-O 120.848 0.356 . . . . 0.0 111.038 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -150.81 116.96 5.61 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.119 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.6 32.15 21.84 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.538 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 46.5 68.16 1.18 Allowed Glycine 0 C--N 1.337 0.595 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.993 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.421 ' HG3' ' CD2' ' A' ' 59' ' ' TYR . 0.3 OUTLIER -110.0 127.53 54.86 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 116.761 0.281 . . . . 0.0 111.039 179.953 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -89.19 126.51 35.51 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.854 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -79.14 -24.51 43.28 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.454 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.452 ' O ' ' O ' ' A' ' 52' ' ' ASP . 4.1 tt0 -78.89 -36.15 42.5 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 121.279 -0.168 . . . . 0.0 111.395 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.452 ' O ' ' O ' ' A' ' 51' ' ' GLU . 0.2 OUTLIER -49.11 -171.62 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 121.57 0.7 . . . . 0.0 111.517 179.952 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -118.9 40.63 2.21 Favored Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 115.329 -0.851 . . . . 0.0 112.18 179.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -97.7 155.23 17.1 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-O 120.66 0.266 . . . . 0.0 111.003 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.8 t -99.14 156.59 16.87 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.939 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.7 mp -62.37 -36.52 82.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.281 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.5 t -58.75 -42.13 88.13 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -179.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -57.28 -25.25 58.92 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -179.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.421 ' CD2' ' HG3' ' A' ' 48' ' ' LYS . 0.5 OUTLIER -97.65 12.8 32.39 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 111.736 0.273 . . . . 0.0 111.736 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.5 m120 54.81 28.68 10.66 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.401 ' O ' ' CG2' ' A' ' 61' ' ' ILE . 0.0 OUTLIER -89.5 96.32 6.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.173 0 CA-C-O 120.877 0.37 . . . . 0.0 110.746 179.668 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.05 172.72 7.96 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.762 0.315 . . . . 0.0 111.024 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.14 155.14 1.01 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.218 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 63.78 22.01 12.9 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.459 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -75.74 177.48 6.84 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-O 120.752 0.31 . . . . 0.0 110.8 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.5 m -107.06 80.98 1.48 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.561 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -98.85 110.47 23.07 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.109 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -107.08 125.13 50.64 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.66 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 9.5 mp -93.98 174.65 7.05 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.658 0.266 . . . . 0.0 110.917 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 30.2 t -103.83 141.29 19.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.036 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.1 mt . . . . . 0 C--N 1.333 -0.118 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.816 -179.94 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.0 mt-30 . . . . . 0 CA--C 1.527 0.088 0 CA-C-O 120.688 0.28 . . . . 0.0 110.691 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 27.3 pt -138.93 173.44 11.85 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.144 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -118.91 100.31 7.29 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.677 0.275 . . . . 0.0 110.896 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.6 t -105.07 149.74 8.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.109 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.417 ' HE3' ' CE1' ' A' ' 68' ' ' HIS . 0.1 OUTLIER -106.96 125.82 51.5 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.86 -179.966 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.3 p -99.21 -166.33 1.34 Allowed 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.45 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.72 -44.06 82.62 Favored 'General case' 0 C--O 1.231 0.115 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -178.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.1 m -111.06 51.62 0.77 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.81 0.338 . . . . 0.0 111.319 -179.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 44.18 40.8 6.03 Favored Glycine 0 C--N 1.335 0.487 0 C-N-CA 121.183 -0.532 . . . . 0.0 113.344 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.6 tttt -84.22 134.9 34.53 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.827 0.314 . . . . 0.0 110.834 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.3 t -99.34 110.1 22.65 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.728 0.299 . . . . 0.0 110.907 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.1 pt -125.09 166.79 20.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.214 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.4 t -101.33 148.78 24.73 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.654 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -137.94 108.9 6.72 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.708 0.289 . . . . 0.0 111.055 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -101.01 138.12 38.48 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.707 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.6 t -140.06 149.0 22.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.745 0.307 . . . . 0.0 111.386 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.412 ' HB2' ' HD2' ' A' ' 19' ' ' PRO . 6.7 pt-20 -96.96 157.46 35.01 Favored Pre-proline 0 C--N 1.332 -0.164 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.7 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.412 ' HD2' ' HB2' ' A' ' 18' ' ' GLU . 10.7 Cg_endo -54.07 -36.03 83.51 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.852 2.368 . . . . 0.0 113.135 -179.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.9 0.47 56.57 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.46 128.09 34.55 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.648 0.261 . . . . 0.0 111.032 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.8 p -85.16 159.96 20.02 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.529 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.4 tt -57.98 -36.38 56.03 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.469 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -71.37 -32.3 68.33 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.751 -0.204 . . . . 0.0 111.288 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -62.88 -43.6 98.35 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.547 0.213 . . . . 0.0 111.164 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.9 p -63.82 -28.6 45.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-N 116.738 -0.21 . . . . 0.0 111.32 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.9 mmpt? -59.61 -30.4 68.66 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-O 120.527 0.204 . . . . 0.0 111.235 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.83 -52.93 63.46 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.546 0.212 . . . . 0.0 111.193 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 18.8 ptmt -63.91 -34.61 78.36 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.692 -0.231 . . . . 0.0 111.014 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 57.8 mt -75.22 -14.51 15.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 116.816 -0.175 . . . . 0.0 111.403 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -65.48 -13.24 58.38 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -50.36 -29.91 11.05 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.3 ptpp? -79.72 -21.91 43.97 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 121.036 -0.265 . . . . 0.0 111.432 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 74.47 40.77 0.39 Allowed 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.657 0.265 . . . . 0.0 110.794 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -142.78 30.78 2.04 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.426 -0.892 . . . . 0.0 113.053 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.535 ' HB ' ' CD ' ' A' ' 37' ' ' PRO . 29.3 mm -78.68 -61.3 0.54 Allowed Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 117.107 0.453 . . . . 0.0 111.681 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.535 ' CD ' ' HB ' ' A' ' 36' ' ' ILE . 5.1 Cg_exo -42.13 -51.19 4.9 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.73 2.287 . . . . 0.0 112.887 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.445 ' HD2' ' N ' ' A' ' 37' ' ' PRO . 57.9 Cg_exo -37.39 140.7 0.22 Allowed 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.985 2.456 . . . . 0.0 113.379 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -69.02 -6.3 27.13 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.6 mm-40 -89.89 -28.48 19.19 Favored 'General case' 0 CA--C 1.53 0.211 0 O-C-N 122.115 -0.365 . . . . 0.0 111.567 -179.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 5.2 tp60 -82.87 71.56 9.97 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-O 120.788 0.327 . . . . 0.0 110.787 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 -133.94 -179.08 5.32 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.814 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -103.78 133.88 48.02 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.942 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.7 tt -101.09 61.86 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.025 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -150.87 120.03 6.76 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.077 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 59.61 27.03 16.15 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.616 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 45.28 40.5 7.83 Favored Glycine 0 C--N 1.336 0.576 0 C-N-CA 120.78 -0.724 . . . . 0.0 113.07 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.43 ' HD3' ' CE1' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -103.85 125.94 50.63 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.86 0.33 . . . . 0.0 111.022 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -89.13 144.21 26.29 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.866 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.1 mp -79.53 -5.56 55.14 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.37 -0.377 . . . . 0.0 112.006 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.445 ' O ' ' O ' ' A' ' 52' ' ' ASP . 5.1 mm-40 -78.69 -34.2 46.3 Favored 'General case' 0 CA--C 1.53 0.205 0 O-C-N 122.37 -0.206 . . . . 0.0 111.431 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.445 ' O ' ' O ' ' A' ' 51' ' ' GLU . 0.9 OUTLIER -48.94 -172.54 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 121.485 0.659 . . . . 0.0 111.51 179.872 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -117.0 41.7 2.04 Favored Glycine 0 N--CA 1.451 -0.361 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.257 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -104.44 162.03 13.58 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.664 0.268 . . . . 0.0 111.037 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.8 t -99.14 148.12 24.4 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.821 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.4 mp -51.85 -47.95 64.19 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.186 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.5 t -52.87 -29.09 26.19 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.728 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -53.65 -40.3 65.75 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.43 0.157 . . . . 0.0 111.357 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.43 ' CE1' ' HD3' ' A' ' 48' ' ' LYS . 36.9 m-85 -103.29 25.27 9.75 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 111.595 0.221 . . . . 0.0 111.595 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 56.27 24.02 7.76 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -90.01 62.69 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-O 120.815 0.341 . . . . 0.0 110.777 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -94.86 -172.16 2.64 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.917 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.439 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 18.4 tttp -40.52 142.35 0.43 Allowed 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.706 0.289 . . . . 0.0 111.55 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.439 ' HG3' ' O ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER 65.07 21.25 12.21 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.642 -179.838 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.4 p -75.59 175.61 8.41 Favored 'General case' 0 CA--C 1.527 0.08 0 CA-C-O 120.63 0.252 . . . . 0.0 110.835 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.0 m -102.59 86.19 2.73 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.682 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.5 mt -99.01 105.48 17.63 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.065 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.417 ' CE1' ' HE3' ' A' ' 6' ' ' LYS . 3.6 t60 -107.09 121.11 43.85 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.785 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -96.69 169.77 9.65 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.748 0.309 . . . . 0.0 110.931 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.3 t -103.99 153.24 6.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.031 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.5 mp . . . . . 0 C--N 1.332 -0.155 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.844 179.993 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 . . . . . 0 CA--C 1.531 0.248 0 N-CA-C 111.62 0.23 . . . . 0.0 111.62 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.2 pt -138.53 174.58 9.96 Favored 'Isoleucine or valine' 0 C--O 1.231 0.092 0 CA-C-O 120.623 0.249 . . . . 0.0 111.159 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -118.9 106.55 12.6 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.732 0.301 . . . . 0.0 110.891 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.4 t -99.17 150.16 5.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.079 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.95 127.46 53.46 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.794 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.1 p -99.21 -168.29 1.6 Allowed 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.356 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.79 -40.45 88.13 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 120.663 0.268 . . . . 0.0 111.355 -178.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -111.17 41.46 1.84 Allowed 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 120.721 0.296 . . . . 0.0 111.086 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 47.28 42.53 17.93 Favored Glycine 0 C--N 1.335 0.504 0 C-N-CA 120.861 -0.685 . . . . 0.0 113.066 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.9 mtpm? -84.22 163.04 19.95 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.749 0.274 . . . . 0.0 110.926 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.4 m -103.07 118.06 35.95 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.895 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.4 pp -125.17 158.16 33.41 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-O 120.697 0.284 . . . . 0.0 111.182 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.8 p -101.19 128.49 47.27 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.86 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.3 144.61 50.71 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.922 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -100.44 162.39 12.97 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.841 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.9 t -129.99 103.88 9.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.106 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.416 ' HB2' ' HD2' ' A' ' 19' ' ' PRO . 10.4 pt-20 -103.72 157.3 34.19 Favored Pre-proline 0 C--N 1.332 -0.172 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.66 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.416 ' HD2' ' HB2' ' A' ' 18' ' ' GLU . 8.0 Cg_endo -50.13 -57.15 2.48 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.621 2.214 . . . . 0.0 112.187 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 44.9 t -90.3 36.41 0.88 Allowed 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -75.26 107.37 7.32 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-O 120.695 0.284 . . . . 0.0 110.93 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.4 m -85.23 157.99 20.46 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.526 -0.307 . . . . 0.0 110.831 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.7 mt -65.78 -34.41 70.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.027 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -75.33 -33.35 61.12 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.725 -0.216 . . . . 0.0 111.151 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -62.79 -41.67 99.37 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.559 0.218 . . . . 0.0 111.059 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.9 m -63.86 -23.5 33.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.614 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -55.82 -36.45 67.49 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 120.494 0.188 . . . . 0.0 111.196 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.78 -45.35 86.13 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-O 120.639 0.257 . . . . 0.0 111.181 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 14.1 mttm -63.91 -42.39 97.44 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.781 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.409 ' CG2' ' CG2' ' A' ' 36' ' ' ILE . 33.2 mm -75.01 -27.48 20.02 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.446 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -65.15 -16.91 64.02 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -50.4 -32.67 18.27 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 111.601 0.223 . . . . 0.0 111.601 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.37 -30.58 23.52 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 121.125 -0.23 . . . . 0.0 111.07 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 65.31 26.22 12.12 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 120.61 0.243 . . . . 0.0 110.871 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -112.08 -48.25 0.67 Allowed Glycine 0 C--N 1.334 0.465 0 C-N-CA 120.453 -0.88 . . . . 0.0 112.952 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.623 ' N ' ' CD ' ' A' ' 37' ' ' PRO . 7.6 tt -84.21 -24.78 0.35 Allowed Pre-proline 0 CA--C 1.54 0.592 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -179.227 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.623 ' CD ' ' N ' ' A' ' 36' ' ' ILE . 78.3 Cg_exo -42.96 -41.7 9.05 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 122.309 2.006 . . . . 0.0 113.791 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.488 ' CD ' ' N ' ' A' ' 37' ' ' PRO . 66.8 Cg_exo -53.39 -147.78 0.0 OUTLIER 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.446 2.097 . . . . 0.0 112.668 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -68.09 -4.08 12.39 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -179.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -90.34 -4.08 57.32 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 121.97 -0.457 . . . . 0.0 111.856 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.21 89.63 6.51 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-O 120.582 0.229 . . . . 0.0 110.971 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -144.01 151.93 40.35 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.973 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.4 tp -107.97 142.38 38.19 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.847 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.2 tt -111.06 65.86 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-O 120.752 0.311 . . . . 0.0 111.097 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -150.89 127.74 10.99 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.194 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.447 ' CB ' ' CE1' ' A' ' 59' ' ' TYR . . . 59.86 31.41 20.74 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.636 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 45.21 39.3 6.91 Favored Glycine 0 C--N 1.337 0.584 0 C-N-CA 120.808 -0.71 . . . . 0.0 113.079 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.1 mttm -109.73 145.43 36.62 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.787 0.294 . . . . 0.0 110.954 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -89.07 174.4 7.9 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.866 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.21 -37.16 38.86 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.184 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -89.35 8.8 28.75 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -47.24 -41.03 17.79 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.646 0.26 . . . . 0.0 111.159 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.98 23.82 24.28 Favored Glycine 0 CA--C 1.522 0.504 0 C-N-CA 120.757 -0.735 . . . . 0.0 113.039 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.6 mmt180 -107.38 177.25 4.9 Favored 'General case' 0 C--N 1.334 -0.083 0 CA-C-N 117.132 0.466 . . . . 0.0 110.753 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 4.4 m -99.44 130.82 45.73 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.491 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.21 -32.45 23.93 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 120.601 0.239 . . . . 0.0 110.916 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.2 t -61.5 -27.25 68.46 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.625 -0.262 . . . . 0.0 111.607 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.404 ' OD1' ' N ' ' A' ' 59' ' ' TYR . 2.5 p30 -53.74 -30.21 43.13 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 120.859 -0.336 . . . . 0.0 111.492 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.447 ' CE1' ' CB ' ' A' ' 46' ' ' ALA . 3.4 t80 -107.8 37.09 2.53 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 120.569 0.223 . . . . 0.0 111.248 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 23.6 m120 54.77 32.91 18.47 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.649 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.455 HG21 HD13 ' A' ' 61' ' ' ILE . 22.1 mt -89.37 76.46 1.3 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-O 120.69 0.281 . . . . 0.0 110.849 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.03 -174.34 2.51 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.0 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.54 144.89 1.41 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.78 0.324 . . . . 0.0 111.255 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 63.37 21.23 12.69 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.617 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.5 m -75.85 162.15 28.38 Favored 'General case' 0 CA--C 1.527 0.092 0 CA-C-O 120.642 0.258 . . . . 0.0 110.808 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -107.03 83.01 1.76 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.552 179.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.9 pp -98.92 126.93 44.72 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.132 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -107.06 117.94 35.4 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.686 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.73 114.77 27.14 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.776 0.322 . . . . 0.0 110.817 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.4 p -111.83 152.61 13.67 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.016 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.331 -0.236 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.883 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 52.6 mm-40 . . . . . 0 CA--C 1.53 0.179 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.422 HD11 HG22 ' A' ' 3' ' ' ILE . 0.9 OUTLIER -138.68 169.0 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.129 0 CA-C-O 120.582 0.23 . . . . 0.0 111.11 -179.607 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -118.5 103.8 10.08 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.74 0.305 . . . . 0.0 111.013 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.8 t -129.5 154.34 40.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.773 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.2 mttt -106.76 152.89 23.23 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.65 0.262 . . . . 0.0 111.022 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -99.88 -143.47 0.33 Allowed 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.62 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.434 ' HG ' ' N ' ' A' ' 9' ' ' THR . 1.7 pt? -64.82 -41.6 95.64 Favored 'General case' 0 C--N 1.341 0.23 0 CA-C-N 118.791 0.723 . . . . 0.0 111.164 -179.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.434 ' N ' ' HG ' ' A' ' 8' ' ' LEU . 94.9 m -111.36 -64.91 1.22 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.774 0.321 . . . . 0.0 110.652 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 178.0 47.71 0.07 OUTLIER Glycine 0 CA--C 1.521 0.42 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.746 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.49 -179.65 7.2 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.729 0.3 . . . . 0.0 110.996 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.2 t -103.07 114.59 29.0 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.709 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 11.9 tt -123.65 136.26 60.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 120.704 0.288 . . . . 0.0 111.228 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.7 t -106.02 168.17 9.3 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.779 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.13 87.3 2.35 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-O 120.702 0.287 . . . . 0.0 110.896 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -101.03 93.88 5.72 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.801 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.5 m -131.47 174.53 12.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.208 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -97.05 164.3 18.15 Favored Pre-proline 0 C--N 1.332 -0.171 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.755 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -60.23 -38.44 75.99 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.64 2.227 . . . . 0.0 112.349 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.4 p -78.82 -24.35 44.56 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.389 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -64.86 118.89 9.69 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-O 120.641 0.257 . . . . 0.0 110.846 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.5 p -85.2 -175.43 5.72 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.826 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.9 mt -63.11 -40.55 89.45 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.027 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -52.09 -44.04 64.2 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.665 0.269 . . . . 0.0 111.075 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.07 -34.83 78.42 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.917 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.3 t -73.84 -12.93 15.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.405 ' HA ' ' CG2' ' A' ' 30' ' ' ILE . 2.5 mmpt? -55.48 -39.15 70.05 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 120.569 0.223 . . . . 0.0 111.073 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.88 -42.39 81.32 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-O 120.717 0.294 . . . . 0.0 111.248 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.8 mttm -74.54 -40.0 61.99 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.669 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.405 ' CG2' ' HA ' ' A' ' 27' ' ' LYS . 20.2 tt -74.35 -23.61 18.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -179.128 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.01 75.21 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 120.856 0.36 . . . . 0.0 110.959 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.404 ' N ' ' O ' ' A' ' 30' ' ' ILE . 36.6 t70 -60.26 -67.89 0.35 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.137 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.77 -86.36 0.14 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.965 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -178.37 43.42 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 121.119 -0.232 . . . . 0.0 111.371 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -151.2 31.2 0.96 Allowed Glycine 0 C--N 1.334 0.458 0 C-N-CA 120.432 -0.889 . . . . 0.0 113.04 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.538 ' HB ' ' CD ' ' A' ' 37' ' ' PRO . 1.8 mp -88.93 -65.53 0.17 Allowed Pre-proline 0 CA--C 1.535 0.375 0 CA-C-N 117.09 0.445 . . . . 0.0 111.411 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.538 ' CD ' ' HB ' ' A' ' 36' ' ' ILE . 3.6 Cg_exo -38.74 -51.08 2.38 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 122.779 2.319 . . . . 0.0 112.977 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_exo -41.33 163.65 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.711 2.274 . . . . 0.0 113.174 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -69.65 2.15 3.52 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -89.78 -21.71 22.5 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 118.17 0.441 . . . . 0.0 111.599 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.5 tp60 -93.11 109.98 21.47 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 120.996 -0.281 . . . . 0.0 110.785 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 3.7 ptp180 -142.36 160.83 39.5 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.015 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -108.03 160.42 15.8 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.824 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 25.1 mm -111.06 69.79 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.157 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -151.13 122.01 7.59 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.176 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 56.59 31.98 20.1 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.547 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 45.86 37.55 7.35 Favored Glycine 0 C--N 1.335 0.522 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.974 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.422 ' HD3' ' CE2' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -110.02 134.29 52.29 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.846 0.323 . . . . 0.0 111.054 -179.977 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -89.09 162.76 15.81 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.837 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -79.15 -13.17 59.89 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.612 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -78.97 -38.26 37.41 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 120.536 0.208 . . . . 0.0 111.141 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -47.98 118.12 2.21 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -68.21 54.18 0.43 Allowed Glycine 0 CA--C 1.521 0.443 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.666 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.07 173.85 6.15 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 117.002 0.401 . . . . 0.0 110.751 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 57.0 m -99.27 137.1 38.25 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.675 -0.239 . . . . 0.0 110.836 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 52.9 mt -52.26 -41.43 62.81 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.919 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.7 t -59.22 -29.38 67.47 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.432 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -53.68 -40.45 65.96 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 121.192 -0.203 . . . . 0.0 111.379 -179.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.422 ' CE2' ' HD3' ' A' ' 48' ' ' LYS . 62.2 m-85 -104.64 36.28 2.47 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-O 120.672 0.272 . . . . 0.0 111.374 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 55.47 25.63 8.0 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.464 HD11 HG21 ' A' ' 61' ' ' ILE . 38.1 mt -89.92 62.52 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.123 0 CA-C-O 120.812 0.339 . . . . 0.0 110.975 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.01 -174.81 2.67 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.033 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -44.47 144.1 1.14 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.823 0.344 . . . . 0.0 111.443 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 64.98 19.22 11.8 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.672 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 7.5 p -75.89 170.12 16.84 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-O 120.616 0.246 . . . . 0.0 110.873 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.8 t -107.12 83.69 1.86 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.437 179.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 13.0 mt -98.85 104.78 16.85 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.767 0.318 . . . . 0.0 111.325 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -107.19 100.88 10.31 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.627 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.5 mp -93.97 163.26 13.56 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.559 -0.292 . . . . 0.0 111.029 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.7 t -103.98 121.38 55.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.065 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.537 HD13 ' O ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.367 0 CA-C-O 121.36 0.6 . . . . 0.0 111.379 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 82.2 mm-40 . . . . . 0 CA--C 1.529 0.153 0 CA-C-O 120.573 0.225 . . . . 0.0 110.944 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.432 HG23 HD12 ' A' ' 3' ' ' ILE . 0.2 OUTLIER -146.21 -175.76 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.096 -179.993 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -118.66 99.22 6.65 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.775 0.322 . . . . 0.0 110.74 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.2 t -116.84 121.25 67.32 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.895 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 41.7 mttt -106.86 122.34 46.2 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.702 0.287 . . . . 0.0 110.845 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -99.75 -75.01 0.58 Allowed 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.64 -110.37 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 111.553 0.205 . . . . 0.0 111.553 -179.27 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.9 t -111.51 57.62 0.63 Allowed 'General case' 0 CA--C 1.529 0.155 0 O-C-N 122.175 -0.328 . . . . 0.0 111.038 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.95 37.01 5.83 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.632 -0.794 . . . . 0.0 113.23 179.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.1 tttm -84.39 142.09 30.38 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 117.077 0.438 . . . . 0.0 110.731 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.9 t -98.22 117.87 33.58 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.846 0.355 . . . . 0.0 110.924 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.3 pt -125.09 146.36 30.89 Favored 'Isoleucine or valine' 0 C--O 1.231 0.112 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.189 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.1 t -97.37 130.76 44.48 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.769 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -129.82 133.42 46.94 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.983 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -100.77 176.03 5.44 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.877 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.7 t -129.99 104.59 10.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.755 0.312 . . . . 0.0 111.16 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -107.09 161.57 22.5 Favored Pre-proline 0 C--O 1.232 0.148 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.811 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_exo -51.74 -56.76 2.66 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.398 2.066 . . . . 0.0 112.365 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 38.7 p -90.3 38.26 0.93 Allowed 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -75.28 84.96 2.45 Favored 'General case' 0 C--O 1.232 0.182 0 O-C-N 122.308 -0.245 . . . . 0.0 110.912 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.2 p -85.04 163.22 18.97 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.637 0.256 . . . . 0.0 110.807 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 34.5 mm -68.13 -42.89 85.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.001 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -54.1 -41.9 68.8 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.653 0.263 . . . . 0.0 110.986 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -68.71 -39.44 80.47 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.823 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 42.5 t -63.95 -44.64 97.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 CA-C-O 120.613 0.244 . . . . 0.0 110.906 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.6 mttm -59.39 -43.96 92.88 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.704 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.04 -37.11 73.75 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.126 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.9 tmtt? -66.9 -40.44 87.7 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.644 -0.253 . . . . 0.0 110.912 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 31.9 mm -69.8 -49.76 54.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.659 0.266 . . . . 0.0 110.895 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -65.08 -24.98 67.6 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.318 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -50.92 -32.25 20.15 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 111.605 0.224 . . . . 0.0 111.605 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.8 -27.81 26.58 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 121.218 -0.193 . . . . 0.0 111.296 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 67.87 31.67 5.61 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-O 120.66 0.267 . . . . 0.0 110.891 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -94.33 -42.27 4.03 Favored Glycine 0 C--N 1.334 0.437 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.377 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.419 ' CG1' ' HD2' ' A' ' 38' ' ' PRO . 19.9 tt -89.17 110.93 41.98 Favored Pre-proline 0 CA--C 1.531 0.223 0 CA-C-O 120.6 0.238 . . . . 0.0 111.062 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.468 ' HB2' ' HD3' ' A' ' 38' ' ' PRO . 33.4 Cg_exo -58.58 -48.52 14.84 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.365 2.043 . . . . 0.0 112.512 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.468 ' HD3' ' HB2' ' A' ' 37' ' ' PRO . 84.4 Cg_exo -44.46 94.25 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.556 2.171 . . . . 0.0 112.488 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -68.2 -31.78 71.54 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.256 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.6 mm-40 -101.01 42.88 1.09 Allowed 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.64 0.257 . . . . 0.0 111.166 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.87 131.81 35.18 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.655 0.264 . . . . 0.0 110.722 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -134.88 -178.18 4.96 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.957 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.87 126.53 43.29 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.766 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -101.06 88.8 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.841 0.353 . . . . 0.0 111.272 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.419 ' CE1' HG21 ' A' ' 66' ' ' THR . 9.5 t80 -150.87 131.92 14.32 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.17 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.6 29.63 19.15 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.656 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 45.53 40.95 8.88 Favored Glycine 0 C--N 1.336 0.555 0 C-N-CA 120.932 -0.652 . . . . 0.0 113.038 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.425 ' HG2' ' CE1' ' A' ' 59' ' ' TYR . 17.1 mttt -108.56 138.54 44.7 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.785 0.293 . . . . 0.0 110.953 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.1 tp-100 -89.11 120.54 30.6 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.974 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.7 mp -79.58 -6.1 56.36 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -78.75 -20.07 50.81 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 111.667 0.247 . . . . 0.0 111.667 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -46.44 -38.33 8.93 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.571 0.224 . . . . 0.0 111.34 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.97 43.04 2.5 Favored Glycine 0 CA--C 1.52 0.395 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.815 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.2 mmt85 -107.12 -176.54 3.1 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.797 0.298 . . . . 0.0 110.756 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 12.9 t -97.27 172.22 7.93 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.66 0.267 . . . . 0.0 110.975 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.36 -58.41 7.76 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.177 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.3 t -52.97 -29.37 28.65 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -53.7 -38.55 64.35 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 111.609 0.226 . . . . 0.0 111.609 -179.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.425 ' CE1' ' HG2' ' A' ' 48' ' ' LYS . 11.7 m-85 -101.55 20.51 15.94 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 62.93 16.91 9.6 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 23.6 pt -89.89 69.91 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 CA-C-O 120.797 0.332 . . . . 0.0 110.849 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -95.02 -174.01 3.12 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.179 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.65 147.61 0.87 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.789 0.328 . . . . 0.0 111.515 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 65.3 16.03 10.32 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.817 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.9 m -76.18 166.87 22.84 Favored 'General case' 0 CA--C 1.527 0.093 0 CA-C-O 120.738 0.304 . . . . 0.0 110.953 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.419 HG21 ' CE1' ' A' ' 45' ' ' PHE . 7.2 t -106.46 85.79 2.24 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.249 179.297 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.9 mp -98.93 114.36 26.94 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.456 -179.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -107.17 123.45 48.28 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.603 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -93.78 141.79 28.1 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.707 0.289 . . . . 0.0 111.045 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.2 p -114.08 152.75 15.71 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.093 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.332 -0.192 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.781 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 . . . . . 0 CA--C 1.535 0.378 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 10.9 pt -138.57 176.64 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.121 0 C-N-CA 120.907 -0.317 . . . . 0.0 111.509 -179.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -118.97 99.82 6.98 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.717 0.294 . . . . 0.0 110.863 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.5 t -107.15 142.03 20.91 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.116 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.052 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.18 141.24 48.4 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.937 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.7 -163.66 1.05 Allowed 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.083 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.404 ' CD2' ' CG2' ' A' ' 9' ' ' THR . 0.0 OUTLIER -68.34 -30.5 69.48 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-O 121.056 0.455 . . . . 0.0 110.117 -179.899 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.404 ' CG2' ' CD2' ' A' ' 8' ' ' LEU . 33.3 p -111.19 -69.46 0.87 Allowed 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.784 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 175.07 47.79 0.05 OUTLIER Glycine 0 C--N 1.333 0.384 0 C-N-CA 120.489 -0.862 . . . . 0.0 112.988 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.68 144.14 28.75 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.861 0.33 . . . . 0.0 110.937 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.2 t -103.06 117.78 35.34 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.574 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.6 pt -125.04 153.24 32.1 Favored 'Isoleucine or valine' 0 C--O 1.231 0.112 0 CA-C-O 120.687 0.28 . . . . 0.0 111.453 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.8 t -106.03 139.16 41.0 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.872 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.4 tp -129.93 144.44 51.32 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.712 0.291 . . . . 0.0 110.903 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.51 147.09 25.11 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.83 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.5 t -130.02 102.07 6.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.201 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -107.12 161.57 22.51 Favored Pre-proline 0 C--O 1.232 0.162 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.507 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -47.1 -53.33 6.48 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.507 2.138 . . . . 0.0 112.256 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.1 m -90.14 41.66 1.06 Allowed 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.801 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 46.1 p-10 -69.13 95.99 0.78 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.679 0.276 . . . . 0.0 110.806 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.03 137.82 32.82 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.951 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 7.5 mt -68.02 -39.72 81.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.193 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -67.32 -41.76 84.76 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.134 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -62.85 -38.39 90.63 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.212 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 12.2 p -73.52 -12.8 15.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 111.957 0.354 . . . . 0.0 111.957 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 12.8 ttmt -55.59 -48.74 74.37 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 120.691 0.282 . . . . 0.0 110.7 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.01 -29.18 68.12 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.14 179.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 24.7 mtpt -63.96 -33.76 76.45 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.753 -0.203 . . . . 0.0 110.953 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 33.8 mm -64.68 -42.73 95.87 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 CA-C-O 120.674 0.273 . . . . 0.0 110.495 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -65.16 -37.06 86.19 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 120.772 0.32 . . . . 0.0 110.68 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -61.49 -18.24 58.18 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.972 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 7.0 mtmm -74.04 -73.83 0.21 Allowed 'General case' 0 C--O 1.231 0.119 0 C-N-CA 121.044 -0.262 . . . . 0.0 111.086 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -137.59 23.7 2.91 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.446 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . 48.65 85.07 0.02 OUTLIER Glycine 0 C--N 1.337 0.636 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.387 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.1 pp -78.44 110.27 13.28 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 120.628 0.251 . . . . 0.0 111.292 -179.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.53 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 34.7 Cg_exo -60.46 -43.41 33.81 Favored 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 122.733 2.288 . . . . 0.0 113.583 -179.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.53 ' HD2' ' N ' ' A' ' 37' ' ' PRO . 55.4 Cg_endo -71.92 118.87 5.84 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.058 1.839 . . . . 0.0 112.943 -179.091 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.0 p-10 -68.66 -12.81 61.83 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.974 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -90.96 22.49 3.63 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -84.45 93.45 8.31 Favored 'General case' 0 CA--C 1.527 0.08 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 179.305 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.5 ttm180 -139.59 177.09 8.19 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.101 -179.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.432 ' N ' ' CD2' ' A' ' 43' ' ' LEU . 2.2 mm? -97.91 165.23 12.03 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.459 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.4 pt -111.02 83.79 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-O 120.696 0.284 . . . . 0.0 111.174 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -150.85 115.46 5.18 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.233 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.78 24.37 14.5 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.859 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 44.37 39.86 5.82 Favored Glycine 0 C--N 1.338 0.654 0 C-N-CA 120.837 -0.697 . . . . 0.0 113.083 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.422 ' HG2' ' CE2' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -100.98 135.49 42.34 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.814 0.307 . . . . 0.0 110.853 -179.82 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -78.96 165.97 22.88 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.828 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.7 pp -79.35 -18.21 52.93 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.74 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -78.91 -26.4 43.78 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 111.782 0.289 . . . . 0.0 111.782 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 38.7 p-10 -47.82 115.52 1.19 Allowed 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 120.807 0.337 . . . . 0.0 110.604 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -70.73 46.73 0.73 Allowed Glycine 0 CA--C 1.521 0.434 0 C-N-CA 120.504 -0.855 . . . . 0.0 112.564 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? -107.26 170.42 7.97 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 117.029 0.414 . . . . 0.0 110.799 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 36.2 m -99.18 137.73 37.29 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.664 -0.243 . . . . 0.0 110.741 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.2 mp -52.05 -42.94 63.52 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.892 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.3 t -57.22 -31.19 65.24 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.479 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -53.83 -34.96 60.86 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 121.194 -0.202 . . . . 0.0 111.404 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.422 ' CE2' ' HG2' ' A' ' 48' ' ' LYS . 39.9 m-85 -103.29 36.23 2.32 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 120.548 0.214 . . . . 0.0 111.396 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 58.14 23.4 10.13 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 26.9 mt -89.81 77.09 1.35 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.141 0 CA-C-O 120.636 0.255 . . . . 0.0 110.962 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -94.96 172.63 8.03 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.714 0.292 . . . . 0.0 111.123 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.08 148.9 3.07 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.212 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 63.3 22.69 13.44 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.444 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.1 m -75.64 177.45 6.8 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-O 120.706 0.288 . . . . 0.0 110.88 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.5 p -107.1 86.65 2.34 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.825 0.345 . . . . 0.0 110.639 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.5 mt -99.02 122.48 42.33 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.153 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 22.6 m-70 -107.09 140.58 39.7 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.813 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.94 -174.42 3.41 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.927 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.1 p -103.71 139.04 25.77 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-O 120.719 0.295 . . . . 0.0 111.046 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.332 -0.169 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.945 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 63.5 mm-40 . . . . . 0 CA--C 1.53 0.175 0 CA-C-O 120.6 0.238 . . . . 0.0 111.097 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.1 pt -138.73 175.57 7.92 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 CA-C-N 116.649 -0.25 . . . . 0.0 110.952 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -118.7 88.99 3.03 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.71 0.291 . . . . 0.0 110.874 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.5 t -108.89 128.35 64.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.179 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -107.51 153.64 22.54 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.752 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.99 -146.95 0.41 Allowed 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 119.488 -0.291 . . . . 0.0 110.616 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.18 -34.24 77.9 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 118.806 0.73 . . . . 0.0 111.542 -179.104 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 73.2 p -111.05 -56.53 2.36 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 120.629 0.252 . . . . 0.0 111.047 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 156.58 57.62 0.01 OUTLIER Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.823 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.2 mmmp? -84.13 154.09 23.33 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.708 0.254 . . . . 0.0 110.886 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.0 t -102.93 114.33 28.53 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.813 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.2 pt -118.25 147.3 21.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.141 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.8 p -105.91 114.5 28.68 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.903 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.28 138.86 51.87 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.876 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -95.18 161.87 13.93 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.911 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.6 t -129.93 117.02 39.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.769 0.318 . . . . 0.0 111.231 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -100.58 164.12 16.83 Favored Pre-proline 0 C--O 1.231 0.101 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.711 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -53.19 -66.36 0.11 Allowed 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.625 2.217 . . . . 0.0 112.38 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.5 m -90.35 35.9 0.87 Allowed 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 112.054 0.391 . . . . 0.0 112.054 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -75.41 113.21 12.55 Favored 'General case' 0 C--O 1.231 0.132 0 CA-C-O 120.647 0.261 . . . . 0.0 110.925 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 10.2 t -85.16 173.8 10.15 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.856 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 51.7 mm -68.16 -40.48 82.94 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.015 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -53.9 -40.01 66.27 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.681 -0.236 . . . . 0.0 111.14 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -62.86 -54.7 34.74 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 120.663 0.268 . . . . 0.0 110.906 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.4 p -63.96 -36.93 78.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.262 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 13.6 tttt -55.87 -41.06 73.83 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.719 -0.219 . . . . 0.0 110.935 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.88 -38.1 75.16 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.147 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.82 -43.31 96.62 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-N 116.67 -0.241 . . . . 0.0 110.806 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.0 mt -66.49 -49.1 77.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.865 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 1.4 tp-100 -59.79 -42.24 92.93 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.818 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -61.01 -25.79 67.15 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.279 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -74.86 -61.68 1.8 Allowed 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 121.173 -0.211 . . . . 0.0 111.095 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -103.17 -46.44 4.62 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.578 0.228 . . . . 0.0 111.089 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.431 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . 85.05 42.97 6.87 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.976 -179.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.431 ' CG1' ' HD2' ' A' ' 38' ' ' PRO . 20.2 tt -78.77 110.55 14.65 Favored Pre-proline 0 CA--C 1.532 0.271 0 CA-C-O 120.713 0.292 . . . . 0.0 111.36 -179.565 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.481 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 31.7 Cg_exo -59.77 -45.72 23.64 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.764 2.309 . . . . 0.0 113.339 -179.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.481 ' HD2' ' N ' ' A' ' 37' ' ' PRO . 46.8 Cg_exo -37.84 122.52 0.51 Allowed 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.988 2.459 . . . . 0.0 113.425 -179.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -69.42 -3.89 16.21 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -90.25 11.21 21.86 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -179.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -88.61 82.54 6.87 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-O 120.693 0.283 . . . . 0.0 110.416 179.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 33.7 mtt180 -136.63 -175.16 3.92 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.976 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.3 mt -97.97 153.97 18.0 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.846 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 17.2 tt -111.04 71.17 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.803 0.335 . . . . 0.0 111.023 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -150.91 132.06 14.41 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.239 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 56.51 28.59 14.03 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.79 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 45.08 40.23 7.11 Favored Glycine 0 C--N 1.337 0.595 0 C-N-CA 120.797 -0.716 . . . . 0.0 113.0 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.02 127.84 46.19 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.837 0.318 . . . . 0.0 110.922 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -89.06 150.66 22.66 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.014 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.9 tp -79.18 -20.94 47.17 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.435 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -78.7 -35.45 44.96 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 120.436 0.16 . . . . 0.0 111.377 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -47.88 115.14 1.07 Allowed 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 110.338 -0.245 . . . . 0.0 110.338 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -69.85 48.49 0.64 Allowed Glycine 0 CA--C 1.522 0.475 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.746 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.0 mtp85 -107.25 -176.69 3.14 Favored 'General case' 0 C--O 1.23 0.07 0 CA-C-N 117.062 0.431 . . . . 0.0 110.646 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.9 m -99.37 134.77 41.76 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.555 0.216 . . . . 0.0 110.488 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.41 ' HB2' ' CG2' ' A' ' 61' ' ' ILE . 0.7 OUTLIER -51.59 -38.45 54.58 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.566 0.222 . . . . 0.0 110.689 179.915 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.6 t -56.23 -28.32 58.02 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.339 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -53.7 -35.04 60.68 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 111.572 0.212 . . . . 0.0 111.572 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -100.32 18.22 19.42 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 64.87 16.16 10.32 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.41 ' CG2' ' HB2' ' A' ' 56' ' ' LEU . 0.6 OUTLIER -89.92 71.23 0.76 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-O 120.878 0.37 . . . . 0.0 110.81 179.488 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -94.77 -178.03 4.39 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.441 -179.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.5 ptpt -47.37 146.1 2.15 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.581 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 65.53 12.62 8.32 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.356 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 41.2 t -76.28 -179.9 5.37 Favored 'General case' 0 C--O 1.231 0.08 0 O-C-N 122.259 -0.276 . . . . 0.0 110.79 179.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -107.12 80.6 1.44 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.342 179.325 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.2 pp -98.89 119.74 38.17 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-O 120.789 0.328 . . . . 0.0 111.319 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 8.8 m170 -107.15 137.0 46.03 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.592 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.7 tp -93.93 171.47 8.84 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.654 0.264 . . . . 0.0 110.846 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.6 t -103.81 129.54 55.75 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.161 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.7 pp . . . . . 0 C--N 1.333 -0.141 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.87 -179.966 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.678 0.275 . . . . 0.0 110.809 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.8 tp -138.69 152.91 25.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.941 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.49 80.77 1.58 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.777 0.322 . . . . 0.0 110.866 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.402 ' CG2' ' CD1' ' A' ' 69' ' ' LEU . 10.6 p -134.48 132.44 54.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.84 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.1 mptt -106.97 172.41 6.84 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.778 0.323 . . . . 0.0 111.071 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.4 p -99.91 -175.68 3.03 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.576 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -67.02 -4.04 8.74 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.4 p -99.78 -44.14 6.19 Favored 'General case' 0 CA--C 1.529 0.167 0 O-C-N 122.258 -0.276 . . . . 0.0 111.366 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 141.71 -26.22 2.39 Favored Glycine 0 CA--C 1.521 0.461 0 C-N-CA 120.264 -0.97 . . . . 0.0 113.486 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.8 tmtm? -73.49 143.28 46.66 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 117.416 0.608 . . . . 0.0 110.86 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.9 t -96.24 149.11 22.03 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.154 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.456 HG21 HD13 ' A' ' 13' ' ' ILE . 11.7 tt -125.03 152.24 31.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.076 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.7 m -96.01 135.1 38.22 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.632 -0.258 . . . . 0.0 110.739 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -138.05 142.62 40.31 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.731 0.3 . . . . 0.0 111.127 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -101.13 146.57 27.3 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.732 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.6 t -140.06 138.58 37.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.721 0.296 . . . . 0.0 111.306 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -107.14 162.88 18.27 Favored Pre-proline 0 C--N 1.334 -0.098 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.514 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -48.26 -54.13 5.72 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.395 2.063 . . . . 0.0 112.208 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 98.1 p -90.4 42.16 1.09 Allowed 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.77 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -72.72 98.12 2.32 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 120.669 0.271 . . . . 0.0 110.989 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.4 p -85.14 136.31 33.6 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.708 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.422 HD12 HG23 ' A' ' 23' ' ' ILE . 59.4 mt -68.1 74.01 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.708 0.289 . . . . 0.0 110.916 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -158.36 -59.38 0.08 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.012 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -72.5 -33.85 67.23 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.045 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 39.6 t -63.77 -24.77 36.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 116.794 -0.184 . . . . 0.0 111.471 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -55.6 -41.71 73.81 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.701 0.286 . . . . 0.0 111.004 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.78 -39.92 90.64 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.201 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 76.6 mttt -63.97 -42.69 97.17 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.935 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 3.8 mt -70.71 -25.25 26.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.457 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -54.8 -28.95 52.97 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 120.514 0.197 . . . . 0.0 111.239 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -54.31 -24.47 19.25 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -74.33 -64.28 1.06 Allowed 'General case' 0 N--CA 1.461 0.111 0 C-N-CA 121.074 -0.25 . . . . 0.0 110.888 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -177.43 50.57 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 120.921 0.391 . . . . 0.0 111.549 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.412 ' O ' ' HG2' ' A' ' 38' ' ' PRO . . . 73.94 91.61 0.14 Allowed Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.556 -0.83 . . . . 0.0 112.796 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.629 ' N ' ' CD ' ' A' ' 37' ' ' PRO . 7.8 tp -81.03 -27.03 0.44 Allowed Pre-proline 0 CA--C 1.54 0.592 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.629 ' CD ' ' N ' ' A' ' 36' ' ' ILE . 72.2 Cg_exo -43.02 -48.68 7.55 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 122.371 2.047 . . . . 0.0 113.997 -179.447 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.628 ' HD2' ' N ' ' A' ' 37' ' ' PRO . 3.9 Cg_exo -35.56 136.15 0.19 Allowed 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.195 2.597 . . . . 0.0 113.213 -179.253 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -69.35 -0.44 6.33 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 12.1 mm100 -89.9 -13.98 35.19 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.219 0.463 . . . . 0.0 111.626 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -93.01 88.44 6.13 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-O 120.699 0.285 . . . . 0.0 110.641 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.2 ttp-105 -136.7 156.33 48.67 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.042 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.4 pp -99.64 153.07 19.36 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.806 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.3 tt -110.75 75.43 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.142 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.401 ' CE1' ' O ' ' A' ' 66' ' ' THR . 0.6 OUTLIER -150.92 118.16 5.98 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.272 179.975 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.41 33.95 23.99 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.547 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 46.2 46.51 15.82 Favored Glycine 0 C--N 1.336 0.548 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.997 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.05 104.26 15.83 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.743 0.272 . . . . 0.0 110.906 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -89.15 152.86 21.38 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.038 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -79.6 -4.38 51.33 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -78.65 -50.28 11.73 Favored 'General case' 0 N--CA 1.462 0.127 0 C-N-CA 121.024 -0.27 . . . . 0.0 111.183 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -47.98 113.21 0.68 Allowed 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -70.31 46.54 0.65 Allowed Glycine 0 CA--C 1.521 0.432 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.624 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.22 -176.68 3.14 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 117.117 0.459 . . . . 0.0 110.881 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.5 m -99.16 141.77 31.5 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.716 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 34.9 mt -53.14 -42.55 66.18 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.902 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.5 t -54.74 -31.49 58.49 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.565 -0.288 . . . . 0.0 111.455 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -53.72 -33.73 56.51 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 111.49 0.182 . . . . 0.0 111.49 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -102.36 40.72 1.31 Allowed 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 120.602 0.239 . . . . 0.0 111.282 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 54.77 28.87 10.86 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 111.721 0.267 . . . . 0.0 111.721 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.2 mt -89.43 86.82 2.65 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 CA-C-O 120.667 0.27 . . . . 0.0 111.053 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -97.98 166.7 11.32 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.727 0.299 . . . . 0.0 111.08 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.6 ptmt -50.12 159.8 0.41 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.137 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 55.23 32.9 19.48 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.213 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.2 m -75.48 153.41 37.57 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-O 120.697 0.284 . . . . 0.0 110.914 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.401 ' O ' ' CE1' ' A' ' 45' ' ' PHE . 1.5 p -106.12 71.56 0.89 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.733 0.301 . . . . 0.0 110.654 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.7 pp -101.82 146.15 28.2 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.024 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -107.1 150.56 26.43 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.838 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.402 ' CD1' ' CG2' ' A' ' 5' ' ' VAL . 0.3 OUTLIER -103.97 159.25 15.82 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.875 -179.938 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.3 t -103.86 153.52 6.05 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.995 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.332 -0.188 0 CA-C-N 116.603 -0.271 . . . . 0.0 110.975 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 90.0 mm-40 . . . . . 0 CA--C 1.529 0.16 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.502 HD11 HG22 ' A' ' 3' ' ' ILE . 28.4 pt -139.06 166.03 22.75 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.101 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.913 -179.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -126.03 104.7 8.41 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.636 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 18.4 t -96.35 156.2 3.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.104 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.48 150.26 26.26 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.73 0.3 . . . . 0.0 110.869 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 34.6 p -99.93 -157.7 0.62 Allowed 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.996 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.442 ' HG ' HG23 ' A' ' 9' ' ' THR . 1.4 pt? -67.08 -33.22 75.02 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 120.894 0.378 . . . . 0.0 110.093 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.442 HG23 ' HG ' ' A' ' 8' ' ' LEU . 0.5 OUTLIER -111.57 -76.81 0.59 Allowed 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.29 178.953 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -174.56 46.57 0.14 Allowed Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.218 -0.992 . . . . 0.0 113.233 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.5 ttmt -84.35 143.03 29.75 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.837 0.319 . . . . 0.0 110.573 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.2 t -92.86 114.17 26.66 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.874 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 24.7 pt -114.92 143.27 25.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.703 0.287 . . . . 0.0 111.119 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.4 p -105.38 118.72 37.27 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.788 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -138.45 159.44 42.06 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.677 0.275 . . . . 0.0 111.233 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -101.14 -175.63 2.92 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.722 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.6 t -136.49 100.61 2.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-O 120.648 0.261 . . . . 0.0 111.223 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -107.09 154.31 40.47 Favored Pre-proline 0 C--O 1.232 0.157 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.981 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -62.61 -22.62 74.16 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.77 2.313 . . . . 0.0 113.165 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 51.6 p -78.8 -35.42 44.32 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 121.264 -0.175 . . . . 0.0 111.385 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -73.5 96.71 2.45 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.606 0.241 . . . . 0.0 111.023 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 10.0 p -85.1 -177.37 6.52 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.912 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 25.6 mm -68.19 -31.17 50.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.653 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.9 tm-20 -70.31 -47.88 59.13 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.583 0.23 . . . . 0.0 111.251 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -74.99 40.8 0.15 Allowed 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -179.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.1 m -74.32 -31.49 28.78 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 O-C-N 122.176 -0.328 . . . . 0.0 111.26 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.74 -33.09 71.19 Favored 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 121.278 -0.169 . . . . 0.0 111.181 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.69 -56.54 20.55 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.619 0.247 . . . . 0.0 111.165 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.0 pttm -63.95 -37.34 87.04 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.677 -0.238 . . . . 0.0 110.996 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 21.7 mt -74.42 -15.97 16.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 116.751 -0.204 . . . . 0.0 111.369 179.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -65.53 -10.79 37.93 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -50.05 -33.12 17.27 Favored 'General case' 0 N--CA 1.464 0.244 0 O-C-N 122.22 -0.3 . . . . 0.0 111.66 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.38 -28.41 25.19 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 121.067 -0.253 . . . . 0.0 110.791 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 61.32 25.92 15.82 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.745 -0.207 . . . . 0.0 111.091 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.501 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . -150.52 33.84 0.99 Allowed Glycine 0 C--N 1.335 0.51 0 C-N-CA 120.041 -1.076 . . . . 0.0 113.262 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 9.3 tp -90.06 106.47 14.72 Favored Pre-proline 0 CA--C 1.531 0.217 0 CA-C-N 117.092 0.446 . . . . 0.0 111.263 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.501 ' HD3' ' O ' ' A' ' 35' ' ' GLY . 23.3 Cg_exo -62.03 -50.01 5.67 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.209 1.939 . . . . 0.0 112.634 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.467 ' CD ' ' HD2' ' A' ' 37' ' ' PRO . 50.1 Cg_exo -55.97 89.88 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.307 2.005 . . . . 0.0 112.551 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -68.17 -37.0 80.51 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.027 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -101.62 45.19 0.98 Allowed 'General case' 0 CA--C 1.528 0.118 0 CA-C-O 120.784 0.326 . . . . 0.0 110.872 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -82.56 136.43 34.84 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.898 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.5 mtt180 -142.1 175.64 9.58 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.964 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -108.03 149.09 28.85 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.687 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.6 mt -100.92 79.43 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.692 0.282 . . . . 0.0 111.197 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -150.91 129.85 12.51 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.099 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 59.99 26.06 15.32 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.65 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 45.29 40.83 8.05 Favored Glycine 0 C--N 1.336 0.569 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.973 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.415 ' HD2' ' CZ ' ' A' ' 59' ' ' TYR . 0.4 OUTLIER -107.42 130.52 54.81 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.796 0.298 . . . . 0.0 111.054 -179.848 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.09 177.92 6.51 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.803 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 12.9 mt -68.96 -22.42 64.11 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.596 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -89.8 28.26 1.38 Allowed 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -47.81 -50.75 25.01 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.665 0.269 . . . . 0.0 111.07 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.44 -23.32 34.55 Favored Glycine 0 CA--C 1.521 0.411 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.976 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -107.13 -175.97 2.94 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.985 0.393 . . . . 0.0 110.837 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.9 m -96.92 151.69 19.44 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-O 120.738 0.304 . . . . 0.0 110.753 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.422 ' O ' HG21 ' A' ' 61' ' ' ILE . 9.5 mt -53.89 -44.01 70.12 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.099 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.7 t -52.89 -53.18 52.83 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.635 -179.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -64.61 -18.77 65.22 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -179.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.415 ' CZ ' ' HD2' ' A' ' 48' ' ' LYS . 0.4 OUTLIER -97.99 31.03 2.82 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -179.578 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.7 m120 66.09 -16.59 0.12 Allowed 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.422 HG21 ' O ' ' A' ' 56' ' ' LEU . 0.6 OUTLIER -89.29 62.69 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 118.471 0.578 . . . . 0.0 110.895 179.852 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -95.4 -167.41 1.61 Allowed 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.02 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -39.85 143.09 0.27 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.855 0.359 . . . . 0.0 111.891 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 65.49 15.79 10.2 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.151 -0.477 . . . . 0.0 112.022 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.1 p -76.19 175.28 9.15 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-O 120.68 0.276 . . . . 0.0 110.996 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -105.47 91.58 3.83 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.205 179.221 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -98.66 109.58 22.32 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.819 0.342 . . . . 0.0 111.41 -179.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -107.05 97.59 7.35 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.474 179.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -93.84 129.47 40.22 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.702 0.286 . . . . 0.0 111.06 -179.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.0 p -114.01 152.94 15.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.96 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.1 pp . . . . . 0 C--N 1.332 -0.17 0 CA-C-N 116.583 -0.281 . . . . 0.0 110.826 179.984 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.659 0.266 . . . . 0.0 110.951 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.8 pt -138.86 174.0 10.77 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.082 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -118.9 105.35 11.4 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.725 0.298 . . . . 0.0 110.869 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.0 p -137.54 132.08 44.69 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.886 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.3 mppt? -106.94 163.09 13.26 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.853 0.358 . . . . 0.0 111.171 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.51 -153.64 0.45 Allowed 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.027 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.85 -21.89 65.16 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-O 120.86 0.362 . . . . 0.0 110.056 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -111.69 -70.58 0.8 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.32 179.378 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 164.89 49.86 0.02 OUTLIER Glycine 0 CA--C 1.52 0.379 0 C-N-CA 120.497 -0.859 . . . . 0.0 113.15 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -84.73 150.77 24.86 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.954 0.377 . . . . 0.0 110.982 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.7 t -96.67 115.94 28.28 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.349 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.0 tt -125.04 135.97 62.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-O 120.735 0.303 . . . . 0.0 111.629 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.6 t -106.19 132.28 52.44 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.48 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.1 mt -134.86 134.71 41.03 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.661 0.267 . . . . 0.0 111.247 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -94.99 155.87 16.55 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.404 179.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.8 t -140.13 136.62 37.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-O 120.957 0.408 . . . . 0.0 111.795 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.493 ' HB2' ' HD2' ' A' ' 19' ' ' PRO . 11.0 pt-20 -96.72 161.0 28.06 Favored Pre-proline 0 CA--C 1.53 0.19 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.324 179.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.493 ' HD2' ' HB2' ' A' ' 18' ' ' GLU . 1.2 Cg_endo -43.18 -66.64 0.15 Allowed 'Trans proline' 0 CA--C 1.532 0.415 0 C-N-CA 122.892 2.395 . . . . 0.0 112.96 -179.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.21 37.13 0.89 Allowed 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -75.7 119.65 20.01 Favored 'General case' 0 N--CA 1.462 0.145 0 O-C-N 122.276 -0.265 . . . . 0.0 111.226 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -85.25 146.58 27.0 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.509 179.279 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.3 tp -57.99 -32.46 43.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 116.769 -0.196 . . . . 0.0 111.376 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -76.19 -39.02 55.8 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 120.547 0.213 . . . . 0.0 111.0 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -63.09 -31.59 72.76 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.729 -0.214 . . . . 0.0 111.448 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.3 p -74.29 -6.4 8.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 16.4 mttt -55.47 -39.41 70.36 Favored 'General case' 0 N--CA 1.463 0.199 0 O-C-N 122.182 -0.324 . . . . 0.0 111.225 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.12 -41.75 81.27 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.561 0.219 . . . . 0.0 111.432 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.8 tttp -74.12 -42.75 59.55 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.695 -0.23 . . . . 0.0 111.243 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.431 ' O ' ' N ' ' A' ' 32' ' ' ASP . 18.8 tt -64.96 -20.69 28.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -63.43 74.65 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.741 0.305 . . . . 0.0 111.111 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.431 ' N ' ' O ' ' A' ' 30' ' ' ILE . 27.9 t70 -61.26 -69.53 0.23 Allowed 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.833 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.71 -85.9 0.14 Allowed 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 121.077 -0.249 . . . . 0.0 110.709 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -177.87 44.34 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -150.14 26.73 1.13 Allowed Glycine 0 CA--C 1.524 0.599 0 C-N-CA 120.182 -1.009 . . . . 0.0 113.539 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.45 ' HB ' ' HD3' ' A' ' 37' ' ' PRO . 32.5 mm -89.17 -46.45 0.42 Allowed Pre-proline 0 CA--C 1.533 0.306 0 CA-C-N 117.497 0.649 . . . . 0.0 112.15 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.472 ' N ' ' CD ' ' A' ' 38' ' ' PRO . 53.6 Cg_exo -52.9 -43.74 54.08 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.337 2.025 . . . . 0.0 113.168 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.472 ' CD ' ' N ' ' A' ' 37' ' ' PRO . 58.9 Cg_exo -39.93 161.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.748 2.299 . . . . 0.0 113.511 -179.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -69.56 0.39 5.42 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -90.06 8.48 32.45 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 118.094 0.407 . . . . 0.0 111.807 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -89.72 110.92 21.78 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 121.038 -0.265 . . . . 0.0 110.664 179.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.4 mtt180 -144.03 152.2 40.69 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.739 0.304 . . . . 0.0 111.237 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.5 mp -108.0 152.03 25.03 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.783 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.0 mm -111.0 61.79 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.157 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -153.66 118.36 4.98 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.754 0.311 . . . . 0.0 111.201 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.74 32.09 21.38 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.677 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 46.36 42.97 13.93 Favored Glycine 0 C--N 1.335 0.527 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.968 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.41 ' HD3' ' CZ ' ' A' ' 59' ' ' TYR . 2.5 tptp -101.36 137.29 39.89 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.643 0.259 . . . . 0.0 110.972 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -89.02 168.81 12.05 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.51 -0.313 . . . . 0.0 110.966 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.11 -38.03 37.19 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.471 -0.332 . . . . 0.0 111.354 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.64 17.55 6.35 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -47.33 -39.79 15.69 Favored 'General case' 0 N--CA 1.466 0.351 0 O-C-N 122.241 -0.287 . . . . 0.0 111.303 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.19 19.85 48.37 Favored Glycine 0 CA--C 1.522 0.487 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.942 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.7 mtt-85 -107.56 175.81 5.36 Favored 'General case' 0 N--CA 1.458 -0.075 0 CA-C-N 117.03 0.415 . . . . 0.0 110.836 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.2 m -99.34 133.17 44.04 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.731 0.301 . . . . 0.0 110.689 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.403 ' CB ' ' CD1' ' A' ' 61' ' ' ILE . 0.4 OUTLIER -51.8 -31.08 25.76 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.561 0.219 . . . . 0.0 111.113 179.974 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.6 t -62.95 -40.05 96.5 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -63.21 -29.37 70.72 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.41 ' CZ ' ' HD3' ' A' ' 48' ' ' LYS . 0.2 OUTLIER -97.66 8.99 43.68 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 111.641 0.237 . . . . 0.0 111.641 179.995 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 65.37 11.19 7.14 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.403 ' CD1' ' CB ' ' A' ' 56' ' ' LEU . 1.2 pt -90.11 63.09 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 CA-C-N 117.961 0.346 . . . . 0.0 110.676 179.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -95.1 -168.66 1.84 Allowed 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.093 -179.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -40.18 152.05 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.601 -179.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 62.14 24.49 14.58 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.363 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.9 p -75.56 145.52 41.17 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.702 0.287 . . . . 0.0 110.939 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.0 m -104.86 66.45 0.77 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.763 0.316 . . . . 0.0 110.577 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.67 144.49 31.65 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.165 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 16.1 m170 -106.97 141.1 38.72 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.749 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -103.81 163.38 12.38 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.667 0.27 . . . . 0.0 111.022 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 33.9 m -105.29 179.44 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.021 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.3 mp . . . . . 0 C--N 1.333 -0.135 0 CA-C-O 120.769 0.319 . . . . 0.0 110.682 179.99 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 . . . . . 0 CA--C 1.529 0.137 0 CA-C-O 120.696 0.284 . . . . 0.0 110.908 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 18.0 tt -138.73 156.27 28.65 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.939 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -118.44 91.83 3.66 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-O 120.739 0.304 . . . . 0.0 110.913 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.5 t -93.35 159.69 2.76 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.747 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.0 ttmt -106.66 135.56 47.97 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.828 0.347 . . . . 0.0 111.044 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.7 p -100.51 -162.19 0.92 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.25 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.14 -38.64 83.69 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 120.649 -0.42 . . . . 0.0 111.199 -179.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.24 -62.08 1.6 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.65 0.262 . . . . 0.0 110.792 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 168.06 50.04 0.03 OUTLIER Glycine 0 CA--C 1.521 0.421 0 C-N-CA 120.512 -0.851 . . . . 0.0 113.125 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.67 157.12 21.21 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 116.858 0.329 . . . . 0.0 110.768 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.1 t -103.01 108.41 19.57 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.715 0.293 . . . . 0.0 110.8 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.8 pt -125.07 168.88 17.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.245 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.02 158.95 16.42 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.778 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.19 115.67 11.23 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.698 0.285 . . . . 0.0 111.036 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -101.05 150.14 23.22 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.743 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.404 ' CG1' ' CD2' ' A' ' 56' ' ' LEU . 30.2 t -140.0 146.8 24.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.377 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -107.1 164.67 14.33 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.783 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -56.97 -55.47 2.62 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.609 2.206 . . . . 0.0 112.539 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.2 m -89.52 8.38 31.41 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -179.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -75.0 118.14 17.64 Favored 'General case' 0 CA--C 1.528 0.125 0 O-C-N 122.245 -0.284 . . . . 0.0 110.924 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.8 p -85.08 165.69 17.28 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.817 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 7.3 tp -58.36 -40.2 77.2 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.261 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -59.32 -38.54 80.56 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.646 0.26 . . . . 0.0 110.924 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -62.79 -23.86 67.45 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.592 -0.277 . . . . 0.0 111.47 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 39.4 t -63.57 -39.5 85.58 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-O 120.566 0.222 . . . . 0.0 111.06 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.7 tttm -57.31 -36.96 71.74 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 120.602 0.239 . . . . 0.0 111.242 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.26 -45.0 74.36 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-O 120.654 0.264 . . . . 0.0 111.444 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.2 ptpm? -74.13 -39.92 63.0 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.522 -179.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.483 HD11 HG23 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -64.81 -36.89 78.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-O 120.56 0.219 . . . . 0.0 111.431 -179.672 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -64.81 -21.0 66.69 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -61.48 -14.31 27.87 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.9 mtpp -73.91 -42.7 60.27 Favored 'General case' 0 C--O 1.232 0.132 0 O-C-N 122.222 -0.299 . . . . 0.0 111.307 -179.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -144.19 -44.2 0.26 Allowed 'General case' 0 C--O 1.232 0.171 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.836 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.471 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . 107.44 68.29 0.66 Allowed Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.625 -0.797 . . . . 0.0 111.543 -179.307 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 19.7 tt -77.86 109.37 9.67 Favored Pre-proline 0 CA--C 1.532 0.287 0 CA-C-O 120.714 0.292 . . . . 0.0 111.533 -179.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.58 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 28.6 Cg_exo -62.96 -41.28 29.87 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.999 2.466 . . . . 0.0 114.422 -179.325 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.58 ' HD2' ' N ' ' A' ' 37' ' ' PRO . 21.8 Cg_endo -64.27 114.33 2.62 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 121.904 1.736 . . . . 0.0 113.086 -178.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -69.78 -1.88 10.49 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.516 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -90.06 10.98 22.14 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 122.073 -0.392 . . . . 0.0 111.998 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -90.02 97.06 10.97 Favored 'General case' 0 C--O 1.231 0.105 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 179.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.91 -177.41 4.55 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.788 0.328 . . . . 0.0 111.174 -179.476 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.0 tp -99.13 143.59 29.23 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.927 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.8 mm -106.13 95.47 3.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.124 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 16.1 t80 -150.88 123.33 8.43 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.093 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.04 33.39 23.13 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.366 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 46.14 36.06 6.97 Favored Glycine 0 C--N 1.336 0.539 0 C-N-CA 120.868 -0.682 . . . . 0.0 113.047 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.42 ' HG2' ' CE2' ' A' ' 59' ' ' TYR . 0.3 OUTLIER -110.21 126.03 53.7 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.849 0.325 . . . . 0.0 110.962 -179.952 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -89.09 149.32 23.25 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.802 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.1 pp -80.39 13.11 2.57 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -78.59 -42.61 28.58 Favored 'General case' 0 CA--C 1.528 0.097 0 O-C-N 121.978 -0.451 . . . . 0.0 110.76 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -48.18 118.46 2.41 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 179.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -68.89 49.28 0.49 Allowed Glycine 0 CA--C 1.522 0.472 0 C-N-CA 120.625 -0.798 . . . . 0.0 113.051 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.58 -172.63 2.11 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 117.169 0.484 . . . . 0.0 110.549 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.8 t -99.03 134.22 42.18 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.567 0.222 . . . . 0.0 110.627 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.404 ' CD2' ' CG1' ' A' ' 17' ' ' VAL . 3.1 pp -51.74 -34.27 38.37 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.624 0.249 . . . . 0.0 111.223 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.2 t -61.22 -35.12 76.35 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.414 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -53.86 -32.1 51.89 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 111.612 0.227 . . . . 0.0 111.612 -179.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.42 ' CE2' ' HG2' ' A' ' 48' ' ' LYS . 28.0 m-85 -97.9 14.95 25.38 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.3 t30 58.48 22.77 9.99 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.3 tp -90.0 62.49 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 CA-C-O 120.775 0.322 . . . . 0.0 110.823 179.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -101.14 179.68 4.3 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.265 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.406 ' C ' ' H ' ' A' ' 65' ' ' SER . 11.7 pttp -50.36 -179.9 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.33 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 67.25 -41.54 0.42 Allowed 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.33 0.492 . . . . 0.0 112.33 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.406 ' H ' ' C ' ' A' ' 63' ' ' LYS . 1.6 m -64.89 172.54 2.79 Favored 'General case' 0 C--N 1.332 -0.191 0 O-C-N 122.266 -0.272 . . . . 0.0 110.779 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.9 p -96.9 117.74 31.78 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.979 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.6 mp -109.04 117.36 33.98 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.013 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -107.18 123.55 48.43 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.906 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -101.33 163.54 12.22 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.851 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.9 m -104.92 173.72 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.134 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.1 mt . . . . . 0 C--N 1.332 -0.186 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.879 179.939 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 . . . . . 0 CA--C 1.529 0.136 0 CA-C-O 120.563 0.22 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 21.7 mt -139.56 155.12 25.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.95 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -118.65 93.96 4.29 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.691 0.281 . . . . 0.0 110.931 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.3 t -119.55 151.97 22.05 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.022 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 6.4 ptpp? -109.87 140.31 43.97 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.808 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 75.5 p -99.97 -148.08 0.35 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.475 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.432 ' HG ' ' N ' ' A' ' 9' ' ' THR . 1.3 pt? -65.31 -41.89 93.59 Favored 'General case' 0 C--N 1.341 0.218 0 CA-C-N 118.68 0.673 . . . . 0.0 111.571 -178.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.432 ' N ' ' HG ' ' A' ' 8' ' ' LEU . 42.7 m -111.4 41.29 1.9 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.678 0.275 . . . . 0.0 111.065 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 50.7 39.03 37.66 Favored Glycine 0 CA--C 1.521 0.439 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.776 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.6 tttm -74.38 145.65 43.62 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.813 0.306 . . . . 0.0 110.767 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.7 t -93.74 106.18 18.17 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.781 0.324 . . . . 0.0 110.898 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.3 pp -125.21 163.29 26.25 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.12 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 16.6 p -101.89 152.5 20.84 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.828 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.7 tp -127.99 92.8 3.53 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.976 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -100.98 121.56 41.98 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.849 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.7 m -140.06 173.94 9.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.156 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -96.88 167.22 12.45 Favored Pre-proline 0 C--O 1.231 0.13 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.934 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.35 -43.3 41.72 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.657 2.238 . . . . 0.0 112.487 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 36.9 m -89.27 3.09 53.2 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -75.06 120.23 20.3 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.664 0.268 . . . . 0.0 111.022 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 10.7 t -85.21 165.74 17.13 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.495 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.411 ' O ' ' CG1' ' A' ' 26' ' ' VAL . 43.4 mm -57.33 -37.45 57.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-O 120.528 0.204 . . . . 0.0 111.034 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -52.98 -31.45 40.82 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 120.487 0.184 . . . . 0.0 111.153 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -70.93 -42.8 69.37 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.765 -0.198 . . . . 0.0 111.335 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.411 ' CG1' ' O ' ' A' ' 23' ' ' ILE . 12.4 p -63.99 -21.7 29.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 111.675 0.25 . . . . 0.0 111.675 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.6 tptp -55.5 -35.03 65.15 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.573 0.225 . . . . 0.0 110.885 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.1 -37.47 87.6 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.581 0.229 . . . . 0.0 110.883 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.5 mttt -63.93 -48.62 75.81 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-O 120.636 0.255 . . . . 0.0 110.819 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.6 tt -64.82 -39.15 84.67 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 CA-C-N 116.633 -0.258 . . . . 0.0 110.931 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -65.25 -21.45 66.74 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.721 -0.218 . . . . 0.0 111.07 179.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -61.33 -12.34 13.45 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 7.5 ptpp? -74.26 -36.73 63.85 Favored 'General case' 0 N--CA 1.461 0.092 0 O-C-N 122.013 -0.429 . . . . 0.0 110.819 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -176.4 -42.07 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.664 0.268 . . . . 0.0 111.558 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.492 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . 123.63 74.92 0.28 Allowed Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.646 -0.788 . . . . 0.0 111.589 -179.66 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.439 ' HA ' ' HD2' ' A' ' 37' ' ' PRO . 1.3 pp -78.31 102.34 0.95 Allowed Pre-proline 0 CA--C 1.532 0.279 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -179.087 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.683 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 10.6 Cg_endo -55.02 -42.63 67.23 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.564 2.176 . . . . 0.0 113.962 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.683 ' HD2' ' N ' ' A' ' 37' ' ' PRO . 6.1 Cg_exo -39.34 106.6 0.06 OUTLIER 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 122.762 2.308 . . . . 0.0 113.106 -179.101 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -68.61 -16.57 63.89 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.622 179.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -93.77 28.53 2.33 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -91.91 89.07 6.86 Favored 'General case' 0 C--O 1.231 0.095 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 179.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.11 -179.06 6.27 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.96 -179.516 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -97.6 160.18 14.47 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 120.718 0.294 . . . . 0.0 110.879 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.401 ' CG2' ' O ' ' A' ' 44' ' ' ILE . 17.6 tt -100.91 80.03 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.13 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.419 ' CE1' ' HB ' ' A' ' 66' ' ' THR . 0.3 OUTLIER -150.94 105.65 3.28 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.078 179.93 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 63.62 31.3 14.65 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.575 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 45.65 52.98 8.79 Favored Glycine 0 C--N 1.336 0.562 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.983 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.446 ' CD ' ' CE1' ' A' ' 59' ' ' TYR . 0.7 OUTLIER -106.62 115.82 30.86 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.785 0.292 . . . . 0.0 110.943 -179.955 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.19 173.19 8.55 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.772 0.32 . . . . 0.0 110.867 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.1 mt -79.15 -22.99 44.28 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.491 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -78.83 -35.68 43.69 Favored 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 121.256 -0.178 . . . . 0.0 111.339 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -48.06 114.69 0.98 Allowed 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 179.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -70.01 49.72 0.7 Allowed Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.483 -0.865 . . . . 0.0 112.592 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 -107.15 161.54 14.67 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.986 0.393 . . . . 0.0 110.815 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.42 ' O ' ' HB2' ' A' ' 58' ' ' ASP . 7.2 t -99.27 142.84 30.24 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.521 -0.308 . . . . 0.0 110.74 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.418 ' HB2' HG13 ' A' ' 61' ' ' ILE . 0.2 OUTLIER -51.99 -43.71 63.73 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 111.745 0.276 . . . . 0.0 111.745 -179.286 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.1 t -58.84 -31.13 68.22 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -179.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.42 ' HB2' ' O ' ' A' ' 55' ' ' THR . 1.6 m-20 -56.82 -39.03 73.45 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 111.549 0.203 . . . . 0.0 111.549 -179.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.446 ' CE1' ' CD ' ' A' ' 48' ' ' LYS . 30.7 m-85 -99.82 17.51 20.58 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 47.5 t30 65.1 15.59 10.08 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 179.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.418 HG13 ' HB2' ' A' ' 56' ' ' LEU . 7.3 pt -90.03 60.97 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-O 120.836 0.351 . . . . 0.0 110.912 179.406 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.45 -160.15 0.77 Allowed 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.701 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.475 ' O ' ' CG ' ' A' ' 64' ' ' GLU . 2.4 pttp -39.89 144.56 0.19 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.682 0.277 . . . . 0.0 111.681 -179.596 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.475 ' CG ' ' O ' ' A' ' 63' ' ' LYS . 3.5 pt-20 54.49 26.68 7.43 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.023 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.4 p -76.05 173.38 11.34 Favored 'General case' 0 C--O 1.23 0.071 0 CA-C-O 120.672 0.272 . . . . 0.0 110.878 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.419 ' HB ' ' CE1' ' A' ' 45' ' ' PHE . 0.2 OUTLIER -107.1 81.86 1.6 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.356 179.395 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.82 107.54 20.01 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.336 -179.405 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 -107.13 103.77 13.25 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.582 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.83 168.41 11.0 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.011 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 32.9 m -103.87 174.41 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.216 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.6 mp . . . . . 0 C--N 1.333 -0.152 0 CA-C-O 120.745 0.307 . . . . 0.0 110.844 -179.931 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.556 0.217 . . . . 0.0 110.911 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 16.8 tt -138.92 153.2 24.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.077 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -118.99 127.52 53.54 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.65 0.262 . . . . 0.0 110.797 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.5 t -101.36 140.45 20.04 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.176 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.416 ' HG2' ' CE1' ' A' ' 68' ' ' HIS . 0.0 OUTLIER -106.78 87.2 2.47 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.444 179.817 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.41 119.94 40.82 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.539 -179.221 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -51.02 -20.87 1.53 Allowed 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 179.353 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 77.5 p -99.96 38.47 1.46 Allowed 'General case' 0 CA--C 1.531 0.248 0 O-C-N 122.033 -0.417 . . . . 0.0 111.442 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 49.03 30.13 9.32 Favored Glycine 0 C--N 1.336 0.567 0 C-N-CA 121.117 -0.563 . . . . 0.0 113.757 179.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.82 65.28 9.06 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 117.332 0.566 . . . . 0.0 110.714 179.489 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.6 t -92.98 99.76 12.33 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.89 0.376 . . . . 0.0 110.883 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.7 pp -125.54 172.55 12.88 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.167 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.27 132.7 51.14 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.656 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 62.3 mt -128.88 124.04 34.2 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.121 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -101.19 131.6 47.09 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.755 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.02 -176.23 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.925 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -102.58 160.87 24.96 Favored Pre-proline 0 C--N 1.333 -0.127 0 CA-C-O 120.636 0.255 . . . . 0.0 110.896 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -53.26 -50.12 15.08 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.482 2.121 . . . . 0.0 112.407 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.9 t -90.21 32.26 0.94 Allowed 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.354 0.501 . . . . 0.0 112.354 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.9 p-10 -75.24 119.48 19.43 Favored 'General case' 0 N--CA 1.461 0.114 0 O-C-N 122.202 -0.311 . . . . 0.0 110.976 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.4 t -84.95 166.08 17.08 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-O 120.673 0.273 . . . . 0.0 110.822 179.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.407 ' HA ' ' CG1' ' A' ' 26' ' ' VAL . 9.8 tp -57.89 -37.99 63.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.641 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -63.45 -41.74 98.64 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.572 0.225 . . . . 0.0 111.25 -179.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -73.14 -48.0 39.25 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 120.616 0.246 . . . . 0.0 111.161 -179.702 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.407 ' CG1' ' HA ' ' A' ' 23' ' ' ILE . 13.6 p -63.97 -21.42 28.76 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 111.698 0.259 . . . . 0.0 111.698 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.2 mtpm? -55.58 -35.06 65.37 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.502 0.191 . . . . 0.0 110.902 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.88 -37.62 74.28 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.625 0.25 . . . . 0.0 110.879 179.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.78 -38.01 64.79 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.849 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 33.2 mm -64.98 -45.16 95.49 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 CA-C-O 120.671 0.272 . . . . 0.0 110.622 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -59.89 -26.58 66.0 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.961 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -57.09 -22.94 43.29 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 111.691 0.256 . . . . 0.0 111.691 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 7.8 mtmp? -74.37 -39.08 62.97 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.605 0.24 . . . . 0.0 110.925 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.06 -48.64 0.24 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.692 -0.231 . . . . 0.0 111.238 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.51 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . 108.83 62.52 0.54 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.04 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.405 ' CG1' ' HD2' ' A' ' 38' ' ' PRO . 17.2 tt -78.51 108.3 7.58 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-O 120.696 0.284 . . . . 0.0 111.486 -179.512 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.564 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 26.0 Cg_exo -63.53 -40.66 29.39 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 122.747 2.298 . . . . 0.0 114.189 -179.448 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.564 ' HD2' ' N ' ' A' ' 37' ' ' PRO . 38.1 Cg_endo -68.5 133.16 27.21 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 122.02 1.813 . . . . 0.0 113.53 -178.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -70.71 14.67 0.13 Allowed 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.659 -0.7 . . . . 0.0 112.45 179.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -89.37 1.51 55.7 Favored 'General case' 0 N--CA 1.456 -0.138 0 O-C-N 122.135 -0.353 . . . . 0.0 110.543 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.6 tp60 -82.77 101.7 11.09 Favored 'General case' 0 C--O 1.231 0.097 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 179.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -133.88 178.19 7.14 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-O 120.742 0.306 . . . . 0.0 111.311 -179.415 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.7 tp -106.56 133.23 51.56 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.101 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.9 pt -111.26 107.4 22.85 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-O 120.752 0.311 . . . . 0.0 111.164 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -150.94 135.22 16.91 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.086 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.95 38.58 30.69 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.209 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 52.91 29.07 33.68 Favored Glycine 0 CA--C 1.522 0.51 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.941 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.432 ' HD3' ' CD1' ' A' ' 59' ' ' TYR . 14.4 mttm -110.47 102.24 10.87 Favored 'General case' 0 N--CA 1.457 -0.102 0 CA-C-N 117.016 0.408 . . . . 0.0 110.89 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -89.12 90.61 8.46 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.681 0.277 . . . . 0.0 110.89 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -79.34 65.81 4.62 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.123 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -89.51 -42.09 11.66 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-O 120.607 0.241 . . . . 0.0 111.103 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -47.34 -69.29 0.13 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.742 0.306 . . . . 0.0 111.203 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 158.26 56.61 0.01 OUTLIER Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.681 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -106.02 177.49 4.84 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.591 0.234 . . . . 0.0 110.861 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.9 t -99.1 154.87 17.78 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.711 0.291 . . . . 0.0 110.86 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.4 mp -59.31 -46.78 87.64 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.061 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.1 t -53.27 -39.15 63.68 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.484 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -53.9 -30.23 45.23 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 111.659 0.244 . . . . 0.0 111.659 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.432 ' CD1' ' HD3' ' A' ' 48' ' ' LYS . 5.1 m-85 -101.99 40.36 1.34 Allowed 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 120.659 0.266 . . . . 0.0 111.601 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 54.84 27.34 8.83 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 179.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 27.6 mt -89.64 101.31 12.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-O 120.643 0.259 . . . . 0.0 110.858 179.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -94.97 166.22 12.05 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.782 0.325 . . . . 0.0 111.223 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -50.23 151.06 2.2 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.259 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 62.67 22.13 13.15 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.593 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.2 m -75.71 170.03 16.97 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-O 120.68 0.276 . . . . 0.0 110.815 179.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.05 111.76 23.84 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.393 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.1 pp -98.72 116.53 31.15 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.791 0.329 . . . . 0.0 111.53 -179.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.416 ' CE1' ' HG2' ' A' ' 6' ' ' LYS . 0.1 OUTLIER -107.29 109.82 21.69 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.581 179.539 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -93.9 179.71 5.25 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.958 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -109.13 -178.2 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.62 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.1 mt . . . . . 0 C--N 1.332 -0.167 0 CA-C-O 120.664 0.268 . . . . 0.0 110.782 179.938 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.652 0.263 . . . . 0.0 110.945 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 15.1 tt -138.92 157.1 28.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.915 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -118.44 102.99 9.34 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.83 0.348 . . . . 0.0 110.864 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.41 ' CG1' HD12 ' A' ' 69' ' ' LEU . 11.8 t -122.22 151.42 25.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.121 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.83 135.12 48.91 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.854 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.75 -147.28 0.34 Allowed 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.331 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.5 tp -68.43 -53.99 20.02 Favored 'General case' 0 C--N 1.342 0.282 0 CA-C-O 120.921 0.391 . . . . 0.0 110.75 -179.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.3 p -101.57 39.07 1.49 Allowed 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.304 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 55.24 38.68 68.68 Favored Glycine 0 C--N 1.334 0.435 0 C-N-CA 120.817 -0.706 . . . . 0.0 113.133 179.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.9 ttmt -84.16 141.63 30.92 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 117.062 0.431 . . . . 0.0 110.556 179.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.9 t -92.95 121.99 34.85 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.64 0.257 . . . . 0.0 111.138 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.7 pt -125.13 136.06 62.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.954 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -98.87 130.31 45.27 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.903 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.9 pp -138.08 151.86 48.23 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.521 -0.308 . . . . 0.0 110.951 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -101.13 156.22 17.55 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.938 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 22.2 t -136.16 113.51 14.03 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.126 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -107.0 165.84 12.15 Favored Pre-proline 0 C--N 1.332 -0.166 0 CA-C-O 120.787 0.327 . . . . 0.0 110.855 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.49 -30.0 52.77 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.66 2.24 . . . . 0.0 112.535 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 82.1 p -78.74 -32.47 46.72 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.802 -0.181 . . . . 0.0 111.232 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -64.89 121.23 14.14 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.659 0.266 . . . . 0.0 110.74 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.05 149.82 25.3 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.02 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.1 tt -68.06 -29.35 44.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.541 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.0 tm-20 -53.06 -60.32 3.43 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.73 0.3 . . . . 0.0 111.107 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 36.9 m-20 -74.85 44.09 0.21 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.857 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 14.6 p -69.12 -40.17 80.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.562 0.22 . . . . 0.0 111.144 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.8 mptt -66.07 -44.71 83.7 Favored 'General case' 0 N--CA 1.461 0.108 0 CA-C-O 120.669 0.271 . . . . 0.0 110.816 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.29 -40.85 98.53 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.053 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.88 -41.11 97.82 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.866 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 31.9 mt -75.03 -42.61 45.51 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.952 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -55.04 -37.82 67.19 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.702 0.287 . . . . 0.0 110.977 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.56 -16.12 44.97 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 112.16 0.429 . . . . 0.0 112.16 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 12.6 mmtt -74.79 -34.72 62.47 Favored 'General case' 0 N--CA 1.461 0.087 0 O-C-N 122.207 -0.308 . . . . 0.0 111.188 -179.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -167.11 -45.82 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 121.013 -0.275 . . . . 0.0 111.576 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 137.14 80.22 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.453 -0.88 . . . . 0.0 112.329 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.408 HG12 ' HG2' ' A' ' 38' ' ' PRO . 9.3 tt -78.35 113.29 32.72 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-O 120.565 0.221 . . . . 0.0 111.106 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.49 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 51.2 Cg_exo -53.36 -51.28 11.32 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.676 2.251 . . . . 0.0 113.291 -179.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.49 ' HD2' ' N ' ' A' ' 37' ' ' PRO . 31.6 Cg_endo -65.65 86.19 0.22 Allowed 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 121.975 1.783 . . . . 0.0 112.363 -179.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.31 -21.55 64.76 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.409 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 29.2 mt-30 -100.2 36.17 1.92 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 120.478 0.18 . . . . 0.0 111.421 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -88.23 131.25 34.83 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.576 0.227 . . . . 0.0 110.704 179.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.3 mtt180 -137.89 169.02 18.51 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.694 0.283 . . . . 0.0 111.061 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 49.6 mt -99.67 151.29 21.38 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.919 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.8 tt -110.99 84.16 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 CA-C-O 120.765 0.317 . . . . 0.0 111.092 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -150.89 131.75 14.15 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.204 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.7 25.74 15.52 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.741 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 44.51 36.83 4.64 Favored Glycine 0 C--N 1.337 0.637 0 C-N-CA 120.777 -0.725 . . . . 0.0 113.081 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.1 mmpm? -110.06 136.46 49.27 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.835 0.317 . . . . 0.0 111.06 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.7 tp60 -89.12 162.98 15.66 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.931 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -80.48 19.57 0.78 Allowed 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -89.04 -41.23 12.45 Favored 'General case' 0 CA--C 1.529 0.155 0 O-C-N 122.038 -0.414 . . . . 0.0 111.171 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -48.28 114.51 0.96 Allowed 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 120.637 0.256 . . . . 0.0 110.325 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -69.97 50.43 0.71 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.411 -0.9 . . . . 0.0 112.467 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.3 mmt180 -104.52 -178.72 3.74 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-N 116.946 0.373 . . . . 0.0 110.926 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.8 m -94.74 149.0 21.7 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.771 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.73 -47.33 73.92 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.988 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.0 p -52.38 -30.26 28.14 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.36 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -53.91 -28.52 37.21 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 111.522 0.193 . . . . 0.0 111.522 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -98.11 24.32 7.23 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 61.4 21.85 12.34 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 179.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.496 HG23 HD13 ' A' ' 61' ' ' ILE . 0.0 OUTLIER -89.56 92.47 3.97 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 CA-C-O 120.853 0.359 . . . . 0.0 110.722 179.454 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -101.73 176.28 5.27 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.141 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.32 145.85 5.8 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.311 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 64.54 21.86 12.54 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.833 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 54.3 p -75.67 149.41 38.15 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 120.734 0.302 . . . . 0.0 110.996 179.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.5 m -107.09 90.2 3.23 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.553 179.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -109.34 135.23 50.74 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.869 0.366 . . . . 0.0 111.261 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 16.4 m80 -107.34 142.07 37.72 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.715 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.41 HD12 ' CG1' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -104.76 158.36 16.56 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.693 0.283 . . . . 0.0 111.159 179.69 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.3 p -114.1 152.43 15.77 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.927 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.7 mp . . . . . 0 C--N 1.332 -0.176 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.84 179.947 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.8 mp0 . . . . . 0 CA--C 1.533 0.309 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.402 ' CD1' ' CG2' ' A' ' 5' ' ' VAL . 14.5 pt -138.66 177.27 5.28 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.108 0 CA-C-O 120.71 0.291 . . . . 0.0 111.306 -179.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -118.88 101.31 7.96 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.703 0.287 . . . . 0.0 110.826 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.402 ' CG2' ' CD1' ' A' ' 3' ' ' ILE . 22.0 t -114.96 149.56 17.14 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.132 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 9.2 mmtt -106.92 130.72 54.54 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.9 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.43 -166.6 1.36 Allowed 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.271 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.407 ' HG ' ' N ' ' A' ' 9' ' ' THR . 0.6 OUTLIER -66.98 -43.39 83.14 Favored 'General case' 0 C--N 1.339 0.128 0 CA-C-O 120.8 0.333 . . . . 0.0 111.183 -178.79 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.407 ' N ' ' HG ' ' A' ' 8' ' ' LEU . 1.3 p -111.27 40.36 2.09 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.035 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 55.24 39.96 73.51 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.681 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.06 163.23 20.0 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.783 0.292 . . . . 0.0 110.898 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -103.04 122.8 45.39 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.864 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.6 pt -124.99 151.5 30.68 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-O 120.703 0.287 . . . . 0.0 111.234 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 16.7 m -105.75 130.55 53.73 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.793 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.56 130.31 30.04 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.576 -0.283 . . . . 0.0 110.984 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -100.95 175.05 5.74 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.77 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.1 t -132.81 108.99 13.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 120.81 0.338 . . . . 0.0 111.272 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.41 ' HB2' ' HD2' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -107.05 158.21 33.49 Favored Pre-proline 0 C--N 1.333 -0.15 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.498 179.811 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.41 ' HD2' ' HB2' ' A' ' 18' ' ' GLU . 3.7 Cg_endo -46.49 -53.36 6.12 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.627 2.218 . . . . 0.0 112.059 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.9 p -90.42 41.16 1.04 Allowed 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -74.56 94.89 2.7 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.65 0.262 . . . . 0.0 110.976 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.21 128.7 34.78 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.658 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 7.1 mt -57.83 -35.04 49.82 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.329 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -71.33 -41.3 70.02 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.608 0.242 . . . . 0.0 111.08 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -73.02 -41.89 63.77 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.242 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 12.3 p -63.78 -36.23 75.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-N 116.759 -0.2 . . . . 0.0 111.285 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.82 -41.15 73.79 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.621 0.248 . . . . 0.0 110.888 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.95 -34.85 70.35 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.322 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 16.8 mtpt -63.68 -43.09 97.69 Favored 'General case' 0 CA--C 1.527 0.092 0 CA-C-O 120.633 0.254 . . . . 0.0 110.822 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 3.4 mt -66.47 -49.32 76.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 CA-C-O 120.702 0.287 . . . . 0.0 110.735 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 1.9 tp60 -65.16 -25.91 67.94 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.185 179.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -51.05 -31.23 17.93 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.64 -24.83 49.39 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 121.162 -0.215 . . . . 0.0 111.45 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 70.61 33.73 2.29 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.673 0.273 . . . . 0.0 110.704 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -89.96 -39.99 5.99 Favored Glycine 0 C--N 1.334 0.454 0 C-N-CA 120.518 -0.849 . . . . 0.0 112.596 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.6 mt -89.33 110.08 36.04 Favored Pre-proline 0 CA--C 1.531 0.224 0 CA-C-N 116.656 0.228 . . . . 0.0 111.163 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.498 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 33.8 Cg_exo -57.65 -46.9 23.96 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.374 2.049 . . . . 0.0 113.077 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.498 ' HD2' ' N ' ' A' ' 37' ' ' PRO . 60.6 Cg_endo -74.11 120.21 6.2 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.224 1.949 . . . . 0.0 112.894 -179.392 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -68.75 -18.83 64.28 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.19 179.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -93.01 34.02 1.13 Allowed 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 111.492 0.182 . . . . 0.0 111.492 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -82.35 111.79 18.73 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 7.1 ptt180 -139.67 178.79 6.98 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.885 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -97.84 166.46 11.46 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.875 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.0 tt -109.47 89.14 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.158 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -150.83 109.09 3.75 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.153 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.34 33.68 18.79 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.556 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 46.23 45.33 15.64 Favored Glycine 0 C--N 1.336 0.541 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.97 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.412 ' HE2' ' CE1' ' A' ' 59' ' ' TYR . 26.1 tptt -101.42 129.92 47.54 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.803 0.302 . . . . 0.0 110.93 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -89.15 158.25 17.99 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.974 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.1 mp -79.22 -34.84 42.5 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.166 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -78.97 -10.46 59.83 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 111.678 0.251 . . . . 0.0 111.678 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -47.07 -42.81 19.39 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.66 0.267 . . . . 0.0 111.227 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.77 37.52 5.75 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.767 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.14 174.93 5.67 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.848 0.324 . . . . 0.0 110.728 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 49.8 m -99.19 135.25 40.87 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.814 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 14.5 mt -52.24 -38.14 57.22 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.011 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.0 t -61.31 -31.49 71.34 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.647 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -53.73 -37.83 63.74 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 121.207 -0.197 . . . . 0.0 111.418 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.412 ' CE1' ' HE2' ' A' ' 48' ' ' LYS . 6.1 m-85 -103.62 34.32 3.02 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 120.511 0.196 . . . . 0.0 111.439 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 54.8 28.0 9.69 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 179.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 28.2 mt -89.48 73.49 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.123 0 CA-C-O 120.768 0.318 . . . . 0.0 110.885 179.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.3 mm-40 -94.8 177.81 5.78 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.058 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -50.23 147.22 4.38 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.863 0.363 . . . . 0.0 111.276 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 63.66 20.73 12.38 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.779 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.8 m -75.83 176.74 7.51 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-O 120.63 0.253 . . . . 0.0 110.951 179.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.5 t -101.44 82.96 2.38 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.472 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.95 108.61 21.34 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.128 -179.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.9 m170 -107.13 124.34 49.55 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.659 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.4 mp -93.9 149.27 21.38 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.887 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.6 t -104.1 144.09 14.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.03 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.4 mt . . . . . 0 C--N 1.332 -0.185 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.908 -179.962 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 . . . . . 0 CA--C 1.534 0.328 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.7 tt -138.91 154.96 26.68 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 O-C-N 122.33 -0.231 . . . . 0.0 111.118 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.83 81.63 1.73 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.719 0.295 . . . . 0.0 110.766 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.6 t -109.2 153.63 10.9 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.969 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.93 138.67 42.65 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.681 0.277 . . . . 0.0 111.046 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.0 p -99.9 -167.44 1.46 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.215 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.36 -35.36 75.51 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.963 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.53 -66.57 1.07 Allowed 'General case' 0 C--O 1.231 0.111 0 CA-C-O 120.827 0.346 . . . . 0.0 110.382 179.396 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 171.45 46.03 0.04 OUTLIER Glycine 0 CA--C 1.522 0.48 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.917 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -84.93 164.14 18.53 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.89 0.345 . . . . 0.0 111.071 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.1 p -103.17 123.57 46.96 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.48 179.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.3 tt -114.94 140.85 34.01 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.107 0 CA-C-O 120.736 0.303 . . . . 0.0 111.275 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 17.0 p -106.03 119.51 39.39 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.784 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.0 mt -138.03 145.39 41.77 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.941 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -100.99 164.69 11.69 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.853 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 24.7 t -129.89 106.11 12.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.031 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -102.09 163.32 17.97 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.812 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -52.67 -48.74 20.36 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.452 2.101 . . . . 0.0 112.189 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.3 p -90.28 34.19 0.88 Allowed 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -75.31 106.65 6.95 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.727 0.299 . . . . 0.0 110.73 179.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.4 m -85.16 142.61 29.35 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.033 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.5 tp -68.05 -23.78 29.38 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.763 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -86.02 -33.96 20.91 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 120.477 0.179 . . . . 0.0 111.298 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -62.83 -38.93 92.71 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.522 0.201 . . . . 0.0 111.29 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.9 p -63.78 -31.1 51.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-N 116.754 -0.203 . . . . 0.0 111.444 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -56.0 -43.38 77.63 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.715 0.293 . . . . 0.0 110.823 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.86 -30.89 71.94 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.345 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.6 mttm -63.82 -39.4 94.15 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 120.567 0.222 . . . . 0.0 110.89 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 38.0 mm -64.98 -46.92 90.12 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 CA-C-O 120.698 0.285 . . . . 0.0 110.555 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.32 -42.88 92.54 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.588 179.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -61.25 -22.98 65.32 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.727 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.78 -44.36 50.02 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-O 120.73 0.3 . . . . 0.0 110.795 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -136.78 -50.61 0.66 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.131 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.44 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . 116.93 67.41 0.38 Allowed Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.931 -179.598 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.416 ' CG1' ' HD2' ' A' ' 38' ' ' PRO . 19.8 tt -78.45 110.1 12.71 Favored Pre-proline 0 CA--C 1.531 0.249 0 CA-C-O 120.679 0.276 . . . . 0.0 111.368 -179.432 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.467 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 35.2 Cg_exo -60.29 -45.92 20.62 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.61 2.206 . . . . 0.0 113.212 -179.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' A' ' 37' ' ' PRO . 58.1 Cg_exo -39.12 95.09 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.866 2.378 . . . . 0.0 113.221 -179.449 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -68.76 -17.57 64.06 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.405 179.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -93.5 30.98 1.61 Allowed 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 111.779 0.289 . . . . 0.0 111.779 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -82.64 116.07 21.87 Favored 'General case' 0 CA--C 1.528 0.105 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 179.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.44 168.23 20.21 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.683 0.278 . . . . 0.0 111.387 -179.256 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -103.96 167.51 9.72 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.711 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.0 tt -111.04 74.14 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.732 0.301 . . . . 0.0 111.129 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -150.91 112.57 4.46 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.343 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.426 ' HB2' ' CE1' ' A' ' 59' ' ' TYR . . . 59.75 25.44 14.44 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.849 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 43.45 45.63 6.79 Favored Glycine 0 C--N 1.337 0.595 0 C-N-CA 120.861 -0.685 . . . . 0.0 113.09 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.01 135.65 41.11 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.794 0.297 . . . . 0.0 110.898 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -89.1 161.06 16.73 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.963 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.3 tp -79.09 -20.4 48.84 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.533 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -78.62 -40.82 33.3 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-O 120.535 0.207 . . . . 0.0 111.065 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -48.0 119.0 2.61 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 179.538 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.86 53.91 0.37 Allowed Glycine 0 CA--C 1.521 0.419 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.875 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.16 164.69 11.95 Favored 'General case' 0 CA--C 1.527 0.093 0 CA-C-N 117.01 0.405 . . . . 0.0 110.725 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.1 m -99.17 131.41 45.23 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.708 0.289 . . . . 0.0 110.666 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -51.39 -33.58 30.67 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.699 -0.228 . . . . 0.0 111.007 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.6 t -63.36 -36.29 83.22 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 111.713 0.264 . . . . 0.0 111.713 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.406 ' OD1' ' CD2' ' A' ' 59' ' ' TYR . 1.5 p30 -55.81 -31.67 62.88 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -179.18 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.426 ' CE1' ' HB2' ' A' ' 46' ' ' ALA . 4.5 m-85 -103.97 29.71 5.69 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 121.077 -0.249 . . . . 0.0 111.597 -179.735 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 65.15 12.97 8.41 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 179.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 21.4 mt -89.91 62.93 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 O-C-N 122.17 -0.332 . . . . 0.0 110.692 179.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -104.19 -173.06 2.22 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.301 -179.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.3 ttpt -46.64 139.57 5.1 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.847 0.356 . . . . 0.0 111.388 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 65.26 15.77 10.18 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.134 -0.484 . . . . 0.0 112.196 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 40.3 t -76.05 -177.39 3.9 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 120.655 0.264 . . . . 0.0 110.67 179.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.33 91.58 3.77 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.515 -0.312 . . . . 0.0 110.409 179.457 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.8 mp -98.72 102.44 14.18 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.745 0.307 . . . . 0.0 111.23 -179.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -107.12 109.33 21.14 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.625 179.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -94.04 179.44 5.33 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.929 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.9 m -103.77 172.41 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.115 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.332 -0.185 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.823 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 53.0 mm-40 . . . . . 0 CA--C 1.529 0.141 0 CA-C-O 120.6 0.238 . . . . 0.0 111.005 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.4 pt -138.8 176.24 6.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-N 116.669 -0.242 . . . . 0.0 111.076 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -118.83 101.16 7.86 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.744 0.307 . . . . 0.0 110.907 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.1 p -136.19 138.37 47.21 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.746 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -107.28 168.74 9.01 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.878 0.37 . . . . 0.0 111.305 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.6 p -99.93 -168.27 1.57 Allowed 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.446 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.55 -22.48 66.98 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 120.933 -0.307 . . . . 0.0 111.563 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.2 t -100.56 -10.75 20.7 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.65 30.13 8.76 Favored Glycine 0 C--N 1.336 0.554 0 C-N-CA 120.507 -0.854 . . . . 0.0 113.111 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.6 tttm -84.29 170.28 13.83 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-N 117.161 0.481 . . . . 0.0 110.714 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.0 t -103.1 118.0 35.82 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.583 -0.281 . . . . 0.0 110.873 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 22.8 pt -125.18 157.55 33.9 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 CA-C-O 120.677 0.275 . . . . 0.0 111.211 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.4 p -106.03 125.82 51.45 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.838 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -129.16 145.78 51.23 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.885 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -101.06 152.43 20.61 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.786 0.326 . . . . 0.0 110.809 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 24.2 t -133.51 132.16 57.49 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.044 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -107.1 159.95 28.17 Favored Pre-proline 0 C--N 1.332 -0.169 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.784 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -50.68 -49.93 15.26 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.465 2.11 . . . . 0.0 112.218 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 p -90.22 36.74 0.88 Allowed 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.0 p-10 -69.13 103.82 2.0 Allowed 'General case' 0 C--O 1.231 0.11 0 O-C-N 122.199 -0.313 . . . . 0.0 110.744 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.3 p -85.09 134.09 34.2 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.979 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.9 tp -65.06 -36.98 79.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.315 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -48.09 -51.64 23.69 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.612 0.244 . . . . 0.0 111.069 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -74.78 43.63 0.2 Allowed 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 111.779 0.288 . . . . 0.0 111.779 179.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.9 p -74.06 -39.52 50.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 CA-C-O 120.626 0.25 . . . . 0.0 111.298 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.94 -44.14 78.11 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.72 0.295 . . . . 0.0 110.936 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.27 -42.68 96.32 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.103 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 21.3 mtmm -70.82 -45.63 64.24 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.948 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.401 ' CG1' HG23 ' A' ' 36' ' ' ILE . 10.8 tp -70.34 -36.53 67.34 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.266 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.7 tm0? -59.33 -24.6 63.47 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.773 -0.194 . . . . 0.0 111.069 179.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -50.99 -25.21 4.41 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.59 -39.94 61.91 Favored 'General case' 0 C--O 1.231 0.089 0 C-N-CA 120.936 -0.306 . . . . 0.0 110.564 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 176.51 -39.17 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.716 0.294 . . . . 0.0 111.453 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.567 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . 131.94 80.49 0.19 Allowed Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.748 -179.559 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.401 HG23 ' CG1' ' A' ' 30' ' ' ILE . 11.2 tt -77.68 106.1 3.42 Favored Pre-proline 0 N--CA 1.466 0.349 0 CA-C-O 120.799 0.333 . . . . 0.0 111.582 -179.19 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.609 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 17.1 Cg_exo -68.59 -35.6 16.72 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 123.03 2.486 . . . . 0.0 115.13 -179.081 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.609 ' HD2' ' N ' ' A' ' 37' ' ' PRO . 15.8 Cg_endo -60.52 113.45 1.7 Allowed 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 121.678 1.585 . . . . 0.0 113.393 -178.343 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -70.28 5.35 1.75 Allowed 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.399 179.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -89.73 8.74 30.17 Favored 'General case' 0 CA--C 1.53 0.199 0 O-C-N 122.088 -0.383 . . . . 0.0 111.4 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.401 ' HB3' HD13 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -82.59 99.41 9.53 Favored 'General case' 0 CA--C 1.527 0.08 0 CA-C-O 120.776 0.322 . . . . 0.0 110.453 179.41 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.77 169.74 16.61 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.971 -179.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.99 140.74 31.88 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.796 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.7 tt -107.83 65.08 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 120.793 0.33 . . . . 0.0 111.102 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -150.89 121.07 7.23 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.737 0.303 . . . . 0.0 111.219 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.93 25.59 15.56 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.787 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 45.13 55.71 6.41 Favored Glycine 0 C--N 1.338 0.65 0 C-N-CA 120.836 -0.697 . . . . 0.0 113.039 179.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -102.03 135.01 44.34 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.702 0.287 . . . . 0.0 110.96 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -89.09 154.17 20.4 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.872 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.5 pp -69.78 -39.44 76.64 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.06 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.76 10.97 21.44 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -47.06 -45.68 21.86 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.683 0.278 . . . . 0.0 111.194 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.39 8.12 56.52 Favored Glycine 0 CA--C 1.523 0.589 0 C-N-CA 120.591 -0.814 . . . . 0.0 113.292 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.0 mmm180 -107.09 -177.61 3.41 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 117.326 0.563 . . . . 0.0 110.702 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.6 t -99.27 150.26 22.28 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.74 0.305 . . . . 0.0 110.71 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.4 mt -61.48 -39.82 92.31 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.734 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.7 t -58.62 -32.07 68.67 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.637 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -53.94 -35.03 61.28 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 121.13 -0.228 . . . . 0.0 111.476 -179.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -103.82 31.75 4.29 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 120.474 0.178 . . . . 0.0 111.401 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 65.18 14.0 9.1 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 47.6 mt -90.01 68.32 0.59 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.139 0 CA-C-O 120.743 0.306 . . . . 0.0 110.809 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -98.87 -178.46 3.97 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.187 -179.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.4 145.81 3.21 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.801 0.334 . . . . 0.0 111.409 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 65.55 13.88 9.15 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.234 -0.439 . . . . 0.0 112.179 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 39.5 t -76.16 -177.48 4.0 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-O 120.634 0.254 . . . . 0.0 110.71 179.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.7 m -100.9 83.65 2.57 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.314 179.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.8 tt -98.83 111.22 23.67 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.751 0.31 . . . . 0.0 111.365 -179.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 17.6 t60 -107.11 125.81 51.55 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.599 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.53 111.14 23.37 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-O 120.732 0.301 . . . . 0.0 111.084 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.1 t -114.1 149.94 16.27 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.015 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.1 pp . . . . . 0 C--O 1.232 0.14 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.962 -179.932 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 . . . . . 0 CA--C 1.527 0.091 0 CA-C-O 120.741 0.305 . . . . 0.0 110.88 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 17.7 tt -138.94 154.14 25.73 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.965 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -118.64 104.37 10.56 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.756 0.312 . . . . 0.0 110.895 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.7 t -103.25 163.4 3.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.892 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.8 tppt? -106.62 121.23 43.91 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.758 0.313 . . . . 0.0 110.662 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.404 ' OG1' ' N ' ' A' ' 11' ' ' LYS . 2.7 p -99.82 -176.44 3.26 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.192 -179.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.67 -40.11 88.45 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-O 120.696 0.284 . . . . 0.0 111.591 -178.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -111.04 43.23 1.48 Allowed 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.204 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 45.0 38.03 5.8 Favored Glycine 0 C--N 1.335 0.511 0 C-N-CA 120.95 -0.643 . . . . 0.0 113.291 179.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.404 ' N ' ' OG1' ' A' ' 7' ' ' THR . 7.8 tttt -84.12 144.46 29.01 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.856 0.328 . . . . 0.0 110.791 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.7 t -95.38 110.65 22.65 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.731 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.0 pt -125.09 164.19 24.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.201 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.7 t -100.55 150.64 22.48 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.781 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -134.87 100.74 4.68 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.676 0.274 . . . . 0.0 110.963 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -96.39 126.46 41.61 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.841 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.1 m -139.26 173.51 11.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.738 0.304 . . . . 0.0 111.272 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.423 ' HB2' ' HD2' ' A' ' 19' ' ' PRO . 0.4 OUTLIER -105.37 158.38 32.34 Favored Pre-proline 0 C--O 1.232 0.162 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.533 179.833 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.423 ' HD2' ' HB2' ' A' ' 18' ' ' GLU . 1.5 Cg_endo -44.49 -48.02 10.54 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.825 2.35 . . . . 0.0 112.165 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 87.9 p -90.33 38.89 0.95 Allowed 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 179.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.9 p-10 -75.04 116.72 16.09 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.658 0.266 . . . . 0.0 110.912 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.13 169.02 14.3 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.794 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 43.7 mm -67.4 -42.04 86.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.862 179.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -64.56 -40.14 95.02 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.005 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -62.74 -44.77 95.33 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.653 0.263 . . . . 0.0 110.788 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.7 m -70.26 -18.65 21.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.5 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.6 tptm -55.62 -35.51 65.95 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.504 0.192 . . . . 0.0 111.116 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.67 -38.89 75.9 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.6 0.238 . . . . 0.0 111.05 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.1 mttm -63.95 -36.53 84.26 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.918 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 35.5 mm -64.93 -44.48 96.14 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.078 0 CA-C-O 120.752 0.31 . . . . 0.0 110.61 179.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -57.88 -28.24 64.0 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.864 179.567 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -51.78 -27.76 13.28 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 7.2 mmtt -74.82 -40.93 60.79 Favored 'General case' 0 C--O 1.23 0.079 0 CA-C-O 120.693 0.282 . . . . 0.0 110.596 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -175.47 -40.89 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.557 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.53 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . 108.87 64.79 0.56 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.544 -0.836 . . . . 0.0 111.632 -179.511 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 12.0 tt -78.22 107.54 5.83 Favored Pre-proline 0 N--CA 1.465 0.295 0 N-CA-C 111.741 0.274 . . . . 0.0 111.741 -179.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.53 ' HD3' ' O ' ' A' ' 35' ' ' GLY . 27.9 Cg_exo -62.49 -43.83 20.58 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.751 2.301 . . . . 0.0 113.578 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' A' ' 37' ' ' PRO . 44.9 Cg_exo -38.03 117.62 0.26 Allowed 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 123.023 2.482 . . . . 0.0 113.685 -179.201 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -69.84 2.32 3.52 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 179.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -89.84 3.45 52.9 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 118.134 0.425 . . . . 0.0 111.803 -179.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 27.2 tp60 -82.88 97.53 8.71 Favored 'General case' 0 C--O 1.232 0.14 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 3.0 mtp180 -137.5 -176.31 4.36 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.151 -179.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -97.4 134.57 40.49 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.623 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 32.1 mt -100.98 83.54 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.406 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.421 ' CE2' ' HB ' ' A' ' 66' ' ' THR . 4.6 t80 -150.94 115.61 5.19 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.018 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.85 35.97 19.17 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.32 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 46.87 36.84 8.86 Favored Glycine 0 C--N 1.336 0.577 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.876 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -110.16 107.61 17.48 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.774 0.287 . . . . 0.0 111.038 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.05 130.68 35.47 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.53 179.618 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.3 pp -79.32 62.86 3.79 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.579 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -89.47 -66.32 0.93 Allowed 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.74 0.305 . . . . 0.0 110.414 179.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.456 ' O ' ' N ' ' A' ' 54' ' ' ARG . 19.0 t0 -48.56 125.44 9.86 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.01 179.112 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -65.2 60.7 0.09 OUTLIER Glycine 0 CA--C 1.522 0.52 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.565 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.456 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.3 OUTLIER -107.15 -172.9 2.17 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.94 0.37 . . . . 0.0 110.797 -179.904 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.4 m -98.39 144.92 27.25 Favored 'General case' 0 N--CA 1.457 -0.11 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.622 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.8 pp -51.78 -40.67 60.76 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.203 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.5 t -55.19 -52.09 64.45 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.395 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -64.66 -16.0 62.15 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 112.265 0.469 . . . . 0.0 112.265 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.414 ' C ' ' H ' ' A' ' 61' ' ' ILE . 0.2 OUTLIER -97.8 38.12 1.33 Allowed 'General case' 0 CA--C 1.533 0.311 0 O-C-N 122.174 -0.329 . . . . 0.0 111.885 -179.527 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 66.74 -40.29 0.37 Allowed 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 179.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.414 ' H ' ' C ' ' A' ' 59' ' ' TYR . 1.1 pt -78.64 108.22 11.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.872 0.367 . . . . 0.0 111.328 -179.504 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.24 -174.8 2.69 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.951 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.2 150.68 2.34 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.791 0.329 . . . . 0.0 111.373 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 65.11 19.29 11.76 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.852 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.2 m -75.83 177.69 6.75 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.59 0.233 . . . . 0.0 110.872 179.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.421 ' HB ' ' CE2' ' A' ' 45' ' ' PHE . 0.2 OUTLIER -96.99 114.85 26.5 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.3 179.376 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.8 mp -98.98 89.85 4.42 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.673 0.273 . . . . 0.0 111.48 -179.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -100.17 95.31 6.73 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.2 179.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -93.86 177.11 6.1 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.244 -179.426 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.0 p -103.62 156.62 5.37 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.766 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.7 mt . . . . . 0 N--CA 1.462 0.136 0 CA-C-O 120.711 0.291 . . . . 0.0 110.939 -179.747 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.403 ' CB ' ' HG2' ' A' ' 63' ' ' LYS . 3.8 mm-40 . . . . . 0 CA--C 1.533 0.31 0 N-CA-C 112.484 0.549 . . . . 0.0 112.484 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 18.6 tt -138.46 147.95 25.01 Favored 'Isoleucine or valine' 0 C--O 1.231 0.1 0 C-N-CA 120.619 -0.432 . . . . 0.0 111.441 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -120.61 94.64 4.43 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.95 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.404 ' CG1' ' CG1' ' A' ' 13' ' ' ILE . 13.7 p -103.02 154.77 5.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.854 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 6.4 mmpt? -106.58 145.36 31.99 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.819 0.342 . . . . 0.0 111.022 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.6 p -99.53 -173.37 2.45 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.161 -179.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -66.9 -33.43 75.57 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-O 120.688 0.28 . . . . 0.0 110.682 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.3 m -107.3 42.22 1.35 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.713 179.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 47.98 32.18 8.76 Favored Glycine 0 CA--C 1.521 0.467 0 C-N-CA 121.1 -0.571 . . . . 0.0 113.403 179.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -84.55 152.95 23.56 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 117.096 0.448 . . . . 0.0 110.788 179.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.2 t -103.14 122.53 44.9 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.716 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.404 ' CG1' ' CG1' ' A' ' 5' ' ' VAL . 38.6 pt -123.07 166.07 18.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 120.829 0.347 . . . . 0.0 111.367 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.5 p -105.96 127.09 52.92 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.647 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.75 139.35 52.73 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-O 120.775 0.321 . . . . 0.0 111.22 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -101.19 165.42 11.3 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.638 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.7 t -140.04 125.91 21.49 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-O 120.687 0.279 . . . . 0.0 111.284 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.451 ' HB2' ' HD2' ' A' ' 19' ' ' PRO . 1.7 pt-20 -107.08 158.19 33.55 Favored Pre-proline 0 C--N 1.333 -0.115 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.453 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.451 ' HD2' ' HB2' ' A' ' 18' ' ' GLU . 4.7 Cg_endo -47.1 -56.29 3.17 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.555 2.17 . . . . 0.0 112.124 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 41.6 p -90.45 41.73 1.07 Allowed 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -72.78 111.35 7.84 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.638 0.256 . . . . 0.0 110.989 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.8 m -85.09 149.28 25.66 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.723 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.7 mt -68.02 -36.82 76.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.285 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -73.92 -40.83 62.85 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 120.564 0.221 . . . . 0.0 110.984 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -67.26 -40.41 86.2 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.682 -0.235 . . . . 0.0 111.126 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 12.1 p -63.83 -33.81 64.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-N 116.703 -0.226 . . . . 0.0 111.367 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -55.81 -45.37 78.29 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.724 0.297 . . . . 0.0 110.814 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.04 -30.26 69.45 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.367 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.5 ttmp? -63.69 -41.27 98.16 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 120.594 0.235 . . . . 0.0 110.899 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.1 mt -64.96 -47.55 87.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-O 120.679 0.276 . . . . 0.0 110.712 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.3 -45.73 83.19 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.594 179.693 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -61.11 -23.97 65.9 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.556 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -74.63 -64.56 1.01 Allowed 'General case' 0 CA--C 1.528 0.103 0 CA-C-O 120.575 0.226 . . . . 0.0 111.285 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -103.27 -41.44 6.04 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 111.5 0.185 . . . . 0.0 111.5 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.484 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . 96.95 56.64 1.13 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.515 -0.85 . . . . 0.0 111.822 -179.475 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.432 HG12 ' HD2' ' A' ' 38' ' ' PRO . 10.1 tt -78.44 108.92 8.82 Favored Pre-proline 0 CA--C 1.531 0.225 0 CA-C-O 120.622 0.249 . . . . 0.0 111.452 -179.474 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.484 ' HD3' ' O ' ' A' ' 35' ' ' GLY . 36.7 Cg_exo -60.8 -46.74 15.35 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.549 2.166 . . . . 0.0 113.036 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.443 ' CD ' ' N ' ' A' ' 37' ' ' PRO . 69.9 Cg_exo -40.72 104.88 0.05 OUTLIER 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.82 2.347 . . . . 0.0 113.287 -179.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.0 p-10 -69.12 -10.98 60.31 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.901 179.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.79 22.31 3.64 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -179.622 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.401 ' HG2' ' CD1' ' A' ' 69' ' ' LEU . 0.6 OUTLIER -84.16 102.8 12.85 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 110.329 -0.249 . . . . 0.0 110.329 179.436 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -143.98 179.16 7.36 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-O 120.778 0.323 . . . . 0.0 111.41 -179.569 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -108.16 141.64 39.58 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.871 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 17.2 tt -111.05 75.39 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-O 120.766 0.317 . . . . 0.0 110.946 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -150.87 121.97 7.72 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.271 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 56.27 34.91 24.89 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.619 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 46.43 44.55 16.04 Favored Glycine 0 C--N 1.335 0.477 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.895 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.422 ' HE2' ' CD1' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -99.99 109.63 21.96 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.713 0.292 . . . . 0.0 110.904 -179.995 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -89.19 151.88 21.92 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.983 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.4 mt -79.24 -8.81 59.32 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.761 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -78.67 -41.47 31.18 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 122.334 -0.229 . . . . 0.0 111.108 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -47.8 114.83 0.98 Allowed 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 116.658 -0.246 . . . . 0.0 110.373 179.665 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -69.85 46.2 0.57 Allowed Glycine 0 CA--C 1.521 0.461 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.892 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -107.3 177.23 4.91 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 117.128 0.464 . . . . 0.0 110.668 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 5.7 t -99.17 142.88 30.08 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.601 0.238 . . . . 0.0 110.436 179.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 84.0 mt -51.86 -43.11 63.1 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.715 0.293 . . . . 0.0 111.349 -179.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.8 t -54.55 -27.93 42.09 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -179.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -53.76 -40.91 66.61 Favored 'General case' 0 N--CA 1.465 0.318 0 O-C-N 122.259 -0.275 . . . . 0.0 111.548 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.422 ' CD1' ' HE2' ' A' ' 48' ' ' LYS . 33.8 m-85 -101.94 19.26 18.71 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 111.914 0.338 . . . . 0.0 111.914 -179.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 64.62 14.64 9.16 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.1 tp -90.0 62.16 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-O 120.841 0.353 . . . . 0.0 110.873 179.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 10.8 pm0 -95.26 -172.78 2.75 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.44 -179.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.403 ' HG2' ' CB ' ' A' ' 2' ' ' GLN . 0.1 OUTLIER -39.84 155.74 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.985 -179.444 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 65.3 16.01 10.31 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.806 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 17.7 p -76.32 145.94 39.21 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-O 120.561 0.219 . . . . 0.0 111.031 179.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 11.7 p -97.68 76.96 2.52 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 179.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.1 mt -99.94 131.77 45.7 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.832 0.348 . . . . 0.0 111.68 -179.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -107.2 139.84 41.0 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.25 179.214 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.401 ' CD1' ' HG2' ' A' ' 41' ' ' GLN . 0.1 OUTLIER -93.87 116.77 29.25 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.678 0.275 . . . . 0.0 110.858 -179.858 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.8 p -114.36 148.26 17.28 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.383 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.331 -0.222 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.563 179.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 64.5 mm-40 . . . . . 0 CA--C 1.528 0.12 0 N-CA-C 111.489 0.181 . . . . 0.0 111.489 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.406 ' CD1' ' CG2' ' A' ' 5' ' ' VAL . 1.1 pp -138.93 164.77 25.09 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 C-N-CA 120.711 -0.396 . . . . 0.0 111.672 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -129.07 111.93 13.48 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.873 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.406 ' CG2' ' CD1' ' A' ' 3' ' ' ILE . 39.0 t -111.4 155.11 12.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.893 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -106.56 165.5 11.24 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.673 0.273 . . . . 0.0 110.718 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 66.7 p -109.82 -142.82 0.38 Allowed 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.647 -179.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -65.25 -38.57 90.75 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 118.615 0.643 . . . . 0.0 111.482 -179.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.9 m -107.98 -60.55 1.7 Allowed 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.607 0.242 . . . . 0.0 110.894 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 165.56 53.32 0.02 OUTLIER Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.417 -0.897 . . . . 0.0 112.949 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.9 tttt -84.27 160.2 20.79 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.822 0.311 . . . . 0.0 110.675 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 26.8 p -94.91 104.68 16.57 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.876 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 25.3 pt -114.96 153.6 16.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-O 120.754 0.312 . . . . 0.0 111.172 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.1 p -106.07 149.89 26.29 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.935 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.97 89.03 2.86 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-O 120.669 0.271 . . . . 0.0 111.264 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.13 94.91 6.22 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.766 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.8 m -129.94 174.12 13.13 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 CA-C-O 120.71 0.291 . . . . 0.0 111.288 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.06 160.06 27.53 Favored Pre-proline 0 C--O 1.231 0.13 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.107 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -55.44 -29.19 67.52 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.648 2.232 . . . . 0.0 112.839 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 42.0 t -78.78 -15.08 58.86 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 111.67 0.248 . . . . 0.0 111.67 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -64.94 122.0 15.96 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-O 120.674 0.273 . . . . 0.0 110.808 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -85.09 178.71 7.45 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.823 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.3 mt -68.17 -39.23 80.91 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.084 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -66.61 -41.25 88.7 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.658 -0.247 . . . . 0.0 111.069 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -62.96 -45.8 90.72 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.649 0.261 . . . . 0.0 111.004 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 31.8 m -63.98 -29.7 48.01 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.524 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.62 -43.99 76.65 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.658 0.266 . . . . 0.0 110.807 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.87 -33.07 74.02 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.046 179.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -63.9 -28.39 69.81 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.038 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 40.8 mm -75.25 -46.04 39.7 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.201 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -65.35 -40.52 93.71 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.91 178.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.27 -24.69 66.57 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.288 179.494 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.8 mmtm -74.78 -55.47 5.8 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.525 0.202 . . . . 0.0 111.295 -179.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -115.47 -49.77 2.74 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.618 0.247 . . . . 0.0 111.19 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 113.69 64.02 0.43 Allowed Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.679 -0.772 . . . . 0.0 111.851 -179.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.3 pp -77.89 111.59 19.07 Favored Pre-proline 0 CA--C 1.531 0.223 0 CA-C-O 120.634 0.254 . . . . 0.0 111.347 -179.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.534 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 31.5 Cg_exo -59.34 -43.61 39.47 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.683 2.255 . . . . 0.0 113.444 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.534 ' HD2' ' N ' ' A' ' 37' ' ' PRO . 54.9 Cg_endo -71.86 111.25 3.11 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.06 1.84 . . . . 0.0 112.755 -179.23 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -68.69 -13.61 62.48 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.055 -0.52 . . . . 0.0 112.098 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -91.08 21.9 4.02 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.454 0.538 . . . . 0.0 112.454 -179.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -93.11 97.77 10.89 Favored 'General case' 0 C--O 1.23 0.067 0 O-C-N 122.249 -0.282 . . . . 0.0 110.289 179.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.0 mtm180 -137.68 -175.82 4.21 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-O 120.715 0.293 . . . . 0.0 111.043 -179.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.1 pp -101.59 141.52 34.33 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.944 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.3 tt -111.17 113.91 45.61 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.239 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.429 ' CE1' HG22 ' A' ' 66' ' ' THR . 5.9 t80 -152.52 130.96 12.14 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.797 0.332 . . . . 0.0 111.306 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.82 28.87 13.04 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.776 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 45.07 48.15 9.86 Favored Glycine 0 C--N 1.336 0.543 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.903 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.42 ' HG2' ' CD1' ' A' ' 59' ' ' TYR . 12.4 mptt -99.88 140.75 33.64 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.764 0.282 . . . . 0.0 110.942 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.15 99.62 12.57 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.885 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -79.27 -8.05 58.75 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.838 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -78.57 -30.45 46.77 Favored 'General case' 0 CA--C 1.53 0.21 0 O-C-N 122.346 -0.221 . . . . 0.0 111.29 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -45.43 -39.23 6.85 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.567 0.222 . . . . 0.0 111.3 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 105.16 49.32 1.0 Allowed Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.745 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.3 -179.11 3.83 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.724 0.262 . . . . 0.0 110.698 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 10.6 m -99.08 140.72 32.81 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.643 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.0 mp -51.77 -48.23 63.82 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.824 0.345 . . . . 0.0 110.833 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.5 t -55.31 -36.99 66.81 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.24 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -54.27 -35.69 62.81 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 111.505 0.187 . . . . 0.0 111.505 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.42 ' CD1' ' HG2' ' A' ' 48' ' ' LYS . 68.7 m-85 -100.09 21.26 13.09 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.3 m120 65.59 8.67 5.29 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 112.791 0.664 . . . . 0.0 112.791 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.436 ' O ' HG22 ' A' ' 61' ' ' ILE . 1.2 tt -90.14 63.13 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-O 120.883 0.373 . . . . 0.0 110.666 179.321 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -94.57 -173.52 3.05 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.245 -179.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.428 ' O ' ' HG2' ' A' ' 64' ' ' GLU . 0.1 OUTLIER -39.96 147.68 0.09 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.727 -179.593 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.428 ' HG2' ' O ' ' A' ' 63' ' ' LYS . 0.7 OUTLIER 65.53 15.02 9.83 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.992 -179.747 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.5 m -76.23 174.2 10.43 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.754 0.312 . . . . 0.0 110.839 179.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.429 HG22 ' CE1' ' A' ' 45' ' ' PHE . 5.9 t -107.24 90.65 3.37 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.248 179.437 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.2 mt -98.9 113.86 26.19 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.747 0.308 . . . . 0.0 111.39 -179.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -107.22 120.93 43.47 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.385 179.361 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -93.76 156.45 16.67 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.713 0.292 . . . . 0.0 111.155 -179.648 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -104.07 166.22 3.08 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.747 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.3 mp . . . . . 0 C--N 1.332 -0.161 0 CA-C-O 120.677 0.275 . . . . 0.0 110.751 -179.975 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.319 0 CA-C-O 120.601 0.238 . . . . 0.0 111.194 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.1 mp0 -95.05 106.67 18.69 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.05 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 17.4 tt -139.01 153.17 24.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.985 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -118.79 97.06 5.53 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.968 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.5 t -98.97 152.72 4.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.981 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.28 130.92 56.11 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.698 0.285 . . . . 0.0 111.014 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.6 p -100.03 175.53 5.73 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.45 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.415 ' CD2' ' CG2' ' A' ' 9' ' ' THR . 0.0 OUTLIER -66.86 -21.91 66.0 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 179.417 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.415 ' CG2' ' CD2' ' A' ' 8' ' ' LEU . 67.8 p -105.54 28.87 7.01 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.19 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 47.59 32.85 8.21 Favored Glycine 0 C--N 1.336 0.541 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.991 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.49 146.37 27.63 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.969 0.385 . . . . 0.0 111.023 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.0 t -103.22 110.32 22.25 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.804 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.0 pt -125.08 166.67 20.36 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.297 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.1 p -104.49 152.52 22.27 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.711 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 tp -137.99 140.29 40.11 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.668 0.271 . . . . 0.0 111.044 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -101.0 139.05 37.24 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.701 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.6 t -138.53 138.3 42.71 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 CA-C-O 120.78 0.324 . . . . 0.0 111.354 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.418 ' HB2' ' HD2' ' A' ' 19' ' ' PRO . 11.6 pt-20 -100.08 167.87 10.33 Favored Pre-proline 0 C--N 1.332 -0.156 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.55 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.418 ' HD2' ' HB2' ' A' ' 18' ' ' GLU . 52.7 Cg_exo -54.86 -58.88 0.99 Allowed 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.39 2.06 . . . . 0.0 112.164 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.5 t -90.58 38.51 0.95 Allowed 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -75.42 114.13 13.61 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-O 120.576 0.227 . . . . 0.0 111.067 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 31.1 p -85.18 158.43 20.37 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.639 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.5 tp -57.97 -32.83 44.56 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-N 116.718 -0.219 . . . . 0.0 111.277 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -77.89 -40.76 38.86 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.642 0.258 . . . . 0.0 110.858 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -62.94 -34.77 78.18 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.15 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 12.1 p -69.32 -15.68 19.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.47 -33.0 63.26 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.582 0.229 . . . . 0.0 111.104 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.19 -36.39 79.51 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.57 0.224 . . . . 0.0 111.045 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.3 mttp -64.04 -43.49 95.39 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.706 -0.225 . . . . 0.0 111.114 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.2 tt -64.82 -30.36 50.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 116.727 -0.215 . . . . 0.0 111.252 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -65.22 -20.81 66.61 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 120.44 0.162 . . . . 0.0 111.238 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -51.99 -24.76 7.05 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 112.181 0.438 . . . . 0.0 112.181 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.88 -73.49 0.22 Allowed 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.967 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -167.1 41.36 0.05 OUTLIER 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.419 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . 53.02 87.81 0.01 OUTLIER Glycine 0 C--N 1.335 0.504 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.443 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.423 ' CG2' ' HD2' ' A' ' 38' ' ' PRO . 4.2 mp -78.55 110.76 15.09 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-O 120.571 0.225 . . . . 0.0 111.02 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.436 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 36.3 Cg_exo -59.86 -47.05 16.86 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.614 2.21 . . . . 0.0 113.085 -179.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.436 ' HD2' ' N ' ' A' ' 37' ' ' PRO . 77.3 Cg_exo -41.12 96.24 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.669 2.246 . . . . 0.0 112.924 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -68.22 -20.29 64.82 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.449 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -99.98 34.39 2.32 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 111.552 0.205 . . . . 0.0 111.552 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 3.7 tp60 -93.2 115.32 27.94 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-O 120.526 0.203 . . . . 0.0 110.485 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 11.1 ptt-85 -143.98 178.92 7.52 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.653 0.263 . . . . 0.0 111.199 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -97.85 152.67 18.95 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.918 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.2 tt -104.59 77.06 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 CA-C-O 120.848 0.356 . . . . 0.0 111.038 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -150.81 116.96 5.61 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.119 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.6 32.15 21.84 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.538 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 46.5 68.16 1.18 Allowed Glycine 0 C--N 1.337 0.595 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.993 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.421 ' HG3' ' CD2' ' A' ' 59' ' ' TYR . 0.3 OUTLIER -110.0 127.53 54.86 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 116.761 0.281 . . . . 0.0 111.039 179.953 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -89.19 126.51 35.51 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.854 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -79.14 -24.51 43.28 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.454 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.452 ' O ' ' O ' ' A' ' 52' ' ' ASP . 4.1 tt0 -78.89 -36.15 42.5 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 121.279 -0.168 . . . . 0.0 111.395 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.452 ' O ' ' O ' ' A' ' 51' ' ' GLU . 0.2 OUTLIER -49.11 -171.62 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 121.57 0.7 . . . . 0.0 111.517 179.952 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -118.9 40.63 2.21 Favored Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 115.329 -0.851 . . . . 0.0 112.18 179.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -97.7 155.23 17.1 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-O 120.66 0.266 . . . . 0.0 111.003 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.8 t -99.14 156.59 16.87 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.939 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.7 mp -62.37 -36.52 82.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.281 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.5 t -58.75 -42.13 88.13 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -179.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -57.28 -25.25 58.92 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -179.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.421 ' CD2' ' HG3' ' A' ' 48' ' ' LYS . 0.5 OUTLIER -97.65 12.8 32.39 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 111.736 0.273 . . . . 0.0 111.736 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.5 m120 54.81 28.68 10.66 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.401 ' O ' ' CG2' ' A' ' 61' ' ' ILE . 0.0 OUTLIER -89.5 96.32 6.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.173 0 CA-C-O 120.877 0.37 . . . . 0.0 110.746 179.668 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.05 172.72 7.96 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.762 0.315 . . . . 0.0 111.024 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.14 155.14 1.01 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.218 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 63.78 22.01 12.9 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.459 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -75.74 177.48 6.84 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-O 120.752 0.31 . . . . 0.0 110.8 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.5 m -107.06 80.98 1.48 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.561 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -98.85 110.47 23.07 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.109 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -107.08 125.13 50.64 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.66 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 9.5 mp -93.98 174.65 7.05 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.658 0.266 . . . . 0.0 110.917 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 30.2 t -103.83 141.29 19.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.036 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.1 mt -77.25 130.94 37.89 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.816 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.3 55.68 2.33 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.127 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.1 tp -80.22 -45.22 18.39 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.708 0.29 . . . . 0.0 110.797 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.02 119.7 30.59 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.89 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -77.62 -42.54 17.29 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.542 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.381 -1.233 . . . . 0.0 112.491 179.978 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.4 ptt? . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 120.667 0.27 . . . . 0.0 111.22 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.0 mt-30 -95.03 127.6 41.21 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.691 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 27.3 pt -138.93 173.44 11.85 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.144 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -118.91 100.31 7.29 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.677 0.275 . . . . 0.0 110.896 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.6 t -105.07 149.74 8.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.109 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.417 ' HE3' ' CE1' ' A' ' 68' ' ' HIS . 0.1 OUTLIER -106.96 125.82 51.5 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.86 -179.966 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.3 p -99.21 -166.33 1.34 Allowed 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.45 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.72 -44.06 82.62 Favored 'General case' 0 C--O 1.231 0.115 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -178.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.1 m -111.06 51.62 0.77 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.81 0.338 . . . . 0.0 111.319 -179.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 44.18 40.8 6.03 Favored Glycine 0 C--N 1.335 0.487 0 C-N-CA 121.183 -0.532 . . . . 0.0 113.344 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.6 tttt -84.22 134.9 34.53 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.827 0.314 . . . . 0.0 110.834 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.3 t -99.34 110.1 22.65 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.728 0.299 . . . . 0.0 110.907 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.1 pt -125.09 166.79 20.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.214 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.4 t -101.33 148.78 24.73 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.654 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -137.94 108.9 6.72 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.708 0.289 . . . . 0.0 111.055 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -101.01 138.12 38.48 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.707 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.6 t -140.06 149.0 22.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.745 0.307 . . . . 0.0 111.386 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.412 ' HB2' ' HD2' ' A' ' 19' ' ' PRO . 6.7 pt-20 -96.96 157.46 35.01 Favored Pre-proline 0 C--N 1.332 -0.164 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.7 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.412 ' HD2' ' HB2' ' A' ' 18' ' ' GLU . 10.7 Cg_endo -54.07 -36.03 83.51 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.852 2.368 . . . . 0.0 113.135 -179.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.9 0.47 56.57 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.46 128.09 34.55 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.648 0.261 . . . . 0.0 111.032 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.8 p -85.16 159.96 20.02 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.529 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.4 tt -57.98 -36.38 56.03 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.469 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -71.37 -32.3 68.33 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.751 -0.204 . . . . 0.0 111.288 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -62.88 -43.6 98.35 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.547 0.213 . . . . 0.0 111.164 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.9 p -63.82 -28.6 45.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-N 116.738 -0.21 . . . . 0.0 111.32 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.9 mmpt? -59.61 -30.4 68.66 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-O 120.527 0.204 . . . . 0.0 111.235 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.83 -52.93 63.46 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.546 0.212 . . . . 0.0 111.193 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 18.8 ptmt -63.91 -34.61 78.36 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.692 -0.231 . . . . 0.0 111.014 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 57.8 mt -75.22 -14.51 15.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 116.816 -0.175 . . . . 0.0 111.403 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -65.48 -13.24 58.38 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -50.36 -29.91 11.05 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.3 ptpp? -79.72 -21.91 43.97 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 121.036 -0.265 . . . . 0.0 111.432 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 74.47 40.77 0.39 Allowed 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.657 0.265 . . . . 0.0 110.794 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -142.78 30.78 2.04 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.426 -0.892 . . . . 0.0 113.053 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.535 ' HB ' ' CD ' ' A' ' 37' ' ' PRO . 29.3 mm -78.68 -61.3 0.54 Allowed Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 117.107 0.453 . . . . 0.0 111.681 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.535 ' CD ' ' HB ' ' A' ' 36' ' ' ILE . 5.1 Cg_exo -42.13 -51.19 4.9 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.73 2.287 . . . . 0.0 112.887 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.445 ' HD2' ' N ' ' A' ' 37' ' ' PRO . 57.9 Cg_exo -37.39 140.7 0.22 Allowed 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.985 2.456 . . . . 0.0 113.379 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -69.02 -6.3 27.13 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.6 mm-40 -89.89 -28.48 19.19 Favored 'General case' 0 CA--C 1.53 0.211 0 O-C-N 122.115 -0.365 . . . . 0.0 111.567 -179.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 5.2 tp60 -82.87 71.56 9.97 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-O 120.788 0.327 . . . . 0.0 110.787 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 -133.94 -179.08 5.32 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.814 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -103.78 133.88 48.02 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.942 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.7 tt -101.09 61.86 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.025 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -150.87 120.03 6.76 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.077 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 59.61 27.03 16.15 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.616 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 45.28 40.5 7.83 Favored Glycine 0 C--N 1.336 0.576 0 C-N-CA 120.78 -0.724 . . . . 0.0 113.07 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.43 ' HD3' ' CE1' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -103.85 125.94 50.63 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.86 0.33 . . . . 0.0 111.022 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -89.13 144.21 26.29 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.866 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.1 mp -79.53 -5.56 55.14 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.37 -0.377 . . . . 0.0 112.006 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.445 ' O ' ' O ' ' A' ' 52' ' ' ASP . 5.1 mm-40 -78.69 -34.2 46.3 Favored 'General case' 0 CA--C 1.53 0.205 0 O-C-N 122.37 -0.206 . . . . 0.0 111.431 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.445 ' O ' ' O ' ' A' ' 51' ' ' GLU . 0.9 OUTLIER -48.94 -172.54 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 121.485 0.659 . . . . 0.0 111.51 179.872 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -117.0 41.7 2.04 Favored Glycine 0 N--CA 1.451 -0.361 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.257 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -104.44 162.03 13.58 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.664 0.268 . . . . 0.0 111.037 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.8 t -99.14 148.12 24.4 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.821 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.4 mp -51.85 -47.95 64.19 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.186 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.5 t -52.87 -29.09 26.19 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.728 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -53.65 -40.3 65.75 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.43 0.157 . . . . 0.0 111.357 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.43 ' CE1' ' HD3' ' A' ' 48' ' ' LYS . 36.9 m-85 -103.29 25.27 9.75 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 111.595 0.221 . . . . 0.0 111.595 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 56.27 24.02 7.76 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -90.01 62.69 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-O 120.815 0.341 . . . . 0.0 110.777 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -94.86 -172.16 2.64 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.917 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.439 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 18.4 tttp -40.52 142.35 0.43 Allowed 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.706 0.289 . . . . 0.0 111.55 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.439 ' HG3' ' O ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER 65.07 21.25 12.21 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.642 -179.838 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.4 p -75.59 175.61 8.41 Favored 'General case' 0 CA--C 1.527 0.08 0 CA-C-O 120.63 0.252 . . . . 0.0 110.835 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.0 m -102.59 86.19 2.73 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.682 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.5 mt -99.01 105.48 17.63 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.065 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.417 ' CE1' ' HE3' ' A' ' 6' ' ' LYS . 3.6 t60 -107.09 121.11 43.85 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.785 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -96.69 169.77 9.65 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.748 0.309 . . . . 0.0 110.931 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.3 t -103.99 153.24 6.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.031 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.5 mp -76.97 112.33 13.48 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.844 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 68.9 ttt-85 -93.14 84.97 4.93 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.894 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -79.99 -45.41 18.48 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.825 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 12.2 mmm-85 -90.03 156.17 18.58 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.883 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -94.08 -46.58 3.06 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.49 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.379 -1.234 . . . . 0.0 112.488 -179.972 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.4 ptt? . . . . . 0 N--CA 1.488 1.425 0 N-CA-C 111.629 0.233 . . . . 0.0 111.629 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -93.43 -26.86 17.04 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 111.62 0.23 . . . . 0.0 111.62 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.2 pt -138.53 174.58 9.96 Favored 'Isoleucine or valine' 0 C--O 1.231 0.092 0 CA-C-O 120.623 0.249 . . . . 0.0 111.159 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -118.9 106.55 12.6 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.732 0.301 . . . . 0.0 110.891 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.4 t -99.17 150.16 5.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.079 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.95 127.46 53.46 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.794 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.1 p -99.21 -168.29 1.6 Allowed 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.356 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.79 -40.45 88.13 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 120.663 0.268 . . . . 0.0 111.355 -178.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -111.17 41.46 1.84 Allowed 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 120.721 0.296 . . . . 0.0 111.086 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 47.28 42.53 17.93 Favored Glycine 0 C--N 1.335 0.504 0 C-N-CA 120.861 -0.685 . . . . 0.0 113.066 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.9 mtpm? -84.22 163.04 19.95 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.749 0.274 . . . . 0.0 110.926 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.4 m -103.07 118.06 35.95 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.895 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.4 pp -125.17 158.16 33.41 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-O 120.697 0.284 . . . . 0.0 111.182 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.8 p -101.19 128.49 47.27 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.86 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.3 144.61 50.71 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.922 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -100.44 162.39 12.97 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.841 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.9 t -129.99 103.88 9.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.106 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.416 ' HB2' ' HD2' ' A' ' 19' ' ' PRO . 10.4 pt-20 -103.72 157.3 34.19 Favored Pre-proline 0 C--N 1.332 -0.172 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.66 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.416 ' HD2' ' HB2' ' A' ' 18' ' ' GLU . 8.0 Cg_endo -50.13 -57.15 2.48 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.621 2.214 . . . . 0.0 112.187 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 44.9 t -90.3 36.41 0.88 Allowed 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -75.26 107.37 7.32 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-O 120.695 0.284 . . . . 0.0 110.93 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.4 m -85.23 157.99 20.46 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.526 -0.307 . . . . 0.0 110.831 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.7 mt -65.78 -34.41 70.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.027 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -75.33 -33.35 61.12 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.725 -0.216 . . . . 0.0 111.151 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -62.79 -41.67 99.37 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.559 0.218 . . . . 0.0 111.059 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.9 m -63.86 -23.5 33.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.614 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -55.82 -36.45 67.49 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 120.494 0.188 . . . . 0.0 111.196 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.78 -45.35 86.13 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-O 120.639 0.257 . . . . 0.0 111.181 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 14.1 mttm -63.91 -42.39 97.44 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.781 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.409 ' CG2' ' CG2' ' A' ' 36' ' ' ILE . 33.2 mm -75.01 -27.48 20.02 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.446 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -65.15 -16.91 64.02 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -50.4 -32.67 18.27 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 111.601 0.223 . . . . 0.0 111.601 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.37 -30.58 23.52 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 121.125 -0.23 . . . . 0.0 111.07 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 65.31 26.22 12.12 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 120.61 0.243 . . . . 0.0 110.871 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -112.08 -48.25 0.67 Allowed Glycine 0 C--N 1.334 0.465 0 C-N-CA 120.453 -0.88 . . . . 0.0 112.952 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.623 ' N ' ' CD ' ' A' ' 37' ' ' PRO . 7.6 tt -84.21 -24.78 0.35 Allowed Pre-proline 0 CA--C 1.54 0.592 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -179.227 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.623 ' CD ' ' N ' ' A' ' 36' ' ' ILE . 78.3 Cg_exo -42.96 -41.7 9.05 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 122.309 2.006 . . . . 0.0 113.791 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.488 ' CD ' ' N ' ' A' ' 37' ' ' PRO . 66.8 Cg_exo -53.39 -147.78 0.0 OUTLIER 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.446 2.097 . . . . 0.0 112.668 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -68.09 -4.08 12.39 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -179.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -90.34 -4.08 57.32 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 121.97 -0.457 . . . . 0.0 111.856 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.21 89.63 6.51 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-O 120.582 0.229 . . . . 0.0 110.971 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -144.01 151.93 40.35 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.973 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.4 tp -107.97 142.38 38.19 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.847 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.2 tt -111.06 65.86 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-O 120.752 0.311 . . . . 0.0 111.097 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -150.89 127.74 10.99 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.194 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.447 ' CB ' ' CE1' ' A' ' 59' ' ' TYR . . . 59.86 31.41 20.74 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.636 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 45.21 39.3 6.91 Favored Glycine 0 C--N 1.337 0.584 0 C-N-CA 120.808 -0.71 . . . . 0.0 113.079 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.1 mttm -109.73 145.43 36.62 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.787 0.294 . . . . 0.0 110.954 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -89.07 174.4 7.9 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.866 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.21 -37.16 38.86 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.184 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -89.35 8.8 28.75 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -47.24 -41.03 17.79 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.646 0.26 . . . . 0.0 111.159 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.98 23.82 24.28 Favored Glycine 0 CA--C 1.522 0.504 0 C-N-CA 120.757 -0.735 . . . . 0.0 113.039 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.6 mmt180 -107.38 177.25 4.9 Favored 'General case' 0 C--N 1.334 -0.083 0 CA-C-N 117.132 0.466 . . . . 0.0 110.753 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 4.4 m -99.44 130.82 45.73 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.491 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.21 -32.45 23.93 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 120.601 0.239 . . . . 0.0 110.916 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.2 t -61.5 -27.25 68.46 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.625 -0.262 . . . . 0.0 111.607 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.404 ' OD1' ' N ' ' A' ' 59' ' ' TYR . 2.5 p30 -53.74 -30.21 43.13 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 120.859 -0.336 . . . . 0.0 111.492 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.447 ' CE1' ' CB ' ' A' ' 46' ' ' ALA . 3.4 t80 -107.8 37.09 2.53 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 120.569 0.223 . . . . 0.0 111.248 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 23.6 m120 54.77 32.91 18.47 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.649 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.455 HG21 HD13 ' A' ' 61' ' ' ILE . 22.1 mt -89.37 76.46 1.3 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-O 120.69 0.281 . . . . 0.0 110.849 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.03 -174.34 2.51 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.0 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.54 144.89 1.41 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.78 0.324 . . . . 0.0 111.255 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 63.37 21.23 12.69 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.617 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.5 m -75.85 162.15 28.38 Favored 'General case' 0 CA--C 1.527 0.092 0 CA-C-O 120.642 0.258 . . . . 0.0 110.808 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -107.03 83.01 1.76 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.552 179.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.9 pp -98.92 126.93 44.72 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.132 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -107.06 117.94 35.4 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.686 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.73 114.77 27.14 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.776 0.322 . . . . 0.0 110.817 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.4 p -111.83 152.61 13.67 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.016 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -87.07 131.09 34.23 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.883 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 13.5 ttp180 -93.02 102.59 14.93 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.957 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -81.73 44.92 0.85 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.618 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 10.9 mtp180 -90.1 102.5 15.22 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.719 0.295 . . . . 0.0 110.877 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -143.15 79.42 0.25 Allowed Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.5 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.441 -1.199 . . . . 0.0 112.53 179.982 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.359 0.124 . . . . 0.0 111.021 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 52.6 mm-40 -84.81 -39.56 18.22 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 -179.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.422 HD11 HG22 ' A' ' 3' ' ' ILE . 0.9 OUTLIER -138.68 169.0 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.129 0 CA-C-O 120.582 0.23 . . . . 0.0 111.11 -179.607 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -118.5 103.8 10.08 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.74 0.305 . . . . 0.0 111.013 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.8 t -129.5 154.34 40.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.773 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.2 mttt -106.76 152.89 23.23 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.65 0.262 . . . . 0.0 111.022 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -99.88 -143.47 0.33 Allowed 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.62 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.434 ' HG ' ' N ' ' A' ' 9' ' ' THR . 1.7 pt? -64.82 -41.6 95.64 Favored 'General case' 0 C--N 1.341 0.23 0 CA-C-N 118.791 0.723 . . . . 0.0 111.164 -179.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.434 ' N ' ' HG ' ' A' ' 8' ' ' LEU . 94.9 m -111.36 -64.91 1.22 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.774 0.321 . . . . 0.0 110.652 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 178.0 47.71 0.07 OUTLIER Glycine 0 CA--C 1.521 0.42 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.746 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.49 -179.65 7.2 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.729 0.3 . . . . 0.0 110.996 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.2 t -103.07 114.59 29.0 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.709 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 11.9 tt -123.65 136.26 60.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 120.704 0.288 . . . . 0.0 111.228 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.7 t -106.02 168.17 9.3 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.779 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.13 87.3 2.35 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-O 120.702 0.287 . . . . 0.0 110.896 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -101.03 93.88 5.72 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.801 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.5 m -131.47 174.53 12.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.208 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -97.05 164.3 18.15 Favored Pre-proline 0 C--N 1.332 -0.171 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.755 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -60.23 -38.44 75.99 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.64 2.227 . . . . 0.0 112.349 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.4 p -78.82 -24.35 44.56 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.389 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -64.86 118.89 9.69 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-O 120.641 0.257 . . . . 0.0 110.846 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.5 p -85.2 -175.43 5.72 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.826 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.9 mt -63.11 -40.55 89.45 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.027 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -52.09 -44.04 64.2 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.665 0.269 . . . . 0.0 111.075 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.07 -34.83 78.42 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.917 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.3 t -73.84 -12.93 15.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.405 ' HA ' ' CG2' ' A' ' 30' ' ' ILE . 2.5 mmpt? -55.48 -39.15 70.05 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 120.569 0.223 . . . . 0.0 111.073 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.88 -42.39 81.32 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-O 120.717 0.294 . . . . 0.0 111.248 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.8 mttm -74.54 -40.0 61.99 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.669 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.405 ' CG2' ' HA ' ' A' ' 27' ' ' LYS . 20.2 tt -74.35 -23.61 18.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -179.128 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.01 75.21 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 120.856 0.36 . . . . 0.0 110.959 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.404 ' N ' ' O ' ' A' ' 30' ' ' ILE . 36.6 t70 -60.26 -67.89 0.35 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.137 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.77 -86.36 0.14 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.965 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -178.37 43.42 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 121.119 -0.232 . . . . 0.0 111.371 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -151.2 31.2 0.96 Allowed Glycine 0 C--N 1.334 0.458 0 C-N-CA 120.432 -0.889 . . . . 0.0 113.04 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.538 ' HB ' ' CD ' ' A' ' 37' ' ' PRO . 1.8 mp -88.93 -65.53 0.17 Allowed Pre-proline 0 CA--C 1.535 0.375 0 CA-C-N 117.09 0.445 . . . . 0.0 111.411 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.538 ' CD ' ' HB ' ' A' ' 36' ' ' ILE . 3.6 Cg_exo -38.74 -51.08 2.38 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 122.779 2.319 . . . . 0.0 112.977 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_exo -41.33 163.65 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.711 2.274 . . . . 0.0 113.174 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -69.65 2.15 3.52 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -89.78 -21.71 22.5 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 118.17 0.441 . . . . 0.0 111.599 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.5 tp60 -93.11 109.98 21.47 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 120.996 -0.281 . . . . 0.0 110.785 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 3.7 ptp180 -142.36 160.83 39.5 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.015 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -108.03 160.42 15.8 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.824 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 25.1 mm -111.06 69.79 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.157 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -151.13 122.01 7.59 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.176 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 56.59 31.98 20.1 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.547 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 45.86 37.55 7.35 Favored Glycine 0 C--N 1.335 0.522 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.974 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.422 ' HD3' ' CE2' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -110.02 134.29 52.29 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.846 0.323 . . . . 0.0 111.054 -179.977 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -89.09 162.76 15.81 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.837 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -79.15 -13.17 59.89 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.612 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -78.97 -38.26 37.41 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 120.536 0.208 . . . . 0.0 111.141 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -47.98 118.12 2.21 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -68.21 54.18 0.43 Allowed Glycine 0 CA--C 1.521 0.443 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.666 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.07 173.85 6.15 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 117.002 0.401 . . . . 0.0 110.751 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 57.0 m -99.27 137.1 38.25 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.675 -0.239 . . . . 0.0 110.836 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 52.9 mt -52.26 -41.43 62.81 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.919 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.7 t -59.22 -29.38 67.47 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.432 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -53.68 -40.45 65.96 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 121.192 -0.203 . . . . 0.0 111.379 -179.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.422 ' CE2' ' HD3' ' A' ' 48' ' ' LYS . 62.2 m-85 -104.64 36.28 2.47 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-O 120.672 0.272 . . . . 0.0 111.374 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 55.47 25.63 8.0 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.464 HD11 HG21 ' A' ' 61' ' ' ILE . 38.1 mt -89.92 62.52 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.123 0 CA-C-O 120.812 0.339 . . . . 0.0 110.975 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.01 -174.81 2.67 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.033 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -44.47 144.1 1.14 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.823 0.344 . . . . 0.0 111.443 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 64.98 19.22 11.8 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.672 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 7.5 p -75.89 170.12 16.84 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-O 120.616 0.246 . . . . 0.0 110.873 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.8 t -107.12 83.69 1.86 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.437 179.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 13.0 mt -98.85 104.78 16.85 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.767 0.318 . . . . 0.0 111.325 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -107.19 100.88 10.31 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.627 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.5 mp -93.97 163.26 13.56 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.559 -0.292 . . . . 0.0 111.029 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.7 t -103.98 121.38 55.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.065 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.537 HD13 ' O ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -76.55 113.34 14.06 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.36 0.6 . . . . 0.0 111.379 -179.514 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.2 mmm180 -93.74 66.57 3.75 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.176 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.402 ' HB2' ' CD2' ' A' ' 71' ' ' LEU . 9.4 tp -80.42 -43.94 20.13 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.667 0.27 . . . . 0.0 110.909 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -88.93 134.07 34.09 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.554 -0.293 . . . . 0.0 110.918 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 78.82 42.19 13.5 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.527 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.411 -1.216 . . . . 0.0 112.521 179.931 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.3 ttt . . . . . 0 N--CA 1.487 1.409 0 CA-C-O 120.65 0.262 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 82.2 mm-40 -94.78 -46.68 6.79 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.944 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.432 HG23 HD12 ' A' ' 3' ' ' ILE . 0.2 OUTLIER -146.21 -175.76 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.096 -179.993 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -118.66 99.22 6.65 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.775 0.322 . . . . 0.0 110.74 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.2 t -116.84 121.25 67.32 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.895 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 41.7 mttt -106.86 122.34 46.2 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.702 0.287 . . . . 0.0 110.845 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -99.75 -75.01 0.58 Allowed 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.64 -110.37 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 111.553 0.205 . . . . 0.0 111.553 -179.27 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.9 t -111.51 57.62 0.63 Allowed 'General case' 0 CA--C 1.529 0.155 0 O-C-N 122.175 -0.328 . . . . 0.0 111.038 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.95 37.01 5.83 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.632 -0.794 . . . . 0.0 113.23 179.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.1 tttm -84.39 142.09 30.38 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 117.077 0.438 . . . . 0.0 110.731 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.9 t -98.22 117.87 33.58 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.846 0.355 . . . . 0.0 110.924 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.3 pt -125.09 146.36 30.89 Favored 'Isoleucine or valine' 0 C--O 1.231 0.112 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.189 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.1 t -97.37 130.76 44.48 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.769 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -129.82 133.42 46.94 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.983 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -100.77 176.03 5.44 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.877 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.7 t -129.99 104.59 10.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.755 0.312 . . . . 0.0 111.16 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -107.09 161.57 22.5 Favored Pre-proline 0 C--O 1.232 0.148 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.811 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_exo -51.74 -56.76 2.66 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.398 2.066 . . . . 0.0 112.365 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 38.7 p -90.3 38.26 0.93 Allowed 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -75.28 84.96 2.45 Favored 'General case' 0 C--O 1.232 0.182 0 O-C-N 122.308 -0.245 . . . . 0.0 110.912 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.2 p -85.04 163.22 18.97 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.637 0.256 . . . . 0.0 110.807 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 34.5 mm -68.13 -42.89 85.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.001 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -54.1 -41.9 68.8 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.653 0.263 . . . . 0.0 110.986 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -68.71 -39.44 80.47 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.823 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 42.5 t -63.95 -44.64 97.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 CA-C-O 120.613 0.244 . . . . 0.0 110.906 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.6 mttm -59.39 -43.96 92.88 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.704 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.04 -37.11 73.75 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.126 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.9 tmtt? -66.9 -40.44 87.7 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.644 -0.253 . . . . 0.0 110.912 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 31.9 mm -69.8 -49.76 54.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.659 0.266 . . . . 0.0 110.895 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -65.08 -24.98 67.6 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.318 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -50.92 -32.25 20.15 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 111.605 0.224 . . . . 0.0 111.605 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.8 -27.81 26.58 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 121.218 -0.193 . . . . 0.0 111.296 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 67.87 31.67 5.61 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-O 120.66 0.267 . . . . 0.0 110.891 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -94.33 -42.27 4.03 Favored Glycine 0 C--N 1.334 0.437 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.377 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.419 ' CG1' ' HD2' ' A' ' 38' ' ' PRO . 19.9 tt -89.17 110.93 41.98 Favored Pre-proline 0 CA--C 1.531 0.223 0 CA-C-O 120.6 0.238 . . . . 0.0 111.062 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.468 ' HB2' ' HD3' ' A' ' 38' ' ' PRO . 33.4 Cg_exo -58.58 -48.52 14.84 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.365 2.043 . . . . 0.0 112.512 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.468 ' HD3' ' HB2' ' A' ' 37' ' ' PRO . 84.4 Cg_exo -44.46 94.25 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.556 2.171 . . . . 0.0 112.488 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -68.2 -31.78 71.54 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.256 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.6 mm-40 -101.01 42.88 1.09 Allowed 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.64 0.257 . . . . 0.0 111.166 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.87 131.81 35.18 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.655 0.264 . . . . 0.0 110.722 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -134.88 -178.18 4.96 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.957 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.87 126.53 43.29 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.766 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -101.06 88.8 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.841 0.353 . . . . 0.0 111.272 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.419 ' CE1' HG21 ' A' ' 66' ' ' THR . 9.5 t80 -150.87 131.92 14.32 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.17 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.6 29.63 19.15 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.656 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 45.53 40.95 8.88 Favored Glycine 0 C--N 1.336 0.555 0 C-N-CA 120.932 -0.652 . . . . 0.0 113.038 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.425 ' HG2' ' CE1' ' A' ' 59' ' ' TYR . 17.1 mttt -108.56 138.54 44.7 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.785 0.293 . . . . 0.0 110.953 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.1 tp-100 -89.11 120.54 30.6 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.974 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.7 mp -79.58 -6.1 56.36 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -78.75 -20.07 50.81 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 111.667 0.247 . . . . 0.0 111.667 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -46.44 -38.33 8.93 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.571 0.224 . . . . 0.0 111.34 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.97 43.04 2.5 Favored Glycine 0 CA--C 1.52 0.395 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.815 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.2 mmt85 -107.12 -176.54 3.1 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.797 0.298 . . . . 0.0 110.756 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 12.9 t -97.27 172.22 7.93 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.66 0.267 . . . . 0.0 110.975 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.36 -58.41 7.76 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.177 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.3 t -52.97 -29.37 28.65 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -53.7 -38.55 64.35 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 111.609 0.226 . . . . 0.0 111.609 -179.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.425 ' CE1' ' HG2' ' A' ' 48' ' ' LYS . 11.7 m-85 -101.55 20.51 15.94 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 62.93 16.91 9.6 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 23.6 pt -89.89 69.91 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 CA-C-O 120.797 0.332 . . . . 0.0 110.849 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -95.02 -174.01 3.12 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.179 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.65 147.61 0.87 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.789 0.328 . . . . 0.0 111.515 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 65.3 16.03 10.32 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.817 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.9 m -76.18 166.87 22.84 Favored 'General case' 0 CA--C 1.527 0.093 0 CA-C-O 120.738 0.304 . . . . 0.0 110.953 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.419 HG21 ' CE1' ' A' ' 45' ' ' PHE . 7.2 t -106.46 85.79 2.24 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.249 179.297 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.9 mp -98.93 114.36 26.94 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.456 -179.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -107.17 123.45 48.28 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.603 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -93.78 141.79 28.1 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.707 0.289 . . . . 0.0 111.045 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.2 p -114.08 152.75 15.71 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.093 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.47 89.66 3.84 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.781 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.7 tpt180 -93.04 95.71 9.62 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.891 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.8 mt -80.11 -58.59 3.08 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.855 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -90.04 144.34 25.98 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.548 -0.297 . . . . 0.0 110.861 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -142.38 -171.26 13.08 Favored Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.513 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.323 -1.265 . . . . 0.0 112.522 179.952 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.439 ' CG ' ' O ' ' A' ' 3' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 120.44 0.162 . . . . 0.0 111.097 . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -89.64 -19.15 25.25 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -179.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.439 ' O ' ' CG ' ' A' ' 1' ' ' MET . 10.9 pt -138.57 176.64 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.121 0 C-N-CA 120.907 -0.317 . . . . 0.0 111.509 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -118.97 99.82 6.98 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.717 0.294 . . . . 0.0 110.863 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.5 t -107.15 142.03 20.91 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.116 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.052 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.18 141.24 48.4 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.937 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.7 -163.66 1.05 Allowed 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.083 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.404 ' CD2' ' CG2' ' A' ' 9' ' ' THR . 0.0 OUTLIER -68.34 -30.5 69.48 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-O 121.056 0.455 . . . . 0.0 110.117 -179.899 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.404 ' CG2' ' CD2' ' A' ' 8' ' ' LEU . 33.3 p -111.19 -69.46 0.87 Allowed 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.784 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 175.07 47.79 0.05 OUTLIER Glycine 0 C--N 1.333 0.384 0 C-N-CA 120.489 -0.862 . . . . 0.0 112.988 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.68 144.14 28.75 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.861 0.33 . . . . 0.0 110.937 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.2 t -103.06 117.78 35.34 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.574 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.6 pt -125.04 153.24 32.1 Favored 'Isoleucine or valine' 0 C--O 1.231 0.112 0 CA-C-O 120.687 0.28 . . . . 0.0 111.453 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.8 t -106.03 139.16 41.0 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.872 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.4 tp -129.93 144.44 51.32 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.712 0.291 . . . . 0.0 110.903 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.51 147.09 25.11 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.83 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.5 t -130.02 102.07 6.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.201 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -107.12 161.57 22.51 Favored Pre-proline 0 C--O 1.232 0.162 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.507 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -47.1 -53.33 6.48 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.507 2.138 . . . . 0.0 112.256 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.1 m -90.14 41.66 1.06 Allowed 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.801 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 46.1 p-10 -69.13 95.99 0.78 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.679 0.276 . . . . 0.0 110.806 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.03 137.82 32.82 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.951 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 7.5 mt -68.02 -39.72 81.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.193 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -67.32 -41.76 84.76 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.134 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -62.85 -38.39 90.63 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.212 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 12.2 p -73.52 -12.8 15.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 111.957 0.354 . . . . 0.0 111.957 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 12.8 ttmt -55.59 -48.74 74.37 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 120.691 0.282 . . . . 0.0 110.7 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.01 -29.18 68.12 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.14 179.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 24.7 mtpt -63.96 -33.76 76.45 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.753 -0.203 . . . . 0.0 110.953 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 33.8 mm -64.68 -42.73 95.87 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 CA-C-O 120.674 0.273 . . . . 0.0 110.495 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -65.16 -37.06 86.19 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 120.772 0.32 . . . . 0.0 110.68 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -61.49 -18.24 58.18 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.972 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 7.0 mtmm -74.04 -73.83 0.21 Allowed 'General case' 0 C--O 1.231 0.119 0 C-N-CA 121.044 -0.262 . . . . 0.0 111.086 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -137.59 23.7 2.91 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.446 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . 48.65 85.07 0.02 OUTLIER Glycine 0 C--N 1.337 0.636 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.387 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.1 pp -78.44 110.27 13.28 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 120.628 0.251 . . . . 0.0 111.292 -179.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.53 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 34.7 Cg_exo -60.46 -43.41 33.81 Favored 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 122.733 2.288 . . . . 0.0 113.583 -179.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.53 ' HD2' ' N ' ' A' ' 37' ' ' PRO . 55.4 Cg_endo -71.92 118.87 5.84 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.058 1.839 . . . . 0.0 112.943 -179.091 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.0 p-10 -68.66 -12.81 61.83 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.974 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -90.96 22.49 3.63 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -84.45 93.45 8.31 Favored 'General case' 0 CA--C 1.527 0.08 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 179.305 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.5 ttm180 -139.59 177.09 8.19 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.101 -179.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.432 ' N ' ' CD2' ' A' ' 43' ' ' LEU . 2.2 mm? -97.91 165.23 12.03 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.459 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.4 pt -111.02 83.79 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-O 120.696 0.284 . . . . 0.0 111.174 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -150.85 115.46 5.18 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.233 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.78 24.37 14.5 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.859 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 44.37 39.86 5.82 Favored Glycine 0 C--N 1.338 0.654 0 C-N-CA 120.837 -0.697 . . . . 0.0 113.083 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.422 ' HG2' ' CE2' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -100.98 135.49 42.34 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.814 0.307 . . . . 0.0 110.853 -179.82 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -78.96 165.97 22.88 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.828 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.7 pp -79.35 -18.21 52.93 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.74 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -78.91 -26.4 43.78 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 111.782 0.289 . . . . 0.0 111.782 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 38.7 p-10 -47.82 115.52 1.19 Allowed 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 120.807 0.337 . . . . 0.0 110.604 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -70.73 46.73 0.73 Allowed Glycine 0 CA--C 1.521 0.434 0 C-N-CA 120.504 -0.855 . . . . 0.0 112.564 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? -107.26 170.42 7.97 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 117.029 0.414 . . . . 0.0 110.799 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 36.2 m -99.18 137.73 37.29 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.664 -0.243 . . . . 0.0 110.741 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.2 mp -52.05 -42.94 63.52 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.892 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.3 t -57.22 -31.19 65.24 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.479 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -53.83 -34.96 60.86 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 121.194 -0.202 . . . . 0.0 111.404 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.422 ' CE2' ' HG2' ' A' ' 48' ' ' LYS . 39.9 m-85 -103.29 36.23 2.32 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 120.548 0.214 . . . . 0.0 111.396 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 58.14 23.4 10.13 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 26.9 mt -89.81 77.09 1.35 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.141 0 CA-C-O 120.636 0.255 . . . . 0.0 110.962 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -94.96 172.63 8.03 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.714 0.292 . . . . 0.0 111.123 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.08 148.9 3.07 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.212 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 63.3 22.69 13.44 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.444 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.1 m -75.64 177.45 6.8 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-O 120.706 0.288 . . . . 0.0 110.88 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.5 p -107.1 86.65 2.34 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.825 0.345 . . . . 0.0 110.639 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.5 mt -99.02 122.48 42.33 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.153 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 22.6 m-70 -107.09 140.58 39.7 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.813 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.94 -174.42 3.41 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.927 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.1 p -103.71 139.04 25.77 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-O 120.719 0.295 . . . . 0.0 111.046 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.08 101.43 13.46 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.945 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 22.5 ttp-105 -93.12 86.12 5.28 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.879 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.2 pp -80.12 -36.65 35.0 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.106 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -90.08 72.75 7.32 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-O 120.749 0.309 . . . . 0.0 110.922 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -127.8 51.06 0.86 Allowed Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.506 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.35 -1.25 . . . . 0.0 112.452 -179.972 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.9 ttt . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.714 0.292 . . . . 0.0 111.261 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 63.5 mm-40 -90.5 -39.69 12.44 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.097 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.1 pt -138.73 175.57 7.92 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 CA-C-N 116.649 -0.25 . . . . 0.0 110.952 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -118.7 88.99 3.03 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.71 0.291 . . . . 0.0 110.874 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.5 t -108.89 128.35 64.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.179 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -107.51 153.64 22.54 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.752 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.99 -146.95 0.41 Allowed 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 119.488 -0.291 . . . . 0.0 110.616 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.18 -34.24 77.9 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 118.806 0.73 . . . . 0.0 111.542 -179.104 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 73.2 p -111.05 -56.53 2.36 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 120.629 0.252 . . . . 0.0 111.047 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 156.58 57.62 0.01 OUTLIER Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.823 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.2 mmmp? -84.13 154.09 23.33 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.708 0.254 . . . . 0.0 110.886 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.0 t -102.93 114.33 28.53 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.813 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.2 pt -118.25 147.3 21.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.141 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.8 p -105.91 114.5 28.68 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.903 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.28 138.86 51.87 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.876 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -95.18 161.87 13.93 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.911 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.6 t -129.93 117.02 39.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.769 0.318 . . . . 0.0 111.231 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -100.58 164.12 16.83 Favored Pre-proline 0 C--O 1.231 0.101 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.711 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -53.19 -66.36 0.11 Allowed 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.625 2.217 . . . . 0.0 112.38 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.5 m -90.35 35.9 0.87 Allowed 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 112.054 0.391 . . . . 0.0 112.054 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -75.41 113.21 12.55 Favored 'General case' 0 C--O 1.231 0.132 0 CA-C-O 120.647 0.261 . . . . 0.0 110.925 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 10.2 t -85.16 173.8 10.15 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.856 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 51.7 mm -68.16 -40.48 82.94 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.015 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -53.9 -40.01 66.27 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.681 -0.236 . . . . 0.0 111.14 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -62.86 -54.7 34.74 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 120.663 0.268 . . . . 0.0 110.906 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.4 p -63.96 -36.93 78.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.262 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 13.6 tttt -55.87 -41.06 73.83 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.719 -0.219 . . . . 0.0 110.935 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.88 -38.1 75.16 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.147 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.82 -43.31 96.62 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-N 116.67 -0.241 . . . . 0.0 110.806 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.0 mt -66.49 -49.1 77.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.865 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 1.4 tp-100 -59.79 -42.24 92.93 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.818 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -61.01 -25.79 67.15 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.279 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -74.86 -61.68 1.8 Allowed 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 121.173 -0.211 . . . . 0.0 111.095 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -103.17 -46.44 4.62 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.578 0.228 . . . . 0.0 111.089 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.431 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . 85.05 42.97 6.87 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.976 -179.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.431 ' CG1' ' HD2' ' A' ' 38' ' ' PRO . 20.2 tt -78.77 110.55 14.65 Favored Pre-proline 0 CA--C 1.532 0.271 0 CA-C-O 120.713 0.292 . . . . 0.0 111.36 -179.565 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.481 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 31.7 Cg_exo -59.77 -45.72 23.64 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.764 2.309 . . . . 0.0 113.339 -179.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.481 ' HD2' ' N ' ' A' ' 37' ' ' PRO . 46.8 Cg_exo -37.84 122.52 0.51 Allowed 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.988 2.459 . . . . 0.0 113.425 -179.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -69.42 -3.89 16.21 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -90.25 11.21 21.86 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -179.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -88.61 82.54 6.87 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-O 120.693 0.283 . . . . 0.0 110.416 179.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 33.7 mtt180 -136.63 -175.16 3.92 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.976 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.3 mt -97.97 153.97 18.0 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.846 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 17.2 tt -111.04 71.17 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.803 0.335 . . . . 0.0 111.023 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -150.91 132.06 14.41 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.239 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 56.51 28.59 14.03 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.79 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 45.08 40.23 7.11 Favored Glycine 0 C--N 1.337 0.595 0 C-N-CA 120.797 -0.716 . . . . 0.0 113.0 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.02 127.84 46.19 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.837 0.318 . . . . 0.0 110.922 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -89.06 150.66 22.66 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.014 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.9 tp -79.18 -20.94 47.17 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.435 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -78.7 -35.45 44.96 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 120.436 0.16 . . . . 0.0 111.377 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -47.88 115.14 1.07 Allowed 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 110.338 -0.245 . . . . 0.0 110.338 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -69.85 48.49 0.64 Allowed Glycine 0 CA--C 1.522 0.475 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.746 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.0 mtp85 -107.25 -176.69 3.14 Favored 'General case' 0 C--O 1.23 0.07 0 CA-C-N 117.062 0.431 . . . . 0.0 110.646 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.9 m -99.37 134.77 41.76 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.555 0.216 . . . . 0.0 110.488 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.41 ' HB2' ' CG2' ' A' ' 61' ' ' ILE . 0.7 OUTLIER -51.59 -38.45 54.58 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.566 0.222 . . . . 0.0 110.689 179.915 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.6 t -56.23 -28.32 58.02 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.339 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -53.7 -35.04 60.68 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 111.572 0.212 . . . . 0.0 111.572 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -100.32 18.22 19.42 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 64.87 16.16 10.32 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.41 ' CG2' ' HB2' ' A' ' 56' ' ' LEU . 0.6 OUTLIER -89.92 71.23 0.76 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-O 120.878 0.37 . . . . 0.0 110.81 179.488 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -94.77 -178.03 4.39 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.441 -179.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.5 ptpt -47.37 146.1 2.15 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.581 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 65.53 12.62 8.32 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.356 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 41.2 t -76.28 -179.9 5.37 Favored 'General case' 0 C--O 1.231 0.08 0 O-C-N 122.259 -0.276 . . . . 0.0 110.79 179.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -107.12 80.6 1.44 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.342 179.325 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.2 pp -98.89 119.74 38.17 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-O 120.789 0.328 . . . . 0.0 111.319 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 8.8 m170 -107.15 137.0 46.03 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.592 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.7 tp -93.93 171.47 8.84 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.654 0.264 . . . . 0.0 110.846 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.6 t -103.81 129.54 55.75 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.161 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.7 pp -76.91 96.57 4.36 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.87 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.0 -40.67 10.42 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.228 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.5 mp -69.75 -34.27 73.59 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.679 -0.237 . . . . 0.0 111.134 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.78 -39.65 30.44 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.645 0.259 . . . . 0.0 110.943 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -71.0 144.87 38.73 Favored Glycine 0 C--N 1.334 0.44 0 C-N-CA 120.539 -0.838 . . . . 0.0 112.48 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.373 -1.237 . . . . 0.0 112.544 179.982 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.693 0.282 . . . . 0.0 111.253 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -95.15 140.66 29.76 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.809 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.8 tp -138.69 152.91 25.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.941 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.49 80.77 1.58 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.777 0.322 . . . . 0.0 110.866 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.402 ' CG2' ' CD1' ' A' ' 69' ' ' LEU . 10.6 p -134.48 132.44 54.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.84 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.1 mptt -106.97 172.41 6.84 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.778 0.323 . . . . 0.0 111.071 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.4 p -99.91 -175.68 3.03 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.576 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -67.02 -4.04 8.74 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.4 p -99.78 -44.14 6.19 Favored 'General case' 0 CA--C 1.529 0.167 0 O-C-N 122.258 -0.276 . . . . 0.0 111.366 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 141.71 -26.22 2.39 Favored Glycine 0 CA--C 1.521 0.461 0 C-N-CA 120.264 -0.97 . . . . 0.0 113.486 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.8 tmtm? -73.49 143.28 46.66 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 117.416 0.608 . . . . 0.0 110.86 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.9 t -96.24 149.11 22.03 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.154 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.456 HG21 HD13 ' A' ' 13' ' ' ILE . 11.7 tt -125.03 152.24 31.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.076 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.7 m -96.01 135.1 38.22 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.632 -0.258 . . . . 0.0 110.739 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -138.05 142.62 40.31 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.731 0.3 . . . . 0.0 111.127 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -101.13 146.57 27.3 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.732 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.6 t -140.06 138.58 37.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.721 0.296 . . . . 0.0 111.306 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -107.14 162.88 18.27 Favored Pre-proline 0 C--N 1.334 -0.098 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.514 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -48.26 -54.13 5.72 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.395 2.063 . . . . 0.0 112.208 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 98.1 p -90.4 42.16 1.09 Allowed 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.77 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -72.72 98.12 2.32 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 120.669 0.271 . . . . 0.0 110.989 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.4 p -85.14 136.31 33.6 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.708 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.422 HD12 HG23 ' A' ' 23' ' ' ILE . 59.4 mt -68.1 74.01 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.708 0.289 . . . . 0.0 110.916 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -158.36 -59.38 0.08 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.012 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -72.5 -33.85 67.23 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.045 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 39.6 t -63.77 -24.77 36.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 116.794 -0.184 . . . . 0.0 111.471 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -55.6 -41.71 73.81 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.701 0.286 . . . . 0.0 111.004 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.78 -39.92 90.64 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.201 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 76.6 mttt -63.97 -42.69 97.17 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.935 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 3.8 mt -70.71 -25.25 26.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.457 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -54.8 -28.95 52.97 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 120.514 0.197 . . . . 0.0 111.239 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -54.31 -24.47 19.25 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -74.33 -64.28 1.06 Allowed 'General case' 0 N--CA 1.461 0.111 0 C-N-CA 121.074 -0.25 . . . . 0.0 110.888 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -177.43 50.57 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 120.921 0.391 . . . . 0.0 111.549 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.412 ' O ' ' HG2' ' A' ' 38' ' ' PRO . . . 73.94 91.61 0.14 Allowed Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.556 -0.83 . . . . 0.0 112.796 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.629 ' N ' ' CD ' ' A' ' 37' ' ' PRO . 7.8 tp -81.03 -27.03 0.44 Allowed Pre-proline 0 CA--C 1.54 0.592 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.629 ' CD ' ' N ' ' A' ' 36' ' ' ILE . 72.2 Cg_exo -43.02 -48.68 7.55 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 122.371 2.047 . . . . 0.0 113.997 -179.447 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.628 ' HD2' ' N ' ' A' ' 37' ' ' PRO . 3.9 Cg_exo -35.56 136.15 0.19 Allowed 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.195 2.597 . . . . 0.0 113.213 -179.253 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -69.35 -0.44 6.33 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 12.1 mm100 -89.9 -13.98 35.19 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.219 0.463 . . . . 0.0 111.626 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -93.01 88.44 6.13 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-O 120.699 0.285 . . . . 0.0 110.641 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.2 ttp-105 -136.7 156.33 48.67 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.042 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.4 pp -99.64 153.07 19.36 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.806 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.3 tt -110.75 75.43 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.142 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.401 ' CE1' ' O ' ' A' ' 66' ' ' THR . 0.6 OUTLIER -150.92 118.16 5.98 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.272 179.975 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.41 33.95 23.99 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.547 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 46.2 46.51 15.82 Favored Glycine 0 C--N 1.336 0.548 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.997 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.05 104.26 15.83 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.743 0.272 . . . . 0.0 110.906 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -89.15 152.86 21.38 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.038 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -79.6 -4.38 51.33 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -78.65 -50.28 11.73 Favored 'General case' 0 N--CA 1.462 0.127 0 C-N-CA 121.024 -0.27 . . . . 0.0 111.183 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -47.98 113.21 0.68 Allowed 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -70.31 46.54 0.65 Allowed Glycine 0 CA--C 1.521 0.432 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.624 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.22 -176.68 3.14 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 117.117 0.459 . . . . 0.0 110.881 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.5 m -99.16 141.77 31.5 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.716 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 34.9 mt -53.14 -42.55 66.18 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.902 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.5 t -54.74 -31.49 58.49 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.565 -0.288 . . . . 0.0 111.455 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -53.72 -33.73 56.51 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 111.49 0.182 . . . . 0.0 111.49 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -102.36 40.72 1.31 Allowed 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 120.602 0.239 . . . . 0.0 111.282 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 54.77 28.87 10.86 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 111.721 0.267 . . . . 0.0 111.721 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.2 mt -89.43 86.82 2.65 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 CA-C-O 120.667 0.27 . . . . 0.0 111.053 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -97.98 166.7 11.32 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.727 0.299 . . . . 0.0 111.08 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.6 ptmt -50.12 159.8 0.41 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.137 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 55.23 32.9 19.48 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.213 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.2 m -75.48 153.41 37.57 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-O 120.697 0.284 . . . . 0.0 110.914 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.401 ' O ' ' CE1' ' A' ' 45' ' ' PHE . 1.5 p -106.12 71.56 0.89 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.733 0.301 . . . . 0.0 110.654 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.7 pp -101.82 146.15 28.2 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.024 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -107.1 150.56 26.43 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.838 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.402 ' CD1' ' CG2' ' A' ' 5' ' ' VAL . 0.3 OUTLIER -103.97 159.25 15.82 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.875 -179.938 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.3 t -103.86 153.52 6.05 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.995 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.3 155.46 24.8 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.603 -0.271 . . . . 0.0 110.975 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.2 ttm180 -93.1 175.96 6.59 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.886 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.2 tt -80.14 -57.06 3.8 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.802 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 -90.08 73.65 7.25 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.87 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -144.09 -90.99 0.12 Allowed Glycine 0 CA--C 1.519 0.33 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.507 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.353 -1.248 . . . . 0.0 112.542 -179.969 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.424 ' CG ' ' HB ' ' A' ' 14' ' ' THR . 1.9 tpt . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.523 0.201 . . . . 0.0 111.099 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 90.0 mm-40 -93.23 -38.38 11.57 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 -179.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.502 HD11 HG22 ' A' ' 3' ' ' ILE . 28.4 pt -139.06 166.03 22.75 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.101 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.913 -179.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -126.03 104.7 8.41 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.636 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 18.4 t -96.35 156.2 3.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.104 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.48 150.26 26.26 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.73 0.3 . . . . 0.0 110.869 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 34.6 p -99.93 -157.7 0.62 Allowed 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.996 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.442 ' HG ' HG23 ' A' ' 9' ' ' THR . 1.4 pt? -67.08 -33.22 75.02 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 120.894 0.378 . . . . 0.0 110.093 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.442 HG23 ' HG ' ' A' ' 8' ' ' LEU . 0.5 OUTLIER -111.57 -76.81 0.59 Allowed 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.29 178.953 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -174.56 46.57 0.14 Allowed Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.218 -0.992 . . . . 0.0 113.233 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.5 ttmt -84.35 143.03 29.75 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.837 0.319 . . . . 0.0 110.573 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.2 t -92.86 114.17 26.66 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.874 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 24.7 pt -114.92 143.27 25.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.703 0.287 . . . . 0.0 111.119 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.424 ' HB ' ' CG ' ' A' ' 1' ' ' MET . 2.4 p -105.38 118.72 37.27 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.788 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -138.45 159.44 42.06 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.677 0.275 . . . . 0.0 111.233 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -101.14 -175.63 2.92 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.722 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.6 t -136.49 100.61 2.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-O 120.648 0.261 . . . . 0.0 111.223 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -107.09 154.31 40.47 Favored Pre-proline 0 C--O 1.232 0.157 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.981 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -62.61 -22.62 74.16 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.77 2.313 . . . . 0.0 113.165 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 51.6 p -78.8 -35.42 44.32 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 121.264 -0.175 . . . . 0.0 111.385 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -73.5 96.71 2.45 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.606 0.241 . . . . 0.0 111.023 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 10.0 p -85.1 -177.37 6.52 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.912 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 25.6 mm -68.19 -31.17 50.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.653 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.9 tm-20 -70.31 -47.88 59.13 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.583 0.23 . . . . 0.0 111.251 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -74.99 40.8 0.15 Allowed 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -179.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.1 m -74.32 -31.49 28.78 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 O-C-N 122.176 -0.328 . . . . 0.0 111.26 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.74 -33.09 71.19 Favored 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 121.278 -0.169 . . . . 0.0 111.181 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.69 -56.54 20.55 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.619 0.247 . . . . 0.0 111.165 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.0 pttm -63.95 -37.34 87.04 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.677 -0.238 . . . . 0.0 110.996 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 21.7 mt -74.42 -15.97 16.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 116.751 -0.204 . . . . 0.0 111.369 179.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -65.53 -10.79 37.93 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -50.05 -33.12 17.27 Favored 'General case' 0 N--CA 1.464 0.244 0 O-C-N 122.22 -0.3 . . . . 0.0 111.66 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.38 -28.41 25.19 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 121.067 -0.253 . . . . 0.0 110.791 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 61.32 25.92 15.82 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.745 -0.207 . . . . 0.0 111.091 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.501 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . -150.52 33.84 0.99 Allowed Glycine 0 C--N 1.335 0.51 0 C-N-CA 120.041 -1.076 . . . . 0.0 113.262 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 9.3 tp -90.06 106.47 14.72 Favored Pre-proline 0 CA--C 1.531 0.217 0 CA-C-N 117.092 0.446 . . . . 0.0 111.263 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.501 ' HD3' ' O ' ' A' ' 35' ' ' GLY . 23.3 Cg_exo -62.03 -50.01 5.67 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.209 1.939 . . . . 0.0 112.634 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.467 ' CD ' ' HD2' ' A' ' 37' ' ' PRO . 50.1 Cg_exo -55.97 89.88 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.307 2.005 . . . . 0.0 112.551 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -68.17 -37.0 80.51 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.027 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -101.62 45.19 0.98 Allowed 'General case' 0 CA--C 1.528 0.118 0 CA-C-O 120.784 0.326 . . . . 0.0 110.872 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -82.56 136.43 34.84 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.898 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.5 mtt180 -142.1 175.64 9.58 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.964 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -108.03 149.09 28.85 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.687 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.6 mt -100.92 79.43 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.692 0.282 . . . . 0.0 111.197 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -150.91 129.85 12.51 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.099 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 59.99 26.06 15.32 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.65 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 45.29 40.83 8.05 Favored Glycine 0 C--N 1.336 0.569 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.973 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.415 ' HD2' ' CZ ' ' A' ' 59' ' ' TYR . 0.4 OUTLIER -107.42 130.52 54.81 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.796 0.298 . . . . 0.0 111.054 -179.848 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.09 177.92 6.51 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.803 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 12.9 mt -68.96 -22.42 64.11 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.596 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -89.8 28.26 1.38 Allowed 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -47.81 -50.75 25.01 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.665 0.269 . . . . 0.0 111.07 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.44 -23.32 34.55 Favored Glycine 0 CA--C 1.521 0.411 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.976 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -107.13 -175.97 2.94 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.985 0.393 . . . . 0.0 110.837 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.9 m -96.92 151.69 19.44 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-O 120.738 0.304 . . . . 0.0 110.753 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.422 ' O ' HG21 ' A' ' 61' ' ' ILE . 9.5 mt -53.89 -44.01 70.12 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.099 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.7 t -52.89 -53.18 52.83 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.635 -179.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -64.61 -18.77 65.22 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -179.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.415 ' CZ ' ' HD2' ' A' ' 48' ' ' LYS . 0.4 OUTLIER -97.99 31.03 2.82 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -179.578 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.7 m120 66.09 -16.59 0.12 Allowed 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.422 HG21 ' O ' ' A' ' 56' ' ' LEU . 0.6 OUTLIER -89.29 62.69 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 118.471 0.578 . . . . 0.0 110.895 179.852 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -95.4 -167.41 1.61 Allowed 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.02 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -39.85 143.09 0.27 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.855 0.359 . . . . 0.0 111.891 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 65.49 15.79 10.2 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.151 -0.477 . . . . 0.0 112.022 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.1 p -76.19 175.28 9.15 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-O 120.68 0.276 . . . . 0.0 110.996 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -105.47 91.58 3.83 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.205 179.221 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -98.66 109.58 22.32 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.819 0.342 . . . . 0.0 111.41 -179.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -107.05 97.59 7.35 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.474 179.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -93.84 129.47 40.22 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.702 0.286 . . . . 0.0 111.06 -179.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.0 p -114.01 152.94 15.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.96 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.1 pp -76.91 132.71 39.23 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.583 -0.281 . . . . 0.0 110.826 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -90.33 125.75 35.63 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.972 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.8 mp -80.12 -42.43 23.56 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.953 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 14.0 mtt180 -80.63 162.97 23.97 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.953 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 142.99 -42.35 1.1 Allowed Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.433 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.381 -1.233 . . . . 0.0 112.511 179.95 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 120.63 0.253 . . . . 0.0 111.183 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -92.47 -44.01 8.88 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.951 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.8 pt -138.86 174.0 10.77 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.082 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -118.9 105.35 11.4 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.725 0.298 . . . . 0.0 110.869 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.0 p -137.54 132.08 44.69 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.886 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.3 mppt? -106.94 163.09 13.26 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.853 0.358 . . . . 0.0 111.171 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.51 -153.64 0.45 Allowed 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.027 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.85 -21.89 65.16 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-O 120.86 0.362 . . . . 0.0 110.056 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -111.69 -70.58 0.8 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.32 179.378 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 164.89 49.86 0.02 OUTLIER Glycine 0 CA--C 1.52 0.379 0 C-N-CA 120.497 -0.859 . . . . 0.0 113.15 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -84.73 150.77 24.86 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.954 0.377 . . . . 0.0 110.982 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.7 t -96.67 115.94 28.28 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.349 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.0 tt -125.04 135.97 62.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-O 120.735 0.303 . . . . 0.0 111.629 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.6 t -106.19 132.28 52.44 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.48 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.1 mt -134.86 134.71 41.03 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.661 0.267 . . . . 0.0 111.247 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -94.99 155.87 16.55 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.404 179.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.8 t -140.13 136.62 37.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-O 120.957 0.408 . . . . 0.0 111.795 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.493 ' HB2' ' HD2' ' A' ' 19' ' ' PRO . 11.0 pt-20 -96.72 161.0 28.06 Favored Pre-proline 0 CA--C 1.53 0.19 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.324 179.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.493 ' HD2' ' HB2' ' A' ' 18' ' ' GLU . 1.2 Cg_endo -43.18 -66.64 0.15 Allowed 'Trans proline' 0 CA--C 1.532 0.415 0 C-N-CA 122.892 2.395 . . . . 0.0 112.96 -179.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.21 37.13 0.89 Allowed 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -75.7 119.65 20.01 Favored 'General case' 0 N--CA 1.462 0.145 0 O-C-N 122.276 -0.265 . . . . 0.0 111.226 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -85.25 146.58 27.0 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.509 179.279 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.3 tp -57.99 -32.46 43.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 116.769 -0.196 . . . . 0.0 111.376 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -76.19 -39.02 55.8 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 120.547 0.213 . . . . 0.0 111.0 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -63.09 -31.59 72.76 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.729 -0.214 . . . . 0.0 111.448 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.3 p -74.29 -6.4 8.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 16.4 mttt -55.47 -39.41 70.36 Favored 'General case' 0 N--CA 1.463 0.199 0 O-C-N 122.182 -0.324 . . . . 0.0 111.225 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.12 -41.75 81.27 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.561 0.219 . . . . 0.0 111.432 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.8 tttp -74.12 -42.75 59.55 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.695 -0.23 . . . . 0.0 111.243 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.431 ' O ' ' N ' ' A' ' 32' ' ' ASP . 18.8 tt -64.96 -20.69 28.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -63.43 74.65 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.741 0.305 . . . . 0.0 111.111 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.431 ' N ' ' O ' ' A' ' 30' ' ' ILE . 27.9 t70 -61.26 -69.53 0.23 Allowed 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.833 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.71 -85.9 0.14 Allowed 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 121.077 -0.249 . . . . 0.0 110.709 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -177.87 44.34 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -150.14 26.73 1.13 Allowed Glycine 0 CA--C 1.524 0.599 0 C-N-CA 120.182 -1.009 . . . . 0.0 113.539 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.45 ' HB ' ' HD3' ' A' ' 37' ' ' PRO . 32.5 mm -89.17 -46.45 0.42 Allowed Pre-proline 0 CA--C 1.533 0.306 0 CA-C-N 117.497 0.649 . . . . 0.0 112.15 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.472 ' N ' ' CD ' ' A' ' 38' ' ' PRO . 53.6 Cg_exo -52.9 -43.74 54.08 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.337 2.025 . . . . 0.0 113.168 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.472 ' CD ' ' N ' ' A' ' 37' ' ' PRO . 58.9 Cg_exo -39.93 161.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.748 2.299 . . . . 0.0 113.511 -179.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -69.56 0.39 5.42 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -90.06 8.48 32.45 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 118.094 0.407 . . . . 0.0 111.807 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -89.72 110.92 21.78 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 121.038 -0.265 . . . . 0.0 110.664 179.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.4 mtt180 -144.03 152.2 40.69 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.739 0.304 . . . . 0.0 111.237 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.5 mp -108.0 152.03 25.03 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.783 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.0 mm -111.0 61.79 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.157 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -153.66 118.36 4.98 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.754 0.311 . . . . 0.0 111.201 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.74 32.09 21.38 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.677 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 46.36 42.97 13.93 Favored Glycine 0 C--N 1.335 0.527 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.968 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.41 ' HD3' ' CZ ' ' A' ' 59' ' ' TYR . 2.5 tptp -101.36 137.29 39.89 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.643 0.259 . . . . 0.0 110.972 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -89.02 168.81 12.05 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.51 -0.313 . . . . 0.0 110.966 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.11 -38.03 37.19 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.471 -0.332 . . . . 0.0 111.354 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.64 17.55 6.35 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -47.33 -39.79 15.69 Favored 'General case' 0 N--CA 1.466 0.351 0 O-C-N 122.241 -0.287 . . . . 0.0 111.303 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.19 19.85 48.37 Favored Glycine 0 CA--C 1.522 0.487 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.942 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.7 mtt-85 -107.56 175.81 5.36 Favored 'General case' 0 N--CA 1.458 -0.075 0 CA-C-N 117.03 0.415 . . . . 0.0 110.836 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.2 m -99.34 133.17 44.04 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.731 0.301 . . . . 0.0 110.689 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.403 ' CB ' ' CD1' ' A' ' 61' ' ' ILE . 0.4 OUTLIER -51.8 -31.08 25.76 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.561 0.219 . . . . 0.0 111.113 179.974 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.6 t -62.95 -40.05 96.5 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -63.21 -29.37 70.72 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.41 ' CZ ' ' HD3' ' A' ' 48' ' ' LYS . 0.2 OUTLIER -97.66 8.99 43.68 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 111.641 0.237 . . . . 0.0 111.641 179.995 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 65.37 11.19 7.14 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.403 ' CD1' ' CB ' ' A' ' 56' ' ' LEU . 1.2 pt -90.11 63.09 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 CA-C-N 117.961 0.346 . . . . 0.0 110.676 179.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -95.1 -168.66 1.84 Allowed 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.093 -179.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -40.18 152.05 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.601 -179.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 62.14 24.49 14.58 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.363 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.9 p -75.56 145.52 41.17 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.702 0.287 . . . . 0.0 110.939 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.0 m -104.86 66.45 0.77 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.763 0.316 . . . . 0.0 110.577 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.67 144.49 31.65 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.165 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 16.1 m170 -106.97 141.1 38.72 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.749 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -103.81 163.38 12.38 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.667 0.27 . . . . 0.0 111.022 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 33.9 m -105.29 179.44 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.021 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.3 mp -76.78 106.23 8.32 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.769 0.319 . . . . 0.0 110.682 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 13.8 mtt180 -90.27 -38.08 13.65 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.267 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 18.6 tp -69.84 -65.26 0.74 Allowed 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.575 0.226 . . . . 0.0 110.914 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -90.09 172.45 8.81 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.67 0.271 . . . . 0.0 110.907 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -90.31 -55.36 1.96 Allowed Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.602 -0.808 . . . . 0.0 112.458 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.431 -1.205 . . . . 0.0 112.467 -179.946 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.1 ptt? . . . . . 0 N--CA 1.487 1.412 0 CA-C-O 120.675 0.274 . . . . 0.0 111.221 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -95.01 108.07 20.13 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.908 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 18.0 tt -138.73 156.27 28.65 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.939 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -118.44 91.83 3.66 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-O 120.739 0.304 . . . . 0.0 110.913 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.5 t -93.35 159.69 2.76 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.747 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.0 ttmt -106.66 135.56 47.97 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.828 0.347 . . . . 0.0 111.044 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.7 p -100.51 -162.19 0.92 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.25 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.14 -38.64 83.69 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 120.649 -0.42 . . . . 0.0 111.199 -179.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.24 -62.08 1.6 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.65 0.262 . . . . 0.0 110.792 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 168.06 50.04 0.03 OUTLIER Glycine 0 CA--C 1.521 0.421 0 C-N-CA 120.512 -0.851 . . . . 0.0 113.125 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.67 157.12 21.21 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 116.858 0.329 . . . . 0.0 110.768 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.1 t -103.01 108.41 19.57 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.715 0.293 . . . . 0.0 110.8 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.8 pt -125.07 168.88 17.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.245 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.02 158.95 16.42 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.778 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.19 115.67 11.23 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.698 0.285 . . . . 0.0 111.036 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -101.05 150.14 23.22 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.743 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.404 ' CG1' ' CD2' ' A' ' 56' ' ' LEU . 30.2 t -140.0 146.8 24.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.377 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -107.1 164.67 14.33 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.783 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -56.97 -55.47 2.62 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.609 2.206 . . . . 0.0 112.539 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.2 m -89.52 8.38 31.41 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -179.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -75.0 118.14 17.64 Favored 'General case' 0 CA--C 1.528 0.125 0 O-C-N 122.245 -0.284 . . . . 0.0 110.924 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.8 p -85.08 165.69 17.28 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.817 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 7.3 tp -58.36 -40.2 77.2 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.261 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -59.32 -38.54 80.56 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.646 0.26 . . . . 0.0 110.924 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -62.79 -23.86 67.45 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.592 -0.277 . . . . 0.0 111.47 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 39.4 t -63.57 -39.5 85.58 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-O 120.566 0.222 . . . . 0.0 111.06 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.7 tttm -57.31 -36.96 71.74 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 120.602 0.239 . . . . 0.0 111.242 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.26 -45.0 74.36 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-O 120.654 0.264 . . . . 0.0 111.444 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.2 ptpm? -74.13 -39.92 63.0 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.522 -179.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.483 HD11 HG23 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -64.81 -36.89 78.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-O 120.56 0.219 . . . . 0.0 111.431 -179.672 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -64.81 -21.0 66.69 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -61.48 -14.31 27.87 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.9 mtpp -73.91 -42.7 60.27 Favored 'General case' 0 C--O 1.232 0.132 0 O-C-N 122.222 -0.299 . . . . 0.0 111.307 -179.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -144.19 -44.2 0.26 Allowed 'General case' 0 C--O 1.232 0.171 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.836 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.471 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . 107.44 68.29 0.66 Allowed Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.625 -0.797 . . . . 0.0 111.543 -179.307 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 19.7 tt -77.86 109.37 9.67 Favored Pre-proline 0 CA--C 1.532 0.287 0 CA-C-O 120.714 0.292 . . . . 0.0 111.533 -179.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.58 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 28.6 Cg_exo -62.96 -41.28 29.87 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.999 2.466 . . . . 0.0 114.422 -179.325 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.58 ' HD2' ' N ' ' A' ' 37' ' ' PRO . 21.8 Cg_endo -64.27 114.33 2.62 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 121.904 1.736 . . . . 0.0 113.086 -178.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -69.78 -1.88 10.49 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.516 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -90.06 10.98 22.14 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 122.073 -0.392 . . . . 0.0 111.998 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -90.02 97.06 10.97 Favored 'General case' 0 C--O 1.231 0.105 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 179.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.91 -177.41 4.55 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.788 0.328 . . . . 0.0 111.174 -179.476 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.0 tp -99.13 143.59 29.23 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.927 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.8 mm -106.13 95.47 3.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.124 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 16.1 t80 -150.88 123.33 8.43 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.093 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.04 33.39 23.13 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.366 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 46.14 36.06 6.97 Favored Glycine 0 C--N 1.336 0.539 0 C-N-CA 120.868 -0.682 . . . . 0.0 113.047 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.42 ' HG2' ' CE2' ' A' ' 59' ' ' TYR . 0.3 OUTLIER -110.21 126.03 53.7 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.849 0.325 . . . . 0.0 110.962 -179.952 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -89.09 149.32 23.25 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.802 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.1 pp -80.39 13.11 2.57 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -78.59 -42.61 28.58 Favored 'General case' 0 CA--C 1.528 0.097 0 O-C-N 121.978 -0.451 . . . . 0.0 110.76 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -48.18 118.46 2.41 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 179.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -68.89 49.28 0.49 Allowed Glycine 0 CA--C 1.522 0.472 0 C-N-CA 120.625 -0.798 . . . . 0.0 113.051 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.58 -172.63 2.11 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 117.169 0.484 . . . . 0.0 110.549 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.8 t -99.03 134.22 42.18 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.567 0.222 . . . . 0.0 110.627 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.404 ' CD2' ' CG1' ' A' ' 17' ' ' VAL . 3.1 pp -51.74 -34.27 38.37 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.624 0.249 . . . . 0.0 111.223 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.2 t -61.22 -35.12 76.35 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.414 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -53.86 -32.1 51.89 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 111.612 0.227 . . . . 0.0 111.612 -179.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.42 ' CE2' ' HG2' ' A' ' 48' ' ' LYS . 28.0 m-85 -97.9 14.95 25.38 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.3 t30 58.48 22.77 9.99 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.3 tp -90.0 62.49 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 CA-C-O 120.775 0.322 . . . . 0.0 110.823 179.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -101.14 179.68 4.3 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.265 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.406 ' C ' ' H ' ' A' ' 65' ' ' SER . 11.7 pttp -50.36 -179.9 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.33 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 67.25 -41.54 0.42 Allowed 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.33 0.492 . . . . 0.0 112.33 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.406 ' H ' ' C ' ' A' ' 63' ' ' LYS . 1.6 m -64.89 172.54 2.79 Favored 'General case' 0 C--N 1.332 -0.191 0 O-C-N 122.266 -0.272 . . . . 0.0 110.779 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.9 p -96.9 117.74 31.78 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.979 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.6 mp -109.04 117.36 33.98 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.013 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -107.18 123.55 48.43 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.906 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -101.33 163.54 12.22 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.851 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.9 m -104.92 173.72 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.134 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.1 mt -78.09 153.24 32.39 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.879 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -92.99 -42.16 9.6 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.244 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -81.67 44.6 0.83 Allowed 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 111.58 0.215 . . . . 0.0 111.58 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.16 98.23 11.65 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.657 0.265 . . . . 0.0 110.905 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 144.39 -72.47 0.35 Allowed Glycine 0 C--N 1.333 0.379 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.546 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.337 -1.257 . . . . 0.0 112.469 179.977 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.668 0.271 . . . . 0.0 111.224 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -95.04 123.05 38.31 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.891 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 21.7 mt -139.56 155.12 25.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.95 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -118.65 93.96 4.29 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.691 0.281 . . . . 0.0 110.931 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.3 t -119.55 151.97 22.05 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.022 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 6.4 ptpp? -109.87 140.31 43.97 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.808 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 75.5 p -99.97 -148.08 0.35 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.475 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.432 ' HG ' ' N ' ' A' ' 9' ' ' THR . 1.3 pt? -65.31 -41.89 93.59 Favored 'General case' 0 C--N 1.341 0.218 0 CA-C-N 118.68 0.673 . . . . 0.0 111.571 -178.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.432 ' N ' ' HG ' ' A' ' 8' ' ' LEU . 42.7 m -111.4 41.29 1.9 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.678 0.275 . . . . 0.0 111.065 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 50.7 39.03 37.66 Favored Glycine 0 CA--C 1.521 0.439 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.776 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.6 tttm -74.38 145.65 43.62 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.813 0.306 . . . . 0.0 110.767 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.7 t -93.74 106.18 18.17 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.781 0.324 . . . . 0.0 110.898 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.3 pp -125.21 163.29 26.25 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.12 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 16.6 p -101.89 152.5 20.84 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.828 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.7 tp -127.99 92.8 3.53 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.976 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -100.98 121.56 41.98 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.849 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.7 m -140.06 173.94 9.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.156 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -96.88 167.22 12.45 Favored Pre-proline 0 C--O 1.231 0.13 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.934 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.35 -43.3 41.72 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.657 2.238 . . . . 0.0 112.487 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 36.9 m -89.27 3.09 53.2 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -75.06 120.23 20.3 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.664 0.268 . . . . 0.0 111.022 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 10.7 t -85.21 165.74 17.13 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.495 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.411 ' O ' ' CG1' ' A' ' 26' ' ' VAL . 43.4 mm -57.33 -37.45 57.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-O 120.528 0.204 . . . . 0.0 111.034 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -52.98 -31.45 40.82 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 120.487 0.184 . . . . 0.0 111.153 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -70.93 -42.8 69.37 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.765 -0.198 . . . . 0.0 111.335 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.411 ' CG1' ' O ' ' A' ' 23' ' ' ILE . 12.4 p -63.99 -21.7 29.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 111.675 0.25 . . . . 0.0 111.675 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.6 tptp -55.5 -35.03 65.15 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.573 0.225 . . . . 0.0 110.885 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.1 -37.47 87.6 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.581 0.229 . . . . 0.0 110.883 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.5 mttt -63.93 -48.62 75.81 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-O 120.636 0.255 . . . . 0.0 110.819 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.6 tt -64.82 -39.15 84.67 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 CA-C-N 116.633 -0.258 . . . . 0.0 110.931 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -65.25 -21.45 66.74 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.721 -0.218 . . . . 0.0 111.07 179.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -61.33 -12.34 13.45 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 7.5 ptpp? -74.26 -36.73 63.85 Favored 'General case' 0 N--CA 1.461 0.092 0 O-C-N 122.013 -0.429 . . . . 0.0 110.819 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -176.4 -42.07 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.664 0.268 . . . . 0.0 111.558 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.492 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . 123.63 74.92 0.28 Allowed Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.646 -0.788 . . . . 0.0 111.589 -179.66 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.439 ' HA ' ' HD2' ' A' ' 37' ' ' PRO . 1.3 pp -78.31 102.34 0.95 Allowed Pre-proline 0 CA--C 1.532 0.279 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -179.087 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.683 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 10.6 Cg_endo -55.02 -42.63 67.23 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.564 2.176 . . . . 0.0 113.962 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.683 ' HD2' ' N ' ' A' ' 37' ' ' PRO . 6.1 Cg_exo -39.34 106.6 0.06 OUTLIER 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 122.762 2.308 . . . . 0.0 113.106 -179.101 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -68.61 -16.57 63.89 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.622 179.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -93.77 28.53 2.33 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -91.91 89.07 6.86 Favored 'General case' 0 C--O 1.231 0.095 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 179.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.11 -179.06 6.27 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.96 -179.516 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -97.6 160.18 14.47 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 120.718 0.294 . . . . 0.0 110.879 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.401 ' CG2' ' O ' ' A' ' 44' ' ' ILE . 17.6 tt -100.91 80.03 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.13 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.419 ' CE1' ' HB ' ' A' ' 66' ' ' THR . 0.3 OUTLIER -150.94 105.65 3.28 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.078 179.93 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 63.62 31.3 14.65 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.575 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 45.65 52.98 8.79 Favored Glycine 0 C--N 1.336 0.562 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.983 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.446 ' CD ' ' CE1' ' A' ' 59' ' ' TYR . 0.7 OUTLIER -106.62 115.82 30.86 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.785 0.292 . . . . 0.0 110.943 -179.955 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.19 173.19 8.55 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.772 0.32 . . . . 0.0 110.867 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.1 mt -79.15 -22.99 44.28 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.491 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -78.83 -35.68 43.69 Favored 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 121.256 -0.178 . . . . 0.0 111.339 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -48.06 114.69 0.98 Allowed 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 179.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -70.01 49.72 0.7 Allowed Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.483 -0.865 . . . . 0.0 112.592 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 -107.15 161.54 14.67 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.986 0.393 . . . . 0.0 110.815 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.42 ' O ' ' HB2' ' A' ' 58' ' ' ASP . 7.2 t -99.27 142.84 30.24 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.521 -0.308 . . . . 0.0 110.74 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.418 ' HB2' HG13 ' A' ' 61' ' ' ILE . 0.2 OUTLIER -51.99 -43.71 63.73 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 111.745 0.276 . . . . 0.0 111.745 -179.286 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.1 t -58.84 -31.13 68.22 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -179.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.42 ' HB2' ' O ' ' A' ' 55' ' ' THR . 1.6 m-20 -56.82 -39.03 73.45 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 111.549 0.203 . . . . 0.0 111.549 -179.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.446 ' CE1' ' CD ' ' A' ' 48' ' ' LYS . 30.7 m-85 -99.82 17.51 20.58 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 47.5 t30 65.1 15.59 10.08 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 179.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.418 HG13 ' HB2' ' A' ' 56' ' ' LEU . 7.3 pt -90.03 60.97 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-O 120.836 0.351 . . . . 0.0 110.912 179.406 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.45 -160.15 0.77 Allowed 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.701 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.475 ' O ' ' CG ' ' A' ' 64' ' ' GLU . 2.4 pttp -39.89 144.56 0.19 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.682 0.277 . . . . 0.0 111.681 -179.596 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.475 ' CG ' ' O ' ' A' ' 63' ' ' LYS . 3.5 pt-20 54.49 26.68 7.43 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.023 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.4 p -76.05 173.38 11.34 Favored 'General case' 0 C--O 1.23 0.071 0 CA-C-O 120.672 0.272 . . . . 0.0 110.878 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.419 ' HB ' ' CE1' ' A' ' 45' ' ' PHE . 0.2 OUTLIER -107.1 81.86 1.6 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.356 179.395 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.82 107.54 20.01 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.336 -179.405 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 -107.13 103.77 13.25 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.582 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.83 168.41 11.0 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.011 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 32.9 m -103.87 174.41 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.216 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.6 mp -77.81 149.65 34.39 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.745 0.307 . . . . 0.0 110.844 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -89.91 -32.77 16.7 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.437 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.19 -53.65 6.48 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.68 0.276 . . . . 0.0 110.866 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.05 141.9 28.23 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.756 0.312 . . . . 0.0 110.873 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 142.5 60.74 0.03 OUTLIER Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.457 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.367 -1.24 . . . . 0.0 112.498 179.982 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.488 1.444 0 CA-C-O 120.69 0.281 . . . . 0.0 111.204 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -94.94 124.92 39.26 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.911 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 16.8 tt -138.92 153.2 24.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.077 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -118.99 127.52 53.54 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.65 0.262 . . . . 0.0 110.797 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.5 t -101.36 140.45 20.04 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.176 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.416 ' HG2' ' CE1' ' A' ' 68' ' ' HIS . 0.0 OUTLIER -106.78 87.2 2.47 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.444 179.817 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.41 119.94 40.82 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.539 -179.221 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -51.02 -20.87 1.53 Allowed 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 179.353 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 77.5 p -99.96 38.47 1.46 Allowed 'General case' 0 CA--C 1.531 0.248 0 O-C-N 122.033 -0.417 . . . . 0.0 111.442 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 49.03 30.13 9.32 Favored Glycine 0 C--N 1.336 0.567 0 C-N-CA 121.117 -0.563 . . . . 0.0 113.757 179.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.82 65.28 9.06 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 117.332 0.566 . . . . 0.0 110.714 179.489 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.6 t -92.98 99.76 12.33 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.89 0.376 . . . . 0.0 110.883 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.7 pp -125.54 172.55 12.88 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.167 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.27 132.7 51.14 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.656 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 62.3 mt -128.88 124.04 34.2 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.121 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -101.19 131.6 47.09 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.755 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.02 -176.23 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.925 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -102.58 160.87 24.96 Favored Pre-proline 0 C--N 1.333 -0.127 0 CA-C-O 120.636 0.255 . . . . 0.0 110.896 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -53.26 -50.12 15.08 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.482 2.121 . . . . 0.0 112.407 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.9 t -90.21 32.26 0.94 Allowed 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.354 0.501 . . . . 0.0 112.354 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.9 p-10 -75.24 119.48 19.43 Favored 'General case' 0 N--CA 1.461 0.114 0 O-C-N 122.202 -0.311 . . . . 0.0 110.976 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.4 t -84.95 166.08 17.08 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-O 120.673 0.273 . . . . 0.0 110.822 179.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.407 ' HA ' ' CG1' ' A' ' 26' ' ' VAL . 9.8 tp -57.89 -37.99 63.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.641 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -63.45 -41.74 98.64 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.572 0.225 . . . . 0.0 111.25 -179.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -73.14 -48.0 39.25 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 120.616 0.246 . . . . 0.0 111.161 -179.702 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.407 ' CG1' ' HA ' ' A' ' 23' ' ' ILE . 13.6 p -63.97 -21.42 28.76 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 111.698 0.259 . . . . 0.0 111.698 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.2 mtpm? -55.58 -35.06 65.37 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.502 0.191 . . . . 0.0 110.902 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.88 -37.62 74.28 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.625 0.25 . . . . 0.0 110.879 179.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.78 -38.01 64.79 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.849 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 33.2 mm -64.98 -45.16 95.49 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 CA-C-O 120.671 0.272 . . . . 0.0 110.622 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -59.89 -26.58 66.0 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.961 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -57.09 -22.94 43.29 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 111.691 0.256 . . . . 0.0 111.691 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 7.8 mtmp? -74.37 -39.08 62.97 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.605 0.24 . . . . 0.0 110.925 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.06 -48.64 0.24 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.692 -0.231 . . . . 0.0 111.238 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.51 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . 108.83 62.52 0.54 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.04 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.405 ' CG1' ' HD2' ' A' ' 38' ' ' PRO . 17.2 tt -78.51 108.3 7.58 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-O 120.696 0.284 . . . . 0.0 111.486 -179.512 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.564 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 26.0 Cg_exo -63.53 -40.66 29.39 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 122.747 2.298 . . . . 0.0 114.189 -179.448 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.564 ' HD2' ' N ' ' A' ' 37' ' ' PRO . 38.1 Cg_endo -68.5 133.16 27.21 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 122.02 1.813 . . . . 0.0 113.53 -178.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -70.71 14.67 0.13 Allowed 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.659 -0.7 . . . . 0.0 112.45 179.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -89.37 1.51 55.7 Favored 'General case' 0 N--CA 1.456 -0.138 0 O-C-N 122.135 -0.353 . . . . 0.0 110.543 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.6 tp60 -82.77 101.7 11.09 Favored 'General case' 0 C--O 1.231 0.097 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 179.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -133.88 178.19 7.14 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-O 120.742 0.306 . . . . 0.0 111.311 -179.415 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.7 tp -106.56 133.23 51.56 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.101 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.9 pt -111.26 107.4 22.85 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-O 120.752 0.311 . . . . 0.0 111.164 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -150.94 135.22 16.91 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.086 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.95 38.58 30.69 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.209 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 52.91 29.07 33.68 Favored Glycine 0 CA--C 1.522 0.51 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.941 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.432 ' HD3' ' CD1' ' A' ' 59' ' ' TYR . 14.4 mttm -110.47 102.24 10.87 Favored 'General case' 0 N--CA 1.457 -0.102 0 CA-C-N 117.016 0.408 . . . . 0.0 110.89 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -89.12 90.61 8.46 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.681 0.277 . . . . 0.0 110.89 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -79.34 65.81 4.62 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.123 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -89.51 -42.09 11.66 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-O 120.607 0.241 . . . . 0.0 111.103 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -47.34 -69.29 0.13 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.742 0.306 . . . . 0.0 111.203 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 158.26 56.61 0.01 OUTLIER Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.681 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -106.02 177.49 4.84 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.591 0.234 . . . . 0.0 110.861 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.9 t -99.1 154.87 17.78 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.711 0.291 . . . . 0.0 110.86 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.4 mp -59.31 -46.78 87.64 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.061 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.1 t -53.27 -39.15 63.68 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.484 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -53.9 -30.23 45.23 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 111.659 0.244 . . . . 0.0 111.659 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.432 ' CD1' ' HD3' ' A' ' 48' ' ' LYS . 5.1 m-85 -101.99 40.36 1.34 Allowed 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 120.659 0.266 . . . . 0.0 111.601 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 54.84 27.34 8.83 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 179.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 27.6 mt -89.64 101.31 12.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-O 120.643 0.259 . . . . 0.0 110.858 179.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -94.97 166.22 12.05 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.782 0.325 . . . . 0.0 111.223 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -50.23 151.06 2.2 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.259 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 62.67 22.13 13.15 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.593 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.2 m -75.71 170.03 16.97 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-O 120.68 0.276 . . . . 0.0 110.815 179.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.05 111.76 23.84 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.393 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.1 pp -98.72 116.53 31.15 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.791 0.329 . . . . 0.0 111.53 -179.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.416 ' CE1' ' HG2' ' A' ' 6' ' ' LYS . 0.1 OUTLIER -107.29 109.82 21.69 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.581 179.539 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -93.9 179.71 5.25 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.958 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -109.13 -178.2 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.62 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.1 mt -76.76 134.95 38.99 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.664 0.268 . . . . 0.0 110.782 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.61 -28.98 20.32 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.569 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.7 tp -70.6 -51.43 28.24 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.711 0.291 . . . . 0.0 110.771 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.9 mtt85 -90.12 168.1 12.22 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.85 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 141.67 155.14 6.36 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.526 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.081 0 CA-C-O 118.377 -1.235 . . . . 0.0 112.517 179.968 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.487 1.394 0 CA-C-O 120.634 0.254 . . . . 0.0 111.242 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -94.97 132.28 39.99 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.532 -0.303 . . . . 0.0 110.945 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 15.1 tt -138.92 157.1 28.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.915 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -118.44 102.99 9.34 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.83 0.348 . . . . 0.0 110.864 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.41 ' CG1' HD12 ' A' ' 69' ' ' LEU . 11.8 t -122.22 151.42 25.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.121 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.83 135.12 48.91 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.854 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.75 -147.28 0.34 Allowed 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.331 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.5 tp -68.43 -53.99 20.02 Favored 'General case' 0 C--N 1.342 0.282 0 CA-C-O 120.921 0.391 . . . . 0.0 110.75 -179.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.3 p -101.57 39.07 1.49 Allowed 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.304 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 55.24 38.68 68.68 Favored Glycine 0 C--N 1.334 0.435 0 C-N-CA 120.817 -0.706 . . . . 0.0 113.133 179.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.9 ttmt -84.16 141.63 30.92 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 117.062 0.431 . . . . 0.0 110.556 179.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.9 t -92.95 121.99 34.85 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.64 0.257 . . . . 0.0 111.138 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.7 pt -125.13 136.06 62.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.954 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -98.87 130.31 45.27 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.903 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.9 pp -138.08 151.86 48.23 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.521 -0.308 . . . . 0.0 110.951 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -101.13 156.22 17.55 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.938 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 22.2 t -136.16 113.51 14.03 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.126 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -107.0 165.84 12.15 Favored Pre-proline 0 C--N 1.332 -0.166 0 CA-C-O 120.787 0.327 . . . . 0.0 110.855 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.49 -30.0 52.77 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.66 2.24 . . . . 0.0 112.535 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 82.1 p -78.74 -32.47 46.72 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.802 -0.181 . . . . 0.0 111.232 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -64.89 121.23 14.14 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.659 0.266 . . . . 0.0 110.74 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.05 149.82 25.3 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.02 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.1 tt -68.06 -29.35 44.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.541 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.0 tm-20 -53.06 -60.32 3.43 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.73 0.3 . . . . 0.0 111.107 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 36.9 m-20 -74.85 44.09 0.21 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.857 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 14.6 p -69.12 -40.17 80.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.562 0.22 . . . . 0.0 111.144 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.8 mptt -66.07 -44.71 83.7 Favored 'General case' 0 N--CA 1.461 0.108 0 CA-C-O 120.669 0.271 . . . . 0.0 110.816 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.29 -40.85 98.53 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.053 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.88 -41.11 97.82 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.866 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 31.9 mt -75.03 -42.61 45.51 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.952 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -55.04 -37.82 67.19 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.702 0.287 . . . . 0.0 110.977 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.56 -16.12 44.97 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 112.16 0.429 . . . . 0.0 112.16 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 12.6 mmtt -74.79 -34.72 62.47 Favored 'General case' 0 N--CA 1.461 0.087 0 O-C-N 122.207 -0.308 . . . . 0.0 111.188 -179.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -167.11 -45.82 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 121.013 -0.275 . . . . 0.0 111.576 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 137.14 80.22 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.453 -0.88 . . . . 0.0 112.329 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.408 HG12 ' HG2' ' A' ' 38' ' ' PRO . 9.3 tt -78.35 113.29 32.72 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-O 120.565 0.221 . . . . 0.0 111.106 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.49 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 51.2 Cg_exo -53.36 -51.28 11.32 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.676 2.251 . . . . 0.0 113.291 -179.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.49 ' HD2' ' N ' ' A' ' 37' ' ' PRO . 31.6 Cg_endo -65.65 86.19 0.22 Allowed 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 121.975 1.783 . . . . 0.0 112.363 -179.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.31 -21.55 64.76 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.409 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 29.2 mt-30 -100.2 36.17 1.92 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 120.478 0.18 . . . . 0.0 111.421 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -88.23 131.25 34.83 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.576 0.227 . . . . 0.0 110.704 179.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.3 mtt180 -137.89 169.02 18.51 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.694 0.283 . . . . 0.0 111.061 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 49.6 mt -99.67 151.29 21.38 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.919 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.8 tt -110.99 84.16 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 CA-C-O 120.765 0.317 . . . . 0.0 111.092 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -150.89 131.75 14.15 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.204 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.7 25.74 15.52 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.741 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 44.51 36.83 4.64 Favored Glycine 0 C--N 1.337 0.637 0 C-N-CA 120.777 -0.725 . . . . 0.0 113.081 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.1 mmpm? -110.06 136.46 49.27 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.835 0.317 . . . . 0.0 111.06 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.7 tp60 -89.12 162.98 15.66 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.931 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -80.48 19.57 0.78 Allowed 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -89.04 -41.23 12.45 Favored 'General case' 0 CA--C 1.529 0.155 0 O-C-N 122.038 -0.414 . . . . 0.0 111.171 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -48.28 114.51 0.96 Allowed 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 120.637 0.256 . . . . 0.0 110.325 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -69.97 50.43 0.71 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.411 -0.9 . . . . 0.0 112.467 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.3 mmt180 -104.52 -178.72 3.74 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-N 116.946 0.373 . . . . 0.0 110.926 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.8 m -94.74 149.0 21.7 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.771 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.73 -47.33 73.92 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.988 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.0 p -52.38 -30.26 28.14 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.36 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -53.91 -28.52 37.21 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 111.522 0.193 . . . . 0.0 111.522 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -98.11 24.32 7.23 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 61.4 21.85 12.34 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 179.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.496 HG23 HD13 ' A' ' 61' ' ' ILE . 0.0 OUTLIER -89.56 92.47 3.97 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 CA-C-O 120.853 0.359 . . . . 0.0 110.722 179.454 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -101.73 176.28 5.27 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.141 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.32 145.85 5.8 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.311 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 64.54 21.86 12.54 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.833 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 54.3 p -75.67 149.41 38.15 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 120.734 0.302 . . . . 0.0 110.996 179.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.5 m -107.09 90.2 3.23 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.553 179.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -109.34 135.23 50.74 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.869 0.366 . . . . 0.0 111.261 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 16.4 m80 -107.34 142.07 37.72 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.715 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.41 HD12 ' CG1' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -104.76 158.36 16.56 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.693 0.283 . . . . 0.0 111.159 179.69 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.3 p -114.1 152.43 15.77 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.927 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.7 mp -81.09 90.06 6.0 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.84 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.63 46.31 1.19 Allowed 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.366 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.8 mt -80.38 -44.58 19.16 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.66 0.266 . . . . 0.0 110.759 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 16.5 ttm180 -90.1 107.76 19.32 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.899 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -98.21 62.22 0.89 Allowed Glycine 0 C--N 1.332 0.36 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.495 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.088 0 CA-C-O 118.421 -1.21 . . . . 0.0 112.506 179.975 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.413 ' CG ' ' O ' ' A' ' 3' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.565 0.222 . . . . 0.0 111.143 . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.8 mp0 -84.94 -17.12 38.75 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -179.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.413 ' O ' ' CG ' ' A' ' 1' ' ' MET . 14.5 pt -138.66 177.27 5.28 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.108 0 CA-C-O 120.71 0.291 . . . . 0.0 111.306 -179.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -118.88 101.31 7.96 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.703 0.287 . . . . 0.0 110.826 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.402 ' CG2' ' CD1' ' A' ' 3' ' ' ILE . 22.0 t -114.96 149.56 17.14 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.132 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 9.2 mmtt -106.92 130.72 54.54 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.9 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.43 -166.6 1.36 Allowed 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.271 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.407 ' HG ' ' N ' ' A' ' 9' ' ' THR . 0.6 OUTLIER -66.98 -43.39 83.14 Favored 'General case' 0 C--N 1.339 0.128 0 CA-C-O 120.8 0.333 . . . . 0.0 111.183 -178.79 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.407 ' N ' ' HG ' ' A' ' 8' ' ' LEU . 1.3 p -111.27 40.36 2.09 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.035 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 55.24 39.96 73.51 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.681 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.06 163.23 20.0 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.783 0.292 . . . . 0.0 110.898 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -103.04 122.8 45.39 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.864 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.6 pt -124.99 151.5 30.68 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-O 120.703 0.287 . . . . 0.0 111.234 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 16.7 m -105.75 130.55 53.73 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.793 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.56 130.31 30.04 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.576 -0.283 . . . . 0.0 110.984 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -100.95 175.05 5.74 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.77 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.1 t -132.81 108.99 13.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 120.81 0.338 . . . . 0.0 111.272 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.41 ' HB2' ' HD2' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -107.05 158.21 33.49 Favored Pre-proline 0 C--N 1.333 -0.15 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.498 179.811 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.41 ' HD2' ' HB2' ' A' ' 18' ' ' GLU . 3.7 Cg_endo -46.49 -53.36 6.12 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.627 2.218 . . . . 0.0 112.059 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.9 p -90.42 41.16 1.04 Allowed 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -74.56 94.89 2.7 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.65 0.262 . . . . 0.0 110.976 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.21 128.7 34.78 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.658 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 7.1 mt -57.83 -35.04 49.82 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.329 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -71.33 -41.3 70.02 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.608 0.242 . . . . 0.0 111.08 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -73.02 -41.89 63.77 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.242 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 12.3 p -63.78 -36.23 75.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-N 116.759 -0.2 . . . . 0.0 111.285 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.82 -41.15 73.79 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.621 0.248 . . . . 0.0 110.888 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.95 -34.85 70.35 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.322 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 16.8 mtpt -63.68 -43.09 97.69 Favored 'General case' 0 CA--C 1.527 0.092 0 CA-C-O 120.633 0.254 . . . . 0.0 110.822 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 3.4 mt -66.47 -49.32 76.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 CA-C-O 120.702 0.287 . . . . 0.0 110.735 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 1.9 tp60 -65.16 -25.91 67.94 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.185 179.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -51.05 -31.23 17.93 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.64 -24.83 49.39 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 121.162 -0.215 . . . . 0.0 111.45 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 70.61 33.73 2.29 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.673 0.273 . . . . 0.0 110.704 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -89.96 -39.99 5.99 Favored Glycine 0 C--N 1.334 0.454 0 C-N-CA 120.518 -0.849 . . . . 0.0 112.596 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.6 mt -89.33 110.08 36.04 Favored Pre-proline 0 CA--C 1.531 0.224 0 CA-C-N 116.656 0.228 . . . . 0.0 111.163 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.498 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 33.8 Cg_exo -57.65 -46.9 23.96 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.374 2.049 . . . . 0.0 113.077 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.498 ' HD2' ' N ' ' A' ' 37' ' ' PRO . 60.6 Cg_endo -74.11 120.21 6.2 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.224 1.949 . . . . 0.0 112.894 -179.392 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -68.75 -18.83 64.28 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.19 179.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -93.01 34.02 1.13 Allowed 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 111.492 0.182 . . . . 0.0 111.492 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -82.35 111.79 18.73 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 7.1 ptt180 -139.67 178.79 6.98 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.885 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -97.84 166.46 11.46 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.875 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.0 tt -109.47 89.14 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.158 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -150.83 109.09 3.75 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.153 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.34 33.68 18.79 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.556 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 46.23 45.33 15.64 Favored Glycine 0 C--N 1.336 0.541 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.97 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.412 ' HE2' ' CE1' ' A' ' 59' ' ' TYR . 26.1 tptt -101.42 129.92 47.54 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.803 0.302 . . . . 0.0 110.93 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -89.15 158.25 17.99 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.974 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.1 mp -79.22 -34.84 42.5 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.166 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -78.97 -10.46 59.83 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 111.678 0.251 . . . . 0.0 111.678 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -47.07 -42.81 19.39 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.66 0.267 . . . . 0.0 111.227 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.77 37.52 5.75 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.767 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.14 174.93 5.67 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.848 0.324 . . . . 0.0 110.728 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 49.8 m -99.19 135.25 40.87 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.814 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 14.5 mt -52.24 -38.14 57.22 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.011 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.0 t -61.31 -31.49 71.34 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.647 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -53.73 -37.83 63.74 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 121.207 -0.197 . . . . 0.0 111.418 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.412 ' CE1' ' HE2' ' A' ' 48' ' ' LYS . 6.1 m-85 -103.62 34.32 3.02 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 120.511 0.196 . . . . 0.0 111.439 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 54.8 28.0 9.69 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 179.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 28.2 mt -89.48 73.49 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.123 0 CA-C-O 120.768 0.318 . . . . 0.0 110.885 179.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.3 mm-40 -94.8 177.81 5.78 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.058 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -50.23 147.22 4.38 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.863 0.363 . . . . 0.0 111.276 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 63.66 20.73 12.38 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.779 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.8 m -75.83 176.74 7.51 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-O 120.63 0.253 . . . . 0.0 110.951 179.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.5 t -101.44 82.96 2.38 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.472 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.95 108.61 21.34 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.128 -179.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.9 m170 -107.13 124.34 49.55 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.659 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.4 mp -93.9 149.27 21.38 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.887 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.6 t -104.1 144.09 14.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.03 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.4 mt -78.77 84.91 4.8 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.908 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 16.4 mmt-85 -92.93 62.53 3.66 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.674 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.6 pp -80.77 3.92 20.75 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -79.46 136.52 36.95 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-O 120.773 0.32 . . . . 0.0 110.904 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 126.74 60.37 0.14 Allowed Glycine 0 C--N 1.334 0.419 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.374 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.317 -1.268 . . . . 0.0 112.562 -179.92 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.417 0 CA-C-O 120.577 0.227 . . . . 0.0 111.135 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 -95.04 1.78 55.15 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -179.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.7 tt -138.91 154.96 26.68 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 O-C-N 122.33 -0.231 . . . . 0.0 111.118 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.83 81.63 1.73 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.719 0.295 . . . . 0.0 110.766 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.6 t -109.2 153.63 10.9 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.969 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.93 138.67 42.65 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.681 0.277 . . . . 0.0 111.046 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.0 p -99.9 -167.44 1.46 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.215 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.36 -35.36 75.51 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.963 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.53 -66.57 1.07 Allowed 'General case' 0 C--O 1.231 0.111 0 CA-C-O 120.827 0.346 . . . . 0.0 110.382 179.396 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 171.45 46.03 0.04 OUTLIER Glycine 0 CA--C 1.522 0.48 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.917 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -84.93 164.14 18.53 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.89 0.345 . . . . 0.0 111.071 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.1 p -103.17 123.57 46.96 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.48 179.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.3 tt -114.94 140.85 34.01 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.107 0 CA-C-O 120.736 0.303 . . . . 0.0 111.275 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 17.0 p -106.03 119.51 39.39 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.784 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.0 mt -138.03 145.39 41.77 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.941 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -100.99 164.69 11.69 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.853 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 24.7 t -129.89 106.11 12.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.031 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -102.09 163.32 17.97 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.812 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -52.67 -48.74 20.36 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.452 2.101 . . . . 0.0 112.189 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.3 p -90.28 34.19 0.88 Allowed 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -75.31 106.65 6.95 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.727 0.299 . . . . 0.0 110.73 179.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.4 m -85.16 142.61 29.35 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.033 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.5 tp -68.05 -23.78 29.38 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.763 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -86.02 -33.96 20.91 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 120.477 0.179 . . . . 0.0 111.298 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -62.83 -38.93 92.71 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.522 0.201 . . . . 0.0 111.29 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.9 p -63.78 -31.1 51.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-N 116.754 -0.203 . . . . 0.0 111.444 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -56.0 -43.38 77.63 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.715 0.293 . . . . 0.0 110.823 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.86 -30.89 71.94 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.345 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.6 mttm -63.82 -39.4 94.15 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 120.567 0.222 . . . . 0.0 110.89 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 38.0 mm -64.98 -46.92 90.12 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 CA-C-O 120.698 0.285 . . . . 0.0 110.555 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.32 -42.88 92.54 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.588 179.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -61.25 -22.98 65.32 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.727 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.78 -44.36 50.02 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-O 120.73 0.3 . . . . 0.0 110.795 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -136.78 -50.61 0.66 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.131 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.44 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . 116.93 67.41 0.38 Allowed Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.931 -179.598 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.416 ' CG1' ' HD2' ' A' ' 38' ' ' PRO . 19.8 tt -78.45 110.1 12.71 Favored Pre-proline 0 CA--C 1.531 0.249 0 CA-C-O 120.679 0.276 . . . . 0.0 111.368 -179.432 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.467 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 35.2 Cg_exo -60.29 -45.92 20.62 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.61 2.206 . . . . 0.0 113.212 -179.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' A' ' 37' ' ' PRO . 58.1 Cg_exo -39.12 95.09 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.866 2.378 . . . . 0.0 113.221 -179.449 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -68.76 -17.57 64.06 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.405 179.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -93.5 30.98 1.61 Allowed 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 111.779 0.289 . . . . 0.0 111.779 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -82.64 116.07 21.87 Favored 'General case' 0 CA--C 1.528 0.105 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 179.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.44 168.23 20.21 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.683 0.278 . . . . 0.0 111.387 -179.256 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -103.96 167.51 9.72 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.711 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.0 tt -111.04 74.14 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.732 0.301 . . . . 0.0 111.129 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -150.91 112.57 4.46 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.343 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.426 ' HB2' ' CE1' ' A' ' 59' ' ' TYR . . . 59.75 25.44 14.44 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.849 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 43.45 45.63 6.79 Favored Glycine 0 C--N 1.337 0.595 0 C-N-CA 120.861 -0.685 . . . . 0.0 113.09 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.01 135.65 41.11 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.794 0.297 . . . . 0.0 110.898 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -89.1 161.06 16.73 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.963 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.3 tp -79.09 -20.4 48.84 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.533 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -78.62 -40.82 33.3 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-O 120.535 0.207 . . . . 0.0 111.065 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -48.0 119.0 2.61 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 179.538 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.86 53.91 0.37 Allowed Glycine 0 CA--C 1.521 0.419 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.875 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.16 164.69 11.95 Favored 'General case' 0 CA--C 1.527 0.093 0 CA-C-N 117.01 0.405 . . . . 0.0 110.725 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.1 m -99.17 131.41 45.23 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.708 0.289 . . . . 0.0 110.666 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -51.39 -33.58 30.67 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.699 -0.228 . . . . 0.0 111.007 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.6 t -63.36 -36.29 83.22 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 111.713 0.264 . . . . 0.0 111.713 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.406 ' OD1' ' CD2' ' A' ' 59' ' ' TYR . 1.5 p30 -55.81 -31.67 62.88 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -179.18 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.426 ' CE1' ' HB2' ' A' ' 46' ' ' ALA . 4.5 m-85 -103.97 29.71 5.69 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 121.077 -0.249 . . . . 0.0 111.597 -179.735 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 65.15 12.97 8.41 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 179.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 21.4 mt -89.91 62.93 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 O-C-N 122.17 -0.332 . . . . 0.0 110.692 179.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -104.19 -173.06 2.22 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.301 -179.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.3 ttpt -46.64 139.57 5.1 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.847 0.356 . . . . 0.0 111.388 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 65.26 15.77 10.18 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.134 -0.484 . . . . 0.0 112.196 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 40.3 t -76.05 -177.39 3.9 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 120.655 0.264 . . . . 0.0 110.67 179.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.33 91.58 3.77 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.515 -0.312 . . . . 0.0 110.409 179.457 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.8 mp -98.72 102.44 14.18 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.745 0.307 . . . . 0.0 111.23 -179.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -107.12 109.33 21.14 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.625 179.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -94.04 179.44 5.33 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.929 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.9 m -103.77 172.41 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.115 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.99 145.12 38.27 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.823 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -93.06 176.54 6.38 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.995 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -80.09 -35.5 36.81 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.164 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.78 128.73 33.79 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.718 0.294 . . . . 0.0 110.914 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 139.64 -42.08 1.26 Allowed Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.492 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.092 0 CA-C-O 118.299 -1.279 . . . . 0.0 112.546 179.946 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.6 ttt . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.66 0.267 . . . . 0.0 111.294 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 53.0 mm-40 -91.9 -42.01 10.28 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.005 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.4 pt -138.8 176.24 6.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-N 116.669 -0.242 . . . . 0.0 111.076 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -118.83 101.16 7.86 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.744 0.307 . . . . 0.0 110.907 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.1 p -136.19 138.37 47.21 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.746 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -107.28 168.74 9.01 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.878 0.37 . . . . 0.0 111.305 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.6 p -99.93 -168.27 1.57 Allowed 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.446 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.55 -22.48 66.98 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 120.933 -0.307 . . . . 0.0 111.563 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.2 t -100.56 -10.75 20.7 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.65 30.13 8.76 Favored Glycine 0 C--N 1.336 0.554 0 C-N-CA 120.507 -0.854 . . . . 0.0 113.111 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.6 tttm -84.29 170.28 13.83 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-N 117.161 0.481 . . . . 0.0 110.714 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.0 t -103.1 118.0 35.82 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.583 -0.281 . . . . 0.0 110.873 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 22.8 pt -125.18 157.55 33.9 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 CA-C-O 120.677 0.275 . . . . 0.0 111.211 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.4 p -106.03 125.82 51.45 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.838 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -129.16 145.78 51.23 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.885 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -101.06 152.43 20.61 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.786 0.326 . . . . 0.0 110.809 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 24.2 t -133.51 132.16 57.49 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.044 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -107.1 159.95 28.17 Favored Pre-proline 0 C--N 1.332 -0.169 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.784 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -50.68 -49.93 15.26 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.465 2.11 . . . . 0.0 112.218 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 p -90.22 36.74 0.88 Allowed 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.0 p-10 -69.13 103.82 2.0 Allowed 'General case' 0 C--O 1.231 0.11 0 O-C-N 122.199 -0.313 . . . . 0.0 110.744 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.3 p -85.09 134.09 34.2 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.979 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.9 tp -65.06 -36.98 79.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.315 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -48.09 -51.64 23.69 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.612 0.244 . . . . 0.0 111.069 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -74.78 43.63 0.2 Allowed 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 111.779 0.288 . . . . 0.0 111.779 179.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.9 p -74.06 -39.52 50.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 CA-C-O 120.626 0.25 . . . . 0.0 111.298 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.94 -44.14 78.11 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.72 0.295 . . . . 0.0 110.936 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.27 -42.68 96.32 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.103 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 21.3 mtmm -70.82 -45.63 64.24 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.948 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.401 ' CG1' HG23 ' A' ' 36' ' ' ILE . 10.8 tp -70.34 -36.53 67.34 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.266 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.7 tm0? -59.33 -24.6 63.47 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.773 -0.194 . . . . 0.0 111.069 179.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -50.99 -25.21 4.41 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.59 -39.94 61.91 Favored 'General case' 0 C--O 1.231 0.089 0 C-N-CA 120.936 -0.306 . . . . 0.0 110.564 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 176.51 -39.17 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.716 0.294 . . . . 0.0 111.453 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.567 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . 131.94 80.49 0.19 Allowed Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.748 -179.559 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.401 HG23 ' CG1' ' A' ' 30' ' ' ILE . 11.2 tt -77.68 106.1 3.42 Favored Pre-proline 0 N--CA 1.466 0.349 0 CA-C-O 120.799 0.333 . . . . 0.0 111.582 -179.19 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.609 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 17.1 Cg_exo -68.59 -35.6 16.72 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 123.03 2.486 . . . . 0.0 115.13 -179.081 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.609 ' HD2' ' N ' ' A' ' 37' ' ' PRO . 15.8 Cg_endo -60.52 113.45 1.7 Allowed 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 121.678 1.585 . . . . 0.0 113.393 -178.343 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -70.28 5.35 1.75 Allowed 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.399 179.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -89.73 8.74 30.17 Favored 'General case' 0 CA--C 1.53 0.199 0 O-C-N 122.088 -0.383 . . . . 0.0 111.4 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.401 ' HB3' HD13 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -82.59 99.41 9.53 Favored 'General case' 0 CA--C 1.527 0.08 0 CA-C-O 120.776 0.322 . . . . 0.0 110.453 179.41 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.77 169.74 16.61 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.971 -179.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.99 140.74 31.88 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.796 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.7 tt -107.83 65.08 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 120.793 0.33 . . . . 0.0 111.102 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -150.89 121.07 7.23 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.737 0.303 . . . . 0.0 111.219 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.93 25.59 15.56 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.787 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 45.13 55.71 6.41 Favored Glycine 0 C--N 1.338 0.65 0 C-N-CA 120.836 -0.697 . . . . 0.0 113.039 179.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -102.03 135.01 44.34 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.702 0.287 . . . . 0.0 110.96 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -89.09 154.17 20.4 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.872 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.5 pp -69.78 -39.44 76.64 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.06 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.76 10.97 21.44 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -47.06 -45.68 21.86 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.683 0.278 . . . . 0.0 111.194 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.39 8.12 56.52 Favored Glycine 0 CA--C 1.523 0.589 0 C-N-CA 120.591 -0.814 . . . . 0.0 113.292 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.0 mmm180 -107.09 -177.61 3.41 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 117.326 0.563 . . . . 0.0 110.702 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.6 t -99.27 150.26 22.28 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.74 0.305 . . . . 0.0 110.71 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.4 mt -61.48 -39.82 92.31 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.734 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.7 t -58.62 -32.07 68.67 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.637 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -53.94 -35.03 61.28 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 121.13 -0.228 . . . . 0.0 111.476 -179.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -103.82 31.75 4.29 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 120.474 0.178 . . . . 0.0 111.401 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 65.18 14.0 9.1 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 47.6 mt -90.01 68.32 0.59 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.139 0 CA-C-O 120.743 0.306 . . . . 0.0 110.809 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -98.87 -178.46 3.97 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.187 -179.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.4 145.81 3.21 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.801 0.334 . . . . 0.0 111.409 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 65.55 13.88 9.15 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.234 -0.439 . . . . 0.0 112.179 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 39.5 t -76.16 -177.48 4.0 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-O 120.634 0.254 . . . . 0.0 110.71 179.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.7 m -100.9 83.65 2.57 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.314 179.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.8 tt -98.83 111.22 23.67 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.751 0.31 . . . . 0.0 111.365 -179.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 17.6 t60 -107.11 125.81 51.55 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.599 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.53 111.14 23.37 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-O 120.732 0.301 . . . . 0.0 111.084 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.1 t -114.1 149.94 16.27 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.015 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.1 pp -87.25 100.03 12.39 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.962 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.15 105.61 17.67 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.864 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.4 mt -70.79 -48.03 56.41 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.857 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -90.02 122.93 33.47 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.913 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 142.35 63.7 0.03 OUTLIER Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.547 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.338 -1.257 . . . . 0.0 112.55 -179.924 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.583 0.23 . . . . 0.0 111.135 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -93.04 91.28 7.28 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.741 0.305 . . . . 0.0 110.88 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 17.7 tt -138.94 154.14 25.73 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.965 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -118.64 104.37 10.56 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.756 0.312 . . . . 0.0 110.895 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.7 t -103.25 163.4 3.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.892 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.8 tppt? -106.62 121.23 43.91 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.758 0.313 . . . . 0.0 110.662 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.404 ' OG1' ' N ' ' A' ' 11' ' ' LYS . 2.7 p -99.82 -176.44 3.26 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.192 -179.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.67 -40.11 88.45 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-O 120.696 0.284 . . . . 0.0 111.591 -178.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -111.04 43.23 1.48 Allowed 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.204 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 45.0 38.03 5.8 Favored Glycine 0 C--N 1.335 0.511 0 C-N-CA 120.95 -0.643 . . . . 0.0 113.291 179.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.404 ' N ' ' OG1' ' A' ' 7' ' ' THR . 7.8 tttt -84.12 144.46 29.01 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.856 0.328 . . . . 0.0 110.791 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.7 t -95.38 110.65 22.65 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.731 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.0 pt -125.09 164.19 24.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.201 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.7 t -100.55 150.64 22.48 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.781 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -134.87 100.74 4.68 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.676 0.274 . . . . 0.0 110.963 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -96.39 126.46 41.61 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.841 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.1 m -139.26 173.51 11.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.738 0.304 . . . . 0.0 111.272 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.423 ' HB2' ' HD2' ' A' ' 19' ' ' PRO . 0.4 OUTLIER -105.37 158.38 32.34 Favored Pre-proline 0 C--O 1.232 0.162 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.533 179.833 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.423 ' HD2' ' HB2' ' A' ' 18' ' ' GLU . 1.5 Cg_endo -44.49 -48.02 10.54 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.825 2.35 . . . . 0.0 112.165 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 87.9 p -90.33 38.89 0.95 Allowed 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 179.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.9 p-10 -75.04 116.72 16.09 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.658 0.266 . . . . 0.0 110.912 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.13 169.02 14.3 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.794 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 43.7 mm -67.4 -42.04 86.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.862 179.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -64.56 -40.14 95.02 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.005 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -62.74 -44.77 95.33 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.653 0.263 . . . . 0.0 110.788 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.7 m -70.26 -18.65 21.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.5 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.6 tptm -55.62 -35.51 65.95 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.504 0.192 . . . . 0.0 111.116 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.67 -38.89 75.9 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.6 0.238 . . . . 0.0 111.05 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.1 mttm -63.95 -36.53 84.26 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.918 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 35.5 mm -64.93 -44.48 96.14 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.078 0 CA-C-O 120.752 0.31 . . . . 0.0 110.61 179.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -57.88 -28.24 64.0 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.864 179.567 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -51.78 -27.76 13.28 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 7.2 mmtt -74.82 -40.93 60.79 Favored 'General case' 0 C--O 1.23 0.079 0 CA-C-O 120.693 0.282 . . . . 0.0 110.596 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -175.47 -40.89 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.557 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.53 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . 108.87 64.79 0.56 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.544 -0.836 . . . . 0.0 111.632 -179.511 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 12.0 tt -78.22 107.54 5.83 Favored Pre-proline 0 N--CA 1.465 0.295 0 N-CA-C 111.741 0.274 . . . . 0.0 111.741 -179.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.53 ' HD3' ' O ' ' A' ' 35' ' ' GLY . 27.9 Cg_exo -62.49 -43.83 20.58 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.751 2.301 . . . . 0.0 113.578 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' A' ' 37' ' ' PRO . 44.9 Cg_exo -38.03 117.62 0.26 Allowed 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 123.023 2.482 . . . . 0.0 113.685 -179.201 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -69.84 2.32 3.52 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 179.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -89.84 3.45 52.9 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 118.134 0.425 . . . . 0.0 111.803 -179.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 27.2 tp60 -82.88 97.53 8.71 Favored 'General case' 0 C--O 1.232 0.14 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 3.0 mtp180 -137.5 -176.31 4.36 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.151 -179.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -97.4 134.57 40.49 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.623 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 32.1 mt -100.98 83.54 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.406 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.421 ' CE2' ' HB ' ' A' ' 66' ' ' THR . 4.6 t80 -150.94 115.61 5.19 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.018 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.85 35.97 19.17 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.32 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 46.87 36.84 8.86 Favored Glycine 0 C--N 1.336 0.577 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.876 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -110.16 107.61 17.48 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.774 0.287 . . . . 0.0 111.038 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.05 130.68 35.47 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.53 179.618 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.3 pp -79.32 62.86 3.79 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.579 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -89.47 -66.32 0.93 Allowed 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.74 0.305 . . . . 0.0 110.414 179.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.456 ' O ' ' N ' ' A' ' 54' ' ' ARG . 19.0 t0 -48.56 125.44 9.86 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.01 179.112 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -65.2 60.7 0.09 OUTLIER Glycine 0 CA--C 1.522 0.52 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.565 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.456 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.3 OUTLIER -107.15 -172.9 2.17 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.94 0.37 . . . . 0.0 110.797 -179.904 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.4 m -98.39 144.92 27.25 Favored 'General case' 0 N--CA 1.457 -0.11 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.622 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.8 pp -51.78 -40.67 60.76 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.203 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.5 t -55.19 -52.09 64.45 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.395 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -64.66 -16.0 62.15 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 112.265 0.469 . . . . 0.0 112.265 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.414 ' C ' ' H ' ' A' ' 61' ' ' ILE . 0.2 OUTLIER -97.8 38.12 1.33 Allowed 'General case' 0 CA--C 1.533 0.311 0 O-C-N 122.174 -0.329 . . . . 0.0 111.885 -179.527 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 66.74 -40.29 0.37 Allowed 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 179.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.414 ' H ' ' C ' ' A' ' 59' ' ' TYR . 1.1 pt -78.64 108.22 11.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.872 0.367 . . . . 0.0 111.328 -179.504 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.24 -174.8 2.69 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.951 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.2 150.68 2.34 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.791 0.329 . . . . 0.0 111.373 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 65.11 19.29 11.76 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.852 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.2 m -75.83 177.69 6.75 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.59 0.233 . . . . 0.0 110.872 179.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.421 ' HB ' ' CE2' ' A' ' 45' ' ' PHE . 0.2 OUTLIER -96.99 114.85 26.5 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.3 179.376 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.8 mp -98.98 89.85 4.42 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.673 0.273 . . . . 0.0 111.48 -179.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -100.17 95.31 6.73 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.2 179.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -93.86 177.11 6.1 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.244 -179.426 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.0 p -103.62 156.62 5.37 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.766 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.7 mt -76.35 153.27 35.94 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 120.711 0.291 . . . . 0.0 110.939 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 15.2 mtt85 -93.83 26.08 3.32 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -80.31 -67.65 0.75 Allowed 'General case' 0 CA--C 1.527 0.093 0 CA-C-O 120.685 0.278 . . . . 0.0 110.795 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 15.6 ttt-85 -90.09 157.75 17.63 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.891 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -142.88 -106.01 0.56 Allowed Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.482 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.331 -1.26 . . . . 0.0 112.533 179.977 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.444 ' HG2' ' HB ' ' A' ' 14' ' ' THR . 5.6 tpt . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.561 0.219 . . . . 0.0 111.002 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.403 ' CB ' ' HG2' ' A' ' 63' ' ' LYS . 3.8 mm-40 -84.54 -6.86 59.4 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 112.484 0.549 . . . . 0.0 112.484 -179.346 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 18.6 tt -138.46 147.95 25.01 Favored 'Isoleucine or valine' 0 C--O 1.231 0.1 0 C-N-CA 120.619 -0.432 . . . . 0.0 111.441 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -120.61 94.64 4.43 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.95 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.404 ' CG1' ' CG1' ' A' ' 13' ' ' ILE . 13.7 p -103.02 154.77 5.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.854 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 6.4 mmpt? -106.58 145.36 31.99 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.819 0.342 . . . . 0.0 111.022 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.6 p -99.53 -173.37 2.45 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.161 -179.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -66.9 -33.43 75.57 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-O 120.688 0.28 . . . . 0.0 110.682 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.3 m -107.3 42.22 1.35 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.713 179.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 47.98 32.18 8.76 Favored Glycine 0 CA--C 1.521 0.467 0 C-N-CA 121.1 -0.571 . . . . 0.0 113.403 179.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -84.55 152.95 23.56 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 117.096 0.448 . . . . 0.0 110.788 179.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.2 t -103.14 122.53 44.9 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.716 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.404 ' CG1' ' CG1' ' A' ' 5' ' ' VAL . 38.6 pt -123.07 166.07 18.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 120.829 0.347 . . . . 0.0 111.367 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.444 ' HB ' ' HG2' ' A' ' 1' ' ' MET . 3.5 p -105.96 127.09 52.92 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.647 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.4 ' N ' ' HG2' ' A' ' 1' ' ' MET . 0.3 OUTLIER -127.75 139.35 52.73 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-O 120.775 0.321 . . . . 0.0 111.22 -179.97 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -101.19 165.42 11.3 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.638 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.7 t -140.04 125.91 21.49 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-O 120.687 0.279 . . . . 0.0 111.284 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.451 ' HB2' ' HD2' ' A' ' 19' ' ' PRO . 1.7 pt-20 -107.08 158.19 33.55 Favored Pre-proline 0 C--N 1.333 -0.115 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.453 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.451 ' HD2' ' HB2' ' A' ' 18' ' ' GLU . 4.7 Cg_endo -47.1 -56.29 3.17 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.555 2.17 . . . . 0.0 112.124 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 41.6 p -90.45 41.73 1.07 Allowed 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -72.78 111.35 7.84 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.638 0.256 . . . . 0.0 110.989 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.8 m -85.09 149.28 25.66 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.723 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.7 mt -68.02 -36.82 76.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.285 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -73.92 -40.83 62.85 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 120.564 0.221 . . . . 0.0 110.984 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -67.26 -40.41 86.2 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.682 -0.235 . . . . 0.0 111.126 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 12.1 p -63.83 -33.81 64.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-N 116.703 -0.226 . . . . 0.0 111.367 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -55.81 -45.37 78.29 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.724 0.297 . . . . 0.0 110.814 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.04 -30.26 69.45 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.367 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.5 ttmp? -63.69 -41.27 98.16 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 120.594 0.235 . . . . 0.0 110.899 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.1 mt -64.96 -47.55 87.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-O 120.679 0.276 . . . . 0.0 110.712 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.3 -45.73 83.19 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.594 179.693 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -61.11 -23.97 65.9 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.556 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -74.63 -64.56 1.01 Allowed 'General case' 0 CA--C 1.528 0.103 0 CA-C-O 120.575 0.226 . . . . 0.0 111.285 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -103.27 -41.44 6.04 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 111.5 0.185 . . . . 0.0 111.5 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.484 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . 96.95 56.64 1.13 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.515 -0.85 . . . . 0.0 111.822 -179.475 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.432 HG12 ' HD2' ' A' ' 38' ' ' PRO . 10.1 tt -78.44 108.92 8.82 Favored Pre-proline 0 CA--C 1.531 0.225 0 CA-C-O 120.622 0.249 . . . . 0.0 111.452 -179.474 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.484 ' HD3' ' O ' ' A' ' 35' ' ' GLY . 36.7 Cg_exo -60.8 -46.74 15.35 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.549 2.166 . . . . 0.0 113.036 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.443 ' CD ' ' N ' ' A' ' 37' ' ' PRO . 69.9 Cg_exo -40.72 104.88 0.05 OUTLIER 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.82 2.347 . . . . 0.0 113.287 -179.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.0 p-10 -69.12 -10.98 60.31 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.901 179.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.79 22.31 3.64 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -179.622 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.401 ' HG2' ' CD1' ' A' ' 69' ' ' LEU . 0.6 OUTLIER -84.16 102.8 12.85 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 110.329 -0.249 . . . . 0.0 110.329 179.436 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -143.98 179.16 7.36 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-O 120.778 0.323 . . . . 0.0 111.41 -179.569 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -108.16 141.64 39.58 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.871 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 17.2 tt -111.05 75.39 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-O 120.766 0.317 . . . . 0.0 110.946 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -150.87 121.97 7.72 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.271 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 56.27 34.91 24.89 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.619 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 46.43 44.55 16.04 Favored Glycine 0 C--N 1.335 0.477 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.895 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.422 ' HE2' ' CD1' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -99.99 109.63 21.96 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.713 0.292 . . . . 0.0 110.904 -179.995 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -89.19 151.88 21.92 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.983 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.4 mt -79.24 -8.81 59.32 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.761 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -78.67 -41.47 31.18 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 122.334 -0.229 . . . . 0.0 111.108 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -47.8 114.83 0.98 Allowed 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 116.658 -0.246 . . . . 0.0 110.373 179.665 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -69.85 46.2 0.57 Allowed Glycine 0 CA--C 1.521 0.461 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.892 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -107.3 177.23 4.91 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 117.128 0.464 . . . . 0.0 110.668 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 5.7 t -99.17 142.88 30.08 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.601 0.238 . . . . 0.0 110.436 179.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 84.0 mt -51.86 -43.11 63.1 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.715 0.293 . . . . 0.0 111.349 -179.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.8 t -54.55 -27.93 42.09 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -179.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -53.76 -40.91 66.61 Favored 'General case' 0 N--CA 1.465 0.318 0 O-C-N 122.259 -0.275 . . . . 0.0 111.548 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.422 ' CD1' ' HE2' ' A' ' 48' ' ' LYS . 33.8 m-85 -101.94 19.26 18.71 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 111.914 0.338 . . . . 0.0 111.914 -179.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 64.62 14.64 9.16 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.1 tp -90.0 62.16 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-O 120.841 0.353 . . . . 0.0 110.873 179.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 10.8 pm0 -95.26 -172.78 2.75 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.44 -179.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.403 ' HG2' ' CB ' ' A' ' 2' ' ' GLN . 0.1 OUTLIER -39.84 155.74 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.985 -179.444 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 65.3 16.01 10.31 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.806 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 17.7 p -76.32 145.94 39.21 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-O 120.561 0.219 . . . . 0.0 111.031 179.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 11.7 p -97.68 76.96 2.52 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 179.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.1 mt -99.94 131.77 45.7 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.832 0.348 . . . . 0.0 111.68 -179.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -107.2 139.84 41.0 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.25 179.214 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.401 ' CD1' ' HG2' ' A' ' 41' ' ' GLN . 0.1 OUTLIER -93.87 116.77 29.25 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.678 0.275 . . . . 0.0 110.858 -179.858 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.8 p -114.36 148.26 17.28 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.383 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -80.49 79.55 7.07 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.563 179.555 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.36 95.1 9.82 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.025 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.2 mt -80.14 -66.56 0.86 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.956 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -90.07 135.62 33.54 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.922 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -92.48 142.52 16.05 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.469 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.39 -1.228 . . . . 0.0 112.499 179.974 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.9 tpt . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.509 0.195 . . . . 0.0 110.945 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 64.5 mm-40 -84.49 -42.63 15.36 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.735 -0.211 . . . . 0.0 111.489 -179.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.406 ' CD1' ' CG2' ' A' ' 5' ' ' VAL . 1.1 pp -138.93 164.77 25.09 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 C-N-CA 120.711 -0.396 . . . . 0.0 111.672 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -129.07 111.93 13.48 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.873 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.406 ' CG2' ' CD1' ' A' ' 3' ' ' ILE . 39.0 t -111.4 155.11 12.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.893 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -106.56 165.5 11.24 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.673 0.273 . . . . 0.0 110.718 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 66.7 p -109.82 -142.82 0.38 Allowed 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.647 -179.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -65.25 -38.57 90.75 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 118.615 0.643 . . . . 0.0 111.482 -179.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.9 m -107.98 -60.55 1.7 Allowed 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.607 0.242 . . . . 0.0 110.894 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 165.56 53.32 0.02 OUTLIER Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.417 -0.897 . . . . 0.0 112.949 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.9 tttt -84.27 160.2 20.79 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.822 0.311 . . . . 0.0 110.675 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 26.8 p -94.91 104.68 16.57 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.876 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 25.3 pt -114.96 153.6 16.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-O 120.754 0.312 . . . . 0.0 111.172 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.1 p -106.07 149.89 26.29 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.935 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.97 89.03 2.86 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-O 120.669 0.271 . . . . 0.0 111.264 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.13 94.91 6.22 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.766 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.8 m -129.94 174.12 13.13 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 CA-C-O 120.71 0.291 . . . . 0.0 111.288 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.06 160.06 27.53 Favored Pre-proline 0 C--O 1.231 0.13 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.107 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -55.44 -29.19 67.52 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.648 2.232 . . . . 0.0 112.839 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 42.0 t -78.78 -15.08 58.86 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 111.67 0.248 . . . . 0.0 111.67 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -64.94 122.0 15.96 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-O 120.674 0.273 . . . . 0.0 110.808 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -85.09 178.71 7.45 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.823 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.3 mt -68.17 -39.23 80.91 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.084 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -66.61 -41.25 88.7 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.658 -0.247 . . . . 0.0 111.069 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -62.96 -45.8 90.72 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.649 0.261 . . . . 0.0 111.004 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 31.8 m -63.98 -29.7 48.01 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.524 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.62 -43.99 76.65 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.658 0.266 . . . . 0.0 110.807 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.87 -33.07 74.02 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.046 179.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -63.9 -28.39 69.81 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.038 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 40.8 mm -75.25 -46.04 39.7 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.201 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -65.35 -40.52 93.71 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.91 178.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.27 -24.69 66.57 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.288 179.494 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.8 mmtm -74.78 -55.47 5.8 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.525 0.202 . . . . 0.0 111.295 -179.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -115.47 -49.77 2.74 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.618 0.247 . . . . 0.0 111.19 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 113.69 64.02 0.43 Allowed Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.679 -0.772 . . . . 0.0 111.851 -179.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.3 pp -77.89 111.59 19.07 Favored Pre-proline 0 CA--C 1.531 0.223 0 CA-C-O 120.634 0.254 . . . . 0.0 111.347 -179.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.534 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 31.5 Cg_exo -59.34 -43.61 39.47 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.683 2.255 . . . . 0.0 113.444 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.534 ' HD2' ' N ' ' A' ' 37' ' ' PRO . 54.9 Cg_endo -71.86 111.25 3.11 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.06 1.84 . . . . 0.0 112.755 -179.23 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -68.69 -13.61 62.48 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.055 -0.52 . . . . 0.0 112.098 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -91.08 21.9 4.02 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.454 0.538 . . . . 0.0 112.454 -179.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -93.11 97.77 10.89 Favored 'General case' 0 C--O 1.23 0.067 0 O-C-N 122.249 -0.282 . . . . 0.0 110.289 179.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.0 mtm180 -137.68 -175.82 4.21 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-O 120.715 0.293 . . . . 0.0 111.043 -179.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.1 pp -101.59 141.52 34.33 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.944 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.3 tt -111.17 113.91 45.61 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.239 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.429 ' CE1' HG22 ' A' ' 66' ' ' THR . 5.9 t80 -152.52 130.96 12.14 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.797 0.332 . . . . 0.0 111.306 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.82 28.87 13.04 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.776 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 45.07 48.15 9.86 Favored Glycine 0 C--N 1.336 0.543 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.903 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.42 ' HG2' ' CD1' ' A' ' 59' ' ' TYR . 12.4 mptt -99.88 140.75 33.64 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.764 0.282 . . . . 0.0 110.942 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.15 99.62 12.57 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.885 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -79.27 -8.05 58.75 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.838 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -78.57 -30.45 46.77 Favored 'General case' 0 CA--C 1.53 0.21 0 O-C-N 122.346 -0.221 . . . . 0.0 111.29 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -45.43 -39.23 6.85 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.567 0.222 . . . . 0.0 111.3 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 105.16 49.32 1.0 Allowed Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.745 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.3 -179.11 3.83 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.724 0.262 . . . . 0.0 110.698 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 10.6 m -99.08 140.72 32.81 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.643 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.0 mp -51.77 -48.23 63.82 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.824 0.345 . . . . 0.0 110.833 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.5 t -55.31 -36.99 66.81 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.24 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -54.27 -35.69 62.81 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 111.505 0.187 . . . . 0.0 111.505 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.42 ' CD1' ' HG2' ' A' ' 48' ' ' LYS . 68.7 m-85 -100.09 21.26 13.09 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.3 m120 65.59 8.67 5.29 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 112.791 0.664 . . . . 0.0 112.791 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.436 ' O ' HG22 ' A' ' 61' ' ' ILE . 1.2 tt -90.14 63.13 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-O 120.883 0.373 . . . . 0.0 110.666 179.321 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -94.57 -173.52 3.05 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.245 -179.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.428 ' O ' ' HG2' ' A' ' 64' ' ' GLU . 0.1 OUTLIER -39.96 147.68 0.09 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.727 -179.593 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.428 ' HG2' ' O ' ' A' ' 63' ' ' LYS . 0.7 OUTLIER 65.53 15.02 9.83 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.992 -179.747 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.5 m -76.23 174.2 10.43 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.754 0.312 . . . . 0.0 110.839 179.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.429 HG22 ' CE1' ' A' ' 45' ' ' PHE . 5.9 t -107.24 90.65 3.37 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.248 179.437 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.2 mt -98.9 113.86 26.19 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.747 0.308 . . . . 0.0 111.39 -179.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -107.22 120.93 43.47 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.385 179.361 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -93.76 156.45 16.67 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.713 0.292 . . . . 0.0 111.155 -179.648 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -104.07 166.22 3.08 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.747 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.3 mp -76.71 141.88 40.72 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.677 0.275 . . . . 0.0 110.751 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.13 106.56 15.03 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.062 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 7.3 mt -80.18 -42.53 23.2 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.84 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.05 133.1 35.42 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.671 0.272 . . . . 0.0 110.872 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 133.2 103.91 0.86 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.497 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.115 0 CA-C-O 118.395 -1.225 . . . . 0.0 112.5 179.997 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.1 mp0 . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.634 0.254 . . . . 0.0 111.05 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.411 HG21 ' HB3' ' A' ' 15' ' ' LEU . 17.4 tt -139.01 153.17 24.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.985 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -118.79 97.06 5.53 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.968 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.516 HG13 HD13 ' A' ' 69' ' ' LEU . 21.5 t -98.97 152.72 4.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.981 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.28 130.92 56.11 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.698 0.285 . . . . 0.0 111.014 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.6 p -100.03 175.53 5.73 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.45 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.941 HD23 HG23 ' A' ' 9' ' ' THR . 0.0 OUTLIER -66.86 -21.91 66.0 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 179.417 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.941 HG23 HD23 ' A' ' 8' ' ' LEU . 67.8 p -105.54 28.87 7.01 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.19 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 47.59 32.85 8.21 Favored Glycine 0 C--N 1.336 0.541 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.991 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.49 146.37 27.63 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.969 0.385 . . . . 0.0 111.023 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.0 t -103.22 110.32 22.25 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.804 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.717 HG21 ' HE3' ' A' ' 33' ' ' LYS . 3.0 pt -125.08 166.67 20.36 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.297 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.1 p -104.49 152.52 22.27 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.711 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.411 ' HB3' HG21 ' A' ' 3' ' ' ILE . 1.2 tp -137.99 140.29 40.11 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.668 0.271 . . . . 0.0 111.044 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -101.0 139.05 37.24 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.701 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.6 t -138.53 138.3 42.71 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 CA-C-O 120.78 0.324 . . . . 0.0 111.354 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.447 ' HB2' ' HD2' ' A' ' 19' ' ' PRO . 11.6 pt-20 -100.08 167.87 10.33 Favored Pre-proline 0 C--N 1.332 -0.156 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.55 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.447 ' HD2' ' HB2' ' A' ' 18' ' ' GLU . 52.7 Cg_exo -54.86 -58.88 0.99 Allowed 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.39 2.06 . . . . 0.0 112.164 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.5 t -90.58 38.51 0.95 Allowed 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -75.42 114.13 13.61 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-O 120.576 0.227 . . . . 0.0 111.067 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 31.1 p -85.18 158.43 20.37 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.639 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.597 ' O ' HG12 ' A' ' 26' ' ' VAL . 9.5 tp -57.97 -32.83 44.56 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-N 116.718 -0.219 . . . . 0.0 111.277 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -77.89 -40.76 38.86 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.642 0.258 . . . . 0.0 110.858 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -62.94 -34.77 78.18 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.15 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.597 HG12 ' O ' ' A' ' 23' ' ' ILE . 12.1 p -69.32 -15.68 19.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.623 ' O ' HG22 ' A' ' 30' ' ' ILE . 0.1 OUTLIER -55.47 -33.0 63.26 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.582 0.229 . . . . 0.0 111.104 -179.992 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.19 -36.39 79.51 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.57 0.224 . . . . 0.0 111.045 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.3 mttp -64.04 -43.49 95.39 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.706 -0.225 . . . . 0.0 111.114 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.823 HG12 HD13 ' A' ' 36' ' ' ILE . 1.2 tt -64.82 -30.36 50.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 116.727 -0.215 . . . . 0.0 111.252 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -65.22 -20.81 66.61 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 120.44 0.162 . . . . 0.0 111.238 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -51.99 -24.76 7.05 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 112.181 0.438 . . . . 0.0 112.181 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.717 ' HE3' HG21 ' A' ' 13' ' ' ILE . 0.3 OUTLIER -73.88 -73.49 0.22 Allowed 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.967 -179.585 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -167.1 41.36 0.05 OUTLIER 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.408 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . 53.02 87.81 0.01 OUTLIER Glycine 0 C--N 1.335 0.504 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.443 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.823 HD13 HG12 ' A' ' 30' ' ' ILE . 4.2 mp -78.55 110.76 15.09 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-O 120.571 0.225 . . . . 0.0 111.02 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.456 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 36.3 Cg_exo -59.86 -47.05 16.86 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.614 2.21 . . . . 0.0 113.085 -179.553 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.466 ' HD2' HG22 ' A' ' 36' ' ' ILE . 77.3 Cg_exo -41.12 96.24 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.669 2.246 . . . . 0.0 112.924 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -68.22 -20.29 64.82 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.449 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -99.98 34.39 2.32 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 111.552 0.205 . . . . 0.0 111.552 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.844 ' O ' HD22 ' A' ' 50' ' ' LEU . 3.7 tp60 -93.2 115.32 27.94 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-O 120.526 0.203 . . . . 0.0 110.485 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 11.1 ptt-85 -143.98 178.92 7.52 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.653 0.263 . . . . 0.0 111.199 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.889 HD22 HD21 ' A' ' 67' ' ' LEU . 0.8 OUTLIER -97.85 152.67 18.95 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.918 179.969 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.629 ' O ' HG23 ' A' ' 44' ' ' ILE . 2.2 tt -104.59 77.06 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 CA-C-O 120.848 0.356 . . . . 0.0 111.038 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -150.81 116.96 5.61 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.119 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.6 32.15 21.84 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.538 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 46.5 68.16 1.18 Allowed Glycine 0 C--N 1.337 0.595 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.993 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.416 ' HG3' ' CD2' ' A' ' 59' ' ' TYR . 0.3 OUTLIER -110.0 127.53 54.86 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 116.761 0.281 . . . . 0.0 111.039 179.953 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -89.19 126.51 35.51 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.854 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.844 HD22 ' O ' ' A' ' 41' ' ' GLN . 0.8 OUTLIER -79.14 -24.51 43.28 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.454 179.936 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.452 ' O ' ' O ' ' A' ' 52' ' ' ASP . 4.1 tt0 -78.89 -36.15 42.5 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 121.279 -0.168 . . . . 0.0 111.395 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.452 ' O ' ' O ' ' A' ' 51' ' ' GLU . 0.2 OUTLIER -49.11 -171.62 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 121.57 0.7 . . . . 0.0 111.517 179.952 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -118.9 40.63 2.21 Favored Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 115.329 -0.851 . . . . 0.0 112.18 179.44 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -97.7 155.23 17.1 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-O 120.66 0.266 . . . . 0.0 111.003 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.561 HG23 ' H ' ' A' ' 58' ' ' ASP . 8.8 t -99.14 156.59 16.87 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.939 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.787 ' O ' HG22 ' A' ' 61' ' ' ILE . 1.7 mp -62.37 -36.52 82.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.281 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.5 t -58.75 -42.13 88.13 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -179.286 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.561 ' H ' HG23 ' A' ' 55' ' ' THR . 4.5 p30 -57.28 -25.25 58.92 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -179.258 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.416 ' CD2' ' HG3' ' A' ' 48' ' ' LYS . 0.5 OUTLIER -97.65 12.8 32.39 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 111.736 0.273 . . . . 0.0 111.736 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.5 m120 54.81 28.68 10.66 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.787 HG22 ' O ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -89.5 96.32 6.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.173 0 CA-C-O 120.877 0.37 . . . . 0.0 110.746 179.668 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.05 172.72 7.96 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.762 0.315 . . . . 0.0 111.024 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.14 155.14 1.01 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.218 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 63.78 22.01 12.9 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.459 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -75.74 177.48 6.84 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-O 120.752 0.31 . . . . 0.0 110.8 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.5 m -107.06 80.98 1.48 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.561 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.889 HD21 HD22 ' A' ' 43' ' ' LEU . 0.7 OUTLIER -98.85 110.47 23.07 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.109 -179.769 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -107.08 125.13 50.64 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.66 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.516 HD13 HG13 ' A' ' 5' ' ' VAL . 9.5 mp -93.98 174.65 7.05 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.658 0.266 . . . . 0.0 110.917 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 30.2 t -103.83 141.29 19.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.036 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.1 mt . . . . . 0 C--N 1.333 -0.118 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.816 -179.94 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.0 mt-30 . . . . . 0 CA--C 1.527 0.088 0 CA-C-O 120.688 0.28 . . . . 0.0 110.691 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.831 HD11 ' HB3' ' A' ' 15' ' ' LEU . 27.3 pt -138.93 173.44 11.85 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.144 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -118.91 100.31 7.29 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.677 0.275 . . . . 0.0 110.896 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.6 t -105.07 149.74 8.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.109 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.96 125.82 51.5 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.86 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.3 p -99.21 -166.33 1.34 Allowed 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.45 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.402 ' HG ' ' N ' ' A' ' 9' ' ' THR . 0.5 OUTLIER -66.72 -44.06 82.62 Favored 'General case' 0 C--O 1.231 0.115 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -178.459 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.405 ' O ' HG22 ' A' ' 9' ' ' THR . 23.1 m -111.06 51.62 0.77 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.81 0.338 . . . . 0.0 111.319 -179.295 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 44.18 40.8 6.03 Favored Glycine 0 C--N 1.335 0.487 0 C-N-CA 121.183 -0.532 . . . . 0.0 113.344 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.6 tttt -84.22 134.9 34.53 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.827 0.314 . . . . 0.0 110.834 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.537 ' O ' HG23 ' A' ' 12' ' ' THR . 12.3 t -99.34 110.1 22.65 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.728 0.299 . . . . 0.0 110.907 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.1 pt -125.09 166.79 20.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.214 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.4 t -101.33 148.78 24.73 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.654 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.831 ' HB3' HD11 ' A' ' 3' ' ' ILE . 0.1 OUTLIER -137.94 108.9 6.72 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.708 0.289 . . . . 0.0 111.055 -179.876 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -101.01 138.12 38.48 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.707 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.6 t -140.06 149.0 22.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.745 0.307 . . . . 0.0 111.386 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.418 ' HB2' ' HD2' ' A' ' 19' ' ' PRO . 6.7 pt-20 -96.96 157.46 35.01 Favored Pre-proline 0 C--N 1.332 -0.164 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.7 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.418 ' HD2' ' HB2' ' A' ' 18' ' ' GLU . 10.7 Cg_endo -54.07 -36.03 83.51 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.852 2.368 . . . . 0.0 113.135 -179.519 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.9 0.47 56.57 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.46 128.09 34.55 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.648 0.261 . . . . 0.0 111.032 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.8 p -85.16 159.96 20.02 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.529 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.65 ' O ' HG12 ' A' ' 26' ' ' VAL . 1.4 tt -57.98 -36.38 56.03 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.469 -179.656 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -71.37 -32.3 68.33 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.751 -0.204 . . . . 0.0 111.288 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -62.88 -43.6 98.35 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.547 0.213 . . . . 0.0 111.164 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.65 HG12 ' O ' ' A' ' 23' ' ' ILE . 9.9 p -63.82 -28.6 45.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-N 116.738 -0.21 . . . . 0.0 111.32 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.661 ' NZ ' HD22 ' A' ' 50' ' ' LEU . 3.9 mmpt? -59.61 -30.4 68.66 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-O 120.527 0.204 . . . . 0.0 111.235 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.83 -52.93 63.46 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.546 0.212 . . . . 0.0 111.193 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 18.8 ptmt -63.91 -34.61 78.36 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.692 -0.231 . . . . 0.0 111.014 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.401 HD12 ' HE2' ' A' ' 27' ' ' LYS . 57.8 mt -75.22 -14.51 15.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 116.816 -0.175 . . . . 0.0 111.403 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -65.48 -13.24 58.38 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -50.36 -29.91 11.05 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.3 ptpp? -79.72 -21.91 43.97 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 121.036 -0.265 . . . . 0.0 111.432 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 74.47 40.77 0.39 Allowed 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.657 0.265 . . . . 0.0 110.794 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -142.78 30.78 2.04 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.426 -0.892 . . . . 0.0 113.053 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.544 ' HB ' ' CD ' ' A' ' 37' ' ' PRO . 29.3 mm -78.68 -61.3 0.54 Allowed Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 117.107 0.453 . . . . 0.0 111.681 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.544 ' CD ' ' HB ' ' A' ' 36' ' ' ILE . 5.1 Cg_exo -42.13 -51.19 4.9 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.73 2.287 . . . . 0.0 112.887 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' A' ' 37' ' ' PRO . 57.9 Cg_exo -37.39 140.7 0.22 Allowed 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.985 2.456 . . . . 0.0 113.379 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -69.02 -6.3 27.13 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.6 mm-40 -89.89 -28.48 19.19 Favored 'General case' 0 CA--C 1.53 0.211 0 O-C-N 122.115 -0.365 . . . . 0.0 111.567 -179.358 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 5.2 tp60 -82.87 71.56 9.97 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-O 120.788 0.327 . . . . 0.0 110.787 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.406 ' HA ' HD12 ' A' ' 50' ' ' LEU . 1.8 mtt180 -133.94 -179.08 5.32 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.814 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.594 HD11 HD23 ' A' ' 67' ' ' LEU . 1.0 OUTLIER -103.78 133.88 48.02 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.942 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.558 ' O ' HG23 ' A' ' 44' ' ' ILE . 12.7 tt -101.09 61.86 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.025 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -150.87 120.03 6.76 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.077 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 59.61 27.03 16.15 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.616 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 45.28 40.5 7.83 Favored Glycine 0 C--N 1.336 0.576 0 C-N-CA 120.78 -0.724 . . . . 0.0 113.07 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.442 ' HD3' ' CE1' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -103.85 125.94 50.63 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.86 0.33 . . . . 0.0 111.022 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -89.13 144.21 26.29 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.866 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.661 HD22 ' NZ ' ' A' ' 27' ' ' LYS . 1.1 mp -79.53 -5.56 55.14 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.37 -0.377 . . . . 0.0 112.006 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.445 ' O ' ' O ' ' A' ' 52' ' ' ASP . 5.1 mm-40 -78.69 -34.2 46.3 Favored 'General case' 0 CA--C 1.53 0.205 0 O-C-N 122.37 -0.206 . . . . 0.0 111.431 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.445 ' O ' ' O ' ' A' ' 51' ' ' GLU . 0.9 OUTLIER -48.94 -172.54 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 121.485 0.659 . . . . 0.0 111.51 179.872 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -117.0 41.7 2.04 Favored Glycine 0 N--CA 1.451 -0.361 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.257 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -104.44 162.03 13.58 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.664 0.268 . . . . 0.0 111.037 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.4 HG23 ' H ' ' A' ' 58' ' ' ASP . 8.8 t -99.14 148.12 24.4 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.821 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.83 ' O ' HG22 ' A' ' 61' ' ' ILE . 1.4 mp -51.85 -47.95 64.19 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.186 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.5 t -52.87 -29.09 26.19 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.728 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.4 ' H ' HG23 ' A' ' 55' ' ' THR . 35.6 t70 -53.65 -40.3 65.75 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.43 0.157 . . . . 0.0 111.357 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.442 ' CE1' ' HD3' ' A' ' 48' ' ' LYS . 36.9 m-85 -103.29 25.27 9.75 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 111.595 0.221 . . . . 0.0 111.595 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 56.27 24.02 7.76 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.83 HG22 ' O ' ' A' ' 56' ' ' LEU . 0.9 OUTLIER -90.01 62.69 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-O 120.815 0.341 . . . . 0.0 110.777 179.468 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -94.86 -172.16 2.64 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.917 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.454 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 18.4 tttp -40.52 142.35 0.43 Allowed 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.706 0.289 . . . . 0.0 111.55 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.454 ' HG3' ' O ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER 65.07 21.25 12.21 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.642 -179.838 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.4 p -75.59 175.61 8.41 Favored 'General case' 0 CA--C 1.527 0.08 0 CA-C-O 120.63 0.252 . . . . 0.0 110.835 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.0 m -102.59 86.19 2.73 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.682 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.594 HD23 HD11 ' A' ' 43' ' ' LEU . 5.5 mt -99.01 105.48 17.63 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.065 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.42 ' O ' HG22 ' A' ' 44' ' ' ILE . 1.1 t-80 -107.09 121.11 43.85 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.785 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -96.69 169.77 9.65 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.748 0.309 . . . . 0.0 110.931 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.3 t -103.99 153.24 6.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.031 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.5 mp . . . . . 0 C--N 1.332 -0.155 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.844 179.993 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 . . . . . 0 CA--C 1.531 0.248 0 N-CA-C 111.62 0.23 . . . . 0.0 111.62 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.673 ' CD1' HD21 ' A' ' 67' ' ' LEU . 2.2 pt -138.53 174.58 9.96 Favored 'Isoleucine or valine' 0 C--O 1.231 0.092 0 CA-C-O 120.623 0.249 . . . . 0.0 111.159 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -118.9 106.55 12.6 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.732 0.301 . . . . 0.0 110.891 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.436 ' HB ' HD11 ' A' ' 13' ' ' ILE . 21.4 t -99.17 150.16 5.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.079 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.95 127.46 53.46 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.794 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.1 p -99.21 -168.29 1.6 Allowed 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.356 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.412 ' HG ' ' N ' ' A' ' 9' ' ' THR . 0.6 OUTLIER -66.79 -40.45 88.13 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 120.663 0.268 . . . . 0.0 111.355 -178.719 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.412 ' N ' ' HG ' ' A' ' 8' ' ' LEU . 0.9 OUTLIER -111.17 41.46 1.84 Allowed 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 120.721 0.296 . . . . 0.0 111.086 179.837 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 47.28 42.53 17.93 Favored Glycine 0 C--N 1.335 0.504 0 C-N-CA 120.861 -0.685 . . . . 0.0 113.066 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.9 mtpm? -84.22 163.04 19.95 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.749 0.274 . . . . 0.0 110.926 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.4 m -103.07 118.06 35.95 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.895 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.737 HD13 HD23 ' A' ' 15' ' ' LEU . 2.4 pp -125.17 158.16 33.41 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-O 120.697 0.284 . . . . 0.0 111.182 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.8 p -101.19 128.49 47.27 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.86 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.737 HD23 HD13 ' A' ' 13' ' ' ILE . 0.2 OUTLIER -132.3 144.61 50.71 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.922 -179.991 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -100.44 162.39 12.97 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.841 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.9 t -129.99 103.88 9.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.106 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.417 ' HB2' ' HD2' ' A' ' 19' ' ' PRO . 10.4 pt-20 -103.72 157.3 34.19 Favored Pre-proline 0 C--N 1.332 -0.172 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.66 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.417 ' HD2' ' HB2' ' A' ' 18' ' ' GLU . 8.0 Cg_endo -50.13 -57.15 2.48 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.621 2.214 . . . . 0.0 112.187 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 44.9 t -90.3 36.41 0.88 Allowed 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.627 ' HB3' HD21 ' A' ' 56' ' ' LEU . 12.7 t0 -75.26 107.37 7.32 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-O 120.695 0.284 . . . . 0.0 110.93 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.4 m -85.23 157.99 20.46 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.526 -0.307 . . . . 0.0 110.831 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.642 HG22 HD13 ' A' ' 50' ' ' LEU . 24.7 mt -65.78 -34.41 70.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.027 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -75.33 -33.35 61.12 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.725 -0.216 . . . . 0.0 111.151 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -62.79 -41.67 99.37 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.559 0.218 . . . . 0.0 111.059 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.635 HG22 ' O ' ' A' ' 23' ' ' ILE . 35.9 m -63.86 -23.5 33.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.614 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -55.82 -36.45 67.49 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 120.494 0.188 . . . . 0.0 111.196 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.78 -45.35 86.13 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-O 120.639 0.257 . . . . 0.0 111.181 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 14.1 mttm -63.91 -42.39 97.44 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.781 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.409 ' CG2' ' CG2' ' A' ' 36' ' ' ILE . 33.2 mm -75.01 -27.48 20.02 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.446 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.413 ' HA ' ' HG3' ' A' ' 37' ' ' PRO . 10.3 tt0 -65.15 -16.91 64.02 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -50.4 -32.67 18.27 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 111.601 0.223 . . . . 0.0 111.601 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.37 -30.58 23.52 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 121.125 -0.23 . . . . 0.0 111.07 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 65.31 26.22 12.12 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 120.61 0.243 . . . . 0.0 110.871 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.422 ' N ' ' HD2' ' A' ' 37' ' ' PRO . . . -112.08 -48.25 0.67 Allowed Glycine 0 C--N 1.334 0.465 0 C-N-CA 120.453 -0.88 . . . . 0.0 112.952 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.718 HD11 HD23 ' A' ' 69' ' ' LEU . 7.6 tt -84.21 -24.78 0.35 Allowed Pre-proline 0 CA--C 1.54 0.592 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -179.227 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.623 ' CD ' ' N ' ' A' ' 36' ' ' ILE . 78.3 Cg_exo -42.96 -41.7 9.05 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 122.309 2.006 . . . . 0.0 113.791 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.488 ' O ' ' O ' ' A' ' 37' ' ' PRO . 66.8 Cg_exo -53.39 -147.78 0.0 OUTLIER 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.446 2.097 . . . . 0.0 112.668 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -68.09 -4.08 12.39 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -179.376 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -90.34 -4.08 57.32 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 121.97 -0.457 . . . . 0.0 111.856 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.415 ' HG3' HG23 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -93.21 89.63 6.51 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-O 120.582 0.229 . . . . 0.0 110.971 179.756 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -144.01 151.93 40.35 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.973 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.4 tp -107.97 142.38 38.19 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.847 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.583 ' O ' HG23 ' A' ' 44' ' ' ILE . 2.2 tt -111.06 65.86 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-O 120.752 0.311 . . . . 0.0 111.097 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -150.89 127.74 10.99 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.194 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.77 ' HB2' ' CZ ' ' A' ' 59' ' ' TYR . . . 59.86 31.41 20.74 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.636 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 45.21 39.3 6.91 Favored Glycine 0 C--N 1.337 0.584 0 C-N-CA 120.808 -0.71 . . . . 0.0 113.079 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.1 mttm -109.73 145.43 36.62 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.787 0.294 . . . . 0.0 110.954 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -89.07 174.4 7.9 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.866 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.642 HD13 HG22 ' A' ' 23' ' ' ILE . 0.2 OUTLIER -79.21 -37.16 38.86 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.184 -179.975 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -89.35 8.8 28.75 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -47.24 -41.03 17.79 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.646 0.26 . . . . 0.0 111.159 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.98 23.82 24.28 Favored Glycine 0 CA--C 1.522 0.504 0 C-N-CA 120.757 -0.735 . . . . 0.0 113.039 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.456 ' H ' HD12 ' A' ' 23' ' ' ILE . 26.6 mmt180 -107.38 177.25 4.9 Favored 'General case' 0 C--N 1.334 -0.083 0 CA-C-N 117.132 0.466 . . . . 0.0 110.753 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.47 HG23 ' O ' ' A' ' 21' ' ' ASP . 4.4 m -99.44 130.82 45.73 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.491 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.627 HD21 ' HB3' ' A' ' 21' ' ' ASP . 0.6 OUTLIER -51.21 -32.45 23.93 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 120.601 0.239 . . . . 0.0 110.916 179.974 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.2 t -61.5 -27.25 68.46 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.625 -0.262 . . . . 0.0 111.607 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.404 ' OD1' ' N ' ' A' ' 59' ' ' TYR . 2.5 p30 -53.74 -30.21 43.13 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 120.859 -0.336 . . . . 0.0 111.492 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.77 ' CZ ' ' HB2' ' A' ' 46' ' ' ALA . 3.4 t80 -107.8 37.09 2.53 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 120.569 0.223 . . . . 0.0 111.248 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 23.6 m120 54.77 32.91 18.47 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.649 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.613 ' O ' HD12 ' A' ' 56' ' ' LEU . 22.1 mt -89.37 76.46 1.3 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-O 120.69 0.281 . . . . 0.0 110.849 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.03 -174.34 2.51 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.0 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.54 144.89 1.41 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.78 0.324 . . . . 0.0 111.255 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 63.37 21.23 12.69 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.617 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.5 m -75.85 162.15 28.38 Favored 'General case' 0 CA--C 1.527 0.092 0 CA-C-O 120.642 0.258 . . . . 0.0 110.808 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -107.03 83.01 1.76 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.552 179.675 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.673 HD21 ' CD1' ' A' ' 3' ' ' ILE . 2.9 pp -98.92 126.93 44.72 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.132 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.43 ' O ' HG22 ' A' ' 44' ' ' ILE . 20.3 t-160 -107.06 117.94 35.4 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.686 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.718 HD23 HD11 ' A' ' 36' ' ' ILE . 0.2 OUTLIER -93.73 114.77 27.14 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.776 0.322 . . . . 0.0 110.817 -179.981 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.4 p -111.83 152.61 13.67 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.016 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.407 HD23 ' H ' ' A' ' 71' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--N 1.331 -0.236 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.883 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 52.6 mm-40 . . . . . 0 CA--C 1.53 0.179 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.415 HD12 ' CB ' ' A' ' 15' ' ' LEU . 0.9 OUTLIER -138.68 169.0 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.129 0 CA-C-O 120.582 0.23 . . . . 0.0 111.11 -179.607 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -118.5 103.8 10.08 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.74 0.305 . . . . 0.0 111.013 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.407 HG13 HD13 ' A' ' 69' ' ' LEU . 16.8 t -129.5 154.34 40.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.773 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.2 mttt -106.76 152.89 23.23 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.65 0.262 . . . . 0.0 111.022 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.431 HG22 ' HE2' ' A' ' 33' ' ' LYS . 0.3 OUTLIER -99.88 -143.47 0.33 Allowed 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.62 179.988 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.453 ' HG ' ' N ' ' A' ' 9' ' ' THR . 1.7 pt? -64.82 -41.6 95.64 Favored 'General case' 0 C--N 1.341 0.23 0 CA-C-N 118.791 0.723 . . . . 0.0 111.164 -179.242 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.453 ' N ' ' HG ' ' A' ' 8' ' ' LEU . 94.9 m -111.36 -64.91 1.22 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.774 0.321 . . . . 0.0 110.652 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 178.0 47.71 0.07 OUTLIER Glycine 0 CA--C 1.521 0.42 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.746 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.49 -179.65 7.2 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.729 0.3 . . . . 0.0 110.996 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.51 ' O ' HG23 ' A' ' 12' ' ' THR . 13.2 t -103.07 114.59 29.0 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.709 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 11.9 tt -123.65 136.26 60.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 120.704 0.288 . . . . 0.0 111.228 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.7 t -106.02 168.17 9.3 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.779 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.423 HD22 ' HA ' ' A' ' 15' ' ' LEU . 0.2 OUTLIER -134.13 87.3 2.35 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-O 120.702 0.287 . . . . 0.0 110.896 -179.977 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -101.03 93.88 5.72 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.801 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.918 HG11 HG22 ' A' ' 26' ' ' VAL . 31.5 m -131.47 174.53 12.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.208 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -97.05 164.3 18.15 Favored Pre-proline 0 C--N 1.332 -0.171 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.755 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -60.23 -38.44 75.99 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.64 2.227 . . . . 0.0 112.349 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.4 p -78.82 -24.35 44.56 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.389 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -64.86 118.89 9.69 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-O 120.641 0.257 . . . . 0.0 110.846 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.5 p -85.2 -175.43 5.72 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.826 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.642 HD12 ' O ' ' A' ' 54' ' ' ARG . 3.9 mt -63.11 -40.55 89.45 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.027 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -52.09 -44.04 64.2 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.665 0.269 . . . . 0.0 111.075 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.07 -34.83 78.42 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.917 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.918 HG22 HG11 ' A' ' 17' ' ' VAL . 21.3 t -73.84 -12.93 15.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.599 ' HE3' HD23 ' A' ' 50' ' ' LEU . 2.5 mmpt? -55.48 -39.15 70.05 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 120.569 0.223 . . . . 0.0 111.073 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.402 ' HA ' ' HG2' ' A' ' 31' ' ' GLN . . . -67.88 -42.39 81.32 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-O 120.717 0.294 . . . . 0.0 111.248 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.8 mttm -74.54 -40.0 61.99 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.669 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.691 HG22 ' O ' ' A' ' 26' ' ' VAL . 20.2 tt -74.35 -23.61 18.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -179.128 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.531 ' HA ' HD13 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -65.01 75.21 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 120.856 0.36 . . . . 0.0 110.959 -179.785 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.404 ' N ' ' O ' ' A' ' 30' ' ' ILE . 36.6 t70 -60.26 -67.89 0.35 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.137 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.431 ' HE2' HG22 ' A' ' 7' ' ' THR . 0.0 OUTLIER -85.77 -86.36 0.14 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.965 179.884 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -178.37 43.42 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 121.119 -0.232 . . . . 0.0 111.371 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -151.2 31.2 0.96 Allowed Glycine 0 C--N 1.334 0.458 0 C-N-CA 120.432 -0.889 . . . . 0.0 113.04 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.647 HG21 HG23 ' A' ' 30' ' ' ILE . 1.8 mp -88.93 -65.53 0.17 Allowed Pre-proline 0 CA--C 1.535 0.375 0 CA-C-N 117.09 0.445 . . . . 0.0 111.411 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.546 ' CD ' ' HB ' ' A' ' 36' ' ' ILE . 3.6 Cg_exo -38.74 -51.08 2.38 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 122.779 2.319 . . . . 0.0 112.977 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.408 ' HD2' ' N ' ' A' ' 37' ' ' PRO . 79.0 Cg_exo -41.33 163.65 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.711 2.274 . . . . 0.0 113.174 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -69.65 2.15 3.52 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -89.78 -21.71 22.5 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 118.17 0.441 . . . . 0.0 111.599 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.554 ' HG2' HG23 ' A' ' 36' ' ' ILE . 2.5 tp60 -93.11 109.98 21.47 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 120.996 -0.281 . . . . 0.0 110.785 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 3.7 ptp180 -142.36 160.83 39.5 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.015 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -108.03 160.42 15.8 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.824 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 25.1 mm -111.06 69.79 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.157 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.556 ' CE1' HG23 ' A' ' 66' ' ' THR . 0.7 OUTLIER -151.13 122.01 7.59 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.176 -179.984 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 56.59 31.98 20.1 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.547 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 45.86 37.55 7.35 Favored Glycine 0 C--N 1.335 0.522 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.974 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.435 ' HD3' ' CE2' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -110.02 134.29 52.29 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.846 0.323 . . . . 0.0 111.054 -179.977 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -89.09 162.76 15.81 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.837 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.599 HD23 ' HE3' ' A' ' 27' ' ' LYS . 0.1 OUTLIER -79.15 -13.17 59.89 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.612 179.868 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -78.97 -38.26 37.41 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 120.536 0.208 . . . . 0.0 111.141 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -47.98 118.12 2.21 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -68.21 54.18 0.43 Allowed Glycine 0 CA--C 1.521 0.443 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.666 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.642 ' O ' HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -107.07 173.85 6.15 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 117.002 0.401 . . . . 0.0 110.751 179.844 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.438 HG22 ' H ' ' A' ' 57' ' ' SER . 57.0 m -99.27 137.1 38.25 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.675 -0.239 . . . . 0.0 110.836 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.547 HD22 HG21 ' A' ' 61' ' ' ILE . 52.9 mt -52.26 -41.43 62.81 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.919 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.438 ' H ' HG22 ' A' ' 55' ' ' THR . 6.7 t -59.22 -29.38 67.47 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.432 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -53.68 -40.45 65.96 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 121.192 -0.203 . . . . 0.0 111.379 -179.653 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.435 ' CE2' ' HD3' ' A' ' 48' ' ' LYS . 62.2 m-85 -104.64 36.28 2.47 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-O 120.672 0.272 . . . . 0.0 111.374 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 55.47 25.63 8.0 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.547 HG21 HD22 ' A' ' 56' ' ' LEU . 38.1 mt -89.92 62.52 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.123 0 CA-C-O 120.812 0.339 . . . . 0.0 110.975 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -102.01 -174.81 2.67 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.033 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -44.47 144.1 1.14 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.823 0.344 . . . . 0.0 111.443 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 64.98 19.22 11.8 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.672 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 7.5 p -75.89 170.12 16.84 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-O 120.616 0.246 . . . . 0.0 110.873 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.567 ' O ' HG23 ' A' ' 66' ' ' THR . 7.8 t -107.12 83.69 1.86 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.437 179.518 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.436 HD11 ' CG2' ' A' ' 61' ' ' ILE . 13.0 mt -98.85 104.78 16.85 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.767 0.318 . . . . 0.0 111.325 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -107.19 100.88 10.31 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.627 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.489 HD12 ' N ' ' A' ' 69' ' ' LEU . 6.5 mp -93.97 163.26 13.56 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.559 -0.292 . . . . 0.0 111.029 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.7 t -103.98 121.38 55.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.065 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.814 ' O ' HD22 ' A' ' 71' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.367 0 CA-C-O 121.36 0.6 . . . . 0.0 111.379 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 82.2 mm-40 . . . . . 0 CA--C 1.529 0.153 0 CA-C-O 120.573 0.225 . . . . 0.0 110.944 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.554 HD13 ' H ' ' A' ' 3' ' ' ILE . 0.2 OUTLIER -146.21 -175.76 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.096 -179.993 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -118.66 99.22 6.65 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.775 0.322 . . . . 0.0 110.74 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.825 HG12 HD12 ' A' ' 69' ' ' LEU . 1.2 t -116.84 121.25 67.32 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.895 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 41.7 mttt -106.86 122.34 46.2 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.702 0.287 . . . . 0.0 110.845 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.62 ' HB ' HD12 ' A' ' 36' ' ' ILE . 0.7 OUTLIER -99.75 -75.01 0.58 Allowed 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -179.414 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.623 HD21 ' HD2' ' A' ' 11' ' ' LYS . 0.3 OUTLIER -68.64 -110.37 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 111.553 0.205 . . . . 0.0 111.553 -179.27 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.9 t -111.51 57.62 0.63 Allowed 'General case' 0 CA--C 1.529 0.155 0 O-C-N 122.175 -0.328 . . . . 0.0 111.038 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.95 37.01 5.83 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.632 -0.794 . . . . 0.0 113.23 179.357 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.623 ' HD2' HD21 ' A' ' 8' ' ' LEU . 13.1 tttm -84.39 142.09 30.38 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 117.077 0.438 . . . . 0.0 110.731 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.9 t -98.22 117.87 33.58 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.846 0.355 . . . . 0.0 110.924 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.3 pt -125.09 146.36 30.89 Favored 'Isoleucine or valine' 0 C--O 1.231 0.112 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.189 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.1 t -97.37 130.76 44.48 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.769 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -129.82 133.42 46.94 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.983 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -100.77 176.03 5.44 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.877 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.5 HG21 ' N ' ' A' ' 63' ' ' LYS . 21.7 t -129.99 104.59 10.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.755 0.312 . . . . 0.0 111.16 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -107.09 161.57 22.5 Favored Pre-proline 0 C--O 1.232 0.148 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.811 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_exo -51.74 -56.76 2.66 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.398 2.066 . . . . 0.0 112.365 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 38.7 p -90.3 38.26 0.93 Allowed 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.44 ' OD2' HD22 ' A' ' 56' ' ' LEU . 4.0 t70 -75.28 84.96 2.45 Favored 'General case' 0 C--O 1.232 0.182 0 O-C-N 122.308 -0.245 . . . . 0.0 110.912 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.726 ' O ' HG23 ' A' ' 26' ' ' VAL . 6.2 p -85.04 163.22 18.97 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.637 0.256 . . . . 0.0 110.807 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.433 HG22 ' HD2' ' A' ' 27' ' ' LYS . 34.5 mm -68.13 -42.89 85.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.001 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -54.1 -41.9 68.8 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.653 0.263 . . . . 0.0 110.986 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 -68.71 -39.44 80.47 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.823 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.726 HG23 ' O ' ' A' ' 22' ' ' THR . 42.5 t -63.95 -44.64 97.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 CA-C-O 120.613 0.244 . . . . 0.0 110.906 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.433 ' HD2' HG22 ' A' ' 23' ' ' ILE . 1.6 mttm -59.39 -43.96 92.88 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.704 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.04 -37.11 73.75 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.126 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.54 ' HD3' HD13 ' A' ' 30' ' ' ILE . 12.9 tmtt? -66.9 -40.44 87.7 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.644 -0.253 . . . . 0.0 110.912 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.54 HD13 ' HD3' ' A' ' 29' ' ' LYS . 31.9 mm -69.8 -49.76 54.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.659 0.266 . . . . 0.0 110.895 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -65.08 -24.98 67.6 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.318 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -50.92 -32.25 20.15 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 111.605 0.224 . . . . 0.0 111.605 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.8 -27.81 26.58 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 121.218 -0.193 . . . . 0.0 111.296 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 67.87 31.67 5.61 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-O 120.66 0.267 . . . . 0.0 110.891 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -94.33 -42.27 4.03 Favored Glycine 0 C--N 1.334 0.437 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.377 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.62 HD12 ' HB ' ' A' ' 7' ' ' THR . 19.9 tt -89.17 110.93 41.98 Favored Pre-proline 0 CA--C 1.531 0.223 0 CA-C-O 120.6 0.238 . . . . 0.0 111.062 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.45 ' HB2' ' HD3' ' A' ' 38' ' ' PRO . 33.4 Cg_exo -58.58 -48.52 14.84 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.365 2.043 . . . . 0.0 112.512 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.45 ' HD3' ' HB2' ' A' ' 37' ' ' PRO . 84.4 Cg_exo -44.46 94.25 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.556 2.171 . . . . 0.0 112.488 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -68.2 -31.78 71.54 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.256 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.6 mm-40 -101.01 42.88 1.09 Allowed 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.64 0.257 . . . . 0.0 111.166 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.548 ' OE1' HD13 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -82.87 131.81 35.18 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.655 0.264 . . . . 0.0 110.722 179.662 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -134.88 -178.18 4.96 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.957 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.629 HD21 ' HB3' ' A' ' 67' ' ' LEU . 0.3 OUTLIER -97.87 126.53 43.29 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.766 179.978 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.637 ' O ' HG23 ' A' ' 44' ' ' ILE . 0.6 OUTLIER -101.06 88.8 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.841 0.353 . . . . 0.0 111.272 -179.992 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -150.87 131.92 14.32 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.17 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.6 29.63 19.15 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.656 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 45.53 40.95 8.88 Favored Glycine 0 C--N 1.336 0.555 0 C-N-CA 120.932 -0.652 . . . . 0.0 113.038 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.417 ' HG2' ' CE1' ' A' ' 59' ' ' TYR . 17.1 mttt -108.56 138.54 44.7 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.785 0.293 . . . . 0.0 110.953 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.1 tp-100 -89.11 120.54 30.6 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.974 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.7 mp -79.58 -6.1 56.36 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -78.75 -20.07 50.81 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 111.667 0.247 . . . . 0.0 111.667 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -46.44 -38.33 8.93 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.571 0.224 . . . . 0.0 111.34 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.97 43.04 2.5 Favored Glycine 0 CA--C 1.52 0.395 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.815 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.2 mmt85 -107.12 -176.54 3.1 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.797 0.298 . . . . 0.0 110.756 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.521 HG23 ' H ' ' A' ' 58' ' ' ASP . 12.9 t -97.27 172.22 7.93 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.66 0.267 . . . . 0.0 110.975 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.44 HD22 ' OD2' ' A' ' 21' ' ' ASP . 1.0 OUTLIER -62.36 -58.41 7.76 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.177 -179.893 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.3 t -52.97 -29.37 28.65 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.579 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.521 ' H ' HG23 ' A' ' 55' ' ' THR . 1.1 m-20 -53.7 -38.55 64.35 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 111.609 0.226 . . . . 0.0 111.609 -179.544 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.417 ' CE1' ' HG2' ' A' ' 48' ' ' LYS . 11.7 m-85 -101.55 20.51 15.94 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 62.93 16.91 9.6 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.54 ' HB ' HD11 ' A' ' 67' ' ' LEU . 23.6 pt -89.89 69.91 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 CA-C-O 120.797 0.332 . . . . 0.0 110.849 179.394 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -95.02 -174.01 3.12 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.179 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.5 ' N ' HG21 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -45.65 147.61 0.87 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.789 0.328 . . . . 0.0 111.515 -179.722 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 65.3 16.03 10.32 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.817 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.9 m -76.18 166.87 22.84 Favored 'General case' 0 CA--C 1.527 0.093 0 CA-C-O 120.738 0.304 . . . . 0.0 110.953 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.551 ' O ' HG23 ' A' ' 66' ' ' THR . 7.2 t -106.46 85.79 2.24 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.249 179.297 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.629 ' HB3' HD21 ' A' ' 43' ' ' LEU . 5.9 mp -98.93 114.36 26.94 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.456 -179.211 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -107.17 123.45 48.28 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.603 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.825 HD12 HG12 ' A' ' 5' ' ' VAL . 0.8 OUTLIER -93.78 141.79 28.1 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.707 0.289 . . . . 0.0 111.045 -179.831 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.2 p -114.08 152.75 15.71 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.093 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.332 -0.192 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.781 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 . . . . . 0 CA--C 1.535 0.378 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.493 HD11 ' HB2' ' A' ' 15' ' ' LEU . 10.9 pt -138.57 176.64 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.121 0 C-N-CA 120.907 -0.317 . . . . 0.0 111.509 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -118.97 99.82 6.98 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.717 0.294 . . . . 0.0 110.863 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.627 HG11 HD11 ' A' ' 13' ' ' ILE . 21.5 t -107.15 142.03 20.91 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.116 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.052 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.18 141.24 48.4 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.937 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.7 -163.66 1.05 Allowed 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.083 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.93 ' CD2' HG23 ' A' ' 9' ' ' THR . 0.0 OUTLIER -68.34 -30.5 69.48 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-O 121.056 0.455 . . . . 0.0 110.117 -179.899 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.93 HG23 ' CD2' ' A' ' 8' ' ' LEU . 33.3 p -111.19 -69.46 0.87 Allowed 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.784 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 175.07 47.79 0.05 OUTLIER Glycine 0 C--N 1.333 0.384 0 C-N-CA 120.489 -0.862 . . . . 0.0 112.988 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.68 144.14 28.75 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.861 0.33 . . . . 0.0 110.937 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.474 ' O ' HG23 ' A' ' 12' ' ' THR . 14.2 t -103.06 117.78 35.34 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.574 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.627 HD11 HG11 ' A' ' 5' ' ' VAL . 26.6 pt -125.04 153.24 32.1 Favored 'Isoleucine or valine' 0 C--O 1.231 0.112 0 CA-C-O 120.687 0.28 . . . . 0.0 111.453 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.8 t -106.03 139.16 41.0 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.872 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.493 ' HB2' HD11 ' A' ' 3' ' ' ILE . 1.4 tp -129.93 144.44 51.32 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.712 0.291 . . . . 0.0 110.903 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.51 147.09 25.11 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.83 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.461 HG21 ' HA ' ' A' ' 63' ' ' LYS . 21.5 t -130.02 102.07 6.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.201 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.412 ' HB2' ' HD2' ' A' ' 19' ' ' PRO . 2.2 pt-20 -107.12 161.57 22.51 Favored Pre-proline 0 C--O 1.232 0.162 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.507 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.412 ' HD2' ' HB2' ' A' ' 18' ' ' GLU . 89.3 Cg_exo -47.1 -53.33 6.48 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.507 2.138 . . . . 0.0 112.256 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.1 m -90.14 41.66 1.06 Allowed 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.801 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 46.1 p-10 -69.13 95.99 0.78 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.679 0.276 . . . . 0.0 110.806 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.03 137.82 32.82 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.951 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.676 HD12 ' O ' ' A' ' 54' ' ' ARG . 7.5 mt -68.02 -39.72 81.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.193 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -67.32 -41.76 84.76 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.134 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -62.85 -38.39 90.63 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.212 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.535 HG12 ' O ' ' A' ' 23' ' ' ILE . 12.2 p -73.52 -12.8 15.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 111.957 0.354 . . . . 0.0 111.957 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.461 ' HE2' HD12 ' A' ' 50' ' ' LEU . 12.8 ttmt -55.59 -48.74 74.37 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 120.691 0.282 . . . . 0.0 110.7 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.01 -29.18 68.12 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.14 179.618 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 24.7 mtpt -63.96 -33.76 76.45 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.753 -0.203 . . . . 0.0 110.953 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 33.8 mm -64.68 -42.73 95.87 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 CA-C-O 120.674 0.273 . . . . 0.0 110.495 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -65.16 -37.06 86.19 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 120.772 0.32 . . . . 0.0 110.68 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -61.49 -18.24 58.18 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.972 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 7.0 mtmm -74.04 -73.83 0.21 Allowed 'General case' 0 C--O 1.231 0.119 0 C-N-CA 121.044 -0.262 . . . . 0.0 111.086 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -137.59 23.7 2.91 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.439 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . 48.65 85.07 0.02 OUTLIER Glycine 0 C--N 1.337 0.636 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.387 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.745 HD13 ' HB2' ' A' ' 41' ' ' GLN . 1.1 pp -78.44 110.27 13.28 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 120.628 0.251 . . . . 0.0 111.292 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.557 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 34.7 Cg_exo -60.46 -43.41 33.81 Favored 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 122.733 2.288 . . . . 0.0 113.583 -179.651 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.557 ' HD2' ' N ' ' A' ' 37' ' ' PRO . 55.4 Cg_endo -71.92 118.87 5.84 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.058 1.839 . . . . 0.0 112.943 -179.091 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.0 p-10 -68.66 -12.81 61.83 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.974 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -90.96 22.49 3.63 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.745 ' HB2' HD13 ' A' ' 36' ' ' ILE . 0.7 OUTLIER -84.45 93.45 8.31 Favored 'General case' 0 CA--C 1.527 0.08 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 179.305 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.732 ' HG3' HD23 ' A' ' 50' ' ' LEU . 4.5 ttm180 -139.59 177.09 8.19 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.101 -179.286 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.56 ' CD1' HD12 ' A' ' 69' ' ' LEU . 2.2 mm? -97.91 165.23 12.03 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.459 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.401 ' CG1' ' HB2' ' A' ' 68' ' ' HIS . 1.4 pt -111.02 83.79 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-O 120.696 0.284 . . . . 0.0 111.174 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -150.85 115.46 5.18 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.233 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.78 24.37 14.5 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.859 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 44.37 39.86 5.82 Favored Glycine 0 C--N 1.338 0.654 0 C-N-CA 120.837 -0.697 . . . . 0.0 113.083 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.428 ' HG2' ' CE2' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -100.98 135.49 42.34 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.814 0.307 . . . . 0.0 110.853 -179.82 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -78.96 165.97 22.88 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.828 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.732 HD23 ' HG3' ' A' ' 42' ' ' ARG . 1.7 pp -79.35 -18.21 52.93 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.74 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -78.91 -26.4 43.78 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 111.782 0.289 . . . . 0.0 111.782 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 38.7 p-10 -47.82 115.52 1.19 Allowed 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 120.807 0.337 . . . . 0.0 110.604 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -70.73 46.73 0.73 Allowed Glycine 0 CA--C 1.521 0.434 0 C-N-CA 120.504 -0.855 . . . . 0.0 112.564 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.676 ' O ' HD12 ' A' ' 23' ' ' ILE . 1.5 mpp_? -107.26 170.42 7.97 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 117.029 0.414 . . . . 0.0 110.799 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 36.2 m -99.18 137.73 37.29 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.664 -0.243 . . . . 0.0 110.741 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.847 HD23 HG21 ' A' ' 61' ' ' ILE . 1.2 mp -52.05 -42.94 63.52 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.892 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.3 t -57.22 -31.19 65.24 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.479 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -53.83 -34.96 60.86 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 121.194 -0.202 . . . . 0.0 111.404 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.428 ' CE2' ' HG2' ' A' ' 48' ' ' LYS . 39.9 m-85 -103.29 36.23 2.32 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 120.548 0.214 . . . . 0.0 111.396 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 58.14 23.4 10.13 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.847 HG21 HD23 ' A' ' 56' ' ' LEU . 26.9 mt -89.81 77.09 1.35 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.141 0 CA-C-O 120.636 0.255 . . . . 0.0 110.962 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -94.96 172.63 8.03 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.714 0.292 . . . . 0.0 111.123 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.461 ' HA ' HG21 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -50.08 148.9 3.07 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.212 -179.892 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 63.3 22.69 13.44 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.444 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.1 m -75.64 177.45 6.8 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-O 120.706 0.288 . . . . 0.0 110.88 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.5 p -107.1 86.65 2.34 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.825 0.345 . . . . 0.0 110.639 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.5 mt -99.02 122.48 42.33 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.153 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.401 ' HB2' ' CG1' ' A' ' 44' ' ' ILE . 22.6 m-70 -107.09 140.58 39.7 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.813 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.56 HD12 ' CD1' ' A' ' 43' ' ' LEU . 0.3 OUTLIER -93.94 -174.42 3.41 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.927 -179.881 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.1 p -103.71 139.04 25.77 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-O 120.719 0.295 . . . . 0.0 111.046 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.332 -0.169 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.945 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 63.5 mm-40 . . . . . 0 CA--C 1.53 0.175 0 CA-C-O 120.6 0.238 . . . . 0.0 111.097 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.514 HD11 ' CB ' ' A' ' 15' ' ' LEU . 30.1 pt -138.73 175.57 7.92 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 CA-C-N 116.649 -0.25 . . . . 0.0 110.952 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -118.7 88.99 3.03 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.71 0.291 . . . . 0.0 110.874 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.894 HG22 HD11 ' A' ' 67' ' ' LEU . 21.5 t -108.89 128.35 64.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.179 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -107.51 153.64 22.54 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.752 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.449 HG21 ' OE2' ' A' ' 34' ' ' GLU . 0.2 OUTLIER -109.99 -146.95 0.41 Allowed 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 119.488 -0.291 . . . . 0.0 110.616 -179.959 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.54 ' HG ' HG23 ' A' ' 9' ' ' THR . 0.7 OUTLIER -65.18 -34.24 77.9 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 118.806 0.73 . . . . 0.0 111.542 -179.104 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.54 HG23 ' HG ' ' A' ' 8' ' ' LEU . 73.2 p -111.05 -56.53 2.36 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 120.629 0.252 . . . . 0.0 111.047 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 156.58 57.62 0.01 OUTLIER Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.823 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.2 mmmp? -84.13 154.09 23.33 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.708 0.254 . . . . 0.0 110.886 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.518 ' O ' HG23 ' A' ' 12' ' ' THR . 14.0 t -102.93 114.33 28.53 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.813 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.504 HD11 ' HB ' ' A' ' 5' ' ' VAL . 3.2 pt -118.25 147.3 21.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.141 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.8 p -105.91 114.5 28.68 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.903 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.514 ' CB ' HD11 ' A' ' 3' ' ' ILE . 0.2 OUTLIER -129.28 138.86 51.87 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.876 179.981 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -95.18 161.87 13.93 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.911 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.6 t -129.93 117.02 39.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.769 0.318 . . . . 0.0 111.231 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -100.58 164.12 16.83 Favored Pre-proline 0 C--O 1.231 0.101 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.711 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -53.19 -66.36 0.11 Allowed 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.625 2.217 . . . . 0.0 112.38 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.5 m -90.35 35.9 0.87 Allowed 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 112.054 0.391 . . . . 0.0 112.054 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.438 ' HB3' HD21 ' A' ' 56' ' ' LEU . 4.6 t70 -75.41 113.21 12.55 Favored 'General case' 0 C--O 1.231 0.132 0 CA-C-O 120.647 0.261 . . . . 0.0 110.925 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 10.2 t -85.16 173.8 10.15 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.856 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.507 HG21 ' O ' ' A' ' 50' ' ' LEU . 51.7 mm -68.16 -40.48 82.94 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.015 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -53.9 -40.01 66.27 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.681 -0.236 . . . . 0.0 111.14 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -62.86 -54.7 34.74 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 120.663 0.268 . . . . 0.0 110.906 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.4 p -63.96 -36.93 78.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.262 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.679 ' HA ' HD12 ' A' ' 30' ' ' ILE . 13.6 tttt -55.87 -41.06 73.83 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.719 -0.219 . . . . 0.0 110.935 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.88 -38.1 75.16 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.147 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.82 -43.31 96.62 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-N 116.67 -0.241 . . . . 0.0 110.806 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.679 HD12 ' HA ' ' A' ' 27' ' ' LYS . 4.0 mt -66.49 -49.1 77.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.865 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 1.4 tp-100 -59.79 -42.24 92.93 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.818 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -61.01 -25.79 67.15 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.279 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -74.86 -61.68 1.8 Allowed 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 121.173 -0.211 . . . . 0.0 111.095 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.449 ' OE2' HG21 ' A' ' 7' ' ' THR . 0.2 OUTLIER -103.17 -46.44 4.62 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.578 0.228 . . . . 0.0 111.089 -179.84 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.425 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . 85.05 42.97 6.87 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.976 -179.596 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.708 HG21 ' HG3' ' A' ' 41' ' ' GLN . 20.2 tt -78.77 110.55 14.65 Favored Pre-proline 0 CA--C 1.532 0.271 0 CA-C-O 120.713 0.292 . . . . 0.0 111.36 -179.565 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.504 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 31.7 Cg_exo -59.77 -45.72 23.64 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.764 2.309 . . . . 0.0 113.339 -179.644 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.504 ' HD2' ' N ' ' A' ' 37' ' ' PRO . 46.8 Cg_exo -37.84 122.52 0.51 Allowed 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.988 2.459 . . . . 0.0 113.425 -179.349 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -69.42 -3.89 16.21 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -90.25 11.21 21.86 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -179.505 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.708 ' HG3' HG21 ' A' ' 36' ' ' ILE . 1.0 OUTLIER -88.61 82.54 6.87 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-O 120.693 0.283 . . . . 0.0 110.416 179.358 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.823 ' O ' HG23 ' A' ' 70' ' ' VAL . 33.7 mtt180 -136.63 -175.16 3.92 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.976 -179.545 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.771 HD23 HD12 ' A' ' 69' ' ' LEU . 2.3 mt -97.97 153.97 18.0 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.846 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.583 ' O ' HG23 ' A' ' 44' ' ' ILE . 17.2 tt -111.04 71.17 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.803 0.335 . . . . 0.0 111.023 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -150.91 132.06 14.41 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.239 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 56.51 28.59 14.03 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.79 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 45.08 40.23 7.11 Favored Glycine 0 C--N 1.337 0.595 0 C-N-CA 120.797 -0.716 . . . . 0.0 113.0 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.02 127.84 46.19 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.837 0.318 . . . . 0.0 110.922 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -89.06 150.66 22.66 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.014 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.579 HD23 ' HG3' ' A' ' 27' ' ' LYS . 1.9 tp -79.18 -20.94 47.17 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.435 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -78.7 -35.45 44.96 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 120.436 0.16 . . . . 0.0 111.377 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -47.88 115.14 1.07 Allowed 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 110.338 -0.245 . . . . 0.0 110.338 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -69.85 48.49 0.64 Allowed Glycine 0 CA--C 1.522 0.475 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.746 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.0 mtp85 -107.25 -176.69 3.14 Favored 'General case' 0 C--O 1.23 0.07 0 CA-C-N 117.062 0.431 . . . . 0.0 110.646 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.9 m -99.37 134.77 41.76 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.555 0.216 . . . . 0.0 110.488 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.729 ' HB2' HG23 ' A' ' 61' ' ' ILE . 0.7 OUTLIER -51.59 -38.45 54.58 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.566 0.222 . . . . 0.0 110.689 179.915 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.6 t -56.23 -28.32 58.02 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.339 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -53.7 -35.04 60.68 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 111.572 0.212 . . . . 0.0 111.572 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -100.32 18.22 19.42 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 64.87 16.16 10.32 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.963 HD11 ' HB3' ' A' ' 67' ' ' LEU . 0.6 OUTLIER -89.92 71.23 0.76 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-O 120.878 0.37 . . . . 0.0 110.81 179.488 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -94.77 -178.03 4.39 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.441 -179.438 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.5 ptpt -47.37 146.1 2.15 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.581 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.504 ' H ' HG22 ' A' ' 3' ' ' ILE . 0.6 OUTLIER 65.53 12.62 8.32 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.356 179.932 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 41.2 t -76.28 -179.9 5.37 Favored 'General case' 0 C--O 1.231 0.08 0 O-C-N 122.259 -0.276 . . . . 0.0 110.79 179.432 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -107.12 80.6 1.44 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.342 179.325 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.963 ' HB3' HD11 ' A' ' 61' ' ' ILE . 3.2 pp -98.89 119.74 38.17 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-O 120.789 0.328 . . . . 0.0 111.319 -179.398 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 8.8 m170 -107.15 137.0 46.03 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.592 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.771 HD12 HD23 ' A' ' 43' ' ' LEU . 1.7 tp -93.93 171.47 8.84 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.654 0.264 . . . . 0.0 110.846 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.823 HG23 ' O ' ' A' ' 42' ' ' ARG . 28.6 t -103.81 129.54 55.75 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.161 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.639 HD12 ' O ' ' A' ' 71' ' ' LEU . 1.7 pp . . . . . 0 C--N 1.333 -0.141 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.87 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.678 0.275 . . . . 0.0 110.809 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.8 tp -138.69 152.91 25.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.941 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.49 80.77 1.58 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.777 0.322 . . . . 0.0 110.866 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.669 ' CG2' HD13 ' A' ' 69' ' ' LEU . 10.6 p -134.48 132.44 54.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.84 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.1 mptt -106.97 172.41 6.84 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.778 0.323 . . . . 0.0 111.071 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.4 p -99.91 -175.68 3.03 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.576 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -67.02 -4.04 8.74 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.4 p -99.78 -44.14 6.19 Favored 'General case' 0 CA--C 1.529 0.167 0 O-C-N 122.258 -0.276 . . . . 0.0 111.366 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 141.71 -26.22 2.39 Favored Glycine 0 CA--C 1.521 0.461 0 C-N-CA 120.264 -0.97 . . . . 0.0 113.486 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.8 tmtm? -73.49 143.28 46.66 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 117.416 0.608 . . . . 0.0 110.86 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.9 t -96.24 149.11 22.03 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.154 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 11.7 tt -125.03 152.24 31.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.076 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.7 m -96.01 135.1 38.22 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.632 -0.258 . . . . 0.0 110.739 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -138.05 142.62 40.31 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.731 0.3 . . . . 0.0 111.127 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -101.13 146.57 27.3 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.732 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.6 t -140.06 138.58 37.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.721 0.296 . . . . 0.0 111.306 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.418 ' HB2' ' HD2' ' A' ' 19' ' ' PRO . 11.4 pt-20 -107.14 162.88 18.27 Favored Pre-proline 0 C--N 1.334 -0.098 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.514 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.418 ' HD2' ' HB2' ' A' ' 18' ' ' GLU . 77.9 Cg_exo -48.26 -54.13 5.72 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.395 2.063 . . . . 0.0 112.208 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 98.1 p -90.4 42.16 1.09 Allowed 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.77 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.684 ' OD1' HG21 ' A' ' 26' ' ' VAL . 12.7 t70 -72.72 98.12 2.32 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 120.669 0.271 . . . . 0.0 110.989 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.4 p -85.14 136.31 33.6 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.708 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.558 HG21 ' O ' ' A' ' 50' ' ' LEU . 59.4 mt -68.1 74.01 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.708 0.289 . . . . 0.0 110.916 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -158.36 -59.38 0.08 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.012 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -72.5 -33.85 67.23 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.045 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.684 HG21 ' OD1' ' A' ' 21' ' ' ASP . 39.6 t -63.77 -24.77 36.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 116.794 -0.184 . . . . 0.0 111.471 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.481 ' CG ' HG23 ' A' ' 36' ' ' ILE . 0.6 OUTLIER -55.6 -41.71 73.81 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.701 0.286 . . . . 0.0 111.004 179.958 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.78 -39.92 90.64 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.201 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 76.6 mttt -63.97 -42.69 97.17 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.935 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.495 ' HB ' HG21 ' A' ' 36' ' ' ILE . 3.8 mt -70.71 -25.25 26.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.457 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -54.8 -28.95 52.97 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 120.514 0.197 . . . . 0.0 111.239 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -54.31 -24.47 19.25 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -74.33 -64.28 1.06 Allowed 'General case' 0 N--CA 1.461 0.111 0 C-N-CA 121.074 -0.25 . . . . 0.0 110.888 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -177.43 50.57 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 120.921 0.391 . . . . 0.0 111.549 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.438 ' O ' ' HG2' ' A' ' 38' ' ' PRO . . . 73.94 91.61 0.14 Allowed Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.556 -0.83 . . . . 0.0 112.796 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.629 ' N ' ' CD ' ' A' ' 37' ' ' PRO . 7.8 tp -81.03 -27.03 0.44 Allowed Pre-proline 0 CA--C 1.54 0.592 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.64 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 72.2 Cg_exo -43.02 -48.68 7.55 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 122.371 2.047 . . . . 0.0 113.997 -179.447 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.64 ' HD2' ' N ' ' A' ' 37' ' ' PRO . 3.9 Cg_exo -35.56 136.15 0.19 Allowed 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.195 2.597 . . . . 0.0 113.213 -179.253 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -69.35 -0.44 6.33 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 12.1 mm100 -89.9 -13.98 35.19 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.219 0.463 . . . . 0.0 111.626 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -93.01 88.44 6.13 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-O 120.699 0.285 . . . . 0.0 110.641 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.2 ttp-105 -136.7 156.33 48.67 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.042 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.4 pp -99.64 153.07 19.36 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.806 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.614 ' O ' HG23 ' A' ' 44' ' ' ILE . 18.3 tt -110.75 75.43 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.142 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.401 ' CE1' ' O ' ' A' ' 66' ' ' THR . 0.6 OUTLIER -150.92 118.16 5.98 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.272 179.975 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.41 33.95 23.99 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.547 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 46.2 46.51 15.82 Favored Glycine 0 C--N 1.336 0.548 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.997 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.547 ' HG3' HD11 ' A' ' 61' ' ' ILE . 0.0 OUTLIER -100.05 104.26 15.83 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.743 0.272 . . . . 0.0 110.906 -179.993 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -89.15 152.86 21.38 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.038 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.558 ' O ' HG21 ' A' ' 23' ' ' ILE . 0.8 OUTLIER -79.6 -4.38 51.33 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -179.834 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -78.65 -50.28 11.73 Favored 'General case' 0 N--CA 1.462 0.127 0 C-N-CA 121.024 -0.27 . . . . 0.0 111.183 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -47.98 113.21 0.68 Allowed 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -70.31 46.54 0.65 Allowed Glycine 0 CA--C 1.521 0.432 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.624 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.22 -176.68 3.14 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 117.117 0.459 . . . . 0.0 110.881 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.441 HG23 ' O ' ' A' ' 21' ' ' ASP . 23.5 m -99.16 141.77 31.5 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.716 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.462 ' HA ' HD12 ' A' ' 61' ' ' ILE . 34.9 mt -53.14 -42.55 66.18 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.902 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.5 t -54.74 -31.49 58.49 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.565 -0.288 . . . . 0.0 111.455 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -53.72 -33.73 56.51 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 111.49 0.182 . . . . 0.0 111.49 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -102.36 40.72 1.31 Allowed 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 120.602 0.239 . . . . 0.0 111.282 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 54.77 28.87 10.86 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 111.721 0.267 . . . . 0.0 111.721 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.547 HD11 ' HG3' ' A' ' 48' ' ' LYS . 22.2 mt -89.43 86.82 2.65 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 CA-C-O 120.667 0.27 . . . . 0.0 111.053 179.624 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -97.98 166.7 11.32 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.727 0.299 . . . . 0.0 111.08 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.6 ptmt -50.12 159.8 0.41 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.137 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 55.23 32.9 19.48 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.213 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.2 m -75.48 153.41 37.57 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-O 120.697 0.284 . . . . 0.0 110.914 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.401 ' O ' ' CE1' ' A' ' 45' ' ' PHE . 1.5 p -106.12 71.56 0.89 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.733 0.301 . . . . 0.0 110.654 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.7 pp -101.82 146.15 28.2 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.024 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -107.1 150.56 26.43 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.838 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.669 HD13 ' CG2' ' A' ' 5' ' ' VAL . 0.3 OUTLIER -103.97 159.25 15.82 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.875 -179.938 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.3 t -103.86 153.52 6.05 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.995 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.592 HD12 ' O ' ' A' ' 71' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--N 1.332 -0.188 0 CA-C-N 116.603 -0.271 . . . . 0.0 110.975 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 90.0 mm-40 . . . . . 0 CA--C 1.529 0.16 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.439 HD11 ' CD1' ' A' ' 15' ' ' LEU . 28.4 pt -139.06 166.03 22.75 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.101 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.913 -179.567 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -126.03 104.7 8.41 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.636 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.813 ' HB ' HD11 ' A' ' 13' ' ' ILE . 18.4 t -96.35 156.2 3.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.104 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.405 ' N ' HG12 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -106.48 150.26 26.26 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.73 0.3 . . . . 0.0 110.869 -179.942 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.645 HG21 ' HB3' ' A' ' 11' ' ' LYS . 34.6 p -99.93 -157.7 0.62 Allowed 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.996 -179.543 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.469 ' HG ' HG22 ' A' ' 9' ' ' THR . 1.4 pt? -67.08 -33.22 75.02 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 120.894 0.378 . . . . 0.0 110.093 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.469 HG22 ' HG ' ' A' ' 8' ' ' LEU . 0.5 OUTLIER -111.57 -76.81 0.59 Allowed 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.29 178.953 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -174.56 46.57 0.14 Allowed Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.218 -0.992 . . . . 0.0 113.233 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.645 ' HB3' HG21 ' A' ' 7' ' ' THR . 6.5 ttmt -84.35 143.03 29.75 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.837 0.319 . . . . 0.0 110.573 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.518 ' O ' HG23 ' A' ' 12' ' ' THR . 11.2 t -92.86 114.17 26.66 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.874 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.813 HD11 ' HB ' ' A' ' 5' ' ' VAL . 24.7 pt -114.92 143.27 25.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.703 0.287 . . . . 0.0 111.119 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.4 p -105.38 118.72 37.27 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.788 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.672 HD21 HG23 ' A' ' 5' ' ' VAL . 0.6 OUTLIER -138.45 159.44 42.06 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.677 0.275 . . . . 0.0 111.233 179.959 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -101.14 -175.63 2.92 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.722 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.6 t -136.49 100.61 2.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-O 120.648 0.261 . . . . 0.0 111.223 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -107.09 154.31 40.47 Favored Pre-proline 0 C--O 1.232 0.157 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.981 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.473 ' HA ' HG21 ' A' ' 55' ' ' THR . 28.5 Cg_endo -62.61 -22.62 74.16 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.77 2.313 . . . . 0.0 113.165 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 51.6 p -78.8 -35.42 44.32 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 121.264 -0.175 . . . . 0.0 111.385 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -73.5 96.71 2.45 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.606 0.241 . . . . 0.0 111.023 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 10.0 p -85.1 -177.37 6.52 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.912 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.823 ' O ' HG13 ' A' ' 26' ' ' VAL . 25.6 mm -68.19 -31.17 50.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.653 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.9 tm-20 -70.31 -47.88 59.13 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.583 0.23 . . . . 0.0 111.251 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -74.99 40.8 0.15 Allowed 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -179.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.823 HG13 ' O ' ' A' ' 23' ' ' ILE . 17.1 m -74.32 -31.49 28.78 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 O-C-N 122.176 -0.328 . . . . 0.0 111.26 179.507 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.494 ' HE3' HG23 ' A' ' 26' ' ' VAL . 0.0 OUTLIER -59.74 -33.09 71.19 Favored 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 121.278 -0.169 . . . . 0.0 111.181 179.998 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.69 -56.54 20.55 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.619 0.247 . . . . 0.0 111.165 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.0 pttm -63.95 -37.34 87.04 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.677 -0.238 . . . . 0.0 110.996 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 21.7 mt -74.42 -15.97 16.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 116.751 -0.204 . . . . 0.0 111.369 179.515 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -65.53 -10.79 37.93 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -50.05 -33.12 17.27 Favored 'General case' 0 N--CA 1.464 0.244 0 O-C-N 122.22 -0.3 . . . . 0.0 111.66 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.412 ' HD2' ' N ' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -85.38 -28.41 25.19 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 121.067 -0.253 . . . . 0.0 110.791 179.508 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 61.32 25.92 15.82 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.745 -0.207 . . . . 0.0 111.091 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.509 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . -150.52 33.84 0.99 Allowed Glycine 0 C--N 1.335 0.51 0 C-N-CA 120.041 -1.076 . . . . 0.0 113.262 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.606 HG23 ' O ' ' A' ' 36' ' ' ILE . 9.3 tp -90.06 106.47 14.72 Favored Pre-proline 0 CA--C 1.531 0.217 0 CA-C-N 117.092 0.446 . . . . 0.0 111.263 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.509 ' HD3' ' O ' ' A' ' 35' ' ' GLY . 23.3 Cg_exo -62.03 -50.01 5.67 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.209 1.939 . . . . 0.0 112.634 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.459 ' HD3' ' CB ' ' A' ' 37' ' ' PRO . 50.1 Cg_exo -55.97 89.88 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.307 2.005 . . . . 0.0 112.551 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -68.17 -37.0 80.51 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.027 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -101.62 45.19 0.98 Allowed 'General case' 0 CA--C 1.528 0.118 0 CA-C-O 120.784 0.326 . . . . 0.0 110.872 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.817 ' O ' HD11 ' A' ' 50' ' ' LEU . 7.7 tt0 -82.56 136.43 34.84 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.898 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.5 mtt180 -142.1 175.64 9.58 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.964 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.549 ' HB3' HD12 ' A' ' 69' ' ' LEU . 0.5 OUTLIER -108.03 149.09 28.85 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.687 179.789 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.6 mt -100.92 79.43 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.692 0.282 . . . . 0.0 111.197 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -150.91 129.85 12.51 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.099 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 59.99 26.06 15.32 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.65 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 45.29 40.83 8.05 Favored Glycine 0 C--N 1.336 0.569 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.973 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.401 ' HD2' ' CZ ' ' A' ' 59' ' ' TYR . 0.4 OUTLIER -107.42 130.52 54.81 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.796 0.298 . . . . 0.0 111.054 -179.848 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.09 177.92 6.51 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.803 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.817 HD11 ' O ' ' A' ' 41' ' ' GLN . 12.9 mt -68.96 -22.42 64.11 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.596 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -89.8 28.26 1.38 Allowed 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -47.81 -50.75 25.01 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.665 0.269 . . . . 0.0 111.07 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.44 -23.32 34.55 Favored Glycine 0 CA--C 1.521 0.411 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.976 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -107.13 -175.97 2.94 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.985 0.393 . . . . 0.0 110.837 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.473 HG21 ' HA ' ' A' ' 19' ' ' PRO . 8.9 m -96.92 151.69 19.44 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-O 120.738 0.304 . . . . 0.0 110.753 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.768 ' HB3' HG23 ' A' ' 61' ' ' ILE . 9.5 mt -53.89 -44.01 70.12 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.099 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.7 t -52.89 -53.18 52.83 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.635 -179.596 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -64.61 -18.77 65.22 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -179.479 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.401 ' CZ ' ' HD2' ' A' ' 48' ' ' LYS . 0.4 OUTLIER -97.99 31.03 2.82 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -179.578 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.7 m120 66.09 -16.59 0.12 Allowed 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.768 HG23 ' HB3' ' A' ' 56' ' ' LEU . 0.6 OUTLIER -89.29 62.69 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 118.471 0.578 . . . . 0.0 110.895 179.852 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -95.4 -167.41 1.61 Allowed 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.02 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -39.85 143.09 0.27 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.855 0.359 . . . . 0.0 111.891 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 65.49 15.79 10.2 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.151 -0.477 . . . . 0.0 112.022 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.1 p -76.19 175.28 9.15 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-O 120.68 0.276 . . . . 0.0 110.996 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -105.47 91.58 3.83 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.205 179.221 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.429 HD12 HD11 ' A' ' 61' ' ' ILE . 1.0 OUTLIER -98.66 109.58 22.32 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.819 0.342 . . . . 0.0 111.41 -179.322 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -107.05 97.59 7.35 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.474 179.523 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.549 HD12 ' HB3' ' A' ' 43' ' ' LEU . 1.0 OUTLIER -93.84 129.47 40.22 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.702 0.286 . . . . 0.0 111.06 -179.696 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.0 p -114.01 152.94 15.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.96 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.715 HD12 ' O ' ' A' ' 71' ' ' LEU . 4.1 pp . . . . . 0 C--N 1.332 -0.17 0 CA-C-N 116.583 -0.281 . . . . 0.0 110.826 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.659 0.266 . . . . 0.0 110.951 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.8 pt -138.86 174.0 10.77 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.082 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -118.9 105.35 11.4 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.725 0.298 . . . . 0.0 110.869 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.769 HG23 HD23 ' A' ' 69' ' ' LEU . 12.0 p -137.54 132.08 44.69 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.886 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.3 mppt? -106.94 163.09 13.26 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.853 0.358 . . . . 0.0 111.171 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.51 -153.64 0.45 Allowed 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.027 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.901 HD23 HG22 ' A' ' 9' ' ' THR . 0.0 OUTLIER -67.85 -21.89 65.16 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-O 120.86 0.362 . . . . 0.0 110.056 179.874 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.901 HG22 HD23 ' A' ' 8' ' ' LEU . 0.3 OUTLIER -111.69 -70.58 0.8 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.32 179.378 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 164.89 49.86 0.02 OUTLIER Glycine 0 CA--C 1.52 0.379 0 C-N-CA 120.497 -0.859 . . . . 0.0 113.15 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -84.73 150.77 24.86 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.954 0.377 . . . . 0.0 110.982 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.486 ' O ' HG23 ' A' ' 12' ' ' THR . 14.7 t -96.67 115.94 28.28 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.349 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.557 ' CG2' HG13 ' A' ' 5' ' ' VAL . 8.0 tt -125.04 135.97 62.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-O 120.735 0.303 . . . . 0.0 111.629 -179.495 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.6 t -106.19 132.28 52.44 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.48 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.788 HD21 ' HA ' ' A' ' 30' ' ' ILE . 2.1 mt -134.86 134.71 41.03 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.661 0.267 . . . . 0.0 111.247 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -94.99 155.87 16.55 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.404 179.513 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 1.012 HG11 HD11 ' A' ' 56' ' ' LEU . 21.8 t -140.13 136.62 37.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-O 120.957 0.408 . . . . 0.0 111.795 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.492 ' HB2' ' HD2' ' A' ' 19' ' ' PRO . 11.0 pt-20 -96.72 161.0 28.06 Favored Pre-proline 0 CA--C 1.53 0.19 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.324 179.469 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.492 ' HD2' ' HB2' ' A' ' 18' ' ' GLU . 1.2 Cg_endo -43.18 -66.64 0.15 Allowed 'Trans proline' 0 CA--C 1.532 0.415 0 C-N-CA 122.892 2.395 . . . . 0.0 112.96 -179.611 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.21 37.13 0.89 Allowed 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.412 ' HB2' ' O ' ' A' ' 18' ' ' GLU . 5.5 t0 -75.7 119.65 20.01 Favored 'General case' 0 N--CA 1.462 0.145 0 O-C-N 122.276 -0.265 . . . . 0.0 111.226 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -85.25 146.58 27.0 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.509 179.279 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.636 ' O ' HG12 ' A' ' 26' ' ' VAL . 8.3 tp -57.99 -32.46 43.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 116.769 -0.196 . . . . 0.0 111.376 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -76.19 -39.02 55.8 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 120.547 0.213 . . . . 0.0 111.0 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -63.09 -31.59 72.76 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.729 -0.214 . . . . 0.0 111.448 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.636 HG12 ' O ' ' A' ' 23' ' ' ILE . 13.3 p -74.29 -6.4 8.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.488 ' HA ' HG22 ' A' ' 30' ' ' ILE . 16.4 mttt -55.47 -39.41 70.36 Favored 'General case' 0 N--CA 1.463 0.199 0 O-C-N 122.182 -0.324 . . . . 0.0 111.225 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.12 -41.75 81.27 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.561 0.219 . . . . 0.0 111.432 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.8 tttp -74.12 -42.75 59.55 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.695 -0.23 . . . . 0.0 111.243 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.788 ' HA ' HD21 ' A' ' 15' ' ' LEU . 18.8 tt -64.96 -20.69 28.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.406 ' HA ' ' CG1' ' A' ' 36' ' ' ILE . 1.2 tt0 -63.43 74.65 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.741 0.305 . . . . 0.0 111.111 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.45 ' HB2' HD12 ' A' ' 13' ' ' ILE . 27.9 t70 -61.26 -69.53 0.23 Allowed 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.833 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.71 -85.9 0.14 Allowed 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 121.077 -0.249 . . . . 0.0 110.709 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -177.87 44.34 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -150.14 26.73 1.13 Allowed Glycine 0 CA--C 1.524 0.599 0 C-N-CA 120.182 -1.009 . . . . 0.0 113.539 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.654 HG21 HG23 ' A' ' 30' ' ' ILE . 32.5 mm -89.17 -46.45 0.42 Allowed Pre-proline 0 CA--C 1.533 0.306 0 CA-C-N 117.497 0.649 . . . . 0.0 112.15 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.48 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 53.6 Cg_exo -52.9 -43.74 54.08 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.337 2.025 . . . . 0.0 113.168 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' A' ' 37' ' ' PRO . 58.9 Cg_exo -39.93 161.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.748 2.299 . . . . 0.0 113.511 -179.459 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -69.56 0.39 5.42 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -90.06 8.48 32.45 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 118.094 0.407 . . . . 0.0 111.807 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -89.72 110.92 21.78 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 121.038 -0.265 . . . . 0.0 110.664 179.387 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.4 mtt180 -144.03 152.2 40.69 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.739 0.304 . . . . 0.0 111.237 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.807 HD11 HD22 ' A' ' 50' ' ' LEU . 1.5 mp -108.0 152.03 25.03 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.783 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.474 HD11 ' CG1' ' A' ' 70' ' ' VAL . 27.0 mm -111.0 61.79 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.157 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.596 ' HB2' HD23 ' A' ' 67' ' ' LEU . 0.2 OUTLIER -153.66 118.36 4.98 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.754 0.311 . . . . 0.0 111.201 179.984 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.74 32.09 21.38 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.677 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 46.36 42.97 13.93 Favored Glycine 0 C--N 1.335 0.527 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.968 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.432 ' HD3' ' CZ ' ' A' ' 59' ' ' TYR . 2.5 tptp -101.36 137.29 39.89 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.643 0.259 . . . . 0.0 110.972 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -89.02 168.81 12.05 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.51 -0.313 . . . . 0.0 110.966 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.807 HD22 HD11 ' A' ' 43' ' ' LEU . 0.2 OUTLIER -79.11 -38.03 37.19 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.471 -0.332 . . . . 0.0 111.354 -179.848 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.64 17.55 6.35 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -47.33 -39.79 15.69 Favored 'General case' 0 N--CA 1.466 0.351 0 O-C-N 122.241 -0.287 . . . . 0.0 111.303 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.19 19.85 48.37 Favored Glycine 0 CA--C 1.522 0.487 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.942 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.7 mtt-85 -107.56 175.81 5.36 Favored 'General case' 0 N--CA 1.458 -0.075 0 CA-C-N 117.03 0.415 . . . . 0.0 110.836 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.532 HG22 ' H ' ' A' ' 57' ' ' SER . 31.2 m -99.34 133.17 44.04 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.731 0.301 . . . . 0.0 110.689 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 1.012 HD11 HG11 ' A' ' 17' ' ' VAL . 0.4 OUTLIER -51.8 -31.08 25.76 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.561 0.219 . . . . 0.0 111.113 179.974 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.532 ' H ' HG22 ' A' ' 55' ' ' THR . 12.6 t -62.95 -40.05 96.5 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -63.21 -29.37 70.72 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.432 ' CZ ' ' HD3' ' A' ' 48' ' ' LYS . 0.2 OUTLIER -97.66 8.99 43.68 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 111.641 0.237 . . . . 0.0 111.641 179.995 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 65.37 11.19 7.14 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.435 ' CG2' HD11 ' A' ' 67' ' ' LEU . 1.2 pt -90.11 63.09 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 CA-C-N 117.961 0.346 . . . . 0.0 110.676 179.251 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -95.1 -168.66 1.84 Allowed 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.093 -179.518 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -40.18 152.05 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.601 -179.645 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 62.14 24.49 14.58 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.363 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.9 p -75.56 145.52 41.17 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.702 0.287 . . . . 0.0 110.939 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.0 m -104.86 66.45 0.77 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.763 0.316 . . . . 0.0 110.577 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.596 HD23 ' HB2' ' A' ' 45' ' ' PHE . 0.4 OUTLIER -104.67 144.49 31.65 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.165 -179.726 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -106.97 141.1 38.72 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.749 179.713 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.769 HD23 HG23 ' A' ' 5' ' ' VAL . 1.3 mm? -103.81 163.38 12.38 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.667 0.27 . . . . 0.0 111.022 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.474 ' CG1' HD11 ' A' ' 44' ' ' ILE . 33.9 m -105.29 179.44 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.021 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.762 HD23 HD12 ' A' ' 8' ' ' LEU . 1.3 mp . . . . . 0 C--N 1.333 -0.135 0 CA-C-O 120.769 0.319 . . . . 0.0 110.682 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 . . . . . 0 CA--C 1.529 0.137 0 CA-C-O 120.696 0.284 . . . . 0.0 110.908 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 1.041 HD11 HD13 ' A' ' 67' ' ' LEU . 18.0 tt -138.73 156.27 28.65 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.939 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -118.44 91.83 3.66 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-O 120.739 0.304 . . . . 0.0 110.913 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.5 t -93.35 159.69 2.76 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.747 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.0 ttmt -106.66 135.56 47.97 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.828 0.347 . . . . 0.0 111.044 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.626 HG21 ' HB3' ' A' ' 11' ' ' LYS . 13.7 p -100.51 -162.19 0.92 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.25 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.686 HD12 ' OG1' ' A' ' 9' ' ' THR . 0.8 OUTLIER -60.14 -38.64 83.69 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 120.649 -0.42 . . . . 0.0 111.199 -179.446 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.686 ' OG1' HD12 ' A' ' 8' ' ' LEU . 0.2 OUTLIER -111.24 -62.08 1.6 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.65 0.262 . . . . 0.0 110.792 179.835 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 168.06 50.04 0.03 OUTLIER Glycine 0 CA--C 1.521 0.421 0 C-N-CA 120.512 -0.851 . . . . 0.0 113.125 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.626 ' HB3' HG21 ' A' ' 7' ' ' THR . 0.0 OUTLIER -84.67 157.12 21.21 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 116.858 0.329 . . . . 0.0 110.768 179.795 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.562 ' O ' HG23 ' A' ' 12' ' ' THR . 12.1 t -103.01 108.41 19.57 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.715 0.293 . . . . 0.0 110.8 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.545 HG23 ' HD2' ' A' ' 11' ' ' LYS . 2.8 pt -125.07 168.88 17.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.245 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.02 158.95 16.42 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.778 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.697 ' CB ' HG21 ' A' ' 3' ' ' ILE . 0.2 OUTLIER -138.19 115.67 11.23 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.698 0.285 . . . . 0.0 111.036 -179.897 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -101.05 150.14 23.22 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.743 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.945 ' CG1' HD21 ' A' ' 56' ' ' LEU . 30.2 t -140.0 146.8 24.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.377 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -107.1 164.67 14.33 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.783 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -56.97 -55.47 2.62 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.609 2.206 . . . . 0.0 112.539 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.2 m -89.52 8.38 31.41 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -179.721 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -75.0 118.14 17.64 Favored 'General case' 0 CA--C 1.528 0.125 0 O-C-N 122.245 -0.284 . . . . 0.0 110.924 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.8 p -85.08 165.69 17.28 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.817 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 7.3 tp -58.36 -40.2 77.2 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.261 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -59.32 -38.54 80.56 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.646 0.26 . . . . 0.0 110.924 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -62.79 -23.86 67.45 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.592 -0.277 . . . . 0.0 111.47 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 39.4 t -63.57 -39.5 85.58 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-O 120.566 0.222 . . . . 0.0 111.06 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.526 ' HA ' HG22 ' A' ' 30' ' ' ILE . 7.7 tttm -57.31 -36.96 71.74 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 120.602 0.239 . . . . 0.0 111.242 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.26 -45.0 74.36 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-O 120.654 0.264 . . . . 0.0 111.444 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.2 ptpm? -74.13 -39.92 63.0 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.522 -179.719 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.855 HD13 ' O ' ' A' ' 30' ' ' ILE . 0.0 OUTLIER -64.81 -36.89 78.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-O 120.56 0.219 . . . . 0.0 111.431 -179.672 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -64.81 -21.0 66.69 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -61.48 -14.31 27.87 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.9 mtpp -73.91 -42.7 60.27 Favored 'General case' 0 C--O 1.232 0.132 0 O-C-N 122.222 -0.299 . . . . 0.0 111.307 -179.311 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -144.19 -44.2 0.26 Allowed 'General case' 0 C--O 1.232 0.171 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.836 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.462 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . 107.44 68.29 0.66 Allowed Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.625 -0.797 . . . . 0.0 111.543 -179.307 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.603 HG23 ' O ' ' A' ' 36' ' ' ILE . 19.7 tt -77.86 109.37 9.67 Favored Pre-proline 0 CA--C 1.532 0.287 0 CA-C-O 120.714 0.292 . . . . 0.0 111.533 -179.037 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.605 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 28.6 Cg_exo -62.96 -41.28 29.87 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.999 2.466 . . . . 0.0 114.422 -179.325 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.605 ' HD2' ' N ' ' A' ' 37' ' ' PRO . 21.8 Cg_endo -64.27 114.33 2.62 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 121.904 1.736 . . . . 0.0 113.086 -178.651 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -69.78 -1.88 10.49 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.516 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -90.06 10.98 22.14 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 122.073 -0.392 . . . . 0.0 111.998 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.461 ' CG ' HD13 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -90.02 97.06 10.97 Favored 'General case' 0 C--O 1.231 0.105 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 179.192 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.611 ' O ' HD13 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -133.91 -177.41 4.55 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.788 0.328 . . . . 0.0 111.174 -179.476 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.784 HD12 HD22 ' A' ' 69' ' ' LEU . 2.0 tp -99.13 143.59 29.23 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.927 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.8 mm -106.13 95.47 3.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.124 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 16.1 t80 -150.88 123.33 8.43 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.093 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.04 33.39 23.13 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.366 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 46.14 36.06 6.97 Favored Glycine 0 C--N 1.336 0.539 0 C-N-CA 120.868 -0.682 . . . . 0.0 113.047 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.425 ' HG2' ' CE2' ' A' ' 59' ' ' TYR . 0.3 OUTLIER -110.21 126.03 53.7 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.849 0.325 . . . . 0.0 110.962 -179.952 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -89.09 149.32 23.25 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.802 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.611 ' O ' HD12 ' A' ' 50' ' ' LEU . 4.1 pp -80.39 13.11 2.57 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -78.59 -42.61 28.58 Favored 'General case' 0 CA--C 1.528 0.097 0 O-C-N 121.978 -0.451 . . . . 0.0 110.76 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -48.18 118.46 2.41 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 179.295 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -68.89 49.28 0.49 Allowed Glycine 0 CA--C 1.522 0.472 0 C-N-CA 120.625 -0.798 . . . . 0.0 113.051 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.58 -172.63 2.11 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 117.169 0.484 . . . . 0.0 110.549 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.62 HG22 ' OD2' ' A' ' 58' ' ' ASP . 8.8 t -99.03 134.22 42.18 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.567 0.222 . . . . 0.0 110.627 179.646 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.945 HD21 ' CG1' ' A' ' 17' ' ' VAL . 3.1 pp -51.74 -34.27 38.37 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.624 0.249 . . . . 0.0 111.223 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.2 t -61.22 -35.12 76.35 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.414 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.62 ' OD2' HG22 ' A' ' 55' ' ' THR . 7.5 m-20 -53.86 -32.1 51.89 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 111.612 0.227 . . . . 0.0 111.612 -179.664 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.425 ' CE2' ' HG2' ' A' ' 48' ' ' LYS . 28.0 m-85 -97.9 14.95 25.38 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.3 t30 58.48 22.77 9.99 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.774 HG22 ' O ' ' A' ' 56' ' ' LEU . 2.3 tp -90.0 62.49 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 CA-C-O 120.775 0.322 . . . . 0.0 110.823 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.14 179.68 4.3 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.265 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.7 pttp -50.36 -179.9 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.33 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 67.25 -41.54 0.42 Allowed 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.33 0.492 . . . . 0.0 112.33 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.6 m -64.89 172.54 2.79 Favored 'General case' 0 C--N 1.332 -0.191 0 O-C-N 122.266 -0.272 . . . . 0.0 110.779 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.9 p -96.9 117.74 31.78 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.979 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 1.041 HD13 HD11 ' A' ' 3' ' ' ILE . 3.6 mp -109.04 117.36 33.98 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.013 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -107.18 123.55 48.43 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.906 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.784 HD22 HD12 ' A' ' 43' ' ' LEU . 2.5 mm? -101.33 163.54 12.22 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.851 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.9 m -104.92 173.72 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.134 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.1 mt . . . . . 0 C--N 1.332 -0.186 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.879 179.939 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 . . . . . 0 CA--C 1.529 0.136 0 CA-C-O 120.563 0.22 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.913 HD12 ' HB3' ' A' ' 15' ' ' LEU . 21.7 mt -139.56 155.12 25.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.95 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -118.65 93.96 4.29 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.691 0.281 . . . . 0.0 110.931 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.566 HG22 ' HB3' ' A' ' 67' ' ' LEU . 21.3 t -119.55 151.97 22.05 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.022 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 6.4 ptpp? -109.87 140.31 43.97 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.808 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 75.5 p -99.97 -148.08 0.35 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.475 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.569 ' O ' HD23 ' A' ' 71' ' ' LEU . 1.3 pt? -65.31 -41.89 93.59 Favored 'General case' 0 C--N 1.341 0.218 0 CA-C-N 118.68 0.673 . . . . 0.0 111.571 -178.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.57 HG22 ' O ' ' A' ' 9' ' ' THR . 42.7 m -111.4 41.29 1.9 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.678 0.275 . . . . 0.0 111.065 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 50.7 39.03 37.66 Favored Glycine 0 CA--C 1.521 0.439 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.776 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.6 tttm -74.38 145.65 43.62 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.813 0.306 . . . . 0.0 110.767 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.56 ' O ' HG23 ' A' ' 12' ' ' THR . 9.7 t -93.74 106.18 18.17 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.781 0.324 . . . . 0.0 110.898 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.509 ' C ' HD12 ' A' ' 13' ' ' ILE . 2.3 pp -125.21 163.29 26.25 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.12 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 16.6 p -101.89 152.5 20.84 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.828 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.913 ' HB3' HD12 ' A' ' 3' ' ' ILE . 2.7 tp -127.99 92.8 3.53 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.976 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -100.98 121.56 41.98 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.849 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.741 HG21 HD21 ' A' ' 56' ' ' LEU . 27.7 m -140.06 173.94 9.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.156 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -96.88 167.22 12.45 Favored Pre-proline 0 C--O 1.231 0.13 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.934 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.35 -43.3 41.72 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.657 2.238 . . . . 0.0 112.487 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 36.9 m -89.27 3.09 53.2 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -75.06 120.23 20.3 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.664 0.268 . . . . 0.0 111.022 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 10.7 t -85.21 165.74 17.13 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.495 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.827 ' O ' HG12 ' A' ' 26' ' ' VAL . 43.4 mm -57.33 -37.45 57.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-O 120.528 0.204 . . . . 0.0 111.034 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -52.98 -31.45 40.82 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 120.487 0.184 . . . . 0.0 111.153 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -70.93 -42.8 69.37 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.765 -0.198 . . . . 0.0 111.335 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.827 HG12 ' O ' ' A' ' 23' ' ' ILE . 12.4 p -63.99 -21.7 29.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 111.675 0.25 . . . . 0.0 111.675 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.755 ' HD3' HD22 ' A' ' 50' ' ' LEU . 5.6 tptp -55.5 -35.03 65.15 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.573 0.225 . . . . 0.0 110.885 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.1 -37.47 87.6 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.581 0.229 . . . . 0.0 110.883 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.5 mttt -63.93 -48.62 75.81 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-O 120.636 0.255 . . . . 0.0 110.819 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.434 HG22 ' O ' ' A' ' 27' ' ' LYS . 2.6 tt -64.82 -39.15 84.67 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 CA-C-N 116.633 -0.258 . . . . 0.0 110.931 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -65.25 -21.45 66.74 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.721 -0.218 . . . . 0.0 111.07 179.394 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -61.33 -12.34 13.45 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 7.5 ptpp? -74.26 -36.73 63.85 Favored 'General case' 0 N--CA 1.461 0.092 0 O-C-N 122.013 -0.429 . . . . 0.0 110.819 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -176.4 -42.07 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.664 0.268 . . . . 0.0 111.558 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.518 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . 123.63 74.92 0.28 Allowed Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.646 -0.788 . . . . 0.0 111.589 -179.66 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.789 HD13 ' CD ' ' A' ' 41' ' ' GLN . 1.3 pp -78.31 102.34 0.95 Allowed Pre-proline 0 CA--C 1.532 0.279 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -179.087 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.698 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 10.6 Cg_endo -55.02 -42.63 67.23 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.564 2.176 . . . . 0.0 113.962 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.698 ' HD2' ' N ' ' A' ' 37' ' ' PRO . 6.1 Cg_exo -39.34 106.6 0.06 OUTLIER 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 122.762 2.308 . . . . 0.0 113.106 -179.101 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -68.61 -16.57 63.89 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.622 179.468 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -93.77 28.53 2.33 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.789 ' CD ' HD13 ' A' ' 36' ' ' ILE . 4.9 tt0 -91.91 89.07 6.86 Favored 'General case' 0 C--O 1.231 0.095 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 179.374 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.11 -179.06 6.27 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.96 -179.516 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.697 HD13 ' HG ' ' A' ' 67' ' ' LEU . 0.6 OUTLIER -97.6 160.18 14.47 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 120.718 0.294 . . . . 0.0 110.879 -179.873 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.643 ' O ' HG23 ' A' ' 44' ' ' ILE . 17.6 tt -100.91 80.03 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.13 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.635 ' HB2' HD12 ' A' ' 43' ' ' LEU . 0.3 OUTLIER -150.94 105.65 3.28 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.078 179.93 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.414 ' HB1' ' CE2' ' A' ' 59' ' ' TYR . . . 63.62 31.3 14.65 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.575 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 45.65 52.98 8.79 Favored Glycine 0 C--N 1.336 0.562 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.983 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.446 ' CD ' ' CE1' ' A' ' 59' ' ' TYR . 0.7 OUTLIER -106.62 115.82 30.86 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.785 0.292 . . . . 0.0 110.943 -179.955 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.19 173.19 8.55 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.772 0.32 . . . . 0.0 110.867 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.758 HD23 HG22 ' A' ' 23' ' ' ILE . 1.1 mt -79.15 -22.99 44.28 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.491 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -78.83 -35.68 43.69 Favored 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 121.256 -0.178 . . . . 0.0 111.339 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -48.06 114.69 0.98 Allowed 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 179.661 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -70.01 49.72 0.7 Allowed Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.483 -0.865 . . . . 0.0 112.592 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 -107.15 161.54 14.67 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.986 0.393 . . . . 0.0 110.815 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.557 HG23 ' H ' ' A' ' 58' ' ' ASP . 7.2 t -99.27 142.84 30.24 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.521 -0.308 . . . . 0.0 110.74 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.741 HD21 HG21 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -51.99 -43.71 63.73 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 111.745 0.276 . . . . 0.0 111.745 -179.286 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.1 t -58.84 -31.13 68.22 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -179.405 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.557 ' H ' HG23 ' A' ' 55' ' ' THR . 1.6 m-20 -56.82 -39.03 73.45 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 111.549 0.203 . . . . 0.0 111.549 -179.438 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.446 ' CE1' ' CD ' ' A' ' 48' ' ' LYS . 30.7 m-85 -99.82 17.51 20.58 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 47.5 t30 65.1 15.59 10.08 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 179.602 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.547 HD11 ' HA ' ' A' ' 56' ' ' LEU . 7.3 pt -90.03 60.97 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-O 120.836 0.351 . . . . 0.0 110.912 179.406 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.45 -160.15 0.77 Allowed 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.701 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.475 ' O ' ' CG ' ' A' ' 64' ' ' GLU . 2.4 pttp -39.89 144.56 0.19 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.682 0.277 . . . . 0.0 111.681 -179.596 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.475 ' CG ' ' O ' ' A' ' 63' ' ' LYS . 3.5 pt-20 54.49 26.68 7.43 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.023 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.4 p -76.05 173.38 11.34 Favored 'General case' 0 C--O 1.23 0.071 0 CA-C-O 120.672 0.272 . . . . 0.0 110.878 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.412 ' HB ' ' CE1' ' A' ' 45' ' ' PHE . 0.2 OUTLIER -107.1 81.86 1.6 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.356 179.395 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.697 ' HG ' HD13 ' A' ' 43' ' ' LEU . 0.3 OUTLIER -98.82 107.54 20.01 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.336 -179.405 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 8.4 t60 -107.13 103.77 13.25 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.582 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.475 HD12 ' CG1' ' A' ' 5' ' ' VAL . 0.2 OUTLIER -93.83 168.41 11.0 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.011 -179.773 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 32.9 m -103.87 174.41 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.216 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.569 HD23 ' O ' ' A' ' 8' ' ' LEU . 2.6 mp . . . . . 0 C--N 1.333 -0.152 0 CA-C-O 120.745 0.307 . . . . 0.0 110.844 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.556 0.217 . . . . 0.0 110.911 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.469 HG12 HD23 ' A' ' 67' ' ' LEU . 16.8 tt -138.92 153.2 24.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.077 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -118.99 127.52 53.54 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.65 0.262 . . . . 0.0 110.797 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 1.058 HG13 HD11 ' A' ' 67' ' ' LEU . 3.5 t -101.36 140.45 20.04 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.176 -179.788 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.78 87.2 2.47 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.444 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.41 119.94 40.82 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.539 -179.221 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -51.02 -20.87 1.53 Allowed 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 179.353 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 77.5 p -99.96 38.47 1.46 Allowed 'General case' 0 CA--C 1.531 0.248 0 O-C-N 122.033 -0.417 . . . . 0.0 111.442 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 49.03 30.13 9.32 Favored Glycine 0 C--N 1.336 0.567 0 C-N-CA 121.117 -0.563 . . . . 0.0 113.757 179.237 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.82 65.28 9.06 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 117.332 0.566 . . . . 0.0 110.714 179.489 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.616 ' O ' HG23 ' A' ' 12' ' ' THR . 13.6 t -92.98 99.76 12.33 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.89 0.376 . . . . 0.0 110.883 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.526 HD11 ' HD3' ' A' ' 33' ' ' LYS . 1.7 pp -125.54 172.55 12.88 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.167 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.27 132.7 51.14 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.656 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.436 ' HG ' HD13 ' A' ' 13' ' ' ILE . 62.3 mt -128.88 124.04 34.2 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.121 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -101.19 131.6 47.09 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.755 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.02 -176.23 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.925 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -102.58 160.87 24.96 Favored Pre-proline 0 C--N 1.333 -0.127 0 CA-C-O 120.636 0.255 . . . . 0.0 110.896 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -53.26 -50.12 15.08 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.482 2.121 . . . . 0.0 112.407 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.9 t -90.21 32.26 0.94 Allowed 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.354 0.501 . . . . 0.0 112.354 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.9 p-10 -75.24 119.48 19.43 Favored 'General case' 0 N--CA 1.461 0.114 0 O-C-N 122.202 -0.311 . . . . 0.0 110.976 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.41 HG23 ' H ' ' A' ' 25' ' ' ASN . 14.4 t -84.95 166.08 17.08 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-O 120.673 0.273 . . . . 0.0 110.822 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.684 ' HB ' HD12 ' A' ' 50' ' ' LEU . 9.8 tp -57.89 -37.99 63.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.641 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -63.45 -41.74 98.64 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.572 0.225 . . . . 0.0 111.25 -179.683 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.41 ' H ' HG23 ' A' ' 22' ' ' THR . 0.7 OUTLIER -73.14 -48.0 39.25 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 120.616 0.246 . . . . 0.0 111.161 -179.702 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.548 HG12 ' HA ' ' A' ' 23' ' ' ILE . 13.6 p -63.97 -21.42 28.76 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 111.698 0.259 . . . . 0.0 111.698 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.2 mtpm? -55.58 -35.06 65.37 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.502 0.191 . . . . 0.0 110.902 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.88 -37.62 74.28 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.625 0.25 . . . . 0.0 110.879 179.652 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.78 -38.01 64.79 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.849 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 33.2 mm -64.98 -45.16 95.49 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 CA-C-O 120.671 0.272 . . . . 0.0 110.622 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -59.89 -26.58 66.0 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.961 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -57.09 -22.94 43.29 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 111.691 0.256 . . . . 0.0 111.691 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.526 ' HD3' HD11 ' A' ' 13' ' ' ILE . 7.8 mtmp? -74.37 -39.08 62.97 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.605 0.24 . . . . 0.0 110.925 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.06 -48.64 0.24 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.692 -0.231 . . . . 0.0 111.238 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.505 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . 108.83 62.52 0.54 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.04 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.853 HD13 ' HB2' ' A' ' 41' ' ' GLN . 17.2 tt -78.51 108.3 7.58 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-O 120.696 0.284 . . . . 0.0 111.486 -179.512 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.591 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 26.0 Cg_exo -63.53 -40.66 29.39 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 122.747 2.298 . . . . 0.0 114.189 -179.448 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.591 ' HD2' ' N ' ' A' ' 37' ' ' PRO . 38.1 Cg_endo -68.5 133.16 27.21 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 122.02 1.813 . . . . 0.0 113.53 -178.62 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -70.71 14.67 0.13 Allowed 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.659 -0.7 . . . . 0.0 112.45 179.114 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -89.37 1.51 55.7 Favored 'General case' 0 N--CA 1.456 -0.138 0 O-C-N 122.135 -0.353 . . . . 0.0 110.543 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.853 ' HB2' HD13 ' A' ' 36' ' ' ILE . 2.6 tp60 -82.77 101.7 11.09 Favored 'General case' 0 C--O 1.231 0.097 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 179.078 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -133.88 178.19 7.14 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-O 120.742 0.306 . . . . 0.0 111.311 -179.415 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.864 ' CD1' HD12 ' A' ' 69' ' ' LEU . 8.7 tp -106.56 133.23 51.56 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.101 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.9 pt -111.26 107.4 22.85 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-O 120.752 0.311 . . . . 0.0 111.164 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -150.94 135.22 16.91 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.086 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.509 ' HB3' ' HD2' ' A' ' 48' ' ' LYS . . . 54.95 38.58 30.69 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.209 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 52.91 29.07 33.68 Favored Glycine 0 CA--C 1.522 0.51 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.941 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.509 ' HD2' ' HB3' ' A' ' 46' ' ' ALA . 14.4 mttm -110.47 102.24 10.87 Favored 'General case' 0 N--CA 1.457 -0.102 0 CA-C-N 117.016 0.408 . . . . 0.0 110.89 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -89.12 90.61 8.46 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.681 0.277 . . . . 0.0 110.89 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.684 HD12 ' HB ' ' A' ' 23' ' ' ILE . 0.6 OUTLIER -79.34 65.81 4.62 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.123 179.952 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -89.51 -42.09 11.66 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-O 120.607 0.241 . . . . 0.0 111.103 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -47.34 -69.29 0.13 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.742 0.306 . . . . 0.0 111.203 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.406 ' HA2' HG22 ' A' ' 23' ' ' ILE . . . 158.26 56.61 0.01 OUTLIER Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.681 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -106.02 177.49 4.84 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.591 0.234 . . . . 0.0 110.861 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.607 HG23 ' H ' ' A' ' 58' ' ' ASP . 9.9 t -99.1 154.87 17.78 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.711 0.291 . . . . 0.0 110.86 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.794 ' HA ' HD12 ' A' ' 61' ' ' ILE . 1.4 mp -59.31 -46.78 87.64 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.061 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.1 t -53.27 -39.15 63.68 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.484 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.607 ' H ' HG23 ' A' ' 55' ' ' THR . 45.2 t0 -53.9 -30.23 45.23 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 111.659 0.244 . . . . 0.0 111.659 -179.773 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.425 ' CD1' ' HD3' ' A' ' 48' ' ' LYS . 5.1 m-85 -101.99 40.36 1.34 Allowed 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 120.659 0.266 . . . . 0.0 111.601 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 54.84 27.34 8.83 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 179.429 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.794 HD12 ' HA ' ' A' ' 56' ' ' LEU . 27.6 mt -89.64 101.31 12.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-O 120.643 0.259 . . . . 0.0 110.858 179.555 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -94.97 166.22 12.05 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.782 0.325 . . . . 0.0 111.223 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -50.23 151.06 2.2 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.259 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 62.67 22.13 13.15 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.593 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.2 m -75.71 170.03 16.97 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-O 120.68 0.276 . . . . 0.0 110.815 179.755 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.05 111.76 23.84 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.393 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 1.058 HD11 HG13 ' A' ' 5' ' ' VAL . 2.1 pp -98.72 116.53 31.15 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.791 0.329 . . . . 0.0 111.53 -179.396 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -107.29 109.82 21.69 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.581 179.539 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.864 HD12 ' CD1' ' A' ' 43' ' ' LEU . 0.1 OUTLIER -93.9 179.71 5.25 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.958 -179.846 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -109.13 -178.2 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.62 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.1 mt . . . . . 0 C--N 1.332 -0.167 0 CA-C-O 120.664 0.268 . . . . 0.0 110.782 179.938 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.652 0.263 . . . . 0.0 110.945 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.641 HD11 HD21 ' A' ' 67' ' ' LEU . 15.1 tt -138.92 157.1 28.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.915 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -118.44 102.99 9.34 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.83 0.348 . . . . 0.0 110.864 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.875 HG22 HD11 ' A' ' 67' ' ' LEU . 11.8 t -122.22 151.42 25.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.121 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.761 ' O ' HD11 ' A' ' 69' ' ' LEU . 0.1 OUTLIER -106.83 135.12 48.91 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.854 179.957 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.75 -147.28 0.34 Allowed 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.331 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.501 ' HG ' HG23 ' A' ' 9' ' ' THR . 2.5 tp -68.43 -53.99 20.02 Favored 'General case' 0 C--N 1.342 0.282 0 CA-C-O 120.921 0.391 . . . . 0.0 110.75 -179.503 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.501 HG23 ' HG ' ' A' ' 8' ' ' LEU . 12.3 p -101.57 39.07 1.49 Allowed 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.304 -179.641 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 55.24 38.68 68.68 Favored Glycine 0 C--N 1.334 0.435 0 C-N-CA 120.817 -0.706 . . . . 0.0 113.133 179.454 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.9 ttmt -84.16 141.63 30.92 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 117.062 0.431 . . . . 0.0 110.556 179.559 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.41 ' O ' HG23 ' A' ' 12' ' ' THR . 14.9 t -92.95 121.99 34.85 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.64 0.257 . . . . 0.0 111.138 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.7 pt -125.13 136.06 62.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.954 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -98.87 130.31 45.27 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.903 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.9 pp -138.08 151.86 48.23 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.521 -0.308 . . . . 0.0 110.951 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -101.13 156.22 17.55 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.938 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 22.2 t -136.16 113.51 14.03 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.126 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -107.0 165.84 12.15 Favored Pre-proline 0 C--N 1.332 -0.166 0 CA-C-O 120.787 0.327 . . . . 0.0 110.855 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.49 -30.0 52.77 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.66 2.24 . . . . 0.0 112.535 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 82.1 p -78.74 -32.47 46.72 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.802 -0.181 . . . . 0.0 111.232 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -64.89 121.23 14.14 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.659 0.266 . . . . 0.0 110.74 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.05 149.82 25.3 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.02 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.812 HG22 ' O ' ' A' ' 54' ' ' ARG . 4.1 tt -68.06 -29.35 44.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.541 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.0 tm-20 -53.06 -60.32 3.43 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.73 0.3 . . . . 0.0 111.107 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 36.9 m-20 -74.85 44.09 0.21 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.857 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 14.6 p -69.12 -40.17 80.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.562 0.22 . . . . 0.0 111.144 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.8 mptt -66.07 -44.71 83.7 Favored 'General case' 0 N--CA 1.461 0.108 0 CA-C-O 120.669 0.271 . . . . 0.0 110.816 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.29 -40.85 98.53 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.053 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.88 -41.11 97.82 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.866 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 31.9 mt -75.03 -42.61 45.51 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.952 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -55.04 -37.82 67.19 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.702 0.287 . . . . 0.0 110.977 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.56 -16.12 44.97 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 112.16 0.429 . . . . 0.0 112.16 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 12.6 mmtt -74.79 -34.72 62.47 Favored 'General case' 0 N--CA 1.461 0.087 0 O-C-N 122.207 -0.308 . . . . 0.0 111.188 -179.634 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -167.11 -45.82 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 121.013 -0.275 . . . . 0.0 111.576 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 137.14 80.22 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.453 -0.88 . . . . 0.0 112.329 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.564 HD13 ' OE1' ' A' ' 41' ' ' GLN . 9.3 tt -78.35 113.29 32.72 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-O 120.565 0.221 . . . . 0.0 111.106 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.51 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 51.2 Cg_exo -53.36 -51.28 11.32 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.676 2.251 . . . . 0.0 113.291 -179.6 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.51 ' HD2' ' N ' ' A' ' 37' ' ' PRO . 31.6 Cg_endo -65.65 86.19 0.22 Allowed 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 121.975 1.783 . . . . 0.0 112.363 -179.617 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.31 -21.55 64.76 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.409 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 29.2 mt-30 -100.2 36.17 1.92 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 120.478 0.18 . . . . 0.0 111.421 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.564 ' OE1' HD13 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -88.23 131.25 34.83 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.576 0.227 . . . . 0.0 110.704 179.637 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.3 mtt180 -137.89 169.02 18.51 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.694 0.283 . . . . 0.0 111.061 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.63 ' CD1' HD22 ' A' ' 67' ' ' LEU . 49.6 mt -99.67 151.29 21.38 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.919 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.644 HG22 ' O ' ' A' ' 68' ' ' HIS . 4.8 tt -110.99 84.16 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 CA-C-O 120.765 0.317 . . . . 0.0 111.092 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -150.89 131.75 14.15 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.204 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.7 25.74 15.52 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.741 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 44.51 36.83 4.64 Favored Glycine 0 C--N 1.337 0.637 0 C-N-CA 120.777 -0.725 . . . . 0.0 113.081 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.1 mmpm? -110.06 136.46 49.27 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.835 0.317 . . . . 0.0 111.06 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.7 tp60 -89.12 162.98 15.66 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.931 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.686 HD13 HG12 ' A' ' 23' ' ' ILE . 4.2 mm? -80.48 19.57 0.78 Allowed 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -89.04 -41.23 12.45 Favored 'General case' 0 CA--C 1.529 0.155 0 O-C-N 122.038 -0.414 . . . . 0.0 111.171 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -48.28 114.51 0.96 Allowed 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 120.637 0.256 . . . . 0.0 110.325 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -69.97 50.43 0.71 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.411 -0.9 . . . . 0.0 112.467 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.812 ' O ' HG22 ' A' ' 23' ' ' ILE . 2.3 mmt180 -104.52 -178.72 3.74 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-N 116.946 0.373 . . . . 0.0 110.926 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.8 m -94.74 149.0 21.7 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.771 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.811 ' O ' HG22 ' A' ' 61' ' ' ILE . 0.4 OUTLIER -54.73 -47.33 73.92 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.988 -179.937 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.0 p -52.38 -30.26 28.14 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.36 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -53.91 -28.52 37.21 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 111.522 0.193 . . . . 0.0 111.522 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.504 ' CE2' HD13 ' A' ' 23' ' ' ILE . 61.7 m-85 -98.11 24.32 7.23 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 61.4 21.85 12.34 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 179.397 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.811 HG22 ' O ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -89.56 92.47 3.97 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 CA-C-O 120.853 0.359 . . . . 0.0 110.722 179.454 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -101.73 176.28 5.27 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.141 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.32 145.85 5.8 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.311 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 64.54 21.86 12.54 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.833 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 54.3 p -75.67 149.41 38.15 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 120.734 0.302 . . . . 0.0 110.996 179.66 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.5 m -107.09 90.2 3.23 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.553 179.517 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.875 HD11 HG22 ' A' ' 5' ' ' VAL . 0.5 OUTLIER -109.34 135.23 50.74 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.869 0.366 . . . . 0.0 111.261 -179.813 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.644 ' O ' HG22 ' A' ' 44' ' ' ILE . 16.4 m80 -107.34 142.07 37.72 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.715 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.761 HD11 ' O ' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -104.76 158.36 16.56 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.693 0.283 . . . . 0.0 111.159 179.69 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.3 p -114.1 152.43 15.77 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.927 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.7 mp . . . . . 0 C--N 1.332 -0.176 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.84 179.947 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.8 mp0 . . . . . 0 CA--C 1.533 0.309 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.507 HD12 ' CG2' ' A' ' 5' ' ' VAL . 14.5 pt -138.66 177.27 5.28 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.108 0 CA-C-O 120.71 0.291 . . . . 0.0 111.306 -179.753 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -118.88 101.31 7.96 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.703 0.287 . . . . 0.0 110.826 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.687 HG13 HD13 ' A' ' 69' ' ' LEU . 22.0 t -114.96 149.56 17.14 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.132 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 9.2 mmtt -106.92 130.72 54.54 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.9 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.43 -166.6 1.36 Allowed 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.271 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.932 HD13 ' HD3' ' A' ' 37' ' ' PRO . 0.6 OUTLIER -66.98 -43.39 83.14 Favored 'General case' 0 C--N 1.339 0.128 0 CA-C-O 120.8 0.333 . . . . 0.0 111.183 -178.79 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.427 ' N ' ' HG ' ' A' ' 8' ' ' LEU . 1.3 p -111.27 40.36 2.09 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.035 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 55.24 39.96 73.51 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.681 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.06 163.23 20.0 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.783 0.292 . . . . 0.0 110.898 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -103.04 122.8 45.39 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.864 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.666 HD11 HG11 ' A' ' 5' ' ' VAL . 10.6 pt -124.99 151.5 30.68 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-O 120.703 0.287 . . . . 0.0 111.234 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 16.7 m -105.75 130.55 53.73 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.793 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.489 ' CB ' HD11 ' A' ' 3' ' ' ILE . 0.3 OUTLIER -137.56 130.31 30.04 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.576 -0.283 . . . . 0.0 110.984 179.98 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -100.95 175.05 5.74 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.77 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.7 HG11 ' HA ' ' A' ' 62' ' ' GLN . 26.1 t -132.81 108.99 13.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 120.81 0.338 . . . . 0.0 111.272 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.413 ' HB2' ' HD2' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -107.05 158.21 33.49 Favored Pre-proline 0 C--N 1.333 -0.15 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.498 179.811 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.413 ' HD2' ' HB2' ' A' ' 18' ' ' GLU . 3.7 Cg_endo -46.49 -53.36 6.12 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.627 2.218 . . . . 0.0 112.059 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.9 p -90.42 41.16 1.04 Allowed 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.636 ' OD1' HD12 ' A' ' 56' ' ' LEU . 13.8 t70 -74.56 94.89 2.7 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.65 0.262 . . . . 0.0 110.976 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.21 128.7 34.78 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.658 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.744 HD12 ' C ' ' A' ' 54' ' ' ARG . 7.1 mt -57.83 -35.04 49.82 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.329 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -71.33 -41.3 70.02 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.608 0.242 . . . . 0.0 111.08 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -73.02 -41.89 63.77 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.242 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.434 HG21 HD21 ' A' ' 15' ' ' LEU . 12.3 p -63.78 -36.23 75.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-N 116.759 -0.2 . . . . 0.0 111.285 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.735 ' HA ' HD12 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -55.82 -41.15 73.79 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.621 0.248 . . . . 0.0 110.888 179.912 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.95 -34.85 70.35 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.322 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 16.8 mtpt -63.68 -43.09 97.69 Favored 'General case' 0 CA--C 1.527 0.092 0 CA-C-O 120.633 0.254 . . . . 0.0 110.822 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.735 HD12 ' HA ' ' A' ' 27' ' ' LYS . 3.4 mt -66.47 -49.32 76.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 CA-C-O 120.702 0.287 . . . . 0.0 110.735 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 1.9 tp60 -65.16 -25.91 67.94 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.185 179.697 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -51.05 -31.23 17.93 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.64 -24.83 49.39 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 121.162 -0.215 . . . . 0.0 111.45 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 70.61 33.73 2.29 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.673 0.273 . . . . 0.0 110.704 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.479 ' O ' HD22 ' A' ' 8' ' ' LEU . . . -89.96 -39.99 5.99 Favored Glycine 0 C--N 1.334 0.454 0 C-N-CA 120.518 -0.849 . . . . 0.0 112.596 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.519 HG22 ' HD2' ' A' ' 38' ' ' PRO . 4.6 mt -89.33 110.08 36.04 Favored Pre-proline 0 CA--C 1.531 0.224 0 CA-C-N 116.656 0.228 . . . . 0.0 111.163 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.932 ' HD3' HD13 ' A' ' 8' ' ' LEU . 33.8 Cg_exo -57.65 -46.9 23.96 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.374 2.049 . . . . 0.0 113.077 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.519 ' HD2' HG22 ' A' ' 36' ' ' ILE . 60.6 Cg_endo -74.11 120.21 6.2 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.224 1.949 . . . . 0.0 112.894 -179.392 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -68.75 -18.83 64.28 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.19 179.402 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -93.01 34.02 1.13 Allowed 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 111.492 0.182 . . . . 0.0 111.492 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.52 ' O ' HD22 ' A' ' 50' ' ' LEU . 55.1 tp60 -82.35 111.79 18.73 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 179.496 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.678 ' CB ' HD13 ' A' ' 50' ' ' LEU . 7.1 ptt180 -139.67 178.79 6.98 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.885 -179.683 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.74 HD22 HD21 ' A' ' 67' ' ' LEU . 0.7 OUTLIER -97.84 166.46 11.46 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.875 179.949 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.625 ' O ' HG23 ' A' ' 44' ' ' ILE . 18.0 tt -109.47 89.14 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.158 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.472 ' HB2' HD12 ' A' ' 43' ' ' LEU . 1.3 t80 -150.83 109.09 3.75 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.153 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.34 33.68 18.79 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.556 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 46.23 45.33 15.64 Favored Glycine 0 C--N 1.336 0.541 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.97 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.417 ' HE2' ' CE1' ' A' ' 59' ' ' TYR . 26.1 tptt -101.42 129.92 47.54 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.803 0.302 . . . . 0.0 110.93 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -89.15 158.25 17.99 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.974 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.678 HD13 ' CB ' ' A' ' 42' ' ' ARG . 3.1 mp -79.22 -34.84 42.5 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.166 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -78.97 -10.46 59.83 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 111.678 0.251 . . . . 0.0 111.678 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -47.07 -42.81 19.39 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.66 0.267 . . . . 0.0 111.227 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.77 37.52 5.75 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.767 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.744 ' C ' HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -107.14 174.93 5.67 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.848 0.324 . . . . 0.0 110.728 179.783 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.494 HG22 ' H ' ' A' ' 57' ' ' SER . 49.8 m -99.19 135.25 40.87 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.814 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.697 HD22 HG21 ' A' ' 61' ' ' ILE . 14.5 mt -52.24 -38.14 57.22 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.011 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.494 ' H ' HG22 ' A' ' 55' ' ' THR . 8.0 t -61.31 -31.49 71.34 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.647 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -53.73 -37.83 63.74 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 121.207 -0.197 . . . . 0.0 111.418 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.417 ' CE1' ' HE2' ' A' ' 48' ' ' LYS . 6.1 m-85 -103.62 34.32 3.02 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 120.511 0.196 . . . . 0.0 111.439 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 54.8 28.0 9.69 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 179.598 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.697 HG21 HD22 ' A' ' 56' ' ' LEU . 28.2 mt -89.48 73.49 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.123 0 CA-C-O 120.768 0.318 . . . . 0.0 110.885 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.7 ' HA ' HG11 ' A' ' 17' ' ' VAL . 4.3 mm-40 -94.8 177.81 5.78 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.058 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.4 ' HA ' HG21 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -50.23 147.22 4.38 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.863 0.363 . . . . 0.0 111.276 -179.758 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 63.66 20.73 12.38 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.779 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.8 m -75.83 176.74 7.51 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-O 120.63 0.253 . . . . 0.0 110.951 179.759 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.621 ' O ' HG23 ' A' ' 66' ' ' THR . 10.5 t -101.44 82.96 2.38 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.472 179.553 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.74 HD21 HD22 ' A' ' 43' ' ' LEU . 0.3 OUTLIER -98.95 108.61 21.34 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.128 -179.626 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.9 m170 -107.13 124.34 49.55 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.659 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.687 HD13 HG13 ' A' ' 5' ' ' VAL . 5.4 mp -93.9 149.27 21.38 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.887 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.464 ' O ' ' NE2' ' A' ' 41' ' ' GLN . 21.6 t -104.1 144.09 14.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.03 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.4 mt . . . . . 0 C--N 1.332 -0.185 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.908 -179.962 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 . . . . . 0 CA--C 1.534 0.328 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.614 HG12 HG23 ' A' ' 5' ' ' VAL . 14.7 tt -138.91 154.96 26.68 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 O-C-N 122.33 -0.231 . . . . 0.0 111.118 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.83 81.63 1.73 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.719 0.295 . . . . 0.0 110.766 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.614 HG23 HG12 ' A' ' 3' ' ' ILE . 16.6 t -109.2 153.63 10.9 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.969 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.93 138.67 42.65 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.681 0.277 . . . . 0.0 111.046 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.567 HG21 ' HB3' ' A' ' 11' ' ' LYS . 6.0 p -99.9 -167.44 1.46 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.215 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.36 -35.36 75.51 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.963 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.53 -66.57 1.07 Allowed 'General case' 0 C--O 1.231 0.111 0 CA-C-O 120.827 0.346 . . . . 0.0 110.382 179.396 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 171.45 46.03 0.04 OUTLIER Glycine 0 CA--C 1.522 0.48 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.917 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.567 ' HB3' HG21 ' A' ' 7' ' ' THR . 0.5 OUTLIER -84.93 164.14 18.53 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.89 0.345 . . . . 0.0 111.071 179.993 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.1 p -103.17 123.57 46.96 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.48 179.52 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.3 tt -114.94 140.85 34.01 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.107 0 CA-C-O 120.736 0.303 . . . . 0.0 111.275 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 17.0 p -106.03 119.51 39.39 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.784 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.525 HD12 HG21 ' A' ' 3' ' ' ILE . 5.0 mt -138.03 145.39 41.77 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.941 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -100.99 164.69 11.69 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.853 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.714 HG13 HD11 ' A' ' 56' ' ' LEU . 24.7 t -129.89 106.11 12.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.031 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.414 ' HB2' ' HD2' ' A' ' 19' ' ' PRO . 0.5 OUTLIER -102.09 163.32 17.97 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.812 179.966 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.414 ' HD2' ' HB2' ' A' ' 18' ' ' GLU . 53.5 Cg_exo -52.67 -48.74 20.36 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.452 2.101 . . . . 0.0 112.189 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.3 p -90.28 34.19 0.88 Allowed 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.778 ' CG ' HD21 ' A' ' 56' ' ' LEU . 18.0 t0 -75.31 106.65 6.95 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.727 0.299 . . . . 0.0 110.73 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.4 m -85.16 142.61 29.35 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.033 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.43 HG13 HD12 ' A' ' 50' ' ' LEU . 9.5 tp -68.05 -23.78 29.38 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.763 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -86.02 -33.96 20.91 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 120.477 0.179 . . . . 0.0 111.298 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -62.83 -38.93 92.71 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.522 0.201 . . . . 0.0 111.29 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.9 p -63.78 -31.1 51.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-N 116.754 -0.203 . . . . 0.0 111.444 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.668 ' CG ' HD23 ' A' ' 50' ' ' LEU . 14.7 tttt -56.0 -43.38 77.63 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.715 0.293 . . . . 0.0 110.823 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.86 -30.89 71.94 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.345 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.6 mttm -63.82 -39.4 94.15 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 120.567 0.222 . . . . 0.0 110.89 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 38.0 mm -64.98 -46.92 90.12 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 CA-C-O 120.698 0.285 . . . . 0.0 110.555 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.32 -42.88 92.54 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.588 179.71 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -61.25 -22.98 65.32 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.727 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.78 -44.36 50.02 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-O 120.73 0.3 . . . . 0.0 110.795 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -136.78 -50.61 0.66 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.131 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.432 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . 116.93 67.41 0.38 Allowed Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.931 -179.598 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.6 HG23 ' O ' ' A' ' 36' ' ' ILE . 19.8 tt -78.45 110.1 12.71 Favored Pre-proline 0 CA--C 1.531 0.249 0 CA-C-O 120.679 0.276 . . . . 0.0 111.368 -179.432 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.49 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 35.2 Cg_exo -60.29 -45.92 20.62 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.61 2.206 . . . . 0.0 113.212 -179.737 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.49 ' HD2' ' N ' ' A' ' 37' ' ' PRO . 58.1 Cg_exo -39.12 95.09 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.866 2.378 . . . . 0.0 113.221 -179.449 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -68.76 -17.57 64.06 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.405 179.482 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -93.5 30.98 1.61 Allowed 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 111.779 0.289 . . . . 0.0 111.779 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.431 ' CD ' HD21 ' A' ' 69' ' ' LEU . 1.8 tt0 -82.64 116.07 21.87 Favored 'General case' 0 CA--C 1.528 0.105 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 179.347 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.44 168.23 20.21 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.683 0.278 . . . . 0.0 111.387 -179.256 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -103.96 167.51 9.72 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.711 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.671 HG22 ' O ' ' A' ' 68' ' ' HIS . 8.0 tt -111.04 74.14 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.732 0.301 . . . . 0.0 111.129 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -150.91 112.57 4.46 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.343 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.6 ' HB1' ' CE1' ' A' ' 59' ' ' TYR . . . 59.75 25.44 14.44 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.849 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 43.45 45.63 6.79 Favored Glycine 0 C--N 1.337 0.595 0 C-N-CA 120.861 -0.685 . . . . 0.0 113.09 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.01 135.65 41.11 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.794 0.297 . . . . 0.0 110.898 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -89.1 161.06 16.73 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.963 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.668 HD23 ' CG ' ' A' ' 27' ' ' LYS . 1.3 tp -79.09 -20.4 48.84 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.533 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -78.62 -40.82 33.3 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-O 120.535 0.207 . . . . 0.0 111.065 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.418 ' O ' ' N ' ' A' ' 54' ' ' ARG . 0.5 OUTLIER -48.0 119.0 2.61 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 179.538 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.86 53.91 0.37 Allowed Glycine 0 CA--C 1.521 0.419 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.875 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.418 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -107.16 164.69 11.95 Favored 'General case' 0 CA--C 1.527 0.093 0 CA-C-N 117.01 0.405 . . . . 0.0 110.725 179.814 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.566 HG22 ' H ' ' A' ' 57' ' ' SER . 71.1 m -99.17 131.41 45.23 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.708 0.289 . . . . 0.0 110.666 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.778 HD21 ' CG ' ' A' ' 21' ' ' ASP . 0.3 OUTLIER -51.39 -33.58 30.67 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.699 -0.228 . . . . 0.0 111.007 -179.951 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.566 ' H ' HG22 ' A' ' 55' ' ' THR . 12.6 t -63.36 -36.29 83.22 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 111.713 0.264 . . . . 0.0 111.713 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.406 ' OD1' ' CD2' ' A' ' 59' ' ' TYR . 1.5 p30 -55.81 -31.67 62.88 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -179.18 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.6 ' CE1' ' HB1' ' A' ' 46' ' ' ALA . 4.5 m-85 -103.97 29.71 5.69 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 121.077 -0.249 . . . . 0.0 111.597 -179.735 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.452 ' ND2' ' O ' ' A' ' 60' ' ' ASN . 0.9 OUTLIER 65.15 12.97 8.41 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 179.62 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.697 ' O ' HD12 ' A' ' 56' ' ' LEU . 21.4 mt -89.91 62.93 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 O-C-N 122.17 -0.332 . . . . 0.0 110.692 179.448 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -104.19 -173.06 2.22 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.301 -179.383 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.3 ttpt -46.64 139.57 5.1 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.847 0.356 . . . . 0.0 111.388 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 65.26 15.77 10.18 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.134 -0.484 . . . . 0.0 112.196 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 40.3 t -76.05 -177.39 3.9 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 120.655 0.264 . . . . 0.0 110.67 179.393 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.33 91.58 3.77 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.515 -0.312 . . . . 0.0 110.409 179.457 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.42 HD11 ' CG2' ' A' ' 61' ' ' ILE . 3.8 mp -98.72 102.44 14.18 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.745 0.307 . . . . 0.0 111.23 -179.564 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.671 ' O ' HG22 ' A' ' 44' ' ' ILE . 0.3 OUTLIER -107.12 109.33 21.14 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.625 179.737 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.431 HD21 ' CD ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -94.04 179.44 5.33 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.929 -179.906 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.9 m -103.77 172.41 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.115 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.332 -0.185 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.823 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 53.0 mm-40 . . . . . 0 CA--C 1.529 0.141 0 CA-C-O 120.6 0.238 . . . . 0.0 111.005 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.487 HD11 ' HB3' ' A' ' 15' ' ' LEU . 2.4 pt -138.8 176.24 6.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-N 116.669 -0.242 . . . . 0.0 111.076 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -118.83 101.16 7.86 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.744 0.307 . . . . 0.0 110.907 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.485 ' CG2' HD13 ' A' ' 69' ' ' LEU . 11.1 p -136.19 138.37 47.21 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.746 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -107.28 168.74 9.01 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.878 0.37 . . . . 0.0 111.305 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.6 p -99.93 -168.27 1.57 Allowed 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.446 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.55 -22.48 66.98 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 120.933 -0.307 . . . . 0.0 111.563 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.2 t -100.56 -10.75 20.7 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.65 30.13 8.76 Favored Glycine 0 C--N 1.336 0.554 0 C-N-CA 120.507 -0.854 . . . . 0.0 113.111 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.6 tttm -84.29 170.28 13.83 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-N 117.161 0.481 . . . . 0.0 110.714 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.468 ' O ' HG23 ' A' ' 12' ' ' THR . 14.0 t -103.1 118.0 35.82 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.583 -0.281 . . . . 0.0 110.873 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.472 HG13 HG13 ' A' ' 5' ' ' VAL . 22.8 pt -125.18 157.55 33.9 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 CA-C-O 120.677 0.275 . . . . 0.0 111.211 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.4 p -106.03 125.82 51.45 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.838 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.487 ' HB3' HD11 ' A' ' 3' ' ' ILE . 0.3 OUTLIER -129.16 145.78 51.23 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.885 179.965 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -101.06 152.43 20.61 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.786 0.326 . . . . 0.0 110.809 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 24.2 t -133.51 132.16 57.49 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.044 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -107.1 159.95 28.17 Favored Pre-proline 0 C--N 1.332 -0.169 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.784 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -50.68 -49.93 15.26 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.465 2.11 . . . . 0.0 112.218 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 p -90.22 36.74 0.88 Allowed 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.0 p-10 -69.13 103.82 2.0 Allowed 'General case' 0 C--O 1.231 0.11 0 O-C-N 122.199 -0.313 . . . . 0.0 110.744 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.3 p -85.09 134.09 34.2 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.979 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.895 HD13 ' HE2' ' A' ' 48' ' ' LYS . 3.9 tp -65.06 -36.98 79.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.315 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -48.09 -51.64 23.69 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.612 0.244 . . . . 0.0 111.069 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.532 ' OD1' ' HB3' ' A' ' 28' ' ' ALA . 0.8 OUTLIER -74.78 43.63 0.2 Allowed 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 111.779 0.288 . . . . 0.0 111.779 179.632 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.531 ' O ' HG22 ' A' ' 30' ' ' ILE . 13.9 p -74.06 -39.52 50.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 CA-C-O 120.626 0.25 . . . . 0.0 111.298 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.487 ' HA ' HG22 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -55.94 -44.14 78.11 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.72 0.295 . . . . 0.0 110.936 179.913 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.532 ' HB3' ' OD1' ' A' ' 25' ' ' ASN . . . -64.27 -42.68 96.32 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.103 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 21.3 mtmm -70.82 -45.63 64.24 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.948 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.543 HG21 ' OE1' ' A' ' 41' ' ' GLN . 10.8 tp -70.34 -36.53 67.34 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.266 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.7 tm0? -59.33 -24.6 63.47 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.773 -0.194 . . . . 0.0 111.069 179.611 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -50.99 -25.21 4.41 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.59 -39.94 61.91 Favored 'General case' 0 C--O 1.231 0.089 0 C-N-CA 120.936 -0.306 . . . . 0.0 110.564 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 176.51 -39.17 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.716 0.294 . . . . 0.0 111.453 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.557 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . 131.94 80.49 0.19 Allowed Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.748 -179.559 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.613 HG23 ' O ' ' A' ' 36' ' ' ILE . 11.2 tt -77.68 106.1 3.42 Favored Pre-proline 0 N--CA 1.466 0.349 0 CA-C-O 120.799 0.333 . . . . 0.0 111.582 -179.19 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.639 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 17.1 Cg_exo -68.59 -35.6 16.72 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 123.03 2.486 . . . . 0.0 115.13 -179.081 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.639 ' HD2' ' N ' ' A' ' 37' ' ' PRO . 15.8 Cg_endo -60.52 113.45 1.7 Allowed 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 121.678 1.585 . . . . 0.0 113.393 -178.343 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -70.28 5.35 1.75 Allowed 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.399 179.047 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -89.73 8.74 30.17 Favored 'General case' 0 CA--C 1.53 0.199 0 O-C-N 122.088 -0.383 . . . . 0.0 111.4 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.543 ' OE1' HG21 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -82.59 99.41 9.53 Favored 'General case' 0 CA--C 1.527 0.08 0 CA-C-O 120.776 0.322 . . . . 0.0 110.453 179.41 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.77 169.74 16.61 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.971 -179.526 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.889 HD21 ' CD2' ' A' ' 67' ' ' LEU . 0.2 OUTLIER -97.99 140.74 31.88 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.796 179.883 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.564 ' O ' HG23 ' A' ' 44' ' ' ILE . 3.7 tt -107.83 65.08 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 120.793 0.33 . . . . 0.0 111.102 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -150.89 121.07 7.23 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.737 0.303 . . . . 0.0 111.219 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.93 25.59 15.56 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.787 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 45.13 55.71 6.41 Favored Glycine 0 C--N 1.338 0.65 0 C-N-CA 120.836 -0.697 . . . . 0.0 113.039 179.763 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.895 ' HE2' HD13 ' A' ' 23' ' ' ILE . 0.3 OUTLIER -102.03 135.01 44.34 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.702 0.287 . . . . 0.0 110.96 -179.934 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -89.09 154.17 20.4 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.872 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.629 HD12 ' N ' ' A' ' 51' ' ' GLU . 4.5 pp -69.78 -39.44 76.64 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.06 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.629 ' N ' HD12 ' A' ' 50' ' ' LEU . 0.0 OUTLIER -89.76 10.97 21.44 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 179.929 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -47.06 -45.68 21.86 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.683 0.278 . . . . 0.0 111.194 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.39 8.12 56.52 Favored Glycine 0 CA--C 1.523 0.589 0 C-N-CA 120.591 -0.814 . . . . 0.0 113.292 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.471 ' O ' HG22 ' A' ' 23' ' ' ILE . 3.0 mmm180 -107.09 -177.61 3.41 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 117.326 0.563 . . . . 0.0 110.702 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.657 HG22 ' OD2' ' A' ' 58' ' ' ASP . 9.6 t -99.27 150.26 22.28 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.74 0.305 . . . . 0.0 110.71 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.4 mt -61.48 -39.82 92.31 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.734 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.7 t -58.62 -32.07 68.67 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.637 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.657 ' OD2' HG22 ' A' ' 55' ' ' THR . 3.1 m-20 -53.94 -35.03 61.28 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 121.13 -0.228 . . . . 0.0 111.476 -179.604 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -103.82 31.75 4.29 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 120.474 0.178 . . . . 0.0 111.401 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 65.18 14.0 9.1 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 47.6 mt -90.01 68.32 0.59 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.139 0 CA-C-O 120.743 0.306 . . . . 0.0 110.809 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -98.87 -178.46 3.97 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.187 -179.591 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.4 145.81 3.21 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.801 0.334 . . . . 0.0 111.409 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 65.55 13.88 9.15 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.234 -0.439 . . . . 0.0 112.179 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 39.5 t -76.16 -177.48 4.0 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-O 120.634 0.254 . . . . 0.0 110.71 179.426 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.7 m -100.9 83.65 2.57 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.314 179.417 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.889 ' CD2' HD21 ' A' ' 43' ' ' LEU . 7.8 tt -98.83 111.22 23.67 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.751 0.31 . . . . 0.0 111.365 -179.467 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 17.6 t60 -107.11 125.81 51.55 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.599 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.485 HD13 ' CG2' ' A' ' 5' ' ' VAL . 0.2 OUTLIER -96.53 111.14 23.37 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-O 120.732 0.301 . . . . 0.0 111.084 -179.776 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.1 t -114.1 149.94 16.27 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.015 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.1 pp . . . . . 0 C--O 1.232 0.14 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.962 -179.932 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 . . . . . 0 CA--C 1.527 0.091 0 CA-C-O 120.741 0.305 . . . . 0.0 110.88 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.49 HG21 ' HB3' ' A' ' 15' ' ' LEU . 17.7 tt -138.94 154.14 25.73 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.965 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -118.64 104.37 10.56 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.756 0.312 . . . . 0.0 110.895 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 1.033 HG13 HD23 ' A' ' 67' ' ' LEU . 1.7 t -103.25 163.4 3.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.892 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.8 tppt? -106.62 121.23 43.91 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.758 0.313 . . . . 0.0 110.662 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.404 ' OG1' ' N ' ' A' ' 11' ' ' LYS . 2.7 p -99.82 -176.44 3.26 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.192 -179.595 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.67 -40.11 88.45 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-O 120.696 0.284 . . . . 0.0 111.591 -178.78 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -111.04 43.23 1.48 Allowed 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.204 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 45.0 38.03 5.8 Favored Glycine 0 C--N 1.335 0.511 0 C-N-CA 120.95 -0.643 . . . . 0.0 113.291 179.562 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.404 ' N ' ' OG1' ' A' ' 7' ' ' THR . 7.8 tttt -84.12 144.46 29.01 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.856 0.328 . . . . 0.0 110.791 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.537 ' O ' HG23 ' A' ' 12' ' ' THR . 14.7 t -95.38 110.65 22.65 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.731 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.0 pt -125.09 164.19 24.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.201 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.7 t -100.55 150.64 22.48 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.781 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.49 ' HB3' HG21 ' A' ' 3' ' ' ILE . 0.9 OUTLIER -134.87 100.74 4.68 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.676 0.274 . . . . 0.0 110.963 -179.87 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -96.39 126.46 41.61 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.841 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.1 m -139.26 173.51 11.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.738 0.304 . . . . 0.0 111.272 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.425 ' HB2' ' HD2' ' A' ' 19' ' ' PRO . 0.4 OUTLIER -105.37 158.38 32.34 Favored Pre-proline 0 C--O 1.232 0.162 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.533 179.833 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.566 ' O ' HG21 ' A' ' 55' ' ' THR . 1.5 Cg_endo -44.49 -48.02 10.54 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.825 2.35 . . . . 0.0 112.165 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 87.9 p -90.33 38.89 0.95 Allowed 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 179.641 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.579 ' OD2' HD23 ' A' ' 56' ' ' LEU . 17.9 p-10 -75.04 116.72 16.09 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.658 0.266 . . . . 0.0 110.912 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.13 169.02 14.3 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.794 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.414 ' O ' HG22 ' A' ' 26' ' ' VAL . 43.7 mm -67.4 -42.04 86.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.862 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -64.56 -40.14 95.02 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.005 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -62.74 -44.77 95.33 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.653 0.263 . . . . 0.0 110.788 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.414 HG22 ' O ' ' A' ' 23' ' ' ILE . 27.7 m -70.26 -18.65 21.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.5 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.6 tptm -55.62 -35.51 65.95 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.504 0.192 . . . . 0.0 111.116 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.67 -38.89 75.9 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.6 0.238 . . . . 0.0 111.05 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.1 mttm -63.95 -36.53 84.26 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.918 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 35.5 mm -64.93 -44.48 96.14 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.078 0 CA-C-O 120.752 0.31 . . . . 0.0 110.61 179.698 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -57.88 -28.24 64.0 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.864 179.567 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -51.78 -27.76 13.28 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 7.2 mmtt -74.82 -40.93 60.79 Favored 'General case' 0 C--O 1.23 0.079 0 CA-C-O 120.693 0.282 . . . . 0.0 110.596 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -175.47 -40.89 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.557 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.525 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . 108.87 64.79 0.56 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.544 -0.836 . . . . 0.0 111.632 -179.511 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.596 HG23 ' O ' ' A' ' 36' ' ' ILE . 12.0 tt -78.22 107.54 5.83 Favored Pre-proline 0 N--CA 1.465 0.295 0 N-CA-C 111.741 0.274 . . . . 0.0 111.741 -179.085 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.525 ' HD3' ' O ' ' A' ' 35' ' ' GLY . 27.9 Cg_exo -62.49 -43.83 20.58 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.751 2.301 . . . . 0.0 113.578 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.505 ' HD2' ' N ' ' A' ' 37' ' ' PRO . 44.9 Cg_exo -38.03 117.62 0.26 Allowed 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 123.023 2.482 . . . . 0.0 113.685 -179.201 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -69.84 2.32 3.52 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 179.522 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -89.84 3.45 52.9 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 118.134 0.425 . . . . 0.0 111.803 -179.555 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 27.2 tp60 -82.88 97.53 8.71 Favored 'General case' 0 C--O 1.232 0.14 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.208 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.473 ' O ' HD23 ' A' ' 69' ' ' LEU . 3.0 mtp180 -137.5 -176.31 4.36 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.151 -179.215 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.673 HD23 ' CD2' ' A' ' 50' ' ' LEU . 4.1 mm? -97.4 134.57 40.49 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.623 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 32.1 mt -100.98 83.54 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.406 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -150.94 115.61 5.19 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.018 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.85 35.97 19.17 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.32 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 46.87 36.84 8.86 Favored Glycine 0 C--N 1.336 0.577 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.876 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -110.16 107.61 17.48 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.774 0.287 . . . . 0.0 111.038 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.05 130.68 35.47 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.53 179.618 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.673 ' CD2' HD23 ' A' ' 43' ' ' LEU . 1.3 pp -79.32 62.86 3.79 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.579 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -89.47 -66.32 0.93 Allowed 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.74 0.305 . . . . 0.0 110.414 179.406 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.456 ' O ' ' N ' ' A' ' 54' ' ' ARG . 19.0 t0 -48.56 125.44 9.86 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.01 179.112 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -65.2 60.7 0.09 OUTLIER Glycine 0 CA--C 1.522 0.52 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.565 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.456 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.3 OUTLIER -107.15 -172.9 2.17 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.94 0.37 . . . . 0.0 110.797 -179.904 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.566 HG21 ' O ' ' A' ' 19' ' ' PRO . 22.4 m -98.39 144.92 27.25 Favored 'General case' 0 N--CA 1.457 -0.11 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.622 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.642 HD12 ' N ' ' A' ' 57' ' ' SER . 3.8 pp -51.78 -40.67 60.76 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.203 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.642 ' N ' HD12 ' A' ' 56' ' ' LEU . 10.5 t -55.19 -52.09 64.45 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.395 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -64.66 -16.0 62.15 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 112.265 0.469 . . . . 0.0 112.265 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -97.8 38.12 1.33 Allowed 'General case' 0 CA--C 1.533 0.311 0 O-C-N 122.174 -0.329 . . . . 0.0 111.885 -179.527 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 66.74 -40.29 0.37 Allowed 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 179.41 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.514 HD12 ' HB2' ' A' ' 56' ' ' LEU . 1.1 pt -78.64 108.22 11.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.872 0.367 . . . . 0.0 111.328 -179.504 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.24 -174.8 2.69 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.951 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.2 150.68 2.34 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.791 0.329 . . . . 0.0 111.373 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 65.11 19.29 11.76 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.852 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.2 m -75.83 177.69 6.75 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.59 0.233 . . . . 0.0 110.872 179.669 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.99 114.85 26.5 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.3 179.376 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 1.033 HD23 HG13 ' A' ' 5' ' ' VAL . 4.8 mp -98.98 89.85 4.42 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.673 0.273 . . . . 0.0 111.48 -179.22 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -100.17 95.31 6.73 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.2 179.233 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.473 HD23 ' O ' ' A' ' 42' ' ' ARG . 0.8 OUTLIER -93.86 177.11 6.1 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.244 -179.426 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.42 HG22 ' N ' ' A' ' 71' ' ' LEU . 12.0 p -103.62 156.62 5.37 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.766 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.42 ' N ' HG22 ' A' ' 70' ' ' VAL . 2.7 mt . . . . . 0 N--CA 1.462 0.136 0 CA-C-O 120.711 0.291 . . . . 0.0 110.939 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.412 ' CB ' ' HG2' ' A' ' 63' ' ' LYS . 3.8 mm-40 . . . . . 0 CA--C 1.533 0.31 0 N-CA-C 112.484 0.549 . . . . 0.0 112.484 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.741 HG22 ' O ' ' A' ' 15' ' ' LEU . 18.6 tt -138.46 147.95 25.01 Favored 'Isoleucine or valine' 0 C--O 1.231 0.1 0 C-N-CA 120.619 -0.432 . . . . 0.0 111.441 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -120.61 94.64 4.43 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.95 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.504 HG11 HD13 ' A' ' 15' ' ' LEU . 13.7 p -103.02 154.77 5.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.854 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 6.4 mmpt? -106.58 145.36 31.99 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.819 0.342 . . . . 0.0 111.022 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.6 p -99.53 -173.37 2.45 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.161 -179.649 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.425 HD13 ' HG2' ' A' ' 38' ' ' PRO . 1.1 pt? -66.9 -33.43 75.57 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-O 120.688 0.28 . . . . 0.0 110.682 -179.665 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.3 m -107.3 42.22 1.35 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.713 179.606 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 47.98 32.18 8.76 Favored Glycine 0 CA--C 1.521 0.467 0 C-N-CA 121.1 -0.571 . . . . 0.0 113.403 179.537 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -84.55 152.95 23.56 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 117.096 0.448 . . . . 0.0 110.788 179.646 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.4 ' O ' HG23 ' A' ' 12' ' ' THR . 12.2 t -103.14 122.53 44.9 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.716 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.404 ' CG1' ' CG1' ' A' ' 5' ' ' VAL . 38.6 pt -123.07 166.07 18.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 120.829 0.347 . . . . 0.0 111.367 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.5 p -105.96 127.09 52.92 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.647 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.741 ' O ' HG22 ' A' ' 3' ' ' ILE . 0.3 OUTLIER -127.75 139.35 52.73 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-O 120.775 0.321 . . . . 0.0 111.22 -179.97 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -101.19 165.42 11.3 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.638 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.7 t -140.04 125.91 21.49 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-O 120.687 0.279 . . . . 0.0 111.284 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.449 ' HB2' ' HD2' ' A' ' 19' ' ' PRO . 1.7 pt-20 -107.08 158.19 33.55 Favored Pre-proline 0 C--N 1.333 -0.115 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.453 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.449 ' HD2' ' HB2' ' A' ' 18' ' ' GLU . 4.7 Cg_endo -47.1 -56.29 3.17 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.555 2.17 . . . . 0.0 112.124 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 41.6 p -90.45 41.73 1.07 Allowed 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.419 ' HB2' ' O ' ' A' ' 18' ' ' GLU . 8.3 t70 -72.78 111.35 7.84 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.638 0.256 . . . . 0.0 110.989 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.8 m -85.09 149.28 25.66 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.723 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.459 ' O ' HG12 ' A' ' 26' ' ' VAL . 28.7 mt -68.02 -36.82 76.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.285 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -73.92 -40.83 62.85 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 120.564 0.221 . . . . 0.0 110.984 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -67.26 -40.41 86.2 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.682 -0.235 . . . . 0.0 111.126 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.459 HG12 ' O ' ' A' ' 23' ' ' ILE . 12.1 p -63.83 -33.81 64.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-N 116.703 -0.226 . . . . 0.0 111.367 -179.79 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.799 ' HE3' HD13 ' A' ' 50' ' ' LEU . 0.4 OUTLIER -55.81 -45.37 78.29 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.724 0.297 . . . . 0.0 110.814 179.961 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.04 -30.26 69.45 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.367 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.5 ttmp? -63.69 -41.27 98.16 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 120.594 0.235 . . . . 0.0 110.899 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.508 HD12 ' HA ' ' A' ' 27' ' ' LYS . 4.1 mt -64.96 -47.55 87.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-O 120.679 0.276 . . . . 0.0 110.712 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.3 -45.73 83.19 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.594 179.693 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -61.11 -23.97 65.9 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.556 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -74.63 -64.56 1.01 Allowed 'General case' 0 CA--C 1.528 0.103 0 CA-C-O 120.575 0.226 . . . . 0.0 111.285 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -103.27 -41.44 6.04 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 111.5 0.185 . . . . 0.0 111.5 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.48 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . 96.95 56.64 1.13 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.515 -0.85 . . . . 0.0 111.822 -179.475 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.609 HG23 ' O ' ' A' ' 36' ' ' ILE . 10.1 tt -78.44 108.92 8.82 Favored Pre-proline 0 CA--C 1.531 0.225 0 CA-C-O 120.622 0.249 . . . . 0.0 111.452 -179.474 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.48 ' HD3' ' O ' ' A' ' 35' ' ' GLY . 36.7 Cg_exo -60.8 -46.74 15.35 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.549 2.166 . . . . 0.0 113.036 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.457 ' HD2' ' N ' ' A' ' 37' ' ' PRO . 69.9 Cg_exo -40.72 104.88 0.05 OUTLIER 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.82 2.347 . . . . 0.0 113.287 -179.606 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.0 p-10 -69.12 -10.98 60.31 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.901 179.469 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -90.79 22.31 3.64 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -179.622 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.851 ' OE1' HD21 ' A' ' 69' ' ' LEU . 0.6 OUTLIER -84.16 102.8 12.85 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 110.329 -0.249 . . . . 0.0 110.329 179.436 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.534 ' O ' HD13 ' A' ' 69' ' ' LEU . 0.9 OUTLIER -143.98 179.16 7.36 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-O 120.778 0.323 . . . . 0.0 111.41 -179.569 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.712 ' HB2' HD22 ' A' ' 67' ' ' LEU . 0.5 OUTLIER -108.16 141.64 39.58 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.871 179.828 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.604 ' O ' HG23 ' A' ' 44' ' ' ILE . 17.2 tt -111.05 75.39 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-O 120.766 0.317 . . . . 0.0 110.946 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -150.87 121.97 7.72 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.271 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 56.27 34.91 24.89 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.619 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 46.43 44.55 16.04 Favored Glycine 0 C--N 1.335 0.477 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.895 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.423 ' HE2' ' CD1' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -99.99 109.63 21.96 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.713 0.292 . . . . 0.0 110.904 -179.995 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -89.19 151.88 21.92 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.983 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.799 HD13 ' HE3' ' A' ' 27' ' ' LYS . 5.4 mt -79.24 -8.81 59.32 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.761 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -78.67 -41.47 31.18 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 122.334 -0.229 . . . . 0.0 111.108 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -47.8 114.83 0.98 Allowed 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 116.658 -0.246 . . . . 0.0 110.373 179.665 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -69.85 46.2 0.57 Allowed Glycine 0 CA--C 1.521 0.461 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.892 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.455 ' C ' HD12 ' A' ' 23' ' ' ILE . 5.0 mmp_? -107.3 177.23 4.91 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 117.128 0.464 . . . . 0.0 110.668 179.798 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 5.7 t -99.17 142.88 30.08 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.601 0.238 . . . . 0.0 110.436 179.7 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.65 ' HB3' HG23 ' A' ' 61' ' ' ILE . 84.0 mt -51.86 -43.11 63.1 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.715 0.293 . . . . 0.0 111.349 -179.522 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.8 t -54.55 -27.93 42.09 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -179.529 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -53.76 -40.91 66.61 Favored 'General case' 0 N--CA 1.465 0.318 0 O-C-N 122.259 -0.275 . . . . 0.0 111.548 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.423 ' CD1' ' HE2' ' A' ' 48' ' ' LYS . 33.8 m-85 -101.94 19.26 18.71 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 111.914 0.338 . . . . 0.0 111.914 -179.813 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 64.62 14.64 9.16 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.868 HD11 ' HG ' ' A' ' 67' ' ' LEU . 1.1 tp -90.0 62.16 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-O 120.841 0.353 . . . . 0.0 110.873 179.507 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 10.8 pm0 -95.26 -172.78 2.75 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.44 -179.307 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.412 ' HG2' ' CB ' ' A' ' 2' ' ' GLN . 0.1 OUTLIER -39.84 155.74 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.985 -179.444 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 65.3 16.01 10.31 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.806 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 17.7 p -76.32 145.94 39.21 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-O 120.561 0.219 . . . . 0.0 111.031 179.711 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 11.7 p -97.68 76.96 2.52 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 179.244 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.868 ' HG ' HD11 ' A' ' 61' ' ' ILE . 14.1 mt -99.94 131.77 45.7 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.832 0.348 . . . . 0.0 111.68 -179.176 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -107.2 139.84 41.0 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.25 179.214 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.851 HD21 ' OE1' ' A' ' 41' ' ' GLN . 0.1 OUTLIER -93.87 116.77 29.25 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.678 0.275 . . . . 0.0 110.858 -179.858 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.8 p -114.36 148.26 17.28 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.383 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.331 -0.222 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.563 179.555 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 64.5 mm-40 . . . . . 0 CA--C 1.528 0.12 0 N-CA-C 111.489 0.181 . . . . 0.0 111.489 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.822 HD12 HG23 ' A' ' 5' ' ' VAL . 1.1 pp -138.93 164.77 25.09 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 C-N-CA 120.711 -0.396 . . . . 0.0 111.672 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -129.07 111.93 13.48 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.873 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.822 HG23 HD12 ' A' ' 3' ' ' ILE . 39.0 t -111.4 155.11 12.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.893 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.712 ' O ' HD22 ' A' ' 69' ' ' LEU . 0.6 OUTLIER -106.56 165.5 11.24 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.673 0.273 . . . . 0.0 110.718 -179.89 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 66.7 p -109.82 -142.82 0.38 Allowed 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.647 -179.744 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.406 ' HG ' ' N ' ' A' ' 9' ' ' THR . 1.7 pt? -65.25 -38.57 90.75 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 118.615 0.643 . . . . 0.0 111.482 -179.316 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.406 ' N ' ' HG ' ' A' ' 8' ' ' LEU . 3.9 m -107.98 -60.55 1.7 Allowed 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.607 0.242 . . . . 0.0 110.894 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 165.56 53.32 0.02 OUTLIER Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.417 -0.897 . . . . 0.0 112.949 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.9 tttt -84.27 160.2 20.79 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.822 0.311 . . . . 0.0 110.675 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 26.8 p -94.91 104.68 16.57 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.876 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.641 HD11 ' HB ' ' A' ' 5' ' ' VAL . 25.3 pt -114.96 153.6 16.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-O 120.754 0.312 . . . . 0.0 111.172 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.1 p -106.07 149.89 26.29 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.935 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.751 ' HB2' HD11 ' A' ' 3' ' ' ILE . 0.3 OUTLIER -127.97 89.03 2.86 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-O 120.669 0.271 . . . . 0.0 111.264 179.954 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.13 94.91 6.22 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.766 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.492 HG11 HG12 ' A' ' 26' ' ' VAL . 29.8 m -129.94 174.12 13.13 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 CA-C-O 120.71 0.291 . . . . 0.0 111.288 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.06 160.06 27.53 Favored Pre-proline 0 C--O 1.231 0.13 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.107 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -55.44 -29.19 67.52 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.648 2.232 . . . . 0.0 112.839 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 42.0 t -78.78 -15.08 58.86 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 111.67 0.248 . . . . 0.0 111.67 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.441 ' OD2' HG12 ' A' ' 26' ' ' VAL . 1.5 t0 -64.94 122.0 15.96 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-O 120.674 0.273 . . . . 0.0 110.808 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.86 HG22 ' O ' ' A' ' 54' ' ' ARG . 0.3 OUTLIER -85.09 178.71 7.45 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.823 179.951 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.8 HG21 ' HB2' ' A' ' 50' ' ' LEU . 16.3 mt -68.17 -39.23 80.91 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.084 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -66.61 -41.25 88.7 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.658 -0.247 . . . . 0.0 111.069 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -62.96 -45.8 90.72 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.649 0.261 . . . . 0.0 111.004 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.494 HG22 ' O ' ' A' ' 23' ' ' ILE . 31.8 m -63.98 -29.7 48.01 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.524 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.498 ' HE2' HD11 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -55.62 -43.99 76.65 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.658 0.266 . . . . 0.0 110.807 -179.875 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.87 -33.07 74.02 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.046 179.597 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -63.9 -28.39 69.81 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.038 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.589 HD11 HD11 ' A' ' 15' ' ' LEU . 40.8 mm -75.25 -46.04 39.7 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.201 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.301 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -65.35 -40.52 93.71 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.91 178.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.27 -24.69 66.57 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.288 179.494 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.8 mmtm -74.78 -55.47 5.8 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.525 0.202 . . . . 0.0 111.295 -179.552 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -115.47 -49.77 2.74 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.618 0.247 . . . . 0.0 111.19 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 113.69 64.02 0.43 Allowed Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.679 -0.772 . . . . 0.0 111.851 -179.455 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.498 HD11 ' HE2' ' A' ' 27' ' ' LYS . 1.3 pp -77.89 111.59 19.07 Favored Pre-proline 0 CA--C 1.531 0.223 0 CA-C-O 120.634 0.254 . . . . 0.0 111.347 -179.296 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.562 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 31.5 Cg_exo -59.34 -43.61 39.47 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.683 2.255 . . . . 0.0 113.444 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.562 ' HD2' ' N ' ' A' ' 37' ' ' PRO . 54.9 Cg_endo -71.86 111.25 3.11 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.06 1.84 . . . . 0.0 112.755 -179.23 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -68.69 -13.61 62.48 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.055 -0.52 . . . . 0.0 112.098 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -91.08 21.9 4.02 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.454 0.538 . . . . 0.0 112.454 -179.414 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -93.11 97.77 10.89 Favored 'General case' 0 C--O 1.23 0.067 0 O-C-N 122.249 -0.282 . . . . 0.0 110.289 179.34 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.522 ' CG ' HD11 ' A' ' 50' ' ' LEU . 22.0 mtm180 -137.68 -175.82 4.21 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-O 120.715 0.293 . . . . 0.0 111.043 -179.451 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.633 HD22 HD22 ' A' ' 67' ' ' LEU . 1.1 pp -101.59 141.52 34.33 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.944 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.565 ' O ' HG23 ' A' ' 44' ' ' ILE . 20.3 tt -111.17 113.91 45.61 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.239 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -152.52 130.96 12.14 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.797 0.332 . . . . 0.0 111.306 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.82 28.87 13.04 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.776 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 45.07 48.15 9.86 Favored Glycine 0 C--N 1.336 0.543 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.903 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.444 ' HG2' ' CD1' ' A' ' 59' ' ' TYR . 12.4 mptt -99.88 140.75 33.64 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.764 0.282 . . . . 0.0 110.942 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.15 99.62 12.57 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.885 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.8 ' HB2' HG21 ' A' ' 23' ' ' ILE . 0.5 OUTLIER -79.27 -8.05 58.75 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.838 179.861 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -78.57 -30.45 46.77 Favored 'General case' 0 CA--C 1.53 0.21 0 O-C-N 122.346 -0.221 . . . . 0.0 111.29 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -45.43 -39.23 6.85 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.567 0.222 . . . . 0.0 111.3 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 105.16 49.32 1.0 Allowed Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.745 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.86 ' O ' HG22 ' A' ' 22' ' ' THR . 0.0 OUTLIER -107.3 -179.11 3.83 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.724 0.262 . . . . 0.0 110.698 179.801 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 10.6 m -99.08 140.72 32.81 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.643 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.617 ' O ' HG22 ' A' ' 61' ' ' ILE . 3.0 mp -51.77 -48.23 63.82 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.824 0.345 . . . . 0.0 110.833 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.5 t -55.31 -36.99 66.81 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.24 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -54.27 -35.69 62.81 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 111.505 0.187 . . . . 0.0 111.505 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.444 ' CD1' ' HG2' ' A' ' 48' ' ' LYS . 68.7 m-85 -100.09 21.26 13.09 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.3 m120 65.59 8.67 5.29 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 112.791 0.664 . . . . 0.0 112.791 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.706 HD11 ' CD2' ' A' ' 67' ' ' LEU . 1.2 tt -90.14 63.13 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-O 120.883 0.373 . . . . 0.0 110.666 179.321 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -94.57 -173.52 3.05 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.245 -179.423 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.416 ' O ' ' HG2' ' A' ' 64' ' ' GLU . 0.1 OUTLIER -39.96 147.68 0.09 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.727 -179.593 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.416 ' HG2' ' O ' ' A' ' 63' ' ' LYS . 0.7 OUTLIER 65.53 15.02 9.83 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.992 -179.747 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.5 m -76.23 174.2 10.43 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.754 0.312 . . . . 0.0 110.839 179.539 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.524 ' O ' HG23 ' A' ' 66' ' ' THR . 5.9 t -107.24 90.65 3.37 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.248 179.437 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.753 HD13 HD13 ' A' ' 3' ' ' ILE . 1.2 mt -98.9 113.86 26.19 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.747 0.308 . . . . 0.0 111.39 -179.376 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -107.22 120.93 43.47 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.385 179.361 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.712 HD22 ' O ' ' A' ' 6' ' ' LYS . 0.9 OUTLIER -93.76 156.45 16.67 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.713 0.292 . . . . 0.0 111.155 -179.648 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -104.07 166.22 3.08 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.747 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.3 mp . . . . . 0 C--N 1.332 -0.161 0 CA-C-O 120.677 0.275 . . . . 0.0 110.751 -179.975 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.319 0 CA-C-O 120.601 0.238 . . . . 0.0 111.194 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.1 mp0 -95.05 106.67 18.69 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.05 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.411 HG21 ' HB3' ' A' ' 15' ' ' LEU . 17.4 tt -139.01 153.17 24.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.985 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -118.79 97.06 5.53 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.968 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.516 HG13 HD13 ' A' ' 69' ' ' LEU . 21.5 t -98.97 152.72 4.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.981 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.28 130.92 56.11 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.698 0.285 . . . . 0.0 111.014 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.6 p -100.03 175.53 5.73 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.45 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.941 HD23 HG23 ' A' ' 9' ' ' THR . 0.0 OUTLIER -66.86 -21.91 66.0 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 179.417 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.941 HG23 HD23 ' A' ' 8' ' ' LEU . 67.8 p -105.54 28.87 7.01 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.19 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 47.59 32.85 8.21 Favored Glycine 0 C--N 1.336 0.541 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.991 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.49 146.37 27.63 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.969 0.385 . . . . 0.0 111.023 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.0 t -103.22 110.32 22.25 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.804 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.717 HG21 ' HE3' ' A' ' 33' ' ' LYS . 3.0 pt -125.08 166.67 20.36 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.297 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.1 p -104.49 152.52 22.27 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.711 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.411 ' HB3' HG21 ' A' ' 3' ' ' ILE . 1.2 tp -137.99 140.29 40.11 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.668 0.271 . . . . 0.0 111.044 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -101.0 139.05 37.24 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.701 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.6 t -138.53 138.3 42.71 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 CA-C-O 120.78 0.324 . . . . 0.0 111.354 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.447 ' HB2' ' HD2' ' A' ' 19' ' ' PRO . 11.6 pt-20 -100.08 167.87 10.33 Favored Pre-proline 0 C--N 1.332 -0.156 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.55 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.447 ' HD2' ' HB2' ' A' ' 18' ' ' GLU . 52.7 Cg_exo -54.86 -58.88 0.99 Allowed 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.39 2.06 . . . . 0.0 112.164 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.5 t -90.58 38.51 0.95 Allowed 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -75.42 114.13 13.61 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-O 120.576 0.227 . . . . 0.0 111.067 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 31.1 p -85.18 158.43 20.37 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.639 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.597 ' O ' HG12 ' A' ' 26' ' ' VAL . 9.5 tp -57.97 -32.83 44.56 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-N 116.718 -0.219 . . . . 0.0 111.277 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -77.89 -40.76 38.86 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.642 0.258 . . . . 0.0 110.858 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -62.94 -34.77 78.18 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.15 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.597 HG12 ' O ' ' A' ' 23' ' ' ILE . 12.1 p -69.32 -15.68 19.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.623 ' O ' HG22 ' A' ' 30' ' ' ILE . 0.1 OUTLIER -55.47 -33.0 63.26 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.582 0.229 . . . . 0.0 111.104 -179.992 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.19 -36.39 79.51 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.57 0.224 . . . . 0.0 111.045 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.3 mttp -64.04 -43.49 95.39 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.706 -0.225 . . . . 0.0 111.114 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.823 HG12 HD13 ' A' ' 36' ' ' ILE . 1.2 tt -64.82 -30.36 50.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 116.727 -0.215 . . . . 0.0 111.252 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -65.22 -20.81 66.61 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 120.44 0.162 . . . . 0.0 111.238 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -51.99 -24.76 7.05 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 112.181 0.438 . . . . 0.0 112.181 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.717 ' HE3' HG21 ' A' ' 13' ' ' ILE . 0.3 OUTLIER -73.88 -73.49 0.22 Allowed 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.967 -179.585 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -167.1 41.36 0.05 OUTLIER 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.408 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . 53.02 87.81 0.01 OUTLIER Glycine 0 C--N 1.335 0.504 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.443 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.823 HD13 HG12 ' A' ' 30' ' ' ILE . 4.2 mp -78.55 110.76 15.09 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-O 120.571 0.225 . . . . 0.0 111.02 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.456 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 36.3 Cg_exo -59.86 -47.05 16.86 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.614 2.21 . . . . 0.0 113.085 -179.553 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.466 ' HD2' HG22 ' A' ' 36' ' ' ILE . 77.3 Cg_exo -41.12 96.24 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.669 2.246 . . . . 0.0 112.924 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -68.22 -20.29 64.82 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.449 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -99.98 34.39 2.32 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 111.552 0.205 . . . . 0.0 111.552 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.844 ' O ' HD22 ' A' ' 50' ' ' LEU . 3.7 tp60 -93.2 115.32 27.94 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-O 120.526 0.203 . . . . 0.0 110.485 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 11.1 ptt-85 -143.98 178.92 7.52 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.653 0.263 . . . . 0.0 111.199 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.889 HD22 HD21 ' A' ' 67' ' ' LEU . 0.8 OUTLIER -97.85 152.67 18.95 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.918 179.969 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.629 ' O ' HG23 ' A' ' 44' ' ' ILE . 2.2 tt -104.59 77.06 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 CA-C-O 120.848 0.356 . . . . 0.0 111.038 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -150.81 116.96 5.61 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.119 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.6 32.15 21.84 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.538 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 46.5 68.16 1.18 Allowed Glycine 0 C--N 1.337 0.595 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.993 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.416 ' HG3' ' CD2' ' A' ' 59' ' ' TYR . 0.3 OUTLIER -110.0 127.53 54.86 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 116.761 0.281 . . . . 0.0 111.039 179.953 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -89.19 126.51 35.51 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.854 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.844 HD22 ' O ' ' A' ' 41' ' ' GLN . 0.8 OUTLIER -79.14 -24.51 43.28 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.454 179.936 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.452 ' O ' ' O ' ' A' ' 52' ' ' ASP . 4.1 tt0 -78.89 -36.15 42.5 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 121.279 -0.168 . . . . 0.0 111.395 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.452 ' O ' ' O ' ' A' ' 51' ' ' GLU . 0.2 OUTLIER -49.11 -171.62 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 121.57 0.7 . . . . 0.0 111.517 179.952 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -118.9 40.63 2.21 Favored Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 115.329 -0.851 . . . . 0.0 112.18 179.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -97.7 155.23 17.1 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-O 120.66 0.266 . . . . 0.0 111.003 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.561 HG23 ' H ' ' A' ' 58' ' ' ASP . 8.8 t -99.14 156.59 16.87 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.939 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.787 ' O ' HG22 ' A' ' 61' ' ' ILE . 1.7 mp -62.37 -36.52 82.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.281 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.5 t -58.75 -42.13 88.13 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -179.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.561 ' H ' HG23 ' A' ' 55' ' ' THR . 4.5 p30 -57.28 -25.25 58.92 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -179.258 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.416 ' CD2' ' HG3' ' A' ' 48' ' ' LYS . 0.5 OUTLIER -97.65 12.8 32.39 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 111.736 0.273 . . . . 0.0 111.736 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.5 m120 54.81 28.68 10.66 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.787 HG22 ' O ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -89.5 96.32 6.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.173 0 CA-C-O 120.877 0.37 . . . . 0.0 110.746 179.668 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.05 172.72 7.96 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.762 0.315 . . . . 0.0 111.024 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.14 155.14 1.01 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.218 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 63.78 22.01 12.9 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.459 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -75.74 177.48 6.84 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-O 120.752 0.31 . . . . 0.0 110.8 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.5 m -107.06 80.98 1.48 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.561 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.889 HD21 HD22 ' A' ' 43' ' ' LEU . 0.7 OUTLIER -98.85 110.47 23.07 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.109 -179.769 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -107.08 125.13 50.64 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.66 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.516 HD13 HG13 ' A' ' 5' ' ' VAL . 9.5 mp -93.98 174.65 7.05 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.658 0.266 . . . . 0.0 110.917 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 30.2 t -103.83 141.29 19.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.036 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.1 mt -77.25 130.94 37.89 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.816 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.3 55.68 2.33 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.127 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.1 tp -80.22 -45.22 18.39 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.708 0.29 . . . . 0.0 110.797 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.02 119.7 30.59 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.89 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -77.62 -42.54 17.29 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.542 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.381 -1.233 . . . . 0.0 112.491 179.978 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.4 ptt? . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 120.667 0.27 . . . . 0.0 111.22 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.0 mt-30 -95.03 127.6 41.21 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.691 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.831 HD11 ' HB3' ' A' ' 15' ' ' LEU . 27.3 pt -138.93 173.44 11.85 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.144 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -118.91 100.31 7.29 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.677 0.275 . . . . 0.0 110.896 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.6 t -105.07 149.74 8.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.109 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.96 125.82 51.5 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.86 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.3 p -99.21 -166.33 1.34 Allowed 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.45 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.402 ' HG ' ' N ' ' A' ' 9' ' ' THR . 0.5 OUTLIER -66.72 -44.06 82.62 Favored 'General case' 0 C--O 1.231 0.115 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -178.459 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.405 ' O ' HG22 ' A' ' 9' ' ' THR . 23.1 m -111.06 51.62 0.77 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.81 0.338 . . . . 0.0 111.319 -179.295 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 44.18 40.8 6.03 Favored Glycine 0 C--N 1.335 0.487 0 C-N-CA 121.183 -0.532 . . . . 0.0 113.344 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.6 tttt -84.22 134.9 34.53 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.827 0.314 . . . . 0.0 110.834 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.537 ' O ' HG23 ' A' ' 12' ' ' THR . 12.3 t -99.34 110.1 22.65 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.728 0.299 . . . . 0.0 110.907 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.1 pt -125.09 166.79 20.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.214 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.4 t -101.33 148.78 24.73 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.654 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.831 ' HB3' HD11 ' A' ' 3' ' ' ILE . 0.1 OUTLIER -137.94 108.9 6.72 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.708 0.289 . . . . 0.0 111.055 -179.876 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -101.01 138.12 38.48 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.707 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.6 t -140.06 149.0 22.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.745 0.307 . . . . 0.0 111.386 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.418 ' HB2' ' HD2' ' A' ' 19' ' ' PRO . 6.7 pt-20 -96.96 157.46 35.01 Favored Pre-proline 0 C--N 1.332 -0.164 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.7 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.418 ' HD2' ' HB2' ' A' ' 18' ' ' GLU . 10.7 Cg_endo -54.07 -36.03 83.51 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.852 2.368 . . . . 0.0 113.135 -179.519 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.9 0.47 56.57 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.46 128.09 34.55 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.648 0.261 . . . . 0.0 111.032 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.8 p -85.16 159.96 20.02 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.529 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.65 ' O ' HG12 ' A' ' 26' ' ' VAL . 1.4 tt -57.98 -36.38 56.03 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.469 -179.656 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -71.37 -32.3 68.33 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.751 -0.204 . . . . 0.0 111.288 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -62.88 -43.6 98.35 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.547 0.213 . . . . 0.0 111.164 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.65 HG12 ' O ' ' A' ' 23' ' ' ILE . 9.9 p -63.82 -28.6 45.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-N 116.738 -0.21 . . . . 0.0 111.32 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.661 ' NZ ' HD22 ' A' ' 50' ' ' LEU . 3.9 mmpt? -59.61 -30.4 68.66 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-O 120.527 0.204 . . . . 0.0 111.235 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.83 -52.93 63.46 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.546 0.212 . . . . 0.0 111.193 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 18.8 ptmt -63.91 -34.61 78.36 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.692 -0.231 . . . . 0.0 111.014 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.401 HD12 ' HE2' ' A' ' 27' ' ' LYS . 57.8 mt -75.22 -14.51 15.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 116.816 -0.175 . . . . 0.0 111.403 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -65.48 -13.24 58.38 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -50.36 -29.91 11.05 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.3 ptpp? -79.72 -21.91 43.97 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 121.036 -0.265 . . . . 0.0 111.432 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 74.47 40.77 0.39 Allowed 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.657 0.265 . . . . 0.0 110.794 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -142.78 30.78 2.04 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.426 -0.892 . . . . 0.0 113.053 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.544 ' HB ' ' CD ' ' A' ' 37' ' ' PRO . 29.3 mm -78.68 -61.3 0.54 Allowed Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 117.107 0.453 . . . . 0.0 111.681 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.544 ' CD ' ' HB ' ' A' ' 36' ' ' ILE . 5.1 Cg_exo -42.13 -51.19 4.9 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.73 2.287 . . . . 0.0 112.887 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' A' ' 37' ' ' PRO . 57.9 Cg_exo -37.39 140.7 0.22 Allowed 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.985 2.456 . . . . 0.0 113.379 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -69.02 -6.3 27.13 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.6 mm-40 -89.89 -28.48 19.19 Favored 'General case' 0 CA--C 1.53 0.211 0 O-C-N 122.115 -0.365 . . . . 0.0 111.567 -179.358 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 5.2 tp60 -82.87 71.56 9.97 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-O 120.788 0.327 . . . . 0.0 110.787 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.406 ' HA ' HD12 ' A' ' 50' ' ' LEU . 1.8 mtt180 -133.94 -179.08 5.32 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.814 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.594 HD11 HD23 ' A' ' 67' ' ' LEU . 1.0 OUTLIER -103.78 133.88 48.02 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.942 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.558 ' O ' HG23 ' A' ' 44' ' ' ILE . 12.7 tt -101.09 61.86 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.025 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -150.87 120.03 6.76 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.077 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 59.61 27.03 16.15 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.616 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 45.28 40.5 7.83 Favored Glycine 0 C--N 1.336 0.576 0 C-N-CA 120.78 -0.724 . . . . 0.0 113.07 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.442 ' HD3' ' CE1' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -103.85 125.94 50.63 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.86 0.33 . . . . 0.0 111.022 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -89.13 144.21 26.29 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.866 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.661 HD22 ' NZ ' ' A' ' 27' ' ' LYS . 1.1 mp -79.53 -5.56 55.14 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.37 -0.377 . . . . 0.0 112.006 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.445 ' O ' ' O ' ' A' ' 52' ' ' ASP . 5.1 mm-40 -78.69 -34.2 46.3 Favored 'General case' 0 CA--C 1.53 0.205 0 O-C-N 122.37 -0.206 . . . . 0.0 111.431 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.445 ' O ' ' O ' ' A' ' 51' ' ' GLU . 0.9 OUTLIER -48.94 -172.54 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 121.485 0.659 . . . . 0.0 111.51 179.872 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -117.0 41.7 2.04 Favored Glycine 0 N--CA 1.451 -0.361 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.257 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -104.44 162.03 13.58 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.664 0.268 . . . . 0.0 111.037 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.4 HG23 ' H ' ' A' ' 58' ' ' ASP . 8.8 t -99.14 148.12 24.4 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.821 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.83 ' O ' HG22 ' A' ' 61' ' ' ILE . 1.4 mp -51.85 -47.95 64.19 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.186 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.5 t -52.87 -29.09 26.19 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.728 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.4 ' H ' HG23 ' A' ' 55' ' ' THR . 35.6 t70 -53.65 -40.3 65.75 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.43 0.157 . . . . 0.0 111.357 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.442 ' CE1' ' HD3' ' A' ' 48' ' ' LYS . 36.9 m-85 -103.29 25.27 9.75 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 111.595 0.221 . . . . 0.0 111.595 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 56.27 24.02 7.76 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.83 HG22 ' O ' ' A' ' 56' ' ' LEU . 0.9 OUTLIER -90.01 62.69 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-O 120.815 0.341 . . . . 0.0 110.777 179.468 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -94.86 -172.16 2.64 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.917 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.454 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 18.4 tttp -40.52 142.35 0.43 Allowed 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.706 0.289 . . . . 0.0 111.55 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.454 ' HG3' ' O ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER 65.07 21.25 12.21 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.642 -179.838 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.4 p -75.59 175.61 8.41 Favored 'General case' 0 CA--C 1.527 0.08 0 CA-C-O 120.63 0.252 . . . . 0.0 110.835 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.0 m -102.59 86.19 2.73 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.682 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.594 HD23 HD11 ' A' ' 43' ' ' LEU . 5.5 mt -99.01 105.48 17.63 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.065 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.42 ' O ' HG22 ' A' ' 44' ' ' ILE . 1.1 t-80 -107.09 121.11 43.85 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.785 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -96.69 169.77 9.65 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.748 0.309 . . . . 0.0 110.931 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.3 t -103.99 153.24 6.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.031 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.5 mp -76.97 112.33 13.48 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.844 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 68.9 ttt-85 -93.14 84.97 4.93 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.894 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.405 HD13 ' HA ' ' A' ' 73' ' ' LEU . 4.0 mm? -79.99 -45.41 18.48 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.825 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 12.2 mmm-85 -90.03 156.17 18.58 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.883 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -94.08 -46.58 3.06 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.49 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.379 -1.234 . . . . 0.0 112.488 -179.972 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.4 ptt? . . . . . 0 N--CA 1.488 1.425 0 N-CA-C 111.629 0.233 . . . . 0.0 111.629 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -93.43 -26.86 17.04 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 111.62 0.23 . . . . 0.0 111.62 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.673 ' CD1' HD21 ' A' ' 67' ' ' LEU . 2.2 pt -138.53 174.58 9.96 Favored 'Isoleucine or valine' 0 C--O 1.231 0.092 0 CA-C-O 120.623 0.249 . . . . 0.0 111.159 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -118.9 106.55 12.6 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.732 0.301 . . . . 0.0 110.891 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.436 ' HB ' HD11 ' A' ' 13' ' ' ILE . 21.4 t -99.17 150.16 5.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.079 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.95 127.46 53.46 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.794 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.1 p -99.21 -168.29 1.6 Allowed 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.356 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.412 ' HG ' ' N ' ' A' ' 9' ' ' THR . 0.6 OUTLIER -66.79 -40.45 88.13 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 120.663 0.268 . . . . 0.0 111.355 -178.719 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.412 ' N ' ' HG ' ' A' ' 8' ' ' LEU . 0.9 OUTLIER -111.17 41.46 1.84 Allowed 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 120.721 0.296 . . . . 0.0 111.086 179.837 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 47.28 42.53 17.93 Favored Glycine 0 C--N 1.335 0.504 0 C-N-CA 120.861 -0.685 . . . . 0.0 113.066 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.9 mtpm? -84.22 163.04 19.95 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.749 0.274 . . . . 0.0 110.926 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.4 m -103.07 118.06 35.95 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.895 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.737 HD13 HD23 ' A' ' 15' ' ' LEU . 2.4 pp -125.17 158.16 33.41 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-O 120.697 0.284 . . . . 0.0 111.182 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.8 p -101.19 128.49 47.27 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.86 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.737 HD23 HD13 ' A' ' 13' ' ' ILE . 0.2 OUTLIER -132.3 144.61 50.71 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.922 -179.991 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -100.44 162.39 12.97 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.841 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.9 t -129.99 103.88 9.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.106 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.417 ' HB2' ' HD2' ' A' ' 19' ' ' PRO . 10.4 pt-20 -103.72 157.3 34.19 Favored Pre-proline 0 C--N 1.332 -0.172 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.66 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.417 ' HD2' ' HB2' ' A' ' 18' ' ' GLU . 8.0 Cg_endo -50.13 -57.15 2.48 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.621 2.214 . . . . 0.0 112.187 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 44.9 t -90.3 36.41 0.88 Allowed 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.627 ' HB3' HD21 ' A' ' 56' ' ' LEU . 12.7 t0 -75.26 107.37 7.32 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-O 120.695 0.284 . . . . 0.0 110.93 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.4 m -85.23 157.99 20.46 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.526 -0.307 . . . . 0.0 110.831 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.642 HG22 HD13 ' A' ' 50' ' ' LEU . 24.7 mt -65.78 -34.41 70.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.027 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -75.33 -33.35 61.12 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.725 -0.216 . . . . 0.0 111.151 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -62.79 -41.67 99.37 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.559 0.218 . . . . 0.0 111.059 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.635 HG22 ' O ' ' A' ' 23' ' ' ILE . 35.9 m -63.86 -23.5 33.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.614 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -55.82 -36.45 67.49 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 120.494 0.188 . . . . 0.0 111.196 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.78 -45.35 86.13 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-O 120.639 0.257 . . . . 0.0 111.181 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 14.1 mttm -63.91 -42.39 97.44 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.781 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.409 ' CG2' ' CG2' ' A' ' 36' ' ' ILE . 33.2 mm -75.01 -27.48 20.02 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.446 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.413 ' HA ' ' HG3' ' A' ' 37' ' ' PRO . 10.3 tt0 -65.15 -16.91 64.02 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -50.4 -32.67 18.27 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 111.601 0.223 . . . . 0.0 111.601 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.37 -30.58 23.52 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 121.125 -0.23 . . . . 0.0 111.07 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 65.31 26.22 12.12 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 120.61 0.243 . . . . 0.0 110.871 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.422 ' N ' ' HD2' ' A' ' 37' ' ' PRO . . . -112.08 -48.25 0.67 Allowed Glycine 0 C--N 1.334 0.465 0 C-N-CA 120.453 -0.88 . . . . 0.0 112.952 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.718 HD11 HD23 ' A' ' 69' ' ' LEU . 7.6 tt -84.21 -24.78 0.35 Allowed Pre-proline 0 CA--C 1.54 0.592 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -179.227 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.623 ' CD ' ' N ' ' A' ' 36' ' ' ILE . 78.3 Cg_exo -42.96 -41.7 9.05 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 122.309 2.006 . . . . 0.0 113.791 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.488 ' O ' ' O ' ' A' ' 37' ' ' PRO . 66.8 Cg_exo -53.39 -147.78 0.0 OUTLIER 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.446 2.097 . . . . 0.0 112.668 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -68.09 -4.08 12.39 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -179.376 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -90.34 -4.08 57.32 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 121.97 -0.457 . . . . 0.0 111.856 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.415 ' HG3' HG23 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -93.21 89.63 6.51 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-O 120.582 0.229 . . . . 0.0 110.971 179.756 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -144.01 151.93 40.35 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.973 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.4 tp -107.97 142.38 38.19 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.847 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.583 ' O ' HG23 ' A' ' 44' ' ' ILE . 2.2 tt -111.06 65.86 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-O 120.752 0.311 . . . . 0.0 111.097 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -150.89 127.74 10.99 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.194 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.77 ' HB2' ' CZ ' ' A' ' 59' ' ' TYR . . . 59.86 31.41 20.74 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.636 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 45.21 39.3 6.91 Favored Glycine 0 C--N 1.337 0.584 0 C-N-CA 120.808 -0.71 . . . . 0.0 113.079 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.1 mttm -109.73 145.43 36.62 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.787 0.294 . . . . 0.0 110.954 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -89.07 174.4 7.9 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.866 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.642 HD13 HG22 ' A' ' 23' ' ' ILE . 0.2 OUTLIER -79.21 -37.16 38.86 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.184 -179.975 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -89.35 8.8 28.75 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -47.24 -41.03 17.79 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.646 0.26 . . . . 0.0 111.159 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.98 23.82 24.28 Favored Glycine 0 CA--C 1.522 0.504 0 C-N-CA 120.757 -0.735 . . . . 0.0 113.039 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.456 ' H ' HD12 ' A' ' 23' ' ' ILE . 26.6 mmt180 -107.38 177.25 4.9 Favored 'General case' 0 C--N 1.334 -0.083 0 CA-C-N 117.132 0.466 . . . . 0.0 110.753 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.47 HG23 ' O ' ' A' ' 21' ' ' ASP . 4.4 m -99.44 130.82 45.73 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.491 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.627 HD21 ' HB3' ' A' ' 21' ' ' ASP . 0.6 OUTLIER -51.21 -32.45 23.93 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 120.601 0.239 . . . . 0.0 110.916 179.974 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.2 t -61.5 -27.25 68.46 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.625 -0.262 . . . . 0.0 111.607 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.404 ' OD1' ' N ' ' A' ' 59' ' ' TYR . 2.5 p30 -53.74 -30.21 43.13 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 120.859 -0.336 . . . . 0.0 111.492 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.77 ' CZ ' ' HB2' ' A' ' 46' ' ' ALA . 3.4 t80 -107.8 37.09 2.53 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 120.569 0.223 . . . . 0.0 111.248 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 23.6 m120 54.77 32.91 18.47 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.649 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.613 ' O ' HD12 ' A' ' 56' ' ' LEU . 22.1 mt -89.37 76.46 1.3 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-O 120.69 0.281 . . . . 0.0 110.849 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.03 -174.34 2.51 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.0 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.54 144.89 1.41 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.78 0.324 . . . . 0.0 111.255 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 63.37 21.23 12.69 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.617 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.5 m -75.85 162.15 28.38 Favored 'General case' 0 CA--C 1.527 0.092 0 CA-C-O 120.642 0.258 . . . . 0.0 110.808 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -107.03 83.01 1.76 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.552 179.675 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.673 HD21 ' CD1' ' A' ' 3' ' ' ILE . 2.9 pp -98.92 126.93 44.72 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.132 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.43 ' O ' HG22 ' A' ' 44' ' ' ILE . 20.3 t-160 -107.06 117.94 35.4 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.686 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.718 HD23 HD11 ' A' ' 36' ' ' ILE . 0.2 OUTLIER -93.73 114.77 27.14 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.776 0.322 . . . . 0.0 110.817 -179.981 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.4 p -111.83 152.61 13.67 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.016 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.407 HD23 ' H ' ' A' ' 71' ' ' LEU . 0.5 OUTLIER -87.07 131.09 34.23 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.883 179.953 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 13.5 ttp180 -93.02 102.59 14.93 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.957 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -81.73 44.92 0.85 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.618 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 10.9 mtp180 -90.1 102.5 15.22 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.719 0.295 . . . . 0.0 110.877 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -143.15 79.42 0.25 Allowed Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.5 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.441 -1.199 . . . . 0.0 112.53 179.982 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.404 ' HG3' ' O ' ' A' ' 3' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.359 0.124 . . . . 0.0 111.021 . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 52.6 mm-40 -84.81 -39.56 18.22 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 -179.273 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.415 HD12 ' CB ' ' A' ' 15' ' ' LEU . 0.9 OUTLIER -138.68 169.0 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.129 0 CA-C-O 120.582 0.23 . . . . 0.0 111.11 -179.607 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -118.5 103.8 10.08 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.74 0.305 . . . . 0.0 111.013 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.407 HG13 HD13 ' A' ' 69' ' ' LEU . 16.8 t -129.5 154.34 40.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.773 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.2 mttt -106.76 152.89 23.23 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.65 0.262 . . . . 0.0 111.022 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.431 HG22 ' HE2' ' A' ' 33' ' ' LYS . 0.3 OUTLIER -99.88 -143.47 0.33 Allowed 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.62 179.988 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.469 HD12 ' CD1' ' A' ' 73' ' ' LEU . 1.7 pt? -64.82 -41.6 95.64 Favored 'General case' 0 C--N 1.341 0.23 0 CA-C-N 118.791 0.723 . . . . 0.0 111.164 -179.242 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.453 ' N ' ' HG ' ' A' ' 8' ' ' LEU . 94.9 m -111.36 -64.91 1.22 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.774 0.321 . . . . 0.0 110.652 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 178.0 47.71 0.07 OUTLIER Glycine 0 CA--C 1.521 0.42 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.746 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.49 -179.65 7.2 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.729 0.3 . . . . 0.0 110.996 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.51 ' O ' HG23 ' A' ' 12' ' ' THR . 13.2 t -103.07 114.59 29.0 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.709 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 11.9 tt -123.65 136.26 60.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 120.704 0.288 . . . . 0.0 111.228 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.7 t -106.02 168.17 9.3 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.779 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.423 HD22 ' HA ' ' A' ' 15' ' ' LEU . 0.2 OUTLIER -134.13 87.3 2.35 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-O 120.702 0.287 . . . . 0.0 110.896 -179.977 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -101.03 93.88 5.72 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.801 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.918 HG11 HG22 ' A' ' 26' ' ' VAL . 31.5 m -131.47 174.53 12.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.208 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -97.05 164.3 18.15 Favored Pre-proline 0 C--N 1.332 -0.171 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.755 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -60.23 -38.44 75.99 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.64 2.227 . . . . 0.0 112.349 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.4 p -78.82 -24.35 44.56 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.389 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -64.86 118.89 9.69 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-O 120.641 0.257 . . . . 0.0 110.846 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.5 p -85.2 -175.43 5.72 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.826 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.642 HD12 ' O ' ' A' ' 54' ' ' ARG . 3.9 mt -63.11 -40.55 89.45 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.027 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -52.09 -44.04 64.2 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.665 0.269 . . . . 0.0 111.075 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.07 -34.83 78.42 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.917 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.918 HG22 HG11 ' A' ' 17' ' ' VAL . 21.3 t -73.84 -12.93 15.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.599 ' HE3' HD23 ' A' ' 50' ' ' LEU . 2.5 mmpt? -55.48 -39.15 70.05 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 120.569 0.223 . . . . 0.0 111.073 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.402 ' HA ' ' HG2' ' A' ' 31' ' ' GLN . . . -67.88 -42.39 81.32 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-O 120.717 0.294 . . . . 0.0 111.248 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.8 mttm -74.54 -40.0 61.99 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.669 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.691 HG22 ' O ' ' A' ' 26' ' ' VAL . 20.2 tt -74.35 -23.61 18.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -179.128 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.531 ' HA ' HD13 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -65.01 75.21 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 120.856 0.36 . . . . 0.0 110.959 -179.785 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.404 ' N ' ' O ' ' A' ' 30' ' ' ILE . 36.6 t70 -60.26 -67.89 0.35 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.137 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.431 ' HE2' HG22 ' A' ' 7' ' ' THR . 0.0 OUTLIER -85.77 -86.36 0.14 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.965 179.884 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -178.37 43.42 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 121.119 -0.232 . . . . 0.0 111.371 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -151.2 31.2 0.96 Allowed Glycine 0 C--N 1.334 0.458 0 C-N-CA 120.432 -0.889 . . . . 0.0 113.04 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.647 HG21 HG23 ' A' ' 30' ' ' ILE . 1.8 mp -88.93 -65.53 0.17 Allowed Pre-proline 0 CA--C 1.535 0.375 0 CA-C-N 117.09 0.445 . . . . 0.0 111.411 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.546 ' CD ' ' HB ' ' A' ' 36' ' ' ILE . 3.6 Cg_exo -38.74 -51.08 2.38 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 122.779 2.319 . . . . 0.0 112.977 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.408 ' HD2' ' N ' ' A' ' 37' ' ' PRO . 79.0 Cg_exo -41.33 163.65 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.711 2.274 . . . . 0.0 113.174 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -69.65 2.15 3.52 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -89.78 -21.71 22.5 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 118.17 0.441 . . . . 0.0 111.599 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.554 ' HG2' HG23 ' A' ' 36' ' ' ILE . 2.5 tp60 -93.11 109.98 21.47 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 120.996 -0.281 . . . . 0.0 110.785 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 3.7 ptp180 -142.36 160.83 39.5 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.015 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -108.03 160.42 15.8 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.824 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 25.1 mm -111.06 69.79 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.157 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.556 ' CE1' HG23 ' A' ' 66' ' ' THR . 0.7 OUTLIER -151.13 122.01 7.59 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.176 -179.984 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 56.59 31.98 20.1 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.547 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 45.86 37.55 7.35 Favored Glycine 0 C--N 1.335 0.522 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.974 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.435 ' HD3' ' CE2' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -110.02 134.29 52.29 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.846 0.323 . . . . 0.0 111.054 -179.977 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -89.09 162.76 15.81 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.837 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.599 HD23 ' HE3' ' A' ' 27' ' ' LYS . 0.1 OUTLIER -79.15 -13.17 59.89 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.612 179.868 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -78.97 -38.26 37.41 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 120.536 0.208 . . . . 0.0 111.141 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -47.98 118.12 2.21 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -68.21 54.18 0.43 Allowed Glycine 0 CA--C 1.521 0.443 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.666 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.642 ' O ' HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -107.07 173.85 6.15 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 117.002 0.401 . . . . 0.0 110.751 179.844 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.438 HG22 ' H ' ' A' ' 57' ' ' SER . 57.0 m -99.27 137.1 38.25 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.675 -0.239 . . . . 0.0 110.836 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.547 HD22 HG21 ' A' ' 61' ' ' ILE . 52.9 mt -52.26 -41.43 62.81 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.919 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.438 ' H ' HG22 ' A' ' 55' ' ' THR . 6.7 t -59.22 -29.38 67.47 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.432 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -53.68 -40.45 65.96 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 121.192 -0.203 . . . . 0.0 111.379 -179.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.435 ' CE2' ' HD3' ' A' ' 48' ' ' LYS . 62.2 m-85 -104.64 36.28 2.47 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-O 120.672 0.272 . . . . 0.0 111.374 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 55.47 25.63 8.0 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.547 HG21 HD22 ' A' ' 56' ' ' LEU . 38.1 mt -89.92 62.52 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.123 0 CA-C-O 120.812 0.339 . . . . 0.0 110.975 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -102.01 -174.81 2.67 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.033 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -44.47 144.1 1.14 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.823 0.344 . . . . 0.0 111.443 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 64.98 19.22 11.8 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.672 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 7.5 p -75.89 170.12 16.84 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-O 120.616 0.246 . . . . 0.0 110.873 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.567 ' O ' HG23 ' A' ' 66' ' ' THR . 7.8 t -107.12 83.69 1.86 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.437 179.518 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.436 HD11 ' CG2' ' A' ' 61' ' ' ILE . 13.0 mt -98.85 104.78 16.85 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.767 0.318 . . . . 0.0 111.325 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -107.19 100.88 10.31 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.627 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.489 HD12 ' N ' ' A' ' 69' ' ' LEU . 6.5 mp -93.97 163.26 13.56 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.559 -0.292 . . . . 0.0 111.029 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.7 t -103.98 121.38 55.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.065 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.814 ' O ' HD22 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -76.55 113.34 14.06 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.36 0.6 . . . . 0.0 111.379 -179.514 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.2 mmm180 -93.74 66.57 3.75 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.176 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.484 ' HB2' HD23 ' A' ' 71' ' ' LEU . 9.4 tp -80.42 -43.94 20.13 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.667 0.27 . . . . 0.0 110.909 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -88.93 134.07 34.09 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.554 -0.293 . . . . 0.0 110.918 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 78.82 42.19 13.5 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.527 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.411 -1.216 . . . . 0.0 112.521 179.931 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.3 ttt . . . . . 0 N--CA 1.487 1.409 0 CA-C-O 120.65 0.262 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 82.2 mm-40 -94.78 -46.68 6.79 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.944 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.554 HD13 ' H ' ' A' ' 3' ' ' ILE . 0.2 OUTLIER -146.21 -175.76 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.096 -179.993 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -118.66 99.22 6.65 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.775 0.322 . . . . 0.0 110.74 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.825 HG12 HD12 ' A' ' 69' ' ' LEU . 1.2 t -116.84 121.25 67.32 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.895 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 41.7 mttt -106.86 122.34 46.2 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.702 0.287 . . . . 0.0 110.845 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.62 ' HB ' HD12 ' A' ' 36' ' ' ILE . 0.7 OUTLIER -99.75 -75.01 0.58 Allowed 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -179.414 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.623 HD21 ' HD2' ' A' ' 11' ' ' LYS . 0.3 OUTLIER -68.64 -110.37 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 111.553 0.205 . . . . 0.0 111.553 -179.27 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.9 t -111.51 57.62 0.63 Allowed 'General case' 0 CA--C 1.529 0.155 0 O-C-N 122.175 -0.328 . . . . 0.0 111.038 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.95 37.01 5.83 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.632 -0.794 . . . . 0.0 113.23 179.357 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.623 ' HD2' HD21 ' A' ' 8' ' ' LEU . 13.1 tttm -84.39 142.09 30.38 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 117.077 0.438 . . . . 0.0 110.731 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.9 t -98.22 117.87 33.58 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.846 0.355 . . . . 0.0 110.924 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.3 pt -125.09 146.36 30.89 Favored 'Isoleucine or valine' 0 C--O 1.231 0.112 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.189 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.1 t -97.37 130.76 44.48 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.769 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -129.82 133.42 46.94 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.983 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -100.77 176.03 5.44 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.877 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.5 HG21 ' N ' ' A' ' 63' ' ' LYS . 21.7 t -129.99 104.59 10.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.755 0.312 . . . . 0.0 111.16 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -107.09 161.57 22.5 Favored Pre-proline 0 C--O 1.232 0.148 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.811 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_exo -51.74 -56.76 2.66 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.398 2.066 . . . . 0.0 112.365 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 38.7 p -90.3 38.26 0.93 Allowed 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.44 ' OD2' HD22 ' A' ' 56' ' ' LEU . 4.0 t70 -75.28 84.96 2.45 Favored 'General case' 0 C--O 1.232 0.182 0 O-C-N 122.308 -0.245 . . . . 0.0 110.912 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.726 ' O ' HG23 ' A' ' 26' ' ' VAL . 6.2 p -85.04 163.22 18.97 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.637 0.256 . . . . 0.0 110.807 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.433 HG22 ' HD2' ' A' ' 27' ' ' LYS . 34.5 mm -68.13 -42.89 85.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.001 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -54.1 -41.9 68.8 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.653 0.263 . . . . 0.0 110.986 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 -68.71 -39.44 80.47 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.823 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.726 HG23 ' O ' ' A' ' 22' ' ' THR . 42.5 t -63.95 -44.64 97.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 CA-C-O 120.613 0.244 . . . . 0.0 110.906 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.433 ' HD2' HG22 ' A' ' 23' ' ' ILE . 1.6 mttm -59.39 -43.96 92.88 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.704 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.04 -37.11 73.75 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.126 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.54 ' HD3' HD13 ' A' ' 30' ' ' ILE . 12.9 tmtt? -66.9 -40.44 87.7 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.644 -0.253 . . . . 0.0 110.912 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.54 HD13 ' HD3' ' A' ' 29' ' ' LYS . 31.9 mm -69.8 -49.76 54.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.659 0.266 . . . . 0.0 110.895 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -65.08 -24.98 67.6 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.318 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -50.92 -32.25 20.15 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 111.605 0.224 . . . . 0.0 111.605 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.8 -27.81 26.58 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 121.218 -0.193 . . . . 0.0 111.296 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 67.87 31.67 5.61 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-O 120.66 0.267 . . . . 0.0 110.891 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -94.33 -42.27 4.03 Favored Glycine 0 C--N 1.334 0.437 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.377 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.62 HD12 ' HB ' ' A' ' 7' ' ' THR . 19.9 tt -89.17 110.93 41.98 Favored Pre-proline 0 CA--C 1.531 0.223 0 CA-C-O 120.6 0.238 . . . . 0.0 111.062 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.45 ' HB2' ' HD3' ' A' ' 38' ' ' PRO . 33.4 Cg_exo -58.58 -48.52 14.84 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.365 2.043 . . . . 0.0 112.512 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.45 ' HD3' ' HB2' ' A' ' 37' ' ' PRO . 84.4 Cg_exo -44.46 94.25 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.556 2.171 . . . . 0.0 112.488 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -68.2 -31.78 71.54 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.256 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.6 mm-40 -101.01 42.88 1.09 Allowed 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.64 0.257 . . . . 0.0 111.166 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.548 ' OE1' HD13 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -82.87 131.81 35.18 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.655 0.264 . . . . 0.0 110.722 179.662 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -134.88 -178.18 4.96 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.957 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.629 HD21 ' HB3' ' A' ' 67' ' ' LEU . 0.3 OUTLIER -97.87 126.53 43.29 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.766 179.978 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.637 ' O ' HG23 ' A' ' 44' ' ' ILE . 0.6 OUTLIER -101.06 88.8 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.841 0.353 . . . . 0.0 111.272 -179.992 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -150.87 131.92 14.32 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.17 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.6 29.63 19.15 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.656 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 45.53 40.95 8.88 Favored Glycine 0 C--N 1.336 0.555 0 C-N-CA 120.932 -0.652 . . . . 0.0 113.038 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.417 ' HG2' ' CE1' ' A' ' 59' ' ' TYR . 17.1 mttt -108.56 138.54 44.7 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.785 0.293 . . . . 0.0 110.953 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.1 tp-100 -89.11 120.54 30.6 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.974 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.7 mp -79.58 -6.1 56.36 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -78.75 -20.07 50.81 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 111.667 0.247 . . . . 0.0 111.667 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -46.44 -38.33 8.93 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.571 0.224 . . . . 0.0 111.34 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.97 43.04 2.5 Favored Glycine 0 CA--C 1.52 0.395 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.815 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.2 mmt85 -107.12 -176.54 3.1 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.797 0.298 . . . . 0.0 110.756 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.521 HG23 ' H ' ' A' ' 58' ' ' ASP . 12.9 t -97.27 172.22 7.93 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.66 0.267 . . . . 0.0 110.975 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.44 HD22 ' OD2' ' A' ' 21' ' ' ASP . 1.0 OUTLIER -62.36 -58.41 7.76 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.177 -179.893 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.3 t -52.97 -29.37 28.65 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.521 ' H ' HG23 ' A' ' 55' ' ' THR . 1.1 m-20 -53.7 -38.55 64.35 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 111.609 0.226 . . . . 0.0 111.609 -179.544 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.417 ' CE1' ' HG2' ' A' ' 48' ' ' LYS . 11.7 m-85 -101.55 20.51 15.94 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 62.93 16.91 9.6 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.54 ' HB ' HD11 ' A' ' 67' ' ' LEU . 23.6 pt -89.89 69.91 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 CA-C-O 120.797 0.332 . . . . 0.0 110.849 179.394 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -95.02 -174.01 3.12 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.179 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.5 ' N ' HG21 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -45.65 147.61 0.87 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.789 0.328 . . . . 0.0 111.515 -179.722 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 65.3 16.03 10.32 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.817 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.9 m -76.18 166.87 22.84 Favored 'General case' 0 CA--C 1.527 0.093 0 CA-C-O 120.738 0.304 . . . . 0.0 110.953 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.551 ' O ' HG23 ' A' ' 66' ' ' THR . 7.2 t -106.46 85.79 2.24 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.249 179.297 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.629 ' HB3' HD21 ' A' ' 43' ' ' LEU . 5.9 mp -98.93 114.36 26.94 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.456 -179.211 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -107.17 123.45 48.28 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.603 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.825 HD12 HG12 ' A' ' 5' ' ' VAL . 0.8 OUTLIER -93.78 141.79 28.1 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.707 0.289 . . . . 0.0 111.045 -179.831 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.2 p -114.08 152.75 15.71 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.093 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.47 89.66 3.84 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.781 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.7 tpt180 -93.04 95.71 9.62 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.891 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.8 mt -80.11 -58.59 3.08 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.855 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -90.04 144.34 25.98 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.548 -0.297 . . . . 0.0 110.861 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -142.38 -171.26 13.08 Favored Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.513 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.323 -1.265 . . . . 0.0 112.522 179.952 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.439 ' CG ' ' O ' ' A' ' 3' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 120.44 0.162 . . . . 0.0 111.097 . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -89.64 -19.15 25.25 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -179.15 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.493 HD11 ' HB2' ' A' ' 15' ' ' LEU . 10.9 pt -138.57 176.64 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.121 0 C-N-CA 120.907 -0.317 . . . . 0.0 111.509 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -118.97 99.82 6.98 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.717 0.294 . . . . 0.0 110.863 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.627 HG11 HD11 ' A' ' 13' ' ' ILE . 21.5 t -107.15 142.03 20.91 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.116 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.052 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.18 141.24 48.4 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.937 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.7 -163.66 1.05 Allowed 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.083 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.93 ' CD2' HG23 ' A' ' 9' ' ' THR . 0.0 OUTLIER -68.34 -30.5 69.48 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-O 121.056 0.455 . . . . 0.0 110.117 -179.899 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.93 HG23 ' CD2' ' A' ' 8' ' ' LEU . 33.3 p -111.19 -69.46 0.87 Allowed 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.784 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 175.07 47.79 0.05 OUTLIER Glycine 0 C--N 1.333 0.384 0 C-N-CA 120.489 -0.862 . . . . 0.0 112.988 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.68 144.14 28.75 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.861 0.33 . . . . 0.0 110.937 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.474 ' O ' HG23 ' A' ' 12' ' ' THR . 14.2 t -103.06 117.78 35.34 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.574 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.627 HD11 HG11 ' A' ' 5' ' ' VAL . 26.6 pt -125.04 153.24 32.1 Favored 'Isoleucine or valine' 0 C--O 1.231 0.112 0 CA-C-O 120.687 0.28 . . . . 0.0 111.453 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.8 t -106.03 139.16 41.0 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.872 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.493 ' HB2' HD11 ' A' ' 3' ' ' ILE . 1.4 tp -129.93 144.44 51.32 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.712 0.291 . . . . 0.0 110.903 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.51 147.09 25.11 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.83 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.461 HG21 ' HA ' ' A' ' 63' ' ' LYS . 21.5 t -130.02 102.07 6.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.201 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.412 ' HB2' ' HD2' ' A' ' 19' ' ' PRO . 2.2 pt-20 -107.12 161.57 22.51 Favored Pre-proline 0 C--O 1.232 0.162 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.507 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.412 ' HD2' ' HB2' ' A' ' 18' ' ' GLU . 89.3 Cg_exo -47.1 -53.33 6.48 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.507 2.138 . . . . 0.0 112.256 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.1 m -90.14 41.66 1.06 Allowed 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.801 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 46.1 p-10 -69.13 95.99 0.78 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.679 0.276 . . . . 0.0 110.806 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.03 137.82 32.82 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.951 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.676 HD12 ' O ' ' A' ' 54' ' ' ARG . 7.5 mt -68.02 -39.72 81.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.193 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -67.32 -41.76 84.76 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.134 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -62.85 -38.39 90.63 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.212 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.535 HG12 ' O ' ' A' ' 23' ' ' ILE . 12.2 p -73.52 -12.8 15.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 111.957 0.354 . . . . 0.0 111.957 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.461 ' HE2' HD12 ' A' ' 50' ' ' LEU . 12.8 ttmt -55.59 -48.74 74.37 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 120.691 0.282 . . . . 0.0 110.7 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.01 -29.18 68.12 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.14 179.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 24.7 mtpt -63.96 -33.76 76.45 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.753 -0.203 . . . . 0.0 110.953 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 33.8 mm -64.68 -42.73 95.87 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 CA-C-O 120.674 0.273 . . . . 0.0 110.495 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -65.16 -37.06 86.19 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 120.772 0.32 . . . . 0.0 110.68 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -61.49 -18.24 58.18 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.972 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 7.0 mtmm -74.04 -73.83 0.21 Allowed 'General case' 0 C--O 1.231 0.119 0 C-N-CA 121.044 -0.262 . . . . 0.0 111.086 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -137.59 23.7 2.91 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.439 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . 48.65 85.07 0.02 OUTLIER Glycine 0 C--N 1.337 0.636 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.387 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.745 HD13 ' HB2' ' A' ' 41' ' ' GLN . 1.1 pp -78.44 110.27 13.28 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 120.628 0.251 . . . . 0.0 111.292 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.557 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 34.7 Cg_exo -60.46 -43.41 33.81 Favored 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 122.733 2.288 . . . . 0.0 113.583 -179.651 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.557 ' HD2' ' N ' ' A' ' 37' ' ' PRO . 55.4 Cg_endo -71.92 118.87 5.84 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.058 1.839 . . . . 0.0 112.943 -179.091 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.0 p-10 -68.66 -12.81 61.83 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.974 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -90.96 22.49 3.63 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.745 ' HB2' HD13 ' A' ' 36' ' ' ILE . 0.7 OUTLIER -84.45 93.45 8.31 Favored 'General case' 0 CA--C 1.527 0.08 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 179.305 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.732 ' HG3' HD23 ' A' ' 50' ' ' LEU . 4.5 ttm180 -139.59 177.09 8.19 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.101 -179.286 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.56 ' CD1' HD12 ' A' ' 69' ' ' LEU . 2.2 mm? -97.91 165.23 12.03 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.459 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.401 ' CG1' ' HB2' ' A' ' 68' ' ' HIS . 1.4 pt -111.02 83.79 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-O 120.696 0.284 . . . . 0.0 111.174 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -150.85 115.46 5.18 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.233 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.78 24.37 14.5 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.859 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 44.37 39.86 5.82 Favored Glycine 0 C--N 1.338 0.654 0 C-N-CA 120.837 -0.697 . . . . 0.0 113.083 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.428 ' HG2' ' CE2' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -100.98 135.49 42.34 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.814 0.307 . . . . 0.0 110.853 -179.82 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -78.96 165.97 22.88 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.828 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.732 HD23 ' HG3' ' A' ' 42' ' ' ARG . 1.7 pp -79.35 -18.21 52.93 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.74 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -78.91 -26.4 43.78 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 111.782 0.289 . . . . 0.0 111.782 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 38.7 p-10 -47.82 115.52 1.19 Allowed 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 120.807 0.337 . . . . 0.0 110.604 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -70.73 46.73 0.73 Allowed Glycine 0 CA--C 1.521 0.434 0 C-N-CA 120.504 -0.855 . . . . 0.0 112.564 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.676 ' O ' HD12 ' A' ' 23' ' ' ILE . 1.5 mpp_? -107.26 170.42 7.97 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 117.029 0.414 . . . . 0.0 110.799 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 36.2 m -99.18 137.73 37.29 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.664 -0.243 . . . . 0.0 110.741 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.847 HD23 HG21 ' A' ' 61' ' ' ILE . 1.2 mp -52.05 -42.94 63.52 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.892 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.3 t -57.22 -31.19 65.24 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.479 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -53.83 -34.96 60.86 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 121.194 -0.202 . . . . 0.0 111.404 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.428 ' CE2' ' HG2' ' A' ' 48' ' ' LYS . 39.9 m-85 -103.29 36.23 2.32 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 120.548 0.214 . . . . 0.0 111.396 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 58.14 23.4 10.13 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.847 HG21 HD23 ' A' ' 56' ' ' LEU . 26.9 mt -89.81 77.09 1.35 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.141 0 CA-C-O 120.636 0.255 . . . . 0.0 110.962 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -94.96 172.63 8.03 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.714 0.292 . . . . 0.0 111.123 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.461 ' HA ' HG21 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -50.08 148.9 3.07 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.212 -179.892 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 63.3 22.69 13.44 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.444 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.1 m -75.64 177.45 6.8 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-O 120.706 0.288 . . . . 0.0 110.88 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.5 p -107.1 86.65 2.34 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.825 0.345 . . . . 0.0 110.639 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.5 mt -99.02 122.48 42.33 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.153 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.401 ' HB2' ' CG1' ' A' ' 44' ' ' ILE . 22.6 m-70 -107.09 140.58 39.7 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.813 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.56 HD12 ' CD1' ' A' ' 43' ' ' LEU . 0.3 OUTLIER -93.94 -174.42 3.41 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.927 -179.881 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.1 p -103.71 139.04 25.77 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-O 120.719 0.295 . . . . 0.0 111.046 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.08 101.43 13.46 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.945 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.501 ' O ' HD12 ' A' ' 8' ' ' LEU . 22.5 ttp-105 -93.12 86.12 5.28 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.879 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.499 HD12 ' N ' ' A' ' 74' ' ' ARG . 4.2 pp -80.12 -36.65 35.0 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.106 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.499 ' N ' HD12 ' A' ' 73' ' ' LEU . 0.1 OUTLIER -90.08 72.75 7.32 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-O 120.749 0.309 . . . . 0.0 110.922 179.923 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -127.8 51.06 0.86 Allowed Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.506 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.35 -1.25 . . . . 0.0 112.452 -179.972 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.9 ttt . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.714 0.292 . . . . 0.0 111.261 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 63.5 mm-40 -90.5 -39.69 12.44 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.097 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.514 HD11 ' CB ' ' A' ' 15' ' ' LEU . 30.1 pt -138.73 175.57 7.92 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 CA-C-N 116.649 -0.25 . . . . 0.0 110.952 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -118.7 88.99 3.03 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.71 0.291 . . . . 0.0 110.874 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.894 HG22 HD11 ' A' ' 67' ' ' LEU . 21.5 t -108.89 128.35 64.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.179 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -107.51 153.64 22.54 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.752 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.449 HG21 ' OE2' ' A' ' 34' ' ' GLU . 0.2 OUTLIER -109.99 -146.95 0.41 Allowed 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 119.488 -0.291 . . . . 0.0 110.616 -179.959 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.54 ' HG ' HG23 ' A' ' 9' ' ' THR . 0.7 OUTLIER -65.18 -34.24 77.9 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 118.806 0.73 . . . . 0.0 111.542 -179.104 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.54 HG23 ' HG ' ' A' ' 8' ' ' LEU . 73.2 p -111.05 -56.53 2.36 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 120.629 0.252 . . . . 0.0 111.047 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 156.58 57.62 0.01 OUTLIER Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.823 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.2 mmmp? -84.13 154.09 23.33 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.708 0.254 . . . . 0.0 110.886 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.518 ' O ' HG23 ' A' ' 12' ' ' THR . 14.0 t -102.93 114.33 28.53 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.813 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.504 HD11 ' HB ' ' A' ' 5' ' ' VAL . 3.2 pt -118.25 147.3 21.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.141 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.8 p -105.91 114.5 28.68 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.903 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.514 ' CB ' HD11 ' A' ' 3' ' ' ILE . 0.2 OUTLIER -129.28 138.86 51.87 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.876 179.981 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -95.18 161.87 13.93 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.911 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.6 t -129.93 117.02 39.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.769 0.318 . . . . 0.0 111.231 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -100.58 164.12 16.83 Favored Pre-proline 0 C--O 1.231 0.101 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.711 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -53.19 -66.36 0.11 Allowed 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.625 2.217 . . . . 0.0 112.38 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.5 m -90.35 35.9 0.87 Allowed 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 112.054 0.391 . . . . 0.0 112.054 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.438 ' HB3' HD21 ' A' ' 56' ' ' LEU . 4.6 t70 -75.41 113.21 12.55 Favored 'General case' 0 C--O 1.231 0.132 0 CA-C-O 120.647 0.261 . . . . 0.0 110.925 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 10.2 t -85.16 173.8 10.15 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.856 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.507 HG21 ' O ' ' A' ' 50' ' ' LEU . 51.7 mm -68.16 -40.48 82.94 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.015 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -53.9 -40.01 66.27 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.681 -0.236 . . . . 0.0 111.14 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -62.86 -54.7 34.74 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 120.663 0.268 . . . . 0.0 110.906 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.4 p -63.96 -36.93 78.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.262 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.679 ' HA ' HD12 ' A' ' 30' ' ' ILE . 13.6 tttt -55.87 -41.06 73.83 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.719 -0.219 . . . . 0.0 110.935 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.88 -38.1 75.16 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.147 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.82 -43.31 96.62 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-N 116.67 -0.241 . . . . 0.0 110.806 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.679 HD12 ' HA ' ' A' ' 27' ' ' LYS . 4.0 mt -66.49 -49.1 77.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.865 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 1.4 tp-100 -59.79 -42.24 92.93 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.818 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -61.01 -25.79 67.15 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.279 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -74.86 -61.68 1.8 Allowed 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 121.173 -0.211 . . . . 0.0 111.095 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.449 ' OE2' HG21 ' A' ' 7' ' ' THR . 0.2 OUTLIER -103.17 -46.44 4.62 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.578 0.228 . . . . 0.0 111.089 -179.84 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.425 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . 85.05 42.97 6.87 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.976 -179.596 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.708 HG21 ' HG3' ' A' ' 41' ' ' GLN . 20.2 tt -78.77 110.55 14.65 Favored Pre-proline 0 CA--C 1.532 0.271 0 CA-C-O 120.713 0.292 . . . . 0.0 111.36 -179.565 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.504 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 31.7 Cg_exo -59.77 -45.72 23.64 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.764 2.309 . . . . 0.0 113.339 -179.644 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.504 ' HD2' ' N ' ' A' ' 37' ' ' PRO . 46.8 Cg_exo -37.84 122.52 0.51 Allowed 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.988 2.459 . . . . 0.0 113.425 -179.349 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -69.42 -3.89 16.21 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -90.25 11.21 21.86 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -179.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.708 ' HG3' HG21 ' A' ' 36' ' ' ILE . 1.0 OUTLIER -88.61 82.54 6.87 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-O 120.693 0.283 . . . . 0.0 110.416 179.358 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.823 ' O ' HG23 ' A' ' 70' ' ' VAL . 33.7 mtt180 -136.63 -175.16 3.92 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.976 -179.545 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.771 HD23 HD12 ' A' ' 69' ' ' LEU . 2.3 mt -97.97 153.97 18.0 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.846 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.583 ' O ' HG23 ' A' ' 44' ' ' ILE . 17.2 tt -111.04 71.17 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.803 0.335 . . . . 0.0 111.023 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -150.91 132.06 14.41 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.239 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 56.51 28.59 14.03 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.79 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 45.08 40.23 7.11 Favored Glycine 0 C--N 1.337 0.595 0 C-N-CA 120.797 -0.716 . . . . 0.0 113.0 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.02 127.84 46.19 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.837 0.318 . . . . 0.0 110.922 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -89.06 150.66 22.66 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.014 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.579 HD23 ' HG3' ' A' ' 27' ' ' LYS . 1.9 tp -79.18 -20.94 47.17 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.435 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -78.7 -35.45 44.96 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 120.436 0.16 . . . . 0.0 111.377 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -47.88 115.14 1.07 Allowed 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 110.338 -0.245 . . . . 0.0 110.338 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -69.85 48.49 0.64 Allowed Glycine 0 CA--C 1.522 0.475 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.746 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.0 mtp85 -107.25 -176.69 3.14 Favored 'General case' 0 C--O 1.23 0.07 0 CA-C-N 117.062 0.431 . . . . 0.0 110.646 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.9 m -99.37 134.77 41.76 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.555 0.216 . . . . 0.0 110.488 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.729 ' HB2' HG23 ' A' ' 61' ' ' ILE . 0.7 OUTLIER -51.59 -38.45 54.58 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.566 0.222 . . . . 0.0 110.689 179.915 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.6 t -56.23 -28.32 58.02 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.339 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -53.7 -35.04 60.68 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 111.572 0.212 . . . . 0.0 111.572 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -100.32 18.22 19.42 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 64.87 16.16 10.32 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.963 HD11 ' HB3' ' A' ' 67' ' ' LEU . 0.6 OUTLIER -89.92 71.23 0.76 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-O 120.878 0.37 . . . . 0.0 110.81 179.488 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -94.77 -178.03 4.39 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.441 -179.438 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.5 ptpt -47.37 146.1 2.15 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.581 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.504 ' H ' HG22 ' A' ' 3' ' ' ILE . 0.6 OUTLIER 65.53 12.62 8.32 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.356 179.932 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 41.2 t -76.28 -179.9 5.37 Favored 'General case' 0 C--O 1.231 0.08 0 O-C-N 122.259 -0.276 . . . . 0.0 110.79 179.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -107.12 80.6 1.44 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.342 179.325 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.963 ' HB3' HD11 ' A' ' 61' ' ' ILE . 3.2 pp -98.89 119.74 38.17 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-O 120.789 0.328 . . . . 0.0 111.319 -179.398 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 8.8 m170 -107.15 137.0 46.03 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.592 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.771 HD12 HD23 ' A' ' 43' ' ' LEU . 1.7 tp -93.93 171.47 8.84 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.654 0.264 . . . . 0.0 110.846 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.823 HG23 ' O ' ' A' ' 42' ' ' ARG . 28.6 t -103.81 129.54 55.75 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.161 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.639 HD12 ' O ' ' A' ' 71' ' ' LEU . 1.7 pp -76.91 96.57 4.36 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.87 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.66 ' CD ' HD11 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -93.0 -40.67 10.42 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.228 179.952 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.5 mp -69.75 -34.27 73.59 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.679 -0.237 . . . . 0.0 111.134 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.78 -39.65 30.44 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.645 0.259 . . . . 0.0 110.943 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -71.0 144.87 38.73 Favored Glycine 0 C--N 1.334 0.44 0 C-N-CA 120.539 -0.838 . . . . 0.0 112.48 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.373 -1.237 . . . . 0.0 112.544 179.982 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.693 0.282 . . . . 0.0 111.253 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -95.15 140.66 29.76 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.809 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.8 tp -138.69 152.91 25.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.941 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.49 80.77 1.58 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.777 0.322 . . . . 0.0 110.866 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.669 ' CG2' HD13 ' A' ' 69' ' ' LEU . 10.6 p -134.48 132.44 54.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.84 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.1 mptt -106.97 172.41 6.84 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.778 0.323 . . . . 0.0 111.071 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.4 p -99.91 -175.68 3.03 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.576 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.624 HD12 ' HA3' ' A' ' 75' ' ' GLY . 1.9 pt? -67.02 -4.04 8.74 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.4 p -99.78 -44.14 6.19 Favored 'General case' 0 CA--C 1.529 0.167 0 O-C-N 122.258 -0.276 . . . . 0.0 111.366 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 141.71 -26.22 2.39 Favored Glycine 0 CA--C 1.521 0.461 0 C-N-CA 120.264 -0.97 . . . . 0.0 113.486 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.8 tmtm? -73.49 143.28 46.66 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 117.416 0.608 . . . . 0.0 110.86 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.9 t -96.24 149.11 22.03 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.154 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 11.7 tt -125.03 152.24 31.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.076 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.7 m -96.01 135.1 38.22 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.632 -0.258 . . . . 0.0 110.739 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -138.05 142.62 40.31 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.731 0.3 . . . . 0.0 111.127 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -101.13 146.57 27.3 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.732 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.6 t -140.06 138.58 37.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.721 0.296 . . . . 0.0 111.306 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.418 ' HB2' ' HD2' ' A' ' 19' ' ' PRO . 11.4 pt-20 -107.14 162.88 18.27 Favored Pre-proline 0 C--N 1.334 -0.098 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.514 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.418 ' HD2' ' HB2' ' A' ' 18' ' ' GLU . 77.9 Cg_exo -48.26 -54.13 5.72 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.395 2.063 . . . . 0.0 112.208 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 98.1 p -90.4 42.16 1.09 Allowed 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.77 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.684 ' OD1' HG21 ' A' ' 26' ' ' VAL . 12.7 t70 -72.72 98.12 2.32 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 120.669 0.271 . . . . 0.0 110.989 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.4 p -85.14 136.31 33.6 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.708 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.558 HG21 ' O ' ' A' ' 50' ' ' LEU . 59.4 mt -68.1 74.01 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.708 0.289 . . . . 0.0 110.916 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -158.36 -59.38 0.08 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.012 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -72.5 -33.85 67.23 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.045 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.684 HG21 ' OD1' ' A' ' 21' ' ' ASP . 39.6 t -63.77 -24.77 36.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 116.794 -0.184 . . . . 0.0 111.471 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.481 ' CG ' HG23 ' A' ' 36' ' ' ILE . 0.6 OUTLIER -55.6 -41.71 73.81 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.701 0.286 . . . . 0.0 111.004 179.958 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.78 -39.92 90.64 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.201 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 76.6 mttt -63.97 -42.69 97.17 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.935 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.495 ' HB ' HG21 ' A' ' 36' ' ' ILE . 3.8 mt -70.71 -25.25 26.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.457 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -54.8 -28.95 52.97 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 120.514 0.197 . . . . 0.0 111.239 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -54.31 -24.47 19.25 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -74.33 -64.28 1.06 Allowed 'General case' 0 N--CA 1.461 0.111 0 C-N-CA 121.074 -0.25 . . . . 0.0 110.888 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -177.43 50.57 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 120.921 0.391 . . . . 0.0 111.549 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.438 ' O ' ' HG2' ' A' ' 38' ' ' PRO . . . 73.94 91.61 0.14 Allowed Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.556 -0.83 . . . . 0.0 112.796 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.629 ' N ' ' CD ' ' A' ' 37' ' ' PRO . 7.8 tp -81.03 -27.03 0.44 Allowed Pre-proline 0 CA--C 1.54 0.592 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.64 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 72.2 Cg_exo -43.02 -48.68 7.55 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 122.371 2.047 . . . . 0.0 113.997 -179.447 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.64 ' HD2' ' N ' ' A' ' 37' ' ' PRO . 3.9 Cg_exo -35.56 136.15 0.19 Allowed 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.195 2.597 . . . . 0.0 113.213 -179.253 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -69.35 -0.44 6.33 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 12.1 mm100 -89.9 -13.98 35.19 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.219 0.463 . . . . 0.0 111.626 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -93.01 88.44 6.13 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-O 120.699 0.285 . . . . 0.0 110.641 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.2 ttp-105 -136.7 156.33 48.67 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.042 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.4 pp -99.64 153.07 19.36 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.806 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.614 ' O ' HG23 ' A' ' 44' ' ' ILE . 18.3 tt -110.75 75.43 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.142 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.401 ' CE1' ' O ' ' A' ' 66' ' ' THR . 0.6 OUTLIER -150.92 118.16 5.98 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.272 179.975 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.41 33.95 23.99 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.547 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 46.2 46.51 15.82 Favored Glycine 0 C--N 1.336 0.548 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.997 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.547 ' HG3' HD11 ' A' ' 61' ' ' ILE . 0.0 OUTLIER -100.05 104.26 15.83 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.743 0.272 . . . . 0.0 110.906 -179.993 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -89.15 152.86 21.38 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.038 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.558 ' O ' HG21 ' A' ' 23' ' ' ILE . 0.8 OUTLIER -79.6 -4.38 51.33 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -179.834 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -78.65 -50.28 11.73 Favored 'General case' 0 N--CA 1.462 0.127 0 C-N-CA 121.024 -0.27 . . . . 0.0 111.183 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -47.98 113.21 0.68 Allowed 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -70.31 46.54 0.65 Allowed Glycine 0 CA--C 1.521 0.432 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.624 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.22 -176.68 3.14 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 117.117 0.459 . . . . 0.0 110.881 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.441 HG23 ' O ' ' A' ' 21' ' ' ASP . 23.5 m -99.16 141.77 31.5 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.716 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.462 ' HA ' HD12 ' A' ' 61' ' ' ILE . 34.9 mt -53.14 -42.55 66.18 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.902 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.5 t -54.74 -31.49 58.49 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.565 -0.288 . . . . 0.0 111.455 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -53.72 -33.73 56.51 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 111.49 0.182 . . . . 0.0 111.49 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -102.36 40.72 1.31 Allowed 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 120.602 0.239 . . . . 0.0 111.282 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 54.77 28.87 10.86 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 111.721 0.267 . . . . 0.0 111.721 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.547 HD11 ' HG3' ' A' ' 48' ' ' LYS . 22.2 mt -89.43 86.82 2.65 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 CA-C-O 120.667 0.27 . . . . 0.0 111.053 179.624 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -97.98 166.7 11.32 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.727 0.299 . . . . 0.0 111.08 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.6 ptmt -50.12 159.8 0.41 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.137 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 55.23 32.9 19.48 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.213 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.2 m -75.48 153.41 37.57 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-O 120.697 0.284 . . . . 0.0 110.914 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.401 ' O ' ' CE1' ' A' ' 45' ' ' PHE . 1.5 p -106.12 71.56 0.89 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.733 0.301 . . . . 0.0 110.654 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.7 pp -101.82 146.15 28.2 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.024 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -107.1 150.56 26.43 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.838 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.669 HD13 ' CG2' ' A' ' 5' ' ' VAL . 0.3 OUTLIER -103.97 159.25 15.82 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.875 -179.938 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.3 t -103.86 153.52 6.05 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.995 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.592 HD12 ' O ' ' A' ' 71' ' ' LEU . 0.2 OUTLIER -82.3 155.46 24.8 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.603 -0.271 . . . . 0.0 110.975 -179.977 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.2 ttm180 -93.1 175.96 6.59 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.886 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.2 tt -80.14 -57.06 3.8 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.802 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 -90.08 73.65 7.25 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.87 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.624 ' HA3' HD12 ' A' ' 8' ' ' LEU . . . -144.09 -90.99 0.12 Allowed Glycine 0 CA--C 1.519 0.33 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.507 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.353 -1.248 . . . . 0.0 112.542 -179.969 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.452 ' CG ' ' HB ' ' A' ' 14' ' ' THR . 1.9 tpt . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.523 0.201 . . . . 0.0 111.099 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 90.0 mm-40 -93.23 -38.38 11.57 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 -179.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.439 HD11 ' CD1' ' A' ' 15' ' ' LEU . 28.4 pt -139.06 166.03 22.75 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.101 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.913 -179.567 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -126.03 104.7 8.41 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.636 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.813 ' HB ' HD11 ' A' ' 13' ' ' ILE . 18.4 t -96.35 156.2 3.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.104 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.405 ' N ' HG12 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -106.48 150.26 26.26 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.73 0.3 . . . . 0.0 110.869 -179.942 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.645 HG21 ' HB3' ' A' ' 11' ' ' LYS . 34.6 p -99.93 -157.7 0.62 Allowed 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.996 -179.543 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.469 ' HG ' HG22 ' A' ' 9' ' ' THR . 1.4 pt? -67.08 -33.22 75.02 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 120.894 0.378 . . . . 0.0 110.093 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.469 HG22 ' HG ' ' A' ' 8' ' ' LEU . 0.5 OUTLIER -111.57 -76.81 0.59 Allowed 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.29 178.953 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -174.56 46.57 0.14 Allowed Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.218 -0.992 . . . . 0.0 113.233 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.645 ' HB3' HG21 ' A' ' 7' ' ' THR . 6.5 ttmt -84.35 143.03 29.75 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.837 0.319 . . . . 0.0 110.573 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.518 ' O ' HG23 ' A' ' 12' ' ' THR . 11.2 t -92.86 114.17 26.66 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.874 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.813 HD11 ' HB ' ' A' ' 5' ' ' VAL . 24.7 pt -114.92 143.27 25.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.703 0.287 . . . . 0.0 111.119 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.452 ' HB ' ' CG ' ' A' ' 1' ' ' MET . 2.4 p -105.38 118.72 37.27 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.788 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.672 HD21 HG23 ' A' ' 5' ' ' VAL . 0.6 OUTLIER -138.45 159.44 42.06 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.677 0.275 . . . . 0.0 111.233 179.959 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -101.14 -175.63 2.92 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.722 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.6 t -136.49 100.61 2.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-O 120.648 0.261 . . . . 0.0 111.223 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -107.09 154.31 40.47 Favored Pre-proline 0 C--O 1.232 0.157 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.981 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.473 ' HA ' HG21 ' A' ' 55' ' ' THR . 28.5 Cg_endo -62.61 -22.62 74.16 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.77 2.313 . . . . 0.0 113.165 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 51.6 p -78.8 -35.42 44.32 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 121.264 -0.175 . . . . 0.0 111.385 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -73.5 96.71 2.45 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.606 0.241 . . . . 0.0 111.023 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 10.0 p -85.1 -177.37 6.52 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.912 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.823 ' O ' HG13 ' A' ' 26' ' ' VAL . 25.6 mm -68.19 -31.17 50.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.653 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.9 tm-20 -70.31 -47.88 59.13 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.583 0.23 . . . . 0.0 111.251 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -74.99 40.8 0.15 Allowed 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -179.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.823 HG13 ' O ' ' A' ' 23' ' ' ILE . 17.1 m -74.32 -31.49 28.78 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 O-C-N 122.176 -0.328 . . . . 0.0 111.26 179.507 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.494 ' HE3' HG23 ' A' ' 26' ' ' VAL . 0.0 OUTLIER -59.74 -33.09 71.19 Favored 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 121.278 -0.169 . . . . 0.0 111.181 179.998 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.69 -56.54 20.55 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.619 0.247 . . . . 0.0 111.165 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.0 pttm -63.95 -37.34 87.04 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.677 -0.238 . . . . 0.0 110.996 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 21.7 mt -74.42 -15.97 16.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 116.751 -0.204 . . . . 0.0 111.369 179.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -65.53 -10.79 37.93 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -50.05 -33.12 17.27 Favored 'General case' 0 N--CA 1.464 0.244 0 O-C-N 122.22 -0.3 . . . . 0.0 111.66 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.412 ' HD2' ' N ' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -85.38 -28.41 25.19 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 121.067 -0.253 . . . . 0.0 110.791 179.508 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 61.32 25.92 15.82 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.745 -0.207 . . . . 0.0 111.091 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.509 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . -150.52 33.84 0.99 Allowed Glycine 0 C--N 1.335 0.51 0 C-N-CA 120.041 -1.076 . . . . 0.0 113.262 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.606 HG23 ' O ' ' A' ' 36' ' ' ILE . 9.3 tp -90.06 106.47 14.72 Favored Pre-proline 0 CA--C 1.531 0.217 0 CA-C-N 117.092 0.446 . . . . 0.0 111.263 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.509 ' HD3' ' O ' ' A' ' 35' ' ' GLY . 23.3 Cg_exo -62.03 -50.01 5.67 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.209 1.939 . . . . 0.0 112.634 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.459 ' HD3' ' CB ' ' A' ' 37' ' ' PRO . 50.1 Cg_exo -55.97 89.88 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.307 2.005 . . . . 0.0 112.551 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -68.17 -37.0 80.51 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.027 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -101.62 45.19 0.98 Allowed 'General case' 0 CA--C 1.528 0.118 0 CA-C-O 120.784 0.326 . . . . 0.0 110.872 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.817 ' O ' HD11 ' A' ' 50' ' ' LEU . 7.7 tt0 -82.56 136.43 34.84 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.898 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.5 mtt180 -142.1 175.64 9.58 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.964 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.549 ' HB3' HD12 ' A' ' 69' ' ' LEU . 0.5 OUTLIER -108.03 149.09 28.85 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.687 179.789 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.6 mt -100.92 79.43 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.692 0.282 . . . . 0.0 111.197 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -150.91 129.85 12.51 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.099 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 59.99 26.06 15.32 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.65 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 45.29 40.83 8.05 Favored Glycine 0 C--N 1.336 0.569 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.973 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.401 ' HD2' ' CZ ' ' A' ' 59' ' ' TYR . 0.4 OUTLIER -107.42 130.52 54.81 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.796 0.298 . . . . 0.0 111.054 -179.848 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.09 177.92 6.51 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.803 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.817 HD11 ' O ' ' A' ' 41' ' ' GLN . 12.9 mt -68.96 -22.42 64.11 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.596 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -89.8 28.26 1.38 Allowed 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -47.81 -50.75 25.01 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.665 0.269 . . . . 0.0 111.07 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.44 -23.32 34.55 Favored Glycine 0 CA--C 1.521 0.411 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.976 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -107.13 -175.97 2.94 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.985 0.393 . . . . 0.0 110.837 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.473 HG21 ' HA ' ' A' ' 19' ' ' PRO . 8.9 m -96.92 151.69 19.44 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-O 120.738 0.304 . . . . 0.0 110.753 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.768 ' HB3' HG23 ' A' ' 61' ' ' ILE . 9.5 mt -53.89 -44.01 70.12 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.099 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.7 t -52.89 -53.18 52.83 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.635 -179.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -64.61 -18.77 65.22 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -179.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.401 ' CZ ' ' HD2' ' A' ' 48' ' ' LYS . 0.4 OUTLIER -97.99 31.03 2.82 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -179.578 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.7 m120 66.09 -16.59 0.12 Allowed 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.768 HG23 ' HB3' ' A' ' 56' ' ' LEU . 0.6 OUTLIER -89.29 62.69 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 118.471 0.578 . . . . 0.0 110.895 179.852 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -95.4 -167.41 1.61 Allowed 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.02 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -39.85 143.09 0.27 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.855 0.359 . . . . 0.0 111.891 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 65.49 15.79 10.2 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.151 -0.477 . . . . 0.0 112.022 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.1 p -76.19 175.28 9.15 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-O 120.68 0.276 . . . . 0.0 110.996 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -105.47 91.58 3.83 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.205 179.221 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.429 HD12 HD11 ' A' ' 61' ' ' ILE . 1.0 OUTLIER -98.66 109.58 22.32 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.819 0.342 . . . . 0.0 111.41 -179.322 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -107.05 97.59 7.35 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.474 179.523 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.549 HD12 ' HB3' ' A' ' 43' ' ' LEU . 1.0 OUTLIER -93.84 129.47 40.22 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.702 0.286 . . . . 0.0 111.06 -179.696 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.0 p -114.01 152.94 15.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.96 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.715 HD12 ' O ' ' A' ' 71' ' ' LEU . 4.1 pp -76.91 132.71 39.23 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.583 -0.281 . . . . 0.0 110.826 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -90.33 125.75 35.63 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.972 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.8 mp -80.12 -42.43 23.56 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.953 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 14.0 mtt180 -80.63 162.97 23.97 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.953 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 142.99 -42.35 1.1 Allowed Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.433 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.381 -1.233 . . . . 0.0 112.511 179.95 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 120.63 0.253 . . . . 0.0 111.183 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -92.47 -44.01 8.88 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.951 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.8 pt -138.86 174.0 10.77 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.082 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -118.9 105.35 11.4 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.725 0.298 . . . . 0.0 110.869 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.769 HG23 HD23 ' A' ' 69' ' ' LEU . 12.0 p -137.54 132.08 44.69 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.886 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.3 mppt? -106.94 163.09 13.26 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.853 0.358 . . . . 0.0 111.171 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.51 -153.64 0.45 Allowed 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.027 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.901 HD23 HG22 ' A' ' 9' ' ' THR . 0.0 OUTLIER -67.85 -21.89 65.16 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-O 120.86 0.362 . . . . 0.0 110.056 179.874 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.901 HG22 HD23 ' A' ' 8' ' ' LEU . 0.3 OUTLIER -111.69 -70.58 0.8 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.32 179.378 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 164.89 49.86 0.02 OUTLIER Glycine 0 CA--C 1.52 0.379 0 C-N-CA 120.497 -0.859 . . . . 0.0 113.15 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -84.73 150.77 24.86 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.954 0.377 . . . . 0.0 110.982 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.486 ' O ' HG23 ' A' ' 12' ' ' THR . 14.7 t -96.67 115.94 28.28 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.349 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.557 ' CG2' HG13 ' A' ' 5' ' ' VAL . 8.0 tt -125.04 135.97 62.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-O 120.735 0.303 . . . . 0.0 111.629 -179.495 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.6 t -106.19 132.28 52.44 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.48 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.788 HD21 ' HA ' ' A' ' 30' ' ' ILE . 2.1 mt -134.86 134.71 41.03 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.661 0.267 . . . . 0.0 111.247 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -94.99 155.87 16.55 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.404 179.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 1.012 HG11 HD11 ' A' ' 56' ' ' LEU . 21.8 t -140.13 136.62 37.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-O 120.957 0.408 . . . . 0.0 111.795 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.492 ' HB2' ' HD2' ' A' ' 19' ' ' PRO . 11.0 pt-20 -96.72 161.0 28.06 Favored Pre-proline 0 CA--C 1.53 0.19 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.324 179.469 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.492 ' HD2' ' HB2' ' A' ' 18' ' ' GLU . 1.2 Cg_endo -43.18 -66.64 0.15 Allowed 'Trans proline' 0 CA--C 1.532 0.415 0 C-N-CA 122.892 2.395 . . . . 0.0 112.96 -179.611 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.21 37.13 0.89 Allowed 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.412 ' HB2' ' O ' ' A' ' 18' ' ' GLU . 5.5 t0 -75.7 119.65 20.01 Favored 'General case' 0 N--CA 1.462 0.145 0 O-C-N 122.276 -0.265 . . . . 0.0 111.226 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -85.25 146.58 27.0 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.509 179.279 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.636 ' O ' HG12 ' A' ' 26' ' ' VAL . 8.3 tp -57.99 -32.46 43.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 116.769 -0.196 . . . . 0.0 111.376 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -76.19 -39.02 55.8 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 120.547 0.213 . . . . 0.0 111.0 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -63.09 -31.59 72.76 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.729 -0.214 . . . . 0.0 111.448 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.636 HG12 ' O ' ' A' ' 23' ' ' ILE . 13.3 p -74.29 -6.4 8.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.488 ' HA ' HG22 ' A' ' 30' ' ' ILE . 16.4 mttt -55.47 -39.41 70.36 Favored 'General case' 0 N--CA 1.463 0.199 0 O-C-N 122.182 -0.324 . . . . 0.0 111.225 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.12 -41.75 81.27 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.561 0.219 . . . . 0.0 111.432 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.8 tttp -74.12 -42.75 59.55 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.695 -0.23 . . . . 0.0 111.243 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.788 ' HA ' HD21 ' A' ' 15' ' ' LEU . 18.8 tt -64.96 -20.69 28.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.406 ' HA ' ' CG1' ' A' ' 36' ' ' ILE . 1.2 tt0 -63.43 74.65 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.741 0.305 . . . . 0.0 111.111 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.45 ' HB2' HD12 ' A' ' 13' ' ' ILE . 27.9 t70 -61.26 -69.53 0.23 Allowed 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.833 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.71 -85.9 0.14 Allowed 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 121.077 -0.249 . . . . 0.0 110.709 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -177.87 44.34 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -150.14 26.73 1.13 Allowed Glycine 0 CA--C 1.524 0.599 0 C-N-CA 120.182 -1.009 . . . . 0.0 113.539 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.654 HG21 HG23 ' A' ' 30' ' ' ILE . 32.5 mm -89.17 -46.45 0.42 Allowed Pre-proline 0 CA--C 1.533 0.306 0 CA-C-N 117.497 0.649 . . . . 0.0 112.15 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.48 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 53.6 Cg_exo -52.9 -43.74 54.08 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.337 2.025 . . . . 0.0 113.168 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' A' ' 37' ' ' PRO . 58.9 Cg_exo -39.93 161.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.748 2.299 . . . . 0.0 113.511 -179.459 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -69.56 0.39 5.42 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -90.06 8.48 32.45 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 118.094 0.407 . . . . 0.0 111.807 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -89.72 110.92 21.78 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 121.038 -0.265 . . . . 0.0 110.664 179.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.4 mtt180 -144.03 152.2 40.69 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.739 0.304 . . . . 0.0 111.237 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.807 HD11 HD22 ' A' ' 50' ' ' LEU . 1.5 mp -108.0 152.03 25.03 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.783 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.474 HD11 ' CG1' ' A' ' 70' ' ' VAL . 27.0 mm -111.0 61.79 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.157 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.596 ' HB2' HD23 ' A' ' 67' ' ' LEU . 0.2 OUTLIER -153.66 118.36 4.98 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.754 0.311 . . . . 0.0 111.201 179.984 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.74 32.09 21.38 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.677 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 46.36 42.97 13.93 Favored Glycine 0 C--N 1.335 0.527 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.968 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.432 ' HD3' ' CZ ' ' A' ' 59' ' ' TYR . 2.5 tptp -101.36 137.29 39.89 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.643 0.259 . . . . 0.0 110.972 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -89.02 168.81 12.05 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.51 -0.313 . . . . 0.0 110.966 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.807 HD22 HD11 ' A' ' 43' ' ' LEU . 0.2 OUTLIER -79.11 -38.03 37.19 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.471 -0.332 . . . . 0.0 111.354 -179.848 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.64 17.55 6.35 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -47.33 -39.79 15.69 Favored 'General case' 0 N--CA 1.466 0.351 0 O-C-N 122.241 -0.287 . . . . 0.0 111.303 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.19 19.85 48.37 Favored Glycine 0 CA--C 1.522 0.487 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.942 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.7 mtt-85 -107.56 175.81 5.36 Favored 'General case' 0 N--CA 1.458 -0.075 0 CA-C-N 117.03 0.415 . . . . 0.0 110.836 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.532 HG22 ' H ' ' A' ' 57' ' ' SER . 31.2 m -99.34 133.17 44.04 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.731 0.301 . . . . 0.0 110.689 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 1.012 HD11 HG11 ' A' ' 17' ' ' VAL . 0.4 OUTLIER -51.8 -31.08 25.76 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.561 0.219 . . . . 0.0 111.113 179.974 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.532 ' H ' HG22 ' A' ' 55' ' ' THR . 12.6 t -62.95 -40.05 96.5 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -63.21 -29.37 70.72 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.432 ' CZ ' ' HD3' ' A' ' 48' ' ' LYS . 0.2 OUTLIER -97.66 8.99 43.68 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 111.641 0.237 . . . . 0.0 111.641 179.995 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 65.37 11.19 7.14 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.435 ' CG2' HD11 ' A' ' 67' ' ' LEU . 1.2 pt -90.11 63.09 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 CA-C-N 117.961 0.346 . . . . 0.0 110.676 179.251 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -95.1 -168.66 1.84 Allowed 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.093 -179.518 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -40.18 152.05 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.601 -179.645 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 62.14 24.49 14.58 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.363 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.9 p -75.56 145.52 41.17 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.702 0.287 . . . . 0.0 110.939 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.0 m -104.86 66.45 0.77 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.763 0.316 . . . . 0.0 110.577 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.596 HD23 ' HB2' ' A' ' 45' ' ' PHE . 0.4 OUTLIER -104.67 144.49 31.65 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.165 -179.726 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -106.97 141.1 38.72 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.749 179.713 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.769 HD23 HG23 ' A' ' 5' ' ' VAL . 1.3 mm? -103.81 163.38 12.38 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.667 0.27 . . . . 0.0 111.022 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.474 ' CG1' HD11 ' A' ' 44' ' ' ILE . 33.9 m -105.29 179.44 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.021 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.762 HD23 HD12 ' A' ' 8' ' ' LEU . 1.3 mp -76.78 106.23 8.32 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.769 0.319 . . . . 0.0 110.682 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.451 ' NH2' HD11 ' A' ' 69' ' ' LEU . 13.8 mtt180 -90.27 -38.08 13.65 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.267 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 18.6 tp -69.84 -65.26 0.74 Allowed 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.575 0.226 . . . . 0.0 110.914 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -90.09 172.45 8.81 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.67 0.271 . . . . 0.0 110.907 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -90.31 -55.36 1.96 Allowed Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.602 -0.808 . . . . 0.0 112.458 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.431 -1.205 . . . . 0.0 112.467 -179.946 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.1 ptt? . . . . . 0 N--CA 1.487 1.412 0 CA-C-O 120.675 0.274 . . . . 0.0 111.221 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -95.01 108.07 20.13 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.908 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 1.041 HD11 HD13 ' A' ' 67' ' ' LEU . 18.0 tt -138.73 156.27 28.65 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.939 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -118.44 91.83 3.66 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-O 120.739 0.304 . . . . 0.0 110.913 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.5 t -93.35 159.69 2.76 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.747 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.0 ttmt -106.66 135.56 47.97 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.828 0.347 . . . . 0.0 111.044 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.626 HG21 ' HB3' ' A' ' 11' ' ' LYS . 13.7 p -100.51 -162.19 0.92 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.25 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.686 HD12 ' OG1' ' A' ' 9' ' ' THR . 0.8 OUTLIER -60.14 -38.64 83.69 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 120.649 -0.42 . . . . 0.0 111.199 -179.446 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.686 ' OG1' HD12 ' A' ' 8' ' ' LEU . 0.2 OUTLIER -111.24 -62.08 1.6 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.65 0.262 . . . . 0.0 110.792 179.835 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 168.06 50.04 0.03 OUTLIER Glycine 0 CA--C 1.521 0.421 0 C-N-CA 120.512 -0.851 . . . . 0.0 113.125 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.626 ' HB3' HG21 ' A' ' 7' ' ' THR . 0.0 OUTLIER -84.67 157.12 21.21 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 116.858 0.329 . . . . 0.0 110.768 179.795 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.562 ' O ' HG23 ' A' ' 12' ' ' THR . 12.1 t -103.01 108.41 19.57 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.715 0.293 . . . . 0.0 110.8 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.545 HG23 ' HD2' ' A' ' 11' ' ' LYS . 2.8 pt -125.07 168.88 17.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.245 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.02 158.95 16.42 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.778 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.697 ' CB ' HG21 ' A' ' 3' ' ' ILE . 0.2 OUTLIER -138.19 115.67 11.23 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.698 0.285 . . . . 0.0 111.036 -179.897 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -101.05 150.14 23.22 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.743 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.945 ' CG1' HD21 ' A' ' 56' ' ' LEU . 30.2 t -140.0 146.8 24.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.377 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -107.1 164.67 14.33 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.783 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -56.97 -55.47 2.62 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.609 2.206 . . . . 0.0 112.539 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.2 m -89.52 8.38 31.41 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -179.721 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -75.0 118.14 17.64 Favored 'General case' 0 CA--C 1.528 0.125 0 O-C-N 122.245 -0.284 . . . . 0.0 110.924 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.8 p -85.08 165.69 17.28 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.817 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 7.3 tp -58.36 -40.2 77.2 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.261 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -59.32 -38.54 80.56 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.646 0.26 . . . . 0.0 110.924 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -62.79 -23.86 67.45 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.592 -0.277 . . . . 0.0 111.47 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 39.4 t -63.57 -39.5 85.58 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-O 120.566 0.222 . . . . 0.0 111.06 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.526 ' HA ' HG22 ' A' ' 30' ' ' ILE . 7.7 tttm -57.31 -36.96 71.74 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 120.602 0.239 . . . . 0.0 111.242 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.26 -45.0 74.36 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-O 120.654 0.264 . . . . 0.0 111.444 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.2 ptpm? -74.13 -39.92 63.0 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.522 -179.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.855 HD13 ' O ' ' A' ' 30' ' ' ILE . 0.0 OUTLIER -64.81 -36.89 78.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-O 120.56 0.219 . . . . 0.0 111.431 -179.672 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -64.81 -21.0 66.69 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -61.48 -14.31 27.87 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.9 mtpp -73.91 -42.7 60.27 Favored 'General case' 0 C--O 1.232 0.132 0 O-C-N 122.222 -0.299 . . . . 0.0 111.307 -179.311 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -144.19 -44.2 0.26 Allowed 'General case' 0 C--O 1.232 0.171 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.836 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.462 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . 107.44 68.29 0.66 Allowed Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.625 -0.797 . . . . 0.0 111.543 -179.307 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.65 HD11 ' CB ' ' A' ' 72' ' ' ARG . 19.7 tt -77.86 109.37 9.67 Favored Pre-proline 0 CA--C 1.532 0.287 0 CA-C-O 120.714 0.292 . . . . 0.0 111.533 -179.037 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.605 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 28.6 Cg_exo -62.96 -41.28 29.87 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.999 2.466 . . . . 0.0 114.422 -179.325 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.605 ' HD2' ' N ' ' A' ' 37' ' ' PRO . 21.8 Cg_endo -64.27 114.33 2.62 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 121.904 1.736 . . . . 0.0 113.086 -178.651 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -69.78 -1.88 10.49 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.516 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -90.06 10.98 22.14 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 122.073 -0.392 . . . . 0.0 111.998 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.461 ' CG ' HD13 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -90.02 97.06 10.97 Favored 'General case' 0 C--O 1.231 0.105 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 179.192 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.611 ' O ' HD13 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -133.91 -177.41 4.55 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.788 0.328 . . . . 0.0 111.174 -179.476 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.784 HD12 HD22 ' A' ' 69' ' ' LEU . 2.0 tp -99.13 143.59 29.23 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.927 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.8 mm -106.13 95.47 3.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.124 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 16.1 t80 -150.88 123.33 8.43 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.093 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.04 33.39 23.13 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.366 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 46.14 36.06 6.97 Favored Glycine 0 C--N 1.336 0.539 0 C-N-CA 120.868 -0.682 . . . . 0.0 113.047 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.425 ' HG2' ' CE2' ' A' ' 59' ' ' TYR . 0.3 OUTLIER -110.21 126.03 53.7 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.849 0.325 . . . . 0.0 110.962 -179.952 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -89.09 149.32 23.25 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.802 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.611 ' O ' HD12 ' A' ' 50' ' ' LEU . 4.1 pp -80.39 13.11 2.57 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -78.59 -42.61 28.58 Favored 'General case' 0 CA--C 1.528 0.097 0 O-C-N 121.978 -0.451 . . . . 0.0 110.76 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -48.18 118.46 2.41 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 179.295 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -68.89 49.28 0.49 Allowed Glycine 0 CA--C 1.522 0.472 0 C-N-CA 120.625 -0.798 . . . . 0.0 113.051 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.58 -172.63 2.11 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 117.169 0.484 . . . . 0.0 110.549 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.62 HG22 ' OD2' ' A' ' 58' ' ' ASP . 8.8 t -99.03 134.22 42.18 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.567 0.222 . . . . 0.0 110.627 179.646 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.945 HD21 ' CG1' ' A' ' 17' ' ' VAL . 3.1 pp -51.74 -34.27 38.37 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.624 0.249 . . . . 0.0 111.223 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.2 t -61.22 -35.12 76.35 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.414 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.62 ' OD2' HG22 ' A' ' 55' ' ' THR . 7.5 m-20 -53.86 -32.1 51.89 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 111.612 0.227 . . . . 0.0 111.612 -179.664 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.425 ' CE2' ' HG2' ' A' ' 48' ' ' LYS . 28.0 m-85 -97.9 14.95 25.38 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.3 t30 58.48 22.77 9.99 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.774 HG22 ' O ' ' A' ' 56' ' ' LEU . 2.3 tp -90.0 62.49 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 CA-C-O 120.775 0.322 . . . . 0.0 110.823 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.14 179.68 4.3 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.265 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.7 pttp -50.36 -179.9 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.33 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 67.25 -41.54 0.42 Allowed 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.33 0.492 . . . . 0.0 112.33 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.6 m -64.89 172.54 2.79 Favored 'General case' 0 C--N 1.332 -0.191 0 O-C-N 122.266 -0.272 . . . . 0.0 110.779 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.9 p -96.9 117.74 31.78 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.979 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 1.041 HD13 HD11 ' A' ' 3' ' ' ILE . 3.6 mp -109.04 117.36 33.98 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.013 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -107.18 123.55 48.43 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.906 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.784 HD22 HD12 ' A' ' 43' ' ' LEU . 2.5 mm? -101.33 163.54 12.22 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.851 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.9 m -104.92 173.72 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.134 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.1 mt -78.09 153.24 32.39 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.879 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.65 ' CB ' HD11 ' A' ' 36' ' ' ILE . 0.6 OUTLIER -92.99 -42.16 9.6 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.244 -179.953 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.404 HD23 ' NH1' ' A' ' 72' ' ' ARG . 2.8 mm? -81.67 44.6 0.83 Allowed 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 111.58 0.215 . . . . 0.0 111.58 179.646 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.16 98.23 11.65 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.657 0.265 . . . . 0.0 110.905 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 144.39 -72.47 0.35 Allowed Glycine 0 C--N 1.333 0.379 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.546 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.337 -1.257 . . . . 0.0 112.469 179.977 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.668 0.271 . . . . 0.0 111.224 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -95.04 123.05 38.31 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.891 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.913 HD12 ' HB3' ' A' ' 15' ' ' LEU . 21.7 mt -139.56 155.12 25.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.95 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -118.65 93.96 4.29 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.691 0.281 . . . . 0.0 110.931 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.566 HG22 ' HB3' ' A' ' 67' ' ' LEU . 21.3 t -119.55 151.97 22.05 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.022 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 6.4 ptpp? -109.87 140.31 43.97 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.808 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 75.5 p -99.97 -148.08 0.35 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.475 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.569 ' O ' HD23 ' A' ' 71' ' ' LEU . 1.3 pt? -65.31 -41.89 93.59 Favored 'General case' 0 C--N 1.341 0.218 0 CA-C-N 118.68 0.673 . . . . 0.0 111.571 -178.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.57 HG22 ' O ' ' A' ' 9' ' ' THR . 42.7 m -111.4 41.29 1.9 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.678 0.275 . . . . 0.0 111.065 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 50.7 39.03 37.66 Favored Glycine 0 CA--C 1.521 0.439 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.776 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.6 tttm -74.38 145.65 43.62 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.813 0.306 . . . . 0.0 110.767 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.56 ' O ' HG23 ' A' ' 12' ' ' THR . 9.7 t -93.74 106.18 18.17 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.781 0.324 . . . . 0.0 110.898 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.509 ' C ' HD12 ' A' ' 13' ' ' ILE . 2.3 pp -125.21 163.29 26.25 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.12 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 16.6 p -101.89 152.5 20.84 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.828 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.913 ' HB3' HD12 ' A' ' 3' ' ' ILE . 2.7 tp -127.99 92.8 3.53 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.976 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -100.98 121.56 41.98 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.849 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.741 HG21 HD21 ' A' ' 56' ' ' LEU . 27.7 m -140.06 173.94 9.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.156 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -96.88 167.22 12.45 Favored Pre-proline 0 C--O 1.231 0.13 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.934 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.35 -43.3 41.72 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.657 2.238 . . . . 0.0 112.487 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 36.9 m -89.27 3.09 53.2 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -75.06 120.23 20.3 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.664 0.268 . . . . 0.0 111.022 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 10.7 t -85.21 165.74 17.13 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.495 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.827 ' O ' HG12 ' A' ' 26' ' ' VAL . 43.4 mm -57.33 -37.45 57.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-O 120.528 0.204 . . . . 0.0 111.034 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -52.98 -31.45 40.82 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 120.487 0.184 . . . . 0.0 111.153 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -70.93 -42.8 69.37 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.765 -0.198 . . . . 0.0 111.335 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.827 HG12 ' O ' ' A' ' 23' ' ' ILE . 12.4 p -63.99 -21.7 29.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 111.675 0.25 . . . . 0.0 111.675 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.755 ' HD3' HD22 ' A' ' 50' ' ' LEU . 5.6 tptp -55.5 -35.03 65.15 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.573 0.225 . . . . 0.0 110.885 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.1 -37.47 87.6 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.581 0.229 . . . . 0.0 110.883 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.5 mttt -63.93 -48.62 75.81 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-O 120.636 0.255 . . . . 0.0 110.819 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.434 HG22 ' O ' ' A' ' 27' ' ' LYS . 2.6 tt -64.82 -39.15 84.67 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 CA-C-N 116.633 -0.258 . . . . 0.0 110.931 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -65.25 -21.45 66.74 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.721 -0.218 . . . . 0.0 111.07 179.394 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -61.33 -12.34 13.45 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 7.5 ptpp? -74.26 -36.73 63.85 Favored 'General case' 0 N--CA 1.461 0.092 0 O-C-N 122.013 -0.429 . . . . 0.0 110.819 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -176.4 -42.07 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.664 0.268 . . . . 0.0 111.558 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.518 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . 123.63 74.92 0.28 Allowed Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.646 -0.788 . . . . 0.0 111.589 -179.66 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.789 HD13 ' CD ' ' A' ' 41' ' ' GLN . 1.3 pp -78.31 102.34 0.95 Allowed Pre-proline 0 CA--C 1.532 0.279 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -179.087 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.698 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 10.6 Cg_endo -55.02 -42.63 67.23 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.564 2.176 . . . . 0.0 113.962 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.698 ' HD2' ' N ' ' A' ' 37' ' ' PRO . 6.1 Cg_exo -39.34 106.6 0.06 OUTLIER 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 122.762 2.308 . . . . 0.0 113.106 -179.101 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -68.61 -16.57 63.89 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.622 179.468 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -93.77 28.53 2.33 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.789 ' CD ' HD13 ' A' ' 36' ' ' ILE . 4.9 tt0 -91.91 89.07 6.86 Favored 'General case' 0 C--O 1.231 0.095 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 179.374 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.11 -179.06 6.27 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.96 -179.516 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.697 HD13 ' HG ' ' A' ' 67' ' ' LEU . 0.6 OUTLIER -97.6 160.18 14.47 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 120.718 0.294 . . . . 0.0 110.879 -179.873 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.643 ' O ' HG23 ' A' ' 44' ' ' ILE . 17.6 tt -100.91 80.03 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.13 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.635 ' HB2' HD12 ' A' ' 43' ' ' LEU . 0.3 OUTLIER -150.94 105.65 3.28 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.078 179.93 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.414 ' HB1' ' CE2' ' A' ' 59' ' ' TYR . . . 63.62 31.3 14.65 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.575 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 45.65 52.98 8.79 Favored Glycine 0 C--N 1.336 0.562 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.983 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.446 ' CD ' ' CE1' ' A' ' 59' ' ' TYR . 0.7 OUTLIER -106.62 115.82 30.86 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.785 0.292 . . . . 0.0 110.943 -179.955 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.19 173.19 8.55 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.772 0.32 . . . . 0.0 110.867 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.758 HD23 HG22 ' A' ' 23' ' ' ILE . 1.1 mt -79.15 -22.99 44.28 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.491 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -78.83 -35.68 43.69 Favored 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 121.256 -0.178 . . . . 0.0 111.339 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -48.06 114.69 0.98 Allowed 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 179.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -70.01 49.72 0.7 Allowed Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.483 -0.865 . . . . 0.0 112.592 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 -107.15 161.54 14.67 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.986 0.393 . . . . 0.0 110.815 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.557 HG23 ' H ' ' A' ' 58' ' ' ASP . 7.2 t -99.27 142.84 30.24 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.521 -0.308 . . . . 0.0 110.74 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.741 HD21 HG21 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -51.99 -43.71 63.73 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 111.745 0.276 . . . . 0.0 111.745 -179.286 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.1 t -58.84 -31.13 68.22 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -179.405 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.557 ' H ' HG23 ' A' ' 55' ' ' THR . 1.6 m-20 -56.82 -39.03 73.45 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 111.549 0.203 . . . . 0.0 111.549 -179.438 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.446 ' CE1' ' CD ' ' A' ' 48' ' ' LYS . 30.7 m-85 -99.82 17.51 20.58 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 47.5 t30 65.1 15.59 10.08 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 179.602 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.547 HD11 ' HA ' ' A' ' 56' ' ' LEU . 7.3 pt -90.03 60.97 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-O 120.836 0.351 . . . . 0.0 110.912 179.406 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.45 -160.15 0.77 Allowed 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.701 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.475 ' O ' ' CG ' ' A' ' 64' ' ' GLU . 2.4 pttp -39.89 144.56 0.19 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.682 0.277 . . . . 0.0 111.681 -179.596 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.475 ' CG ' ' O ' ' A' ' 63' ' ' LYS . 3.5 pt-20 54.49 26.68 7.43 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.023 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.4 p -76.05 173.38 11.34 Favored 'General case' 0 C--O 1.23 0.071 0 CA-C-O 120.672 0.272 . . . . 0.0 110.878 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.412 ' HB ' ' CE1' ' A' ' 45' ' ' PHE . 0.2 OUTLIER -107.1 81.86 1.6 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.356 179.395 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.697 ' HG ' HD13 ' A' ' 43' ' ' LEU . 0.3 OUTLIER -98.82 107.54 20.01 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.336 -179.405 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 8.4 t60 -107.13 103.77 13.25 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.582 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.475 HD12 ' CG1' ' A' ' 5' ' ' VAL . 0.2 OUTLIER -93.83 168.41 11.0 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.011 -179.773 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 32.9 m -103.87 174.41 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.216 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.569 HD23 ' O ' ' A' ' 8' ' ' LEU . 2.6 mp -77.81 149.65 34.39 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.745 0.307 . . . . 0.0 110.844 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.507 ' CZ ' HD13 ' A' ' 8' ' ' LEU . 0.4 OUTLIER -89.91 -32.77 16.7 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.437 -179.944 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.19 -53.65 6.48 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.68 0.276 . . . . 0.0 110.866 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.05 141.9 28.23 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.756 0.312 . . . . 0.0 110.873 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 142.5 60.74 0.03 OUTLIER Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.457 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.367 -1.24 . . . . 0.0 112.498 179.982 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.488 1.444 0 CA-C-O 120.69 0.281 . . . . 0.0 111.204 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -94.94 124.92 39.26 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.911 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.469 HG12 HD23 ' A' ' 67' ' ' LEU . 16.8 tt -138.92 153.2 24.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.077 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -118.99 127.52 53.54 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.65 0.262 . . . . 0.0 110.797 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 1.058 HG13 HD11 ' A' ' 67' ' ' LEU . 3.5 t -101.36 140.45 20.04 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.176 -179.788 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.78 87.2 2.47 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.444 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.41 119.94 40.82 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.539 -179.221 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -51.02 -20.87 1.53 Allowed 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 179.353 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 77.5 p -99.96 38.47 1.46 Allowed 'General case' 0 CA--C 1.531 0.248 0 O-C-N 122.033 -0.417 . . . . 0.0 111.442 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 49.03 30.13 9.32 Favored Glycine 0 C--N 1.336 0.567 0 C-N-CA 121.117 -0.563 . . . . 0.0 113.757 179.237 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.82 65.28 9.06 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 117.332 0.566 . . . . 0.0 110.714 179.489 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.616 ' O ' HG23 ' A' ' 12' ' ' THR . 13.6 t -92.98 99.76 12.33 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.89 0.376 . . . . 0.0 110.883 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.526 HD11 ' HD3' ' A' ' 33' ' ' LYS . 1.7 pp -125.54 172.55 12.88 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.167 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.27 132.7 51.14 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.656 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.436 ' HG ' HD13 ' A' ' 13' ' ' ILE . 62.3 mt -128.88 124.04 34.2 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.121 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -101.19 131.6 47.09 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.755 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.02 -176.23 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.925 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -102.58 160.87 24.96 Favored Pre-proline 0 C--N 1.333 -0.127 0 CA-C-O 120.636 0.255 . . . . 0.0 110.896 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -53.26 -50.12 15.08 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.482 2.121 . . . . 0.0 112.407 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.9 t -90.21 32.26 0.94 Allowed 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.354 0.501 . . . . 0.0 112.354 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.9 p-10 -75.24 119.48 19.43 Favored 'General case' 0 N--CA 1.461 0.114 0 O-C-N 122.202 -0.311 . . . . 0.0 110.976 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.41 HG23 ' H ' ' A' ' 25' ' ' ASN . 14.4 t -84.95 166.08 17.08 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-O 120.673 0.273 . . . . 0.0 110.822 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.684 ' HB ' HD12 ' A' ' 50' ' ' LEU . 9.8 tp -57.89 -37.99 63.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.641 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -63.45 -41.74 98.64 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.572 0.225 . . . . 0.0 111.25 -179.683 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.41 ' H ' HG23 ' A' ' 22' ' ' THR . 0.7 OUTLIER -73.14 -48.0 39.25 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 120.616 0.246 . . . . 0.0 111.161 -179.702 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.548 HG12 ' HA ' ' A' ' 23' ' ' ILE . 13.6 p -63.97 -21.42 28.76 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 111.698 0.259 . . . . 0.0 111.698 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.2 mtpm? -55.58 -35.06 65.37 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.502 0.191 . . . . 0.0 110.902 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.88 -37.62 74.28 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.625 0.25 . . . . 0.0 110.879 179.652 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.78 -38.01 64.79 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.849 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 33.2 mm -64.98 -45.16 95.49 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 CA-C-O 120.671 0.272 . . . . 0.0 110.622 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -59.89 -26.58 66.0 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.961 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -57.09 -22.94 43.29 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 111.691 0.256 . . . . 0.0 111.691 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.526 ' HD3' HD11 ' A' ' 13' ' ' ILE . 7.8 mtmp? -74.37 -39.08 62.97 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.605 0.24 . . . . 0.0 110.925 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.06 -48.64 0.24 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.692 -0.231 . . . . 0.0 111.238 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.505 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . 108.83 62.52 0.54 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.04 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.853 HD13 ' HB2' ' A' ' 41' ' ' GLN . 17.2 tt -78.51 108.3 7.58 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-O 120.696 0.284 . . . . 0.0 111.486 -179.512 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.591 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 26.0 Cg_exo -63.53 -40.66 29.39 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 122.747 2.298 . . . . 0.0 114.189 -179.448 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.591 ' HD2' ' N ' ' A' ' 37' ' ' PRO . 38.1 Cg_endo -68.5 133.16 27.21 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 122.02 1.813 . . . . 0.0 113.53 -178.62 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -70.71 14.67 0.13 Allowed 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.659 -0.7 . . . . 0.0 112.45 179.114 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -89.37 1.51 55.7 Favored 'General case' 0 N--CA 1.456 -0.138 0 O-C-N 122.135 -0.353 . . . . 0.0 110.543 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.853 ' HB2' HD13 ' A' ' 36' ' ' ILE . 2.6 tp60 -82.77 101.7 11.09 Favored 'General case' 0 C--O 1.231 0.097 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 179.078 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -133.88 178.19 7.14 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-O 120.742 0.306 . . . . 0.0 111.311 -179.415 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.864 ' CD1' HD12 ' A' ' 69' ' ' LEU . 8.7 tp -106.56 133.23 51.56 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.101 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.9 pt -111.26 107.4 22.85 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-O 120.752 0.311 . . . . 0.0 111.164 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -150.94 135.22 16.91 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.086 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.509 ' HB3' ' HD2' ' A' ' 48' ' ' LYS . . . 54.95 38.58 30.69 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.209 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 52.91 29.07 33.68 Favored Glycine 0 CA--C 1.522 0.51 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.941 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.509 ' HD2' ' HB3' ' A' ' 46' ' ' ALA . 14.4 mttm -110.47 102.24 10.87 Favored 'General case' 0 N--CA 1.457 -0.102 0 CA-C-N 117.016 0.408 . . . . 0.0 110.89 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -89.12 90.61 8.46 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.681 0.277 . . . . 0.0 110.89 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.684 HD12 ' HB ' ' A' ' 23' ' ' ILE . 0.6 OUTLIER -79.34 65.81 4.62 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.123 179.952 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -89.51 -42.09 11.66 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-O 120.607 0.241 . . . . 0.0 111.103 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -47.34 -69.29 0.13 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.742 0.306 . . . . 0.0 111.203 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.406 ' HA2' HG22 ' A' ' 23' ' ' ILE . . . 158.26 56.61 0.01 OUTLIER Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.681 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -106.02 177.49 4.84 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.591 0.234 . . . . 0.0 110.861 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.607 HG23 ' H ' ' A' ' 58' ' ' ASP . 9.9 t -99.1 154.87 17.78 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.711 0.291 . . . . 0.0 110.86 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.794 ' HA ' HD12 ' A' ' 61' ' ' ILE . 1.4 mp -59.31 -46.78 87.64 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.061 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.1 t -53.27 -39.15 63.68 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.484 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.607 ' H ' HG23 ' A' ' 55' ' ' THR . 45.2 t0 -53.9 -30.23 45.23 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 111.659 0.244 . . . . 0.0 111.659 -179.773 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.425 ' CD1' ' HD3' ' A' ' 48' ' ' LYS . 5.1 m-85 -101.99 40.36 1.34 Allowed 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 120.659 0.266 . . . . 0.0 111.601 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 54.84 27.34 8.83 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 179.429 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.794 HD12 ' HA ' ' A' ' 56' ' ' LEU . 27.6 mt -89.64 101.31 12.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-O 120.643 0.259 . . . . 0.0 110.858 179.555 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -94.97 166.22 12.05 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.782 0.325 . . . . 0.0 111.223 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -50.23 151.06 2.2 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.259 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 62.67 22.13 13.15 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.593 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.2 m -75.71 170.03 16.97 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-O 120.68 0.276 . . . . 0.0 110.815 179.755 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.05 111.76 23.84 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.393 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 1.058 HD11 HG13 ' A' ' 5' ' ' VAL . 2.1 pp -98.72 116.53 31.15 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.791 0.329 . . . . 0.0 111.53 -179.396 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -107.29 109.82 21.69 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.581 179.539 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.864 HD12 ' CD1' ' A' ' 43' ' ' LEU . 0.1 OUTLIER -93.9 179.71 5.25 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.958 -179.846 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -109.13 -178.2 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.62 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.1 mt -76.76 134.95 38.99 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.664 0.268 . . . . 0.0 110.782 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.602 ' CB ' HD12 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -88.61 -28.98 20.32 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.569 -179.843 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.7 tp -70.6 -51.43 28.24 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.711 0.291 . . . . 0.0 110.771 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.9 mtt85 -90.12 168.1 12.22 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.85 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 141.67 155.14 6.36 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.526 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.081 0 CA-C-O 118.377 -1.235 . . . . 0.0 112.517 179.968 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.487 1.394 0 CA-C-O 120.634 0.254 . . . . 0.0 111.242 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -94.97 132.28 39.99 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.532 -0.303 . . . . 0.0 110.945 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.641 HD11 HD21 ' A' ' 67' ' ' LEU . 15.1 tt -138.92 157.1 28.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.915 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -118.44 102.99 9.34 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.83 0.348 . . . . 0.0 110.864 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.875 HG22 HD11 ' A' ' 67' ' ' LEU . 11.8 t -122.22 151.42 25.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.121 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.761 ' O ' HD11 ' A' ' 69' ' ' LEU . 0.1 OUTLIER -106.83 135.12 48.91 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.854 179.957 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.75 -147.28 0.34 Allowed 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.331 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.501 ' HG ' HG23 ' A' ' 9' ' ' THR . 2.5 tp -68.43 -53.99 20.02 Favored 'General case' 0 C--N 1.342 0.282 0 CA-C-O 120.921 0.391 . . . . 0.0 110.75 -179.503 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.501 HG23 ' HG ' ' A' ' 8' ' ' LEU . 12.3 p -101.57 39.07 1.49 Allowed 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.304 -179.641 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 55.24 38.68 68.68 Favored Glycine 0 C--N 1.334 0.435 0 C-N-CA 120.817 -0.706 . . . . 0.0 113.133 179.454 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.9 ttmt -84.16 141.63 30.92 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 117.062 0.431 . . . . 0.0 110.556 179.559 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.41 ' O ' HG23 ' A' ' 12' ' ' THR . 14.9 t -92.95 121.99 34.85 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.64 0.257 . . . . 0.0 111.138 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.7 pt -125.13 136.06 62.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.954 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -98.87 130.31 45.27 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.903 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.9 pp -138.08 151.86 48.23 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.521 -0.308 . . . . 0.0 110.951 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -101.13 156.22 17.55 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.938 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 22.2 t -136.16 113.51 14.03 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.126 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -107.0 165.84 12.15 Favored Pre-proline 0 C--N 1.332 -0.166 0 CA-C-O 120.787 0.327 . . . . 0.0 110.855 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.49 -30.0 52.77 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.66 2.24 . . . . 0.0 112.535 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 82.1 p -78.74 -32.47 46.72 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.802 -0.181 . . . . 0.0 111.232 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -64.89 121.23 14.14 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.659 0.266 . . . . 0.0 110.74 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.05 149.82 25.3 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.02 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.812 HG22 ' O ' ' A' ' 54' ' ' ARG . 4.1 tt -68.06 -29.35 44.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.541 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.0 tm-20 -53.06 -60.32 3.43 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.73 0.3 . . . . 0.0 111.107 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 36.9 m-20 -74.85 44.09 0.21 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.857 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 14.6 p -69.12 -40.17 80.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.562 0.22 . . . . 0.0 111.144 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.8 mptt -66.07 -44.71 83.7 Favored 'General case' 0 N--CA 1.461 0.108 0 CA-C-O 120.669 0.271 . . . . 0.0 110.816 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.29 -40.85 98.53 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.053 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.88 -41.11 97.82 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.866 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 31.9 mt -75.03 -42.61 45.51 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.952 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -55.04 -37.82 67.19 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.702 0.287 . . . . 0.0 110.977 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.56 -16.12 44.97 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 112.16 0.429 . . . . 0.0 112.16 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 12.6 mmtt -74.79 -34.72 62.47 Favored 'General case' 0 N--CA 1.461 0.087 0 O-C-N 122.207 -0.308 . . . . 0.0 111.188 -179.634 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -167.11 -45.82 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 121.013 -0.275 . . . . 0.0 111.576 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 137.14 80.22 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.453 -0.88 . . . . 0.0 112.329 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.564 HD13 ' OE1' ' A' ' 41' ' ' GLN . 9.3 tt -78.35 113.29 32.72 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-O 120.565 0.221 . . . . 0.0 111.106 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.51 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 51.2 Cg_exo -53.36 -51.28 11.32 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.676 2.251 . . . . 0.0 113.291 -179.6 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.51 ' HD2' ' N ' ' A' ' 37' ' ' PRO . 31.6 Cg_endo -65.65 86.19 0.22 Allowed 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 121.975 1.783 . . . . 0.0 112.363 -179.617 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.31 -21.55 64.76 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.409 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 29.2 mt-30 -100.2 36.17 1.92 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 120.478 0.18 . . . . 0.0 111.421 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.564 ' OE1' HD13 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -88.23 131.25 34.83 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.576 0.227 . . . . 0.0 110.704 179.637 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.3 mtt180 -137.89 169.02 18.51 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.694 0.283 . . . . 0.0 111.061 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.63 ' CD1' HD22 ' A' ' 67' ' ' LEU . 49.6 mt -99.67 151.29 21.38 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.919 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.644 HG22 ' O ' ' A' ' 68' ' ' HIS . 4.8 tt -110.99 84.16 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 CA-C-O 120.765 0.317 . . . . 0.0 111.092 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -150.89 131.75 14.15 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.204 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.7 25.74 15.52 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.741 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 44.51 36.83 4.64 Favored Glycine 0 C--N 1.337 0.637 0 C-N-CA 120.777 -0.725 . . . . 0.0 113.081 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.1 mmpm? -110.06 136.46 49.27 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.835 0.317 . . . . 0.0 111.06 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.7 tp60 -89.12 162.98 15.66 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.931 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.686 HD13 HG12 ' A' ' 23' ' ' ILE . 4.2 mm? -80.48 19.57 0.78 Allowed 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -89.04 -41.23 12.45 Favored 'General case' 0 CA--C 1.529 0.155 0 O-C-N 122.038 -0.414 . . . . 0.0 111.171 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -48.28 114.51 0.96 Allowed 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 120.637 0.256 . . . . 0.0 110.325 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -69.97 50.43 0.71 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.411 -0.9 . . . . 0.0 112.467 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.812 ' O ' HG22 ' A' ' 23' ' ' ILE . 2.3 mmt180 -104.52 -178.72 3.74 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-N 116.946 0.373 . . . . 0.0 110.926 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.8 m -94.74 149.0 21.7 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.771 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.811 ' O ' HG22 ' A' ' 61' ' ' ILE . 0.4 OUTLIER -54.73 -47.33 73.92 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.988 -179.937 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.0 p -52.38 -30.26 28.14 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.36 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -53.91 -28.52 37.21 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 111.522 0.193 . . . . 0.0 111.522 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.504 ' CE2' HD13 ' A' ' 23' ' ' ILE . 61.7 m-85 -98.11 24.32 7.23 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 61.4 21.85 12.34 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 179.397 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.811 HG22 ' O ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -89.56 92.47 3.97 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 CA-C-O 120.853 0.359 . . . . 0.0 110.722 179.454 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -101.73 176.28 5.27 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.141 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.32 145.85 5.8 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.311 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 64.54 21.86 12.54 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.833 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 54.3 p -75.67 149.41 38.15 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 120.734 0.302 . . . . 0.0 110.996 179.66 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.5 m -107.09 90.2 3.23 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.553 179.517 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.875 HD11 HG22 ' A' ' 5' ' ' VAL . 0.5 OUTLIER -109.34 135.23 50.74 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.869 0.366 . . . . 0.0 111.261 -179.813 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.644 ' O ' HG22 ' A' ' 44' ' ' ILE . 16.4 m80 -107.34 142.07 37.72 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.715 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.761 HD11 ' O ' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -104.76 158.36 16.56 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.693 0.283 . . . . 0.0 111.159 179.69 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.3 p -114.1 152.43 15.77 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.927 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.7 mp -81.09 90.06 6.0 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.84 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.63 46.31 1.19 Allowed 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.366 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.8 mt -80.38 -44.58 19.16 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.66 0.266 . . . . 0.0 110.759 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 16.5 ttm180 -90.1 107.76 19.32 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.899 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -98.21 62.22 0.89 Allowed Glycine 0 C--N 1.332 0.36 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.495 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.088 0 CA-C-O 118.421 -1.21 . . . . 0.0 112.506 179.975 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.606 ' HB2' HG23 ' A' ' 14' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.565 0.222 . . . . 0.0 111.143 . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.8 mp0 -84.94 -17.12 38.75 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -179.39 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.507 HD12 ' CG2' ' A' ' 5' ' ' VAL . 14.5 pt -138.66 177.27 5.28 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.108 0 CA-C-O 120.71 0.291 . . . . 0.0 111.306 -179.753 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -118.88 101.31 7.96 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.703 0.287 . . . . 0.0 110.826 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.687 HG13 HD13 ' A' ' 69' ' ' LEU . 22.0 t -114.96 149.56 17.14 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.132 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 9.2 mmtt -106.92 130.72 54.54 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.9 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.43 -166.6 1.36 Allowed 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.271 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.932 HD13 ' HD3' ' A' ' 37' ' ' PRO . 0.6 OUTLIER -66.98 -43.39 83.14 Favored 'General case' 0 C--N 1.339 0.128 0 CA-C-O 120.8 0.333 . . . . 0.0 111.183 -178.79 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.427 ' N ' ' HG ' ' A' ' 8' ' ' LEU . 1.3 p -111.27 40.36 2.09 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.035 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 55.24 39.96 73.51 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.681 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.06 163.23 20.0 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.783 0.292 . . . . 0.0 110.898 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -103.04 122.8 45.39 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.864 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.666 HD11 HG11 ' A' ' 5' ' ' VAL . 10.6 pt -124.99 151.5 30.68 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-O 120.703 0.287 . . . . 0.0 111.234 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.606 HG23 ' HB2' ' A' ' 1' ' ' MET . 16.7 m -105.75 130.55 53.73 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.793 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.489 ' CB ' HD11 ' A' ' 3' ' ' ILE . 0.3 OUTLIER -137.56 130.31 30.04 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.576 -0.283 . . . . 0.0 110.984 179.98 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -100.95 175.05 5.74 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.77 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.7 HG11 ' HA ' ' A' ' 62' ' ' GLN . 26.1 t -132.81 108.99 13.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 120.81 0.338 . . . . 0.0 111.272 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.413 ' HB2' ' HD2' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -107.05 158.21 33.49 Favored Pre-proline 0 C--N 1.333 -0.15 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.498 179.811 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.413 ' HD2' ' HB2' ' A' ' 18' ' ' GLU . 3.7 Cg_endo -46.49 -53.36 6.12 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.627 2.218 . . . . 0.0 112.059 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.9 p -90.42 41.16 1.04 Allowed 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.636 ' OD1' HD12 ' A' ' 56' ' ' LEU . 13.8 t70 -74.56 94.89 2.7 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.65 0.262 . . . . 0.0 110.976 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.21 128.7 34.78 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.658 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.744 HD12 ' C ' ' A' ' 54' ' ' ARG . 7.1 mt -57.83 -35.04 49.82 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.329 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -71.33 -41.3 70.02 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.608 0.242 . . . . 0.0 111.08 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -73.02 -41.89 63.77 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.242 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.434 HG21 HD21 ' A' ' 15' ' ' LEU . 12.3 p -63.78 -36.23 75.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-N 116.759 -0.2 . . . . 0.0 111.285 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.735 ' HA ' HD12 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -55.82 -41.15 73.79 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.621 0.248 . . . . 0.0 110.888 179.912 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.95 -34.85 70.35 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.322 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 16.8 mtpt -63.68 -43.09 97.69 Favored 'General case' 0 CA--C 1.527 0.092 0 CA-C-O 120.633 0.254 . . . . 0.0 110.822 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.735 HD12 ' HA ' ' A' ' 27' ' ' LYS . 3.4 mt -66.47 -49.32 76.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 CA-C-O 120.702 0.287 . . . . 0.0 110.735 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 1.9 tp60 -65.16 -25.91 67.94 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.185 179.697 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -51.05 -31.23 17.93 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.64 -24.83 49.39 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 121.162 -0.215 . . . . 0.0 111.45 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 70.61 33.73 2.29 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.673 0.273 . . . . 0.0 110.704 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.479 ' O ' HD22 ' A' ' 8' ' ' LEU . . . -89.96 -39.99 5.99 Favored Glycine 0 C--N 1.334 0.454 0 C-N-CA 120.518 -0.849 . . . . 0.0 112.596 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.519 HG22 ' HD2' ' A' ' 38' ' ' PRO . 4.6 mt -89.33 110.08 36.04 Favored Pre-proline 0 CA--C 1.531 0.224 0 CA-C-N 116.656 0.228 . . . . 0.0 111.163 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.932 ' HD3' HD13 ' A' ' 8' ' ' LEU . 33.8 Cg_exo -57.65 -46.9 23.96 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.374 2.049 . . . . 0.0 113.077 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.519 ' HD2' HG22 ' A' ' 36' ' ' ILE . 60.6 Cg_endo -74.11 120.21 6.2 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.224 1.949 . . . . 0.0 112.894 -179.392 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -68.75 -18.83 64.28 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.19 179.402 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -93.01 34.02 1.13 Allowed 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 111.492 0.182 . . . . 0.0 111.492 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.52 ' O ' HD22 ' A' ' 50' ' ' LEU . 55.1 tp60 -82.35 111.79 18.73 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 179.496 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.678 ' CB ' HD13 ' A' ' 50' ' ' LEU . 7.1 ptt180 -139.67 178.79 6.98 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.885 -179.683 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.74 HD22 HD21 ' A' ' 67' ' ' LEU . 0.7 OUTLIER -97.84 166.46 11.46 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.875 179.949 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.625 ' O ' HG23 ' A' ' 44' ' ' ILE . 18.0 tt -109.47 89.14 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.158 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.472 ' HB2' HD12 ' A' ' 43' ' ' LEU . 1.3 t80 -150.83 109.09 3.75 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.153 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.34 33.68 18.79 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.556 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 46.23 45.33 15.64 Favored Glycine 0 C--N 1.336 0.541 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.97 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.417 ' HE2' ' CE1' ' A' ' 59' ' ' TYR . 26.1 tptt -101.42 129.92 47.54 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.803 0.302 . . . . 0.0 110.93 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -89.15 158.25 17.99 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.974 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.678 HD13 ' CB ' ' A' ' 42' ' ' ARG . 3.1 mp -79.22 -34.84 42.5 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.166 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -78.97 -10.46 59.83 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 111.678 0.251 . . . . 0.0 111.678 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -47.07 -42.81 19.39 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.66 0.267 . . . . 0.0 111.227 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.77 37.52 5.75 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.767 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.744 ' C ' HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -107.14 174.93 5.67 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.848 0.324 . . . . 0.0 110.728 179.783 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.494 HG22 ' H ' ' A' ' 57' ' ' SER . 49.8 m -99.19 135.25 40.87 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.814 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.697 HD22 HG21 ' A' ' 61' ' ' ILE . 14.5 mt -52.24 -38.14 57.22 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.011 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.494 ' H ' HG22 ' A' ' 55' ' ' THR . 8.0 t -61.31 -31.49 71.34 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.647 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -53.73 -37.83 63.74 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 121.207 -0.197 . . . . 0.0 111.418 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.417 ' CE1' ' HE2' ' A' ' 48' ' ' LYS . 6.1 m-85 -103.62 34.32 3.02 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 120.511 0.196 . . . . 0.0 111.439 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 54.8 28.0 9.69 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 179.598 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.697 HG21 HD22 ' A' ' 56' ' ' LEU . 28.2 mt -89.48 73.49 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.123 0 CA-C-O 120.768 0.318 . . . . 0.0 110.885 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.7 ' HA ' HG11 ' A' ' 17' ' ' VAL . 4.3 mm-40 -94.8 177.81 5.78 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.058 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.4 ' HA ' HG21 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -50.23 147.22 4.38 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.863 0.363 . . . . 0.0 111.276 -179.758 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 63.66 20.73 12.38 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.779 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.8 m -75.83 176.74 7.51 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-O 120.63 0.253 . . . . 0.0 110.951 179.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.621 ' O ' HG23 ' A' ' 66' ' ' THR . 10.5 t -101.44 82.96 2.38 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.472 179.553 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.74 HD21 HD22 ' A' ' 43' ' ' LEU . 0.3 OUTLIER -98.95 108.61 21.34 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.128 -179.626 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.9 m170 -107.13 124.34 49.55 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.659 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.687 HD13 HG13 ' A' ' 5' ' ' VAL . 5.4 mp -93.9 149.27 21.38 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.887 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.464 ' O ' ' NE2' ' A' ' 41' ' ' GLN . 21.6 t -104.1 144.09 14.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.03 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.4 mt -78.77 84.91 4.8 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.908 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 16.4 mmt-85 -92.93 62.53 3.66 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.674 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.6 pp -80.77 3.92 20.75 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -79.46 136.52 36.95 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-O 120.773 0.32 . . . . 0.0 110.904 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 126.74 60.37 0.14 Allowed Glycine 0 C--N 1.334 0.419 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.374 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.317 -1.268 . . . . 0.0 112.562 -179.92 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.737 ' HB3' HG22 ' A' ' 14' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.417 0 CA-C-O 120.577 0.227 . . . . 0.0 111.135 . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 -95.04 1.78 55.15 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -179.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.614 HG12 HG23 ' A' ' 5' ' ' VAL . 14.7 tt -138.91 154.96 26.68 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 O-C-N 122.33 -0.231 . . . . 0.0 111.118 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.83 81.63 1.73 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.719 0.295 . . . . 0.0 110.766 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.614 HG23 HG12 ' A' ' 3' ' ' ILE . 16.6 t -109.2 153.63 10.9 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.969 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.93 138.67 42.65 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.681 0.277 . . . . 0.0 111.046 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.567 HG21 ' HB3' ' A' ' 11' ' ' LYS . 6.0 p -99.9 -167.44 1.46 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.215 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.473 HD22 ' NE ' ' A' ' 72' ' ' ARG . 0.5 OUTLIER -60.36 -35.36 75.51 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.963 -179.814 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.53 -66.57 1.07 Allowed 'General case' 0 C--O 1.231 0.111 0 CA-C-O 120.827 0.346 . . . . 0.0 110.382 179.396 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 171.45 46.03 0.04 OUTLIER Glycine 0 CA--C 1.522 0.48 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.917 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.567 ' HB3' HG21 ' A' ' 7' ' ' THR . 0.5 OUTLIER -84.93 164.14 18.53 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.89 0.345 . . . . 0.0 111.071 179.993 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.1 p -103.17 123.57 46.96 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.48 179.52 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.3 tt -114.94 140.85 34.01 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.107 0 CA-C-O 120.736 0.303 . . . . 0.0 111.275 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.737 HG22 ' HB3' ' A' ' 1' ' ' MET . 17.0 p -106.03 119.51 39.39 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.784 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.525 HD12 HG21 ' A' ' 3' ' ' ILE . 5.0 mt -138.03 145.39 41.77 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.941 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -100.99 164.69 11.69 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.853 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.714 HG13 HD11 ' A' ' 56' ' ' LEU . 24.7 t -129.89 106.11 12.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.031 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.414 ' HB2' ' HD2' ' A' ' 19' ' ' PRO . 0.5 OUTLIER -102.09 163.32 17.97 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.812 179.966 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.414 ' HD2' ' HB2' ' A' ' 18' ' ' GLU . 53.5 Cg_exo -52.67 -48.74 20.36 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.452 2.101 . . . . 0.0 112.189 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.3 p -90.28 34.19 0.88 Allowed 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.778 ' CG ' HD21 ' A' ' 56' ' ' LEU . 18.0 t0 -75.31 106.65 6.95 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.727 0.299 . . . . 0.0 110.73 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.4 m -85.16 142.61 29.35 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.033 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.43 HG13 HD12 ' A' ' 50' ' ' LEU . 9.5 tp -68.05 -23.78 29.38 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.763 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -86.02 -33.96 20.91 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 120.477 0.179 . . . . 0.0 111.298 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -62.83 -38.93 92.71 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.522 0.201 . . . . 0.0 111.29 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.9 p -63.78 -31.1 51.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-N 116.754 -0.203 . . . . 0.0 111.444 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.668 ' CG ' HD23 ' A' ' 50' ' ' LEU . 14.7 tttt -56.0 -43.38 77.63 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.715 0.293 . . . . 0.0 110.823 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.86 -30.89 71.94 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.345 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.6 mttm -63.82 -39.4 94.15 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 120.567 0.222 . . . . 0.0 110.89 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 38.0 mm -64.98 -46.92 90.12 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 CA-C-O 120.698 0.285 . . . . 0.0 110.555 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.32 -42.88 92.54 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.588 179.71 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -61.25 -22.98 65.32 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.727 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.78 -44.36 50.02 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-O 120.73 0.3 . . . . 0.0 110.795 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -136.78 -50.61 0.66 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.131 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.432 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . 116.93 67.41 0.38 Allowed Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.931 -179.598 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.6 HG23 ' O ' ' A' ' 36' ' ' ILE . 19.8 tt -78.45 110.1 12.71 Favored Pre-proline 0 CA--C 1.531 0.249 0 CA-C-O 120.679 0.276 . . . . 0.0 111.368 -179.432 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.49 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 35.2 Cg_exo -60.29 -45.92 20.62 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.61 2.206 . . . . 0.0 113.212 -179.737 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.49 ' HD2' ' N ' ' A' ' 37' ' ' PRO . 58.1 Cg_exo -39.12 95.09 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.866 2.378 . . . . 0.0 113.221 -179.449 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -68.76 -17.57 64.06 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.405 179.482 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -93.5 30.98 1.61 Allowed 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 111.779 0.289 . . . . 0.0 111.779 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.431 ' CD ' HD21 ' A' ' 69' ' ' LEU . 1.8 tt0 -82.64 116.07 21.87 Favored 'General case' 0 CA--C 1.528 0.105 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 179.347 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.44 168.23 20.21 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.683 0.278 . . . . 0.0 111.387 -179.256 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -103.96 167.51 9.72 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.711 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.671 HG22 ' O ' ' A' ' 68' ' ' HIS . 8.0 tt -111.04 74.14 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.732 0.301 . . . . 0.0 111.129 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -150.91 112.57 4.46 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.343 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.6 ' HB1' ' CE1' ' A' ' 59' ' ' TYR . . . 59.75 25.44 14.44 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.849 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 43.45 45.63 6.79 Favored Glycine 0 C--N 1.337 0.595 0 C-N-CA 120.861 -0.685 . . . . 0.0 113.09 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.01 135.65 41.11 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.794 0.297 . . . . 0.0 110.898 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -89.1 161.06 16.73 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.963 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.668 HD23 ' CG ' ' A' ' 27' ' ' LYS . 1.3 tp -79.09 -20.4 48.84 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.533 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -78.62 -40.82 33.3 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-O 120.535 0.207 . . . . 0.0 111.065 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.418 ' O ' ' N ' ' A' ' 54' ' ' ARG . 0.5 OUTLIER -48.0 119.0 2.61 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 179.538 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.86 53.91 0.37 Allowed Glycine 0 CA--C 1.521 0.419 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.875 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.418 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -107.16 164.69 11.95 Favored 'General case' 0 CA--C 1.527 0.093 0 CA-C-N 117.01 0.405 . . . . 0.0 110.725 179.814 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.566 HG22 ' H ' ' A' ' 57' ' ' SER . 71.1 m -99.17 131.41 45.23 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.708 0.289 . . . . 0.0 110.666 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.778 HD21 ' CG ' ' A' ' 21' ' ' ASP . 0.3 OUTLIER -51.39 -33.58 30.67 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.699 -0.228 . . . . 0.0 111.007 -179.951 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.566 ' H ' HG22 ' A' ' 55' ' ' THR . 12.6 t -63.36 -36.29 83.22 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 111.713 0.264 . . . . 0.0 111.713 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.406 ' OD1' ' CD2' ' A' ' 59' ' ' TYR . 1.5 p30 -55.81 -31.67 62.88 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -179.18 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.6 ' CE1' ' HB1' ' A' ' 46' ' ' ALA . 4.5 m-85 -103.97 29.71 5.69 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 121.077 -0.249 . . . . 0.0 111.597 -179.735 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.452 ' ND2' ' O ' ' A' ' 60' ' ' ASN . 0.9 OUTLIER 65.15 12.97 8.41 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 179.62 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.697 ' O ' HD12 ' A' ' 56' ' ' LEU . 21.4 mt -89.91 62.93 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 O-C-N 122.17 -0.332 . . . . 0.0 110.692 179.448 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -104.19 -173.06 2.22 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.301 -179.383 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.3 ttpt -46.64 139.57 5.1 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.847 0.356 . . . . 0.0 111.388 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 65.26 15.77 10.18 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.134 -0.484 . . . . 0.0 112.196 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 40.3 t -76.05 -177.39 3.9 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 120.655 0.264 . . . . 0.0 110.67 179.393 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.33 91.58 3.77 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.515 -0.312 . . . . 0.0 110.409 179.457 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.42 HD11 ' CG2' ' A' ' 61' ' ' ILE . 3.8 mp -98.72 102.44 14.18 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.745 0.307 . . . . 0.0 111.23 -179.564 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.671 ' O ' HG22 ' A' ' 44' ' ' ILE . 0.3 OUTLIER -107.12 109.33 21.14 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.625 179.737 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.431 HD21 ' CD ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -94.04 179.44 5.33 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.929 -179.906 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.9 m -103.77 172.41 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.115 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.99 145.12 38.27 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.823 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.473 ' NE ' HD22 ' A' ' 8' ' ' LEU . 16.1 ptt180 -93.06 176.54 6.38 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.995 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -80.09 -35.5 36.81 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.164 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.78 128.73 33.79 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.718 0.294 . . . . 0.0 110.914 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 139.64 -42.08 1.26 Allowed Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.492 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.092 0 CA-C-O 118.299 -1.279 . . . . 0.0 112.546 179.946 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.6 ttt . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.66 0.267 . . . . 0.0 111.294 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 53.0 mm-40 -91.9 -42.01 10.28 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.005 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.487 HD11 ' HB3' ' A' ' 15' ' ' LEU . 2.4 pt -138.8 176.24 6.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-N 116.669 -0.242 . . . . 0.0 111.076 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -118.83 101.16 7.86 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.744 0.307 . . . . 0.0 110.907 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.485 ' CG2' HD13 ' A' ' 69' ' ' LEU . 11.1 p -136.19 138.37 47.21 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.746 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -107.28 168.74 9.01 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.878 0.37 . . . . 0.0 111.305 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.6 p -99.93 -168.27 1.57 Allowed 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.446 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.55 -22.48 66.98 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 120.933 -0.307 . . . . 0.0 111.563 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.2 t -100.56 -10.75 20.7 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.65 30.13 8.76 Favored Glycine 0 C--N 1.336 0.554 0 C-N-CA 120.507 -0.854 . . . . 0.0 113.111 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.6 tttm -84.29 170.28 13.83 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-N 117.161 0.481 . . . . 0.0 110.714 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.468 ' O ' HG23 ' A' ' 12' ' ' THR . 14.0 t -103.1 118.0 35.82 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.583 -0.281 . . . . 0.0 110.873 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.472 HG13 HG13 ' A' ' 5' ' ' VAL . 22.8 pt -125.18 157.55 33.9 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 CA-C-O 120.677 0.275 . . . . 0.0 111.211 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.4 p -106.03 125.82 51.45 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.838 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.487 ' HB3' HD11 ' A' ' 3' ' ' ILE . 0.3 OUTLIER -129.16 145.78 51.23 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.885 179.965 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -101.06 152.43 20.61 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.786 0.326 . . . . 0.0 110.809 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 24.2 t -133.51 132.16 57.49 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.044 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -107.1 159.95 28.17 Favored Pre-proline 0 C--N 1.332 -0.169 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.784 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -50.68 -49.93 15.26 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.465 2.11 . . . . 0.0 112.218 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 p -90.22 36.74 0.88 Allowed 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.0 p-10 -69.13 103.82 2.0 Allowed 'General case' 0 C--O 1.231 0.11 0 O-C-N 122.199 -0.313 . . . . 0.0 110.744 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.3 p -85.09 134.09 34.2 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.979 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.895 HD13 ' HE2' ' A' ' 48' ' ' LYS . 3.9 tp -65.06 -36.98 79.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.315 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -48.09 -51.64 23.69 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.612 0.244 . . . . 0.0 111.069 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.532 ' OD1' ' HB3' ' A' ' 28' ' ' ALA . 0.8 OUTLIER -74.78 43.63 0.2 Allowed 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 111.779 0.288 . . . . 0.0 111.779 179.632 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.531 ' O ' HG22 ' A' ' 30' ' ' ILE . 13.9 p -74.06 -39.52 50.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 CA-C-O 120.626 0.25 . . . . 0.0 111.298 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.487 ' HA ' HG22 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -55.94 -44.14 78.11 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.72 0.295 . . . . 0.0 110.936 179.913 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.532 ' HB3' ' OD1' ' A' ' 25' ' ' ASN . . . -64.27 -42.68 96.32 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.103 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 21.3 mtmm -70.82 -45.63 64.24 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.948 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.543 HG21 ' OE1' ' A' ' 41' ' ' GLN . 10.8 tp -70.34 -36.53 67.34 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.266 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.7 tm0? -59.33 -24.6 63.47 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.773 -0.194 . . . . 0.0 111.069 179.611 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -50.99 -25.21 4.41 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.59 -39.94 61.91 Favored 'General case' 0 C--O 1.231 0.089 0 C-N-CA 120.936 -0.306 . . . . 0.0 110.564 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 176.51 -39.17 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.716 0.294 . . . . 0.0 111.453 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.557 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . 131.94 80.49 0.19 Allowed Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.748 -179.559 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.613 HG23 ' O ' ' A' ' 36' ' ' ILE . 11.2 tt -77.68 106.1 3.42 Favored Pre-proline 0 N--CA 1.466 0.349 0 CA-C-O 120.799 0.333 . . . . 0.0 111.582 -179.19 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.639 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 17.1 Cg_exo -68.59 -35.6 16.72 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 123.03 2.486 . . . . 0.0 115.13 -179.081 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.639 ' HD2' ' N ' ' A' ' 37' ' ' PRO . 15.8 Cg_endo -60.52 113.45 1.7 Allowed 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 121.678 1.585 . . . . 0.0 113.393 -178.343 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -70.28 5.35 1.75 Allowed 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.399 179.047 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -89.73 8.74 30.17 Favored 'General case' 0 CA--C 1.53 0.199 0 O-C-N 122.088 -0.383 . . . . 0.0 111.4 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.543 ' OE1' HG21 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -82.59 99.41 9.53 Favored 'General case' 0 CA--C 1.527 0.08 0 CA-C-O 120.776 0.322 . . . . 0.0 110.453 179.41 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.77 169.74 16.61 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.971 -179.526 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.889 HD21 ' CD2' ' A' ' 67' ' ' LEU . 0.2 OUTLIER -97.99 140.74 31.88 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.796 179.883 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.564 ' O ' HG23 ' A' ' 44' ' ' ILE . 3.7 tt -107.83 65.08 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 120.793 0.33 . . . . 0.0 111.102 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -150.89 121.07 7.23 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.737 0.303 . . . . 0.0 111.219 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.93 25.59 15.56 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.787 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 45.13 55.71 6.41 Favored Glycine 0 C--N 1.338 0.65 0 C-N-CA 120.836 -0.697 . . . . 0.0 113.039 179.763 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.895 ' HE2' HD13 ' A' ' 23' ' ' ILE . 0.3 OUTLIER -102.03 135.01 44.34 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.702 0.287 . . . . 0.0 110.96 -179.934 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -89.09 154.17 20.4 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.872 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.629 HD12 ' N ' ' A' ' 51' ' ' GLU . 4.5 pp -69.78 -39.44 76.64 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.06 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.629 ' N ' HD12 ' A' ' 50' ' ' LEU . 0.0 OUTLIER -89.76 10.97 21.44 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 179.929 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -47.06 -45.68 21.86 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.683 0.278 . . . . 0.0 111.194 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.39 8.12 56.52 Favored Glycine 0 CA--C 1.523 0.589 0 C-N-CA 120.591 -0.814 . . . . 0.0 113.292 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.471 ' O ' HG22 ' A' ' 23' ' ' ILE . 3.0 mmm180 -107.09 -177.61 3.41 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 117.326 0.563 . . . . 0.0 110.702 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.657 HG22 ' OD2' ' A' ' 58' ' ' ASP . 9.6 t -99.27 150.26 22.28 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.74 0.305 . . . . 0.0 110.71 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.4 mt -61.48 -39.82 92.31 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.734 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.7 t -58.62 -32.07 68.67 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.637 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.657 ' OD2' HG22 ' A' ' 55' ' ' THR . 3.1 m-20 -53.94 -35.03 61.28 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 121.13 -0.228 . . . . 0.0 111.476 -179.604 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -103.82 31.75 4.29 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 120.474 0.178 . . . . 0.0 111.401 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 65.18 14.0 9.1 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 47.6 mt -90.01 68.32 0.59 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.139 0 CA-C-O 120.743 0.306 . . . . 0.0 110.809 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -98.87 -178.46 3.97 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.187 -179.591 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.4 145.81 3.21 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.801 0.334 . . . . 0.0 111.409 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 65.55 13.88 9.15 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.234 -0.439 . . . . 0.0 112.179 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 39.5 t -76.16 -177.48 4.0 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-O 120.634 0.254 . . . . 0.0 110.71 179.426 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.7 m -100.9 83.65 2.57 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.314 179.417 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.889 ' CD2' HD21 ' A' ' 43' ' ' LEU . 7.8 tt -98.83 111.22 23.67 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.751 0.31 . . . . 0.0 111.365 -179.467 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 17.6 t60 -107.11 125.81 51.55 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.599 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.485 HD13 ' CG2' ' A' ' 5' ' ' VAL . 0.2 OUTLIER -96.53 111.14 23.37 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-O 120.732 0.301 . . . . 0.0 111.084 -179.776 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.1 t -114.1 149.94 16.27 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.015 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.1 pp -87.25 100.03 12.39 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.962 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.487 ' NH2' HD12 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -93.15 105.61 17.67 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.864 179.852 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.4 mt -70.79 -48.03 56.41 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.857 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -90.02 122.93 33.47 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.913 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 142.35 63.7 0.03 OUTLIER Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.547 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.338 -1.257 . . . . 0.0 112.55 -179.924 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.583 0.23 . . . . 0.0 111.135 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -93.04 91.28 7.28 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.741 0.305 . . . . 0.0 110.88 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.49 HG21 ' HB3' ' A' ' 15' ' ' LEU . 17.7 tt -138.94 154.14 25.73 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.965 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -118.64 104.37 10.56 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.756 0.312 . . . . 0.0 110.895 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 1.033 HG13 HD23 ' A' ' 67' ' ' LEU . 1.7 t -103.25 163.4 3.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.892 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.8 tppt? -106.62 121.23 43.91 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.758 0.313 . . . . 0.0 110.662 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.404 ' OG1' ' N ' ' A' ' 11' ' ' LYS . 2.7 p -99.82 -176.44 3.26 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.192 -179.595 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.67 -40.11 88.45 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-O 120.696 0.284 . . . . 0.0 111.591 -178.78 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -111.04 43.23 1.48 Allowed 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.204 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 45.0 38.03 5.8 Favored Glycine 0 C--N 1.335 0.511 0 C-N-CA 120.95 -0.643 . . . . 0.0 113.291 179.562 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.404 ' N ' ' OG1' ' A' ' 7' ' ' THR . 7.8 tttt -84.12 144.46 29.01 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.856 0.328 . . . . 0.0 110.791 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.537 ' O ' HG23 ' A' ' 12' ' ' THR . 14.7 t -95.38 110.65 22.65 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.731 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.0 pt -125.09 164.19 24.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.201 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.7 t -100.55 150.64 22.48 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.781 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.49 ' HB3' HG21 ' A' ' 3' ' ' ILE . 0.9 OUTLIER -134.87 100.74 4.68 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.676 0.274 . . . . 0.0 110.963 -179.87 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -96.39 126.46 41.61 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.841 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.1 m -139.26 173.51 11.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.738 0.304 . . . . 0.0 111.272 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.425 ' HB2' ' HD2' ' A' ' 19' ' ' PRO . 0.4 OUTLIER -105.37 158.38 32.34 Favored Pre-proline 0 C--O 1.232 0.162 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.533 179.833 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.566 ' O ' HG21 ' A' ' 55' ' ' THR . 1.5 Cg_endo -44.49 -48.02 10.54 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.825 2.35 . . . . 0.0 112.165 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 87.9 p -90.33 38.89 0.95 Allowed 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 179.641 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.579 ' OD2' HD23 ' A' ' 56' ' ' LEU . 17.9 p-10 -75.04 116.72 16.09 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.658 0.266 . . . . 0.0 110.912 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.13 169.02 14.3 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.794 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.414 ' O ' HG22 ' A' ' 26' ' ' VAL . 43.7 mm -67.4 -42.04 86.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.862 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -64.56 -40.14 95.02 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.005 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -62.74 -44.77 95.33 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.653 0.263 . . . . 0.0 110.788 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.414 HG22 ' O ' ' A' ' 23' ' ' ILE . 27.7 m -70.26 -18.65 21.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.5 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.6 tptm -55.62 -35.51 65.95 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.504 0.192 . . . . 0.0 111.116 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.67 -38.89 75.9 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.6 0.238 . . . . 0.0 111.05 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.1 mttm -63.95 -36.53 84.26 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.918 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 35.5 mm -64.93 -44.48 96.14 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.078 0 CA-C-O 120.752 0.31 . . . . 0.0 110.61 179.698 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -57.88 -28.24 64.0 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.864 179.567 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -51.78 -27.76 13.28 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 7.2 mmtt -74.82 -40.93 60.79 Favored 'General case' 0 C--O 1.23 0.079 0 CA-C-O 120.693 0.282 . . . . 0.0 110.596 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -175.47 -40.89 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.557 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.525 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . 108.87 64.79 0.56 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.544 -0.836 . . . . 0.0 111.632 -179.511 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.715 HD12 ' HG2' ' A' ' 72' ' ' ARG . 12.0 tt -78.22 107.54 5.83 Favored Pre-proline 0 N--CA 1.465 0.295 0 N-CA-C 111.741 0.274 . . . . 0.0 111.741 -179.085 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.525 ' HD3' ' O ' ' A' ' 35' ' ' GLY . 27.9 Cg_exo -62.49 -43.83 20.58 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.751 2.301 . . . . 0.0 113.578 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.505 ' HD2' ' N ' ' A' ' 37' ' ' PRO . 44.9 Cg_exo -38.03 117.62 0.26 Allowed 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 123.023 2.482 . . . . 0.0 113.685 -179.201 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -69.84 2.32 3.52 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 179.522 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -89.84 3.45 52.9 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 118.134 0.425 . . . . 0.0 111.803 -179.555 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 27.2 tp60 -82.88 97.53 8.71 Favored 'General case' 0 C--O 1.232 0.14 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.208 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.473 ' O ' HD23 ' A' ' 69' ' ' LEU . 3.0 mtp180 -137.5 -176.31 4.36 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.151 -179.215 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.673 HD23 ' CD2' ' A' ' 50' ' ' LEU . 4.1 mm? -97.4 134.57 40.49 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.623 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 32.1 mt -100.98 83.54 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.406 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -150.94 115.61 5.19 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.018 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.85 35.97 19.17 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.32 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 46.87 36.84 8.86 Favored Glycine 0 C--N 1.336 0.577 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.876 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -110.16 107.61 17.48 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.774 0.287 . . . . 0.0 111.038 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.05 130.68 35.47 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.53 179.618 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.673 ' CD2' HD23 ' A' ' 43' ' ' LEU . 1.3 pp -79.32 62.86 3.79 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.579 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -89.47 -66.32 0.93 Allowed 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.74 0.305 . . . . 0.0 110.414 179.406 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.456 ' O ' ' N ' ' A' ' 54' ' ' ARG . 19.0 t0 -48.56 125.44 9.86 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.01 179.112 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -65.2 60.7 0.09 OUTLIER Glycine 0 CA--C 1.522 0.52 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.565 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.456 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.3 OUTLIER -107.15 -172.9 2.17 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.94 0.37 . . . . 0.0 110.797 -179.904 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.566 HG21 ' O ' ' A' ' 19' ' ' PRO . 22.4 m -98.39 144.92 27.25 Favored 'General case' 0 N--CA 1.457 -0.11 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.622 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.642 HD12 ' N ' ' A' ' 57' ' ' SER . 3.8 pp -51.78 -40.67 60.76 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.203 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.642 ' N ' HD12 ' A' ' 56' ' ' LEU . 10.5 t -55.19 -52.09 64.45 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.395 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -64.66 -16.0 62.15 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 112.265 0.469 . . . . 0.0 112.265 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -97.8 38.12 1.33 Allowed 'General case' 0 CA--C 1.533 0.311 0 O-C-N 122.174 -0.329 . . . . 0.0 111.885 -179.527 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 66.74 -40.29 0.37 Allowed 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 179.41 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.514 HD12 ' HB2' ' A' ' 56' ' ' LEU . 1.1 pt -78.64 108.22 11.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.872 0.367 . . . . 0.0 111.328 -179.504 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.24 -174.8 2.69 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.951 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.2 150.68 2.34 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.791 0.329 . . . . 0.0 111.373 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 65.11 19.29 11.76 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.852 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.2 m -75.83 177.69 6.75 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.59 0.233 . . . . 0.0 110.872 179.669 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.99 114.85 26.5 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.3 179.376 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 1.033 HD23 HG13 ' A' ' 5' ' ' VAL . 4.8 mp -98.98 89.85 4.42 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.673 0.273 . . . . 0.0 111.48 -179.22 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -100.17 95.31 6.73 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.2 179.233 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.473 HD23 ' O ' ' A' ' 42' ' ' ARG . 0.8 OUTLIER -93.86 177.11 6.1 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.244 -179.426 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.42 HG22 ' N ' ' A' ' 71' ' ' LEU . 12.0 p -103.62 156.62 5.37 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.766 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.42 ' N ' HG22 ' A' ' 70' ' ' VAL . 2.7 mt -76.35 153.27 35.94 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 120.711 0.291 . . . . 0.0 110.939 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.715 ' HG2' HD12 ' A' ' 36' ' ' ILE . 15.2 mtt85 -93.83 26.08 3.32 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.402 HD13 ' HA ' ' A' ' 73' ' ' LEU . 4.4 mm? -80.31 -67.65 0.75 Allowed 'General case' 0 CA--C 1.527 0.093 0 CA-C-O 120.685 0.278 . . . . 0.0 110.795 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 15.6 ttt-85 -90.09 157.75 17.63 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.891 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -142.88 -106.01 0.56 Allowed Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.482 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.331 -1.26 . . . . 0.0 112.533 179.977 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.478 ' HG2' ' HB ' ' A' ' 14' ' ' THR . 5.6 tpt . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.561 0.219 . . . . 0.0 111.002 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.412 ' CB ' ' HG2' ' A' ' 63' ' ' LYS . 3.8 mm-40 -84.54 -6.86 59.4 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 112.484 0.549 . . . . 0.0 112.484 -179.346 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.741 HG22 ' O ' ' A' ' 15' ' ' LEU . 18.6 tt -138.46 147.95 25.01 Favored 'Isoleucine or valine' 0 C--O 1.231 0.1 0 C-N-CA 120.619 -0.432 . . . . 0.0 111.441 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -120.61 94.64 4.43 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.95 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.504 HG11 HD13 ' A' ' 15' ' ' LEU . 13.7 p -103.02 154.77 5.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.854 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 6.4 mmpt? -106.58 145.36 31.99 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.819 0.342 . . . . 0.0 111.022 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.6 p -99.53 -173.37 2.45 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.161 -179.649 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.425 HD13 ' HG2' ' A' ' 38' ' ' PRO . 1.1 pt? -66.9 -33.43 75.57 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-O 120.688 0.28 . . . . 0.0 110.682 -179.665 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.3 m -107.3 42.22 1.35 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.713 179.606 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 47.98 32.18 8.76 Favored Glycine 0 CA--C 1.521 0.467 0 C-N-CA 121.1 -0.571 . . . . 0.0 113.403 179.537 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -84.55 152.95 23.56 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 117.096 0.448 . . . . 0.0 110.788 179.646 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.4 ' O ' HG23 ' A' ' 12' ' ' THR . 12.2 t -103.14 122.53 44.9 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.716 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.404 ' CG1' ' CG1' ' A' ' 5' ' ' VAL . 38.6 pt -123.07 166.07 18.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 120.829 0.347 . . . . 0.0 111.367 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.478 ' HB ' ' HG2' ' A' ' 1' ' ' MET . 3.5 p -105.96 127.09 52.92 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.647 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.741 ' O ' HG22 ' A' ' 3' ' ' ILE . 0.3 OUTLIER -127.75 139.35 52.73 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-O 120.775 0.321 . . . . 0.0 111.22 -179.97 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -101.19 165.42 11.3 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.638 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.7 t -140.04 125.91 21.49 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-O 120.687 0.279 . . . . 0.0 111.284 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.449 ' HB2' ' HD2' ' A' ' 19' ' ' PRO . 1.7 pt-20 -107.08 158.19 33.55 Favored Pre-proline 0 C--N 1.333 -0.115 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.453 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.449 ' HD2' ' HB2' ' A' ' 18' ' ' GLU . 4.7 Cg_endo -47.1 -56.29 3.17 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.555 2.17 . . . . 0.0 112.124 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 41.6 p -90.45 41.73 1.07 Allowed 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.419 ' HB2' ' O ' ' A' ' 18' ' ' GLU . 8.3 t70 -72.78 111.35 7.84 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.638 0.256 . . . . 0.0 110.989 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.8 m -85.09 149.28 25.66 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.723 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.459 ' O ' HG12 ' A' ' 26' ' ' VAL . 28.7 mt -68.02 -36.82 76.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.285 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -73.92 -40.83 62.85 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 120.564 0.221 . . . . 0.0 110.984 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -67.26 -40.41 86.2 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.682 -0.235 . . . . 0.0 111.126 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.459 HG12 ' O ' ' A' ' 23' ' ' ILE . 12.1 p -63.83 -33.81 64.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-N 116.703 -0.226 . . . . 0.0 111.367 -179.79 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.799 ' HE3' HD13 ' A' ' 50' ' ' LEU . 0.4 OUTLIER -55.81 -45.37 78.29 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.724 0.297 . . . . 0.0 110.814 179.961 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.04 -30.26 69.45 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.367 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.5 ttmp? -63.69 -41.27 98.16 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 120.594 0.235 . . . . 0.0 110.899 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.508 HD12 ' HA ' ' A' ' 27' ' ' LYS . 4.1 mt -64.96 -47.55 87.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-O 120.679 0.276 . . . . 0.0 110.712 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.3 -45.73 83.19 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.594 179.693 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -61.11 -23.97 65.9 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.556 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -74.63 -64.56 1.01 Allowed 'General case' 0 CA--C 1.528 0.103 0 CA-C-O 120.575 0.226 . . . . 0.0 111.285 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -103.27 -41.44 6.04 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 111.5 0.185 . . . . 0.0 111.5 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.48 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . 96.95 56.64 1.13 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.515 -0.85 . . . . 0.0 111.822 -179.475 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.609 HG23 ' O ' ' A' ' 36' ' ' ILE . 10.1 tt -78.44 108.92 8.82 Favored Pre-proline 0 CA--C 1.531 0.225 0 CA-C-O 120.622 0.249 . . . . 0.0 111.452 -179.474 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.48 ' HD3' ' O ' ' A' ' 35' ' ' GLY . 36.7 Cg_exo -60.8 -46.74 15.35 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.549 2.166 . . . . 0.0 113.036 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.457 ' HD2' ' N ' ' A' ' 37' ' ' PRO . 69.9 Cg_exo -40.72 104.88 0.05 OUTLIER 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.82 2.347 . . . . 0.0 113.287 -179.606 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.0 p-10 -69.12 -10.98 60.31 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.901 179.469 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.489 ' HG2' HD23 ' A' ' 73' ' ' LEU . 2.2 mp0 -90.79 22.31 3.64 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -179.622 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.851 ' OE1' HD21 ' A' ' 69' ' ' LEU . 0.6 OUTLIER -84.16 102.8 12.85 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 110.329 -0.249 . . . . 0.0 110.329 179.436 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.534 ' O ' HD13 ' A' ' 69' ' ' LEU . 0.9 OUTLIER -143.98 179.16 7.36 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-O 120.778 0.323 . . . . 0.0 111.41 -179.569 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.712 ' HB2' HD22 ' A' ' 67' ' ' LEU . 0.5 OUTLIER -108.16 141.64 39.58 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.871 179.828 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.604 ' O ' HG23 ' A' ' 44' ' ' ILE . 17.2 tt -111.05 75.39 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-O 120.766 0.317 . . . . 0.0 110.946 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -150.87 121.97 7.72 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.271 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 56.27 34.91 24.89 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.619 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 46.43 44.55 16.04 Favored Glycine 0 C--N 1.335 0.477 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.895 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.423 ' HE2' ' CD1' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -99.99 109.63 21.96 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.713 0.292 . . . . 0.0 110.904 -179.995 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -89.19 151.88 21.92 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.983 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.799 HD13 ' HE3' ' A' ' 27' ' ' LYS . 5.4 mt -79.24 -8.81 59.32 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.761 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -78.67 -41.47 31.18 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 122.334 -0.229 . . . . 0.0 111.108 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -47.8 114.83 0.98 Allowed 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 116.658 -0.246 . . . . 0.0 110.373 179.665 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -69.85 46.2 0.57 Allowed Glycine 0 CA--C 1.521 0.461 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.892 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.455 ' C ' HD12 ' A' ' 23' ' ' ILE . 5.0 mmp_? -107.3 177.23 4.91 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 117.128 0.464 . . . . 0.0 110.668 179.798 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 5.7 t -99.17 142.88 30.08 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.601 0.238 . . . . 0.0 110.436 179.7 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.65 ' HB3' HG23 ' A' ' 61' ' ' ILE . 84.0 mt -51.86 -43.11 63.1 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.715 0.293 . . . . 0.0 111.349 -179.522 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.8 t -54.55 -27.93 42.09 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -179.529 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -53.76 -40.91 66.61 Favored 'General case' 0 N--CA 1.465 0.318 0 O-C-N 122.259 -0.275 . . . . 0.0 111.548 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.423 ' CD1' ' HE2' ' A' ' 48' ' ' LYS . 33.8 m-85 -101.94 19.26 18.71 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 111.914 0.338 . . . . 0.0 111.914 -179.813 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 64.62 14.64 9.16 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.868 HD11 ' HG ' ' A' ' 67' ' ' LEU . 1.1 tp -90.0 62.16 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-O 120.841 0.353 . . . . 0.0 110.873 179.507 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 10.8 pm0 -95.26 -172.78 2.75 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.44 -179.307 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.412 ' HG2' ' CB ' ' A' ' 2' ' ' GLN . 0.1 OUTLIER -39.84 155.74 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.985 -179.444 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 65.3 16.01 10.31 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.806 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 17.7 p -76.32 145.94 39.21 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-O 120.561 0.219 . . . . 0.0 111.031 179.711 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 11.7 p -97.68 76.96 2.52 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 179.244 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.868 ' HG ' HD11 ' A' ' 61' ' ' ILE . 14.1 mt -99.94 131.77 45.7 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.832 0.348 . . . . 0.0 111.68 -179.176 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -107.2 139.84 41.0 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.25 179.214 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.851 HD21 ' OE1' ' A' ' 41' ' ' GLN . 0.1 OUTLIER -93.87 116.77 29.25 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.678 0.275 . . . . 0.0 110.858 -179.858 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.8 p -114.36 148.26 17.28 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.383 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -80.49 79.55 7.07 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.563 179.555 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.36 95.1 9.82 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.025 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.489 HD23 ' HG2' ' A' ' 40' ' ' GLN . 3.2 mt -80.14 -66.56 0.86 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.956 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -90.07 135.62 33.54 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.922 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -92.48 142.52 16.05 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.469 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.39 -1.228 . . . . 0.0 112.499 179.974 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.9 tpt . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.509 0.195 . . . . 0.0 110.945 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 64.5 mm-40 -84.49 -42.63 15.36 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.735 -0.211 . . . . 0.0 111.489 -179.345 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.822 HD12 HG23 ' A' ' 5' ' ' VAL . 1.1 pp -138.93 164.77 25.09 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 C-N-CA 120.711 -0.396 . . . . 0.0 111.672 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -129.07 111.93 13.48 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.873 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.822 HG23 HD12 ' A' ' 3' ' ' ILE . 39.0 t -111.4 155.11 12.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.893 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.712 ' O ' HD22 ' A' ' 69' ' ' LEU . 0.6 OUTLIER -106.56 165.5 11.24 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.673 0.273 . . . . 0.0 110.718 -179.89 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 66.7 p -109.82 -142.82 0.38 Allowed 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.647 -179.744 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.406 ' HG ' ' N ' ' A' ' 9' ' ' THR . 1.7 pt? -65.25 -38.57 90.75 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 118.615 0.643 . . . . 0.0 111.482 -179.316 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.406 ' N ' ' HG ' ' A' ' 8' ' ' LEU . 3.9 m -107.98 -60.55 1.7 Allowed 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.607 0.242 . . . . 0.0 110.894 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 165.56 53.32 0.02 OUTLIER Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.417 -0.897 . . . . 0.0 112.949 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.9 tttt -84.27 160.2 20.79 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.822 0.311 . . . . 0.0 110.675 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 26.8 p -94.91 104.68 16.57 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.876 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.641 HD11 ' HB ' ' A' ' 5' ' ' VAL . 25.3 pt -114.96 153.6 16.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-O 120.754 0.312 . . . . 0.0 111.172 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.1 p -106.07 149.89 26.29 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.935 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.751 ' HB2' HD11 ' A' ' 3' ' ' ILE . 0.3 OUTLIER -127.97 89.03 2.86 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-O 120.669 0.271 . . . . 0.0 111.264 179.954 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.13 94.91 6.22 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.766 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.492 HG11 HG12 ' A' ' 26' ' ' VAL . 29.8 m -129.94 174.12 13.13 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 CA-C-O 120.71 0.291 . . . . 0.0 111.288 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.06 160.06 27.53 Favored Pre-proline 0 C--O 1.231 0.13 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.107 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -55.44 -29.19 67.52 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.648 2.232 . . . . 0.0 112.839 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 42.0 t -78.78 -15.08 58.86 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 111.67 0.248 . . . . 0.0 111.67 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.441 ' OD2' HG12 ' A' ' 26' ' ' VAL . 1.5 t0 -64.94 122.0 15.96 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-O 120.674 0.273 . . . . 0.0 110.808 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.86 HG22 ' O ' ' A' ' 54' ' ' ARG . 0.3 OUTLIER -85.09 178.71 7.45 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.823 179.951 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.8 HG21 ' HB2' ' A' ' 50' ' ' LEU . 16.3 mt -68.17 -39.23 80.91 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.084 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -66.61 -41.25 88.7 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.658 -0.247 . . . . 0.0 111.069 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -62.96 -45.8 90.72 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.649 0.261 . . . . 0.0 111.004 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.494 HG22 ' O ' ' A' ' 23' ' ' ILE . 31.8 m -63.98 -29.7 48.01 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.524 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.498 ' HE2' HD11 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -55.62 -43.99 76.65 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.658 0.266 . . . . 0.0 110.807 -179.875 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.87 -33.07 74.02 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.046 179.597 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -63.9 -28.39 69.81 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.038 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.589 HD11 HD11 ' A' ' 15' ' ' LEU . 40.8 mm -75.25 -46.04 39.7 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.201 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.301 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -65.35 -40.52 93.71 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.91 178.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.27 -24.69 66.57 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.288 179.494 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.8 mmtm -74.78 -55.47 5.8 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.525 0.202 . . . . 0.0 111.295 -179.552 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -115.47 -49.77 2.74 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.618 0.247 . . . . 0.0 111.19 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 113.69 64.02 0.43 Allowed Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.679 -0.772 . . . . 0.0 111.851 -179.455 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.498 HD11 ' HE2' ' A' ' 27' ' ' LYS . 1.3 pp -77.89 111.59 19.07 Favored Pre-proline 0 CA--C 1.531 0.223 0 CA-C-O 120.634 0.254 . . . . 0.0 111.347 -179.296 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.562 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 31.5 Cg_exo -59.34 -43.61 39.47 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.683 2.255 . . . . 0.0 113.444 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.562 ' HD2' ' N ' ' A' ' 37' ' ' PRO . 54.9 Cg_endo -71.86 111.25 3.11 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.06 1.84 . . . . 0.0 112.755 -179.23 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -68.69 -13.61 62.48 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.055 -0.52 . . . . 0.0 112.098 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -91.08 21.9 4.02 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.454 0.538 . . . . 0.0 112.454 -179.414 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -93.11 97.77 10.89 Favored 'General case' 0 C--O 1.23 0.067 0 O-C-N 122.249 -0.282 . . . . 0.0 110.289 179.34 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.522 ' CG ' HD11 ' A' ' 50' ' ' LEU . 22.0 mtm180 -137.68 -175.82 4.21 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-O 120.715 0.293 . . . . 0.0 111.043 -179.451 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.633 HD22 HD22 ' A' ' 67' ' ' LEU . 1.1 pp -101.59 141.52 34.33 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.944 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.565 ' O ' HG23 ' A' ' 44' ' ' ILE . 20.3 tt -111.17 113.91 45.61 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.239 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -152.52 130.96 12.14 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.797 0.332 . . . . 0.0 111.306 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.82 28.87 13.04 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.776 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 45.07 48.15 9.86 Favored Glycine 0 C--N 1.336 0.543 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.903 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.444 ' HG2' ' CD1' ' A' ' 59' ' ' TYR . 12.4 mptt -99.88 140.75 33.64 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.764 0.282 . . . . 0.0 110.942 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.15 99.62 12.57 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.885 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.8 ' HB2' HG21 ' A' ' 23' ' ' ILE . 0.5 OUTLIER -79.27 -8.05 58.75 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.838 179.861 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -78.57 -30.45 46.77 Favored 'General case' 0 CA--C 1.53 0.21 0 O-C-N 122.346 -0.221 . . . . 0.0 111.29 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -45.43 -39.23 6.85 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.567 0.222 . . . . 0.0 111.3 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 105.16 49.32 1.0 Allowed Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.745 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.86 ' O ' HG22 ' A' ' 22' ' ' THR . 0.0 OUTLIER -107.3 -179.11 3.83 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.724 0.262 . . . . 0.0 110.698 179.801 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 10.6 m -99.08 140.72 32.81 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.643 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.617 ' O ' HG22 ' A' ' 61' ' ' ILE . 3.0 mp -51.77 -48.23 63.82 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.824 0.345 . . . . 0.0 110.833 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.5 t -55.31 -36.99 66.81 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.24 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -54.27 -35.69 62.81 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 111.505 0.187 . . . . 0.0 111.505 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.444 ' CD1' ' HG2' ' A' ' 48' ' ' LYS . 68.7 m-85 -100.09 21.26 13.09 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.3 m120 65.59 8.67 5.29 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 112.791 0.664 . . . . 0.0 112.791 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.706 HD11 ' CD2' ' A' ' 67' ' ' LEU . 1.2 tt -90.14 63.13 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-O 120.883 0.373 . . . . 0.0 110.666 179.321 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -94.57 -173.52 3.05 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.245 -179.423 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.416 ' O ' ' HG2' ' A' ' 64' ' ' GLU . 0.1 OUTLIER -39.96 147.68 0.09 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.727 -179.593 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.416 ' HG2' ' O ' ' A' ' 63' ' ' LYS . 0.7 OUTLIER 65.53 15.02 9.83 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.992 -179.747 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.5 m -76.23 174.2 10.43 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.754 0.312 . . . . 0.0 110.839 179.539 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.524 ' O ' HG23 ' A' ' 66' ' ' THR . 5.9 t -107.24 90.65 3.37 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.248 179.437 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.753 HD13 HD13 ' A' ' 3' ' ' ILE . 1.2 mt -98.9 113.86 26.19 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.747 0.308 . . . . 0.0 111.39 -179.376 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -107.22 120.93 43.47 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.385 179.361 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.712 HD22 ' O ' ' A' ' 6' ' ' LYS . 0.9 OUTLIER -93.76 156.45 16.67 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.713 0.292 . . . . 0.0 111.155 -179.648 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -104.07 166.22 3.08 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.747 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.3 mp -76.71 141.88 40.72 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.677 0.275 . . . . 0.0 110.751 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.13 106.56 15.03 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.062 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 7.3 mt -80.18 -42.53 23.2 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.84 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.05 133.1 35.42 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.671 0.272 . . . . 0.0 110.872 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 133.2 103.91 0.86 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.497 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.115 0 CA-C-O 118.395 -1.225 . . . . 0.0 112.5 179.997 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.1 mp0 . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.634 0.254 . . . . 0.0 111.05 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.411 HG21 ' HB3' ' A' ' 15' ' ' LEU . 17.4 tt -139.01 153.17 24.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.985 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -118.79 97.06 5.53 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.968 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.516 HG13 HD13 ' A' ' 69' ' ' LEU . 21.5 t -98.97 152.72 4.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.981 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.28 130.92 56.11 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.698 0.285 . . . . 0.0 111.014 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.6 p -100.03 175.53 5.73 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.45 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.941 HD23 HG23 ' A' ' 9' ' ' THR . 0.0 OUTLIER -66.86 -21.91 66.0 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 179.417 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.941 HG23 HD23 ' A' ' 8' ' ' LEU . 67.8 p -105.54 28.87 7.01 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.19 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 47.59 32.85 8.21 Favored Glycine 0 C--N 1.336 0.541 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.991 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.49 146.37 27.63 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.969 0.385 . . . . 0.0 111.023 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.0 t -103.22 110.32 22.25 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.804 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.717 HG21 ' HE3' ' A' ' 33' ' ' LYS . 3.0 pt -125.08 166.67 20.36 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.297 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.1 p -104.49 152.52 22.27 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.711 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.411 ' HB3' HG21 ' A' ' 3' ' ' ILE . 1.2 tp -137.99 140.29 40.11 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.668 0.271 . . . . 0.0 111.044 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -101.0 139.05 37.24 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.701 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.6 t -138.53 138.3 42.71 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 CA-C-O 120.78 0.324 . . . . 0.0 111.354 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.447 ' HB2' ' HD2' ' A' ' 19' ' ' PRO . 11.6 pt-20 -100.08 167.87 10.33 Favored Pre-proline 0 C--N 1.332 -0.156 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.55 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.447 ' HD2' ' HB2' ' A' ' 18' ' ' GLU . 52.7 Cg_exo -54.86 -58.88 0.99 Allowed 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.39 2.06 . . . . 0.0 112.164 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.5 t -90.58 38.51 0.95 Allowed 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -75.42 114.13 13.61 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-O 120.576 0.227 . . . . 0.0 111.067 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 31.1 p -85.18 158.43 20.37 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.639 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.597 ' O ' HG12 ' A' ' 26' ' ' VAL . 9.5 tp -57.97 -32.83 44.56 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-N 116.718 -0.219 . . . . 0.0 111.277 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -77.89 -40.76 38.86 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.642 0.258 . . . . 0.0 110.858 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -62.94 -34.77 78.18 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.15 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.597 HG12 ' O ' ' A' ' 23' ' ' ILE . 12.1 p -69.32 -15.68 19.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.623 ' O ' HG22 ' A' ' 30' ' ' ILE . 0.1 OUTLIER -55.47 -33.0 63.26 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.582 0.229 . . . . 0.0 111.104 -179.992 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.19 -36.39 79.51 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.57 0.224 . . . . 0.0 111.045 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.3 mttp -64.04 -43.49 95.39 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.706 -0.225 . . . . 0.0 111.114 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.823 HG12 HD13 ' A' ' 36' ' ' ILE . 1.2 tt -64.82 -30.36 50.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 116.727 -0.215 . . . . 0.0 111.252 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -65.22 -20.81 66.61 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 120.44 0.162 . . . . 0.0 111.238 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -51.99 -24.76 7.05 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 112.181 0.438 . . . . 0.0 112.181 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.717 ' HE3' HG21 ' A' ' 13' ' ' ILE . 0.3 OUTLIER -73.88 -73.49 0.22 Allowed 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.967 -179.585 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -167.1 41.36 0.05 OUTLIER 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.408 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . 53.02 87.81 0.01 OUTLIER Glycine 0 C--N 1.335 0.504 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.443 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.823 HD13 HG12 ' A' ' 30' ' ' ILE . 4.2 mp -78.55 110.76 15.09 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-O 120.571 0.225 . . . . 0.0 111.02 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.456 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 36.3 Cg_exo -59.86 -47.05 16.86 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.614 2.21 . . . . 0.0 113.085 -179.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.466 ' HD2' HG22 ' A' ' 36' ' ' ILE . 77.3 Cg_exo -41.12 96.24 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.669 2.246 . . . . 0.0 112.924 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -68.22 -20.29 64.82 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.449 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -99.98 34.39 2.32 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 111.552 0.205 . . . . 0.0 111.552 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.844 ' O ' HD22 ' A' ' 50' ' ' LEU . 3.7 tp60 -93.2 115.32 27.94 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-O 120.526 0.203 . . . . 0.0 110.485 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 11.1 ptt-85 -143.98 178.92 7.52 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.653 0.263 . . . . 0.0 111.199 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.889 HD22 HD21 ' A' ' 67' ' ' LEU . 0.8 OUTLIER -97.85 152.67 18.95 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.918 179.969 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.629 HG23 ' O ' ' A' ' 44' ' ' ILE . 2.2 tt -104.59 77.06 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 CA-C-O 120.848 0.356 . . . . 0.0 111.038 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -150.81 116.96 5.61 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.119 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.6 32.15 21.84 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.538 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 46.5 68.16 1.18 Allowed Glycine 0 C--N 1.337 0.595 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.993 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.416 ' HG3' ' CD2' ' A' ' 59' ' ' TYR . 0.3 OUTLIER -110.0 127.53 54.86 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 116.761 0.281 . . . . 0.0 111.039 179.953 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -89.19 126.51 35.51 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.854 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.844 HD22 ' O ' ' A' ' 41' ' ' GLN . 0.8 OUTLIER -79.14 -24.51 43.28 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.454 179.936 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.452 ' O ' ' O ' ' A' ' 52' ' ' ASP . 4.1 tt0 -78.89 -36.15 42.5 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 121.279 -0.168 . . . . 0.0 111.395 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.452 ' O ' ' O ' ' A' ' 51' ' ' GLU . 0.2 OUTLIER -49.11 -171.62 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 121.57 0.7 . . . . 0.0 111.517 179.952 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -118.9 40.63 2.21 Favored Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 115.329 -0.851 . . . . 0.0 112.18 179.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -97.7 155.23 17.1 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-O 120.66 0.266 . . . . 0.0 111.003 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.561 HG23 ' H ' ' A' ' 58' ' ' ASP . 8.8 t -99.14 156.59 16.87 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.939 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.787 ' O ' HG22 ' A' ' 61' ' ' ILE . 1.7 mp -62.37 -36.52 82.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.281 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.5 t -58.75 -42.13 88.13 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -179.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.561 ' H ' HG23 ' A' ' 55' ' ' THR . 4.5 p30 -57.28 -25.25 58.92 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -179.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.416 ' CD2' ' HG3' ' A' ' 48' ' ' LYS . 0.5 OUTLIER -97.65 12.8 32.39 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 111.736 0.273 . . . . 0.0 111.736 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.5 m120 54.81 28.68 10.66 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.787 HG22 ' O ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -89.5 96.32 6.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.173 0 CA-C-O 120.877 0.37 . . . . 0.0 110.746 179.668 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.05 172.72 7.96 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.762 0.315 . . . . 0.0 111.024 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.14 155.14 1.01 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.218 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 63.78 22.01 12.9 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.459 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -75.74 177.48 6.84 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-O 120.752 0.31 . . . . 0.0 110.8 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.5 m -107.06 80.98 1.48 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.561 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.889 HD21 HD22 ' A' ' 43' ' ' LEU . 0.7 OUTLIER -98.85 110.47 23.07 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.109 -179.769 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -107.08 125.13 50.64 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.66 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.516 HD13 HG13 ' A' ' 5' ' ' VAL . 9.5 mp -93.98 174.65 7.05 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.658 0.266 . . . . 0.0 110.917 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 30.2 t -103.83 141.29 19.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.036 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.1 mt . . . . . 0 C--N 1.333 -0.118 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.816 -179.94 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.0 mt-30 . . . . . 0 CA--C 1.527 0.088 0 CA-C-O 120.688 0.28 . . . . 0.0 110.691 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.831 HD11 ' HB3' ' A' ' 15' ' ' LEU . 27.3 pt -138.93 173.44 11.85 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.144 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -118.91 100.31 7.29 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.677 0.275 . . . . 0.0 110.896 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.6 t -105.07 149.74 8.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.109 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.409 ' HE3' ' CE1' ' A' ' 68' ' ' HIS . 0.1 OUTLIER -106.96 125.82 51.5 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.86 -179.966 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.3 p -99.21 -166.33 1.34 Allowed 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.45 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.402 ' HG ' ' N ' ' A' ' 9' ' ' THR . 0.5 OUTLIER -66.72 -44.06 82.62 Favored 'General case' 0 C--O 1.231 0.115 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -178.459 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.405 ' O ' HG22 ' A' ' 9' ' ' THR . 23.1 m -111.06 51.62 0.77 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.81 0.338 . . . . 0.0 111.319 -179.295 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 44.18 40.8 6.03 Favored Glycine 0 C--N 1.335 0.487 0 C-N-CA 121.183 -0.532 . . . . 0.0 113.344 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.6 tttt -84.22 134.9 34.53 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.827 0.314 . . . . 0.0 110.834 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.537 HG23 ' O ' ' A' ' 12' ' ' THR . 12.3 t -99.34 110.1 22.65 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.728 0.299 . . . . 0.0 110.907 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.1 pt -125.09 166.79 20.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.214 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.4 t -101.33 148.78 24.73 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.654 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.831 ' HB3' HD11 ' A' ' 3' ' ' ILE . 0.1 OUTLIER -137.94 108.9 6.72 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.708 0.289 . . . . 0.0 111.055 -179.876 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -101.01 138.12 38.48 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.707 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.6 t -140.06 149.0 22.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.745 0.307 . . . . 0.0 111.386 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.418 ' HB2' ' HD2' ' A' ' 19' ' ' PRO . 6.7 pt-20 -96.96 157.46 35.01 Favored Pre-proline 0 C--N 1.332 -0.164 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.7 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.418 ' HD2' ' HB2' ' A' ' 18' ' ' GLU . 10.7 Cg_endo -54.07 -36.03 83.51 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.852 2.368 . . . . 0.0 113.135 -179.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.9 0.47 56.57 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.46 128.09 34.55 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.648 0.261 . . . . 0.0 111.032 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.8 p -85.16 159.96 20.02 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.529 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.65 ' O ' HG12 ' A' ' 26' ' ' VAL . 1.4 tt -57.98 -36.38 56.03 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.469 -179.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -71.37 -32.3 68.33 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.751 -0.204 . . . . 0.0 111.288 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -62.88 -43.6 98.35 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.547 0.213 . . . . 0.0 111.164 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.65 HG12 ' O ' ' A' ' 23' ' ' ILE . 9.9 p -63.82 -28.6 45.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-N 116.738 -0.21 . . . . 0.0 111.32 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.661 ' NZ ' HD22 ' A' ' 50' ' ' LEU . 3.9 mmpt? -59.61 -30.4 68.66 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-O 120.527 0.204 . . . . 0.0 111.235 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.83 -52.93 63.46 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.546 0.212 . . . . 0.0 111.193 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 18.8 ptmt -63.91 -34.61 78.36 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.692 -0.231 . . . . 0.0 111.014 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.401 HD12 ' HE2' ' A' ' 27' ' ' LYS . 57.8 mt -75.22 -14.51 15.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 116.816 -0.175 . . . . 0.0 111.403 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -65.48 -13.24 58.38 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -50.36 -29.91 11.05 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.3 ptpp? -79.72 -21.91 43.97 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 121.036 -0.265 . . . . 0.0 111.432 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 74.47 40.77 0.39 Allowed 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.657 0.265 . . . . 0.0 110.794 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -142.78 30.78 2.04 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.426 -0.892 . . . . 0.0 113.053 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.544 ' HB ' ' CD ' ' A' ' 37' ' ' PRO . 29.3 mm -78.68 -61.3 0.54 Allowed Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 117.107 0.453 . . . . 0.0 111.681 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.544 ' CD ' ' HB ' ' A' ' 36' ' ' ILE . 5.1 Cg_exo -42.13 -51.19 4.9 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.73 2.287 . . . . 0.0 112.887 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' A' ' 37' ' ' PRO . 57.9 Cg_exo -37.39 140.7 0.22 Allowed 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.985 2.456 . . . . 0.0 113.379 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -69.02 -6.3 27.13 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.6 mm-40 -89.89 -28.48 19.19 Favored 'General case' 0 CA--C 1.53 0.211 0 O-C-N 122.115 -0.365 . . . . 0.0 111.567 -179.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 5.2 tp60 -82.87 71.56 9.97 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-O 120.788 0.327 . . . . 0.0 110.787 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.406 ' HA ' HD12 ' A' ' 50' ' ' LEU . 1.8 mtt180 -133.94 -179.08 5.32 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.814 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.594 HD11 HD23 ' A' ' 67' ' ' LEU . 1.0 OUTLIER -103.78 133.88 48.02 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.942 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.558 HG23 ' O ' ' A' ' 44' ' ' ILE . 12.7 tt -101.09 61.86 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.025 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -150.87 120.03 6.76 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.077 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 59.61 27.03 16.15 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.616 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 45.28 40.5 7.83 Favored Glycine 0 C--N 1.336 0.576 0 C-N-CA 120.78 -0.724 . . . . 0.0 113.07 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.442 ' HD3' ' CE1' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -103.85 125.94 50.63 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.86 0.33 . . . . 0.0 111.022 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -89.13 144.21 26.29 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.866 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.661 HD22 ' NZ ' ' A' ' 27' ' ' LYS . 1.1 mp -79.53 -5.56 55.14 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.37 -0.377 . . . . 0.0 112.006 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.445 ' O ' ' O ' ' A' ' 52' ' ' ASP . 5.1 mm-40 -78.69 -34.2 46.3 Favored 'General case' 0 CA--C 1.53 0.205 0 O-C-N 122.37 -0.206 . . . . 0.0 111.431 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.445 ' O ' ' O ' ' A' ' 51' ' ' GLU . 0.9 OUTLIER -48.94 -172.54 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 121.485 0.659 . . . . 0.0 111.51 179.872 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -117.0 41.7 2.04 Favored Glycine 0 N--CA 1.451 -0.361 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.257 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -104.44 162.03 13.58 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.664 0.268 . . . . 0.0 111.037 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.4 HG23 ' H ' ' A' ' 58' ' ' ASP . 8.8 t -99.14 148.12 24.4 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.821 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.83 ' O ' HG22 ' A' ' 61' ' ' ILE . 1.4 mp -51.85 -47.95 64.19 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.186 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.5 t -52.87 -29.09 26.19 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.728 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.4 ' H ' HG23 ' A' ' 55' ' ' THR . 35.6 t70 -53.65 -40.3 65.75 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.43 0.157 . . . . 0.0 111.357 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.442 ' CE1' ' HD3' ' A' ' 48' ' ' LYS . 36.9 m-85 -103.29 25.27 9.75 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 111.595 0.221 . . . . 0.0 111.595 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 56.27 24.02 7.76 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.83 HG22 ' O ' ' A' ' 56' ' ' LEU . 0.9 OUTLIER -90.01 62.69 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-O 120.815 0.341 . . . . 0.0 110.777 179.468 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -94.86 -172.16 2.64 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.917 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.454 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 18.4 tttp -40.52 142.35 0.43 Allowed 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.706 0.289 . . . . 0.0 111.55 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.454 ' HG3' ' O ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER 65.07 21.25 12.21 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.642 -179.838 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.4 p -75.59 175.61 8.41 Favored 'General case' 0 CA--C 1.527 0.08 0 CA-C-O 120.63 0.252 . . . . 0.0 110.835 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.0 m -102.59 86.19 2.73 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.682 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.594 HD23 HD11 ' A' ' 43' ' ' LEU . 5.5 mt -99.01 105.48 17.63 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.065 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.42 ' O ' HG22 ' A' ' 44' ' ' ILE . 3.6 t60 -107.09 121.11 43.85 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.785 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -96.69 169.77 9.65 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.748 0.309 . . . . 0.0 110.931 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.3 t -103.99 153.24 6.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.031 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.5 mp . . . . . 0 C--N 1.332 -0.155 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.844 179.993 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 . . . . . 0 CA--C 1.531 0.248 0 N-CA-C 111.62 0.23 . . . . 0.0 111.62 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.673 ' CD1' HD21 ' A' ' 67' ' ' LEU . 2.2 pt -138.53 174.58 9.96 Favored 'Isoleucine or valine' 0 C--O 1.231 0.092 0 CA-C-O 120.623 0.249 . . . . 0.0 111.159 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -118.9 106.55 12.6 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.732 0.301 . . . . 0.0 110.891 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.436 ' HB ' HD11 ' A' ' 13' ' ' ILE . 21.4 t -99.17 150.16 5.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.079 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.95 127.46 53.46 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.794 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.1 p -99.21 -168.29 1.6 Allowed 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.356 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.412 ' HG ' ' N ' ' A' ' 9' ' ' THR . 0.6 OUTLIER -66.79 -40.45 88.13 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 120.663 0.268 . . . . 0.0 111.355 -178.719 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.412 ' N ' ' HG ' ' A' ' 8' ' ' LEU . 0.9 OUTLIER -111.17 41.46 1.84 Allowed 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 120.721 0.296 . . . . 0.0 111.086 179.837 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 47.28 42.53 17.93 Favored Glycine 0 C--N 1.335 0.504 0 C-N-CA 120.861 -0.685 . . . . 0.0 113.066 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.9 mtpm? -84.22 163.04 19.95 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.749 0.274 . . . . 0.0 110.926 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.4 m -103.07 118.06 35.95 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.895 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.737 HD13 HD23 ' A' ' 15' ' ' LEU . 2.4 pp -125.17 158.16 33.41 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-O 120.697 0.284 . . . . 0.0 111.182 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.8 p -101.19 128.49 47.27 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.86 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.737 HD23 HD13 ' A' ' 13' ' ' ILE . 0.2 OUTLIER -132.3 144.61 50.71 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.922 -179.991 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -100.44 162.39 12.97 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.841 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.9 t -129.99 103.88 9.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.106 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.417 ' HB2' ' HD2' ' A' ' 19' ' ' PRO . 10.4 pt-20 -103.72 157.3 34.19 Favored Pre-proline 0 C--N 1.332 -0.172 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.66 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.417 ' HD2' ' HB2' ' A' ' 18' ' ' GLU . 8.0 Cg_endo -50.13 -57.15 2.48 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.621 2.214 . . . . 0.0 112.187 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 44.9 t -90.3 36.41 0.88 Allowed 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.627 ' HB3' HD21 ' A' ' 56' ' ' LEU . 12.7 t0 -75.26 107.37 7.32 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-O 120.695 0.284 . . . . 0.0 110.93 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.4 m -85.23 157.99 20.46 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.526 -0.307 . . . . 0.0 110.831 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.642 HG22 HD13 ' A' ' 50' ' ' LEU . 24.7 mt -65.78 -34.41 70.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.027 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -75.33 -33.35 61.12 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.725 -0.216 . . . . 0.0 111.151 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -62.79 -41.67 99.37 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.559 0.218 . . . . 0.0 111.059 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.635 HG22 ' O ' ' A' ' 23' ' ' ILE . 35.9 m -63.86 -23.5 33.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.614 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -55.82 -36.45 67.49 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 120.494 0.188 . . . . 0.0 111.196 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.78 -45.35 86.13 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-O 120.639 0.257 . . . . 0.0 111.181 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 14.1 mttm -63.91 -42.39 97.44 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.781 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.409 ' CG2' ' CG2' ' A' ' 36' ' ' ILE . 33.2 mm -75.01 -27.48 20.02 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.446 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.413 ' HA ' ' HG3' ' A' ' 37' ' ' PRO . 10.3 tt0 -65.15 -16.91 64.02 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -50.4 -32.67 18.27 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 111.601 0.223 . . . . 0.0 111.601 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.37 -30.58 23.52 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 121.125 -0.23 . . . . 0.0 111.07 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 65.31 26.22 12.12 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 120.61 0.243 . . . . 0.0 110.871 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.422 ' N ' ' HD2' ' A' ' 37' ' ' PRO . . . -112.08 -48.25 0.67 Allowed Glycine 0 C--N 1.334 0.465 0 C-N-CA 120.453 -0.88 . . . . 0.0 112.952 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.718 HD11 HD23 ' A' ' 69' ' ' LEU . 7.6 tt -84.21 -24.78 0.35 Allowed Pre-proline 0 CA--C 1.54 0.592 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -179.227 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.623 ' CD ' ' N ' ' A' ' 36' ' ' ILE . 78.3 Cg_exo -42.96 -41.7 9.05 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 122.309 2.006 . . . . 0.0 113.791 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.488 ' CD ' ' N ' ' A' ' 37' ' ' PRO . 66.8 Cg_exo -53.39 -147.78 0.0 OUTLIER 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.446 2.097 . . . . 0.0 112.668 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -68.09 -4.08 12.39 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -179.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -90.34 -4.08 57.32 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 121.97 -0.457 . . . . 0.0 111.856 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.415 ' HG3' HG23 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -93.21 89.63 6.51 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-O 120.582 0.229 . . . . 0.0 110.971 179.756 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -144.01 151.93 40.35 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.973 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.4 tp -107.97 142.38 38.19 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.847 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.583 HG23 ' O ' ' A' ' 44' ' ' ILE . 2.2 tt -111.06 65.86 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-O 120.752 0.311 . . . . 0.0 111.097 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -150.89 127.74 10.99 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.194 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.77 ' HB2' ' CZ ' ' A' ' 59' ' ' TYR . . . 59.86 31.41 20.74 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.636 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 45.21 39.3 6.91 Favored Glycine 0 C--N 1.337 0.584 0 C-N-CA 120.808 -0.71 . . . . 0.0 113.079 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.1 mttm -109.73 145.43 36.62 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.787 0.294 . . . . 0.0 110.954 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -89.07 174.4 7.9 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.866 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.642 HD13 HG22 ' A' ' 23' ' ' ILE . 0.2 OUTLIER -79.21 -37.16 38.86 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.184 -179.975 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -89.35 8.8 28.75 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -47.24 -41.03 17.79 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.646 0.26 . . . . 0.0 111.159 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.98 23.82 24.28 Favored Glycine 0 CA--C 1.522 0.504 0 C-N-CA 120.757 -0.735 . . . . 0.0 113.039 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.456 ' H ' HD12 ' A' ' 23' ' ' ILE . 26.6 mmt180 -107.38 177.25 4.9 Favored 'General case' 0 C--N 1.334 -0.083 0 CA-C-N 117.132 0.466 . . . . 0.0 110.753 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.47 HG23 ' O ' ' A' ' 21' ' ' ASP . 4.4 m -99.44 130.82 45.73 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.491 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.627 HD21 ' HB3' ' A' ' 21' ' ' ASP . 0.6 OUTLIER -51.21 -32.45 23.93 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 120.601 0.239 . . . . 0.0 110.916 179.974 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.2 t -61.5 -27.25 68.46 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.625 -0.262 . . . . 0.0 111.607 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.404 ' OD1' ' N ' ' A' ' 59' ' ' TYR . 2.5 p30 -53.74 -30.21 43.13 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 120.859 -0.336 . . . . 0.0 111.492 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.77 ' CZ ' ' HB2' ' A' ' 46' ' ' ALA . 3.4 t80 -107.8 37.09 2.53 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 120.569 0.223 . . . . 0.0 111.248 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 23.6 m120 54.77 32.91 18.47 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.649 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.613 ' O ' HD12 ' A' ' 56' ' ' LEU . 22.1 mt -89.37 76.46 1.3 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-O 120.69 0.281 . . . . 0.0 110.849 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.03 -174.34 2.51 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.0 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.54 144.89 1.41 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.78 0.324 . . . . 0.0 111.255 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 63.37 21.23 12.69 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.617 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.5 m -75.85 162.15 28.38 Favored 'General case' 0 CA--C 1.527 0.092 0 CA-C-O 120.642 0.258 . . . . 0.0 110.808 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -107.03 83.01 1.76 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.552 179.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.673 HD21 ' CD1' ' A' ' 3' ' ' ILE . 2.9 pp -98.92 126.93 44.72 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.132 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.571 ' CD2' HG21 ' A' ' 44' ' ' ILE . 3.1 t60 -107.06 117.94 35.4 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.686 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.718 HD23 HD11 ' A' ' 36' ' ' ILE . 0.2 OUTLIER -93.73 114.77 27.14 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.776 0.322 . . . . 0.0 110.817 -179.981 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.4 p -111.83 152.61 13.67 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.016 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.407 HD23 ' H ' ' A' ' 71' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--N 1.331 -0.236 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.883 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 52.6 mm-40 . . . . . 0 CA--C 1.53 0.179 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.415 HD12 ' CB ' ' A' ' 15' ' ' LEU . 0.9 OUTLIER -138.68 169.0 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.129 0 CA-C-O 120.582 0.23 . . . . 0.0 111.11 -179.607 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -118.5 103.8 10.08 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.74 0.305 . . . . 0.0 111.013 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.407 HG13 HD13 ' A' ' 69' ' ' LEU . 16.8 t -129.5 154.34 40.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.773 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.2 mttt -106.76 152.89 23.23 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.65 0.262 . . . . 0.0 111.022 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.431 HG22 ' HE2' ' A' ' 33' ' ' LYS . 0.3 OUTLIER -99.88 -143.47 0.33 Allowed 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.62 179.988 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.453 ' HG ' ' N ' ' A' ' 9' ' ' THR . 1.7 pt? -64.82 -41.6 95.64 Favored 'General case' 0 C--N 1.341 0.23 0 CA-C-N 118.791 0.723 . . . . 0.0 111.164 -179.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.453 ' N ' ' HG ' ' A' ' 8' ' ' LEU . 94.9 m -111.36 -64.91 1.22 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.774 0.321 . . . . 0.0 110.652 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 178.0 47.71 0.07 OUTLIER Glycine 0 CA--C 1.521 0.42 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.746 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.49 -179.65 7.2 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.729 0.3 . . . . 0.0 110.996 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.51 HG23 ' O ' ' A' ' 12' ' ' THR . 13.2 t -103.07 114.59 29.0 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.709 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 11.9 tt -123.65 136.26 60.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 120.704 0.288 . . . . 0.0 111.228 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.7 t -106.02 168.17 9.3 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.779 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.423 HD22 ' HA ' ' A' ' 15' ' ' LEU . 0.2 OUTLIER -134.13 87.3 2.35 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-O 120.702 0.287 . . . . 0.0 110.896 -179.977 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -101.03 93.88 5.72 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.801 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.918 HG11 HG22 ' A' ' 26' ' ' VAL . 31.5 m -131.47 174.53 12.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.208 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -97.05 164.3 18.15 Favored Pre-proline 0 C--N 1.332 -0.171 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.755 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -60.23 -38.44 75.99 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.64 2.227 . . . . 0.0 112.349 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.4 p -78.82 -24.35 44.56 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.389 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -64.86 118.89 9.69 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-O 120.641 0.257 . . . . 0.0 110.846 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.5 p -85.2 -175.43 5.72 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.826 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.642 HD12 ' O ' ' A' ' 54' ' ' ARG . 3.9 mt -63.11 -40.55 89.45 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.027 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -52.09 -44.04 64.2 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.665 0.269 . . . . 0.0 111.075 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.07 -34.83 78.42 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.917 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.918 HG22 HG11 ' A' ' 17' ' ' VAL . 21.3 t -73.84 -12.93 15.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.599 ' HE3' HD23 ' A' ' 50' ' ' LEU . 2.5 mmpt? -55.48 -39.15 70.05 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 120.569 0.223 . . . . 0.0 111.073 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.402 ' HA ' ' HG2' ' A' ' 31' ' ' GLN . . . -67.88 -42.39 81.32 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-O 120.717 0.294 . . . . 0.0 111.248 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.8 mttm -74.54 -40.0 61.99 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.669 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.691 HG22 ' O ' ' A' ' 26' ' ' VAL . 20.2 tt -74.35 -23.61 18.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -179.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.531 ' HA ' HD13 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -65.01 75.21 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 120.856 0.36 . . . . 0.0 110.959 -179.785 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.404 ' N ' ' O ' ' A' ' 30' ' ' ILE . 36.6 t70 -60.26 -67.89 0.35 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.137 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.431 ' HE2' HG22 ' A' ' 7' ' ' THR . 0.0 OUTLIER -85.77 -86.36 0.14 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.965 179.884 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -178.37 43.42 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 121.119 -0.232 . . . . 0.0 111.371 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -151.2 31.2 0.96 Allowed Glycine 0 C--N 1.334 0.458 0 C-N-CA 120.432 -0.889 . . . . 0.0 113.04 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.647 HG21 HG23 ' A' ' 30' ' ' ILE . 1.8 mp -88.93 -65.53 0.17 Allowed Pre-proline 0 CA--C 1.535 0.375 0 CA-C-N 117.09 0.445 . . . . 0.0 111.411 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.546 ' CD ' ' HB ' ' A' ' 36' ' ' ILE . 3.6 Cg_exo -38.74 -51.08 2.38 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 122.779 2.319 . . . . 0.0 112.977 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.408 ' HD2' ' N ' ' A' ' 37' ' ' PRO . 79.0 Cg_exo -41.33 163.65 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.711 2.274 . . . . 0.0 113.174 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -69.65 2.15 3.52 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -89.78 -21.71 22.5 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 118.17 0.441 . . . . 0.0 111.599 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.554 ' HG2' HG23 ' A' ' 36' ' ' ILE . 2.5 tp60 -93.11 109.98 21.47 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 120.996 -0.281 . . . . 0.0 110.785 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 3.7 ptp180 -142.36 160.83 39.5 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.015 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -108.03 160.42 15.8 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.824 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 25.1 mm -111.06 69.79 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.157 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.556 ' CE1' HG23 ' A' ' 66' ' ' THR . 0.7 OUTLIER -151.13 122.01 7.59 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.176 -179.984 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 56.59 31.98 20.1 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.547 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 45.86 37.55 7.35 Favored Glycine 0 C--N 1.335 0.522 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.974 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.435 ' HD3' ' CE2' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -110.02 134.29 52.29 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.846 0.323 . . . . 0.0 111.054 -179.977 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -89.09 162.76 15.81 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.837 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.599 HD23 ' HE3' ' A' ' 27' ' ' LYS . 0.1 OUTLIER -79.15 -13.17 59.89 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.612 179.868 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -78.97 -38.26 37.41 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 120.536 0.208 . . . . 0.0 111.141 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -47.98 118.12 2.21 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -68.21 54.18 0.43 Allowed Glycine 0 CA--C 1.521 0.443 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.666 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.642 ' O ' HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -107.07 173.85 6.15 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 117.002 0.401 . . . . 0.0 110.751 179.844 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.438 HG22 ' H ' ' A' ' 57' ' ' SER . 57.0 m -99.27 137.1 38.25 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.675 -0.239 . . . . 0.0 110.836 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.547 HD22 HG21 ' A' ' 61' ' ' ILE . 52.9 mt -52.26 -41.43 62.81 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.919 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.438 ' H ' HG22 ' A' ' 55' ' ' THR . 6.7 t -59.22 -29.38 67.47 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.432 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -53.68 -40.45 65.96 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 121.192 -0.203 . . . . 0.0 111.379 -179.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.435 ' CE2' ' HD3' ' A' ' 48' ' ' LYS . 62.2 m-85 -104.64 36.28 2.47 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-O 120.672 0.272 . . . . 0.0 111.374 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 55.47 25.63 8.0 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.547 HG21 HD22 ' A' ' 56' ' ' LEU . 38.1 mt -89.92 62.52 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.123 0 CA-C-O 120.812 0.339 . . . . 0.0 110.975 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.01 -174.81 2.67 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.033 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -44.47 144.1 1.14 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.823 0.344 . . . . 0.0 111.443 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 64.98 19.22 11.8 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.672 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 7.5 p -75.89 170.12 16.84 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-O 120.616 0.246 . . . . 0.0 110.873 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.567 ' O ' HG23 ' A' ' 66' ' ' THR . 7.8 t -107.12 83.69 1.86 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.437 179.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.436 HD11 ' CG2' ' A' ' 61' ' ' ILE . 13.0 mt -98.85 104.78 16.85 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.767 0.318 . . . . 0.0 111.325 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -107.19 100.88 10.31 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.627 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.489 ' N ' HD12 ' A' ' 69' ' ' LEU . 6.5 mp -93.97 163.26 13.56 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.559 -0.292 . . . . 0.0 111.029 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.7 t -103.98 121.38 55.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.065 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.814 ' O ' HD22 ' A' ' 71' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.367 0 CA-C-O 121.36 0.6 . . . . 0.0 111.379 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 82.2 mm-40 . . . . . 0 CA--C 1.529 0.153 0 CA-C-O 120.573 0.225 . . . . 0.0 110.944 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.554 ' H ' HD13 ' A' ' 3' ' ' ILE . 0.2 OUTLIER -146.21 -175.76 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.096 -179.993 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -118.66 99.22 6.65 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.775 0.322 . . . . 0.0 110.74 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.825 HG12 HD12 ' A' ' 69' ' ' LEU . 1.2 t -116.84 121.25 67.32 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.895 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 41.7 mttt -106.86 122.34 46.2 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.702 0.287 . . . . 0.0 110.845 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.62 ' HB ' HD12 ' A' ' 36' ' ' ILE . 0.7 OUTLIER -99.75 -75.01 0.58 Allowed 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -179.414 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.623 HD21 ' HD2' ' A' ' 11' ' ' LYS . 0.3 OUTLIER -68.64 -110.37 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 111.553 0.205 . . . . 0.0 111.553 -179.27 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.9 t -111.51 57.62 0.63 Allowed 'General case' 0 CA--C 1.529 0.155 0 O-C-N 122.175 -0.328 . . . . 0.0 111.038 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.95 37.01 5.83 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.632 -0.794 . . . . 0.0 113.23 179.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.623 ' HD2' HD21 ' A' ' 8' ' ' LEU . 13.1 tttm -84.39 142.09 30.38 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 117.077 0.438 . . . . 0.0 110.731 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.9 t -98.22 117.87 33.58 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.846 0.355 . . . . 0.0 110.924 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.3 pt -125.09 146.36 30.89 Favored 'Isoleucine or valine' 0 C--O 1.231 0.112 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.189 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.1 t -97.37 130.76 44.48 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.769 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -129.82 133.42 46.94 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.983 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -100.77 176.03 5.44 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.877 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.5 HG21 ' N ' ' A' ' 63' ' ' LYS . 21.7 t -129.99 104.59 10.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.755 0.312 . . . . 0.0 111.16 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -107.09 161.57 22.5 Favored Pre-proline 0 C--O 1.232 0.148 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.811 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_exo -51.74 -56.76 2.66 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.398 2.066 . . . . 0.0 112.365 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 38.7 p -90.3 38.26 0.93 Allowed 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.44 ' OD2' HD22 ' A' ' 56' ' ' LEU . 4.0 t70 -75.28 84.96 2.45 Favored 'General case' 0 C--O 1.232 0.182 0 O-C-N 122.308 -0.245 . . . . 0.0 110.912 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.726 ' O ' HG23 ' A' ' 26' ' ' VAL . 6.2 p -85.04 163.22 18.97 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.637 0.256 . . . . 0.0 110.807 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.433 HG22 ' HD2' ' A' ' 27' ' ' LYS . 34.5 mm -68.13 -42.89 85.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.001 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -54.1 -41.9 68.8 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.653 0.263 . . . . 0.0 110.986 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -68.71 -39.44 80.47 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.823 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.726 HG23 ' O ' ' A' ' 22' ' ' THR . 42.5 t -63.95 -44.64 97.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 CA-C-O 120.613 0.244 . . . . 0.0 110.906 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.433 ' HD2' HG22 ' A' ' 23' ' ' ILE . 1.6 mttm -59.39 -43.96 92.88 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.704 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.04 -37.11 73.75 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.126 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.54 ' HD3' HD13 ' A' ' 30' ' ' ILE . 12.9 tmtt? -66.9 -40.44 87.7 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.644 -0.253 . . . . 0.0 110.912 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.54 HD13 ' HD3' ' A' ' 29' ' ' LYS . 31.9 mm -69.8 -49.76 54.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.659 0.266 . . . . 0.0 110.895 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -65.08 -24.98 67.6 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.318 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -50.92 -32.25 20.15 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 111.605 0.224 . . . . 0.0 111.605 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.8 -27.81 26.58 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 121.218 -0.193 . . . . 0.0 111.296 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 67.87 31.67 5.61 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-O 120.66 0.267 . . . . 0.0 110.891 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -94.33 -42.27 4.03 Favored Glycine 0 C--N 1.334 0.437 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.377 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.62 HD12 ' HB ' ' A' ' 7' ' ' THR . 19.9 tt -89.17 110.93 41.98 Favored Pre-proline 0 CA--C 1.531 0.223 0 CA-C-O 120.6 0.238 . . . . 0.0 111.062 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.45 ' HB2' ' HD3' ' A' ' 38' ' ' PRO . 33.4 Cg_exo -58.58 -48.52 14.84 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.365 2.043 . . . . 0.0 112.512 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.45 ' HD3' ' HB2' ' A' ' 37' ' ' PRO . 84.4 Cg_exo -44.46 94.25 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.556 2.171 . . . . 0.0 112.488 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -68.2 -31.78 71.54 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.256 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.6 mm-40 -101.01 42.88 1.09 Allowed 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.64 0.257 . . . . 0.0 111.166 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.548 ' OE1' HD13 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -82.87 131.81 35.18 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.655 0.264 . . . . 0.0 110.722 179.662 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -134.88 -178.18 4.96 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.957 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.629 HD21 ' HB3' ' A' ' 67' ' ' LEU . 0.3 OUTLIER -97.87 126.53 43.29 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.766 179.978 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.637 HG23 ' O ' ' A' ' 44' ' ' ILE . 0.6 OUTLIER -101.06 88.8 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.841 0.353 . . . . 0.0 111.272 -179.992 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -150.87 131.92 14.32 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.17 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.6 29.63 19.15 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.656 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 45.53 40.95 8.88 Favored Glycine 0 C--N 1.336 0.555 0 C-N-CA 120.932 -0.652 . . . . 0.0 113.038 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.417 ' HG2' ' CE1' ' A' ' 59' ' ' TYR . 17.1 mttt -108.56 138.54 44.7 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.785 0.293 . . . . 0.0 110.953 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.1 tp-100 -89.11 120.54 30.6 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.974 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.7 mp -79.58 -6.1 56.36 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -78.75 -20.07 50.81 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 111.667 0.247 . . . . 0.0 111.667 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -46.44 -38.33 8.93 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.571 0.224 . . . . 0.0 111.34 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.97 43.04 2.5 Favored Glycine 0 CA--C 1.52 0.395 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.815 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.2 mmt85 -107.12 -176.54 3.1 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.797 0.298 . . . . 0.0 110.756 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.521 HG23 ' H ' ' A' ' 58' ' ' ASP . 12.9 t -97.27 172.22 7.93 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.66 0.267 . . . . 0.0 110.975 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.44 HD22 ' OD2' ' A' ' 21' ' ' ASP . 1.0 OUTLIER -62.36 -58.41 7.76 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.177 -179.893 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.3 t -52.97 -29.37 28.65 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.521 ' H ' HG23 ' A' ' 55' ' ' THR . 1.1 m-20 -53.7 -38.55 64.35 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 111.609 0.226 . . . . 0.0 111.609 -179.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.417 ' CE1' ' HG2' ' A' ' 48' ' ' LYS . 11.7 m-85 -101.55 20.51 15.94 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 62.93 16.91 9.6 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.54 ' HB ' HD11 ' A' ' 67' ' ' LEU . 23.6 pt -89.89 69.91 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 CA-C-O 120.797 0.332 . . . . 0.0 110.849 179.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -95.02 -174.01 3.12 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.179 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.5 ' N ' HG21 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -45.65 147.61 0.87 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.789 0.328 . . . . 0.0 111.515 -179.722 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 65.3 16.03 10.32 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.817 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.9 m -76.18 166.87 22.84 Favored 'General case' 0 CA--C 1.527 0.093 0 CA-C-O 120.738 0.304 . . . . 0.0 110.953 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.551 ' O ' HG23 ' A' ' 66' ' ' THR . 7.2 t -106.46 85.79 2.24 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.249 179.297 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.629 ' HB3' HD21 ' A' ' 43' ' ' LEU . 5.9 mp -98.93 114.36 26.94 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.456 -179.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -107.17 123.45 48.28 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.603 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.825 HD12 HG12 ' A' ' 5' ' ' VAL . 0.8 OUTLIER -93.78 141.79 28.1 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.707 0.289 . . . . 0.0 111.045 -179.831 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.2 p -114.08 152.75 15.71 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.093 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.332 -0.192 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.781 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 . . . . . 0 CA--C 1.535 0.378 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.493 HD11 ' HB2' ' A' ' 15' ' ' LEU . 10.9 pt -138.57 176.64 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.121 0 C-N-CA 120.907 -0.317 . . . . 0.0 111.509 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -118.97 99.82 6.98 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.717 0.294 . . . . 0.0 110.863 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.627 HG11 HD11 ' A' ' 13' ' ' ILE . 21.5 t -107.15 142.03 20.91 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.116 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.052 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.18 141.24 48.4 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.937 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.7 -163.66 1.05 Allowed 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.083 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.93 ' CD2' HG23 ' A' ' 9' ' ' THR . 0.0 OUTLIER -68.34 -30.5 69.48 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-O 121.056 0.455 . . . . 0.0 110.117 -179.899 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.93 HG23 ' CD2' ' A' ' 8' ' ' LEU . 33.3 p -111.19 -69.46 0.87 Allowed 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.784 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 175.07 47.79 0.05 OUTLIER Glycine 0 C--N 1.333 0.384 0 C-N-CA 120.489 -0.862 . . . . 0.0 112.988 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.68 144.14 28.75 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.861 0.33 . . . . 0.0 110.937 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.474 HG23 ' O ' ' A' ' 12' ' ' THR . 14.2 t -103.06 117.78 35.34 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.574 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.627 HD11 HG11 ' A' ' 5' ' ' VAL . 26.6 pt -125.04 153.24 32.1 Favored 'Isoleucine or valine' 0 C--O 1.231 0.112 0 CA-C-O 120.687 0.28 . . . . 0.0 111.453 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.8 t -106.03 139.16 41.0 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.872 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.493 ' HB2' HD11 ' A' ' 3' ' ' ILE . 1.4 tp -129.93 144.44 51.32 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.712 0.291 . . . . 0.0 110.903 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.51 147.09 25.11 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.83 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.461 HG21 ' HA ' ' A' ' 63' ' ' LYS . 21.5 t -130.02 102.07 6.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.201 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.412 ' HB2' ' HD2' ' A' ' 19' ' ' PRO . 2.2 pt-20 -107.12 161.57 22.51 Favored Pre-proline 0 C--O 1.232 0.162 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.507 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.412 ' HD2' ' HB2' ' A' ' 18' ' ' GLU . 89.3 Cg_exo -47.1 -53.33 6.48 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.507 2.138 . . . . 0.0 112.256 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.1 m -90.14 41.66 1.06 Allowed 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.801 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 46.1 p-10 -69.13 95.99 0.78 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.679 0.276 . . . . 0.0 110.806 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.03 137.82 32.82 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.951 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.676 HD12 ' O ' ' A' ' 54' ' ' ARG . 7.5 mt -68.02 -39.72 81.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.193 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -67.32 -41.76 84.76 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.134 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -62.85 -38.39 90.63 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.212 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.535 HG12 ' O ' ' A' ' 23' ' ' ILE . 12.2 p -73.52 -12.8 15.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 111.957 0.354 . . . . 0.0 111.957 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.461 ' HE2' HD12 ' A' ' 50' ' ' LEU . 12.8 ttmt -55.59 -48.74 74.37 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 120.691 0.282 . . . . 0.0 110.7 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.01 -29.18 68.12 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.14 179.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 24.7 mtpt -63.96 -33.76 76.45 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.753 -0.203 . . . . 0.0 110.953 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 33.8 mm -64.68 -42.73 95.87 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 CA-C-O 120.674 0.273 . . . . 0.0 110.495 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -65.16 -37.06 86.19 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 120.772 0.32 . . . . 0.0 110.68 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -61.49 -18.24 58.18 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.972 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 7.0 mtmm -74.04 -73.83 0.21 Allowed 'General case' 0 C--O 1.231 0.119 0 C-N-CA 121.044 -0.262 . . . . 0.0 111.086 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -137.59 23.7 2.91 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.439 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . 48.65 85.07 0.02 OUTLIER Glycine 0 C--N 1.337 0.636 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.387 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.745 HD13 ' HB2' ' A' ' 41' ' ' GLN . 1.1 pp -78.44 110.27 13.28 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 120.628 0.251 . . . . 0.0 111.292 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.557 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 34.7 Cg_exo -60.46 -43.41 33.81 Favored 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 122.733 2.288 . . . . 0.0 113.583 -179.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.557 ' HD2' ' N ' ' A' ' 37' ' ' PRO . 55.4 Cg_endo -71.92 118.87 5.84 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.058 1.839 . . . . 0.0 112.943 -179.091 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.0 p-10 -68.66 -12.81 61.83 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.974 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -90.96 22.49 3.63 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.745 ' HB2' HD13 ' A' ' 36' ' ' ILE . 0.7 OUTLIER -84.45 93.45 8.31 Favored 'General case' 0 CA--C 1.527 0.08 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 179.305 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.732 ' HG3' HD23 ' A' ' 50' ' ' LEU . 4.5 ttm180 -139.59 177.09 8.19 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.101 -179.286 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.56 ' CD1' HD12 ' A' ' 69' ' ' LEU . 2.2 mm? -97.91 165.23 12.03 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.459 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.401 ' CG1' ' HB2' ' A' ' 68' ' ' HIS . 1.4 pt -111.02 83.79 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-O 120.696 0.284 . . . . 0.0 111.174 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -150.85 115.46 5.18 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.233 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.78 24.37 14.5 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.859 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 44.37 39.86 5.82 Favored Glycine 0 C--N 1.338 0.654 0 C-N-CA 120.837 -0.697 . . . . 0.0 113.083 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.428 ' HG2' ' CE2' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -100.98 135.49 42.34 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.814 0.307 . . . . 0.0 110.853 -179.82 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -78.96 165.97 22.88 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.828 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.732 HD23 ' HG3' ' A' ' 42' ' ' ARG . 1.7 pp -79.35 -18.21 52.93 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.74 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -78.91 -26.4 43.78 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 111.782 0.289 . . . . 0.0 111.782 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 38.7 p-10 -47.82 115.52 1.19 Allowed 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 120.807 0.337 . . . . 0.0 110.604 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -70.73 46.73 0.73 Allowed Glycine 0 CA--C 1.521 0.434 0 C-N-CA 120.504 -0.855 . . . . 0.0 112.564 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.676 ' O ' HD12 ' A' ' 23' ' ' ILE . 1.5 mpp_? -107.26 170.42 7.97 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 117.029 0.414 . . . . 0.0 110.799 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 36.2 m -99.18 137.73 37.29 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.664 -0.243 . . . . 0.0 110.741 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.847 HD23 HG21 ' A' ' 61' ' ' ILE . 1.2 mp -52.05 -42.94 63.52 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.892 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.3 t -57.22 -31.19 65.24 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.479 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -53.83 -34.96 60.86 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 121.194 -0.202 . . . . 0.0 111.404 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.428 ' CE2' ' HG2' ' A' ' 48' ' ' LYS . 39.9 m-85 -103.29 36.23 2.32 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 120.548 0.214 . . . . 0.0 111.396 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 58.14 23.4 10.13 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.847 HG21 HD23 ' A' ' 56' ' ' LEU . 26.9 mt -89.81 77.09 1.35 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.141 0 CA-C-O 120.636 0.255 . . . . 0.0 110.962 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -94.96 172.63 8.03 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.714 0.292 . . . . 0.0 111.123 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.461 ' HA ' HG21 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -50.08 148.9 3.07 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.212 -179.892 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 63.3 22.69 13.44 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.444 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.1 m -75.64 177.45 6.8 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-O 120.706 0.288 . . . . 0.0 110.88 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.5 p -107.1 86.65 2.34 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.825 0.345 . . . . 0.0 110.639 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.5 mt -99.02 122.48 42.33 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.153 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.401 ' HB2' ' CG1' ' A' ' 44' ' ' ILE . 22.6 m-70 -107.09 140.58 39.7 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.813 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.56 HD12 ' CD1' ' A' ' 43' ' ' LEU . 0.3 OUTLIER -93.94 -174.42 3.41 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.927 -179.881 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.1 p -103.71 139.04 25.77 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-O 120.719 0.295 . . . . 0.0 111.046 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.332 -0.169 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.945 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 63.5 mm-40 . . . . . 0 CA--C 1.53 0.175 0 CA-C-O 120.6 0.238 . . . . 0.0 111.097 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.514 HD11 ' CB ' ' A' ' 15' ' ' LEU . 30.1 pt -138.73 175.57 7.92 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 CA-C-N 116.649 -0.25 . . . . 0.0 110.952 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -118.7 88.99 3.03 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.71 0.291 . . . . 0.0 110.874 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.894 HG22 HD11 ' A' ' 67' ' ' LEU . 21.5 t -108.89 128.35 64.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.179 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -107.51 153.64 22.54 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.752 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.449 HG21 ' OE2' ' A' ' 34' ' ' GLU . 0.2 OUTLIER -109.99 -146.95 0.41 Allowed 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 119.488 -0.291 . . . . 0.0 110.616 -179.959 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.54 ' HG ' HG23 ' A' ' 9' ' ' THR . 0.7 OUTLIER -65.18 -34.24 77.9 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 118.806 0.73 . . . . 0.0 111.542 -179.104 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.54 HG23 ' HG ' ' A' ' 8' ' ' LEU . 73.2 p -111.05 -56.53 2.36 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 120.629 0.252 . . . . 0.0 111.047 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 156.58 57.62 0.01 OUTLIER Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.823 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.2 mmmp? -84.13 154.09 23.33 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.708 0.254 . . . . 0.0 110.886 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.518 HG23 ' O ' ' A' ' 12' ' ' THR . 14.0 t -102.93 114.33 28.53 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.813 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.504 HD11 ' HB ' ' A' ' 5' ' ' VAL . 3.2 pt -118.25 147.3 21.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.141 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.8 p -105.91 114.5 28.68 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.903 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.514 ' CB ' HD11 ' A' ' 3' ' ' ILE . 0.2 OUTLIER -129.28 138.86 51.87 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.876 179.981 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -95.18 161.87 13.93 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.911 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.6 t -129.93 117.02 39.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.769 0.318 . . . . 0.0 111.231 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -100.58 164.12 16.83 Favored Pre-proline 0 C--O 1.231 0.101 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.711 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -53.19 -66.36 0.11 Allowed 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.625 2.217 . . . . 0.0 112.38 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.5 m -90.35 35.9 0.87 Allowed 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 112.054 0.391 . . . . 0.0 112.054 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.438 ' HB3' HD21 ' A' ' 56' ' ' LEU . 4.6 t70 -75.41 113.21 12.55 Favored 'General case' 0 C--O 1.231 0.132 0 CA-C-O 120.647 0.261 . . . . 0.0 110.925 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 10.2 t -85.16 173.8 10.15 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.856 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.507 HG21 ' O ' ' A' ' 50' ' ' LEU . 51.7 mm -68.16 -40.48 82.94 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.015 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -53.9 -40.01 66.27 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.681 -0.236 . . . . 0.0 111.14 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -62.86 -54.7 34.74 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 120.663 0.268 . . . . 0.0 110.906 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.4 p -63.96 -36.93 78.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.262 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.679 ' HA ' HD12 ' A' ' 30' ' ' ILE . 13.6 tttt -55.87 -41.06 73.83 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.719 -0.219 . . . . 0.0 110.935 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.88 -38.1 75.16 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.147 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.82 -43.31 96.62 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-N 116.67 -0.241 . . . . 0.0 110.806 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.679 HD12 ' HA ' ' A' ' 27' ' ' LYS . 4.0 mt -66.49 -49.1 77.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.865 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 1.4 tp-100 -59.79 -42.24 92.93 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.818 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -61.01 -25.79 67.15 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.279 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -74.86 -61.68 1.8 Allowed 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 121.173 -0.211 . . . . 0.0 111.095 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.449 ' OE2' HG21 ' A' ' 7' ' ' THR . 0.2 OUTLIER -103.17 -46.44 4.62 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.578 0.228 . . . . 0.0 111.089 -179.84 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.425 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . 85.05 42.97 6.87 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.976 -179.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.708 HG21 ' HG3' ' A' ' 41' ' ' GLN . 20.2 tt -78.77 110.55 14.65 Favored Pre-proline 0 CA--C 1.532 0.271 0 CA-C-O 120.713 0.292 . . . . 0.0 111.36 -179.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.504 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 31.7 Cg_exo -59.77 -45.72 23.64 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.764 2.309 . . . . 0.0 113.339 -179.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.504 ' HD2' ' N ' ' A' ' 37' ' ' PRO . 46.8 Cg_exo -37.84 122.52 0.51 Allowed 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.988 2.459 . . . . 0.0 113.425 -179.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -69.42 -3.89 16.21 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -90.25 11.21 21.86 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -179.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.708 ' HG3' HG21 ' A' ' 36' ' ' ILE . 1.0 OUTLIER -88.61 82.54 6.87 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-O 120.693 0.283 . . . . 0.0 110.416 179.358 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.823 ' O ' HG23 ' A' ' 70' ' ' VAL . 33.7 mtt180 -136.63 -175.16 3.92 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.976 -179.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.771 HD23 HD12 ' A' ' 69' ' ' LEU . 2.3 mt -97.97 153.97 18.0 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.846 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.583 HG23 ' O ' ' A' ' 44' ' ' ILE . 17.2 tt -111.04 71.17 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.803 0.335 . . . . 0.0 111.023 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -150.91 132.06 14.41 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.239 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 56.51 28.59 14.03 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.79 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 45.08 40.23 7.11 Favored Glycine 0 C--N 1.337 0.595 0 C-N-CA 120.797 -0.716 . . . . 0.0 113.0 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.02 127.84 46.19 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.837 0.318 . . . . 0.0 110.922 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -89.06 150.66 22.66 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.014 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.579 HD23 ' HG3' ' A' ' 27' ' ' LYS . 1.9 tp -79.18 -20.94 47.17 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.435 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -78.7 -35.45 44.96 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 120.436 0.16 . . . . 0.0 111.377 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -47.88 115.14 1.07 Allowed 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 110.338 -0.245 . . . . 0.0 110.338 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -69.85 48.49 0.64 Allowed Glycine 0 CA--C 1.522 0.475 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.746 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.0 mtp85 -107.25 -176.69 3.14 Favored 'General case' 0 C--O 1.23 0.07 0 CA-C-N 117.062 0.431 . . . . 0.0 110.646 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.9 m -99.37 134.77 41.76 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.555 0.216 . . . . 0.0 110.488 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.729 ' HB2' HG23 ' A' ' 61' ' ' ILE . 0.7 OUTLIER -51.59 -38.45 54.58 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.566 0.222 . . . . 0.0 110.689 179.915 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.6 t -56.23 -28.32 58.02 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.339 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -53.7 -35.04 60.68 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 111.572 0.212 . . . . 0.0 111.572 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -100.32 18.22 19.42 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 64.87 16.16 10.32 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.963 HD11 ' HB3' ' A' ' 67' ' ' LEU . 0.6 OUTLIER -89.92 71.23 0.76 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-O 120.878 0.37 . . . . 0.0 110.81 179.488 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -94.77 -178.03 4.39 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.441 -179.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.5 ptpt -47.37 146.1 2.15 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.581 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.504 ' H ' HG22 ' A' ' 3' ' ' ILE . 0.6 OUTLIER 65.53 12.62 8.32 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.356 179.932 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 41.2 t -76.28 -179.9 5.37 Favored 'General case' 0 C--O 1.231 0.08 0 O-C-N 122.259 -0.276 . . . . 0.0 110.79 179.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -107.12 80.6 1.44 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.342 179.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.963 ' HB3' HD11 ' A' ' 61' ' ' ILE . 3.2 pp -98.89 119.74 38.17 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-O 120.789 0.328 . . . . 0.0 111.319 -179.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 8.8 m170 -107.15 137.0 46.03 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.592 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.771 HD12 HD23 ' A' ' 43' ' ' LEU . 1.7 tp -93.93 171.47 8.84 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.654 0.264 . . . . 0.0 110.846 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.823 HG23 ' O ' ' A' ' 42' ' ' ARG . 28.6 t -103.81 129.54 55.75 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.161 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.639 HD12 ' O ' ' A' ' 71' ' ' LEU . 1.7 pp . . . . . 0 C--N 1.333 -0.141 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.87 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.678 0.275 . . . . 0.0 110.809 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.8 tp -138.69 152.91 25.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.941 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.49 80.77 1.58 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.777 0.322 . . . . 0.0 110.866 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.669 ' CG2' HD13 ' A' ' 69' ' ' LEU . 10.6 p -134.48 132.44 54.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.84 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.1 mptt -106.97 172.41 6.84 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.778 0.323 . . . . 0.0 111.071 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.4 p -99.91 -175.68 3.03 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.576 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -67.02 -4.04 8.74 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.4 p -99.78 -44.14 6.19 Favored 'General case' 0 CA--C 1.529 0.167 0 O-C-N 122.258 -0.276 . . . . 0.0 111.366 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 141.71 -26.22 2.39 Favored Glycine 0 CA--C 1.521 0.461 0 C-N-CA 120.264 -0.97 . . . . 0.0 113.486 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.8 tmtm? -73.49 143.28 46.66 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 117.416 0.608 . . . . 0.0 110.86 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.9 t -96.24 149.11 22.03 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.154 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 11.7 tt -125.03 152.24 31.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.076 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.7 m -96.01 135.1 38.22 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.632 -0.258 . . . . 0.0 110.739 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -138.05 142.62 40.31 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.731 0.3 . . . . 0.0 111.127 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -101.13 146.57 27.3 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.732 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.6 t -140.06 138.58 37.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.721 0.296 . . . . 0.0 111.306 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.418 ' HB2' ' HD2' ' A' ' 19' ' ' PRO . 11.4 pt-20 -107.14 162.88 18.27 Favored Pre-proline 0 C--N 1.334 -0.098 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.514 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.418 ' HD2' ' HB2' ' A' ' 18' ' ' GLU . 77.9 Cg_exo -48.26 -54.13 5.72 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.395 2.063 . . . . 0.0 112.208 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 98.1 p -90.4 42.16 1.09 Allowed 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.77 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.684 ' OD1' HG21 ' A' ' 26' ' ' VAL . 12.7 t70 -72.72 98.12 2.32 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 120.669 0.271 . . . . 0.0 110.989 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.4 p -85.14 136.31 33.6 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.708 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.558 HG21 ' O ' ' A' ' 50' ' ' LEU . 59.4 mt -68.1 74.01 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.708 0.289 . . . . 0.0 110.916 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -158.36 -59.38 0.08 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.012 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -72.5 -33.85 67.23 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.045 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.684 HG21 ' OD1' ' A' ' 21' ' ' ASP . 39.6 t -63.77 -24.77 36.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 116.794 -0.184 . . . . 0.0 111.471 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.481 ' CG ' HG23 ' A' ' 36' ' ' ILE . 0.6 OUTLIER -55.6 -41.71 73.81 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.701 0.286 . . . . 0.0 111.004 179.958 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.78 -39.92 90.64 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.201 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 76.6 mttt -63.97 -42.69 97.17 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.935 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.495 ' HB ' HG21 ' A' ' 36' ' ' ILE . 3.8 mt -70.71 -25.25 26.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.457 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -54.8 -28.95 52.97 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 120.514 0.197 . . . . 0.0 111.239 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -54.31 -24.47 19.25 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -74.33 -64.28 1.06 Allowed 'General case' 0 N--CA 1.461 0.111 0 C-N-CA 121.074 -0.25 . . . . 0.0 110.888 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -177.43 50.57 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 120.921 0.391 . . . . 0.0 111.549 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.438 ' O ' ' HG2' ' A' ' 38' ' ' PRO . . . 73.94 91.61 0.14 Allowed Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.556 -0.83 . . . . 0.0 112.796 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.629 ' N ' ' CD ' ' A' ' 37' ' ' PRO . 7.8 tp -81.03 -27.03 0.44 Allowed Pre-proline 0 CA--C 1.54 0.592 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.64 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 72.2 Cg_exo -43.02 -48.68 7.55 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 122.371 2.047 . . . . 0.0 113.997 -179.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.64 ' HD2' ' N ' ' A' ' 37' ' ' PRO . 3.9 Cg_exo -35.56 136.15 0.19 Allowed 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.195 2.597 . . . . 0.0 113.213 -179.253 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -69.35 -0.44 6.33 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 12.1 mm100 -89.9 -13.98 35.19 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.219 0.463 . . . . 0.0 111.626 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -93.01 88.44 6.13 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-O 120.699 0.285 . . . . 0.0 110.641 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.2 ttp-105 -136.7 156.33 48.67 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.042 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.4 pp -99.64 153.07 19.36 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.806 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.614 HG23 ' O ' ' A' ' 44' ' ' ILE . 18.3 tt -110.75 75.43 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.142 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.401 ' CE1' ' O ' ' A' ' 66' ' ' THR . 0.6 OUTLIER -150.92 118.16 5.98 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.272 179.975 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.41 33.95 23.99 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.547 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 46.2 46.51 15.82 Favored Glycine 0 C--N 1.336 0.548 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.997 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.547 ' HG3' HD11 ' A' ' 61' ' ' ILE . 0.0 OUTLIER -100.05 104.26 15.83 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.743 0.272 . . . . 0.0 110.906 -179.993 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -89.15 152.86 21.38 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.038 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.558 ' O ' HG21 ' A' ' 23' ' ' ILE . 0.8 OUTLIER -79.6 -4.38 51.33 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -179.834 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -78.65 -50.28 11.73 Favored 'General case' 0 N--CA 1.462 0.127 0 C-N-CA 121.024 -0.27 . . . . 0.0 111.183 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -47.98 113.21 0.68 Allowed 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -70.31 46.54 0.65 Allowed Glycine 0 CA--C 1.521 0.432 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.624 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.22 -176.68 3.14 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 117.117 0.459 . . . . 0.0 110.881 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.441 HG23 ' O ' ' A' ' 21' ' ' ASP . 23.5 m -99.16 141.77 31.5 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.716 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.462 ' HA ' HD12 ' A' ' 61' ' ' ILE . 34.9 mt -53.14 -42.55 66.18 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.902 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.5 t -54.74 -31.49 58.49 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.565 -0.288 . . . . 0.0 111.455 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -53.72 -33.73 56.51 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 111.49 0.182 . . . . 0.0 111.49 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -102.36 40.72 1.31 Allowed 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 120.602 0.239 . . . . 0.0 111.282 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 54.77 28.87 10.86 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 111.721 0.267 . . . . 0.0 111.721 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.547 HD11 ' HG3' ' A' ' 48' ' ' LYS . 22.2 mt -89.43 86.82 2.65 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 CA-C-O 120.667 0.27 . . . . 0.0 111.053 179.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -97.98 166.7 11.32 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.727 0.299 . . . . 0.0 111.08 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.6 ptmt -50.12 159.8 0.41 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.137 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 55.23 32.9 19.48 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.213 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.2 m -75.48 153.41 37.57 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-O 120.697 0.284 . . . . 0.0 110.914 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.401 ' O ' ' CE1' ' A' ' 45' ' ' PHE . 1.5 p -106.12 71.56 0.89 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.733 0.301 . . . . 0.0 110.654 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.7 pp -101.82 146.15 28.2 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.024 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -107.1 150.56 26.43 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.838 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.669 HD13 ' CG2' ' A' ' 5' ' ' VAL . 0.3 OUTLIER -103.97 159.25 15.82 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.875 -179.938 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.3 t -103.86 153.52 6.05 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.995 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.592 HD12 ' O ' ' A' ' 71' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--N 1.332 -0.188 0 CA-C-N 116.603 -0.271 . . . . 0.0 110.975 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 90.0 mm-40 . . . . . 0 CA--C 1.529 0.16 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.439 HD11 ' CD1' ' A' ' 15' ' ' LEU . 28.4 pt -139.06 166.03 22.75 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.101 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.913 -179.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -126.03 104.7 8.41 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.636 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.813 ' HB ' HD11 ' A' ' 13' ' ' ILE . 18.4 t -96.35 156.2 3.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.104 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.405 ' N ' HG12 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -106.48 150.26 26.26 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.73 0.3 . . . . 0.0 110.869 -179.942 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.645 HG21 ' HB3' ' A' ' 11' ' ' LYS . 34.6 p -99.93 -157.7 0.62 Allowed 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.996 -179.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.469 ' HG ' HG22 ' A' ' 9' ' ' THR . 1.4 pt? -67.08 -33.22 75.02 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 120.894 0.378 . . . . 0.0 110.093 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.469 HG22 ' HG ' ' A' ' 8' ' ' LEU . 0.5 OUTLIER -111.57 -76.81 0.59 Allowed 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.29 178.953 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -174.56 46.57 0.14 Allowed Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.218 -0.992 . . . . 0.0 113.233 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.645 ' HB3' HG21 ' A' ' 7' ' ' THR . 6.5 ttmt -84.35 143.03 29.75 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.837 0.319 . . . . 0.0 110.573 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.518 HG23 ' O ' ' A' ' 12' ' ' THR . 11.2 t -92.86 114.17 26.66 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.874 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.813 HD11 ' HB ' ' A' ' 5' ' ' VAL . 24.7 pt -114.92 143.27 25.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.703 0.287 . . . . 0.0 111.119 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.4 p -105.38 118.72 37.27 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.788 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.672 HD21 HG23 ' A' ' 5' ' ' VAL . 0.6 OUTLIER -138.45 159.44 42.06 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.677 0.275 . . . . 0.0 111.233 179.959 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -101.14 -175.63 2.92 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.722 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.6 t -136.49 100.61 2.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-O 120.648 0.261 . . . . 0.0 111.223 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -107.09 154.31 40.47 Favored Pre-proline 0 C--O 1.232 0.157 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.981 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.473 ' HA ' HG21 ' A' ' 55' ' ' THR . 28.5 Cg_endo -62.61 -22.62 74.16 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.77 2.313 . . . . 0.0 113.165 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 51.6 p -78.8 -35.42 44.32 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 121.264 -0.175 . . . . 0.0 111.385 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -73.5 96.71 2.45 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.606 0.241 . . . . 0.0 111.023 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 10.0 p -85.1 -177.37 6.52 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.912 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.823 ' O ' HG13 ' A' ' 26' ' ' VAL . 25.6 mm -68.19 -31.17 50.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.653 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.9 tm-20 -70.31 -47.88 59.13 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.583 0.23 . . . . 0.0 111.251 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -74.99 40.8 0.15 Allowed 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -179.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.823 HG13 ' O ' ' A' ' 23' ' ' ILE . 17.1 m -74.32 -31.49 28.78 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 O-C-N 122.176 -0.328 . . . . 0.0 111.26 179.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.494 ' HE3' HG23 ' A' ' 26' ' ' VAL . 0.0 OUTLIER -59.74 -33.09 71.19 Favored 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 121.278 -0.169 . . . . 0.0 111.181 179.998 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.69 -56.54 20.55 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.619 0.247 . . . . 0.0 111.165 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.0 pttm -63.95 -37.34 87.04 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.677 -0.238 . . . . 0.0 110.996 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 21.7 mt -74.42 -15.97 16.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 116.751 -0.204 . . . . 0.0 111.369 179.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -65.53 -10.79 37.93 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -50.05 -33.12 17.27 Favored 'General case' 0 N--CA 1.464 0.244 0 O-C-N 122.22 -0.3 . . . . 0.0 111.66 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.412 ' HD2' ' N ' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -85.38 -28.41 25.19 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 121.067 -0.253 . . . . 0.0 110.791 179.508 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 61.32 25.92 15.82 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.745 -0.207 . . . . 0.0 111.091 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.509 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . -150.52 33.84 0.99 Allowed Glycine 0 C--N 1.335 0.51 0 C-N-CA 120.041 -1.076 . . . . 0.0 113.262 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.606 HG23 ' O ' ' A' ' 36' ' ' ILE . 9.3 tp -90.06 106.47 14.72 Favored Pre-proline 0 CA--C 1.531 0.217 0 CA-C-N 117.092 0.446 . . . . 0.0 111.263 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.509 ' HD3' ' O ' ' A' ' 35' ' ' GLY . 23.3 Cg_exo -62.03 -50.01 5.67 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.209 1.939 . . . . 0.0 112.634 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.459 ' HD3' ' CB ' ' A' ' 37' ' ' PRO . 50.1 Cg_exo -55.97 89.88 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.307 2.005 . . . . 0.0 112.551 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -68.17 -37.0 80.51 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.027 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -101.62 45.19 0.98 Allowed 'General case' 0 CA--C 1.528 0.118 0 CA-C-O 120.784 0.326 . . . . 0.0 110.872 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.817 ' O ' HD11 ' A' ' 50' ' ' LEU . 7.7 tt0 -82.56 136.43 34.84 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.898 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.5 mtt180 -142.1 175.64 9.58 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.964 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.549 ' HB3' HD12 ' A' ' 69' ' ' LEU . 0.5 OUTLIER -108.03 149.09 28.85 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.687 179.789 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.6 mt -100.92 79.43 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.692 0.282 . . . . 0.0 111.197 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -150.91 129.85 12.51 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.099 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 59.99 26.06 15.32 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.65 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 45.29 40.83 8.05 Favored Glycine 0 C--N 1.336 0.569 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.973 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.401 ' HD2' ' CZ ' ' A' ' 59' ' ' TYR . 0.4 OUTLIER -107.42 130.52 54.81 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.796 0.298 . . . . 0.0 111.054 -179.848 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.09 177.92 6.51 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.803 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.817 HD11 ' O ' ' A' ' 41' ' ' GLN . 12.9 mt -68.96 -22.42 64.11 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.596 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -89.8 28.26 1.38 Allowed 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -47.81 -50.75 25.01 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.665 0.269 . . . . 0.0 111.07 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.44 -23.32 34.55 Favored Glycine 0 CA--C 1.521 0.411 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.976 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -107.13 -175.97 2.94 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.985 0.393 . . . . 0.0 110.837 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.473 HG21 ' HA ' ' A' ' 19' ' ' PRO . 8.9 m -96.92 151.69 19.44 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-O 120.738 0.304 . . . . 0.0 110.753 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.768 ' HB3' HG23 ' A' ' 61' ' ' ILE . 9.5 mt -53.89 -44.01 70.12 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.099 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.7 t -52.89 -53.18 52.83 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.635 -179.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -64.61 -18.77 65.22 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -179.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.401 ' CZ ' ' HD2' ' A' ' 48' ' ' LYS . 0.4 OUTLIER -97.99 31.03 2.82 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -179.578 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.7 m120 66.09 -16.59 0.12 Allowed 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.768 HG23 ' HB3' ' A' ' 56' ' ' LEU . 0.6 OUTLIER -89.29 62.69 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 118.471 0.578 . . . . 0.0 110.895 179.852 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -95.4 -167.41 1.61 Allowed 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.02 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -39.85 143.09 0.27 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.855 0.359 . . . . 0.0 111.891 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 65.49 15.79 10.2 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.151 -0.477 . . . . 0.0 112.022 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.1 p -76.19 175.28 9.15 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-O 120.68 0.276 . . . . 0.0 110.996 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -105.47 91.58 3.83 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.205 179.221 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.429 HD12 HD11 ' A' ' 61' ' ' ILE . 1.0 OUTLIER -98.66 109.58 22.32 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.819 0.342 . . . . 0.0 111.41 -179.322 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -107.05 97.59 7.35 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.474 179.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.549 HD12 ' HB3' ' A' ' 43' ' ' LEU . 1.0 OUTLIER -93.84 129.47 40.22 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.702 0.286 . . . . 0.0 111.06 -179.696 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.0 p -114.01 152.94 15.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.96 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.715 HD12 ' O ' ' A' ' 71' ' ' LEU . 4.1 pp . . . . . 0 C--N 1.332 -0.17 0 CA-C-N 116.583 -0.281 . . . . 0.0 110.826 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.659 0.266 . . . . 0.0 110.951 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.8 pt -138.86 174.0 10.77 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.082 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -118.9 105.35 11.4 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.725 0.298 . . . . 0.0 110.869 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.769 HG23 HD23 ' A' ' 69' ' ' LEU . 12.0 p -137.54 132.08 44.69 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.886 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.3 mppt? -106.94 163.09 13.26 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.853 0.358 . . . . 0.0 111.171 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.51 -153.64 0.45 Allowed 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.027 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.901 HD23 HG22 ' A' ' 9' ' ' THR . 0.0 OUTLIER -67.85 -21.89 65.16 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-O 120.86 0.362 . . . . 0.0 110.056 179.874 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.901 HG22 HD23 ' A' ' 8' ' ' LEU . 0.3 OUTLIER -111.69 -70.58 0.8 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.32 179.378 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 164.89 49.86 0.02 OUTLIER Glycine 0 CA--C 1.52 0.379 0 C-N-CA 120.497 -0.859 . . . . 0.0 113.15 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -84.73 150.77 24.86 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.954 0.377 . . . . 0.0 110.982 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.486 HG23 ' O ' ' A' ' 12' ' ' THR . 14.7 t -96.67 115.94 28.28 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.349 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.557 ' CG2' HG13 ' A' ' 5' ' ' VAL . 8.0 tt -125.04 135.97 62.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-O 120.735 0.303 . . . . 0.0 111.629 -179.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.6 t -106.19 132.28 52.44 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.48 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.788 HD21 ' HA ' ' A' ' 30' ' ' ILE . 2.1 mt -134.86 134.71 41.03 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.661 0.267 . . . . 0.0 111.247 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -94.99 155.87 16.55 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.404 179.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 1.012 HG11 HD11 ' A' ' 56' ' ' LEU . 21.8 t -140.13 136.62 37.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-O 120.957 0.408 . . . . 0.0 111.795 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.492 ' HB2' ' HD2' ' A' ' 19' ' ' PRO . 11.0 pt-20 -96.72 161.0 28.06 Favored Pre-proline 0 CA--C 1.53 0.19 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.324 179.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.492 ' HD2' ' HB2' ' A' ' 18' ' ' GLU . 1.2 Cg_endo -43.18 -66.64 0.15 Allowed 'Trans proline' 0 CA--C 1.532 0.415 0 C-N-CA 122.892 2.395 . . . . 0.0 112.96 -179.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.21 37.13 0.89 Allowed 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.412 ' HB2' ' O ' ' A' ' 18' ' ' GLU . 5.5 t0 -75.7 119.65 20.01 Favored 'General case' 0 N--CA 1.462 0.145 0 O-C-N 122.276 -0.265 . . . . 0.0 111.226 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -85.25 146.58 27.0 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.509 179.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.636 ' O ' HG12 ' A' ' 26' ' ' VAL . 8.3 tp -57.99 -32.46 43.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 116.769 -0.196 . . . . 0.0 111.376 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -76.19 -39.02 55.8 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 120.547 0.213 . . . . 0.0 111.0 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -63.09 -31.59 72.76 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.729 -0.214 . . . . 0.0 111.448 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.636 HG12 ' O ' ' A' ' 23' ' ' ILE . 13.3 p -74.29 -6.4 8.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.488 ' HA ' HG22 ' A' ' 30' ' ' ILE . 16.4 mttt -55.47 -39.41 70.36 Favored 'General case' 0 N--CA 1.463 0.199 0 O-C-N 122.182 -0.324 . . . . 0.0 111.225 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.12 -41.75 81.27 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.561 0.219 . . . . 0.0 111.432 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.8 tttp -74.12 -42.75 59.55 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.695 -0.23 . . . . 0.0 111.243 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.788 ' HA ' HD21 ' A' ' 15' ' ' LEU . 18.8 tt -64.96 -20.69 28.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.406 ' HA ' ' CG1' ' A' ' 36' ' ' ILE . 1.2 tt0 -63.43 74.65 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.741 0.305 . . . . 0.0 111.111 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.45 ' HB2' HD12 ' A' ' 13' ' ' ILE . 27.9 t70 -61.26 -69.53 0.23 Allowed 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.833 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.71 -85.9 0.14 Allowed 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 121.077 -0.249 . . . . 0.0 110.709 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -177.87 44.34 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -150.14 26.73 1.13 Allowed Glycine 0 CA--C 1.524 0.599 0 C-N-CA 120.182 -1.009 . . . . 0.0 113.539 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.654 HG21 HG23 ' A' ' 30' ' ' ILE . 32.5 mm -89.17 -46.45 0.42 Allowed Pre-proline 0 CA--C 1.533 0.306 0 CA-C-N 117.497 0.649 . . . . 0.0 112.15 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.48 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 53.6 Cg_exo -52.9 -43.74 54.08 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.337 2.025 . . . . 0.0 113.168 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' A' ' 37' ' ' PRO . 58.9 Cg_exo -39.93 161.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.748 2.299 . . . . 0.0 113.511 -179.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -69.56 0.39 5.42 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -90.06 8.48 32.45 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 118.094 0.407 . . . . 0.0 111.807 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -89.72 110.92 21.78 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 121.038 -0.265 . . . . 0.0 110.664 179.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.4 mtt180 -144.03 152.2 40.69 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.739 0.304 . . . . 0.0 111.237 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.807 HD11 HD22 ' A' ' 50' ' ' LEU . 1.5 mp -108.0 152.03 25.03 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.783 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.474 HD11 ' CG1' ' A' ' 70' ' ' VAL . 27.0 mm -111.0 61.79 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.157 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.596 ' HB2' HD23 ' A' ' 67' ' ' LEU . 0.2 OUTLIER -153.66 118.36 4.98 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.754 0.311 . . . . 0.0 111.201 179.984 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.74 32.09 21.38 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.677 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 46.36 42.97 13.93 Favored Glycine 0 C--N 1.335 0.527 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.968 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.432 ' HD3' ' CZ ' ' A' ' 59' ' ' TYR . 2.5 tptp -101.36 137.29 39.89 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.643 0.259 . . . . 0.0 110.972 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -89.02 168.81 12.05 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.51 -0.313 . . . . 0.0 110.966 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.807 HD22 HD11 ' A' ' 43' ' ' LEU . 0.2 OUTLIER -79.11 -38.03 37.19 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.471 -0.332 . . . . 0.0 111.354 -179.848 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.64 17.55 6.35 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -47.33 -39.79 15.69 Favored 'General case' 0 N--CA 1.466 0.351 0 O-C-N 122.241 -0.287 . . . . 0.0 111.303 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.19 19.85 48.37 Favored Glycine 0 CA--C 1.522 0.487 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.942 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.7 mtt-85 -107.56 175.81 5.36 Favored 'General case' 0 N--CA 1.458 -0.075 0 CA-C-N 117.03 0.415 . . . . 0.0 110.836 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.532 HG22 ' H ' ' A' ' 57' ' ' SER . 31.2 m -99.34 133.17 44.04 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.731 0.301 . . . . 0.0 110.689 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 1.012 HD11 HG11 ' A' ' 17' ' ' VAL . 0.4 OUTLIER -51.8 -31.08 25.76 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.561 0.219 . . . . 0.0 111.113 179.974 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.532 ' H ' HG22 ' A' ' 55' ' ' THR . 12.6 t -62.95 -40.05 96.5 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -63.21 -29.37 70.72 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.432 ' CZ ' ' HD3' ' A' ' 48' ' ' LYS . 0.2 OUTLIER -97.66 8.99 43.68 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 111.641 0.237 . . . . 0.0 111.641 179.995 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 65.37 11.19 7.14 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.435 ' CG2' HD11 ' A' ' 67' ' ' LEU . 1.2 pt -90.11 63.09 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 CA-C-N 117.961 0.346 . . . . 0.0 110.676 179.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -95.1 -168.66 1.84 Allowed 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.093 -179.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -40.18 152.05 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.601 -179.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 62.14 24.49 14.58 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.363 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.9 p -75.56 145.52 41.17 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.702 0.287 . . . . 0.0 110.939 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.0 m -104.86 66.45 0.77 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.763 0.316 . . . . 0.0 110.577 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.596 HD23 ' HB2' ' A' ' 45' ' ' PHE . 0.4 OUTLIER -104.67 144.49 31.65 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.165 -179.726 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 16.1 m170 -106.97 141.1 38.72 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.749 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.769 HD23 HG23 ' A' ' 5' ' ' VAL . 1.3 mm? -103.81 163.38 12.38 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.667 0.27 . . . . 0.0 111.022 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.474 ' CG1' HD11 ' A' ' 44' ' ' ILE . 33.9 m -105.29 179.44 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.021 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.762 HD23 HD12 ' A' ' 8' ' ' LEU . 1.3 mp . . . . . 0 C--N 1.333 -0.135 0 CA-C-O 120.769 0.319 . . . . 0.0 110.682 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 . . . . . 0 CA--C 1.529 0.137 0 CA-C-O 120.696 0.284 . . . . 0.0 110.908 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 1.041 HD11 HD13 ' A' ' 67' ' ' LEU . 18.0 tt -138.73 156.27 28.65 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.939 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -118.44 91.83 3.66 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-O 120.739 0.304 . . . . 0.0 110.913 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.5 t -93.35 159.69 2.76 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.747 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.0 ttmt -106.66 135.56 47.97 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.828 0.347 . . . . 0.0 111.044 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.626 HG21 ' HB3' ' A' ' 11' ' ' LYS . 13.7 p -100.51 -162.19 0.92 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.25 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.686 HD12 ' OG1' ' A' ' 9' ' ' THR . 0.8 OUTLIER -60.14 -38.64 83.69 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 120.649 -0.42 . . . . 0.0 111.199 -179.446 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.686 ' OG1' HD12 ' A' ' 8' ' ' LEU . 0.2 OUTLIER -111.24 -62.08 1.6 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.65 0.262 . . . . 0.0 110.792 179.835 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 168.06 50.04 0.03 OUTLIER Glycine 0 CA--C 1.521 0.421 0 C-N-CA 120.512 -0.851 . . . . 0.0 113.125 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.626 ' HB3' HG21 ' A' ' 7' ' ' THR . 0.0 OUTLIER -84.67 157.12 21.21 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 116.858 0.329 . . . . 0.0 110.768 179.795 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.562 HG23 ' O ' ' A' ' 12' ' ' THR . 12.1 t -103.01 108.41 19.57 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.715 0.293 . . . . 0.0 110.8 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.545 HG23 ' HD2' ' A' ' 11' ' ' LYS . 2.8 pt -125.07 168.88 17.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.245 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.02 158.95 16.42 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.778 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.697 ' CB ' HG21 ' A' ' 3' ' ' ILE . 0.2 OUTLIER -138.19 115.67 11.23 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.698 0.285 . . . . 0.0 111.036 -179.897 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -101.05 150.14 23.22 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.743 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.945 ' CG1' HD21 ' A' ' 56' ' ' LEU . 30.2 t -140.0 146.8 24.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.377 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -107.1 164.67 14.33 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.783 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -56.97 -55.47 2.62 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.609 2.206 . . . . 0.0 112.539 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.2 m -89.52 8.38 31.41 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -179.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -75.0 118.14 17.64 Favored 'General case' 0 CA--C 1.528 0.125 0 O-C-N 122.245 -0.284 . . . . 0.0 110.924 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.8 p -85.08 165.69 17.28 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.817 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 7.3 tp -58.36 -40.2 77.2 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.261 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -59.32 -38.54 80.56 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.646 0.26 . . . . 0.0 110.924 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -62.79 -23.86 67.45 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.592 -0.277 . . . . 0.0 111.47 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 39.4 t -63.57 -39.5 85.58 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-O 120.566 0.222 . . . . 0.0 111.06 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.526 ' HA ' HG22 ' A' ' 30' ' ' ILE . 7.7 tttm -57.31 -36.96 71.74 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 120.602 0.239 . . . . 0.0 111.242 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.26 -45.0 74.36 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-O 120.654 0.264 . . . . 0.0 111.444 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.2 ptpm? -74.13 -39.92 63.0 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.522 -179.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.855 ' O ' HD13 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -64.81 -36.89 78.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-O 120.56 0.219 . . . . 0.0 111.431 -179.672 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -64.81 -21.0 66.69 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -61.48 -14.31 27.87 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.9 mtpp -73.91 -42.7 60.27 Favored 'General case' 0 C--O 1.232 0.132 0 O-C-N 122.222 -0.299 . . . . 0.0 111.307 -179.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -144.19 -44.2 0.26 Allowed 'General case' 0 C--O 1.232 0.171 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.836 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.462 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . 107.44 68.29 0.66 Allowed Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.625 -0.797 . . . . 0.0 111.543 -179.307 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.603 HG23 ' O ' ' A' ' 36' ' ' ILE . 19.7 tt -77.86 109.37 9.67 Favored Pre-proline 0 CA--C 1.532 0.287 0 CA-C-O 120.714 0.292 . . . . 0.0 111.533 -179.037 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.605 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 28.6 Cg_exo -62.96 -41.28 29.87 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.999 2.466 . . . . 0.0 114.422 -179.325 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.605 ' HD2' ' N ' ' A' ' 37' ' ' PRO . 21.8 Cg_endo -64.27 114.33 2.62 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 121.904 1.736 . . . . 0.0 113.086 -178.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -69.78 -1.88 10.49 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.516 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -90.06 10.98 22.14 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 122.073 -0.392 . . . . 0.0 111.998 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.461 ' CG ' HD13 ' A' ' 36' ' ' ILE . 1.6 tm0? -90.02 97.06 10.97 Favored 'General case' 0 C--O 1.231 0.105 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 179.192 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.611 ' O ' HD13 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -133.91 -177.41 4.55 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.788 0.328 . . . . 0.0 111.174 -179.476 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.784 HD12 HD22 ' A' ' 69' ' ' LEU . 2.0 tp -99.13 143.59 29.23 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.927 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.8 mm -106.13 95.47 3.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.124 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 16.1 t80 -150.88 123.33 8.43 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.093 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.04 33.39 23.13 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.366 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 46.14 36.06 6.97 Favored Glycine 0 C--N 1.336 0.539 0 C-N-CA 120.868 -0.682 . . . . 0.0 113.047 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.425 ' HG2' ' CE2' ' A' ' 59' ' ' TYR . 0.3 OUTLIER -110.21 126.03 53.7 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.849 0.325 . . . . 0.0 110.962 -179.952 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -89.09 149.32 23.25 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.802 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.611 HD12 ' O ' ' A' ' 50' ' ' LEU . 4.1 pp -80.39 13.11 2.57 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -78.59 -42.61 28.58 Favored 'General case' 0 CA--C 1.528 0.097 0 O-C-N 121.978 -0.451 . . . . 0.0 110.76 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -48.18 118.46 2.41 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 179.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -68.89 49.28 0.49 Allowed Glycine 0 CA--C 1.522 0.472 0 C-N-CA 120.625 -0.798 . . . . 0.0 113.051 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.58 -172.63 2.11 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 117.169 0.484 . . . . 0.0 110.549 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.62 HG22 ' OD2' ' A' ' 58' ' ' ASP . 8.8 t -99.03 134.22 42.18 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.567 0.222 . . . . 0.0 110.627 179.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.945 HD21 ' CG1' ' A' ' 17' ' ' VAL . 3.1 pp -51.74 -34.27 38.37 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.624 0.249 . . . . 0.0 111.223 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.2 t -61.22 -35.12 76.35 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.414 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.62 ' OD2' HG22 ' A' ' 55' ' ' THR . 7.5 m-20 -53.86 -32.1 51.89 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 111.612 0.227 . . . . 0.0 111.612 -179.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.425 ' CE2' ' HG2' ' A' ' 48' ' ' LYS . 28.0 m-85 -97.9 14.95 25.38 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.3 t30 58.48 22.77 9.99 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.774 HG22 ' O ' ' A' ' 56' ' ' LEU . 2.3 tp -90.0 62.49 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 CA-C-O 120.775 0.322 . . . . 0.0 110.823 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -101.14 179.68 4.3 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.265 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.7 pttp -50.36 -179.9 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.33 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 67.25 -41.54 0.42 Allowed 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.33 0.492 . . . . 0.0 112.33 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.6 m -64.89 172.54 2.79 Favored 'General case' 0 C--N 1.332 -0.191 0 O-C-N 122.266 -0.272 . . . . 0.0 110.779 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.9 p -96.9 117.74 31.78 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.979 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 1.041 HD13 HD11 ' A' ' 3' ' ' ILE . 3.6 mp -109.04 117.36 33.98 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.013 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -107.18 123.55 48.43 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.906 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.784 HD22 HD12 ' A' ' 43' ' ' LEU . 2.5 mm? -101.33 163.54 12.22 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.851 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.9 m -104.92 173.72 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.134 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.1 mt . . . . . 0 C--N 1.332 -0.186 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.879 179.939 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 . . . . . 0 CA--C 1.529 0.136 0 CA-C-O 120.563 0.22 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.913 HD12 ' HB3' ' A' ' 15' ' ' LEU . 21.7 mt -139.56 155.12 25.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.95 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -118.65 93.96 4.29 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.691 0.281 . . . . 0.0 110.931 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.566 HG22 ' HB3' ' A' ' 67' ' ' LEU . 21.3 t -119.55 151.97 22.05 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.022 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 6.4 ptpp? -109.87 140.31 43.97 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.808 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 75.5 p -99.97 -148.08 0.35 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.475 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.569 ' O ' HD23 ' A' ' 71' ' ' LEU . 1.3 pt? -65.31 -41.89 93.59 Favored 'General case' 0 C--N 1.341 0.218 0 CA-C-N 118.68 0.673 . . . . 0.0 111.571 -178.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.57 ' O ' HG22 ' A' ' 9' ' ' THR . 42.7 m -111.4 41.29 1.9 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.678 0.275 . . . . 0.0 111.065 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 50.7 39.03 37.66 Favored Glycine 0 CA--C 1.521 0.439 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.776 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.6 tttm -74.38 145.65 43.62 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.813 0.306 . . . . 0.0 110.767 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.56 HG23 ' O ' ' A' ' 12' ' ' THR . 9.7 t -93.74 106.18 18.17 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.781 0.324 . . . . 0.0 110.898 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.509 ' C ' HD12 ' A' ' 13' ' ' ILE . 2.3 pp -125.21 163.29 26.25 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.12 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 16.6 p -101.89 152.5 20.84 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.828 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.913 ' HB3' HD12 ' A' ' 3' ' ' ILE . 2.7 tp -127.99 92.8 3.53 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.976 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -100.98 121.56 41.98 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.849 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.741 HG21 HD21 ' A' ' 56' ' ' LEU . 27.7 m -140.06 173.94 9.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.156 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -96.88 167.22 12.45 Favored Pre-proline 0 C--O 1.231 0.13 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.934 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.35 -43.3 41.72 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.657 2.238 . . . . 0.0 112.487 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 36.9 m -89.27 3.09 53.2 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -75.06 120.23 20.3 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.664 0.268 . . . . 0.0 111.022 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 10.7 t -85.21 165.74 17.13 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.495 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.827 ' O ' HG12 ' A' ' 26' ' ' VAL . 43.4 mm -57.33 -37.45 57.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-O 120.528 0.204 . . . . 0.0 111.034 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -52.98 -31.45 40.82 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 120.487 0.184 . . . . 0.0 111.153 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -70.93 -42.8 69.37 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.765 -0.198 . . . . 0.0 111.335 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.827 HG12 ' O ' ' A' ' 23' ' ' ILE . 12.4 p -63.99 -21.7 29.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 111.675 0.25 . . . . 0.0 111.675 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.755 ' HD3' HD22 ' A' ' 50' ' ' LEU . 5.6 tptp -55.5 -35.03 65.15 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.573 0.225 . . . . 0.0 110.885 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.1 -37.47 87.6 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.581 0.229 . . . . 0.0 110.883 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.5 mttt -63.93 -48.62 75.81 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-O 120.636 0.255 . . . . 0.0 110.819 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.434 HG22 ' O ' ' A' ' 27' ' ' LYS . 2.6 tt -64.82 -39.15 84.67 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 CA-C-N 116.633 -0.258 . . . . 0.0 110.931 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -65.25 -21.45 66.74 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.721 -0.218 . . . . 0.0 111.07 179.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -61.33 -12.34 13.45 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 7.5 ptpp? -74.26 -36.73 63.85 Favored 'General case' 0 N--CA 1.461 0.092 0 O-C-N 122.013 -0.429 . . . . 0.0 110.819 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -176.4 -42.07 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.664 0.268 . . . . 0.0 111.558 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.518 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . 123.63 74.92 0.28 Allowed Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.646 -0.788 . . . . 0.0 111.589 -179.66 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.789 HD13 ' CD ' ' A' ' 41' ' ' GLN . 1.3 pp -78.31 102.34 0.95 Allowed Pre-proline 0 CA--C 1.532 0.279 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -179.087 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.698 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 10.6 Cg_endo -55.02 -42.63 67.23 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.564 2.176 . . . . 0.0 113.962 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.698 ' HD2' ' N ' ' A' ' 37' ' ' PRO . 6.1 Cg_exo -39.34 106.6 0.06 OUTLIER 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 122.762 2.308 . . . . 0.0 113.106 -179.101 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -68.61 -16.57 63.89 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.622 179.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -93.77 28.53 2.33 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.789 ' CD ' HD13 ' A' ' 36' ' ' ILE . 4.9 tt0 -91.91 89.07 6.86 Favored 'General case' 0 C--O 1.231 0.095 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 179.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.11 -179.06 6.27 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.96 -179.516 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.697 HD13 ' HG ' ' A' ' 67' ' ' LEU . 0.6 OUTLIER -97.6 160.18 14.47 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 120.718 0.294 . . . . 0.0 110.879 -179.873 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.643 HG23 ' O ' ' A' ' 44' ' ' ILE . 17.6 tt -100.91 80.03 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.13 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.635 ' HB2' HD12 ' A' ' 43' ' ' LEU . 0.3 OUTLIER -150.94 105.65 3.28 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.078 179.93 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.414 ' HB1' ' CE2' ' A' ' 59' ' ' TYR . . . 63.62 31.3 14.65 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.575 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 45.65 52.98 8.79 Favored Glycine 0 C--N 1.336 0.562 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.983 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.446 ' CD ' ' CE1' ' A' ' 59' ' ' TYR . 0.7 OUTLIER -106.62 115.82 30.86 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.785 0.292 . . . . 0.0 110.943 -179.955 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.19 173.19 8.55 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.772 0.32 . . . . 0.0 110.867 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.758 HD23 HG22 ' A' ' 23' ' ' ILE . 1.1 mt -79.15 -22.99 44.28 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.491 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -78.83 -35.68 43.69 Favored 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 121.256 -0.178 . . . . 0.0 111.339 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -48.06 114.69 0.98 Allowed 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 179.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -70.01 49.72 0.7 Allowed Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.483 -0.865 . . . . 0.0 112.592 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 -107.15 161.54 14.67 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.986 0.393 . . . . 0.0 110.815 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.557 HG23 ' H ' ' A' ' 58' ' ' ASP . 7.2 t -99.27 142.84 30.24 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.521 -0.308 . . . . 0.0 110.74 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.741 HD21 HG21 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -51.99 -43.71 63.73 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 111.745 0.276 . . . . 0.0 111.745 -179.286 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.1 t -58.84 -31.13 68.22 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -179.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.557 ' H ' HG23 ' A' ' 55' ' ' THR . 1.6 m-20 -56.82 -39.03 73.45 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 111.549 0.203 . . . . 0.0 111.549 -179.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.446 ' CE1' ' CD ' ' A' ' 48' ' ' LYS . 30.7 m-85 -99.82 17.51 20.58 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 47.5 t30 65.1 15.59 10.08 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 179.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.547 HD11 ' HA ' ' A' ' 56' ' ' LEU . 7.3 pt -90.03 60.97 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-O 120.836 0.351 . . . . 0.0 110.912 179.406 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.45 -160.15 0.77 Allowed 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.701 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.475 ' O ' ' CG ' ' A' ' 64' ' ' GLU . 2.4 pttp -39.89 144.56 0.19 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.682 0.277 . . . . 0.0 111.681 -179.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.475 ' CG ' ' O ' ' A' ' 63' ' ' LYS . 3.5 pt-20 54.49 26.68 7.43 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.023 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.4 p -76.05 173.38 11.34 Favored 'General case' 0 C--O 1.23 0.071 0 CA-C-O 120.672 0.272 . . . . 0.0 110.878 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.412 ' HB ' ' CE1' ' A' ' 45' ' ' PHE . 0.2 OUTLIER -107.1 81.86 1.6 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.356 179.395 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.697 ' HG ' HD13 ' A' ' 43' ' ' LEU . 0.3 OUTLIER -98.82 107.54 20.01 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.336 -179.405 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 -107.13 103.77 13.25 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.582 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.475 HD12 ' CG1' ' A' ' 5' ' ' VAL . 0.2 OUTLIER -93.83 168.41 11.0 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.011 -179.773 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 32.9 m -103.87 174.41 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.216 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.569 HD23 ' O ' ' A' ' 8' ' ' LEU . 2.6 mp . . . . . 0 C--N 1.333 -0.152 0 CA-C-O 120.745 0.307 . . . . 0.0 110.844 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.556 0.217 . . . . 0.0 110.911 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.469 HG12 HD23 ' A' ' 67' ' ' LEU . 16.8 tt -138.92 153.2 24.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.077 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -118.99 127.52 53.54 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.65 0.262 . . . . 0.0 110.797 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 1.058 HG13 HD11 ' A' ' 67' ' ' LEU . 3.5 t -101.36 140.45 20.04 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.176 -179.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.426 ' HG2' ' CE1' ' A' ' 68' ' ' HIS . 0.0 OUTLIER -106.78 87.2 2.47 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.444 179.817 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.41 119.94 40.82 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.539 -179.221 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -51.02 -20.87 1.53 Allowed 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 179.353 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 77.5 p -99.96 38.47 1.46 Allowed 'General case' 0 CA--C 1.531 0.248 0 O-C-N 122.033 -0.417 . . . . 0.0 111.442 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 49.03 30.13 9.32 Favored Glycine 0 C--N 1.336 0.567 0 C-N-CA 121.117 -0.563 . . . . 0.0 113.757 179.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.82 65.28 9.06 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 117.332 0.566 . . . . 0.0 110.714 179.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.616 HG23 ' O ' ' A' ' 12' ' ' THR . 13.6 t -92.98 99.76 12.33 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.89 0.376 . . . . 0.0 110.883 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.526 HD11 ' HD3' ' A' ' 33' ' ' LYS . 1.7 pp -125.54 172.55 12.88 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.167 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.27 132.7 51.14 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.656 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.436 ' HG ' HD13 ' A' ' 13' ' ' ILE . 62.3 mt -128.88 124.04 34.2 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.121 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -101.19 131.6 47.09 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.755 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.02 -176.23 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.925 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -102.58 160.87 24.96 Favored Pre-proline 0 C--N 1.333 -0.127 0 CA-C-O 120.636 0.255 . . . . 0.0 110.896 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -53.26 -50.12 15.08 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.482 2.121 . . . . 0.0 112.407 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.9 t -90.21 32.26 0.94 Allowed 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.354 0.501 . . . . 0.0 112.354 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.9 p-10 -75.24 119.48 19.43 Favored 'General case' 0 N--CA 1.461 0.114 0 O-C-N 122.202 -0.311 . . . . 0.0 110.976 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.41 HG23 ' H ' ' A' ' 25' ' ' ASN . 14.4 t -84.95 166.08 17.08 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-O 120.673 0.273 . . . . 0.0 110.822 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.684 ' HB ' HD12 ' A' ' 50' ' ' LEU . 9.8 tp -57.89 -37.99 63.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.641 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -63.45 -41.74 98.64 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.572 0.225 . . . . 0.0 111.25 -179.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.41 ' H ' HG23 ' A' ' 22' ' ' THR . 0.7 OUTLIER -73.14 -48.0 39.25 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 120.616 0.246 . . . . 0.0 111.161 -179.702 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.548 HG12 ' HA ' ' A' ' 23' ' ' ILE . 13.6 p -63.97 -21.42 28.76 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 111.698 0.259 . . . . 0.0 111.698 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.2 mtpm? -55.58 -35.06 65.37 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.502 0.191 . . . . 0.0 110.902 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.88 -37.62 74.28 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.625 0.25 . . . . 0.0 110.879 179.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.78 -38.01 64.79 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.849 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 33.2 mm -64.98 -45.16 95.49 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 CA-C-O 120.671 0.272 . . . . 0.0 110.622 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -59.89 -26.58 66.0 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.961 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -57.09 -22.94 43.29 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 111.691 0.256 . . . . 0.0 111.691 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.526 ' HD3' HD11 ' A' ' 13' ' ' ILE . 7.8 mtmp? -74.37 -39.08 62.97 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.605 0.24 . . . . 0.0 110.925 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.06 -48.64 0.24 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.692 -0.231 . . . . 0.0 111.238 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.505 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . 108.83 62.52 0.54 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.04 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.853 HD13 ' HB2' ' A' ' 41' ' ' GLN . 17.2 tt -78.51 108.3 7.58 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-O 120.696 0.284 . . . . 0.0 111.486 -179.512 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.591 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 26.0 Cg_exo -63.53 -40.66 29.39 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 122.747 2.298 . . . . 0.0 114.189 -179.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.591 ' HD2' ' N ' ' A' ' 37' ' ' PRO . 38.1 Cg_endo -68.5 133.16 27.21 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 122.02 1.813 . . . . 0.0 113.53 -178.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -70.71 14.67 0.13 Allowed 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.659 -0.7 . . . . 0.0 112.45 179.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -89.37 1.51 55.7 Favored 'General case' 0 N--CA 1.456 -0.138 0 O-C-N 122.135 -0.353 . . . . 0.0 110.543 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.853 ' HB2' HD13 ' A' ' 36' ' ' ILE . 2.6 tp60 -82.77 101.7 11.09 Favored 'General case' 0 C--O 1.231 0.097 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 179.078 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -133.88 178.19 7.14 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-O 120.742 0.306 . . . . 0.0 111.311 -179.415 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.864 ' CD1' HD12 ' A' ' 69' ' ' LEU . 8.7 tp -106.56 133.23 51.56 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.101 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.9 pt -111.26 107.4 22.85 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-O 120.752 0.311 . . . . 0.0 111.164 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -150.94 135.22 16.91 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.086 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.509 ' HB3' ' HD2' ' A' ' 48' ' ' LYS . . . 54.95 38.58 30.69 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.209 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 52.91 29.07 33.68 Favored Glycine 0 CA--C 1.522 0.51 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.941 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.509 ' HD2' ' HB3' ' A' ' 46' ' ' ALA . 14.4 mttm -110.47 102.24 10.87 Favored 'General case' 0 N--CA 1.457 -0.102 0 CA-C-N 117.016 0.408 . . . . 0.0 110.89 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -89.12 90.61 8.46 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.681 0.277 . . . . 0.0 110.89 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.684 HD12 ' HB ' ' A' ' 23' ' ' ILE . 0.6 OUTLIER -79.34 65.81 4.62 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.123 179.952 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -89.51 -42.09 11.66 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-O 120.607 0.241 . . . . 0.0 111.103 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -47.34 -69.29 0.13 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.742 0.306 . . . . 0.0 111.203 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.406 ' HA2' HG22 ' A' ' 23' ' ' ILE . . . 158.26 56.61 0.01 OUTLIER Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.681 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -106.02 177.49 4.84 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.591 0.234 . . . . 0.0 110.861 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.607 HG23 ' H ' ' A' ' 58' ' ' ASP . 9.9 t -99.1 154.87 17.78 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.711 0.291 . . . . 0.0 110.86 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.794 ' HA ' HD12 ' A' ' 61' ' ' ILE . 1.4 mp -59.31 -46.78 87.64 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.061 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.1 t -53.27 -39.15 63.68 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.484 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.607 ' H ' HG23 ' A' ' 55' ' ' THR . 45.2 t0 -53.9 -30.23 45.23 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 111.659 0.244 . . . . 0.0 111.659 -179.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.425 ' CD1' ' HD3' ' A' ' 48' ' ' LYS . 5.1 m-85 -101.99 40.36 1.34 Allowed 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 120.659 0.266 . . . . 0.0 111.601 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 54.84 27.34 8.83 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 179.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.794 HD12 ' HA ' ' A' ' 56' ' ' LEU . 27.6 mt -89.64 101.31 12.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-O 120.643 0.259 . . . . 0.0 110.858 179.555 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -94.97 166.22 12.05 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.782 0.325 . . . . 0.0 111.223 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -50.23 151.06 2.2 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.259 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 62.67 22.13 13.15 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.593 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.2 m -75.71 170.03 16.97 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-O 120.68 0.276 . . . . 0.0 110.815 179.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.05 111.76 23.84 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.393 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 1.058 HD11 HG13 ' A' ' 5' ' ' VAL . 2.1 pp -98.72 116.53 31.15 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.791 0.329 . . . . 0.0 111.53 -179.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.426 ' CE1' ' HG2' ' A' ' 6' ' ' LYS . 0.1 OUTLIER -107.29 109.82 21.69 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.581 179.539 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.864 HD12 ' CD1' ' A' ' 43' ' ' LEU . 0.1 OUTLIER -93.9 179.71 5.25 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.958 -179.846 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -109.13 -178.2 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.62 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.1 mt . . . . . 0 C--N 1.332 -0.167 0 CA-C-O 120.664 0.268 . . . . 0.0 110.782 179.938 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.652 0.263 . . . . 0.0 110.945 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.641 HD11 HD21 ' A' ' 67' ' ' LEU . 15.1 tt -138.92 157.1 28.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.915 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -118.44 102.99 9.34 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.83 0.348 . . . . 0.0 110.864 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.875 HG22 HD11 ' A' ' 67' ' ' LEU . 11.8 t -122.22 151.42 25.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.121 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.761 ' O ' HD11 ' A' ' 69' ' ' LEU . 0.1 OUTLIER -106.83 135.12 48.91 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.854 179.957 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.75 -147.28 0.34 Allowed 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.331 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.501 ' HG ' HG23 ' A' ' 9' ' ' THR . 2.5 tp -68.43 -53.99 20.02 Favored 'General case' 0 C--N 1.342 0.282 0 CA-C-O 120.921 0.391 . . . . 0.0 110.75 -179.503 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.501 HG23 ' HG ' ' A' ' 8' ' ' LEU . 12.3 p -101.57 39.07 1.49 Allowed 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.304 -179.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 55.24 38.68 68.68 Favored Glycine 0 C--N 1.334 0.435 0 C-N-CA 120.817 -0.706 . . . . 0.0 113.133 179.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.9 ttmt -84.16 141.63 30.92 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 117.062 0.431 . . . . 0.0 110.556 179.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.41 HG23 ' O ' ' A' ' 12' ' ' THR . 14.9 t -92.95 121.99 34.85 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.64 0.257 . . . . 0.0 111.138 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.7 pt -125.13 136.06 62.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.954 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -98.87 130.31 45.27 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.903 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.9 pp -138.08 151.86 48.23 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.521 -0.308 . . . . 0.0 110.951 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -101.13 156.22 17.55 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.938 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 22.2 t -136.16 113.51 14.03 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.126 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -107.0 165.84 12.15 Favored Pre-proline 0 C--N 1.332 -0.166 0 CA-C-O 120.787 0.327 . . . . 0.0 110.855 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.49 -30.0 52.77 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.66 2.24 . . . . 0.0 112.535 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 82.1 p -78.74 -32.47 46.72 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.802 -0.181 . . . . 0.0 111.232 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -64.89 121.23 14.14 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.659 0.266 . . . . 0.0 110.74 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.05 149.82 25.3 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.02 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.812 HG22 ' O ' ' A' ' 54' ' ' ARG . 4.1 tt -68.06 -29.35 44.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.541 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.0 tm-20 -53.06 -60.32 3.43 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.73 0.3 . . . . 0.0 111.107 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 36.9 m-20 -74.85 44.09 0.21 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.857 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 14.6 p -69.12 -40.17 80.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.562 0.22 . . . . 0.0 111.144 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.8 mptt -66.07 -44.71 83.7 Favored 'General case' 0 N--CA 1.461 0.108 0 CA-C-O 120.669 0.271 . . . . 0.0 110.816 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.29 -40.85 98.53 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.053 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.88 -41.11 97.82 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.866 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.424 HD13 HE22 ' A' ' 41' ' ' GLN . 31.9 mt -75.03 -42.61 45.51 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.952 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -55.04 -37.82 67.19 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.702 0.287 . . . . 0.0 110.977 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.56 -16.12 44.97 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 112.16 0.429 . . . . 0.0 112.16 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 12.6 mmtt -74.79 -34.72 62.47 Favored 'General case' 0 N--CA 1.461 0.087 0 O-C-N 122.207 -0.308 . . . . 0.0 111.188 -179.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -167.11 -45.82 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 121.013 -0.275 . . . . 0.0 111.576 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 137.14 80.22 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.453 -0.88 . . . . 0.0 112.329 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.718 HD13 ' NE2' ' A' ' 41' ' ' GLN . 9.3 tt -78.35 113.29 32.72 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-O 120.565 0.221 . . . . 0.0 111.106 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.51 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 51.2 Cg_exo -53.36 -51.28 11.32 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.676 2.251 . . . . 0.0 113.291 -179.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.51 ' HD2' ' N ' ' A' ' 37' ' ' PRO . 31.6 Cg_endo -65.65 86.19 0.22 Allowed 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 121.975 1.783 . . . . 0.0 112.363 -179.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.31 -21.55 64.76 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.409 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 29.2 mt-30 -100.2 36.17 1.92 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 120.478 0.18 . . . . 0.0 111.421 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.718 ' NE2' HD13 ' A' ' 36' ' ' ILE . 1.7 pt20 -88.23 131.25 34.83 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.576 0.227 . . . . 0.0 110.704 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.3 mtt180 -137.89 169.02 18.51 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.694 0.283 . . . . 0.0 111.061 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.63 ' CD1' HD22 ' A' ' 67' ' ' LEU . 49.6 mt -99.67 151.29 21.38 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.919 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.644 HG22 ' O ' ' A' ' 68' ' ' HIS . 4.8 tt -110.99 84.16 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 CA-C-O 120.765 0.317 . . . . 0.0 111.092 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -150.89 131.75 14.15 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.204 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.7 25.74 15.52 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.741 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 44.51 36.83 4.64 Favored Glycine 0 C--N 1.337 0.637 0 C-N-CA 120.777 -0.725 . . . . 0.0 113.081 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.1 mmpm? -110.06 136.46 49.27 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.835 0.317 . . . . 0.0 111.06 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.7 tp60 -89.12 162.98 15.66 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.931 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.686 HD13 HG12 ' A' ' 23' ' ' ILE . 4.2 mm? -80.48 19.57 0.78 Allowed 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -89.04 -41.23 12.45 Favored 'General case' 0 CA--C 1.529 0.155 0 O-C-N 122.038 -0.414 . . . . 0.0 111.171 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -48.28 114.51 0.96 Allowed 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 120.637 0.256 . . . . 0.0 110.325 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -69.97 50.43 0.71 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.411 -0.9 . . . . 0.0 112.467 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.812 ' O ' HG22 ' A' ' 23' ' ' ILE . 2.3 mmt180 -104.52 -178.72 3.74 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-N 116.946 0.373 . . . . 0.0 110.926 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.8 m -94.74 149.0 21.7 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.771 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.811 ' O ' HG22 ' A' ' 61' ' ' ILE . 0.4 OUTLIER -54.73 -47.33 73.92 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.988 -179.937 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.0 p -52.38 -30.26 28.14 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.36 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -53.91 -28.52 37.21 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 111.522 0.193 . . . . 0.0 111.522 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.504 ' CE2' HD13 ' A' ' 23' ' ' ILE . 61.7 m-85 -98.11 24.32 7.23 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 61.4 21.85 12.34 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 179.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.811 HG22 ' O ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -89.56 92.47 3.97 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 CA-C-O 120.853 0.359 . . . . 0.0 110.722 179.454 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -101.73 176.28 5.27 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.141 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.32 145.85 5.8 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.311 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 64.54 21.86 12.54 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.833 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 54.3 p -75.67 149.41 38.15 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 120.734 0.302 . . . . 0.0 110.996 179.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.5 m -107.09 90.2 3.23 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.553 179.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.875 HD11 HG22 ' A' ' 5' ' ' VAL . 0.5 OUTLIER -109.34 135.23 50.74 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.869 0.366 . . . . 0.0 111.261 -179.813 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.644 ' O ' HG22 ' A' ' 44' ' ' ILE . 16.4 m80 -107.34 142.07 37.72 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.715 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.761 HD11 ' O ' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -104.76 158.36 16.56 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.693 0.283 . . . . 0.0 111.159 179.69 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.3 p -114.1 152.43 15.77 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.927 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.7 mp . . . . . 0 C--N 1.332 -0.176 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.84 179.947 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.8 mp0 . . . . . 0 CA--C 1.533 0.309 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.507 HD12 ' CG2' ' A' ' 5' ' ' VAL . 14.5 pt -138.66 177.27 5.28 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.108 0 CA-C-O 120.71 0.291 . . . . 0.0 111.306 -179.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -118.88 101.31 7.96 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.703 0.287 . . . . 0.0 110.826 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.687 HG13 HD13 ' A' ' 69' ' ' LEU . 22.0 t -114.96 149.56 17.14 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.132 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 9.2 mmtt -106.92 130.72 54.54 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.9 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.43 -166.6 1.36 Allowed 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.271 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.932 HD13 ' HD3' ' A' ' 37' ' ' PRO . 0.6 OUTLIER -66.98 -43.39 83.14 Favored 'General case' 0 C--N 1.339 0.128 0 CA-C-O 120.8 0.333 . . . . 0.0 111.183 -178.79 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.427 ' N ' ' HG ' ' A' ' 8' ' ' LEU . 1.3 p -111.27 40.36 2.09 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.035 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 55.24 39.96 73.51 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.681 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.06 163.23 20.0 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.783 0.292 . . . . 0.0 110.898 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -103.04 122.8 45.39 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.864 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.666 HD11 HG11 ' A' ' 5' ' ' VAL . 10.6 pt -124.99 151.5 30.68 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-O 120.703 0.287 . . . . 0.0 111.234 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 16.7 m -105.75 130.55 53.73 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.793 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.489 ' CB ' HD11 ' A' ' 3' ' ' ILE . 0.3 OUTLIER -137.56 130.31 30.04 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.576 -0.283 . . . . 0.0 110.984 179.98 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -100.95 175.05 5.74 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.77 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.7 HG11 ' HA ' ' A' ' 62' ' ' GLN . 26.1 t -132.81 108.99 13.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 120.81 0.338 . . . . 0.0 111.272 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.413 ' HB2' ' HD2' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -107.05 158.21 33.49 Favored Pre-proline 0 C--N 1.333 -0.15 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.498 179.811 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.413 ' HD2' ' HB2' ' A' ' 18' ' ' GLU . 3.7 Cg_endo -46.49 -53.36 6.12 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.627 2.218 . . . . 0.0 112.059 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.9 p -90.42 41.16 1.04 Allowed 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.636 ' OD1' HD12 ' A' ' 56' ' ' LEU . 13.8 t70 -74.56 94.89 2.7 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.65 0.262 . . . . 0.0 110.976 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.21 128.7 34.78 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.658 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.744 HD12 ' C ' ' A' ' 54' ' ' ARG . 7.1 mt -57.83 -35.04 49.82 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.329 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -71.33 -41.3 70.02 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.608 0.242 . . . . 0.0 111.08 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -73.02 -41.89 63.77 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.242 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.434 HG21 HD21 ' A' ' 15' ' ' LEU . 12.3 p -63.78 -36.23 75.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-N 116.759 -0.2 . . . . 0.0 111.285 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.735 ' HA ' HD12 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -55.82 -41.15 73.79 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.621 0.248 . . . . 0.0 110.888 179.912 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.95 -34.85 70.35 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.322 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 16.8 mtpt -63.68 -43.09 97.69 Favored 'General case' 0 CA--C 1.527 0.092 0 CA-C-O 120.633 0.254 . . . . 0.0 110.822 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.735 HD12 ' HA ' ' A' ' 27' ' ' LYS . 3.4 mt -66.47 -49.32 76.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 CA-C-O 120.702 0.287 . . . . 0.0 110.735 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 1.9 tp60 -65.16 -25.91 67.94 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.185 179.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -51.05 -31.23 17.93 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.64 -24.83 49.39 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 121.162 -0.215 . . . . 0.0 111.45 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 70.61 33.73 2.29 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.673 0.273 . . . . 0.0 110.704 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.479 ' O ' HD22 ' A' ' 8' ' ' LEU . . . -89.96 -39.99 5.99 Favored Glycine 0 C--N 1.334 0.454 0 C-N-CA 120.518 -0.849 . . . . 0.0 112.596 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.519 HG22 ' HD2' ' A' ' 38' ' ' PRO . 4.6 mt -89.33 110.08 36.04 Favored Pre-proline 0 CA--C 1.531 0.224 0 CA-C-N 116.656 0.228 . . . . 0.0 111.163 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.932 ' HD3' HD13 ' A' ' 8' ' ' LEU . 33.8 Cg_exo -57.65 -46.9 23.96 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.374 2.049 . . . . 0.0 113.077 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.519 ' HD2' HG22 ' A' ' 36' ' ' ILE . 60.6 Cg_endo -74.11 120.21 6.2 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.224 1.949 . . . . 0.0 112.894 -179.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -68.75 -18.83 64.28 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.19 179.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -93.01 34.02 1.13 Allowed 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 111.492 0.182 . . . . 0.0 111.492 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.52 ' O ' HD22 ' A' ' 50' ' ' LEU . 7.9 tp-100 -82.35 111.79 18.73 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 179.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.678 ' CB ' HD13 ' A' ' 50' ' ' LEU . 7.1 ptt180 -139.67 178.79 6.98 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.885 -179.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.74 HD22 HD21 ' A' ' 67' ' ' LEU . 0.7 OUTLIER -97.84 166.46 11.46 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.875 179.949 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.625 HG23 ' O ' ' A' ' 44' ' ' ILE . 18.0 tt -109.47 89.14 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.158 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.472 ' HB2' HD12 ' A' ' 43' ' ' LEU . 1.3 t80 -150.83 109.09 3.75 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.153 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.34 33.68 18.79 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.556 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 46.23 45.33 15.64 Favored Glycine 0 C--N 1.336 0.541 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.97 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.417 ' HE2' ' CE1' ' A' ' 59' ' ' TYR . 26.1 tptt -101.42 129.92 47.54 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.803 0.302 . . . . 0.0 110.93 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -89.15 158.25 17.99 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.974 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.678 HD13 ' CB ' ' A' ' 42' ' ' ARG . 3.1 mp -79.22 -34.84 42.5 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.166 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -78.97 -10.46 59.83 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 111.678 0.251 . . . . 0.0 111.678 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -47.07 -42.81 19.39 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.66 0.267 . . . . 0.0 111.227 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.77 37.52 5.75 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.767 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.744 ' C ' HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -107.14 174.93 5.67 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.848 0.324 . . . . 0.0 110.728 179.783 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.494 HG22 ' H ' ' A' ' 57' ' ' SER . 49.8 m -99.19 135.25 40.87 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.814 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.697 HD22 HG21 ' A' ' 61' ' ' ILE . 14.5 mt -52.24 -38.14 57.22 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.011 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.494 ' H ' HG22 ' A' ' 55' ' ' THR . 8.0 t -61.31 -31.49 71.34 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.647 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -53.73 -37.83 63.74 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 121.207 -0.197 . . . . 0.0 111.418 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.417 ' CE1' ' HE2' ' A' ' 48' ' ' LYS . 6.1 m-85 -103.62 34.32 3.02 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 120.511 0.196 . . . . 0.0 111.439 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 54.8 28.0 9.69 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 179.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.697 HG21 HD22 ' A' ' 56' ' ' LEU . 28.2 mt -89.48 73.49 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.123 0 CA-C-O 120.768 0.318 . . . . 0.0 110.885 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.7 ' HA ' HG11 ' A' ' 17' ' ' VAL . 4.3 mm-40 -94.8 177.81 5.78 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.058 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.4 ' HA ' HG21 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -50.23 147.22 4.38 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.863 0.363 . . . . 0.0 111.276 -179.758 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 63.66 20.73 12.38 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.779 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.8 m -75.83 176.74 7.51 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-O 120.63 0.253 . . . . 0.0 110.951 179.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.621 ' O ' HG23 ' A' ' 66' ' ' THR . 10.5 t -101.44 82.96 2.38 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.472 179.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.74 HD21 HD22 ' A' ' 43' ' ' LEU . 0.3 OUTLIER -98.95 108.61 21.34 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.128 -179.626 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.9 m170 -107.13 124.34 49.55 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.659 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.687 HD13 HG13 ' A' ' 5' ' ' VAL . 5.4 mp -93.9 149.27 21.38 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.887 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.6 t -104.1 144.09 14.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.03 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.4 mt . . . . . 0 C--N 1.332 -0.185 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.908 -179.962 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 . . . . . 0 CA--C 1.534 0.328 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.614 HG12 HG23 ' A' ' 5' ' ' VAL . 14.7 tt -138.91 154.96 26.68 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 O-C-N 122.33 -0.231 . . . . 0.0 111.118 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.83 81.63 1.73 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.719 0.295 . . . . 0.0 110.766 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.614 HG23 HG12 ' A' ' 3' ' ' ILE . 16.6 t -109.2 153.63 10.9 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.969 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.93 138.67 42.65 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.681 0.277 . . . . 0.0 111.046 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.567 HG21 ' HB3' ' A' ' 11' ' ' LYS . 6.0 p -99.9 -167.44 1.46 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.215 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.36 -35.36 75.51 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.963 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.53 -66.57 1.07 Allowed 'General case' 0 C--O 1.231 0.111 0 CA-C-O 120.827 0.346 . . . . 0.0 110.382 179.396 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 171.45 46.03 0.04 OUTLIER Glycine 0 CA--C 1.522 0.48 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.917 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.567 ' HB3' HG21 ' A' ' 7' ' ' THR . 0.5 OUTLIER -84.93 164.14 18.53 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.89 0.345 . . . . 0.0 111.071 179.993 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.1 p -103.17 123.57 46.96 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.48 179.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.3 tt -114.94 140.85 34.01 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.107 0 CA-C-O 120.736 0.303 . . . . 0.0 111.275 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 17.0 p -106.03 119.51 39.39 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.784 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.525 HD12 HG21 ' A' ' 3' ' ' ILE . 5.0 mt -138.03 145.39 41.77 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.941 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -100.99 164.69 11.69 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.853 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.714 HG13 HD11 ' A' ' 56' ' ' LEU . 24.7 t -129.89 106.11 12.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.031 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.414 ' HB2' ' HD2' ' A' ' 19' ' ' PRO . 0.5 OUTLIER -102.09 163.32 17.97 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.812 179.966 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.414 ' HD2' ' HB2' ' A' ' 18' ' ' GLU . 53.5 Cg_exo -52.67 -48.74 20.36 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.452 2.101 . . . . 0.0 112.189 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.3 p -90.28 34.19 0.88 Allowed 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.778 ' CG ' HD21 ' A' ' 56' ' ' LEU . 18.0 t0 -75.31 106.65 6.95 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.727 0.299 . . . . 0.0 110.73 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.4 m -85.16 142.61 29.35 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.033 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.43 HG13 HD12 ' A' ' 50' ' ' LEU . 9.5 tp -68.05 -23.78 29.38 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.763 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -86.02 -33.96 20.91 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 120.477 0.179 . . . . 0.0 111.298 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -62.83 -38.93 92.71 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.522 0.201 . . . . 0.0 111.29 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.9 p -63.78 -31.1 51.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-N 116.754 -0.203 . . . . 0.0 111.444 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.668 ' CG ' HD23 ' A' ' 50' ' ' LEU . 14.7 tttt -56.0 -43.38 77.63 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.715 0.293 . . . . 0.0 110.823 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.86 -30.89 71.94 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.345 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.6 mttm -63.82 -39.4 94.15 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 120.567 0.222 . . . . 0.0 110.89 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 38.0 mm -64.98 -46.92 90.12 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 CA-C-O 120.698 0.285 . . . . 0.0 110.555 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.32 -42.88 92.54 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.588 179.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -61.25 -22.98 65.32 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.727 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.78 -44.36 50.02 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-O 120.73 0.3 . . . . 0.0 110.795 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -136.78 -50.61 0.66 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.131 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.432 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . 116.93 67.41 0.38 Allowed Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.931 -179.598 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.6 HG23 ' O ' ' A' ' 36' ' ' ILE . 19.8 tt -78.45 110.1 12.71 Favored Pre-proline 0 CA--C 1.531 0.249 0 CA-C-O 120.679 0.276 . . . . 0.0 111.368 -179.432 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.49 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 35.2 Cg_exo -60.29 -45.92 20.62 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.61 2.206 . . . . 0.0 113.212 -179.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.49 ' HD2' ' N ' ' A' ' 37' ' ' PRO . 58.1 Cg_exo -39.12 95.09 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.866 2.378 . . . . 0.0 113.221 -179.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -68.76 -17.57 64.06 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.405 179.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -93.5 30.98 1.61 Allowed 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 111.779 0.289 . . . . 0.0 111.779 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.431 ' CD ' HD21 ' A' ' 69' ' ' LEU . 1.8 tt0 -82.64 116.07 21.87 Favored 'General case' 0 CA--C 1.528 0.105 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 179.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.44 168.23 20.21 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.683 0.278 . . . . 0.0 111.387 -179.256 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -103.96 167.51 9.72 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.711 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.671 HG22 ' O ' ' A' ' 68' ' ' HIS . 8.0 tt -111.04 74.14 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.732 0.301 . . . . 0.0 111.129 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -150.91 112.57 4.46 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.343 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.6 ' HB1' ' CE1' ' A' ' 59' ' ' TYR . . . 59.75 25.44 14.44 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.849 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 43.45 45.63 6.79 Favored Glycine 0 C--N 1.337 0.595 0 C-N-CA 120.861 -0.685 . . . . 0.0 113.09 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.01 135.65 41.11 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.794 0.297 . . . . 0.0 110.898 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -89.1 161.06 16.73 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.963 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.668 HD23 ' CG ' ' A' ' 27' ' ' LYS . 1.3 tp -79.09 -20.4 48.84 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.533 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -78.62 -40.82 33.3 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-O 120.535 0.207 . . . . 0.0 111.065 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.418 ' O ' ' N ' ' A' ' 54' ' ' ARG . 0.5 OUTLIER -48.0 119.0 2.61 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 179.538 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.86 53.91 0.37 Allowed Glycine 0 CA--C 1.521 0.419 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.875 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.418 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -107.16 164.69 11.95 Favored 'General case' 0 CA--C 1.527 0.093 0 CA-C-N 117.01 0.405 . . . . 0.0 110.725 179.814 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.566 HG22 ' H ' ' A' ' 57' ' ' SER . 71.1 m -99.17 131.41 45.23 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.708 0.289 . . . . 0.0 110.666 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.778 HD21 ' CG ' ' A' ' 21' ' ' ASP . 0.3 OUTLIER -51.39 -33.58 30.67 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.699 -0.228 . . . . 0.0 111.007 -179.951 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.566 ' H ' HG22 ' A' ' 55' ' ' THR . 12.6 t -63.36 -36.29 83.22 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 111.713 0.264 . . . . 0.0 111.713 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.406 ' OD1' ' CD2' ' A' ' 59' ' ' TYR . 1.5 p30 -55.81 -31.67 62.88 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -179.18 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.6 ' CE1' ' HB1' ' A' ' 46' ' ' ALA . 4.5 m-85 -103.97 29.71 5.69 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 121.077 -0.249 . . . . 0.0 111.597 -179.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 65.15 12.97 8.41 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 179.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.697 ' O ' HD12 ' A' ' 56' ' ' LEU . 21.4 mt -89.91 62.93 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 O-C-N 122.17 -0.332 . . . . 0.0 110.692 179.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -104.19 -173.06 2.22 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.301 -179.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.3 ttpt -46.64 139.57 5.1 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.847 0.356 . . . . 0.0 111.388 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 65.26 15.77 10.18 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.134 -0.484 . . . . 0.0 112.196 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 40.3 t -76.05 -177.39 3.9 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 120.655 0.264 . . . . 0.0 110.67 179.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.33 91.58 3.77 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.515 -0.312 . . . . 0.0 110.409 179.457 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.42 HD11 ' CG2' ' A' ' 61' ' ' ILE . 3.8 mp -98.72 102.44 14.18 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.745 0.307 . . . . 0.0 111.23 -179.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.671 ' O ' HG22 ' A' ' 44' ' ' ILE . 0.3 OUTLIER -107.12 109.33 21.14 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.625 179.737 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.431 HD21 ' CD ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -94.04 179.44 5.33 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.929 -179.906 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.9 m -103.77 172.41 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.115 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.332 -0.185 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.823 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 53.0 mm-40 . . . . . 0 CA--C 1.529 0.141 0 CA-C-O 120.6 0.238 . . . . 0.0 111.005 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.487 HD11 ' HB3' ' A' ' 15' ' ' LEU . 2.4 pt -138.8 176.24 6.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-N 116.669 -0.242 . . . . 0.0 111.076 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -118.83 101.16 7.86 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.744 0.307 . . . . 0.0 110.907 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.485 ' CG2' HD13 ' A' ' 69' ' ' LEU . 11.1 p -136.19 138.37 47.21 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.746 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -107.28 168.74 9.01 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.878 0.37 . . . . 0.0 111.305 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.6 p -99.93 -168.27 1.57 Allowed 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.446 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.55 -22.48 66.98 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 120.933 -0.307 . . . . 0.0 111.563 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.2 t -100.56 -10.75 20.7 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.65 30.13 8.76 Favored Glycine 0 C--N 1.336 0.554 0 C-N-CA 120.507 -0.854 . . . . 0.0 113.111 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.6 tttm -84.29 170.28 13.83 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-N 117.161 0.481 . . . . 0.0 110.714 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.468 HG23 ' O ' ' A' ' 12' ' ' THR . 14.0 t -103.1 118.0 35.82 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.583 -0.281 . . . . 0.0 110.873 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.472 HG13 HG13 ' A' ' 5' ' ' VAL . 22.8 pt -125.18 157.55 33.9 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 CA-C-O 120.677 0.275 . . . . 0.0 111.211 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.4 p -106.03 125.82 51.45 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.838 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.487 ' HB3' HD11 ' A' ' 3' ' ' ILE . 0.3 OUTLIER -129.16 145.78 51.23 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.885 179.965 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -101.06 152.43 20.61 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.786 0.326 . . . . 0.0 110.809 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 24.2 t -133.51 132.16 57.49 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.044 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -107.1 159.95 28.17 Favored Pre-proline 0 C--N 1.332 -0.169 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.784 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -50.68 -49.93 15.26 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.465 2.11 . . . . 0.0 112.218 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 p -90.22 36.74 0.88 Allowed 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.0 p-10 -69.13 103.82 2.0 Allowed 'General case' 0 C--O 1.231 0.11 0 O-C-N 122.199 -0.313 . . . . 0.0 110.744 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.3 p -85.09 134.09 34.2 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.979 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.895 HD13 ' HE2' ' A' ' 48' ' ' LYS . 3.9 tp -65.06 -36.98 79.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.315 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -48.09 -51.64 23.69 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.612 0.244 . . . . 0.0 111.069 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.532 ' OD1' ' HB3' ' A' ' 28' ' ' ALA . 0.8 OUTLIER -74.78 43.63 0.2 Allowed 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 111.779 0.288 . . . . 0.0 111.779 179.632 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.531 ' O ' HG22 ' A' ' 30' ' ' ILE . 13.9 p -74.06 -39.52 50.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 CA-C-O 120.626 0.25 . . . . 0.0 111.298 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.487 ' HA ' HG22 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -55.94 -44.14 78.11 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.72 0.295 . . . . 0.0 110.936 179.913 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.532 ' HB3' ' OD1' ' A' ' 25' ' ' ASN . . . -64.27 -42.68 96.32 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.103 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 21.3 mtmm -70.82 -45.63 64.24 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.948 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.543 HG21 ' OE1' ' A' ' 41' ' ' GLN . 10.8 tp -70.34 -36.53 67.34 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.266 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.7 tm0? -59.33 -24.6 63.47 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.773 -0.194 . . . . 0.0 111.069 179.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -50.99 -25.21 4.41 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.59 -39.94 61.91 Favored 'General case' 0 C--O 1.231 0.089 0 C-N-CA 120.936 -0.306 . . . . 0.0 110.564 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 176.51 -39.17 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.716 0.294 . . . . 0.0 111.453 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.557 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . 131.94 80.49 0.19 Allowed Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.748 -179.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.613 HG23 ' O ' ' A' ' 36' ' ' ILE . 11.2 tt -77.68 106.1 3.42 Favored Pre-proline 0 N--CA 1.466 0.349 0 CA-C-O 120.799 0.333 . . . . 0.0 111.582 -179.19 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.639 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 17.1 Cg_exo -68.59 -35.6 16.72 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 123.03 2.486 . . . . 0.0 115.13 -179.081 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.639 ' HD2' ' N ' ' A' ' 37' ' ' PRO . 15.8 Cg_endo -60.52 113.45 1.7 Allowed 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 121.678 1.585 . . . . 0.0 113.393 -178.343 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -70.28 5.35 1.75 Allowed 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.399 179.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -89.73 8.74 30.17 Favored 'General case' 0 CA--C 1.53 0.199 0 O-C-N 122.088 -0.383 . . . . 0.0 111.4 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.543 ' OE1' HG21 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -82.59 99.41 9.53 Favored 'General case' 0 CA--C 1.527 0.08 0 CA-C-O 120.776 0.322 . . . . 0.0 110.453 179.41 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.77 169.74 16.61 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.971 -179.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.889 HD21 ' CD2' ' A' ' 67' ' ' LEU . 0.2 OUTLIER -97.99 140.74 31.88 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.796 179.883 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.564 HG23 ' O ' ' A' ' 44' ' ' ILE . 3.7 tt -107.83 65.08 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 120.793 0.33 . . . . 0.0 111.102 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -150.89 121.07 7.23 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.737 0.303 . . . . 0.0 111.219 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.93 25.59 15.56 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.787 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 45.13 55.71 6.41 Favored Glycine 0 C--N 1.338 0.65 0 C-N-CA 120.836 -0.697 . . . . 0.0 113.039 179.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.895 ' HE2' HD13 ' A' ' 23' ' ' ILE . 0.3 OUTLIER -102.03 135.01 44.34 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.702 0.287 . . . . 0.0 110.96 -179.934 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -89.09 154.17 20.4 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.872 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.629 HD12 ' N ' ' A' ' 51' ' ' GLU . 4.5 pp -69.78 -39.44 76.64 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.06 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.629 ' N ' HD12 ' A' ' 50' ' ' LEU . 0.0 OUTLIER -89.76 10.97 21.44 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 179.929 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -47.06 -45.68 21.86 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.683 0.278 . . . . 0.0 111.194 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.39 8.12 56.52 Favored Glycine 0 CA--C 1.523 0.589 0 C-N-CA 120.591 -0.814 . . . . 0.0 113.292 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.471 ' O ' HG22 ' A' ' 23' ' ' ILE . 3.0 mmm180 -107.09 -177.61 3.41 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 117.326 0.563 . . . . 0.0 110.702 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.657 HG22 ' OD2' ' A' ' 58' ' ' ASP . 9.6 t -99.27 150.26 22.28 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.74 0.305 . . . . 0.0 110.71 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.4 mt -61.48 -39.82 92.31 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.734 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.7 t -58.62 -32.07 68.67 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.637 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.657 ' OD2' HG22 ' A' ' 55' ' ' THR . 3.1 m-20 -53.94 -35.03 61.28 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 121.13 -0.228 . . . . 0.0 111.476 -179.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -103.82 31.75 4.29 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 120.474 0.178 . . . . 0.0 111.401 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 65.18 14.0 9.1 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 47.6 mt -90.01 68.32 0.59 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.139 0 CA-C-O 120.743 0.306 . . . . 0.0 110.809 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -98.87 -178.46 3.97 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.187 -179.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.4 145.81 3.21 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.801 0.334 . . . . 0.0 111.409 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 65.55 13.88 9.15 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.234 -0.439 . . . . 0.0 112.179 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 39.5 t -76.16 -177.48 4.0 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-O 120.634 0.254 . . . . 0.0 110.71 179.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.7 m -100.9 83.65 2.57 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.314 179.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.889 ' CD2' HD21 ' A' ' 43' ' ' LEU . 7.8 tt -98.83 111.22 23.67 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.751 0.31 . . . . 0.0 111.365 -179.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 17.6 t60 -107.11 125.81 51.55 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.599 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.485 HD13 ' CG2' ' A' ' 5' ' ' VAL . 0.2 OUTLIER -96.53 111.14 23.37 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-O 120.732 0.301 . . . . 0.0 111.084 -179.776 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.1 t -114.1 149.94 16.27 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.015 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.1 pp . . . . . 0 C--O 1.232 0.14 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.962 -179.932 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 . . . . . 0 CA--C 1.527 0.091 0 CA-C-O 120.741 0.305 . . . . 0.0 110.88 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.49 HG21 ' HB3' ' A' ' 15' ' ' LEU . 17.7 tt -138.94 154.14 25.73 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.965 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -118.64 104.37 10.56 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.756 0.312 . . . . 0.0 110.895 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 1.033 HG13 HD23 ' A' ' 67' ' ' LEU . 1.7 t -103.25 163.4 3.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.892 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.8 tppt? -106.62 121.23 43.91 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.758 0.313 . . . . 0.0 110.662 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.404 ' OG1' ' N ' ' A' ' 11' ' ' LYS . 2.7 p -99.82 -176.44 3.26 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.192 -179.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.67 -40.11 88.45 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-O 120.696 0.284 . . . . 0.0 111.591 -178.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -111.04 43.23 1.48 Allowed 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.204 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 45.0 38.03 5.8 Favored Glycine 0 C--N 1.335 0.511 0 C-N-CA 120.95 -0.643 . . . . 0.0 113.291 179.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.404 ' N ' ' OG1' ' A' ' 7' ' ' THR . 7.8 tttt -84.12 144.46 29.01 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.856 0.328 . . . . 0.0 110.791 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.537 HG23 ' O ' ' A' ' 12' ' ' THR . 14.7 t -95.38 110.65 22.65 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.731 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.0 pt -125.09 164.19 24.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.201 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.7 t -100.55 150.64 22.48 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.781 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.49 ' HB3' HG21 ' A' ' 3' ' ' ILE . 0.9 OUTLIER -134.87 100.74 4.68 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.676 0.274 . . . . 0.0 110.963 -179.87 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -96.39 126.46 41.61 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.841 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.1 m -139.26 173.51 11.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.738 0.304 . . . . 0.0 111.272 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.425 ' HB2' ' HD2' ' A' ' 19' ' ' PRO . 0.4 OUTLIER -105.37 158.38 32.34 Favored Pre-proline 0 C--O 1.232 0.162 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.533 179.833 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.566 ' O ' HG21 ' A' ' 55' ' ' THR . 1.5 Cg_endo -44.49 -48.02 10.54 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.825 2.35 . . . . 0.0 112.165 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 87.9 p -90.33 38.89 0.95 Allowed 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 179.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.579 ' OD2' HD23 ' A' ' 56' ' ' LEU . 17.9 p-10 -75.04 116.72 16.09 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.658 0.266 . . . . 0.0 110.912 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.13 169.02 14.3 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.794 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.414 ' O ' HG22 ' A' ' 26' ' ' VAL . 43.7 mm -67.4 -42.04 86.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.862 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -64.56 -40.14 95.02 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.005 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -62.74 -44.77 95.33 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.653 0.263 . . . . 0.0 110.788 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.414 HG22 ' O ' ' A' ' 23' ' ' ILE . 27.7 m -70.26 -18.65 21.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.5 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.6 tptm -55.62 -35.51 65.95 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.504 0.192 . . . . 0.0 111.116 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.67 -38.89 75.9 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.6 0.238 . . . . 0.0 111.05 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.1 mttm -63.95 -36.53 84.26 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.918 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 35.5 mm -64.93 -44.48 96.14 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.078 0 CA-C-O 120.752 0.31 . . . . 0.0 110.61 179.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -57.88 -28.24 64.0 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.864 179.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -51.78 -27.76 13.28 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 7.2 mmtt -74.82 -40.93 60.79 Favored 'General case' 0 C--O 1.23 0.079 0 CA-C-O 120.693 0.282 . . . . 0.0 110.596 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -175.47 -40.89 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.557 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.525 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . 108.87 64.79 0.56 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.544 -0.836 . . . . 0.0 111.632 -179.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.596 HG23 ' O ' ' A' ' 36' ' ' ILE . 12.0 tt -78.22 107.54 5.83 Favored Pre-proline 0 N--CA 1.465 0.295 0 N-CA-C 111.741 0.274 . . . . 0.0 111.741 -179.085 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.525 ' HD3' ' O ' ' A' ' 35' ' ' GLY . 27.9 Cg_exo -62.49 -43.83 20.58 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.751 2.301 . . . . 0.0 113.578 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.505 ' HD2' ' N ' ' A' ' 37' ' ' PRO . 44.9 Cg_exo -38.03 117.62 0.26 Allowed 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 123.023 2.482 . . . . 0.0 113.685 -179.201 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -69.84 2.32 3.52 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 179.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -89.84 3.45 52.9 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 118.134 0.425 . . . . 0.0 111.803 -179.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 27.2 tp60 -82.88 97.53 8.71 Favored 'General case' 0 C--O 1.232 0.14 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.473 ' O ' HD23 ' A' ' 69' ' ' LEU . 3.0 mtp180 -137.5 -176.31 4.36 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.151 -179.215 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.673 HD23 ' CD2' ' A' ' 50' ' ' LEU . 4.1 mm? -97.4 134.57 40.49 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.623 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 32.1 mt -100.98 83.54 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.406 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -150.94 115.61 5.19 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.018 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.85 35.97 19.17 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.32 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 46.87 36.84 8.86 Favored Glycine 0 C--N 1.336 0.577 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.876 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -110.16 107.61 17.48 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.774 0.287 . . . . 0.0 111.038 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.05 130.68 35.47 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.53 179.618 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.673 ' CD2' HD23 ' A' ' 43' ' ' LEU . 1.3 pp -79.32 62.86 3.79 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.579 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -89.47 -66.32 0.93 Allowed 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.74 0.305 . . . . 0.0 110.414 179.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.456 ' O ' ' N ' ' A' ' 54' ' ' ARG . 19.0 t0 -48.56 125.44 9.86 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.01 179.112 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -65.2 60.7 0.09 OUTLIER Glycine 0 CA--C 1.522 0.52 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.565 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.456 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.3 OUTLIER -107.15 -172.9 2.17 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.94 0.37 . . . . 0.0 110.797 -179.904 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.566 HG21 ' O ' ' A' ' 19' ' ' PRO . 22.4 m -98.39 144.92 27.25 Favored 'General case' 0 N--CA 1.457 -0.11 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.622 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.642 HD12 ' N ' ' A' ' 57' ' ' SER . 3.8 pp -51.78 -40.67 60.76 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.203 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.642 ' N ' HD12 ' A' ' 56' ' ' LEU . 10.5 t -55.19 -52.09 64.45 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.395 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -64.66 -16.0 62.15 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 112.265 0.469 . . . . 0.0 112.265 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -97.8 38.12 1.33 Allowed 'General case' 0 CA--C 1.533 0.311 0 O-C-N 122.174 -0.329 . . . . 0.0 111.885 -179.527 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 66.74 -40.29 0.37 Allowed 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 179.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.514 HD12 ' HB2' ' A' ' 56' ' ' LEU . 1.1 pt -78.64 108.22 11.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.872 0.367 . . . . 0.0 111.328 -179.504 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.24 -174.8 2.69 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.951 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.2 150.68 2.34 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.791 0.329 . . . . 0.0 111.373 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 65.11 19.29 11.76 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.852 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.2 m -75.83 177.69 6.75 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.59 0.233 . . . . 0.0 110.872 179.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.99 114.85 26.5 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.3 179.376 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 1.033 HD23 HG13 ' A' ' 5' ' ' VAL . 4.8 mp -98.98 89.85 4.42 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.673 0.273 . . . . 0.0 111.48 -179.22 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -100.17 95.31 6.73 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.2 179.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.473 HD23 ' O ' ' A' ' 42' ' ' ARG . 0.8 OUTLIER -93.86 177.11 6.1 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.244 -179.426 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.42 HG22 ' N ' ' A' ' 71' ' ' LEU . 12.0 p -103.62 156.62 5.37 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.766 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.42 ' N ' HG22 ' A' ' 70' ' ' VAL . 2.7 mt . . . . . 0 N--CA 1.462 0.136 0 CA-C-O 120.711 0.291 . . . . 0.0 110.939 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.412 ' CB ' ' HG2' ' A' ' 63' ' ' LYS . 3.8 mm-40 . . . . . 0 CA--C 1.533 0.31 0 N-CA-C 112.484 0.549 . . . . 0.0 112.484 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.741 HG22 ' O ' ' A' ' 15' ' ' LEU . 18.6 tt -138.46 147.95 25.01 Favored 'Isoleucine or valine' 0 C--O 1.231 0.1 0 C-N-CA 120.619 -0.432 . . . . 0.0 111.441 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -120.61 94.64 4.43 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.95 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.504 HG11 HD13 ' A' ' 15' ' ' LEU . 13.7 p -103.02 154.77 5.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.854 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 6.4 mmpt? -106.58 145.36 31.99 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.819 0.342 . . . . 0.0 111.022 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.6 p -99.53 -173.37 2.45 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.161 -179.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.425 HD13 ' HG2' ' A' ' 38' ' ' PRO . 1.1 pt? -66.9 -33.43 75.57 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-O 120.688 0.28 . . . . 0.0 110.682 -179.665 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.3 m -107.3 42.22 1.35 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.713 179.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 47.98 32.18 8.76 Favored Glycine 0 CA--C 1.521 0.467 0 C-N-CA 121.1 -0.571 . . . . 0.0 113.403 179.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -84.55 152.95 23.56 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 117.096 0.448 . . . . 0.0 110.788 179.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.4 ' O ' HG23 ' A' ' 12' ' ' THR . 12.2 t -103.14 122.53 44.9 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.716 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.404 ' CG1' ' CG1' ' A' ' 5' ' ' VAL . 38.6 pt -123.07 166.07 18.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 120.829 0.347 . . . . 0.0 111.367 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.5 p -105.96 127.09 52.92 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.647 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.741 ' O ' HG22 ' A' ' 3' ' ' ILE . 0.3 OUTLIER -127.75 139.35 52.73 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-O 120.775 0.321 . . . . 0.0 111.22 -179.97 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -101.19 165.42 11.3 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.638 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.7 t -140.04 125.91 21.49 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-O 120.687 0.279 . . . . 0.0 111.284 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.449 ' HB2' ' HD2' ' A' ' 19' ' ' PRO . 1.7 pt-20 -107.08 158.19 33.55 Favored Pre-proline 0 C--N 1.333 -0.115 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.453 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.449 ' HD2' ' HB2' ' A' ' 18' ' ' GLU . 4.7 Cg_endo -47.1 -56.29 3.17 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.555 2.17 . . . . 0.0 112.124 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 41.6 p -90.45 41.73 1.07 Allowed 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.419 ' HB2' ' O ' ' A' ' 18' ' ' GLU . 8.3 t70 -72.78 111.35 7.84 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.638 0.256 . . . . 0.0 110.989 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.8 m -85.09 149.28 25.66 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.723 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.459 ' O ' HG12 ' A' ' 26' ' ' VAL . 28.7 mt -68.02 -36.82 76.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.285 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -73.92 -40.83 62.85 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 120.564 0.221 . . . . 0.0 110.984 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -67.26 -40.41 86.2 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.682 -0.235 . . . . 0.0 111.126 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.459 HG12 ' O ' ' A' ' 23' ' ' ILE . 12.1 p -63.83 -33.81 64.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-N 116.703 -0.226 . . . . 0.0 111.367 -179.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.799 ' HE3' HD13 ' A' ' 50' ' ' LEU . 0.4 OUTLIER -55.81 -45.37 78.29 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.724 0.297 . . . . 0.0 110.814 179.961 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.04 -30.26 69.45 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.367 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.5 ttmp? -63.69 -41.27 98.16 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 120.594 0.235 . . . . 0.0 110.899 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.508 HD12 ' HA ' ' A' ' 27' ' ' LYS . 4.1 mt -64.96 -47.55 87.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-O 120.679 0.276 . . . . 0.0 110.712 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.3 -45.73 83.19 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.594 179.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -61.11 -23.97 65.9 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.556 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -74.63 -64.56 1.01 Allowed 'General case' 0 CA--C 1.528 0.103 0 CA-C-O 120.575 0.226 . . . . 0.0 111.285 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -103.27 -41.44 6.04 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 111.5 0.185 . . . . 0.0 111.5 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.48 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . 96.95 56.64 1.13 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.515 -0.85 . . . . 0.0 111.822 -179.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.609 HG23 ' O ' ' A' ' 36' ' ' ILE . 10.1 tt -78.44 108.92 8.82 Favored Pre-proline 0 CA--C 1.531 0.225 0 CA-C-O 120.622 0.249 . . . . 0.0 111.452 -179.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.48 ' HD3' ' O ' ' A' ' 35' ' ' GLY . 36.7 Cg_exo -60.8 -46.74 15.35 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.549 2.166 . . . . 0.0 113.036 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.457 ' HD2' ' N ' ' A' ' 37' ' ' PRO . 69.9 Cg_exo -40.72 104.88 0.05 OUTLIER 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.82 2.347 . . . . 0.0 113.287 -179.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.0 p-10 -69.12 -10.98 60.31 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.901 179.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.79 22.31 3.64 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -179.622 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.851 ' OE1' HD21 ' A' ' 69' ' ' LEU . 0.6 OUTLIER -84.16 102.8 12.85 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 110.329 -0.249 . . . . 0.0 110.329 179.436 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.534 ' O ' HD13 ' A' ' 69' ' ' LEU . 0.9 OUTLIER -143.98 179.16 7.36 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-O 120.778 0.323 . . . . 0.0 111.41 -179.569 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.712 ' HB2' HD22 ' A' ' 67' ' ' LEU . 0.5 OUTLIER -108.16 141.64 39.58 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.871 179.828 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.604 HG23 ' O ' ' A' ' 44' ' ' ILE . 17.2 tt -111.05 75.39 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-O 120.766 0.317 . . . . 0.0 110.946 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -150.87 121.97 7.72 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.271 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 56.27 34.91 24.89 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.619 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 46.43 44.55 16.04 Favored Glycine 0 C--N 1.335 0.477 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.895 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.423 ' HE2' ' CD1' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -99.99 109.63 21.96 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.713 0.292 . . . . 0.0 110.904 -179.995 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -89.19 151.88 21.92 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.983 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.799 HD13 ' HE3' ' A' ' 27' ' ' LYS . 5.4 mt -79.24 -8.81 59.32 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.761 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -78.67 -41.47 31.18 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 122.334 -0.229 . . . . 0.0 111.108 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -47.8 114.83 0.98 Allowed 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 116.658 -0.246 . . . . 0.0 110.373 179.665 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -69.85 46.2 0.57 Allowed Glycine 0 CA--C 1.521 0.461 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.892 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.455 ' C ' HD12 ' A' ' 23' ' ' ILE . 5.0 mmp_? -107.3 177.23 4.91 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 117.128 0.464 . . . . 0.0 110.668 179.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 5.7 t -99.17 142.88 30.08 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.601 0.238 . . . . 0.0 110.436 179.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.65 ' HB3' HG23 ' A' ' 61' ' ' ILE . 84.0 mt -51.86 -43.11 63.1 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.715 0.293 . . . . 0.0 111.349 -179.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.8 t -54.55 -27.93 42.09 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -179.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -53.76 -40.91 66.61 Favored 'General case' 0 N--CA 1.465 0.318 0 O-C-N 122.259 -0.275 . . . . 0.0 111.548 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.423 ' CD1' ' HE2' ' A' ' 48' ' ' LYS . 33.8 m-85 -101.94 19.26 18.71 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 111.914 0.338 . . . . 0.0 111.914 -179.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 64.62 14.64 9.16 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.868 HD11 ' HG ' ' A' ' 67' ' ' LEU . 1.1 tp -90.0 62.16 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-O 120.841 0.353 . . . . 0.0 110.873 179.507 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 10.8 pm0 -95.26 -172.78 2.75 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.44 -179.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.412 ' HG2' ' CB ' ' A' ' 2' ' ' GLN . 0.1 OUTLIER -39.84 155.74 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.985 -179.444 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 65.3 16.01 10.31 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.806 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 17.7 p -76.32 145.94 39.21 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-O 120.561 0.219 . . . . 0.0 111.031 179.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 11.7 p -97.68 76.96 2.52 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 179.244 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.868 ' HG ' HD11 ' A' ' 61' ' ' ILE . 14.1 mt -99.94 131.77 45.7 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.832 0.348 . . . . 0.0 111.68 -179.176 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -107.2 139.84 41.0 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.25 179.214 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.851 HD21 ' OE1' ' A' ' 41' ' ' GLN . 0.1 OUTLIER -93.87 116.77 29.25 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.678 0.275 . . . . 0.0 110.858 -179.858 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.8 p -114.36 148.26 17.28 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.383 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.331 -0.222 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.563 179.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 64.5 mm-40 . . . . . 0 CA--C 1.528 0.12 0 N-CA-C 111.489 0.181 . . . . 0.0 111.489 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.822 HD12 HG23 ' A' ' 5' ' ' VAL . 1.1 pp -138.93 164.77 25.09 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 C-N-CA 120.711 -0.396 . . . . 0.0 111.672 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -129.07 111.93 13.48 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.873 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.822 HG23 HD12 ' A' ' 3' ' ' ILE . 39.0 t -111.4 155.11 12.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.893 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.712 ' O ' HD22 ' A' ' 69' ' ' LEU . 0.6 OUTLIER -106.56 165.5 11.24 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.673 0.273 . . . . 0.0 110.718 -179.89 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 66.7 p -109.82 -142.82 0.38 Allowed 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.647 -179.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.406 ' HG ' ' N ' ' A' ' 9' ' ' THR . 1.7 pt? -65.25 -38.57 90.75 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 118.615 0.643 . . . . 0.0 111.482 -179.316 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.406 ' N ' ' HG ' ' A' ' 8' ' ' LEU . 3.9 m -107.98 -60.55 1.7 Allowed 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.607 0.242 . . . . 0.0 110.894 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 165.56 53.32 0.02 OUTLIER Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.417 -0.897 . . . . 0.0 112.949 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.9 tttt -84.27 160.2 20.79 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.822 0.311 . . . . 0.0 110.675 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 26.8 p -94.91 104.68 16.57 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.876 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.641 HD11 ' HB ' ' A' ' 5' ' ' VAL . 25.3 pt -114.96 153.6 16.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-O 120.754 0.312 . . . . 0.0 111.172 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.1 p -106.07 149.89 26.29 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.935 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.751 ' HB2' HD11 ' A' ' 3' ' ' ILE . 0.3 OUTLIER -127.97 89.03 2.86 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-O 120.669 0.271 . . . . 0.0 111.264 179.954 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.13 94.91 6.22 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.766 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.492 HG11 HG12 ' A' ' 26' ' ' VAL . 29.8 m -129.94 174.12 13.13 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 CA-C-O 120.71 0.291 . . . . 0.0 111.288 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.06 160.06 27.53 Favored Pre-proline 0 C--O 1.231 0.13 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.107 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -55.44 -29.19 67.52 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.648 2.232 . . . . 0.0 112.839 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 42.0 t -78.78 -15.08 58.86 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 111.67 0.248 . . . . 0.0 111.67 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.441 ' OD2' HG12 ' A' ' 26' ' ' VAL . 1.5 t0 -64.94 122.0 15.96 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-O 120.674 0.273 . . . . 0.0 110.808 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.86 HG22 ' O ' ' A' ' 54' ' ' ARG . 0.3 OUTLIER -85.09 178.71 7.45 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.823 179.951 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.8 HG21 ' HB2' ' A' ' 50' ' ' LEU . 16.3 mt -68.17 -39.23 80.91 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.084 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -66.61 -41.25 88.7 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.658 -0.247 . . . . 0.0 111.069 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -62.96 -45.8 90.72 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.649 0.261 . . . . 0.0 111.004 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.494 HG22 ' O ' ' A' ' 23' ' ' ILE . 31.8 m -63.98 -29.7 48.01 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.524 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.498 ' HE2' HD11 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -55.62 -43.99 76.65 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.658 0.266 . . . . 0.0 110.807 -179.875 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.87 -33.07 74.02 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.046 179.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -63.9 -28.39 69.81 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.038 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.589 HD11 HD11 ' A' ' 15' ' ' LEU . 40.8 mm -75.25 -46.04 39.7 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.201 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.301 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -65.35 -40.52 93.71 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.91 178.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.27 -24.69 66.57 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.288 179.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.8 mmtm -74.78 -55.47 5.8 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.525 0.202 . . . . 0.0 111.295 -179.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -115.47 -49.77 2.74 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.618 0.247 . . . . 0.0 111.19 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 113.69 64.02 0.43 Allowed Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.679 -0.772 . . . . 0.0 111.851 -179.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.498 HD11 ' HE2' ' A' ' 27' ' ' LYS . 1.3 pp -77.89 111.59 19.07 Favored Pre-proline 0 CA--C 1.531 0.223 0 CA-C-O 120.634 0.254 . . . . 0.0 111.347 -179.296 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.562 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 31.5 Cg_exo -59.34 -43.61 39.47 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.683 2.255 . . . . 0.0 113.444 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.562 ' HD2' ' N ' ' A' ' 37' ' ' PRO . 54.9 Cg_endo -71.86 111.25 3.11 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.06 1.84 . . . . 0.0 112.755 -179.23 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -68.69 -13.61 62.48 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.055 -0.52 . . . . 0.0 112.098 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -91.08 21.9 4.02 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.454 0.538 . . . . 0.0 112.454 -179.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -93.11 97.77 10.89 Favored 'General case' 0 C--O 1.23 0.067 0 O-C-N 122.249 -0.282 . . . . 0.0 110.289 179.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.522 ' CG ' HD11 ' A' ' 50' ' ' LEU . 22.0 mtm180 -137.68 -175.82 4.21 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-O 120.715 0.293 . . . . 0.0 111.043 -179.451 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.633 HD22 HD22 ' A' ' 67' ' ' LEU . 1.1 pp -101.59 141.52 34.33 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.944 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.565 HG23 ' O ' ' A' ' 44' ' ' ILE . 20.3 tt -111.17 113.91 45.61 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.239 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -152.52 130.96 12.14 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.797 0.332 . . . . 0.0 111.306 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.82 28.87 13.04 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.776 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 45.07 48.15 9.86 Favored Glycine 0 C--N 1.336 0.543 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.903 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.444 ' HG2' ' CD1' ' A' ' 59' ' ' TYR . 12.4 mptt -99.88 140.75 33.64 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.764 0.282 . . . . 0.0 110.942 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.15 99.62 12.57 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.885 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.8 ' HB2' HG21 ' A' ' 23' ' ' ILE . 0.5 OUTLIER -79.27 -8.05 58.75 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.838 179.861 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -78.57 -30.45 46.77 Favored 'General case' 0 CA--C 1.53 0.21 0 O-C-N 122.346 -0.221 . . . . 0.0 111.29 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -45.43 -39.23 6.85 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.567 0.222 . . . . 0.0 111.3 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 105.16 49.32 1.0 Allowed Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.745 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.86 ' O ' HG22 ' A' ' 22' ' ' THR . 0.0 OUTLIER -107.3 -179.11 3.83 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.724 0.262 . . . . 0.0 110.698 179.801 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 10.6 m -99.08 140.72 32.81 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.643 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.617 ' O ' HG22 ' A' ' 61' ' ' ILE . 3.0 mp -51.77 -48.23 63.82 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.824 0.345 . . . . 0.0 110.833 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.5 t -55.31 -36.99 66.81 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.24 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -54.27 -35.69 62.81 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 111.505 0.187 . . . . 0.0 111.505 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.444 ' CD1' ' HG2' ' A' ' 48' ' ' LYS . 68.7 m-85 -100.09 21.26 13.09 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.3 m120 65.59 8.67 5.29 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 112.791 0.664 . . . . 0.0 112.791 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.706 HD11 ' CD2' ' A' ' 67' ' ' LEU . 1.2 tt -90.14 63.13 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-O 120.883 0.373 . . . . 0.0 110.666 179.321 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -94.57 -173.52 3.05 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.245 -179.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.416 ' O ' ' HG2' ' A' ' 64' ' ' GLU . 0.1 OUTLIER -39.96 147.68 0.09 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.727 -179.593 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.416 ' HG2' ' O ' ' A' ' 63' ' ' LYS . 0.7 OUTLIER 65.53 15.02 9.83 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.992 -179.747 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.5 m -76.23 174.2 10.43 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.754 0.312 . . . . 0.0 110.839 179.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.524 ' O ' HG23 ' A' ' 66' ' ' THR . 5.9 t -107.24 90.65 3.37 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.248 179.437 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.753 HD13 HD13 ' A' ' 3' ' ' ILE . 1.2 mt -98.9 113.86 26.19 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.747 0.308 . . . . 0.0 111.39 -179.376 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -107.22 120.93 43.47 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.385 179.361 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.712 HD22 ' O ' ' A' ' 6' ' ' LYS . 0.9 OUTLIER -93.76 156.45 16.67 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.713 0.292 . . . . 0.0 111.155 -179.648 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -104.07 166.22 3.08 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.747 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.3 mp . . . . . 0 C--N 1.332 -0.161 0 CA-C-O 120.677 0.275 . . . . 0.0 110.751 -179.975 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.319 0 CA-C-O 120.601 0.238 . . . . 0.0 111.194 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.1 mp0 -95.05 106.67 18.69 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.05 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.411 HG21 ' HB3' ' A' ' 15' ' ' LEU . 17.4 tt -139.01 153.17 24.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.985 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -118.79 97.06 5.53 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.968 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.516 HG13 HD13 ' A' ' 69' ' ' LEU . 21.5 t -98.97 152.72 4.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.981 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.28 130.92 56.11 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.698 0.285 . . . . 0.0 111.014 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.6 p -100.03 175.53 5.73 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.45 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.941 HD23 HG23 ' A' ' 9' ' ' THR . 0.0 OUTLIER -66.86 -21.91 66.0 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 179.417 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.941 HG23 HD23 ' A' ' 8' ' ' LEU . 67.8 p -105.54 28.87 7.01 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.19 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 47.59 32.85 8.21 Favored Glycine 0 C--N 1.336 0.541 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.991 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.49 146.37 27.63 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.969 0.385 . . . . 0.0 111.023 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.0 t -103.22 110.32 22.25 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.804 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.717 HG21 ' HE3' ' A' ' 33' ' ' LYS . 3.0 pt -125.08 166.67 20.36 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.297 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.1 p -104.49 152.52 22.27 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.711 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.411 ' HB3' HG21 ' A' ' 3' ' ' ILE . 1.2 tp -137.99 140.29 40.11 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.668 0.271 . . . . 0.0 111.044 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -101.0 139.05 37.24 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.701 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.6 t -138.53 138.3 42.71 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 CA-C-O 120.78 0.324 . . . . 0.0 111.354 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.447 ' HB2' ' HD2' ' A' ' 19' ' ' PRO . 11.6 pt-20 -100.08 167.87 10.33 Favored Pre-proline 0 C--N 1.332 -0.156 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.55 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.447 ' HD2' ' HB2' ' A' ' 18' ' ' GLU . 52.7 Cg_exo -54.86 -58.88 0.99 Allowed 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.39 2.06 . . . . 0.0 112.164 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.5 t -90.58 38.51 0.95 Allowed 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -75.42 114.13 13.61 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-O 120.576 0.227 . . . . 0.0 111.067 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 31.1 p -85.18 158.43 20.37 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.639 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.597 ' O ' HG12 ' A' ' 26' ' ' VAL . 9.5 tp -57.97 -32.83 44.56 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-N 116.718 -0.219 . . . . 0.0 111.277 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -77.89 -40.76 38.86 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.642 0.258 . . . . 0.0 110.858 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -62.94 -34.77 78.18 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.15 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.597 HG12 ' O ' ' A' ' 23' ' ' ILE . 12.1 p -69.32 -15.68 19.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.623 ' O ' HG22 ' A' ' 30' ' ' ILE . 0.1 OUTLIER -55.47 -33.0 63.26 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.582 0.229 . . . . 0.0 111.104 -179.992 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.19 -36.39 79.51 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.57 0.224 . . . . 0.0 111.045 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.3 mttp -64.04 -43.49 95.39 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.706 -0.225 . . . . 0.0 111.114 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.823 HG12 HD13 ' A' ' 36' ' ' ILE . 1.2 tt -64.82 -30.36 50.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 116.727 -0.215 . . . . 0.0 111.252 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -65.22 -20.81 66.61 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 120.44 0.162 . . . . 0.0 111.238 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -51.99 -24.76 7.05 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 112.181 0.438 . . . . 0.0 112.181 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.717 ' HE3' HG21 ' A' ' 13' ' ' ILE . 0.3 OUTLIER -73.88 -73.49 0.22 Allowed 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.967 -179.585 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -167.1 41.36 0.05 OUTLIER 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.408 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . 53.02 87.81 0.01 OUTLIER Glycine 0 C--N 1.335 0.504 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.443 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.823 HD13 HG12 ' A' ' 30' ' ' ILE . 4.2 mp -78.55 110.76 15.09 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-O 120.571 0.225 . . . . 0.0 111.02 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.456 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 36.3 Cg_exo -59.86 -47.05 16.86 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.614 2.21 . . . . 0.0 113.085 -179.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.466 ' HD2' HG22 ' A' ' 36' ' ' ILE . 77.3 Cg_exo -41.12 96.24 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.669 2.246 . . . . 0.0 112.924 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -68.22 -20.29 64.82 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.449 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -99.98 34.39 2.32 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 111.552 0.205 . . . . 0.0 111.552 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.844 ' O ' HD22 ' A' ' 50' ' ' LEU . 3.7 tp60 -93.2 115.32 27.94 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-O 120.526 0.203 . . . . 0.0 110.485 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 11.1 ptt-85 -143.98 178.92 7.52 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.653 0.263 . . . . 0.0 111.199 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.889 HD22 HD21 ' A' ' 67' ' ' LEU . 0.8 OUTLIER -97.85 152.67 18.95 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.918 179.969 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.629 HG23 ' O ' ' A' ' 44' ' ' ILE . 2.2 tt -104.59 77.06 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 CA-C-O 120.848 0.356 . . . . 0.0 111.038 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -150.81 116.96 5.61 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.119 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.6 32.15 21.84 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.538 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 46.5 68.16 1.18 Allowed Glycine 0 C--N 1.337 0.595 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.993 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.416 ' HG3' ' CD2' ' A' ' 59' ' ' TYR . 0.3 OUTLIER -110.0 127.53 54.86 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 116.761 0.281 . . . . 0.0 111.039 179.953 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -89.19 126.51 35.51 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.854 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.844 HD22 ' O ' ' A' ' 41' ' ' GLN . 0.8 OUTLIER -79.14 -24.51 43.28 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.454 179.936 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.452 ' O ' ' O ' ' A' ' 52' ' ' ASP . 4.1 tt0 -78.89 -36.15 42.5 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 121.279 -0.168 . . . . 0.0 111.395 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.452 ' O ' ' O ' ' A' ' 51' ' ' GLU . 0.2 OUTLIER -49.11 -171.62 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 121.57 0.7 . . . . 0.0 111.517 179.952 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -118.9 40.63 2.21 Favored Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 115.329 -0.851 . . . . 0.0 112.18 179.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -97.7 155.23 17.1 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-O 120.66 0.266 . . . . 0.0 111.003 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.561 HG23 ' H ' ' A' ' 58' ' ' ASP . 8.8 t -99.14 156.59 16.87 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.939 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.787 ' O ' HG22 ' A' ' 61' ' ' ILE . 1.7 mp -62.37 -36.52 82.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.281 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.5 t -58.75 -42.13 88.13 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -179.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.561 ' H ' HG23 ' A' ' 55' ' ' THR . 4.5 p30 -57.28 -25.25 58.92 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -179.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.416 ' CD2' ' HG3' ' A' ' 48' ' ' LYS . 0.5 OUTLIER -97.65 12.8 32.39 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 111.736 0.273 . . . . 0.0 111.736 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.5 m120 54.81 28.68 10.66 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.787 HG22 ' O ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -89.5 96.32 6.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.173 0 CA-C-O 120.877 0.37 . . . . 0.0 110.746 179.668 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.05 172.72 7.96 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.762 0.315 . . . . 0.0 111.024 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.14 155.14 1.01 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.218 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 63.78 22.01 12.9 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.459 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -75.74 177.48 6.84 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-O 120.752 0.31 . . . . 0.0 110.8 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.5 m -107.06 80.98 1.48 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.561 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.889 HD21 HD22 ' A' ' 43' ' ' LEU . 0.7 OUTLIER -98.85 110.47 23.07 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.109 -179.769 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -107.08 125.13 50.64 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.66 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.516 HD13 HG13 ' A' ' 5' ' ' VAL . 9.5 mp -93.98 174.65 7.05 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.658 0.266 . . . . 0.0 110.917 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 30.2 t -103.83 141.29 19.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.036 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.1 mt -77.25 130.94 37.89 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.816 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.3 55.68 2.33 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.127 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.1 tp -80.22 -45.22 18.39 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.708 0.29 . . . . 0.0 110.797 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.02 119.7 30.59 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.89 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -77.62 -42.54 17.29 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.542 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.381 -1.233 . . . . 0.0 112.491 179.978 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.4 ptt? . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 120.667 0.27 . . . . 0.0 111.22 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.0 mt-30 -95.03 127.6 41.21 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.691 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.831 HD11 ' HB3' ' A' ' 15' ' ' LEU . 27.3 pt -138.93 173.44 11.85 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.144 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -118.91 100.31 7.29 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.677 0.275 . . . . 0.0 110.896 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.6 t -105.07 149.74 8.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.109 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.409 ' HE3' ' CE1' ' A' ' 68' ' ' HIS . 0.1 OUTLIER -106.96 125.82 51.5 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.86 -179.966 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.3 p -99.21 -166.33 1.34 Allowed 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.45 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.402 ' HG ' ' N ' ' A' ' 9' ' ' THR . 0.5 OUTLIER -66.72 -44.06 82.62 Favored 'General case' 0 C--O 1.231 0.115 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -178.459 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.405 ' O ' HG22 ' A' ' 9' ' ' THR . 23.1 m -111.06 51.62 0.77 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.81 0.338 . . . . 0.0 111.319 -179.295 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 44.18 40.8 6.03 Favored Glycine 0 C--N 1.335 0.487 0 C-N-CA 121.183 -0.532 . . . . 0.0 113.344 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.6 tttt -84.22 134.9 34.53 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.827 0.314 . . . . 0.0 110.834 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.537 HG23 ' O ' ' A' ' 12' ' ' THR . 12.3 t -99.34 110.1 22.65 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.728 0.299 . . . . 0.0 110.907 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.1 pt -125.09 166.79 20.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.214 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.4 t -101.33 148.78 24.73 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.654 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.831 ' HB3' HD11 ' A' ' 3' ' ' ILE . 0.1 OUTLIER -137.94 108.9 6.72 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.708 0.289 . . . . 0.0 111.055 -179.876 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -101.01 138.12 38.48 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.707 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.6 t -140.06 149.0 22.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.745 0.307 . . . . 0.0 111.386 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.418 ' HB2' ' HD2' ' A' ' 19' ' ' PRO . 6.7 pt-20 -96.96 157.46 35.01 Favored Pre-proline 0 C--N 1.332 -0.164 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.7 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.418 ' HD2' ' HB2' ' A' ' 18' ' ' GLU . 10.7 Cg_endo -54.07 -36.03 83.51 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.852 2.368 . . . . 0.0 113.135 -179.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.9 0.47 56.57 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.46 128.09 34.55 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.648 0.261 . . . . 0.0 111.032 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.8 p -85.16 159.96 20.02 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.529 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.65 ' O ' HG12 ' A' ' 26' ' ' VAL . 1.4 tt -57.98 -36.38 56.03 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.469 -179.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -71.37 -32.3 68.33 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.751 -0.204 . . . . 0.0 111.288 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -62.88 -43.6 98.35 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.547 0.213 . . . . 0.0 111.164 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.65 HG12 ' O ' ' A' ' 23' ' ' ILE . 9.9 p -63.82 -28.6 45.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-N 116.738 -0.21 . . . . 0.0 111.32 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.661 ' NZ ' HD22 ' A' ' 50' ' ' LEU . 3.9 mmpt? -59.61 -30.4 68.66 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-O 120.527 0.204 . . . . 0.0 111.235 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.83 -52.93 63.46 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.546 0.212 . . . . 0.0 111.193 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 18.8 ptmt -63.91 -34.61 78.36 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.692 -0.231 . . . . 0.0 111.014 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.401 HD12 ' HE2' ' A' ' 27' ' ' LYS . 57.8 mt -75.22 -14.51 15.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 116.816 -0.175 . . . . 0.0 111.403 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -65.48 -13.24 58.38 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -50.36 -29.91 11.05 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.3 ptpp? -79.72 -21.91 43.97 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 121.036 -0.265 . . . . 0.0 111.432 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 74.47 40.77 0.39 Allowed 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.657 0.265 . . . . 0.0 110.794 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -142.78 30.78 2.04 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.426 -0.892 . . . . 0.0 113.053 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.544 ' HB ' ' CD ' ' A' ' 37' ' ' PRO . 29.3 mm -78.68 -61.3 0.54 Allowed Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 117.107 0.453 . . . . 0.0 111.681 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.544 ' CD ' ' HB ' ' A' ' 36' ' ' ILE . 5.1 Cg_exo -42.13 -51.19 4.9 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.73 2.287 . . . . 0.0 112.887 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' A' ' 37' ' ' PRO . 57.9 Cg_exo -37.39 140.7 0.22 Allowed 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.985 2.456 . . . . 0.0 113.379 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -69.02 -6.3 27.13 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.6 mm-40 -89.89 -28.48 19.19 Favored 'General case' 0 CA--C 1.53 0.211 0 O-C-N 122.115 -0.365 . . . . 0.0 111.567 -179.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 5.2 tp60 -82.87 71.56 9.97 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-O 120.788 0.327 . . . . 0.0 110.787 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.406 ' HA ' HD12 ' A' ' 50' ' ' LEU . 1.8 mtt180 -133.94 -179.08 5.32 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.814 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.594 HD11 HD23 ' A' ' 67' ' ' LEU . 1.0 OUTLIER -103.78 133.88 48.02 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.942 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.558 HG23 ' O ' ' A' ' 44' ' ' ILE . 12.7 tt -101.09 61.86 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.025 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -150.87 120.03 6.76 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.077 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 59.61 27.03 16.15 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.616 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 45.28 40.5 7.83 Favored Glycine 0 C--N 1.336 0.576 0 C-N-CA 120.78 -0.724 . . . . 0.0 113.07 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.442 ' HD3' ' CE1' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -103.85 125.94 50.63 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.86 0.33 . . . . 0.0 111.022 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -89.13 144.21 26.29 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.866 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.661 HD22 ' NZ ' ' A' ' 27' ' ' LYS . 1.1 mp -79.53 -5.56 55.14 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.37 -0.377 . . . . 0.0 112.006 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.445 ' O ' ' O ' ' A' ' 52' ' ' ASP . 5.1 mm-40 -78.69 -34.2 46.3 Favored 'General case' 0 CA--C 1.53 0.205 0 O-C-N 122.37 -0.206 . . . . 0.0 111.431 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.445 ' O ' ' O ' ' A' ' 51' ' ' GLU . 0.9 OUTLIER -48.94 -172.54 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 121.485 0.659 . . . . 0.0 111.51 179.872 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -117.0 41.7 2.04 Favored Glycine 0 N--CA 1.451 -0.361 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.257 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -104.44 162.03 13.58 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.664 0.268 . . . . 0.0 111.037 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.4 HG23 ' H ' ' A' ' 58' ' ' ASP . 8.8 t -99.14 148.12 24.4 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.821 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.83 ' O ' HG22 ' A' ' 61' ' ' ILE . 1.4 mp -51.85 -47.95 64.19 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.186 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.5 t -52.87 -29.09 26.19 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.728 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.4 ' H ' HG23 ' A' ' 55' ' ' THR . 35.6 t70 -53.65 -40.3 65.75 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.43 0.157 . . . . 0.0 111.357 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.442 ' CE1' ' HD3' ' A' ' 48' ' ' LYS . 36.9 m-85 -103.29 25.27 9.75 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 111.595 0.221 . . . . 0.0 111.595 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 56.27 24.02 7.76 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.83 HG22 ' O ' ' A' ' 56' ' ' LEU . 0.9 OUTLIER -90.01 62.69 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-O 120.815 0.341 . . . . 0.0 110.777 179.468 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -94.86 -172.16 2.64 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.917 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.454 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 18.4 tttp -40.52 142.35 0.43 Allowed 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.706 0.289 . . . . 0.0 111.55 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.454 ' HG3' ' O ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER 65.07 21.25 12.21 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.642 -179.838 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.4 p -75.59 175.61 8.41 Favored 'General case' 0 CA--C 1.527 0.08 0 CA-C-O 120.63 0.252 . . . . 0.0 110.835 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.0 m -102.59 86.19 2.73 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.682 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.594 HD23 HD11 ' A' ' 43' ' ' LEU . 5.5 mt -99.01 105.48 17.63 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.065 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.42 ' O ' HG22 ' A' ' 44' ' ' ILE . 3.6 t60 -107.09 121.11 43.85 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.785 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -96.69 169.77 9.65 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.748 0.309 . . . . 0.0 110.931 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.3 t -103.99 153.24 6.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.031 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.5 mp -76.97 112.33 13.48 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.844 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 68.9 ttt-85 -93.14 84.97 4.93 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.894 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.405 HD13 ' HA ' ' A' ' 73' ' ' LEU . 4.0 mm? -79.99 -45.41 18.48 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.825 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 12.2 mmm-85 -90.03 156.17 18.58 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.883 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -94.08 -46.58 3.06 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.49 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.379 -1.234 . . . . 0.0 112.488 -179.972 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.4 ptt? . . . . . 0 N--CA 1.488 1.425 0 N-CA-C 111.629 0.233 . . . . 0.0 111.629 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -93.43 -26.86 17.04 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 111.62 0.23 . . . . 0.0 111.62 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.673 ' CD1' HD21 ' A' ' 67' ' ' LEU . 2.2 pt -138.53 174.58 9.96 Favored 'Isoleucine or valine' 0 C--O 1.231 0.092 0 CA-C-O 120.623 0.249 . . . . 0.0 111.159 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -118.9 106.55 12.6 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.732 0.301 . . . . 0.0 110.891 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.436 ' HB ' HD11 ' A' ' 13' ' ' ILE . 21.4 t -99.17 150.16 5.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.079 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.95 127.46 53.46 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.794 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.1 p -99.21 -168.29 1.6 Allowed 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.356 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.412 ' HG ' ' N ' ' A' ' 9' ' ' THR . 0.6 OUTLIER -66.79 -40.45 88.13 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 120.663 0.268 . . . . 0.0 111.355 -178.719 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.412 ' N ' ' HG ' ' A' ' 8' ' ' LEU . 0.9 OUTLIER -111.17 41.46 1.84 Allowed 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 120.721 0.296 . . . . 0.0 111.086 179.837 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 47.28 42.53 17.93 Favored Glycine 0 C--N 1.335 0.504 0 C-N-CA 120.861 -0.685 . . . . 0.0 113.066 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.9 mtpm? -84.22 163.04 19.95 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.749 0.274 . . . . 0.0 110.926 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.4 m -103.07 118.06 35.95 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.895 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.737 HD13 HD23 ' A' ' 15' ' ' LEU . 2.4 pp -125.17 158.16 33.41 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-O 120.697 0.284 . . . . 0.0 111.182 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.8 p -101.19 128.49 47.27 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.86 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.737 HD23 HD13 ' A' ' 13' ' ' ILE . 0.2 OUTLIER -132.3 144.61 50.71 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.922 -179.991 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -100.44 162.39 12.97 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.841 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.9 t -129.99 103.88 9.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.106 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.417 ' HB2' ' HD2' ' A' ' 19' ' ' PRO . 10.4 pt-20 -103.72 157.3 34.19 Favored Pre-proline 0 C--N 1.332 -0.172 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.66 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.417 ' HD2' ' HB2' ' A' ' 18' ' ' GLU . 8.0 Cg_endo -50.13 -57.15 2.48 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.621 2.214 . . . . 0.0 112.187 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 44.9 t -90.3 36.41 0.88 Allowed 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.627 ' HB3' HD21 ' A' ' 56' ' ' LEU . 12.7 t0 -75.26 107.37 7.32 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-O 120.695 0.284 . . . . 0.0 110.93 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.4 m -85.23 157.99 20.46 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.526 -0.307 . . . . 0.0 110.831 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.642 HG22 HD13 ' A' ' 50' ' ' LEU . 24.7 mt -65.78 -34.41 70.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.027 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -75.33 -33.35 61.12 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.725 -0.216 . . . . 0.0 111.151 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -62.79 -41.67 99.37 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.559 0.218 . . . . 0.0 111.059 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.635 HG22 ' O ' ' A' ' 23' ' ' ILE . 35.9 m -63.86 -23.5 33.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.614 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -55.82 -36.45 67.49 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 120.494 0.188 . . . . 0.0 111.196 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.78 -45.35 86.13 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-O 120.639 0.257 . . . . 0.0 111.181 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 14.1 mttm -63.91 -42.39 97.44 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.781 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.409 ' CG2' ' CG2' ' A' ' 36' ' ' ILE . 33.2 mm -75.01 -27.48 20.02 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.446 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.413 ' HA ' ' HG3' ' A' ' 37' ' ' PRO . 10.3 tt0 -65.15 -16.91 64.02 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -50.4 -32.67 18.27 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 111.601 0.223 . . . . 0.0 111.601 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.37 -30.58 23.52 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 121.125 -0.23 . . . . 0.0 111.07 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 65.31 26.22 12.12 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 120.61 0.243 . . . . 0.0 110.871 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.422 ' N ' ' HD2' ' A' ' 37' ' ' PRO . . . -112.08 -48.25 0.67 Allowed Glycine 0 C--N 1.334 0.465 0 C-N-CA 120.453 -0.88 . . . . 0.0 112.952 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.718 HD11 HD23 ' A' ' 69' ' ' LEU . 7.6 tt -84.21 -24.78 0.35 Allowed Pre-proline 0 CA--C 1.54 0.592 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -179.227 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.623 ' CD ' ' N ' ' A' ' 36' ' ' ILE . 78.3 Cg_exo -42.96 -41.7 9.05 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 122.309 2.006 . . . . 0.0 113.791 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.488 ' CD ' ' N ' ' A' ' 37' ' ' PRO . 66.8 Cg_exo -53.39 -147.78 0.0 OUTLIER 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.446 2.097 . . . . 0.0 112.668 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -68.09 -4.08 12.39 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -179.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -90.34 -4.08 57.32 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 121.97 -0.457 . . . . 0.0 111.856 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.415 ' HG3' HG23 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -93.21 89.63 6.51 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-O 120.582 0.229 . . . . 0.0 110.971 179.756 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -144.01 151.93 40.35 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.973 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.4 tp -107.97 142.38 38.19 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.847 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.583 HG23 ' O ' ' A' ' 44' ' ' ILE . 2.2 tt -111.06 65.86 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-O 120.752 0.311 . . . . 0.0 111.097 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -150.89 127.74 10.99 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.194 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.77 ' HB2' ' CZ ' ' A' ' 59' ' ' TYR . . . 59.86 31.41 20.74 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.636 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 45.21 39.3 6.91 Favored Glycine 0 C--N 1.337 0.584 0 C-N-CA 120.808 -0.71 . . . . 0.0 113.079 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.1 mttm -109.73 145.43 36.62 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.787 0.294 . . . . 0.0 110.954 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -89.07 174.4 7.9 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.866 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.642 HD13 HG22 ' A' ' 23' ' ' ILE . 0.2 OUTLIER -79.21 -37.16 38.86 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.184 -179.975 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -89.35 8.8 28.75 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -47.24 -41.03 17.79 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.646 0.26 . . . . 0.0 111.159 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.98 23.82 24.28 Favored Glycine 0 CA--C 1.522 0.504 0 C-N-CA 120.757 -0.735 . . . . 0.0 113.039 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.456 ' H ' HD12 ' A' ' 23' ' ' ILE . 26.6 mmt180 -107.38 177.25 4.9 Favored 'General case' 0 C--N 1.334 -0.083 0 CA-C-N 117.132 0.466 . . . . 0.0 110.753 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.47 HG23 ' O ' ' A' ' 21' ' ' ASP . 4.4 m -99.44 130.82 45.73 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.491 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.627 HD21 ' HB3' ' A' ' 21' ' ' ASP . 0.6 OUTLIER -51.21 -32.45 23.93 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 120.601 0.239 . . . . 0.0 110.916 179.974 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.2 t -61.5 -27.25 68.46 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.625 -0.262 . . . . 0.0 111.607 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.404 ' OD1' ' N ' ' A' ' 59' ' ' TYR . 2.5 p30 -53.74 -30.21 43.13 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 120.859 -0.336 . . . . 0.0 111.492 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.77 ' CZ ' ' HB2' ' A' ' 46' ' ' ALA . 3.4 t80 -107.8 37.09 2.53 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 120.569 0.223 . . . . 0.0 111.248 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 23.6 m120 54.77 32.91 18.47 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.649 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.613 ' O ' HD12 ' A' ' 56' ' ' LEU . 22.1 mt -89.37 76.46 1.3 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-O 120.69 0.281 . . . . 0.0 110.849 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.03 -174.34 2.51 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.0 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.54 144.89 1.41 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.78 0.324 . . . . 0.0 111.255 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 63.37 21.23 12.69 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.617 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.5 m -75.85 162.15 28.38 Favored 'General case' 0 CA--C 1.527 0.092 0 CA-C-O 120.642 0.258 . . . . 0.0 110.808 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -107.03 83.01 1.76 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.552 179.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.673 HD21 ' CD1' ' A' ' 3' ' ' ILE . 2.9 pp -98.92 126.93 44.72 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.132 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.571 ' CD2' HG21 ' A' ' 44' ' ' ILE . 3.1 t60 -107.06 117.94 35.4 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.686 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.718 HD23 HD11 ' A' ' 36' ' ' ILE . 0.2 OUTLIER -93.73 114.77 27.14 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.776 0.322 . . . . 0.0 110.817 -179.981 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.4 p -111.83 152.61 13.67 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.016 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.407 HD23 ' H ' ' A' ' 71' ' ' LEU . 0.5 OUTLIER -87.07 131.09 34.23 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.883 179.953 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 13.5 ttp180 -93.02 102.59 14.93 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.957 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -81.73 44.92 0.85 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.618 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 10.9 mtp180 -90.1 102.5 15.22 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.719 0.295 . . . . 0.0 110.877 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -143.15 79.42 0.25 Allowed Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.5 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.441 -1.199 . . . . 0.0 112.53 179.982 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.404 ' HG3' ' O ' ' A' ' 3' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.359 0.124 . . . . 0.0 111.021 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 52.6 mm-40 -84.81 -39.56 18.22 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 -179.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.415 HD12 ' CB ' ' A' ' 15' ' ' LEU . 0.9 OUTLIER -138.68 169.0 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.129 0 CA-C-O 120.582 0.23 . . . . 0.0 111.11 -179.607 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -118.5 103.8 10.08 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.74 0.305 . . . . 0.0 111.013 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.407 HG13 HD13 ' A' ' 69' ' ' LEU . 16.8 t -129.5 154.34 40.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.773 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.2 mttt -106.76 152.89 23.23 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.65 0.262 . . . . 0.0 111.022 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.431 HG22 ' HE2' ' A' ' 33' ' ' LYS . 0.3 OUTLIER -99.88 -143.47 0.33 Allowed 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.62 179.988 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.469 HD12 ' CD1' ' A' ' 73' ' ' LEU . 1.7 pt? -64.82 -41.6 95.64 Favored 'General case' 0 C--N 1.341 0.23 0 CA-C-N 118.791 0.723 . . . . 0.0 111.164 -179.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.453 ' N ' ' HG ' ' A' ' 8' ' ' LEU . 94.9 m -111.36 -64.91 1.22 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.774 0.321 . . . . 0.0 110.652 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 178.0 47.71 0.07 OUTLIER Glycine 0 CA--C 1.521 0.42 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.746 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.49 -179.65 7.2 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.729 0.3 . . . . 0.0 110.996 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.51 HG23 ' O ' ' A' ' 12' ' ' THR . 13.2 t -103.07 114.59 29.0 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.709 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 11.9 tt -123.65 136.26 60.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 120.704 0.288 . . . . 0.0 111.228 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.7 t -106.02 168.17 9.3 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.779 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.423 HD22 ' HA ' ' A' ' 15' ' ' LEU . 0.2 OUTLIER -134.13 87.3 2.35 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-O 120.702 0.287 . . . . 0.0 110.896 -179.977 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -101.03 93.88 5.72 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.801 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.918 HG11 HG22 ' A' ' 26' ' ' VAL . 31.5 m -131.47 174.53 12.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.208 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -97.05 164.3 18.15 Favored Pre-proline 0 C--N 1.332 -0.171 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.755 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -60.23 -38.44 75.99 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.64 2.227 . . . . 0.0 112.349 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.4 p -78.82 -24.35 44.56 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.389 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -64.86 118.89 9.69 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-O 120.641 0.257 . . . . 0.0 110.846 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.5 p -85.2 -175.43 5.72 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.826 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.642 HD12 ' O ' ' A' ' 54' ' ' ARG . 3.9 mt -63.11 -40.55 89.45 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.027 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -52.09 -44.04 64.2 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.665 0.269 . . . . 0.0 111.075 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.07 -34.83 78.42 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.917 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.918 HG22 HG11 ' A' ' 17' ' ' VAL . 21.3 t -73.84 -12.93 15.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.599 ' HE3' HD23 ' A' ' 50' ' ' LEU . 2.5 mmpt? -55.48 -39.15 70.05 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 120.569 0.223 . . . . 0.0 111.073 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.402 ' HA ' ' HG2' ' A' ' 31' ' ' GLN . . . -67.88 -42.39 81.32 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-O 120.717 0.294 . . . . 0.0 111.248 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.8 mttm -74.54 -40.0 61.99 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.669 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.691 HG22 ' O ' ' A' ' 26' ' ' VAL . 20.2 tt -74.35 -23.61 18.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -179.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.531 ' HA ' HD13 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -65.01 75.21 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 120.856 0.36 . . . . 0.0 110.959 -179.785 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.404 ' N ' ' O ' ' A' ' 30' ' ' ILE . 36.6 t70 -60.26 -67.89 0.35 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.137 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.431 ' HE2' HG22 ' A' ' 7' ' ' THR . 0.0 OUTLIER -85.77 -86.36 0.14 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.965 179.884 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -178.37 43.42 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 121.119 -0.232 . . . . 0.0 111.371 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -151.2 31.2 0.96 Allowed Glycine 0 C--N 1.334 0.458 0 C-N-CA 120.432 -0.889 . . . . 0.0 113.04 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.647 HG21 HG23 ' A' ' 30' ' ' ILE . 1.8 mp -88.93 -65.53 0.17 Allowed Pre-proline 0 CA--C 1.535 0.375 0 CA-C-N 117.09 0.445 . . . . 0.0 111.411 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.546 ' CD ' ' HB ' ' A' ' 36' ' ' ILE . 3.6 Cg_exo -38.74 -51.08 2.38 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 122.779 2.319 . . . . 0.0 112.977 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.408 ' HD2' ' N ' ' A' ' 37' ' ' PRO . 79.0 Cg_exo -41.33 163.65 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.711 2.274 . . . . 0.0 113.174 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -69.65 2.15 3.52 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -89.78 -21.71 22.5 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 118.17 0.441 . . . . 0.0 111.599 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.554 ' HG2' HG23 ' A' ' 36' ' ' ILE . 2.5 tp60 -93.11 109.98 21.47 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 120.996 -0.281 . . . . 0.0 110.785 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 3.7 ptp180 -142.36 160.83 39.5 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.015 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -108.03 160.42 15.8 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.824 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 25.1 mm -111.06 69.79 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.157 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.556 ' CE1' HG23 ' A' ' 66' ' ' THR . 0.7 OUTLIER -151.13 122.01 7.59 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.176 -179.984 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 56.59 31.98 20.1 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.547 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 45.86 37.55 7.35 Favored Glycine 0 C--N 1.335 0.522 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.974 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.435 ' HD3' ' CE2' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -110.02 134.29 52.29 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.846 0.323 . . . . 0.0 111.054 -179.977 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -89.09 162.76 15.81 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.837 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.599 HD23 ' HE3' ' A' ' 27' ' ' LYS . 0.1 OUTLIER -79.15 -13.17 59.89 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.612 179.868 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -78.97 -38.26 37.41 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 120.536 0.208 . . . . 0.0 111.141 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -47.98 118.12 2.21 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -68.21 54.18 0.43 Allowed Glycine 0 CA--C 1.521 0.443 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.666 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.642 ' O ' HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -107.07 173.85 6.15 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 117.002 0.401 . . . . 0.0 110.751 179.844 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.438 HG22 ' H ' ' A' ' 57' ' ' SER . 57.0 m -99.27 137.1 38.25 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.675 -0.239 . . . . 0.0 110.836 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.547 HD22 HG21 ' A' ' 61' ' ' ILE . 52.9 mt -52.26 -41.43 62.81 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.919 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.438 ' H ' HG22 ' A' ' 55' ' ' THR . 6.7 t -59.22 -29.38 67.47 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.432 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -53.68 -40.45 65.96 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 121.192 -0.203 . . . . 0.0 111.379 -179.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.435 ' CE2' ' HD3' ' A' ' 48' ' ' LYS . 62.2 m-85 -104.64 36.28 2.47 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-O 120.672 0.272 . . . . 0.0 111.374 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 55.47 25.63 8.0 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.547 HG21 HD22 ' A' ' 56' ' ' LEU . 38.1 mt -89.92 62.52 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.123 0 CA-C-O 120.812 0.339 . . . . 0.0 110.975 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.01 -174.81 2.67 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.033 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -44.47 144.1 1.14 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.823 0.344 . . . . 0.0 111.443 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 64.98 19.22 11.8 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.672 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 7.5 p -75.89 170.12 16.84 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-O 120.616 0.246 . . . . 0.0 110.873 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.567 ' O ' HG23 ' A' ' 66' ' ' THR . 7.8 t -107.12 83.69 1.86 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.437 179.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.436 HD11 ' CG2' ' A' ' 61' ' ' ILE . 13.0 mt -98.85 104.78 16.85 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.767 0.318 . . . . 0.0 111.325 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -107.19 100.88 10.31 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.627 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.489 ' N ' HD12 ' A' ' 69' ' ' LEU . 6.5 mp -93.97 163.26 13.56 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.559 -0.292 . . . . 0.0 111.029 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.7 t -103.98 121.38 55.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.065 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.814 ' O ' HD22 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -76.55 113.34 14.06 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.36 0.6 . . . . 0.0 111.379 -179.514 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.2 mmm180 -93.74 66.57 3.75 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.176 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.484 ' HB2' HD23 ' A' ' 71' ' ' LEU . 9.4 tp -80.42 -43.94 20.13 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.667 0.27 . . . . 0.0 110.909 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -88.93 134.07 34.09 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.554 -0.293 . . . . 0.0 110.918 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 78.82 42.19 13.5 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.527 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.411 -1.216 . . . . 0.0 112.521 179.931 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.3 ttt . . . . . 0 N--CA 1.487 1.409 0 CA-C-O 120.65 0.262 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 82.2 mm-40 -94.78 -46.68 6.79 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.944 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.554 ' H ' HD13 ' A' ' 3' ' ' ILE . 0.2 OUTLIER -146.21 -175.76 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.096 -179.993 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -118.66 99.22 6.65 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.775 0.322 . . . . 0.0 110.74 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.825 HG12 HD12 ' A' ' 69' ' ' LEU . 1.2 t -116.84 121.25 67.32 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.895 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 41.7 mttt -106.86 122.34 46.2 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.702 0.287 . . . . 0.0 110.845 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.62 ' HB ' HD12 ' A' ' 36' ' ' ILE . 0.7 OUTLIER -99.75 -75.01 0.58 Allowed 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -179.414 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.623 HD21 ' HD2' ' A' ' 11' ' ' LYS . 0.3 OUTLIER -68.64 -110.37 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 111.553 0.205 . . . . 0.0 111.553 -179.27 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.9 t -111.51 57.62 0.63 Allowed 'General case' 0 CA--C 1.529 0.155 0 O-C-N 122.175 -0.328 . . . . 0.0 111.038 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.95 37.01 5.83 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.632 -0.794 . . . . 0.0 113.23 179.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.623 ' HD2' HD21 ' A' ' 8' ' ' LEU . 13.1 tttm -84.39 142.09 30.38 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 117.077 0.438 . . . . 0.0 110.731 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.9 t -98.22 117.87 33.58 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.846 0.355 . . . . 0.0 110.924 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.3 pt -125.09 146.36 30.89 Favored 'Isoleucine or valine' 0 C--O 1.231 0.112 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.189 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.1 t -97.37 130.76 44.48 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.769 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -129.82 133.42 46.94 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.983 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -100.77 176.03 5.44 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.877 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.5 HG21 ' N ' ' A' ' 63' ' ' LYS . 21.7 t -129.99 104.59 10.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.755 0.312 . . . . 0.0 111.16 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -107.09 161.57 22.5 Favored Pre-proline 0 C--O 1.232 0.148 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.811 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_exo -51.74 -56.76 2.66 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.398 2.066 . . . . 0.0 112.365 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 38.7 p -90.3 38.26 0.93 Allowed 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.44 ' OD2' HD22 ' A' ' 56' ' ' LEU . 4.0 t70 -75.28 84.96 2.45 Favored 'General case' 0 C--O 1.232 0.182 0 O-C-N 122.308 -0.245 . . . . 0.0 110.912 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.726 ' O ' HG23 ' A' ' 26' ' ' VAL . 6.2 p -85.04 163.22 18.97 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.637 0.256 . . . . 0.0 110.807 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.433 HG22 ' HD2' ' A' ' 27' ' ' LYS . 34.5 mm -68.13 -42.89 85.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.001 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -54.1 -41.9 68.8 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.653 0.263 . . . . 0.0 110.986 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -68.71 -39.44 80.47 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.823 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.726 HG23 ' O ' ' A' ' 22' ' ' THR . 42.5 t -63.95 -44.64 97.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 CA-C-O 120.613 0.244 . . . . 0.0 110.906 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.433 ' HD2' HG22 ' A' ' 23' ' ' ILE . 1.6 mttm -59.39 -43.96 92.88 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.704 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.04 -37.11 73.75 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.126 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.54 ' HD3' HD13 ' A' ' 30' ' ' ILE . 12.9 tmtt? -66.9 -40.44 87.7 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.644 -0.253 . . . . 0.0 110.912 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.54 HD13 ' HD3' ' A' ' 29' ' ' LYS . 31.9 mm -69.8 -49.76 54.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.659 0.266 . . . . 0.0 110.895 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -65.08 -24.98 67.6 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.318 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -50.92 -32.25 20.15 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 111.605 0.224 . . . . 0.0 111.605 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.8 -27.81 26.58 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 121.218 -0.193 . . . . 0.0 111.296 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 67.87 31.67 5.61 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-O 120.66 0.267 . . . . 0.0 110.891 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -94.33 -42.27 4.03 Favored Glycine 0 C--N 1.334 0.437 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.377 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.62 HD12 ' HB ' ' A' ' 7' ' ' THR . 19.9 tt -89.17 110.93 41.98 Favored Pre-proline 0 CA--C 1.531 0.223 0 CA-C-O 120.6 0.238 . . . . 0.0 111.062 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.45 ' HB2' ' HD3' ' A' ' 38' ' ' PRO . 33.4 Cg_exo -58.58 -48.52 14.84 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.365 2.043 . . . . 0.0 112.512 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.45 ' HD3' ' HB2' ' A' ' 37' ' ' PRO . 84.4 Cg_exo -44.46 94.25 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.556 2.171 . . . . 0.0 112.488 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -68.2 -31.78 71.54 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.256 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.6 mm-40 -101.01 42.88 1.09 Allowed 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.64 0.257 . . . . 0.0 111.166 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.548 ' OE1' HD13 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -82.87 131.81 35.18 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.655 0.264 . . . . 0.0 110.722 179.662 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -134.88 -178.18 4.96 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.957 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.629 HD21 ' HB3' ' A' ' 67' ' ' LEU . 0.3 OUTLIER -97.87 126.53 43.29 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.766 179.978 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.637 HG23 ' O ' ' A' ' 44' ' ' ILE . 0.6 OUTLIER -101.06 88.8 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.841 0.353 . . . . 0.0 111.272 -179.992 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -150.87 131.92 14.32 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.17 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.6 29.63 19.15 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.656 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 45.53 40.95 8.88 Favored Glycine 0 C--N 1.336 0.555 0 C-N-CA 120.932 -0.652 . . . . 0.0 113.038 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.417 ' HG2' ' CE1' ' A' ' 59' ' ' TYR . 17.1 mttt -108.56 138.54 44.7 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.785 0.293 . . . . 0.0 110.953 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.1 tp-100 -89.11 120.54 30.6 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.974 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.7 mp -79.58 -6.1 56.36 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -78.75 -20.07 50.81 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 111.667 0.247 . . . . 0.0 111.667 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -46.44 -38.33 8.93 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.571 0.224 . . . . 0.0 111.34 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.97 43.04 2.5 Favored Glycine 0 CA--C 1.52 0.395 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.815 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.2 mmt85 -107.12 -176.54 3.1 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.797 0.298 . . . . 0.0 110.756 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.521 HG23 ' H ' ' A' ' 58' ' ' ASP . 12.9 t -97.27 172.22 7.93 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.66 0.267 . . . . 0.0 110.975 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.44 HD22 ' OD2' ' A' ' 21' ' ' ASP . 1.0 OUTLIER -62.36 -58.41 7.76 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.177 -179.893 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.3 t -52.97 -29.37 28.65 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.521 ' H ' HG23 ' A' ' 55' ' ' THR . 1.1 m-20 -53.7 -38.55 64.35 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 111.609 0.226 . . . . 0.0 111.609 -179.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.417 ' CE1' ' HG2' ' A' ' 48' ' ' LYS . 11.7 m-85 -101.55 20.51 15.94 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 62.93 16.91 9.6 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.54 ' HB ' HD11 ' A' ' 67' ' ' LEU . 23.6 pt -89.89 69.91 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 CA-C-O 120.797 0.332 . . . . 0.0 110.849 179.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -95.02 -174.01 3.12 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.179 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.5 ' N ' HG21 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -45.65 147.61 0.87 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.789 0.328 . . . . 0.0 111.515 -179.722 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 65.3 16.03 10.32 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.817 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.9 m -76.18 166.87 22.84 Favored 'General case' 0 CA--C 1.527 0.093 0 CA-C-O 120.738 0.304 . . . . 0.0 110.953 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.551 ' O ' HG23 ' A' ' 66' ' ' THR . 7.2 t -106.46 85.79 2.24 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.249 179.297 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.629 ' HB3' HD21 ' A' ' 43' ' ' LEU . 5.9 mp -98.93 114.36 26.94 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.456 -179.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -107.17 123.45 48.28 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.603 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.825 HD12 HG12 ' A' ' 5' ' ' VAL . 0.8 OUTLIER -93.78 141.79 28.1 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.707 0.289 . . . . 0.0 111.045 -179.831 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.2 p -114.08 152.75 15.71 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.093 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.47 89.66 3.84 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.781 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.7 tpt180 -93.04 95.71 9.62 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.891 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.8 mt -80.11 -58.59 3.08 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.855 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -90.04 144.34 25.98 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.548 -0.297 . . . . 0.0 110.861 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -142.38 -171.26 13.08 Favored Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.513 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.323 -1.265 . . . . 0.0 112.522 179.952 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.439 ' CG ' ' O ' ' A' ' 3' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 120.44 0.162 . . . . 0.0 111.097 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -89.64 -19.15 25.25 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -179.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.493 HD11 ' HB2' ' A' ' 15' ' ' LEU . 10.9 pt -138.57 176.64 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.121 0 C-N-CA 120.907 -0.317 . . . . 0.0 111.509 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -118.97 99.82 6.98 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.717 0.294 . . . . 0.0 110.863 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.627 HG11 HD11 ' A' ' 13' ' ' ILE . 21.5 t -107.15 142.03 20.91 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.116 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.052 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.18 141.24 48.4 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.937 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.7 -163.66 1.05 Allowed 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.083 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.93 ' CD2' HG23 ' A' ' 9' ' ' THR . 0.0 OUTLIER -68.34 -30.5 69.48 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-O 121.056 0.455 . . . . 0.0 110.117 -179.899 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.93 HG23 ' CD2' ' A' ' 8' ' ' LEU . 33.3 p -111.19 -69.46 0.87 Allowed 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.784 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 175.07 47.79 0.05 OUTLIER Glycine 0 C--N 1.333 0.384 0 C-N-CA 120.489 -0.862 . . . . 0.0 112.988 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.68 144.14 28.75 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.861 0.33 . . . . 0.0 110.937 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.474 HG23 ' O ' ' A' ' 12' ' ' THR . 14.2 t -103.06 117.78 35.34 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.574 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.627 HD11 HG11 ' A' ' 5' ' ' VAL . 26.6 pt -125.04 153.24 32.1 Favored 'Isoleucine or valine' 0 C--O 1.231 0.112 0 CA-C-O 120.687 0.28 . . . . 0.0 111.453 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.8 t -106.03 139.16 41.0 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.872 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.493 ' HB2' HD11 ' A' ' 3' ' ' ILE . 1.4 tp -129.93 144.44 51.32 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.712 0.291 . . . . 0.0 110.903 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.51 147.09 25.11 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.83 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.461 HG21 ' HA ' ' A' ' 63' ' ' LYS . 21.5 t -130.02 102.07 6.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.201 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.412 ' HB2' ' HD2' ' A' ' 19' ' ' PRO . 2.2 pt-20 -107.12 161.57 22.51 Favored Pre-proline 0 C--O 1.232 0.162 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.507 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.412 ' HD2' ' HB2' ' A' ' 18' ' ' GLU . 89.3 Cg_exo -47.1 -53.33 6.48 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.507 2.138 . . . . 0.0 112.256 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.1 m -90.14 41.66 1.06 Allowed 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.801 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 46.1 p-10 -69.13 95.99 0.78 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.679 0.276 . . . . 0.0 110.806 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.03 137.82 32.82 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.951 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.676 HD12 ' O ' ' A' ' 54' ' ' ARG . 7.5 mt -68.02 -39.72 81.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.193 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -67.32 -41.76 84.76 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.134 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -62.85 -38.39 90.63 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.212 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.535 HG12 ' O ' ' A' ' 23' ' ' ILE . 12.2 p -73.52 -12.8 15.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 111.957 0.354 . . . . 0.0 111.957 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.461 ' HE2' HD12 ' A' ' 50' ' ' LEU . 12.8 ttmt -55.59 -48.74 74.37 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 120.691 0.282 . . . . 0.0 110.7 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.01 -29.18 68.12 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.14 179.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 24.7 mtpt -63.96 -33.76 76.45 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.753 -0.203 . . . . 0.0 110.953 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 33.8 mm -64.68 -42.73 95.87 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 CA-C-O 120.674 0.273 . . . . 0.0 110.495 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -65.16 -37.06 86.19 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 120.772 0.32 . . . . 0.0 110.68 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -61.49 -18.24 58.18 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.972 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 7.0 mtmm -74.04 -73.83 0.21 Allowed 'General case' 0 C--O 1.231 0.119 0 C-N-CA 121.044 -0.262 . . . . 0.0 111.086 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -137.59 23.7 2.91 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.439 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . 48.65 85.07 0.02 OUTLIER Glycine 0 C--N 1.337 0.636 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.387 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.745 HD13 ' HB2' ' A' ' 41' ' ' GLN . 1.1 pp -78.44 110.27 13.28 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 120.628 0.251 . . . . 0.0 111.292 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.557 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 34.7 Cg_exo -60.46 -43.41 33.81 Favored 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 122.733 2.288 . . . . 0.0 113.583 -179.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.557 ' HD2' ' N ' ' A' ' 37' ' ' PRO . 55.4 Cg_endo -71.92 118.87 5.84 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.058 1.839 . . . . 0.0 112.943 -179.091 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.0 p-10 -68.66 -12.81 61.83 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.974 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -90.96 22.49 3.63 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.745 ' HB2' HD13 ' A' ' 36' ' ' ILE . 0.7 OUTLIER -84.45 93.45 8.31 Favored 'General case' 0 CA--C 1.527 0.08 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 179.305 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.732 ' HG3' HD23 ' A' ' 50' ' ' LEU . 4.5 ttm180 -139.59 177.09 8.19 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.101 -179.286 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.56 ' CD1' HD12 ' A' ' 69' ' ' LEU . 2.2 mm? -97.91 165.23 12.03 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.459 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.401 ' CG1' ' HB2' ' A' ' 68' ' ' HIS . 1.4 pt -111.02 83.79 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-O 120.696 0.284 . . . . 0.0 111.174 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -150.85 115.46 5.18 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.233 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.78 24.37 14.5 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.859 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 44.37 39.86 5.82 Favored Glycine 0 C--N 1.338 0.654 0 C-N-CA 120.837 -0.697 . . . . 0.0 113.083 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.428 ' HG2' ' CE2' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -100.98 135.49 42.34 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.814 0.307 . . . . 0.0 110.853 -179.82 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -78.96 165.97 22.88 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.828 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.732 HD23 ' HG3' ' A' ' 42' ' ' ARG . 1.7 pp -79.35 -18.21 52.93 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.74 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -78.91 -26.4 43.78 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 111.782 0.289 . . . . 0.0 111.782 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 38.7 p-10 -47.82 115.52 1.19 Allowed 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 120.807 0.337 . . . . 0.0 110.604 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -70.73 46.73 0.73 Allowed Glycine 0 CA--C 1.521 0.434 0 C-N-CA 120.504 -0.855 . . . . 0.0 112.564 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.676 ' O ' HD12 ' A' ' 23' ' ' ILE . 1.5 mpp_? -107.26 170.42 7.97 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 117.029 0.414 . . . . 0.0 110.799 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 36.2 m -99.18 137.73 37.29 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.664 -0.243 . . . . 0.0 110.741 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.847 HD23 HG21 ' A' ' 61' ' ' ILE . 1.2 mp -52.05 -42.94 63.52 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.892 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.3 t -57.22 -31.19 65.24 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.479 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -53.83 -34.96 60.86 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 121.194 -0.202 . . . . 0.0 111.404 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.428 ' CE2' ' HG2' ' A' ' 48' ' ' LYS . 39.9 m-85 -103.29 36.23 2.32 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 120.548 0.214 . . . . 0.0 111.396 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 58.14 23.4 10.13 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.847 HG21 HD23 ' A' ' 56' ' ' LEU . 26.9 mt -89.81 77.09 1.35 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.141 0 CA-C-O 120.636 0.255 . . . . 0.0 110.962 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -94.96 172.63 8.03 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.714 0.292 . . . . 0.0 111.123 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.461 ' HA ' HG21 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -50.08 148.9 3.07 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.212 -179.892 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 63.3 22.69 13.44 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.444 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.1 m -75.64 177.45 6.8 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-O 120.706 0.288 . . . . 0.0 110.88 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.5 p -107.1 86.65 2.34 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.825 0.345 . . . . 0.0 110.639 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.5 mt -99.02 122.48 42.33 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.153 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.401 ' HB2' ' CG1' ' A' ' 44' ' ' ILE . 22.6 m-70 -107.09 140.58 39.7 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.813 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.56 HD12 ' CD1' ' A' ' 43' ' ' LEU . 0.3 OUTLIER -93.94 -174.42 3.41 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.927 -179.881 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.1 p -103.71 139.04 25.77 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-O 120.719 0.295 . . . . 0.0 111.046 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.08 101.43 13.46 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.945 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.501 ' O ' HD12 ' A' ' 8' ' ' LEU . 22.5 ttp-105 -93.12 86.12 5.28 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.879 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.499 HD12 ' N ' ' A' ' 74' ' ' ARG . 4.2 pp -80.12 -36.65 35.0 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.106 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.499 ' N ' HD12 ' A' ' 73' ' ' LEU . 0.1 OUTLIER -90.08 72.75 7.32 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-O 120.749 0.309 . . . . 0.0 110.922 179.923 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -127.8 51.06 0.86 Allowed Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.506 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.35 -1.25 . . . . 0.0 112.452 -179.972 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.9 ttt . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.714 0.292 . . . . 0.0 111.261 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 63.5 mm-40 -90.5 -39.69 12.44 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.097 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.514 HD11 ' CB ' ' A' ' 15' ' ' LEU . 30.1 pt -138.73 175.57 7.92 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 CA-C-N 116.649 -0.25 . . . . 0.0 110.952 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -118.7 88.99 3.03 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.71 0.291 . . . . 0.0 110.874 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.894 HG22 HD11 ' A' ' 67' ' ' LEU . 21.5 t -108.89 128.35 64.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.179 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -107.51 153.64 22.54 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.752 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.449 HG21 ' OE2' ' A' ' 34' ' ' GLU . 0.2 OUTLIER -109.99 -146.95 0.41 Allowed 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 119.488 -0.291 . . . . 0.0 110.616 -179.959 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.54 ' HG ' HG23 ' A' ' 9' ' ' THR . 0.7 OUTLIER -65.18 -34.24 77.9 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 118.806 0.73 . . . . 0.0 111.542 -179.104 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.54 HG23 ' HG ' ' A' ' 8' ' ' LEU . 73.2 p -111.05 -56.53 2.36 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 120.629 0.252 . . . . 0.0 111.047 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 156.58 57.62 0.01 OUTLIER Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.823 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.2 mmmp? -84.13 154.09 23.33 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.708 0.254 . . . . 0.0 110.886 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.518 HG23 ' O ' ' A' ' 12' ' ' THR . 14.0 t -102.93 114.33 28.53 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.813 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.504 HD11 ' HB ' ' A' ' 5' ' ' VAL . 3.2 pt -118.25 147.3 21.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.141 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.8 p -105.91 114.5 28.68 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.903 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.514 ' CB ' HD11 ' A' ' 3' ' ' ILE . 0.2 OUTLIER -129.28 138.86 51.87 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.876 179.981 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -95.18 161.87 13.93 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.911 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.6 t -129.93 117.02 39.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.769 0.318 . . . . 0.0 111.231 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -100.58 164.12 16.83 Favored Pre-proline 0 C--O 1.231 0.101 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.711 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -53.19 -66.36 0.11 Allowed 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.625 2.217 . . . . 0.0 112.38 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.5 m -90.35 35.9 0.87 Allowed 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 112.054 0.391 . . . . 0.0 112.054 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.438 ' HB3' HD21 ' A' ' 56' ' ' LEU . 4.6 t70 -75.41 113.21 12.55 Favored 'General case' 0 C--O 1.231 0.132 0 CA-C-O 120.647 0.261 . . . . 0.0 110.925 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 10.2 t -85.16 173.8 10.15 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.856 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.507 HG21 ' O ' ' A' ' 50' ' ' LEU . 51.7 mm -68.16 -40.48 82.94 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.015 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -53.9 -40.01 66.27 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.681 -0.236 . . . . 0.0 111.14 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -62.86 -54.7 34.74 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 120.663 0.268 . . . . 0.0 110.906 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.4 p -63.96 -36.93 78.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.262 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.679 ' HA ' HD12 ' A' ' 30' ' ' ILE . 13.6 tttt -55.87 -41.06 73.83 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.719 -0.219 . . . . 0.0 110.935 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.88 -38.1 75.16 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.147 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.82 -43.31 96.62 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-N 116.67 -0.241 . . . . 0.0 110.806 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.679 HD12 ' HA ' ' A' ' 27' ' ' LYS . 4.0 mt -66.49 -49.1 77.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.865 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 1.4 tp-100 -59.79 -42.24 92.93 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.818 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -61.01 -25.79 67.15 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.279 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -74.86 -61.68 1.8 Allowed 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 121.173 -0.211 . . . . 0.0 111.095 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.449 ' OE2' HG21 ' A' ' 7' ' ' THR . 0.2 OUTLIER -103.17 -46.44 4.62 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.578 0.228 . . . . 0.0 111.089 -179.84 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.425 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . 85.05 42.97 6.87 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.976 -179.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.708 HG21 ' HG3' ' A' ' 41' ' ' GLN . 20.2 tt -78.77 110.55 14.65 Favored Pre-proline 0 CA--C 1.532 0.271 0 CA-C-O 120.713 0.292 . . . . 0.0 111.36 -179.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.504 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 31.7 Cg_exo -59.77 -45.72 23.64 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.764 2.309 . . . . 0.0 113.339 -179.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.504 ' HD2' ' N ' ' A' ' 37' ' ' PRO . 46.8 Cg_exo -37.84 122.52 0.51 Allowed 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.988 2.459 . . . . 0.0 113.425 -179.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -69.42 -3.89 16.21 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -90.25 11.21 21.86 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -179.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.708 ' HG3' HG21 ' A' ' 36' ' ' ILE . 1.0 OUTLIER -88.61 82.54 6.87 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-O 120.693 0.283 . . . . 0.0 110.416 179.358 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.823 ' O ' HG23 ' A' ' 70' ' ' VAL . 33.7 mtt180 -136.63 -175.16 3.92 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.976 -179.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.771 HD23 HD12 ' A' ' 69' ' ' LEU . 2.3 mt -97.97 153.97 18.0 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.846 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.583 HG23 ' O ' ' A' ' 44' ' ' ILE . 17.2 tt -111.04 71.17 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.803 0.335 . . . . 0.0 111.023 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -150.91 132.06 14.41 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.239 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 56.51 28.59 14.03 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.79 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 45.08 40.23 7.11 Favored Glycine 0 C--N 1.337 0.595 0 C-N-CA 120.797 -0.716 . . . . 0.0 113.0 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.02 127.84 46.19 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.837 0.318 . . . . 0.0 110.922 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -89.06 150.66 22.66 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.014 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.579 HD23 ' HG3' ' A' ' 27' ' ' LYS . 1.9 tp -79.18 -20.94 47.17 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.435 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -78.7 -35.45 44.96 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 120.436 0.16 . . . . 0.0 111.377 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -47.88 115.14 1.07 Allowed 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 110.338 -0.245 . . . . 0.0 110.338 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -69.85 48.49 0.64 Allowed Glycine 0 CA--C 1.522 0.475 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.746 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.0 mtp85 -107.25 -176.69 3.14 Favored 'General case' 0 C--O 1.23 0.07 0 CA-C-N 117.062 0.431 . . . . 0.0 110.646 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.9 m -99.37 134.77 41.76 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.555 0.216 . . . . 0.0 110.488 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.729 ' HB2' HG23 ' A' ' 61' ' ' ILE . 0.7 OUTLIER -51.59 -38.45 54.58 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.566 0.222 . . . . 0.0 110.689 179.915 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.6 t -56.23 -28.32 58.02 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.339 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -53.7 -35.04 60.68 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 111.572 0.212 . . . . 0.0 111.572 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -100.32 18.22 19.42 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 64.87 16.16 10.32 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.963 HD11 ' HB3' ' A' ' 67' ' ' LEU . 0.6 OUTLIER -89.92 71.23 0.76 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-O 120.878 0.37 . . . . 0.0 110.81 179.488 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -94.77 -178.03 4.39 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.441 -179.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.5 ptpt -47.37 146.1 2.15 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.581 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.504 ' H ' HG22 ' A' ' 3' ' ' ILE . 0.6 OUTLIER 65.53 12.62 8.32 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.356 179.932 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 41.2 t -76.28 -179.9 5.37 Favored 'General case' 0 C--O 1.231 0.08 0 O-C-N 122.259 -0.276 . . . . 0.0 110.79 179.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -107.12 80.6 1.44 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.342 179.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.963 ' HB3' HD11 ' A' ' 61' ' ' ILE . 3.2 pp -98.89 119.74 38.17 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-O 120.789 0.328 . . . . 0.0 111.319 -179.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 8.8 m170 -107.15 137.0 46.03 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.592 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.771 HD12 HD23 ' A' ' 43' ' ' LEU . 1.7 tp -93.93 171.47 8.84 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.654 0.264 . . . . 0.0 110.846 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.823 HG23 ' O ' ' A' ' 42' ' ' ARG . 28.6 t -103.81 129.54 55.75 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.161 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.639 HD12 ' O ' ' A' ' 71' ' ' LEU . 1.7 pp -76.91 96.57 4.36 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.87 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.66 ' CD ' HD11 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -93.0 -40.67 10.42 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.228 179.952 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.5 mp -69.75 -34.27 73.59 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.679 -0.237 . . . . 0.0 111.134 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.78 -39.65 30.44 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.645 0.259 . . . . 0.0 110.943 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -71.0 144.87 38.73 Favored Glycine 0 C--N 1.334 0.44 0 C-N-CA 120.539 -0.838 . . . . 0.0 112.48 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.373 -1.237 . . . . 0.0 112.544 179.982 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.693 0.282 . . . . 0.0 111.253 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -95.15 140.66 29.76 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.809 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.8 tp -138.69 152.91 25.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.941 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.49 80.77 1.58 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.777 0.322 . . . . 0.0 110.866 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.669 ' CG2' HD13 ' A' ' 69' ' ' LEU . 10.6 p -134.48 132.44 54.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.84 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.1 mptt -106.97 172.41 6.84 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.778 0.323 . . . . 0.0 111.071 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.4 p -99.91 -175.68 3.03 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.576 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.624 HD12 ' HA3' ' A' ' 75' ' ' GLY . 1.9 pt? -67.02 -4.04 8.74 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.4 p -99.78 -44.14 6.19 Favored 'General case' 0 CA--C 1.529 0.167 0 O-C-N 122.258 -0.276 . . . . 0.0 111.366 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 141.71 -26.22 2.39 Favored Glycine 0 CA--C 1.521 0.461 0 C-N-CA 120.264 -0.97 . . . . 0.0 113.486 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.8 tmtm? -73.49 143.28 46.66 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 117.416 0.608 . . . . 0.0 110.86 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.9 t -96.24 149.11 22.03 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.154 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 11.7 tt -125.03 152.24 31.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.076 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.7 m -96.01 135.1 38.22 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.632 -0.258 . . . . 0.0 110.739 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -138.05 142.62 40.31 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.731 0.3 . . . . 0.0 111.127 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -101.13 146.57 27.3 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.732 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.6 t -140.06 138.58 37.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.721 0.296 . . . . 0.0 111.306 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.418 ' HB2' ' HD2' ' A' ' 19' ' ' PRO . 11.4 pt-20 -107.14 162.88 18.27 Favored Pre-proline 0 C--N 1.334 -0.098 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.514 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.418 ' HD2' ' HB2' ' A' ' 18' ' ' GLU . 77.9 Cg_exo -48.26 -54.13 5.72 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.395 2.063 . . . . 0.0 112.208 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 98.1 p -90.4 42.16 1.09 Allowed 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.77 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.684 ' OD1' HG21 ' A' ' 26' ' ' VAL . 12.7 t70 -72.72 98.12 2.32 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 120.669 0.271 . . . . 0.0 110.989 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.4 p -85.14 136.31 33.6 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.708 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.558 HG21 ' O ' ' A' ' 50' ' ' LEU . 59.4 mt -68.1 74.01 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.708 0.289 . . . . 0.0 110.916 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -158.36 -59.38 0.08 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.012 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -72.5 -33.85 67.23 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.045 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.684 HG21 ' OD1' ' A' ' 21' ' ' ASP . 39.6 t -63.77 -24.77 36.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 116.794 -0.184 . . . . 0.0 111.471 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.481 ' CG ' HG23 ' A' ' 36' ' ' ILE . 0.6 OUTLIER -55.6 -41.71 73.81 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.701 0.286 . . . . 0.0 111.004 179.958 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.78 -39.92 90.64 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.201 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 76.6 mttt -63.97 -42.69 97.17 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.935 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.495 ' HB ' HG21 ' A' ' 36' ' ' ILE . 3.8 mt -70.71 -25.25 26.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.457 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -54.8 -28.95 52.97 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 120.514 0.197 . . . . 0.0 111.239 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -54.31 -24.47 19.25 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -74.33 -64.28 1.06 Allowed 'General case' 0 N--CA 1.461 0.111 0 C-N-CA 121.074 -0.25 . . . . 0.0 110.888 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -177.43 50.57 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 120.921 0.391 . . . . 0.0 111.549 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.438 ' O ' ' HG2' ' A' ' 38' ' ' PRO . . . 73.94 91.61 0.14 Allowed Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.556 -0.83 . . . . 0.0 112.796 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.629 ' N ' ' CD ' ' A' ' 37' ' ' PRO . 7.8 tp -81.03 -27.03 0.44 Allowed Pre-proline 0 CA--C 1.54 0.592 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.64 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 72.2 Cg_exo -43.02 -48.68 7.55 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 122.371 2.047 . . . . 0.0 113.997 -179.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.64 ' HD2' ' N ' ' A' ' 37' ' ' PRO . 3.9 Cg_exo -35.56 136.15 0.19 Allowed 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.195 2.597 . . . . 0.0 113.213 -179.253 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -69.35 -0.44 6.33 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 12.1 mm100 -89.9 -13.98 35.19 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.219 0.463 . . . . 0.0 111.626 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -93.01 88.44 6.13 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-O 120.699 0.285 . . . . 0.0 110.641 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.2 ttp-105 -136.7 156.33 48.67 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.042 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.4 pp -99.64 153.07 19.36 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.806 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.614 HG23 ' O ' ' A' ' 44' ' ' ILE . 18.3 tt -110.75 75.43 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.142 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.401 ' CE1' ' O ' ' A' ' 66' ' ' THR . 0.6 OUTLIER -150.92 118.16 5.98 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.272 179.975 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.41 33.95 23.99 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.547 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 46.2 46.51 15.82 Favored Glycine 0 C--N 1.336 0.548 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.997 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.547 ' HG3' HD11 ' A' ' 61' ' ' ILE . 0.0 OUTLIER -100.05 104.26 15.83 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.743 0.272 . . . . 0.0 110.906 -179.993 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -89.15 152.86 21.38 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.038 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.558 ' O ' HG21 ' A' ' 23' ' ' ILE . 0.8 OUTLIER -79.6 -4.38 51.33 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -179.834 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -78.65 -50.28 11.73 Favored 'General case' 0 N--CA 1.462 0.127 0 C-N-CA 121.024 -0.27 . . . . 0.0 111.183 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -47.98 113.21 0.68 Allowed 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -70.31 46.54 0.65 Allowed Glycine 0 CA--C 1.521 0.432 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.624 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.22 -176.68 3.14 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 117.117 0.459 . . . . 0.0 110.881 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.441 HG23 ' O ' ' A' ' 21' ' ' ASP . 23.5 m -99.16 141.77 31.5 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.716 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.462 ' HA ' HD12 ' A' ' 61' ' ' ILE . 34.9 mt -53.14 -42.55 66.18 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.902 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.5 t -54.74 -31.49 58.49 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.565 -0.288 . . . . 0.0 111.455 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -53.72 -33.73 56.51 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 111.49 0.182 . . . . 0.0 111.49 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -102.36 40.72 1.31 Allowed 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 120.602 0.239 . . . . 0.0 111.282 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 54.77 28.87 10.86 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 111.721 0.267 . . . . 0.0 111.721 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.547 HD11 ' HG3' ' A' ' 48' ' ' LYS . 22.2 mt -89.43 86.82 2.65 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 CA-C-O 120.667 0.27 . . . . 0.0 111.053 179.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -97.98 166.7 11.32 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.727 0.299 . . . . 0.0 111.08 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.6 ptmt -50.12 159.8 0.41 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.137 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 55.23 32.9 19.48 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.213 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.2 m -75.48 153.41 37.57 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-O 120.697 0.284 . . . . 0.0 110.914 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.401 ' O ' ' CE1' ' A' ' 45' ' ' PHE . 1.5 p -106.12 71.56 0.89 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.733 0.301 . . . . 0.0 110.654 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.7 pp -101.82 146.15 28.2 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.024 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -107.1 150.56 26.43 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.838 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.669 HD13 ' CG2' ' A' ' 5' ' ' VAL . 0.3 OUTLIER -103.97 159.25 15.82 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.875 -179.938 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.3 t -103.86 153.52 6.05 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.995 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.592 HD12 ' O ' ' A' ' 71' ' ' LEU . 0.2 OUTLIER -82.3 155.46 24.8 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.603 -0.271 . . . . 0.0 110.975 -179.977 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.2 ttm180 -93.1 175.96 6.59 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.886 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.2 tt -80.14 -57.06 3.8 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.802 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 -90.08 73.65 7.25 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.87 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.624 ' HA3' HD12 ' A' ' 8' ' ' LEU . . . -144.09 -90.99 0.12 Allowed Glycine 0 CA--C 1.519 0.33 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.507 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.353 -1.248 . . . . 0.0 112.542 -179.969 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.452 ' CG ' ' HB ' ' A' ' 14' ' ' THR . 1.9 tpt . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.523 0.201 . . . . 0.0 111.099 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 90.0 mm-40 -93.23 -38.38 11.57 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 -179.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.439 HD11 ' CD1' ' A' ' 15' ' ' LEU . 28.4 pt -139.06 166.03 22.75 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.101 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.913 -179.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -126.03 104.7 8.41 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.636 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.813 ' HB ' HD11 ' A' ' 13' ' ' ILE . 18.4 t -96.35 156.2 3.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.104 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.405 ' N ' HG12 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -106.48 150.26 26.26 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.73 0.3 . . . . 0.0 110.869 -179.942 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.645 HG21 ' HB3' ' A' ' 11' ' ' LYS . 34.6 p -99.93 -157.7 0.62 Allowed 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.996 -179.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.469 ' HG ' HG22 ' A' ' 9' ' ' THR . 1.4 pt? -67.08 -33.22 75.02 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 120.894 0.378 . . . . 0.0 110.093 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.469 HG22 ' HG ' ' A' ' 8' ' ' LEU . 0.5 OUTLIER -111.57 -76.81 0.59 Allowed 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.29 178.953 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -174.56 46.57 0.14 Allowed Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.218 -0.992 . . . . 0.0 113.233 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.645 ' HB3' HG21 ' A' ' 7' ' ' THR . 6.5 ttmt -84.35 143.03 29.75 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.837 0.319 . . . . 0.0 110.573 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.518 HG23 ' O ' ' A' ' 12' ' ' THR . 11.2 t -92.86 114.17 26.66 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.874 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.813 HD11 ' HB ' ' A' ' 5' ' ' VAL . 24.7 pt -114.92 143.27 25.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.703 0.287 . . . . 0.0 111.119 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.452 ' HB ' ' CG ' ' A' ' 1' ' ' MET . 2.4 p -105.38 118.72 37.27 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.788 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.672 HD21 HG23 ' A' ' 5' ' ' VAL . 0.6 OUTLIER -138.45 159.44 42.06 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.677 0.275 . . . . 0.0 111.233 179.959 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -101.14 -175.63 2.92 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.722 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.6 t -136.49 100.61 2.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-O 120.648 0.261 . . . . 0.0 111.223 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -107.09 154.31 40.47 Favored Pre-proline 0 C--O 1.232 0.157 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.981 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.473 ' HA ' HG21 ' A' ' 55' ' ' THR . 28.5 Cg_endo -62.61 -22.62 74.16 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.77 2.313 . . . . 0.0 113.165 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 51.6 p -78.8 -35.42 44.32 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 121.264 -0.175 . . . . 0.0 111.385 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -73.5 96.71 2.45 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.606 0.241 . . . . 0.0 111.023 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 10.0 p -85.1 -177.37 6.52 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.912 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.823 ' O ' HG13 ' A' ' 26' ' ' VAL . 25.6 mm -68.19 -31.17 50.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.653 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.9 tm-20 -70.31 -47.88 59.13 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.583 0.23 . . . . 0.0 111.251 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -74.99 40.8 0.15 Allowed 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -179.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.823 HG13 ' O ' ' A' ' 23' ' ' ILE . 17.1 m -74.32 -31.49 28.78 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 O-C-N 122.176 -0.328 . . . . 0.0 111.26 179.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.494 ' HE3' HG23 ' A' ' 26' ' ' VAL . 0.0 OUTLIER -59.74 -33.09 71.19 Favored 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 121.278 -0.169 . . . . 0.0 111.181 179.998 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.69 -56.54 20.55 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.619 0.247 . . . . 0.0 111.165 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.0 pttm -63.95 -37.34 87.04 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.677 -0.238 . . . . 0.0 110.996 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 21.7 mt -74.42 -15.97 16.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 116.751 -0.204 . . . . 0.0 111.369 179.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -65.53 -10.79 37.93 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -50.05 -33.12 17.27 Favored 'General case' 0 N--CA 1.464 0.244 0 O-C-N 122.22 -0.3 . . . . 0.0 111.66 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.412 ' HD2' ' N ' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -85.38 -28.41 25.19 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 121.067 -0.253 . . . . 0.0 110.791 179.508 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 61.32 25.92 15.82 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.745 -0.207 . . . . 0.0 111.091 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.509 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . -150.52 33.84 0.99 Allowed Glycine 0 C--N 1.335 0.51 0 C-N-CA 120.041 -1.076 . . . . 0.0 113.262 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.606 HG23 ' O ' ' A' ' 36' ' ' ILE . 9.3 tp -90.06 106.47 14.72 Favored Pre-proline 0 CA--C 1.531 0.217 0 CA-C-N 117.092 0.446 . . . . 0.0 111.263 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.509 ' HD3' ' O ' ' A' ' 35' ' ' GLY . 23.3 Cg_exo -62.03 -50.01 5.67 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.209 1.939 . . . . 0.0 112.634 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.459 ' HD3' ' CB ' ' A' ' 37' ' ' PRO . 50.1 Cg_exo -55.97 89.88 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.307 2.005 . . . . 0.0 112.551 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -68.17 -37.0 80.51 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.027 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -101.62 45.19 0.98 Allowed 'General case' 0 CA--C 1.528 0.118 0 CA-C-O 120.784 0.326 . . . . 0.0 110.872 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.817 ' O ' HD11 ' A' ' 50' ' ' LEU . 7.7 tt0 -82.56 136.43 34.84 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.898 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.5 mtt180 -142.1 175.64 9.58 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.964 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.549 ' HB3' HD12 ' A' ' 69' ' ' LEU . 0.5 OUTLIER -108.03 149.09 28.85 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.687 179.789 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.6 mt -100.92 79.43 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.692 0.282 . . . . 0.0 111.197 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -150.91 129.85 12.51 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.099 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 59.99 26.06 15.32 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.65 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 45.29 40.83 8.05 Favored Glycine 0 C--N 1.336 0.569 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.973 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.401 ' HD2' ' CZ ' ' A' ' 59' ' ' TYR . 0.4 OUTLIER -107.42 130.52 54.81 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.796 0.298 . . . . 0.0 111.054 -179.848 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.09 177.92 6.51 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.803 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.817 HD11 ' O ' ' A' ' 41' ' ' GLN . 12.9 mt -68.96 -22.42 64.11 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.596 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -89.8 28.26 1.38 Allowed 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -47.81 -50.75 25.01 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.665 0.269 . . . . 0.0 111.07 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.44 -23.32 34.55 Favored Glycine 0 CA--C 1.521 0.411 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.976 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -107.13 -175.97 2.94 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.985 0.393 . . . . 0.0 110.837 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.473 HG21 ' HA ' ' A' ' 19' ' ' PRO . 8.9 m -96.92 151.69 19.44 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-O 120.738 0.304 . . . . 0.0 110.753 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.768 ' HB3' HG23 ' A' ' 61' ' ' ILE . 9.5 mt -53.89 -44.01 70.12 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.099 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.7 t -52.89 -53.18 52.83 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.635 -179.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -64.61 -18.77 65.22 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -179.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.401 ' CZ ' ' HD2' ' A' ' 48' ' ' LYS . 0.4 OUTLIER -97.99 31.03 2.82 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -179.578 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.7 m120 66.09 -16.59 0.12 Allowed 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.768 HG23 ' HB3' ' A' ' 56' ' ' LEU . 0.6 OUTLIER -89.29 62.69 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 118.471 0.578 . . . . 0.0 110.895 179.852 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -95.4 -167.41 1.61 Allowed 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.02 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -39.85 143.09 0.27 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.855 0.359 . . . . 0.0 111.891 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 65.49 15.79 10.2 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.151 -0.477 . . . . 0.0 112.022 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.1 p -76.19 175.28 9.15 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-O 120.68 0.276 . . . . 0.0 110.996 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -105.47 91.58 3.83 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.205 179.221 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.429 HD12 HD11 ' A' ' 61' ' ' ILE . 1.0 OUTLIER -98.66 109.58 22.32 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.819 0.342 . . . . 0.0 111.41 -179.322 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -107.05 97.59 7.35 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.474 179.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.549 HD12 ' HB3' ' A' ' 43' ' ' LEU . 1.0 OUTLIER -93.84 129.47 40.22 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.702 0.286 . . . . 0.0 111.06 -179.696 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.0 p -114.01 152.94 15.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.96 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.715 HD12 ' O ' ' A' ' 71' ' ' LEU . 4.1 pp -76.91 132.71 39.23 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.583 -0.281 . . . . 0.0 110.826 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -90.33 125.75 35.63 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.972 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.8 mp -80.12 -42.43 23.56 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.953 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 14.0 mtt180 -80.63 162.97 23.97 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.953 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 142.99 -42.35 1.1 Allowed Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.433 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.381 -1.233 . . . . 0.0 112.511 179.95 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 120.63 0.253 . . . . 0.0 111.183 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -92.47 -44.01 8.88 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.951 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.8 pt -138.86 174.0 10.77 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.082 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -118.9 105.35 11.4 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.725 0.298 . . . . 0.0 110.869 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.769 HG23 HD23 ' A' ' 69' ' ' LEU . 12.0 p -137.54 132.08 44.69 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.886 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.3 mppt? -106.94 163.09 13.26 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.853 0.358 . . . . 0.0 111.171 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.51 -153.64 0.45 Allowed 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.027 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.901 HD23 HG22 ' A' ' 9' ' ' THR . 0.0 OUTLIER -67.85 -21.89 65.16 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-O 120.86 0.362 . . . . 0.0 110.056 179.874 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.901 HG22 HD23 ' A' ' 8' ' ' LEU . 0.3 OUTLIER -111.69 -70.58 0.8 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.32 179.378 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 164.89 49.86 0.02 OUTLIER Glycine 0 CA--C 1.52 0.379 0 C-N-CA 120.497 -0.859 . . . . 0.0 113.15 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -84.73 150.77 24.86 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.954 0.377 . . . . 0.0 110.982 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.486 HG23 ' O ' ' A' ' 12' ' ' THR . 14.7 t -96.67 115.94 28.28 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.349 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.557 ' CG2' HG13 ' A' ' 5' ' ' VAL . 8.0 tt -125.04 135.97 62.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-O 120.735 0.303 . . . . 0.0 111.629 -179.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.6 t -106.19 132.28 52.44 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.48 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.788 HD21 ' HA ' ' A' ' 30' ' ' ILE . 2.1 mt -134.86 134.71 41.03 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.661 0.267 . . . . 0.0 111.247 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -94.99 155.87 16.55 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.404 179.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 1.012 HG11 HD11 ' A' ' 56' ' ' LEU . 21.8 t -140.13 136.62 37.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-O 120.957 0.408 . . . . 0.0 111.795 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.492 ' HB2' ' HD2' ' A' ' 19' ' ' PRO . 11.0 pt-20 -96.72 161.0 28.06 Favored Pre-proline 0 CA--C 1.53 0.19 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.324 179.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.492 ' HD2' ' HB2' ' A' ' 18' ' ' GLU . 1.2 Cg_endo -43.18 -66.64 0.15 Allowed 'Trans proline' 0 CA--C 1.532 0.415 0 C-N-CA 122.892 2.395 . . . . 0.0 112.96 -179.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.21 37.13 0.89 Allowed 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.412 ' HB2' ' O ' ' A' ' 18' ' ' GLU . 5.5 t0 -75.7 119.65 20.01 Favored 'General case' 0 N--CA 1.462 0.145 0 O-C-N 122.276 -0.265 . . . . 0.0 111.226 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -85.25 146.58 27.0 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.509 179.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.636 ' O ' HG12 ' A' ' 26' ' ' VAL . 8.3 tp -57.99 -32.46 43.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 116.769 -0.196 . . . . 0.0 111.376 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -76.19 -39.02 55.8 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 120.547 0.213 . . . . 0.0 111.0 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -63.09 -31.59 72.76 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.729 -0.214 . . . . 0.0 111.448 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.636 HG12 ' O ' ' A' ' 23' ' ' ILE . 13.3 p -74.29 -6.4 8.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.488 ' HA ' HG22 ' A' ' 30' ' ' ILE . 16.4 mttt -55.47 -39.41 70.36 Favored 'General case' 0 N--CA 1.463 0.199 0 O-C-N 122.182 -0.324 . . . . 0.0 111.225 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.12 -41.75 81.27 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.561 0.219 . . . . 0.0 111.432 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.8 tttp -74.12 -42.75 59.55 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.695 -0.23 . . . . 0.0 111.243 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.788 ' HA ' HD21 ' A' ' 15' ' ' LEU . 18.8 tt -64.96 -20.69 28.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.406 ' HA ' ' CG1' ' A' ' 36' ' ' ILE . 1.2 tt0 -63.43 74.65 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.741 0.305 . . . . 0.0 111.111 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.45 ' HB2' HD12 ' A' ' 13' ' ' ILE . 27.9 t70 -61.26 -69.53 0.23 Allowed 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.833 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.71 -85.9 0.14 Allowed 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 121.077 -0.249 . . . . 0.0 110.709 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -177.87 44.34 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -150.14 26.73 1.13 Allowed Glycine 0 CA--C 1.524 0.599 0 C-N-CA 120.182 -1.009 . . . . 0.0 113.539 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.654 HG21 HG23 ' A' ' 30' ' ' ILE . 32.5 mm -89.17 -46.45 0.42 Allowed Pre-proline 0 CA--C 1.533 0.306 0 CA-C-N 117.497 0.649 . . . . 0.0 112.15 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.48 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 53.6 Cg_exo -52.9 -43.74 54.08 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.337 2.025 . . . . 0.0 113.168 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' A' ' 37' ' ' PRO . 58.9 Cg_exo -39.93 161.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.748 2.299 . . . . 0.0 113.511 -179.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -69.56 0.39 5.42 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -90.06 8.48 32.45 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 118.094 0.407 . . . . 0.0 111.807 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -89.72 110.92 21.78 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 121.038 -0.265 . . . . 0.0 110.664 179.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.4 mtt180 -144.03 152.2 40.69 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.739 0.304 . . . . 0.0 111.237 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.807 HD11 HD22 ' A' ' 50' ' ' LEU . 1.5 mp -108.0 152.03 25.03 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.783 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.474 HD11 ' CG1' ' A' ' 70' ' ' VAL . 27.0 mm -111.0 61.79 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.157 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.596 ' HB2' HD23 ' A' ' 67' ' ' LEU . 0.2 OUTLIER -153.66 118.36 4.98 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.754 0.311 . . . . 0.0 111.201 179.984 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.74 32.09 21.38 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.677 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 46.36 42.97 13.93 Favored Glycine 0 C--N 1.335 0.527 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.968 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.432 ' HD3' ' CZ ' ' A' ' 59' ' ' TYR . 2.5 tptp -101.36 137.29 39.89 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.643 0.259 . . . . 0.0 110.972 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -89.02 168.81 12.05 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.51 -0.313 . . . . 0.0 110.966 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.807 HD22 HD11 ' A' ' 43' ' ' LEU . 0.2 OUTLIER -79.11 -38.03 37.19 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.471 -0.332 . . . . 0.0 111.354 -179.848 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.64 17.55 6.35 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -47.33 -39.79 15.69 Favored 'General case' 0 N--CA 1.466 0.351 0 O-C-N 122.241 -0.287 . . . . 0.0 111.303 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.19 19.85 48.37 Favored Glycine 0 CA--C 1.522 0.487 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.942 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.7 mtt-85 -107.56 175.81 5.36 Favored 'General case' 0 N--CA 1.458 -0.075 0 CA-C-N 117.03 0.415 . . . . 0.0 110.836 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.532 HG22 ' H ' ' A' ' 57' ' ' SER . 31.2 m -99.34 133.17 44.04 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.731 0.301 . . . . 0.0 110.689 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 1.012 HD11 HG11 ' A' ' 17' ' ' VAL . 0.4 OUTLIER -51.8 -31.08 25.76 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.561 0.219 . . . . 0.0 111.113 179.974 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.532 ' H ' HG22 ' A' ' 55' ' ' THR . 12.6 t -62.95 -40.05 96.5 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -63.21 -29.37 70.72 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.432 ' CZ ' ' HD3' ' A' ' 48' ' ' LYS . 0.2 OUTLIER -97.66 8.99 43.68 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 111.641 0.237 . . . . 0.0 111.641 179.995 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 65.37 11.19 7.14 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.435 ' CG2' HD11 ' A' ' 67' ' ' LEU . 1.2 pt -90.11 63.09 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 CA-C-N 117.961 0.346 . . . . 0.0 110.676 179.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -95.1 -168.66 1.84 Allowed 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.093 -179.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -40.18 152.05 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.601 -179.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 62.14 24.49 14.58 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.363 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.9 p -75.56 145.52 41.17 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.702 0.287 . . . . 0.0 110.939 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.0 m -104.86 66.45 0.77 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.763 0.316 . . . . 0.0 110.577 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.596 HD23 ' HB2' ' A' ' 45' ' ' PHE . 0.4 OUTLIER -104.67 144.49 31.65 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.165 -179.726 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 16.1 m170 -106.97 141.1 38.72 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.749 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.769 HD23 HG23 ' A' ' 5' ' ' VAL . 1.3 mm? -103.81 163.38 12.38 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.667 0.27 . . . . 0.0 111.022 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.474 ' CG1' HD11 ' A' ' 44' ' ' ILE . 33.9 m -105.29 179.44 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.021 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.762 HD23 HD12 ' A' ' 8' ' ' LEU . 1.3 mp -76.78 106.23 8.32 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.769 0.319 . . . . 0.0 110.682 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.451 ' NH2' HD11 ' A' ' 69' ' ' LEU . 13.8 mtt180 -90.27 -38.08 13.65 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.267 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 18.6 tp -69.84 -65.26 0.74 Allowed 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.575 0.226 . . . . 0.0 110.914 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -90.09 172.45 8.81 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.67 0.271 . . . . 0.0 110.907 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -90.31 -55.36 1.96 Allowed Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.602 -0.808 . . . . 0.0 112.458 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.431 -1.205 . . . . 0.0 112.467 -179.946 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.1 ptt? . . . . . 0 N--CA 1.487 1.412 0 CA-C-O 120.675 0.274 . . . . 0.0 111.221 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -95.01 108.07 20.13 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.908 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 1.041 HD11 HD13 ' A' ' 67' ' ' LEU . 18.0 tt -138.73 156.27 28.65 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.939 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -118.44 91.83 3.66 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-O 120.739 0.304 . . . . 0.0 110.913 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.5 t -93.35 159.69 2.76 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.747 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.0 ttmt -106.66 135.56 47.97 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.828 0.347 . . . . 0.0 111.044 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.626 HG21 ' HB3' ' A' ' 11' ' ' LYS . 13.7 p -100.51 -162.19 0.92 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.25 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.686 HD12 ' OG1' ' A' ' 9' ' ' THR . 0.8 OUTLIER -60.14 -38.64 83.69 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 120.649 -0.42 . . . . 0.0 111.199 -179.446 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.686 ' OG1' HD12 ' A' ' 8' ' ' LEU . 0.2 OUTLIER -111.24 -62.08 1.6 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.65 0.262 . . . . 0.0 110.792 179.835 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 168.06 50.04 0.03 OUTLIER Glycine 0 CA--C 1.521 0.421 0 C-N-CA 120.512 -0.851 . . . . 0.0 113.125 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.626 ' HB3' HG21 ' A' ' 7' ' ' THR . 0.0 OUTLIER -84.67 157.12 21.21 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 116.858 0.329 . . . . 0.0 110.768 179.795 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.562 HG23 ' O ' ' A' ' 12' ' ' THR . 12.1 t -103.01 108.41 19.57 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.715 0.293 . . . . 0.0 110.8 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.545 HG23 ' HD2' ' A' ' 11' ' ' LYS . 2.8 pt -125.07 168.88 17.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.245 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.02 158.95 16.42 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.778 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.697 ' CB ' HG21 ' A' ' 3' ' ' ILE . 0.2 OUTLIER -138.19 115.67 11.23 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.698 0.285 . . . . 0.0 111.036 -179.897 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -101.05 150.14 23.22 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.743 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.945 ' CG1' HD21 ' A' ' 56' ' ' LEU . 30.2 t -140.0 146.8 24.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.377 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -107.1 164.67 14.33 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.783 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -56.97 -55.47 2.62 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.609 2.206 . . . . 0.0 112.539 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.2 m -89.52 8.38 31.41 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -179.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -75.0 118.14 17.64 Favored 'General case' 0 CA--C 1.528 0.125 0 O-C-N 122.245 -0.284 . . . . 0.0 110.924 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.8 p -85.08 165.69 17.28 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.817 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 7.3 tp -58.36 -40.2 77.2 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.261 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -59.32 -38.54 80.56 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.646 0.26 . . . . 0.0 110.924 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -62.79 -23.86 67.45 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.592 -0.277 . . . . 0.0 111.47 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 39.4 t -63.57 -39.5 85.58 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-O 120.566 0.222 . . . . 0.0 111.06 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.526 ' HA ' HG22 ' A' ' 30' ' ' ILE . 7.7 tttm -57.31 -36.96 71.74 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 120.602 0.239 . . . . 0.0 111.242 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.26 -45.0 74.36 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-O 120.654 0.264 . . . . 0.0 111.444 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.2 ptpm? -74.13 -39.92 63.0 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.522 -179.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.855 ' O ' HD13 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -64.81 -36.89 78.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-O 120.56 0.219 . . . . 0.0 111.431 -179.672 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -64.81 -21.0 66.69 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -61.48 -14.31 27.87 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.9 mtpp -73.91 -42.7 60.27 Favored 'General case' 0 C--O 1.232 0.132 0 O-C-N 122.222 -0.299 . . . . 0.0 111.307 -179.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -144.19 -44.2 0.26 Allowed 'General case' 0 C--O 1.232 0.171 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.836 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.462 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . 107.44 68.29 0.66 Allowed Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.625 -0.797 . . . . 0.0 111.543 -179.307 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.65 HD11 ' CB ' ' A' ' 72' ' ' ARG . 19.7 tt -77.86 109.37 9.67 Favored Pre-proline 0 CA--C 1.532 0.287 0 CA-C-O 120.714 0.292 . . . . 0.0 111.533 -179.037 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.605 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 28.6 Cg_exo -62.96 -41.28 29.87 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.999 2.466 . . . . 0.0 114.422 -179.325 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.605 ' HD2' ' N ' ' A' ' 37' ' ' PRO . 21.8 Cg_endo -64.27 114.33 2.62 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 121.904 1.736 . . . . 0.0 113.086 -178.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -69.78 -1.88 10.49 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.516 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -90.06 10.98 22.14 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 122.073 -0.392 . . . . 0.0 111.998 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.461 ' CG ' HD13 ' A' ' 36' ' ' ILE . 1.6 tm0? -90.02 97.06 10.97 Favored 'General case' 0 C--O 1.231 0.105 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 179.192 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.611 ' O ' HD13 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -133.91 -177.41 4.55 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.788 0.328 . . . . 0.0 111.174 -179.476 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.784 HD12 HD22 ' A' ' 69' ' ' LEU . 2.0 tp -99.13 143.59 29.23 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.927 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.8 mm -106.13 95.47 3.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.124 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 16.1 t80 -150.88 123.33 8.43 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.093 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.04 33.39 23.13 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.366 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 46.14 36.06 6.97 Favored Glycine 0 C--N 1.336 0.539 0 C-N-CA 120.868 -0.682 . . . . 0.0 113.047 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.425 ' HG2' ' CE2' ' A' ' 59' ' ' TYR . 0.3 OUTLIER -110.21 126.03 53.7 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.849 0.325 . . . . 0.0 110.962 -179.952 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -89.09 149.32 23.25 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.802 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.611 HD12 ' O ' ' A' ' 50' ' ' LEU . 4.1 pp -80.39 13.11 2.57 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -78.59 -42.61 28.58 Favored 'General case' 0 CA--C 1.528 0.097 0 O-C-N 121.978 -0.451 . . . . 0.0 110.76 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -48.18 118.46 2.41 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 179.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -68.89 49.28 0.49 Allowed Glycine 0 CA--C 1.522 0.472 0 C-N-CA 120.625 -0.798 . . . . 0.0 113.051 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.58 -172.63 2.11 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 117.169 0.484 . . . . 0.0 110.549 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.62 HG22 ' OD2' ' A' ' 58' ' ' ASP . 8.8 t -99.03 134.22 42.18 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.567 0.222 . . . . 0.0 110.627 179.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.945 HD21 ' CG1' ' A' ' 17' ' ' VAL . 3.1 pp -51.74 -34.27 38.37 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.624 0.249 . . . . 0.0 111.223 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.2 t -61.22 -35.12 76.35 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.414 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.62 ' OD2' HG22 ' A' ' 55' ' ' THR . 7.5 m-20 -53.86 -32.1 51.89 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 111.612 0.227 . . . . 0.0 111.612 -179.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.425 ' CE2' ' HG2' ' A' ' 48' ' ' LYS . 28.0 m-85 -97.9 14.95 25.38 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.3 t30 58.48 22.77 9.99 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.774 HG22 ' O ' ' A' ' 56' ' ' LEU . 2.3 tp -90.0 62.49 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 CA-C-O 120.775 0.322 . . . . 0.0 110.823 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -101.14 179.68 4.3 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.265 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.7 pttp -50.36 -179.9 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.33 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 67.25 -41.54 0.42 Allowed 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.33 0.492 . . . . 0.0 112.33 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.6 m -64.89 172.54 2.79 Favored 'General case' 0 C--N 1.332 -0.191 0 O-C-N 122.266 -0.272 . . . . 0.0 110.779 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.9 p -96.9 117.74 31.78 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.979 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 1.041 HD13 HD11 ' A' ' 3' ' ' ILE . 3.6 mp -109.04 117.36 33.98 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.013 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -107.18 123.55 48.43 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.906 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.784 HD22 HD12 ' A' ' 43' ' ' LEU . 2.5 mm? -101.33 163.54 12.22 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.851 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.9 m -104.92 173.72 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.134 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.1 mt -78.09 153.24 32.39 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.879 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.65 ' CB ' HD11 ' A' ' 36' ' ' ILE . 0.6 OUTLIER -92.99 -42.16 9.6 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.244 -179.953 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.404 HD23 ' NH1' ' A' ' 72' ' ' ARG . 2.8 mm? -81.67 44.6 0.83 Allowed 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 111.58 0.215 . . . . 0.0 111.58 179.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.16 98.23 11.65 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.657 0.265 . . . . 0.0 110.905 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 144.39 -72.47 0.35 Allowed Glycine 0 C--N 1.333 0.379 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.546 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.337 -1.257 . . . . 0.0 112.469 179.977 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.668 0.271 . . . . 0.0 111.224 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -95.04 123.05 38.31 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.891 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.913 HD12 ' HB3' ' A' ' 15' ' ' LEU . 21.7 mt -139.56 155.12 25.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.95 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -118.65 93.96 4.29 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.691 0.281 . . . . 0.0 110.931 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.566 HG22 ' HB3' ' A' ' 67' ' ' LEU . 21.3 t -119.55 151.97 22.05 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.022 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 6.4 ptpp? -109.87 140.31 43.97 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.808 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 75.5 p -99.97 -148.08 0.35 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.475 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.569 ' O ' HD23 ' A' ' 71' ' ' LEU . 1.3 pt? -65.31 -41.89 93.59 Favored 'General case' 0 C--N 1.341 0.218 0 CA-C-N 118.68 0.673 . . . . 0.0 111.571 -178.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.57 ' O ' HG22 ' A' ' 9' ' ' THR . 42.7 m -111.4 41.29 1.9 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.678 0.275 . . . . 0.0 111.065 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 50.7 39.03 37.66 Favored Glycine 0 CA--C 1.521 0.439 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.776 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.6 tttm -74.38 145.65 43.62 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.813 0.306 . . . . 0.0 110.767 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.56 HG23 ' O ' ' A' ' 12' ' ' THR . 9.7 t -93.74 106.18 18.17 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.781 0.324 . . . . 0.0 110.898 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.509 ' C ' HD12 ' A' ' 13' ' ' ILE . 2.3 pp -125.21 163.29 26.25 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.12 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 16.6 p -101.89 152.5 20.84 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.828 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.913 ' HB3' HD12 ' A' ' 3' ' ' ILE . 2.7 tp -127.99 92.8 3.53 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.976 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -100.98 121.56 41.98 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.849 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.741 HG21 HD21 ' A' ' 56' ' ' LEU . 27.7 m -140.06 173.94 9.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.156 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -96.88 167.22 12.45 Favored Pre-proline 0 C--O 1.231 0.13 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.934 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.35 -43.3 41.72 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.657 2.238 . . . . 0.0 112.487 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 36.9 m -89.27 3.09 53.2 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -75.06 120.23 20.3 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.664 0.268 . . . . 0.0 111.022 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 10.7 t -85.21 165.74 17.13 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.495 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.827 ' O ' HG12 ' A' ' 26' ' ' VAL . 43.4 mm -57.33 -37.45 57.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-O 120.528 0.204 . . . . 0.0 111.034 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -52.98 -31.45 40.82 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 120.487 0.184 . . . . 0.0 111.153 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -70.93 -42.8 69.37 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.765 -0.198 . . . . 0.0 111.335 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.827 HG12 ' O ' ' A' ' 23' ' ' ILE . 12.4 p -63.99 -21.7 29.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 111.675 0.25 . . . . 0.0 111.675 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.755 ' HD3' HD22 ' A' ' 50' ' ' LEU . 5.6 tptp -55.5 -35.03 65.15 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.573 0.225 . . . . 0.0 110.885 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.1 -37.47 87.6 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.581 0.229 . . . . 0.0 110.883 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.5 mttt -63.93 -48.62 75.81 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-O 120.636 0.255 . . . . 0.0 110.819 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.434 HG22 ' O ' ' A' ' 27' ' ' LYS . 2.6 tt -64.82 -39.15 84.67 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 CA-C-N 116.633 -0.258 . . . . 0.0 110.931 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -65.25 -21.45 66.74 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.721 -0.218 . . . . 0.0 111.07 179.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -61.33 -12.34 13.45 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 7.5 ptpp? -74.26 -36.73 63.85 Favored 'General case' 0 N--CA 1.461 0.092 0 O-C-N 122.013 -0.429 . . . . 0.0 110.819 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -176.4 -42.07 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.664 0.268 . . . . 0.0 111.558 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.518 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . 123.63 74.92 0.28 Allowed Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.646 -0.788 . . . . 0.0 111.589 -179.66 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.789 HD13 ' CD ' ' A' ' 41' ' ' GLN . 1.3 pp -78.31 102.34 0.95 Allowed Pre-proline 0 CA--C 1.532 0.279 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -179.087 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.698 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 10.6 Cg_endo -55.02 -42.63 67.23 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.564 2.176 . . . . 0.0 113.962 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.698 ' HD2' ' N ' ' A' ' 37' ' ' PRO . 6.1 Cg_exo -39.34 106.6 0.06 OUTLIER 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 122.762 2.308 . . . . 0.0 113.106 -179.101 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -68.61 -16.57 63.89 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.622 179.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -93.77 28.53 2.33 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.789 ' CD ' HD13 ' A' ' 36' ' ' ILE . 4.9 tt0 -91.91 89.07 6.86 Favored 'General case' 0 C--O 1.231 0.095 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 179.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.11 -179.06 6.27 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.96 -179.516 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.697 HD13 ' HG ' ' A' ' 67' ' ' LEU . 0.6 OUTLIER -97.6 160.18 14.47 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 120.718 0.294 . . . . 0.0 110.879 -179.873 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.643 HG23 ' O ' ' A' ' 44' ' ' ILE . 17.6 tt -100.91 80.03 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.13 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.635 ' HB2' HD12 ' A' ' 43' ' ' LEU . 0.3 OUTLIER -150.94 105.65 3.28 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.078 179.93 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.414 ' HB1' ' CE2' ' A' ' 59' ' ' TYR . . . 63.62 31.3 14.65 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.575 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 45.65 52.98 8.79 Favored Glycine 0 C--N 1.336 0.562 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.983 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.446 ' CD ' ' CE1' ' A' ' 59' ' ' TYR . 0.7 OUTLIER -106.62 115.82 30.86 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.785 0.292 . . . . 0.0 110.943 -179.955 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.19 173.19 8.55 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.772 0.32 . . . . 0.0 110.867 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.758 HD23 HG22 ' A' ' 23' ' ' ILE . 1.1 mt -79.15 -22.99 44.28 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.491 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -78.83 -35.68 43.69 Favored 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 121.256 -0.178 . . . . 0.0 111.339 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -48.06 114.69 0.98 Allowed 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 179.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -70.01 49.72 0.7 Allowed Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.483 -0.865 . . . . 0.0 112.592 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 -107.15 161.54 14.67 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.986 0.393 . . . . 0.0 110.815 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.557 HG23 ' H ' ' A' ' 58' ' ' ASP . 7.2 t -99.27 142.84 30.24 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.521 -0.308 . . . . 0.0 110.74 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.741 HD21 HG21 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -51.99 -43.71 63.73 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 111.745 0.276 . . . . 0.0 111.745 -179.286 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.1 t -58.84 -31.13 68.22 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -179.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.557 ' H ' HG23 ' A' ' 55' ' ' THR . 1.6 m-20 -56.82 -39.03 73.45 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 111.549 0.203 . . . . 0.0 111.549 -179.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.446 ' CE1' ' CD ' ' A' ' 48' ' ' LYS . 30.7 m-85 -99.82 17.51 20.58 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 47.5 t30 65.1 15.59 10.08 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 179.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.547 HD11 ' HA ' ' A' ' 56' ' ' LEU . 7.3 pt -90.03 60.97 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-O 120.836 0.351 . . . . 0.0 110.912 179.406 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.45 -160.15 0.77 Allowed 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.701 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.475 ' O ' ' CG ' ' A' ' 64' ' ' GLU . 2.4 pttp -39.89 144.56 0.19 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.682 0.277 . . . . 0.0 111.681 -179.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.475 ' CG ' ' O ' ' A' ' 63' ' ' LYS . 3.5 pt-20 54.49 26.68 7.43 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.023 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.4 p -76.05 173.38 11.34 Favored 'General case' 0 C--O 1.23 0.071 0 CA-C-O 120.672 0.272 . . . . 0.0 110.878 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.412 ' HB ' ' CE1' ' A' ' 45' ' ' PHE . 0.2 OUTLIER -107.1 81.86 1.6 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.356 179.395 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.697 ' HG ' HD13 ' A' ' 43' ' ' LEU . 0.3 OUTLIER -98.82 107.54 20.01 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.336 -179.405 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 -107.13 103.77 13.25 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.582 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.475 HD12 ' CG1' ' A' ' 5' ' ' VAL . 0.2 OUTLIER -93.83 168.41 11.0 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.011 -179.773 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 32.9 m -103.87 174.41 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.216 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.569 HD23 ' O ' ' A' ' 8' ' ' LEU . 2.6 mp -77.81 149.65 34.39 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.745 0.307 . . . . 0.0 110.844 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.507 ' CZ ' HD13 ' A' ' 8' ' ' LEU . 0.4 OUTLIER -89.91 -32.77 16.7 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.437 -179.944 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.19 -53.65 6.48 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.68 0.276 . . . . 0.0 110.866 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.05 141.9 28.23 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.756 0.312 . . . . 0.0 110.873 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 142.5 60.74 0.03 OUTLIER Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.457 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.367 -1.24 . . . . 0.0 112.498 179.982 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.488 1.444 0 CA-C-O 120.69 0.281 . . . . 0.0 111.204 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -94.94 124.92 39.26 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.911 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.469 HG12 HD23 ' A' ' 67' ' ' LEU . 16.8 tt -138.92 153.2 24.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.077 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -118.99 127.52 53.54 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.65 0.262 . . . . 0.0 110.797 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 1.058 HG13 HD11 ' A' ' 67' ' ' LEU . 3.5 t -101.36 140.45 20.04 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.176 -179.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.426 ' HG2' ' CE1' ' A' ' 68' ' ' HIS . 0.0 OUTLIER -106.78 87.2 2.47 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.444 179.817 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.41 119.94 40.82 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.539 -179.221 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -51.02 -20.87 1.53 Allowed 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 179.353 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 77.5 p -99.96 38.47 1.46 Allowed 'General case' 0 CA--C 1.531 0.248 0 O-C-N 122.033 -0.417 . . . . 0.0 111.442 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 49.03 30.13 9.32 Favored Glycine 0 C--N 1.336 0.567 0 C-N-CA 121.117 -0.563 . . . . 0.0 113.757 179.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.82 65.28 9.06 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 117.332 0.566 . . . . 0.0 110.714 179.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.616 HG23 ' O ' ' A' ' 12' ' ' THR . 13.6 t -92.98 99.76 12.33 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.89 0.376 . . . . 0.0 110.883 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.526 HD11 ' HD3' ' A' ' 33' ' ' LYS . 1.7 pp -125.54 172.55 12.88 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.167 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.27 132.7 51.14 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.656 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.436 ' HG ' HD13 ' A' ' 13' ' ' ILE . 62.3 mt -128.88 124.04 34.2 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.121 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -101.19 131.6 47.09 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.755 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.02 -176.23 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.925 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -102.58 160.87 24.96 Favored Pre-proline 0 C--N 1.333 -0.127 0 CA-C-O 120.636 0.255 . . . . 0.0 110.896 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -53.26 -50.12 15.08 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.482 2.121 . . . . 0.0 112.407 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.9 t -90.21 32.26 0.94 Allowed 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.354 0.501 . . . . 0.0 112.354 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.9 p-10 -75.24 119.48 19.43 Favored 'General case' 0 N--CA 1.461 0.114 0 O-C-N 122.202 -0.311 . . . . 0.0 110.976 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.41 HG23 ' H ' ' A' ' 25' ' ' ASN . 14.4 t -84.95 166.08 17.08 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-O 120.673 0.273 . . . . 0.0 110.822 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.684 ' HB ' HD12 ' A' ' 50' ' ' LEU . 9.8 tp -57.89 -37.99 63.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.641 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -63.45 -41.74 98.64 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.572 0.225 . . . . 0.0 111.25 -179.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.41 ' H ' HG23 ' A' ' 22' ' ' THR . 0.7 OUTLIER -73.14 -48.0 39.25 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 120.616 0.246 . . . . 0.0 111.161 -179.702 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.548 HG12 ' HA ' ' A' ' 23' ' ' ILE . 13.6 p -63.97 -21.42 28.76 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 111.698 0.259 . . . . 0.0 111.698 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.2 mtpm? -55.58 -35.06 65.37 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.502 0.191 . . . . 0.0 110.902 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.88 -37.62 74.28 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.625 0.25 . . . . 0.0 110.879 179.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.78 -38.01 64.79 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.849 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 33.2 mm -64.98 -45.16 95.49 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 CA-C-O 120.671 0.272 . . . . 0.0 110.622 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -59.89 -26.58 66.0 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.961 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -57.09 -22.94 43.29 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 111.691 0.256 . . . . 0.0 111.691 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.526 ' HD3' HD11 ' A' ' 13' ' ' ILE . 7.8 mtmp? -74.37 -39.08 62.97 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.605 0.24 . . . . 0.0 110.925 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.06 -48.64 0.24 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.692 -0.231 . . . . 0.0 111.238 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.505 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . 108.83 62.52 0.54 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.04 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.853 HD13 ' HB2' ' A' ' 41' ' ' GLN . 17.2 tt -78.51 108.3 7.58 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-O 120.696 0.284 . . . . 0.0 111.486 -179.512 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.591 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 26.0 Cg_exo -63.53 -40.66 29.39 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 122.747 2.298 . . . . 0.0 114.189 -179.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.591 ' HD2' ' N ' ' A' ' 37' ' ' PRO . 38.1 Cg_endo -68.5 133.16 27.21 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 122.02 1.813 . . . . 0.0 113.53 -178.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -70.71 14.67 0.13 Allowed 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.659 -0.7 . . . . 0.0 112.45 179.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -89.37 1.51 55.7 Favored 'General case' 0 N--CA 1.456 -0.138 0 O-C-N 122.135 -0.353 . . . . 0.0 110.543 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.853 ' HB2' HD13 ' A' ' 36' ' ' ILE . 2.6 tp60 -82.77 101.7 11.09 Favored 'General case' 0 C--O 1.231 0.097 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 179.078 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -133.88 178.19 7.14 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-O 120.742 0.306 . . . . 0.0 111.311 -179.415 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.864 ' CD1' HD12 ' A' ' 69' ' ' LEU . 8.7 tp -106.56 133.23 51.56 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.101 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.9 pt -111.26 107.4 22.85 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-O 120.752 0.311 . . . . 0.0 111.164 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -150.94 135.22 16.91 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.086 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.509 ' HB3' ' HD2' ' A' ' 48' ' ' LYS . . . 54.95 38.58 30.69 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.209 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 52.91 29.07 33.68 Favored Glycine 0 CA--C 1.522 0.51 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.941 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.509 ' HD2' ' HB3' ' A' ' 46' ' ' ALA . 14.4 mttm -110.47 102.24 10.87 Favored 'General case' 0 N--CA 1.457 -0.102 0 CA-C-N 117.016 0.408 . . . . 0.0 110.89 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -89.12 90.61 8.46 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.681 0.277 . . . . 0.0 110.89 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.684 HD12 ' HB ' ' A' ' 23' ' ' ILE . 0.6 OUTLIER -79.34 65.81 4.62 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.123 179.952 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -89.51 -42.09 11.66 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-O 120.607 0.241 . . . . 0.0 111.103 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -47.34 -69.29 0.13 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.742 0.306 . . . . 0.0 111.203 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.406 ' HA2' HG22 ' A' ' 23' ' ' ILE . . . 158.26 56.61 0.01 OUTLIER Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.681 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -106.02 177.49 4.84 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.591 0.234 . . . . 0.0 110.861 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.607 HG23 ' H ' ' A' ' 58' ' ' ASP . 9.9 t -99.1 154.87 17.78 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.711 0.291 . . . . 0.0 110.86 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.794 ' HA ' HD12 ' A' ' 61' ' ' ILE . 1.4 mp -59.31 -46.78 87.64 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.061 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.1 t -53.27 -39.15 63.68 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.484 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.607 ' H ' HG23 ' A' ' 55' ' ' THR . 45.2 t0 -53.9 -30.23 45.23 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 111.659 0.244 . . . . 0.0 111.659 -179.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.425 ' CD1' ' HD3' ' A' ' 48' ' ' LYS . 5.1 m-85 -101.99 40.36 1.34 Allowed 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 120.659 0.266 . . . . 0.0 111.601 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 54.84 27.34 8.83 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 179.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.794 HD12 ' HA ' ' A' ' 56' ' ' LEU . 27.6 mt -89.64 101.31 12.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-O 120.643 0.259 . . . . 0.0 110.858 179.555 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -94.97 166.22 12.05 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.782 0.325 . . . . 0.0 111.223 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -50.23 151.06 2.2 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.259 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 62.67 22.13 13.15 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.593 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.2 m -75.71 170.03 16.97 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-O 120.68 0.276 . . . . 0.0 110.815 179.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.05 111.76 23.84 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.393 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 1.058 HD11 HG13 ' A' ' 5' ' ' VAL . 2.1 pp -98.72 116.53 31.15 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.791 0.329 . . . . 0.0 111.53 -179.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.426 ' CE1' ' HG2' ' A' ' 6' ' ' LYS . 0.1 OUTLIER -107.29 109.82 21.69 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.581 179.539 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.864 HD12 ' CD1' ' A' ' 43' ' ' LEU . 0.1 OUTLIER -93.9 179.71 5.25 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.958 -179.846 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -109.13 -178.2 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.62 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.1 mt -76.76 134.95 38.99 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.664 0.268 . . . . 0.0 110.782 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.602 ' CB ' HD12 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -88.61 -28.98 20.32 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.569 -179.843 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.7 tp -70.6 -51.43 28.24 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.711 0.291 . . . . 0.0 110.771 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.9 mtt85 -90.12 168.1 12.22 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.85 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 141.67 155.14 6.36 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.526 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.081 0 CA-C-O 118.377 -1.235 . . . . 0.0 112.517 179.968 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.487 1.394 0 CA-C-O 120.634 0.254 . . . . 0.0 111.242 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -94.97 132.28 39.99 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.532 -0.303 . . . . 0.0 110.945 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.641 HD11 HD21 ' A' ' 67' ' ' LEU . 15.1 tt -138.92 157.1 28.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.915 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -118.44 102.99 9.34 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.83 0.348 . . . . 0.0 110.864 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.875 HG22 HD11 ' A' ' 67' ' ' LEU . 11.8 t -122.22 151.42 25.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.121 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.761 ' O ' HD11 ' A' ' 69' ' ' LEU . 0.1 OUTLIER -106.83 135.12 48.91 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.854 179.957 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.75 -147.28 0.34 Allowed 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.331 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.501 ' HG ' HG23 ' A' ' 9' ' ' THR . 2.5 tp -68.43 -53.99 20.02 Favored 'General case' 0 C--N 1.342 0.282 0 CA-C-O 120.921 0.391 . . . . 0.0 110.75 -179.503 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.501 HG23 ' HG ' ' A' ' 8' ' ' LEU . 12.3 p -101.57 39.07 1.49 Allowed 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.304 -179.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 55.24 38.68 68.68 Favored Glycine 0 C--N 1.334 0.435 0 C-N-CA 120.817 -0.706 . . . . 0.0 113.133 179.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.9 ttmt -84.16 141.63 30.92 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 117.062 0.431 . . . . 0.0 110.556 179.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.41 HG23 ' O ' ' A' ' 12' ' ' THR . 14.9 t -92.95 121.99 34.85 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.64 0.257 . . . . 0.0 111.138 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.7 pt -125.13 136.06 62.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.954 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -98.87 130.31 45.27 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.903 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.9 pp -138.08 151.86 48.23 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.521 -0.308 . . . . 0.0 110.951 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -101.13 156.22 17.55 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.938 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 22.2 t -136.16 113.51 14.03 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.126 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -107.0 165.84 12.15 Favored Pre-proline 0 C--N 1.332 -0.166 0 CA-C-O 120.787 0.327 . . . . 0.0 110.855 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.49 -30.0 52.77 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.66 2.24 . . . . 0.0 112.535 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 82.1 p -78.74 -32.47 46.72 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.802 -0.181 . . . . 0.0 111.232 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -64.89 121.23 14.14 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.659 0.266 . . . . 0.0 110.74 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.05 149.82 25.3 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.02 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.812 HG22 ' O ' ' A' ' 54' ' ' ARG . 4.1 tt -68.06 -29.35 44.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.541 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.0 tm-20 -53.06 -60.32 3.43 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.73 0.3 . . . . 0.0 111.107 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 36.9 m-20 -74.85 44.09 0.21 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.857 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 14.6 p -69.12 -40.17 80.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.562 0.22 . . . . 0.0 111.144 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.8 mptt -66.07 -44.71 83.7 Favored 'General case' 0 N--CA 1.461 0.108 0 CA-C-O 120.669 0.271 . . . . 0.0 110.816 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.29 -40.85 98.53 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.053 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.88 -41.11 97.82 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.866 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.424 HD13 HE22 ' A' ' 41' ' ' GLN . 31.9 mt -75.03 -42.61 45.51 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.952 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -55.04 -37.82 67.19 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.702 0.287 . . . . 0.0 110.977 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.56 -16.12 44.97 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 112.16 0.429 . . . . 0.0 112.16 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 12.6 mmtt -74.79 -34.72 62.47 Favored 'General case' 0 N--CA 1.461 0.087 0 O-C-N 122.207 -0.308 . . . . 0.0 111.188 -179.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -167.11 -45.82 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 121.013 -0.275 . . . . 0.0 111.576 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 137.14 80.22 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.453 -0.88 . . . . 0.0 112.329 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.718 HD13 ' NE2' ' A' ' 41' ' ' GLN . 9.3 tt -78.35 113.29 32.72 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-O 120.565 0.221 . . . . 0.0 111.106 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.51 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 51.2 Cg_exo -53.36 -51.28 11.32 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.676 2.251 . . . . 0.0 113.291 -179.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.51 ' HD2' ' N ' ' A' ' 37' ' ' PRO . 31.6 Cg_endo -65.65 86.19 0.22 Allowed 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 121.975 1.783 . . . . 0.0 112.363 -179.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.31 -21.55 64.76 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.409 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 29.2 mt-30 -100.2 36.17 1.92 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 120.478 0.18 . . . . 0.0 111.421 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.718 ' NE2' HD13 ' A' ' 36' ' ' ILE . 1.7 pt20 -88.23 131.25 34.83 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.576 0.227 . . . . 0.0 110.704 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.3 mtt180 -137.89 169.02 18.51 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.694 0.283 . . . . 0.0 111.061 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.63 ' CD1' HD22 ' A' ' 67' ' ' LEU . 49.6 mt -99.67 151.29 21.38 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.919 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.644 HG22 ' O ' ' A' ' 68' ' ' HIS . 4.8 tt -110.99 84.16 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 CA-C-O 120.765 0.317 . . . . 0.0 111.092 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -150.89 131.75 14.15 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.204 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.7 25.74 15.52 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.741 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 44.51 36.83 4.64 Favored Glycine 0 C--N 1.337 0.637 0 C-N-CA 120.777 -0.725 . . . . 0.0 113.081 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.1 mmpm? -110.06 136.46 49.27 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.835 0.317 . . . . 0.0 111.06 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.7 tp60 -89.12 162.98 15.66 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.931 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.686 HD13 HG12 ' A' ' 23' ' ' ILE . 4.2 mm? -80.48 19.57 0.78 Allowed 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -89.04 -41.23 12.45 Favored 'General case' 0 CA--C 1.529 0.155 0 O-C-N 122.038 -0.414 . . . . 0.0 111.171 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -48.28 114.51 0.96 Allowed 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 120.637 0.256 . . . . 0.0 110.325 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -69.97 50.43 0.71 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.411 -0.9 . . . . 0.0 112.467 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.812 ' O ' HG22 ' A' ' 23' ' ' ILE . 2.3 mmt180 -104.52 -178.72 3.74 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-N 116.946 0.373 . . . . 0.0 110.926 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.8 m -94.74 149.0 21.7 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.771 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.811 ' O ' HG22 ' A' ' 61' ' ' ILE . 0.4 OUTLIER -54.73 -47.33 73.92 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.988 -179.937 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.0 p -52.38 -30.26 28.14 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.36 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -53.91 -28.52 37.21 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 111.522 0.193 . . . . 0.0 111.522 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.504 ' CE2' HD13 ' A' ' 23' ' ' ILE . 61.7 m-85 -98.11 24.32 7.23 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 61.4 21.85 12.34 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 179.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.811 HG22 ' O ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -89.56 92.47 3.97 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 CA-C-O 120.853 0.359 . . . . 0.0 110.722 179.454 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -101.73 176.28 5.27 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.141 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.32 145.85 5.8 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.311 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 64.54 21.86 12.54 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.833 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 54.3 p -75.67 149.41 38.15 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 120.734 0.302 . . . . 0.0 110.996 179.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.5 m -107.09 90.2 3.23 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.553 179.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.875 HD11 HG22 ' A' ' 5' ' ' VAL . 0.5 OUTLIER -109.34 135.23 50.74 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.869 0.366 . . . . 0.0 111.261 -179.813 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.644 ' O ' HG22 ' A' ' 44' ' ' ILE . 16.4 m80 -107.34 142.07 37.72 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.715 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.761 HD11 ' O ' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -104.76 158.36 16.56 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.693 0.283 . . . . 0.0 111.159 179.69 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.3 p -114.1 152.43 15.77 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.927 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.7 mp -81.09 90.06 6.0 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.84 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.63 46.31 1.19 Allowed 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.366 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.8 mt -80.38 -44.58 19.16 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.66 0.266 . . . . 0.0 110.759 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 16.5 ttm180 -90.1 107.76 19.32 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.899 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -98.21 62.22 0.89 Allowed Glycine 0 C--N 1.332 0.36 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.495 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.088 0 CA-C-O 118.421 -1.21 . . . . 0.0 112.506 179.975 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.606 ' HB2' HG23 ' A' ' 14' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.565 0.222 . . . . 0.0 111.143 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.8 mp0 -84.94 -17.12 38.75 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -179.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.507 HD12 ' CG2' ' A' ' 5' ' ' VAL . 14.5 pt -138.66 177.27 5.28 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.108 0 CA-C-O 120.71 0.291 . . . . 0.0 111.306 -179.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -118.88 101.31 7.96 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.703 0.287 . . . . 0.0 110.826 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.687 HG13 HD13 ' A' ' 69' ' ' LEU . 22.0 t -114.96 149.56 17.14 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.132 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 9.2 mmtt -106.92 130.72 54.54 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.9 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.43 -166.6 1.36 Allowed 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.271 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.932 HD13 ' HD3' ' A' ' 37' ' ' PRO . 0.6 OUTLIER -66.98 -43.39 83.14 Favored 'General case' 0 C--N 1.339 0.128 0 CA-C-O 120.8 0.333 . . . . 0.0 111.183 -178.79 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.427 ' N ' ' HG ' ' A' ' 8' ' ' LEU . 1.3 p -111.27 40.36 2.09 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.035 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 55.24 39.96 73.51 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.681 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.06 163.23 20.0 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.783 0.292 . . . . 0.0 110.898 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -103.04 122.8 45.39 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.864 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.666 HD11 HG11 ' A' ' 5' ' ' VAL . 10.6 pt -124.99 151.5 30.68 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-O 120.703 0.287 . . . . 0.0 111.234 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.606 HG23 ' HB2' ' A' ' 1' ' ' MET . 16.7 m -105.75 130.55 53.73 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.793 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.489 ' CB ' HD11 ' A' ' 3' ' ' ILE . 0.3 OUTLIER -137.56 130.31 30.04 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.576 -0.283 . . . . 0.0 110.984 179.98 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -100.95 175.05 5.74 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.77 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.7 HG11 ' HA ' ' A' ' 62' ' ' GLN . 26.1 t -132.81 108.99 13.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 120.81 0.338 . . . . 0.0 111.272 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.413 ' HB2' ' HD2' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -107.05 158.21 33.49 Favored Pre-proline 0 C--N 1.333 -0.15 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.498 179.811 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.413 ' HD2' ' HB2' ' A' ' 18' ' ' GLU . 3.7 Cg_endo -46.49 -53.36 6.12 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.627 2.218 . . . . 0.0 112.059 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.9 p -90.42 41.16 1.04 Allowed 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.636 ' OD1' HD12 ' A' ' 56' ' ' LEU . 13.8 t70 -74.56 94.89 2.7 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.65 0.262 . . . . 0.0 110.976 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.21 128.7 34.78 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.658 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.744 HD12 ' C ' ' A' ' 54' ' ' ARG . 7.1 mt -57.83 -35.04 49.82 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.329 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -71.33 -41.3 70.02 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.608 0.242 . . . . 0.0 111.08 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -73.02 -41.89 63.77 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.242 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.434 HG21 HD21 ' A' ' 15' ' ' LEU . 12.3 p -63.78 -36.23 75.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-N 116.759 -0.2 . . . . 0.0 111.285 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.735 ' HA ' HD12 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -55.82 -41.15 73.79 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.621 0.248 . . . . 0.0 110.888 179.912 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.95 -34.85 70.35 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.322 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 16.8 mtpt -63.68 -43.09 97.69 Favored 'General case' 0 CA--C 1.527 0.092 0 CA-C-O 120.633 0.254 . . . . 0.0 110.822 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.735 HD12 ' HA ' ' A' ' 27' ' ' LYS . 3.4 mt -66.47 -49.32 76.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 CA-C-O 120.702 0.287 . . . . 0.0 110.735 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 1.9 tp60 -65.16 -25.91 67.94 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.185 179.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -51.05 -31.23 17.93 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.64 -24.83 49.39 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 121.162 -0.215 . . . . 0.0 111.45 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 70.61 33.73 2.29 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.673 0.273 . . . . 0.0 110.704 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.479 ' O ' HD22 ' A' ' 8' ' ' LEU . . . -89.96 -39.99 5.99 Favored Glycine 0 C--N 1.334 0.454 0 C-N-CA 120.518 -0.849 . . . . 0.0 112.596 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.519 HG22 ' HD2' ' A' ' 38' ' ' PRO . 4.6 mt -89.33 110.08 36.04 Favored Pre-proline 0 CA--C 1.531 0.224 0 CA-C-N 116.656 0.228 . . . . 0.0 111.163 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.932 ' HD3' HD13 ' A' ' 8' ' ' LEU . 33.8 Cg_exo -57.65 -46.9 23.96 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.374 2.049 . . . . 0.0 113.077 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.519 ' HD2' HG22 ' A' ' 36' ' ' ILE . 60.6 Cg_endo -74.11 120.21 6.2 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.224 1.949 . . . . 0.0 112.894 -179.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -68.75 -18.83 64.28 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.19 179.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -93.01 34.02 1.13 Allowed 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 111.492 0.182 . . . . 0.0 111.492 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.52 ' O ' HD22 ' A' ' 50' ' ' LEU . 7.9 tp-100 -82.35 111.79 18.73 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 179.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.678 ' CB ' HD13 ' A' ' 50' ' ' LEU . 7.1 ptt180 -139.67 178.79 6.98 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.885 -179.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.74 HD22 HD21 ' A' ' 67' ' ' LEU . 0.7 OUTLIER -97.84 166.46 11.46 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.875 179.949 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.625 HG23 ' O ' ' A' ' 44' ' ' ILE . 18.0 tt -109.47 89.14 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.158 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.472 ' HB2' HD12 ' A' ' 43' ' ' LEU . 1.3 t80 -150.83 109.09 3.75 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.153 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.34 33.68 18.79 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.556 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 46.23 45.33 15.64 Favored Glycine 0 C--N 1.336 0.541 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.97 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.417 ' HE2' ' CE1' ' A' ' 59' ' ' TYR . 26.1 tptt -101.42 129.92 47.54 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.803 0.302 . . . . 0.0 110.93 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -89.15 158.25 17.99 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.974 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.678 HD13 ' CB ' ' A' ' 42' ' ' ARG . 3.1 mp -79.22 -34.84 42.5 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.166 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -78.97 -10.46 59.83 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 111.678 0.251 . . . . 0.0 111.678 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -47.07 -42.81 19.39 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.66 0.267 . . . . 0.0 111.227 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.77 37.52 5.75 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.767 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.744 ' C ' HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -107.14 174.93 5.67 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.848 0.324 . . . . 0.0 110.728 179.783 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.494 HG22 ' H ' ' A' ' 57' ' ' SER . 49.8 m -99.19 135.25 40.87 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.814 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.697 HD22 HG21 ' A' ' 61' ' ' ILE . 14.5 mt -52.24 -38.14 57.22 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.011 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.494 ' H ' HG22 ' A' ' 55' ' ' THR . 8.0 t -61.31 -31.49 71.34 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.647 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -53.73 -37.83 63.74 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 121.207 -0.197 . . . . 0.0 111.418 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.417 ' CE1' ' HE2' ' A' ' 48' ' ' LYS . 6.1 m-85 -103.62 34.32 3.02 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 120.511 0.196 . . . . 0.0 111.439 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 54.8 28.0 9.69 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 179.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.697 HG21 HD22 ' A' ' 56' ' ' LEU . 28.2 mt -89.48 73.49 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.123 0 CA-C-O 120.768 0.318 . . . . 0.0 110.885 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.7 ' HA ' HG11 ' A' ' 17' ' ' VAL . 4.3 mm-40 -94.8 177.81 5.78 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.058 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.4 ' HA ' HG21 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -50.23 147.22 4.38 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.863 0.363 . . . . 0.0 111.276 -179.758 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 63.66 20.73 12.38 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.779 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.8 m -75.83 176.74 7.51 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-O 120.63 0.253 . . . . 0.0 110.951 179.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.621 ' O ' HG23 ' A' ' 66' ' ' THR . 10.5 t -101.44 82.96 2.38 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.472 179.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.74 HD21 HD22 ' A' ' 43' ' ' LEU . 0.3 OUTLIER -98.95 108.61 21.34 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.128 -179.626 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.9 m170 -107.13 124.34 49.55 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.659 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.687 HD13 HG13 ' A' ' 5' ' ' VAL . 5.4 mp -93.9 149.27 21.38 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.887 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.6 t -104.1 144.09 14.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.03 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.4 mt -78.77 84.91 4.8 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.908 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 16.4 mmt-85 -92.93 62.53 3.66 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.674 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.6 pp -80.77 3.92 20.75 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -79.46 136.52 36.95 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-O 120.773 0.32 . . . . 0.0 110.904 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 126.74 60.37 0.14 Allowed Glycine 0 C--N 1.334 0.419 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.374 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.317 -1.268 . . . . 0.0 112.562 -179.92 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.737 ' HB3' HG22 ' A' ' 14' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.417 0 CA-C-O 120.577 0.227 . . . . 0.0 111.135 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 -95.04 1.78 55.15 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -179.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.614 HG12 HG23 ' A' ' 5' ' ' VAL . 14.7 tt -138.91 154.96 26.68 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 O-C-N 122.33 -0.231 . . . . 0.0 111.118 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.83 81.63 1.73 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.719 0.295 . . . . 0.0 110.766 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.614 HG23 HG12 ' A' ' 3' ' ' ILE . 16.6 t -109.2 153.63 10.9 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.969 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.93 138.67 42.65 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.681 0.277 . . . . 0.0 111.046 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.567 HG21 ' HB3' ' A' ' 11' ' ' LYS . 6.0 p -99.9 -167.44 1.46 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.215 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.473 HD22 ' NE ' ' A' ' 72' ' ' ARG . 0.5 OUTLIER -60.36 -35.36 75.51 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.963 -179.814 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.53 -66.57 1.07 Allowed 'General case' 0 C--O 1.231 0.111 0 CA-C-O 120.827 0.346 . . . . 0.0 110.382 179.396 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 171.45 46.03 0.04 OUTLIER Glycine 0 CA--C 1.522 0.48 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.917 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.567 ' HB3' HG21 ' A' ' 7' ' ' THR . 0.5 OUTLIER -84.93 164.14 18.53 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.89 0.345 . . . . 0.0 111.071 179.993 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.1 p -103.17 123.57 46.96 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.48 179.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.3 tt -114.94 140.85 34.01 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.107 0 CA-C-O 120.736 0.303 . . . . 0.0 111.275 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.737 HG22 ' HB3' ' A' ' 1' ' ' MET . 17.0 p -106.03 119.51 39.39 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.784 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.525 HD12 HG21 ' A' ' 3' ' ' ILE . 5.0 mt -138.03 145.39 41.77 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.941 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -100.99 164.69 11.69 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.853 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.714 HG13 HD11 ' A' ' 56' ' ' LEU . 24.7 t -129.89 106.11 12.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.031 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.414 ' HB2' ' HD2' ' A' ' 19' ' ' PRO . 0.5 OUTLIER -102.09 163.32 17.97 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.812 179.966 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.414 ' HD2' ' HB2' ' A' ' 18' ' ' GLU . 53.5 Cg_exo -52.67 -48.74 20.36 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.452 2.101 . . . . 0.0 112.189 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.3 p -90.28 34.19 0.88 Allowed 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.778 ' CG ' HD21 ' A' ' 56' ' ' LEU . 18.0 t0 -75.31 106.65 6.95 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.727 0.299 . . . . 0.0 110.73 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.4 m -85.16 142.61 29.35 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.033 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.43 HG13 HD12 ' A' ' 50' ' ' LEU . 9.5 tp -68.05 -23.78 29.38 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.763 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -86.02 -33.96 20.91 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 120.477 0.179 . . . . 0.0 111.298 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -62.83 -38.93 92.71 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.522 0.201 . . . . 0.0 111.29 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.9 p -63.78 -31.1 51.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-N 116.754 -0.203 . . . . 0.0 111.444 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.668 ' CG ' HD23 ' A' ' 50' ' ' LEU . 14.7 tttt -56.0 -43.38 77.63 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.715 0.293 . . . . 0.0 110.823 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.86 -30.89 71.94 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.345 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.6 mttm -63.82 -39.4 94.15 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 120.567 0.222 . . . . 0.0 110.89 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 38.0 mm -64.98 -46.92 90.12 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 CA-C-O 120.698 0.285 . . . . 0.0 110.555 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.32 -42.88 92.54 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.588 179.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -61.25 -22.98 65.32 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.727 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.78 -44.36 50.02 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-O 120.73 0.3 . . . . 0.0 110.795 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -136.78 -50.61 0.66 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.131 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.432 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . 116.93 67.41 0.38 Allowed Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.931 -179.598 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.6 HG23 ' O ' ' A' ' 36' ' ' ILE . 19.8 tt -78.45 110.1 12.71 Favored Pre-proline 0 CA--C 1.531 0.249 0 CA-C-O 120.679 0.276 . . . . 0.0 111.368 -179.432 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.49 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 35.2 Cg_exo -60.29 -45.92 20.62 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.61 2.206 . . . . 0.0 113.212 -179.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.49 ' HD2' ' N ' ' A' ' 37' ' ' PRO . 58.1 Cg_exo -39.12 95.09 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.866 2.378 . . . . 0.0 113.221 -179.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -68.76 -17.57 64.06 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.405 179.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -93.5 30.98 1.61 Allowed 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 111.779 0.289 . . . . 0.0 111.779 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.431 ' CD ' HD21 ' A' ' 69' ' ' LEU . 1.8 tt0 -82.64 116.07 21.87 Favored 'General case' 0 CA--C 1.528 0.105 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 179.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.44 168.23 20.21 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.683 0.278 . . . . 0.0 111.387 -179.256 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -103.96 167.51 9.72 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.711 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.671 HG22 ' O ' ' A' ' 68' ' ' HIS . 8.0 tt -111.04 74.14 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.732 0.301 . . . . 0.0 111.129 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -150.91 112.57 4.46 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.343 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.6 ' HB1' ' CE1' ' A' ' 59' ' ' TYR . . . 59.75 25.44 14.44 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.849 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 43.45 45.63 6.79 Favored Glycine 0 C--N 1.337 0.595 0 C-N-CA 120.861 -0.685 . . . . 0.0 113.09 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.01 135.65 41.11 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.794 0.297 . . . . 0.0 110.898 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -89.1 161.06 16.73 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.963 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.668 HD23 ' CG ' ' A' ' 27' ' ' LYS . 1.3 tp -79.09 -20.4 48.84 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.533 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -78.62 -40.82 33.3 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-O 120.535 0.207 . . . . 0.0 111.065 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.418 ' O ' ' N ' ' A' ' 54' ' ' ARG . 0.5 OUTLIER -48.0 119.0 2.61 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 179.538 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.86 53.91 0.37 Allowed Glycine 0 CA--C 1.521 0.419 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.875 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.418 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -107.16 164.69 11.95 Favored 'General case' 0 CA--C 1.527 0.093 0 CA-C-N 117.01 0.405 . . . . 0.0 110.725 179.814 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.566 HG22 ' H ' ' A' ' 57' ' ' SER . 71.1 m -99.17 131.41 45.23 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.708 0.289 . . . . 0.0 110.666 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.778 HD21 ' CG ' ' A' ' 21' ' ' ASP . 0.3 OUTLIER -51.39 -33.58 30.67 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.699 -0.228 . . . . 0.0 111.007 -179.951 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.566 ' H ' HG22 ' A' ' 55' ' ' THR . 12.6 t -63.36 -36.29 83.22 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 111.713 0.264 . . . . 0.0 111.713 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.406 ' OD1' ' CD2' ' A' ' 59' ' ' TYR . 1.5 p30 -55.81 -31.67 62.88 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -179.18 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.6 ' CE1' ' HB1' ' A' ' 46' ' ' ALA . 4.5 m-85 -103.97 29.71 5.69 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 121.077 -0.249 . . . . 0.0 111.597 -179.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 65.15 12.97 8.41 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 179.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.697 ' O ' HD12 ' A' ' 56' ' ' LEU . 21.4 mt -89.91 62.93 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 O-C-N 122.17 -0.332 . . . . 0.0 110.692 179.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -104.19 -173.06 2.22 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.301 -179.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.3 ttpt -46.64 139.57 5.1 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.847 0.356 . . . . 0.0 111.388 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 65.26 15.77 10.18 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.134 -0.484 . . . . 0.0 112.196 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 40.3 t -76.05 -177.39 3.9 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 120.655 0.264 . . . . 0.0 110.67 179.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.33 91.58 3.77 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.515 -0.312 . . . . 0.0 110.409 179.457 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.42 HD11 ' CG2' ' A' ' 61' ' ' ILE . 3.8 mp -98.72 102.44 14.18 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.745 0.307 . . . . 0.0 111.23 -179.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.671 ' O ' HG22 ' A' ' 44' ' ' ILE . 0.3 OUTLIER -107.12 109.33 21.14 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.625 179.737 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.431 HD21 ' CD ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -94.04 179.44 5.33 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.929 -179.906 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.9 m -103.77 172.41 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.115 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.99 145.12 38.27 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.823 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.473 ' NE ' HD22 ' A' ' 8' ' ' LEU . 16.1 ptt180 -93.06 176.54 6.38 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.995 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -80.09 -35.5 36.81 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.164 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.78 128.73 33.79 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.718 0.294 . . . . 0.0 110.914 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 139.64 -42.08 1.26 Allowed Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.492 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.092 0 CA-C-O 118.299 -1.279 . . . . 0.0 112.546 179.946 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.6 ttt . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.66 0.267 . . . . 0.0 111.294 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 53.0 mm-40 -91.9 -42.01 10.28 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.005 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.487 HD11 ' HB3' ' A' ' 15' ' ' LEU . 2.4 pt -138.8 176.24 6.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-N 116.669 -0.242 . . . . 0.0 111.076 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -118.83 101.16 7.86 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.744 0.307 . . . . 0.0 110.907 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.485 ' CG2' HD13 ' A' ' 69' ' ' LEU . 11.1 p -136.19 138.37 47.21 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.746 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -107.28 168.74 9.01 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.878 0.37 . . . . 0.0 111.305 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.6 p -99.93 -168.27 1.57 Allowed 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.446 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.55 -22.48 66.98 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 120.933 -0.307 . . . . 0.0 111.563 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.2 t -100.56 -10.75 20.7 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.65 30.13 8.76 Favored Glycine 0 C--N 1.336 0.554 0 C-N-CA 120.507 -0.854 . . . . 0.0 113.111 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.6 tttm -84.29 170.28 13.83 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-N 117.161 0.481 . . . . 0.0 110.714 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.468 HG23 ' O ' ' A' ' 12' ' ' THR . 14.0 t -103.1 118.0 35.82 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.583 -0.281 . . . . 0.0 110.873 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.472 HG13 HG13 ' A' ' 5' ' ' VAL . 22.8 pt -125.18 157.55 33.9 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 CA-C-O 120.677 0.275 . . . . 0.0 111.211 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.4 p -106.03 125.82 51.45 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.838 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.487 ' HB3' HD11 ' A' ' 3' ' ' ILE . 0.3 OUTLIER -129.16 145.78 51.23 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.885 179.965 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -101.06 152.43 20.61 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.786 0.326 . . . . 0.0 110.809 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 24.2 t -133.51 132.16 57.49 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.044 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -107.1 159.95 28.17 Favored Pre-proline 0 C--N 1.332 -0.169 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.784 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -50.68 -49.93 15.26 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.465 2.11 . . . . 0.0 112.218 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 p -90.22 36.74 0.88 Allowed 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.0 p-10 -69.13 103.82 2.0 Allowed 'General case' 0 C--O 1.231 0.11 0 O-C-N 122.199 -0.313 . . . . 0.0 110.744 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.3 p -85.09 134.09 34.2 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.979 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.895 HD13 ' HE2' ' A' ' 48' ' ' LYS . 3.9 tp -65.06 -36.98 79.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.315 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -48.09 -51.64 23.69 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.612 0.244 . . . . 0.0 111.069 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.532 ' OD1' ' HB3' ' A' ' 28' ' ' ALA . 0.8 OUTLIER -74.78 43.63 0.2 Allowed 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 111.779 0.288 . . . . 0.0 111.779 179.632 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.531 ' O ' HG22 ' A' ' 30' ' ' ILE . 13.9 p -74.06 -39.52 50.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 CA-C-O 120.626 0.25 . . . . 0.0 111.298 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.487 ' HA ' HG22 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -55.94 -44.14 78.11 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.72 0.295 . . . . 0.0 110.936 179.913 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.532 ' HB3' ' OD1' ' A' ' 25' ' ' ASN . . . -64.27 -42.68 96.32 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.103 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 21.3 mtmm -70.82 -45.63 64.24 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.948 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.543 HG21 ' OE1' ' A' ' 41' ' ' GLN . 10.8 tp -70.34 -36.53 67.34 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.266 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.7 tm0? -59.33 -24.6 63.47 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.773 -0.194 . . . . 0.0 111.069 179.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -50.99 -25.21 4.41 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.59 -39.94 61.91 Favored 'General case' 0 C--O 1.231 0.089 0 C-N-CA 120.936 -0.306 . . . . 0.0 110.564 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 176.51 -39.17 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.716 0.294 . . . . 0.0 111.453 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.557 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . 131.94 80.49 0.19 Allowed Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.748 -179.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.613 HG23 ' O ' ' A' ' 36' ' ' ILE . 11.2 tt -77.68 106.1 3.42 Favored Pre-proline 0 N--CA 1.466 0.349 0 CA-C-O 120.799 0.333 . . . . 0.0 111.582 -179.19 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.639 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 17.1 Cg_exo -68.59 -35.6 16.72 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 123.03 2.486 . . . . 0.0 115.13 -179.081 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.639 ' HD2' ' N ' ' A' ' 37' ' ' PRO . 15.8 Cg_endo -60.52 113.45 1.7 Allowed 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 121.678 1.585 . . . . 0.0 113.393 -178.343 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -70.28 5.35 1.75 Allowed 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.399 179.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -89.73 8.74 30.17 Favored 'General case' 0 CA--C 1.53 0.199 0 O-C-N 122.088 -0.383 . . . . 0.0 111.4 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.543 ' OE1' HG21 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -82.59 99.41 9.53 Favored 'General case' 0 CA--C 1.527 0.08 0 CA-C-O 120.776 0.322 . . . . 0.0 110.453 179.41 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.77 169.74 16.61 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.971 -179.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.889 HD21 ' CD2' ' A' ' 67' ' ' LEU . 0.2 OUTLIER -97.99 140.74 31.88 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.796 179.883 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.564 HG23 ' O ' ' A' ' 44' ' ' ILE . 3.7 tt -107.83 65.08 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 120.793 0.33 . . . . 0.0 111.102 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -150.89 121.07 7.23 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.737 0.303 . . . . 0.0 111.219 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.93 25.59 15.56 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.787 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 45.13 55.71 6.41 Favored Glycine 0 C--N 1.338 0.65 0 C-N-CA 120.836 -0.697 . . . . 0.0 113.039 179.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.895 ' HE2' HD13 ' A' ' 23' ' ' ILE . 0.3 OUTLIER -102.03 135.01 44.34 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.702 0.287 . . . . 0.0 110.96 -179.934 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -89.09 154.17 20.4 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.872 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.629 HD12 ' N ' ' A' ' 51' ' ' GLU . 4.5 pp -69.78 -39.44 76.64 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.06 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.629 ' N ' HD12 ' A' ' 50' ' ' LEU . 0.0 OUTLIER -89.76 10.97 21.44 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 179.929 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -47.06 -45.68 21.86 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.683 0.278 . . . . 0.0 111.194 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.39 8.12 56.52 Favored Glycine 0 CA--C 1.523 0.589 0 C-N-CA 120.591 -0.814 . . . . 0.0 113.292 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.471 ' O ' HG22 ' A' ' 23' ' ' ILE . 3.0 mmm180 -107.09 -177.61 3.41 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 117.326 0.563 . . . . 0.0 110.702 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.657 HG22 ' OD2' ' A' ' 58' ' ' ASP . 9.6 t -99.27 150.26 22.28 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.74 0.305 . . . . 0.0 110.71 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.4 mt -61.48 -39.82 92.31 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.734 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.7 t -58.62 -32.07 68.67 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.637 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.657 ' OD2' HG22 ' A' ' 55' ' ' THR . 3.1 m-20 -53.94 -35.03 61.28 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 121.13 -0.228 . . . . 0.0 111.476 -179.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -103.82 31.75 4.29 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 120.474 0.178 . . . . 0.0 111.401 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 65.18 14.0 9.1 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 47.6 mt -90.01 68.32 0.59 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.139 0 CA-C-O 120.743 0.306 . . . . 0.0 110.809 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -98.87 -178.46 3.97 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.187 -179.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.4 145.81 3.21 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.801 0.334 . . . . 0.0 111.409 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 65.55 13.88 9.15 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.234 -0.439 . . . . 0.0 112.179 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 39.5 t -76.16 -177.48 4.0 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-O 120.634 0.254 . . . . 0.0 110.71 179.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.7 m -100.9 83.65 2.57 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.314 179.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.889 ' CD2' HD21 ' A' ' 43' ' ' LEU . 7.8 tt -98.83 111.22 23.67 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.751 0.31 . . . . 0.0 111.365 -179.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 17.6 t60 -107.11 125.81 51.55 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.599 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.485 HD13 ' CG2' ' A' ' 5' ' ' VAL . 0.2 OUTLIER -96.53 111.14 23.37 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-O 120.732 0.301 . . . . 0.0 111.084 -179.776 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.1 t -114.1 149.94 16.27 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.015 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.1 pp -87.25 100.03 12.39 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.962 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.487 ' NH2' HD12 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -93.15 105.61 17.67 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.864 179.852 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.4 mt -70.79 -48.03 56.41 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.857 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -90.02 122.93 33.47 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.913 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 142.35 63.7 0.03 OUTLIER Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.547 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.338 -1.257 . . . . 0.0 112.55 -179.924 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.583 0.23 . . . . 0.0 111.135 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -93.04 91.28 7.28 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.741 0.305 . . . . 0.0 110.88 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.49 HG21 ' HB3' ' A' ' 15' ' ' LEU . 17.7 tt -138.94 154.14 25.73 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.965 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -118.64 104.37 10.56 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.756 0.312 . . . . 0.0 110.895 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 1.033 HG13 HD23 ' A' ' 67' ' ' LEU . 1.7 t -103.25 163.4 3.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.892 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.8 tppt? -106.62 121.23 43.91 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.758 0.313 . . . . 0.0 110.662 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.404 ' OG1' ' N ' ' A' ' 11' ' ' LYS . 2.7 p -99.82 -176.44 3.26 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.192 -179.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.67 -40.11 88.45 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-O 120.696 0.284 . . . . 0.0 111.591 -178.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -111.04 43.23 1.48 Allowed 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.204 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 45.0 38.03 5.8 Favored Glycine 0 C--N 1.335 0.511 0 C-N-CA 120.95 -0.643 . . . . 0.0 113.291 179.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.404 ' N ' ' OG1' ' A' ' 7' ' ' THR . 7.8 tttt -84.12 144.46 29.01 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.856 0.328 . . . . 0.0 110.791 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.537 HG23 ' O ' ' A' ' 12' ' ' THR . 14.7 t -95.38 110.65 22.65 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.731 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.0 pt -125.09 164.19 24.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.201 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.7 t -100.55 150.64 22.48 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.781 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.49 ' HB3' HG21 ' A' ' 3' ' ' ILE . 0.9 OUTLIER -134.87 100.74 4.68 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.676 0.274 . . . . 0.0 110.963 -179.87 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -96.39 126.46 41.61 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.841 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.1 m -139.26 173.51 11.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.738 0.304 . . . . 0.0 111.272 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.425 ' HB2' ' HD2' ' A' ' 19' ' ' PRO . 0.4 OUTLIER -105.37 158.38 32.34 Favored Pre-proline 0 C--O 1.232 0.162 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.533 179.833 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.566 ' O ' HG21 ' A' ' 55' ' ' THR . 1.5 Cg_endo -44.49 -48.02 10.54 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.825 2.35 . . . . 0.0 112.165 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 87.9 p -90.33 38.89 0.95 Allowed 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 179.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.579 ' OD2' HD23 ' A' ' 56' ' ' LEU . 17.9 p-10 -75.04 116.72 16.09 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.658 0.266 . . . . 0.0 110.912 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.13 169.02 14.3 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.794 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.414 ' O ' HG22 ' A' ' 26' ' ' VAL . 43.7 mm -67.4 -42.04 86.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.862 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -64.56 -40.14 95.02 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.005 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -62.74 -44.77 95.33 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.653 0.263 . . . . 0.0 110.788 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.414 HG22 ' O ' ' A' ' 23' ' ' ILE . 27.7 m -70.26 -18.65 21.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.5 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.6 tptm -55.62 -35.51 65.95 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.504 0.192 . . . . 0.0 111.116 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.67 -38.89 75.9 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.6 0.238 . . . . 0.0 111.05 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.1 mttm -63.95 -36.53 84.26 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.918 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 35.5 mm -64.93 -44.48 96.14 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.078 0 CA-C-O 120.752 0.31 . . . . 0.0 110.61 179.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -57.88 -28.24 64.0 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.864 179.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -51.78 -27.76 13.28 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 7.2 mmtt -74.82 -40.93 60.79 Favored 'General case' 0 C--O 1.23 0.079 0 CA-C-O 120.693 0.282 . . . . 0.0 110.596 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -175.47 -40.89 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.557 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.525 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . 108.87 64.79 0.56 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.544 -0.836 . . . . 0.0 111.632 -179.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.715 HD12 ' HG2' ' A' ' 72' ' ' ARG . 12.0 tt -78.22 107.54 5.83 Favored Pre-proline 0 N--CA 1.465 0.295 0 N-CA-C 111.741 0.274 . . . . 0.0 111.741 -179.085 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.525 ' HD3' ' O ' ' A' ' 35' ' ' GLY . 27.9 Cg_exo -62.49 -43.83 20.58 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.751 2.301 . . . . 0.0 113.578 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.505 ' HD2' ' N ' ' A' ' 37' ' ' PRO . 44.9 Cg_exo -38.03 117.62 0.26 Allowed 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 123.023 2.482 . . . . 0.0 113.685 -179.201 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -69.84 2.32 3.52 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 179.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -89.84 3.45 52.9 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 118.134 0.425 . . . . 0.0 111.803 -179.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 27.2 tp60 -82.88 97.53 8.71 Favored 'General case' 0 C--O 1.232 0.14 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.473 ' O ' HD23 ' A' ' 69' ' ' LEU . 3.0 mtp180 -137.5 -176.31 4.36 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.151 -179.215 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.673 HD23 ' CD2' ' A' ' 50' ' ' LEU . 4.1 mm? -97.4 134.57 40.49 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.623 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 32.1 mt -100.98 83.54 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.406 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -150.94 115.61 5.19 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.018 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.85 35.97 19.17 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.32 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 46.87 36.84 8.86 Favored Glycine 0 C--N 1.336 0.577 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.876 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -110.16 107.61 17.48 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.774 0.287 . . . . 0.0 111.038 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.05 130.68 35.47 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.53 179.618 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.673 ' CD2' HD23 ' A' ' 43' ' ' LEU . 1.3 pp -79.32 62.86 3.79 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.579 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -89.47 -66.32 0.93 Allowed 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.74 0.305 . . . . 0.0 110.414 179.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.456 ' O ' ' N ' ' A' ' 54' ' ' ARG . 19.0 t0 -48.56 125.44 9.86 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.01 179.112 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -65.2 60.7 0.09 OUTLIER Glycine 0 CA--C 1.522 0.52 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.565 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.456 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.3 OUTLIER -107.15 -172.9 2.17 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.94 0.37 . . . . 0.0 110.797 -179.904 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.566 HG21 ' O ' ' A' ' 19' ' ' PRO . 22.4 m -98.39 144.92 27.25 Favored 'General case' 0 N--CA 1.457 -0.11 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.622 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.642 HD12 ' N ' ' A' ' 57' ' ' SER . 3.8 pp -51.78 -40.67 60.76 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.203 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.642 ' N ' HD12 ' A' ' 56' ' ' LEU . 10.5 t -55.19 -52.09 64.45 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.395 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -64.66 -16.0 62.15 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 112.265 0.469 . . . . 0.0 112.265 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -97.8 38.12 1.33 Allowed 'General case' 0 CA--C 1.533 0.311 0 O-C-N 122.174 -0.329 . . . . 0.0 111.885 -179.527 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 66.74 -40.29 0.37 Allowed 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 179.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.514 HD12 ' HB2' ' A' ' 56' ' ' LEU . 1.1 pt -78.64 108.22 11.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.872 0.367 . . . . 0.0 111.328 -179.504 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.24 -174.8 2.69 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.951 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.2 150.68 2.34 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.791 0.329 . . . . 0.0 111.373 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 65.11 19.29 11.76 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.852 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.2 m -75.83 177.69 6.75 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.59 0.233 . . . . 0.0 110.872 179.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.99 114.85 26.5 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.3 179.376 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 1.033 HD23 HG13 ' A' ' 5' ' ' VAL . 4.8 mp -98.98 89.85 4.42 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.673 0.273 . . . . 0.0 111.48 -179.22 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -100.17 95.31 6.73 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.2 179.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.473 HD23 ' O ' ' A' ' 42' ' ' ARG . 0.8 OUTLIER -93.86 177.11 6.1 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.244 -179.426 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.42 HG22 ' N ' ' A' ' 71' ' ' LEU . 12.0 p -103.62 156.62 5.37 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.766 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.42 ' N ' HG22 ' A' ' 70' ' ' VAL . 2.7 mt -76.35 153.27 35.94 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 120.711 0.291 . . . . 0.0 110.939 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.715 ' HG2' HD12 ' A' ' 36' ' ' ILE . 15.2 mtt85 -93.83 26.08 3.32 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.402 HD13 ' HA ' ' A' ' 73' ' ' LEU . 4.4 mm? -80.31 -67.65 0.75 Allowed 'General case' 0 CA--C 1.527 0.093 0 CA-C-O 120.685 0.278 . . . . 0.0 110.795 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 15.6 ttt-85 -90.09 157.75 17.63 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.891 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -142.88 -106.01 0.56 Allowed Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.482 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.331 -1.26 . . . . 0.0 112.533 179.977 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.478 ' HG2' ' HB ' ' A' ' 14' ' ' THR . 5.6 tpt . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.561 0.219 . . . . 0.0 111.002 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.412 ' CB ' ' HG2' ' A' ' 63' ' ' LYS . 3.8 mm-40 -84.54 -6.86 59.4 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 112.484 0.549 . . . . 0.0 112.484 -179.346 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.741 HG22 ' O ' ' A' ' 15' ' ' LEU . 18.6 tt -138.46 147.95 25.01 Favored 'Isoleucine or valine' 0 C--O 1.231 0.1 0 C-N-CA 120.619 -0.432 . . . . 0.0 111.441 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -120.61 94.64 4.43 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.95 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.504 HG11 HD13 ' A' ' 15' ' ' LEU . 13.7 p -103.02 154.77 5.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.854 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 6.4 mmpt? -106.58 145.36 31.99 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.819 0.342 . . . . 0.0 111.022 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.6 p -99.53 -173.37 2.45 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.161 -179.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.425 HD13 ' HG2' ' A' ' 38' ' ' PRO . 1.1 pt? -66.9 -33.43 75.57 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-O 120.688 0.28 . . . . 0.0 110.682 -179.665 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.3 m -107.3 42.22 1.35 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.713 179.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 47.98 32.18 8.76 Favored Glycine 0 CA--C 1.521 0.467 0 C-N-CA 121.1 -0.571 . . . . 0.0 113.403 179.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -84.55 152.95 23.56 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 117.096 0.448 . . . . 0.0 110.788 179.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.4 ' O ' HG23 ' A' ' 12' ' ' THR . 12.2 t -103.14 122.53 44.9 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.716 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.404 ' CG1' ' CG1' ' A' ' 5' ' ' VAL . 38.6 pt -123.07 166.07 18.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 120.829 0.347 . . . . 0.0 111.367 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.478 ' HB ' ' HG2' ' A' ' 1' ' ' MET . 3.5 p -105.96 127.09 52.92 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.647 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.741 ' O ' HG22 ' A' ' 3' ' ' ILE . 0.3 OUTLIER -127.75 139.35 52.73 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-O 120.775 0.321 . . . . 0.0 111.22 -179.97 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -101.19 165.42 11.3 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.638 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.7 t -140.04 125.91 21.49 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-O 120.687 0.279 . . . . 0.0 111.284 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.449 ' HB2' ' HD2' ' A' ' 19' ' ' PRO . 1.7 pt-20 -107.08 158.19 33.55 Favored Pre-proline 0 C--N 1.333 -0.115 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.453 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.449 ' HD2' ' HB2' ' A' ' 18' ' ' GLU . 4.7 Cg_endo -47.1 -56.29 3.17 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.555 2.17 . . . . 0.0 112.124 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 41.6 p -90.45 41.73 1.07 Allowed 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.419 ' HB2' ' O ' ' A' ' 18' ' ' GLU . 8.3 t70 -72.78 111.35 7.84 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.638 0.256 . . . . 0.0 110.989 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.8 m -85.09 149.28 25.66 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.723 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.459 ' O ' HG12 ' A' ' 26' ' ' VAL . 28.7 mt -68.02 -36.82 76.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.285 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -73.92 -40.83 62.85 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 120.564 0.221 . . . . 0.0 110.984 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -67.26 -40.41 86.2 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.682 -0.235 . . . . 0.0 111.126 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.459 HG12 ' O ' ' A' ' 23' ' ' ILE . 12.1 p -63.83 -33.81 64.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-N 116.703 -0.226 . . . . 0.0 111.367 -179.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.799 ' HE3' HD13 ' A' ' 50' ' ' LEU . 0.4 OUTLIER -55.81 -45.37 78.29 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.724 0.297 . . . . 0.0 110.814 179.961 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.04 -30.26 69.45 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.367 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.5 ttmp? -63.69 -41.27 98.16 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 120.594 0.235 . . . . 0.0 110.899 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.508 HD12 ' HA ' ' A' ' 27' ' ' LYS . 4.1 mt -64.96 -47.55 87.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-O 120.679 0.276 . . . . 0.0 110.712 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.3 -45.73 83.19 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.594 179.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -61.11 -23.97 65.9 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.556 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -74.63 -64.56 1.01 Allowed 'General case' 0 CA--C 1.528 0.103 0 CA-C-O 120.575 0.226 . . . . 0.0 111.285 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -103.27 -41.44 6.04 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 111.5 0.185 . . . . 0.0 111.5 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.48 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . 96.95 56.64 1.13 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.515 -0.85 . . . . 0.0 111.822 -179.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.609 HG23 ' O ' ' A' ' 36' ' ' ILE . 10.1 tt -78.44 108.92 8.82 Favored Pre-proline 0 CA--C 1.531 0.225 0 CA-C-O 120.622 0.249 . . . . 0.0 111.452 -179.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.48 ' HD3' ' O ' ' A' ' 35' ' ' GLY . 36.7 Cg_exo -60.8 -46.74 15.35 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.549 2.166 . . . . 0.0 113.036 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.457 ' HD2' ' N ' ' A' ' 37' ' ' PRO . 69.9 Cg_exo -40.72 104.88 0.05 OUTLIER 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.82 2.347 . . . . 0.0 113.287 -179.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.0 p-10 -69.12 -10.98 60.31 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.901 179.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.489 ' HG2' HD23 ' A' ' 73' ' ' LEU . 0.0 OUTLIER -90.79 22.31 3.64 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -179.622 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.851 ' OE1' HD21 ' A' ' 69' ' ' LEU . 0.6 OUTLIER -84.16 102.8 12.85 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 110.329 -0.249 . . . . 0.0 110.329 179.436 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.534 ' O ' HD13 ' A' ' 69' ' ' LEU . 0.9 OUTLIER -143.98 179.16 7.36 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-O 120.778 0.323 . . . . 0.0 111.41 -179.569 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.712 ' HB2' HD22 ' A' ' 67' ' ' LEU . 0.5 OUTLIER -108.16 141.64 39.58 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.871 179.828 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.604 HG23 ' O ' ' A' ' 44' ' ' ILE . 17.2 tt -111.05 75.39 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-O 120.766 0.317 . . . . 0.0 110.946 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -150.87 121.97 7.72 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.271 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 56.27 34.91 24.89 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.619 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 46.43 44.55 16.04 Favored Glycine 0 C--N 1.335 0.477 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.895 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.423 ' HE2' ' CD1' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -99.99 109.63 21.96 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.713 0.292 . . . . 0.0 110.904 -179.995 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -89.19 151.88 21.92 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.983 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.799 HD13 ' HE3' ' A' ' 27' ' ' LYS . 5.4 mt -79.24 -8.81 59.32 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.761 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -78.67 -41.47 31.18 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 122.334 -0.229 . . . . 0.0 111.108 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -47.8 114.83 0.98 Allowed 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 116.658 -0.246 . . . . 0.0 110.373 179.665 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -69.85 46.2 0.57 Allowed Glycine 0 CA--C 1.521 0.461 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.892 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.455 ' C ' HD12 ' A' ' 23' ' ' ILE . 5.0 mmp_? -107.3 177.23 4.91 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 117.128 0.464 . . . . 0.0 110.668 179.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 5.7 t -99.17 142.88 30.08 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.601 0.238 . . . . 0.0 110.436 179.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.65 ' HB3' HG23 ' A' ' 61' ' ' ILE . 84.0 mt -51.86 -43.11 63.1 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.715 0.293 . . . . 0.0 111.349 -179.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.8 t -54.55 -27.93 42.09 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -179.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -53.76 -40.91 66.61 Favored 'General case' 0 N--CA 1.465 0.318 0 O-C-N 122.259 -0.275 . . . . 0.0 111.548 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.423 ' CD1' ' HE2' ' A' ' 48' ' ' LYS . 33.8 m-85 -101.94 19.26 18.71 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 111.914 0.338 . . . . 0.0 111.914 -179.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 64.62 14.64 9.16 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.868 HD11 ' HG ' ' A' ' 67' ' ' LEU . 1.1 tp -90.0 62.16 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-O 120.841 0.353 . . . . 0.0 110.873 179.507 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 10.8 pm0 -95.26 -172.78 2.75 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.44 -179.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.412 ' HG2' ' CB ' ' A' ' 2' ' ' GLN . 0.1 OUTLIER -39.84 155.74 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.985 -179.444 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 65.3 16.01 10.31 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.806 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 17.7 p -76.32 145.94 39.21 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-O 120.561 0.219 . . . . 0.0 111.031 179.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 11.7 p -97.68 76.96 2.52 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 179.244 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.868 ' HG ' HD11 ' A' ' 61' ' ' ILE . 14.1 mt -99.94 131.77 45.7 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.832 0.348 . . . . 0.0 111.68 -179.176 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -107.2 139.84 41.0 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.25 179.214 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.851 HD21 ' OE1' ' A' ' 41' ' ' GLN . 0.1 OUTLIER -93.87 116.77 29.25 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.678 0.275 . . . . 0.0 110.858 -179.858 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.8 p -114.36 148.26 17.28 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.383 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -80.49 79.55 7.07 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.563 179.555 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.36 95.1 9.82 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.025 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.489 HD23 ' HG2' ' A' ' 40' ' ' GLN . 3.2 mt -80.14 -66.56 0.86 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.956 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -90.07 135.62 33.54 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.922 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -92.48 142.52 16.05 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.469 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.39 -1.228 . . . . 0.0 112.499 179.974 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.9 tpt . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.509 0.195 . . . . 0.0 110.945 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 64.5 mm-40 -84.49 -42.63 15.36 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.735 -0.211 . . . . 0.0 111.489 -179.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.822 HD12 HG23 ' A' ' 5' ' ' VAL . 1.1 pp -138.93 164.77 25.09 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 C-N-CA 120.711 -0.396 . . . . 0.0 111.672 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -129.07 111.93 13.48 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.873 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.822 HG23 HD12 ' A' ' 3' ' ' ILE . 39.0 t -111.4 155.11 12.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.893 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.712 ' O ' HD22 ' A' ' 69' ' ' LEU . 0.6 OUTLIER -106.56 165.5 11.24 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.673 0.273 . . . . 0.0 110.718 -179.89 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 66.7 p -109.82 -142.82 0.38 Allowed 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.647 -179.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.406 ' HG ' ' N ' ' A' ' 9' ' ' THR . 1.7 pt? -65.25 -38.57 90.75 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 118.615 0.643 . . . . 0.0 111.482 -179.316 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.406 ' N ' ' HG ' ' A' ' 8' ' ' LEU . 3.9 m -107.98 -60.55 1.7 Allowed 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.607 0.242 . . . . 0.0 110.894 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 165.56 53.32 0.02 OUTLIER Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.417 -0.897 . . . . 0.0 112.949 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.9 tttt -84.27 160.2 20.79 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.822 0.311 . . . . 0.0 110.675 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 26.8 p -94.91 104.68 16.57 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.876 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.641 HD11 ' HB ' ' A' ' 5' ' ' VAL . 25.3 pt -114.96 153.6 16.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-O 120.754 0.312 . . . . 0.0 111.172 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.1 p -106.07 149.89 26.29 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.935 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.751 ' HB2' HD11 ' A' ' 3' ' ' ILE . 0.3 OUTLIER -127.97 89.03 2.86 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-O 120.669 0.271 . . . . 0.0 111.264 179.954 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.13 94.91 6.22 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.766 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.492 HG11 HG12 ' A' ' 26' ' ' VAL . 29.8 m -129.94 174.12 13.13 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 CA-C-O 120.71 0.291 . . . . 0.0 111.288 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.06 160.06 27.53 Favored Pre-proline 0 C--O 1.231 0.13 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.107 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -55.44 -29.19 67.52 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.648 2.232 . . . . 0.0 112.839 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 42.0 t -78.78 -15.08 58.86 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 111.67 0.248 . . . . 0.0 111.67 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.441 ' OD2' HG12 ' A' ' 26' ' ' VAL . 1.5 t0 -64.94 122.0 15.96 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-O 120.674 0.273 . . . . 0.0 110.808 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.86 HG22 ' O ' ' A' ' 54' ' ' ARG . 0.3 OUTLIER -85.09 178.71 7.45 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.823 179.951 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.8 HG21 ' HB2' ' A' ' 50' ' ' LEU . 16.3 mt -68.17 -39.23 80.91 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.084 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -66.61 -41.25 88.7 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.658 -0.247 . . . . 0.0 111.069 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -62.96 -45.8 90.72 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.649 0.261 . . . . 0.0 111.004 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.494 HG22 ' O ' ' A' ' 23' ' ' ILE . 31.8 m -63.98 -29.7 48.01 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.524 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.498 ' HE2' HD11 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -55.62 -43.99 76.65 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.658 0.266 . . . . 0.0 110.807 -179.875 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.87 -33.07 74.02 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.046 179.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -63.9 -28.39 69.81 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.038 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.589 HD11 HD11 ' A' ' 15' ' ' LEU . 40.8 mm -75.25 -46.04 39.7 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.201 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.301 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -65.35 -40.52 93.71 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.91 178.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.27 -24.69 66.57 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.288 179.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.8 mmtm -74.78 -55.47 5.8 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.525 0.202 . . . . 0.0 111.295 -179.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -115.47 -49.77 2.74 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.618 0.247 . . . . 0.0 111.19 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 113.69 64.02 0.43 Allowed Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.679 -0.772 . . . . 0.0 111.851 -179.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.498 HD11 ' HE2' ' A' ' 27' ' ' LYS . 1.3 pp -77.89 111.59 19.07 Favored Pre-proline 0 CA--C 1.531 0.223 0 CA-C-O 120.634 0.254 . . . . 0.0 111.347 -179.296 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.562 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 31.5 Cg_exo -59.34 -43.61 39.47 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.683 2.255 . . . . 0.0 113.444 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.562 ' HD2' ' N ' ' A' ' 37' ' ' PRO . 54.9 Cg_endo -71.86 111.25 3.11 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.06 1.84 . . . . 0.0 112.755 -179.23 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -68.69 -13.61 62.48 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.055 -0.52 . . . . 0.0 112.098 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -91.08 21.9 4.02 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.454 0.538 . . . . 0.0 112.454 -179.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -93.11 97.77 10.89 Favored 'General case' 0 C--O 1.23 0.067 0 O-C-N 122.249 -0.282 . . . . 0.0 110.289 179.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.522 ' CG ' HD11 ' A' ' 50' ' ' LEU . 22.0 mtm180 -137.68 -175.82 4.21 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-O 120.715 0.293 . . . . 0.0 111.043 -179.451 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.633 HD22 HD22 ' A' ' 67' ' ' LEU . 1.1 pp -101.59 141.52 34.33 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.944 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.565 HG23 ' O ' ' A' ' 44' ' ' ILE . 20.3 tt -111.17 113.91 45.61 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.239 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -152.52 130.96 12.14 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.797 0.332 . . . . 0.0 111.306 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.82 28.87 13.04 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.776 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 45.07 48.15 9.86 Favored Glycine 0 C--N 1.336 0.543 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.903 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.444 ' HG2' ' CD1' ' A' ' 59' ' ' TYR . 12.4 mptt -99.88 140.75 33.64 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.764 0.282 . . . . 0.0 110.942 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.15 99.62 12.57 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.885 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.8 ' HB2' HG21 ' A' ' 23' ' ' ILE . 0.5 OUTLIER -79.27 -8.05 58.75 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.838 179.861 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -78.57 -30.45 46.77 Favored 'General case' 0 CA--C 1.53 0.21 0 O-C-N 122.346 -0.221 . . . . 0.0 111.29 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -45.43 -39.23 6.85 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.567 0.222 . . . . 0.0 111.3 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 105.16 49.32 1.0 Allowed Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.745 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.86 ' O ' HG22 ' A' ' 22' ' ' THR . 0.0 OUTLIER -107.3 -179.11 3.83 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.724 0.262 . . . . 0.0 110.698 179.801 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 10.6 m -99.08 140.72 32.81 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.643 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.617 ' O ' HG22 ' A' ' 61' ' ' ILE . 3.0 mp -51.77 -48.23 63.82 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.824 0.345 . . . . 0.0 110.833 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.5 t -55.31 -36.99 66.81 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.24 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -54.27 -35.69 62.81 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 111.505 0.187 . . . . 0.0 111.505 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.444 ' CD1' ' HG2' ' A' ' 48' ' ' LYS . 68.7 m-85 -100.09 21.26 13.09 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.3 m120 65.59 8.67 5.29 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 112.791 0.664 . . . . 0.0 112.791 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.706 HD11 ' CD2' ' A' ' 67' ' ' LEU . 1.2 tt -90.14 63.13 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-O 120.883 0.373 . . . . 0.0 110.666 179.321 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -94.57 -173.52 3.05 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.245 -179.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.416 ' O ' ' HG2' ' A' ' 64' ' ' GLU . 0.1 OUTLIER -39.96 147.68 0.09 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.727 -179.593 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.416 ' HG2' ' O ' ' A' ' 63' ' ' LYS . 0.7 OUTLIER 65.53 15.02 9.83 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.992 -179.747 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.5 m -76.23 174.2 10.43 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.754 0.312 . . . . 0.0 110.839 179.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.524 ' O ' HG23 ' A' ' 66' ' ' THR . 5.9 t -107.24 90.65 3.37 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.248 179.437 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.753 HD13 HD13 ' A' ' 3' ' ' ILE . 1.2 mt -98.9 113.86 26.19 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.747 0.308 . . . . 0.0 111.39 -179.376 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -107.22 120.93 43.47 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.385 179.361 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.712 HD22 ' O ' ' A' ' 6' ' ' LYS . 0.9 OUTLIER -93.76 156.45 16.67 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.713 0.292 . . . . 0.0 111.155 -179.648 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -104.07 166.22 3.08 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.747 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.3 mp -76.71 141.88 40.72 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.677 0.275 . . . . 0.0 110.751 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.13 106.56 15.03 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.062 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 7.3 mt -80.18 -42.53 23.2 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.84 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.05 133.1 35.42 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.671 0.272 . . . . 0.0 110.872 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 133.2 103.91 0.86 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.497 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.115 0 CA-C-O 118.395 -1.225 . . . . 0.0 112.5 179.997 . . . . . . . . 0 0 . 1 stop_ save_